Clustering O 0 0.027559449896216393
of O 0 0.011267474852502346
missense O 0 0.02310957945883274
mutations O 0 0.007017640862613916
in O 0 0.0032743471674621105
the O 0 0.2009386122226715
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999959468841553
telangiectasia I-Disease 1 0.9999994039535522
gene O 0 0.005900464951992035
in O 0 0.0021960875019431114
a O 0 0.005573438946157694
sporadic B-Disease 1 0.9793654680252075
T I-Disease 1 0.9999862909317017
- I-Disease 1 0.9969737529754639
cell I-Disease 1 0.8717058897018433
leukaemia I-Disease 1 0.9999679327011108
. O 0 0.018398012965917587

Ataxia B-Disease 1 0.9999934434890747
- I-Disease 1 0.9988228678703308
telangiectasia I-Disease 1 0.9999926090240479
( O 0 0.21898773312568665
A B-Disease 1 0.9919782876968384
- I-Disease 1 0.9988023042678833
T I-Disease 1 0.9966909885406494
) O 0 0.0018473987001925707
is O 0 0.001600176328793168
a O 0 0.0029286593198776245
recessive B-Disease 1 0.9670682549476624
multi I-Disease 1 0.9998098015785217
- I-Disease 1 0.999958872795105
system I-Disease 1 0.9957786798477173
disorder I-Disease 1 0.9999991655349731
caused O 1 0.9841222763061523
by O 0 0.002461475320160389
mutations O 0 0.002929041162133217
in O 0 0.001499699312262237
the O 0 0.00258741807192564
ATM O 0 0.0077156787738204
gene O 0 0.0024353736080229282
at O 0 0.0027456290554255247
11q22 O 0 0.02594938687980175
- O 0 0.012344044633209705
q23 O 0 0.07892812043428421
( O 0 0.005549822002649307
ref O 0 0.019195016473531723
. O 0 0.0035766775254160166
3 O 0 0.006046217866241932
) O 0 0.006412283051759005
. O 0 0.009906581602990627

The O 0 0.011929537169635296
risk O 0 0.08069318532943726
of O 0 0.3326864242553711
cancer B-Disease 1 0.9999992847442627
, O 0 0.07079743593931198
especially O 0 0.361476331949234
lymphoid B-Disease 1 0.9999884366989136
neoplasias I-Disease 1 0.9973888993263245
, O 0 0.002362182131037116
is O 0 0.0022135337349027395
substantially O 0 0.003978640306740999
elevated O 1 0.7466040849685669
in O 0 0.0023545543663203716
A B-Disease 1 0.9998626708984375
- I-Disease 1 0.9999982118606567
T I-Disease 1 0.9999992847442627
patients O 1 0.8977775573730469
and O 0 0.001454068347811699
has O 0 0.0017751033883541822
long O 0 0.0024136709980666637
been O 0 0.0019910004921257496
associated O 0 0.0036245910450816154
with O 0 0.00502961128950119
chromosomal O 1 0.9997424483299255
instability O 1 0.9999306201934814
. O 0 0.02710607275366783

By O 0 0.010163861326873302
analysing O 0 0.4178612232208252
tumour B-Disease 1 0.9999910593032837
DNA O 0 0.007806040812283754
from O 0 0.002706931671127677
patients O 0 0.022799629718065262
with O 0 0.0020659391302615404
sporadic B-Disease 1 0.653789758682251
T I-Disease 1 0.9990680813789368
- I-Disease 0 0.3278026878833771
cell I-Disease 0 0.04882660508155823
prolymphocytic I-Disease 1 0.9983693957328796
leukaemia I-Disease 1 0.999997615814209
( O 0 0.22447924315929413
T B-Disease 1 0.9995360374450684
- I-Disease 1 0.8084943294525146
PLL I-Disease 1 0.99946528673172
) O 0 0.0023992834612727165
, O 0 0.0013861621264368296
a O 0 0.0020548265893012285
rare O 0 0.005771568976342678
clonal B-Disease 1 0.9671956896781921
malignancy I-Disease 1 0.9994993209838867
with O 0 0.0016042129136621952
similarities O 0 0.002770595019683242
to O 0 0.0014624141622334719
a O 0 0.0031998627819120884
mature B-Disease 0 0.1401384472846985
T I-Disease 1 0.9978534579277039
- I-Disease 0 0.34757691621780396
cell I-Disease 0 0.026079414412379265
leukaemia I-Disease 1 0.9996036887168884
seen O 0 0.003113633021712303
in O 0 0.0024245623499155045
A B-Disease 1 0.9910863041877747
- I-Disease 1 0.999784529209137
T I-Disease 1 0.9993380904197693
, O 0 0.0015240621287375689
we O 0 0.0010364910122007132
demonstrate O 0 0.0019309446215629578
a O 0 0.0015729458536952734
high O 0 0.0027074632234871387
frequency O 0 0.002107027219608426
of O 0 0.0022122294176369905
ATM O 0 0.011195103637874126
mutations O 0 0.00547410873696208
in O 0 0.005832117050886154
T B-Disease 1 0.9981194138526917
- I-Disease 1 0.5239229798316956
PLL I-Disease 1 0.9920794367790222
. O 0 0.018392838537693024

In O 0 0.008049075491726398
marked O 0 0.009790318086743355
contrast O 0 0.005353453569114208
to O 0 0.00215026643127203
the O 0 0.0031439699232578278
ATM O 0 0.016978083178400993
mutation O 0 0.00479132728651166
pattern O 0 0.004126377869397402
in O 0 0.0026811487041413784
A B-Disease 1 0.9958294034004211
- I-Disease 1 0.9990777969360352
T I-Disease 1 0.9981356859207153
, O 0 0.0016071557765826583
the O 0 0.001337067922577262
most O 0 0.0010890160920098424
frequent O 0 0.0024457008112221956
nucleotide O 0 0.0027321982197463512
changes O 0 0.0012946970527991652
in O 0 0.0015205380041152239
this O 0 0.0029387606773525476
leukaemia B-Disease 1 0.9999337196350098
were O 0 0.00636172853410244
missense O 0 0.4107377827167511
mutations O 0 0.017420073971152306
. O 0 0.011759619228541851

These O 0 0.005855215713381767
clustered O 0 0.010028082877397537
in O 0 0.003039604751393199
the O 0 0.002740189665928483
region O 0 0.003123791189864278
corresponding O 0 0.002665990497916937
to O 0 0.0012796290684491396
the O 0 0.0020154209341853857
kinase O 0 0.004536984488368034
domain O 0 0.0018749276641756296
, O 0 0.0010586506687104702
which O 0 0.0007338081486523151
is O 0 0.001021861331537366
highly O 0 0.0016296361573040485
conserved O 0 0.002016571117565036
in O 0 0.0016888316022232175
ATM O 0 0.01218483131378889
- O 0 0.0043175239115953445
related O 0 0.0023415435571223497
proteins O 0 0.0018985801143571734
in O 0 0.002046695677563548
mouse O 0 0.0067460183054208755
, O 0 0.00413435697555542
yeast O 0 0.01176344882696867
and O 0 0.00637182779610157
Drosophila O 0 0.028866294771432877
. O 0 0.014450201764702797

The O 0 0.012213976122438908
resulting O 0 0.013215233571827412
amino O 0 0.011446776799857616
- O 0 0.019188279286026955
acid O 0 0.007344304118305445
substitutions O 0 0.004806318785995245
are O 0 0.001468332251533866
predicted O 0 0.004023992922157049
to O 0 0.0017783510265871882
interfere O 0 0.00398592371493578
with O 0 0.002419860102236271
ATP O 1 0.5074313282966614
binding O 0 0.004681398160755634
or O 0 0.004499733913689852
substrate O 0 0.013610306195914745
recognition O 0 0.012831386178731918
. O 0 0.012812321074306965

Two O 0 0.006679809186607599
of O 0 0.007035883143544197
seventeen O 0 0.027433276176452637
mutated O 1 0.909997284412384
T B-Disease 1 0.9946065545082092
- I-Disease 0 0.07536518573760986
PLL I-Disease 1 0.9146137833595276
samples O 0 0.003133743768557906
had O 0 0.0018974057165905833
a O 0 0.0019853953272104263
previously O 0 0.0031244505662471056
reported O 0 0.006198539864271879
A B-Disease 1 0.9726352095603943
- I-Disease 1 0.9984896183013916
T I-Disease 1 0.9994775652885437
allele O 0 0.021355638280510902
. O 0 0.011118163354694843

In O 0 0.006955833174288273
contrast O 0 0.00711109908297658
, O 0 0.0028950897976756096
no O 0 0.002025685040280223
mutations O 0 0.002503101248294115
were O 0 0.0013060644268989563
detected O 0 0.00279041170142591
in O 0 0.0013253857614472508
the O 0 0.002642914419993758
p53 O 0 0.006255455780774355
gene O 0 0.002427097177132964
, O 0 0.001622565439902246
suggesting O 0 0.0028647941071540117
that O 0 0.0017622311133891344
this O 0 0.003719744738191366
tumour B-Disease 1 0.9999995231628418
suppressor O 1 0.953883171081543
is O 0 0.002404493745416403
not O 0 0.0013163884868845344
frequently O 0 0.002326737158000469
altered O 0 0.004075400531291962
in O 0 0.003930862061679363
this O 0 0.006994356866925955
leukaemia B-Disease 1 0.9998990297317505
. O 0 0.018230831250548363

Occasional O 0 0.03210211172699928
missense O 0 0.04434454068541527
mutations O 0 0.009145129472017288
in O 0 0.0034648783039301634
ATM O 0 0.011094408109784126
were O 0 0.0021531847305595875
also O 0 0.0017536942614242435
found O 0 0.0020006715785712004
in O 0 0.002522614086046815
tumour B-Disease 1 0.9999934434890747
DNA O 0 0.003383371513336897
from O 0 0.0015940602170303464
patients O 0 0.0059322332963347435
with O 0 0.0015194916632026434
B B-Disease 1 0.5791900753974915
- I-Disease 0 0.02156541682779789
cell I-Disease 0 0.005565383937209845
non I-Disease 0 0.05015813931822777
- I-Disease 1 0.9966805577278137
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999791383743286
( O 0 0.014016074128448963
B B-Disease 1 0.5260776281356812
- I-Disease 0 0.005957355257123709
NHL I-Disease 0 0.0048154848627746105
) O 0 0.00137536961119622
and O 0 0.0013003622880205512
a O 0 0.003377723041921854
B B-Disease 0 0.24800819158554077
- I-Disease 0 0.02108389511704445
NHL I-Disease 0 0.021147774532437325
cell O 0 0.011361360549926758
line O 0 0.012453019618988037
. O 0 0.012072782963514328

The O 0 0.008838645182549953
evidence O 0 0.004904497880488634
of O 0 0.0030840381514281034
a O 0 0.0029679888393729925
significant O 0 0.002595988567918539
proportion O 0 0.003431090619415045
of O 0 0.0026864835526794195
loss O 1 0.921335756778717
- O 0 0.31608501076698303
of O 0 0.014069763943552971
- O 1 0.6066322922706604
function O 0 0.0026118871755898
mutations O 0 0.002122049918398261
and O 0 0.000941831327509135
a O 0 0.0015651502180844545
complete O 0 0.002315201098099351
absence O 0 0.0032918385695666075
of O 0 0.0020882824901491404
the O 0 0.002422463148832321
normal O 0 0.0028627582360059023
copy O 0 0.0028323112055659294
of O 0 0.0014476451324298978
ATM O 0 0.004336872603744268
in O 0 0.0011470108292996883
the O 0 0.001542767626233399
majority O 0 0.002056088764220476
of O 0 0.003437667153775692
mutated O 1 0.8521052598953247
tumours B-Disease 1 0.9999538660049438
establishes O 1 0.7101966142654419
somatic O 0 0.24954231083393097
inactivation O 0 0.25297117233276367
of O 0 0.00271395780146122
this O 0 0.0014556145761162043
gene O 0 0.0016686065355315804
in O 0 0.0010916811879724264
the O 0 0.002073905663564801
pathogenesis O 1 0.9674926400184631
of O 0 0.0061123063787817955
sporadic B-Disease 1 0.9910699129104614
T I-Disease 1 0.9999105930328369
- I-Disease 1 0.9098312854766846
PLL I-Disease 1 0.9966592788696289
and O 0 0.002099685138091445
suggests O 0 0.0032270457595586777
that O 0 0.0015227390686050057
ATM O 0 0.006689738016575575
acts O 0 0.0033883964642882347
as O 0 0.0037564095109701157
a O 0 0.023828430101275444
tumour B-Disease 1 0.999998927116394
suppressor O 1 0.99774569272995
. O 0 0.018968885764479637

As O 0 0.009199725463986397
constitutional O 0 0.009989812038838863
DNA O 0 0.00637395353987813
was O 0 0.00403508311137557
not O 0 0.00115266814827919
available O 0 0.0010962606174871325
, O 0 0.0014061834663152695
a O 0 0.0026160816196352243
putative O 0 0.0660160630941391
hereditary O 1 0.9992408752441406
predisposition O 1 0.9997871518135071
to O 0 0.020017266273498535
T B-Disease 1 0.9999769926071167
- I-Disease 1 0.9822392463684082
PLL I-Disease 1 0.9977931976318359
will O 0 0.002074799733236432
require O 0 0.0021779246162623167
further O 0 0.002415446564555168
investigation O 0 0.005975371692329645
. O 0 0.005108017008751631
. O 0 0.00898069143295288

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
protein O 0 0.2666488289833069
kinase O 0 0.02093716710805893
is O 0 0.003470200812444091
involved O 0 0.0023712171241641045
in O 0 0.0019974408205598593
the O 0 0.002514901338145137
modulation O 0 0.0050378222949802876
of O 0 0.00273307622410357
the O 0 0.008231628686189651
Ca2 O 1 0.9757177233695984
+ O 0 0.0706622302532196
homeostasis O 1 0.701758861541748
in O 0 0.008947079069912434
skeletal O 1 0.9999955892562866
muscle O 1 0.9999449253082275
cells O 0 0.20191076397895813
. O 0 0.012339598499238491

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9999091625213623
DM B-Disease 1 1.0
) O 0 0.005483449436724186
, O 0 0.0020013379398733377
the O 0 0.002245385432615876
most O 0 0.002670538378879428
prevalent O 1 0.9997279047966003
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.6091995239257812
adults O 0 0.17006173729896545
, O 0 0.001891707070171833
is O 0 0.0015343043487519026
caused O 0 0.005826123990118504
by O 0 0.0013382757315412164
( O 0 0.003912730608135462
CTG O 1 0.9870644807815552
) O 0 0.00238058902323246
n O 0 0.004153385292738676
- O 0 0.003993527963757515
repeat O 0 0.00393662229180336
expansion O 0 0.002355183707550168
in O 0 0.0013585102278739214
a O 0 0.002000414300709963
gene O 0 0.002521723974496126
encoding O 0 0.0026085565332323313
a O 0 0.0024251264985650778
protein O 0 0.004572049714624882
kinase O 0 0.008292978629469872
( O 0 0.006368936505168676
DM B-Disease 1 0.9996629953384399
protein O 0 0.005258083343505859
kinase O 0 0.00657868105918169
; O 0 0.00245276209898293
DMPK O 0 0.21764573454856873
) O 0 0.0019804281182587147
and O 0 0.0013971286825835705
involves O 0 0.002926786197349429
changes O 0 0.00243163900449872
in O 0 0.003376798238605261
cytoarchitecture O 1 0.9159603118896484
and O 0 0.0091761015355587
ion O 1 0.8416337966918945
homeostasis O 1 0.9397220015525818
. O 0 0.015185638330876827

To O 0 0.005899256560951471
obtain O 0 0.005642293486744165
clues O 0 0.004967705812305212
to O 0 0.0020740781910717487
the O 0 0.0023922838736325502
normal O 0 0.002742304466664791
biological O 0 0.002742252079769969
role O 0 0.0026222537271678448
of O 0 0.002810498932376504
DMPK O 1 0.9989798665046692
in O 0 0.003225523279979825
cellular O 0 0.0182131789624691
ion O 0 0.36161020398139954
homeostasis O 1 0.5147155523300171
, O 0 0.0014716526493430138
we O 0 0.0009544083732180297
have O 0 0.0008046462316997349
compared O 0 0.0017664115875959396
the O 0 0.002120910445228219
resting O 1 0.570999026298523
[ O 0 0.06099431961774826
Ca2 O 0 0.10970859229564667
+ O 0 0.008304853923618793
] O 0 0.004528687801212072
i O 0 0.002050187438726425
, O 0 0.0014086937298998237
the O 0 0.0016542625380679965
amplitude O 0 0.003288526786491275
and O 0 0.001396438805386424
shape O 0 0.003908803220838308
of O 0 0.004847691394388676
depolarization O 1 0.9994474053382874
- O 1 0.9997350573539734
induced O 1 0.9999676942825317
Ca2 O 1 0.991439938545227
+ O 0 0.011370141990482807
transients O 0 0.007852982729673386
, O 0 0.0016839884920045733
and O 0 0.0011603942839428782
the O 0 0.0015113104600459337
content O 0 0.0013334257528185844
of O 0 0.0021656807512044907
ATP O 1 0.9213950634002686
- O 0 0.028528084978461266
driven O 0 0.006292298901826143
ion O 0 0.009760500863194466
pumps O 0 0.008834348991513252
in O 0 0.003089374862611294
cultured O 0 0.4534142017364502
skeletal O 1 0.9993076324462891
muscle O 1 0.7801589369773865
cells O 0 0.002374345902353525
of O 0 0.002139406045898795
wild O 0 0.005340175237506628
- O 0 0.016982728615403175
type O 0 0.004601685330271721
and O 0 0.0023947181180119514
DMPK O 1 0.9888768792152405
[ O 0 0.06019781529903412
- O 1 0.554838240146637
/ O 1 0.8651926517486572
- O 0 0.09892158955335617
] O 0 0.020089877769351006
knockout O 0 0.08775654435157776
mice O 0 0.025121351704001427
. O 0 0.014087514951825142

In O 0 0.010447925888001919
vitro O 0 0.026615669950842857
- O 0 0.08869672566652298
differentiated O 0 0.11176677793264389
DMPK O 1 0.9984240531921387
[ O 0 0.21394073963165283
- O 1 0.6157135963439941
/ O 1 0.6480120420455933
- O 0 0.027795247733592987
] O 0 0.007977202534675598
myotubes O 0 0.01051240786910057
exhibit O 0 0.004152533132582903
a O 0 0.0030586207285523415
higher O 0 0.0044695851393043995
resting O 1 0.5759016871452332
[ O 0 0.016804993152618408
Ca2 O 0 0.039460912346839905
+ O 0 0.009148458018898964
] O 0 0.004799379035830498
i O 0 0.002347769448533654
than O 0 0.001044933800585568
do O 0 0.0012810498010367155
wild O 0 0.003417626488953829
- O 0 0.0068403263576328754
type O 0 0.006755594629794359
myotubes O 0 0.014280825853347778
because O 0 0.0015563240740448236
of O 0 0.0014157978584989905
an O 0 0.001482937135733664
altered O 0 0.002505345270037651
open O 0 0.00158033799380064
probability O 0 0.0018002454889938235
of O 0 0.0019988692365586758
voltage O 0 0.007127291057258844
- O 0 0.01163418311625719
dependent O 0 0.005974323954433203
l O 0 0.1355677843093872
- O 0 0.018989495933055878
type O 0 0.01605154387652874
Ca2 O 0 0.06421420723199844
+ O 0 0.01082628034055233
and O 0 0.004517059773206711
Na O 1 0.9773373603820801
+ O 0 0.018216578289866447
channels O 0 0.010944298468530178
. O 0 0.011596010997891426

The O 0 0.018854843452572823
mutant O 0 0.03868843987584114
myotubes O 0 0.24349528551101685
exhibit O 0 0.010278420522809029
smaller O 0 0.004547792952507734
and O 0 0.003800982376560569
slower O 0 0.009635621681809425
Ca2 O 0 0.016726789996027946
+ O 0 0.0052954815328121185
responses O 0 0.002946543740108609
upon O 0 0.002798480214551091
triggering O 0 0.007017501629889011
by O 0 0.0029903356917202473
acetylcholine O 0 0.11112166196107864
or O 0 0.003912637475878
high O 0 0.011127164587378502
external O 0 0.025368789210915565
K O 0 0.417600154876709
+ O 0 0.024312425404787064
. O 0 0.012178909033536911

In O 0 0.006915624253451824
addition O 0 0.004782883450388908
, O 0 0.0025483802892267704
we O 0 0.0016676870873197913
observed O 0 0.002119780285283923
that O 0 0.0012104829074814916
these O 0 0.0015342208789661527
Ca2 O 0 0.02333579584956169
+ O 0 0.009864362888038158
transients O 0 0.015710873529314995
partially O 0 0.005302734673023224
result O 0 0.0021007084287703037
from O 0 0.001691043027676642
an O 0 0.0019516419852152467
influx O 0 0.006600140128284693
of O 0 0.0040233260951936245
extracellular O 0 0.06971882283687592
Ca2 O 0 0.02533876523375511
+ O 0 0.005015383940190077
through O 0 0.0019743142183870077
the O 0 0.00430100504308939
l O 1 0.6590643525123596
- O 0 0.12554198503494263
type O 0 0.1142151802778244
Ca2 O 0 0.08700386434793472
+ O 0 0.021314427256584167
channel O 0 0.017206575721502304
. O 0 0.01387332659214735

Neither O 0 0.015437331981956959
the O 0 0.005822992417961359
content O 0 0.0043576364405453205
nor O 0 0.0041864244267344475
the O 0 0.0031807911582291126
activity O 0 0.004143830388784409
of O 0 0.006775200366973877
Na O 1 0.9999568462371826
+ O 1 0.5596332550048828
/ O 0 0.19883225858211517
K O 0 0.03489476069808006
+ O 0 0.01500563882291317
ATPase O 0 0.029429323971271515
and O 0 0.006524458061903715
sarcoplasmic O 1 0.9997922778129578
reticulum O 1 0.9993171691894531
Ca2 O 1 0.9899721145629883
+ O 0 0.18821677565574646
- O 0 0.015796108171343803
ATPase O 0 0.01858450286090374
are O 0 0.0023911662865430117
affected O 0 0.004565617069602013
by O 0 0.004607818089425564
DMPK O 1 0.9859848022460938
absence O 0 0.15355534851551056
. O 0 0.014974907040596008

In O 0 0.009813264012336731
conclusion O 0 0.008017430081963539
, O 0 0.0030482434667646885
our O 0 0.002398635493591428
data O 0 0.0022728743497282267
suggest O 0 0.0028875155840069056
that O 0 0.0021004604641348124
DMPK O 0 0.12975387275218964
is O 0 0.0022162452805787325
involved O 0 0.0020100942347198725
in O 0 0.0020830342546105385
modulating O 0 0.0062288036569952965
the O 0 0.002036238322034478
initial O 0 0.0028618169017136097
events O 0 0.0019837210420519114
of O 0 0.0028357692062854767
excitation O 0 0.07984879612922668
- O 1 0.555374264717102
contraction O 1 0.6765344738960266
coupling O 0 0.03197367116808891
in O 0 0.007780794054269791
skeletal O 1 0.9999788999557495
muscle O 1 0.9993064403533936
. O 0 0.008857806213200092
. O 0 0.01139826886355877

Constitutional O 0 0.058114390820264816
RB1 O 1 0.9998613595962524
- O 1 0.5895905494689941
gene O 0 0.00936849880963564
mutations O 0 0.006310838274657726
in O 0 0.0036737516056746244
patients O 1 0.7388771176338196
with O 0 0.006017201114445925
isolated O 1 0.8725935220718384
unilateral B-Disease 1 0.9223889112472534
retinoblastoma I-Disease 1 0.9999024868011475
. O 0 0.019298501312732697

In O 0 0.00748924957588315
most O 0 0.004267980810254812
patients O 0 0.05956472456455231
with O 0 0.0029131348710507154
isolated O 1 0.7643911242485046
unilateral B-Disease 1 0.9946725964546204
retinoblastoma I-Disease 1 0.9999991655349731
, O 1 0.8927832245826721
tumor B-Disease 1 0.9999938011169434
development O 0 0.012667948380112648
is O 0 0.002445182064548135
initiated O 0 0.006622948683798313
by O 0 0.0020470854360610247
somatic O 0 0.010353839956223965
inactivation O 0 0.023025808855891228
of O 0 0.002498326590284705
both O 0 0.0018188582034781575
alleles O 0 0.004852950572967529
of O 0 0.004146960098296404
the O 0 0.1621779054403305
RB1 O 1 0.9999370574951172
gene O 0 0.01701861247420311
. O 0 0.012225095182657242

However O 0 0.007330804131925106
, O 0 0.003948361147195101
some O 0 0.0019316172692924738
of O 0 0.0026354240253567696
these O 0 0.002760068979114294
patients O 1 0.9893506169319153
can O 0 0.003921411465853453
transmit O 0 0.052575185894966125
retinoblastoma B-Disease 1 0.993889331817627
predisposition O 1 0.610817015171051
to O 0 0.004750298336148262
their O 0 0.005409936420619488
offspring O 0 0.017213454470038414
. O 0 0.011900367215275764

To O 0 0.005574974697083235
determine O 0 0.004356704652309418
the O 0 0.0026773058343678713
frequency O 0 0.002069989452138543
and O 0 0.0011477743973955512
nature O 0 0.0019196484936401248
of O 0 0.0024706057738512754
constitutional O 0 0.061679065227508545
RB1 O 1 0.9999926090240479
- O 1 0.5002079606056213
gene O 0 0.004087753593921661
mutations O 0 0.002569098025560379
in O 0 0.0017587031470611691
patients O 0 0.031308822333812714
with O 0 0.0017344960942864418
isolated O 0 0.0518675297498703
unilateral B-Disease 0 0.06911759823560715
retinoblastoma I-Disease 1 0.9521287083625793
, O 0 0.0017761581111699343
we O 0 0.0013129214057698846
analyzed O 0 0.0023914624471217394
DNA O 0 0.0027460206765681505
from O 0 0.002508302219212055
peripheral O 1 0.9881721138954163
blood O 1 0.8366730809211731
and O 0 0.010126817040145397
from O 0 0.45136070251464844
tumor B-Disease 1 0.9999990463256836
tissue O 1 0.9993919134140015
. O 0 0.013836945407092571

The O 0 0.009483903646469116
analysis O 0 0.005791017320007086
of O 0 0.005186218302696943
tumors B-Disease 1 0.996141254901886
from O 0 0.003188396105542779
54 O 0 0.00603228947147727
( O 0 0.002661065896973014
71 O 0 0.004103484563529491
% O 0 0.001644787611439824
) O 0 0.0012748093577101827
of O 0 0.0015375246293842793
76 O 0 0.006703104358166456
informative O 0 0.00684118177741766
patients O 0 0.029741963371634483
showed O 0 0.0043157367035746574
loss O 0 0.005579211749136448
of O 0 0.00401530135422945
constitutional O 0 0.06253434717655182
heterozygosity O 1 0.9999066591262817
( O 0 0.37481287121772766
LOH O 1 0.999987006187439
) O 0 0.006829929072409868
at O 0 0.009766455739736557
intragenic O 1 0.5344544053077698
loci O 0 0.03661482781171799
. O 0 0.01574622094631195

Three O 0 0.007492514327168465
of O 0 0.008376682177186012
13 O 0 0.016136687248945236
uninformative O 1 0.9972314238548279
patients O 1 0.898669421672821
had O 0 0.012369317933917046
constitutional O 0 0.021687621250748634
deletions O 0 0.2513425052165985
. O 0 0.01561996340751648

For O 0 0.008007261902093887
39 O 0 0.01006583496928215
randomly O 0 0.006686748005449772
selected O 0 0.006453046575188637
tumors B-Disease 1 0.934971272945404
, O 0 0.005077540874481201
SSCP O 1 0.9850068688392639
, O 0 0.006934637203812599
hetero O 1 0.9948223829269409
- O 0 0.06435876339673996
duplex O 0 0.026778599247336388
analysis O 0 0.0027936086989939213
, O 0 0.002074155258014798
sequencing O 0 0.00392615282908082
, O 0 0.0018602862255647779
and O 0 0.0015447682235389948
Southern O 0 0.0037015387788414955
blot O 0 0.01075400598347187
analysis O 0 0.0025830150116235018
were O 0 0.001890529878437519
used O 0 0.0020504919812083244
to O 0 0.002712265122681856
identify O 0 0.007877354510128498
mutations O 0 0.012352239340543747
. O 0 0.012751981616020203

Mutations O 0 0.01406047958880663
were O 0 0.0051861051470041275
detected O 0 0.0067340536043047905
in O 0 0.0028290622867643833
21 O 0 0.003812095383182168
( O 0 0.0030775193590670824
91 O 0 0.0046013155952095985
% O 0 0.002199693350121379
) O 0 0.0018208641558885574
of O 0 0.0030555918347090483
23 O 0 0.029988454654812813
tumors B-Disease 1 0.9999837875366211
with O 0 0.11363852024078369
LOH O 1 0.9999992847442627
. O 0 0.023579351603984833

In O 0 0.007746485527604818
6 O 0 0.006782224867492914
( O 0 0.0037335483357310295
38 O 0 0.003694297280162573
% O 0 0.0020215874537825584
) O 0 0.0014636359410360456
of O 0 0.0017367242835462093
16 O 0 0.005517810117453337
tumors B-Disease 1 0.9999229907989502
without O 0 0.005173416808247566
LOH O 1 0.9999991655349731
, O 0 0.002195863053202629
one O 0 0.0016551559092476964
mutation O 0 0.003077354282140732
was O 0 0.0025452501140534878
detected O 0 0.0024060155265033245
, O 0 0.0009263839456252754
and O 0 0.0007508046110160649
in O 0 0.0009472024976275861
9 O 0 0.001752457581460476
( O 0 0.0012440065620467067
56 O 0 0.0016607026336714625
% O 0 0.0011393027380108833
) O 0 0.0009331880137324333
of O 0 0.0013355686096474528
the O 0 0.008350063115358353
tumors B-Disease 1 0.9999978542327881
without O 0 0.045615170150995255
LOH O 1 0.9999990463256836
, O 0 0.00369410403072834
both O 0 0.0021830673795193434
mutations O 0 0.004403081722557545
were O 0 0.0034774804953485727
found O 0 0.007183404639363289
. O 0 0.009636408649384975

Thus O 0 0.009329053573310375
, O 0 0.004390001762658358
a O 0 0.002866828814148903
total O 0 0.002386105712503195
of O 0 0.0022622246760874987
45 O 0 0.0028810754884034395
mutations O 0 0.002236655680462718
were O 0 0.001513361930847168
identified O 0 0.0026823370717465878
in O 0 0.0026045844424515963
tumors B-Disease 1 0.9915822148323059
of O 0 0.030557457357645035
36 O 0 0.44892004132270813
patients O 1 0.9959656000137329
. O 0 0.013141848146915436

Thirty O 0 0.021570712327957153
- O 0 0.009881758131086826
nine O 0 0.0037166872061789036
of O 0 0.002835392951965332
the O 0 0.0031666879076510668
mutations O 0 0.003996444400399923
- O 0 0.0032913661561906338
including O 0 0.0013884479412809014
34 O 0 0.0025045471265912056
small O 0 0.0015946523053571582
mutations O 0 0.0022281308192759752
, O 0 0.0014247515937313437
2 O 0 0.0021470175124704838
large O 0 0.002183640841394663
structural O 0 0.23394306004047394
alterations O 0 0.007274741772562265
, O 0 0.001995436381548643
and O 0 0.002036609221249819
hypermethylation O 1 0.9347109198570251
in O 0 0.003106486750766635
3 O 0 0.03466622531414032
tumors O 1 0.9999111890792847
- O 0 0.006419164128601551
were O 0 0.001382932299748063
not O 0 0.0009514581179246306
detected O 0 0.0020763089414685965
in O 0 0.0011674200650304556
the O 0 0.003043303033336997
corresponding O 0 0.026381390169262886
peripheral O 1 0.9996836185455322
blood O 1 0.9840553998947144
DNA O 0 0.016968805342912674
. O 0 0.012525973841547966

In O 0 0.0069496408104896545
6 O 0 0.0073240092024207115
( O 0 0.003473229706287384
17 O 0 0.0028862690087407827
% O 0 0.0017148578772321343
) O 0 0.0010945157846435905
of O 0 0.0010285204043611884
the O 0 0.0015909743960946798
36 O 0 0.002845902694389224
patients O 0 0.04553576558828354
, O 0 0.0013364867772907019
a O 0 0.0017862831009551883
mutation O 0 0.002806121716275811
was O 0 0.002107560634613037
detected O 0 0.0021590813994407654
in O 0 0.0008270855178125203
constitutional O 0 0.0017109327018260956
DNA O 0 0.001790498266927898
, O 0 0.0009949200320988894
and O 0 0.0008077937527559698
1 O 0 0.0014018333749845624
of O 0 0.000920589838642627
these O 0 0.000768365862313658
mutations O 0 0.0019322102889418602
is O 0 0.0011539524421095848
known O 0 0.001472798059694469
to O 0 0.0010983654065057635
be O 0 0.0012252399465069175
associated O 0 0.0026691772509366274
with O 0 0.0031637540087103844
reduced O 0 0.11606122553348541
expressivity O 1 0.9980231523513794
. O 0 0.015025301836431026

The O 0 0.009186000563204288
presence O 0 0.005250541493296623
of O 0 0.00369272124953568
a O 0 0.00447014719247818
constitutional O 0 0.00810230616480112
mutation O 0 0.009562965482473373
was O 0 0.004015160724520683
not O 0 0.0009938465664163232
associated O 0 0.0011845033150166273
with O 0 0.0008964916341938078
an O 0 0.0014821654185652733
early O 0 0.0028860713355243206
age O 0 0.006691792048513889
at O 0 0.009751176461577415
treatment O 1 0.9949498176574707
. O 0 0.012327284552156925

In O 0 0.009359050542116165
1 O 0 0.013353533111512661
patient O 1 0.6867717504501343
, O 0 0.007054753601551056
somatic O 1 0.7248405814170837
mosaicism O 1 0.9912521243095398
was O 0 0.008229751139879227
demonstrated O 0 0.004098681267350912
by O 0 0.001492970739491284
molecular O 0 0.0025642234832048416
analysis O 0 0.0019170246087014675
of O 0 0.0022635143250226974
DNA O 0 0.004050643183290958
and O 0 0.002643472282215953
RNA O 0 0.009188231080770493
from O 0 0.006288745906203985
peripheral O 1 0.9482748508453369
blood O 0 0.4029824733734131
. O 0 0.016614247113466263

In O 0 0.008537789806723595
2 O 0 0.008487201295793056
patients O 0 0.007340292911976576
without O 0 0.002503641415387392
a O 0 0.003303502220660448
detectable O 0 0.07458151131868362
mutation O 0 0.006154055707156658
in O 0 0.0037710450123995543
peripheral O 1 0.9999412298202515
blood O 1 0.9964842796325684
, O 0 0.005555019713938236
mosaicism O 1 0.9968709349632263
was O 0 0.005740209482610226
suggested O 0 0.0021626066882163286
because O 0 0.0010865931399166584
1 O 0 0.0017805530223995447
of O 0 0.0014761213678866625
the O 0 0.0059640477411448956
patients O 1 0.9995961785316467
showed O 1 0.9975301623344421
multifocal O 1 1.0
tumors B-Disease 1 0.9999991655349731
and O 0 0.0036494529340416193
the O 0 0.0036895947996526957
other O 0 0.0019442257471382618
later O 0 0.005237174686044455
developed O 0 0.012248287908732891
bilateral B-Disease 0 0.14058144390583038
retinoblastoma I-Disease 1 0.999762237071991
. O 0 0.018442796543240547

In O 0 0.008248141966760159
conclusion O 0 0.009038634598255157
, O 0 0.0035093962214887142
our O 0 0.0025143944658339024
results O 0 0.002423519967123866
emphasize O 0 0.004013905767351389
that O 0 0.001355486223474145
the O 0 0.0028112689033150673
manifestation O 1 0.9557187557220459
and O 0 0.003737217979505658
transmissibility O 1 0.9975612163543701
of O 0 0.02490272745490074
retinoblastoma B-Disease 1 0.9992923736572266
depend O 0 0.0024884191807359457
on O 0 0.0014382174704223871
the O 0 0.0014450831804424524
nature O 0 0.0016650588950142264
of O 0 0.0011360547505319118
the O 0 0.0016432513948529959
first O 0 0.0018153551500290632
mutation O 0 0.001970950048416853
, O 0 0.0008990860660560429
its O 0 0.000790941237937659
time O 0 0.0009271379676647484
in O 0 0.0008962336578406394
development O 0 0.0014340052148327231
, O 0 0.0009303407859988511
and O 0 0.0007241297862492502
the O 0 0.0009470006916671991
number O 0 0.0007883316138759255
and O 0 0.0008542475407011807
types O 0 0.0013228000607341528
of O 0 0.002447497798129916
cells O 0 0.0035476391203701496
that O 0 0.001321035553701222
are O 0 0.0015453618252649903
affected O 0 0.004558146931231022
. O 0 0.004408623091876507
. O 0 0.008717662654817104

Hereditary B-Disease 1 0.9999953508377075
deficiency I-Disease 1 0.9999995231628418
of I-Disease 1 0.6146073341369629
the I-Disease 1 0.9447858333587646
fifth I-Disease 1 0.9996622800827026
component I-Disease 1 0.8131224513053894
of I-Disease 0 0.028706101700663567
complement I-Disease 0 0.06099126487970352
in O 0 0.005720301531255245
man O 0 0.063711017370224
. O 0 0.012289394624531269

I O 0 0.09944777190685272
. O 0 0.03744213283061981

Clinical O 1 0.8767769932746887
, O 0 0.012870445847511292
immunochemical O 1 0.9913825392723083
, O 0 0.005886685568839312
and O 0 0.004982085432857275
family O 0 0.011701030656695366
studies O 0 0.013399164192378521
. O 0 0.015372861176729202

The O 0 0.008908743038773537
first O 0 0.005548485089093447
recognized O 0 0.00620916998013854
human O 0 0.008668586611747742
kindred O 1 0.9989148378372192
with O 0 0.17337413132190704
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9964052438735962
the I-Disease 1 0.994010865688324
fifth I-Disease 1 0.9997871518135071
component I-Disease 1 0.5079959630966187
of I-Disease 0 0.04209857061505318
complement I-Disease 1 0.6097948551177979
( O 0 0.014458652585744858
C5 O 1 0.8878361582756042
) O 0 0.0043673207983374596
is O 0 0.0043581570498645306
described O 0 0.012210904620587826
. O 0 0.011726072989404202

The O 0 0.012877863831818104
proband O 0 0.024010226130485535
, O 0 0.0032485623378306627
a O 0 0.0025319610722362995
20 O 0 0.00266044563613832
- O 0 0.004743484314531088
year O 0 0.002111089648678899
- O 0 0.0060124690644443035
old O 0 0.01016633678227663
black O 0 0.0511954165995121
female O 0 0.42510244250297546
with O 1 0.9860763549804688
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9989550113677979
age O 1 0.9917296767234802
11 O 0 0.07976668328046799
, O 0 0.011978371068835258
lacked O 1 0.9987289309501648
serum O 1 0.9999960660934448
hemolytic O 1 0.9999997615814209
complement O 0 0.08569685369729996
activity O 0 0.003866777988150716
, O 0 0.0031486423686146736
even O 0 0.0038664143066853285
during O 0 0.010872764512896538
remission O 1 0.9859916567802429
. O 0 0.014753337949514389

C5 O 1 0.9926256537437439
was O 0 0.07209935039281845
undetectable O 1 0.9864864349365234
in O 0 0.005982915870845318
her O 0 0.13065294921398163
serum O 1 0.9894311428070068
by O 0 0.0036587254144251347
both O 0 0.0048612128011882305
immunodiffusion O 1 0.9991785883903503
and O 0 0.042328670620918274
hemolytic O 1 0.9999990463256836
assays O 0 0.3018147945404053
. O 0 0.019568201154470444

Other O 0 0.0054631647653877735
complement O 0 0.006921691354364157
components O 0 0.004143387544900179
were O 0 0.002182502532377839
normal O 0 0.0032588248141109943
during O 0 0.004719162359833717
remission O 1 0.999771773815155
of O 1 0.9751381278038025
lupus O 1 1.0
, O 0 0.25162965059280396
but O 0 0.0033848879393190145
C1 O 1 0.9999744892120361
, O 0 0.003997784573584795
C4 O 1 0.9717469811439514
, O 0 0.00395931676030159
C2 O 1 0.9966537952423096
, O 0 0.003105731913819909
and O 0 0.003999379463493824
C3 O 1 0.9972007274627686
levels O 0 0.011028398759663105
fell O 0 0.12017446011304855
during O 0 0.03857310116291046
exacerbations O 1 0.9999631643295288
. O 0 0.018467886373400688

A O 0 0.016514409333467484
younger O 0 0.013235632330179214
half O 0 0.006821479182690382
- O 0 0.03037216141819954
sister O 0 0.012093341909348965
, O 0 0.0019415655406191945
who O 0 0.0024930397048592567
had O 0 0.003704435657709837
no O 0 0.014450500719249249
underlying O 1 0.9999629259109497
disease O 1 0.9999997615814209
, O 0 0.04257645085453987
was O 0 0.35433968901634216
also O 0 0.001721700537018478
found O 0 0.0021104125771671534
to O 0 0.002344646491110325
lack O 0 0.015028632245957851
immunochemically O 1 0.9968974590301514
detectable O 1 0.9685184955596924
C5 O 1 0.9683957099914551
. O 0 0.018540367484092712

By O 0 0.015699537470936775
hemolytic O 1 0.9999773502349854
assay O 0 0.06880295276641846
, O 0 0.004404106643050909
she O 0 0.004133253823965788
exhibited O 0 0.0071479035541415215
1 O 0 0.004045509733259678
- O 0 0.003359136637300253
2 O 0 0.001890385989099741
% O 0 0.0010767427738755941
of O 0 0.0012767852749675512
the O 0 0.0025227495934814215
normal O 0 0.008655725978314877
serum O 1 0.993224561214447
C5 O 1 0.5806281566619873
level O 0 0.003424763446673751
and O 0 0.0017973225330933928
normal O 0 0.0030958198476582766
concentrations O 0 0.003890726948156953
of O 0 0.002805316122248769
other O 0 0.003069300204515457
complement O 0 0.011322823353111744
components O 0 0.01254991814494133
. O 0 0.015228807926177979

C5 O 1 0.9621273279190063
levels O 0 0.00797240436077118
of O 0 0.0029516734648495913
other O 0 0.0015632153954356909
family O 0 0.0023402406368404627
members O 0 0.0011254347627982497
were O 0 0.0009230293799191713
either O 0 0.001107949996367097
normal O 0 0.0013645944418385625
or O 0 0.0008978148689493537
approximately O 0 0.001317656016908586
half O 0 0.0018271227600052953
- O 0 0.004041243344545364
normal O 0 0.0020882582757622004
, O 0 0.0014037350192666054
consistent O 0 0.002163498429581523
with O 0 0.0015733585460111499
autosomal O 0 0.3544694781303406
codominant O 1 0.923923909664154
inheritance O 0 0.012927851639688015
of O 0 0.005466062109917402
the O 0 0.2702989876270294
gene O 1 0.6596843600273132
determining O 1 0.9578250646591187
C5 B-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.9999998807907104
. O 0 0.027905838564038277

Normal O 0 0.4179995656013489
hemolytic O 1 0.999991774559021
titers O 1 0.8503642678260803
were O 0 0.004620353691279888
restored O 0 0.006992036011070013
to O 0 0.0019369119545444846
both O 0 0.0024385438300669193
homozygous O 0 0.052101969718933105
C5 B-Disease 1 0.9999860525131226
- I-Disease 1 0.9988454580307007
deficient I-Disease 1 0.9999929666519165
( O 0 0.16502706706523895
C5D B-Disease 1 0.9999783039093018
) O 0 0.0036473714280873537
sera O 0 0.0652555525302887
by O 0 0.0021409355103969574
addition O 0 0.0027699603233486414
of O 0 0.004190073348581791
highly O 0 0.030918028205633163
purified O 1 0.9460225701332092
human O 0 0.06860485672950745
C5 O 1 0.9945346117019653
. O 0 0.016750065609812737

In O 0 0.009841307997703552
specific O 0 0.009082783944904804
C5 O 1 0.995147168636322
titrations O 1 0.5024818778038025
, O 0 0.003568951738998294
however O 0 0.002447888720780611
, O 0 0.0017350040143355727
it O 0 0.0012000631541013718
was O 0 0.0024535120464861393
noted O 0 0.0017726883525028825
that O 0 0.0008976933895610273
when O 0 0.0010675534140318632
limited O 0 0.0012642581714317203
amounts O 0 0.0017954311333596706
of O 0 0.0023068783339112997
C5 O 1 0.6698142290115356
were O 0 0.0016890944680199027
assayed O 0 0.005753756035119295
in O 0 0.0012178659671917558
the O 0 0.001504809013567865
presence O 0 0.0017509224126115441
of O 0 0.0018618530593812466
low O 0 0.004602480214089155
dilutions O 0 0.10241200774908066
of O 0 0.003910345025360584
either O 0 0.006494442000985146
C5D B-Disease 1 0.9999880790710449
serum O 1 0.9838910698890686
, O 0 0.0022819682490080595
curving O 0 0.005476242862641811
rather O 0 0.0018862735014408827
than O 0 0.0014350599376484752
linear O 0 0.004309721291065216
dose O 0 0.48695671558380127
- O 0 0.005231945309787989
response O 0 0.002363123930990696
plots O 0 0.0027595742139965296
were O 0 0.0016173104522749782
consistently O 0 0.0036761572118848562
obtained O 0 0.002921871142461896
, O 0 0.0028532841242849827
suggesting O 0 0.006768061313778162
some O 0 0.0039690472185611725
inhibitory O 0 0.017081329599022865
effect O 0 0.010942058637738228
. O 0 0.010909991338849068

Further O 0 0.010937384329736233
studies O 0 0.0073667108081281185
suggested O 0 0.006117908284068108
that O 0 0.002659270539879799
low O 0 0.006248651538044214
dilutions O 0 0.07815757393836975
of O 0 0.011803293600678444
C5D B-Disease 1 0.999997615814209
serum O 1 0.9925372004508972
contain O 0 0.003893638961017132
a O 0 0.002456525107845664
factor O 0 0.0036401438992470503
( O 0 0.0017314760480076075
or O 0 0.0010145163396373391
factors O 0 0.001495885313488543
) O 0 0.0013055707095190883
interfering O 0 0.0020868638530373573
at O 0 0.0016191255999729037
some O 0 0.0009062582976184785
step O 0 0.0020460374653339386
in O 0 0.0014735206495970488
the O 0 0.0037251191679388285
hemolytic O 1 0.9999959468841553
assay O 0 0.07972010225057602
of O 0 0.047184091061353683
C5 O 1 0.9988631010055542
, O 0 0.0014625047333538532
rather O 0 0.00125061662402004
than O 0 0.0010672274511307478
a O 0 0.0028079920448362827
true O 0 0.01609714888036251
C5 O 1 0.999595582485199
inhibitor O 1 0.9804578423500061
or O 0 0.00810253620147705
inactivator O 1 0.9217202067375183
. O 0 0.014786851592361927

Of O 0 0.012196717783808708
clinical O 0 0.05159404128789902
interest O 0 0.004574359394609928
are O 0 0.001640024478547275
( O 0 0.0022660926915705204
a O 0 0.0018464985769242048
) O 0 0.0014578007394447923
the O 0 0.0015112205874174833
documentation O 0 0.0050990828312933445
of O 0 0.13618440926074982
membranous O 1 0.9999998807907104
glomerulonephritis B-Disease 1 1.0
, O 1 0.998939573764801
vasculitis B-Disease 1 1.0
, O 1 0.9540436267852783
and O 1 0.9459661245346069
arthritis B-Disease 1 1.0
in O 0 0.006531484890729189
an O 0 0.0037859217263758183
individual O 0 0.004876017104834318
lacking O 1 0.9899305105209351
C5 O 1 0.9993252754211426
( O 0 0.002029106253758073
and O 0 0.0010414539137855172
its O 0 0.0012708373833447695
biologic O 0 0.026663120836019516
functions O 0 0.0017863271059468389
) O 0 0.0013929536798968911
, O 0 0.0010238649556413293
and O 0 0.0012786909937858582
( O 0 0.0023899907246232033
b O 0 0.0032192696817219257
) O 0 0.0014314183499664068
a O 0 0.001663688919506967
remarkable O 0 0.004515338689088821
propensity O 0 0.2051234096288681
to O 0 0.0037843571044504642
bacterial B-Disease 1 0.9999971389770508
infections I-Disease 1 0.9999988079071045
in O 0 0.00419921800494194
the O 0 0.019813494756817818
proband O 1 0.9854778051376343
, O 0 0.0015612385468557477
even O 0 0.0012107816291972995
during O 0 0.0017375395400449634
periods O 0 0.0025753150694072247
of O 0 0.0025622376706451178
low O 0 0.013040733523666859
- O 0 0.035616423934698105
dose O 0 0.021196777001023293
or O 0 0.0023293886333703995
alternate O 0 0.006025143899023533
- O 0 0.019779546186327934
day O 0 0.013412926346063614
corticosteroid O 1 0.9990284442901611
therapy O 1 0.981994092464447
. O 0 0.017495084553956985

Other O 0 0.004765644203871489
observations O 0 0.005475035402923822
indicate O 0 0.004230440128594637
that O 0 0.001842255238443613
the O 0 0.0031397868879139423
C5D B-Disease 1 0.9994994401931763
state O 0 0.002223456744104624
is O 0 0.001768255839124322
compatible O 0 0.002858120948076248
with O 0 0.0014898661756888032
normal O 0 0.0037247047293931246
coagulation O 0 0.2772500514984131
function O 0 0.0022055807057768106
and O 0 0.0012773368507623672
the O 0 0.001675984589383006
capacity O 0 0.0025174194015562534
to O 0 0.0015547097427770495
mount O 0 0.036115050315856934
a O 0 0.011422177776694298
neutrophilic O 1 0.9999878406524658
leukocytosis O 1 0.9999865293502808
during O 1 0.9911598563194275
pyogenic B-Disease 1 0.9999980926513672
infection I-Disease 1 0.9999948740005493
. O 0 0.010471753776073456
. O 0 0.011801653541624546

Susceptibility O 1 0.9950259327888489
to O 0 0.08433376252651215
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.4729805588722229
twins O 1 0.905389666557312
: O 0 0.002867163857445121
the O 0 0.001957472413778305
role O 0 0.0025827568024396896
of O 0 0.002795136533677578
genes O 0 0.0075678955763578415
, O 0 0.009368976578116417
HLA O 1 0.9999721050262451
, O 0 0.002691876608878374
and O 0 0.0024902699515223503
the O 0 0.004553799983114004
environment O 0 0.013269016519188881
. O 0 0.010441458784043789

OBJECTIVE O 0 0.018992653116583824
To O 0 0.00416610948741436
determine O 0 0.003401521360501647
the O 0 0.0030109372455626726
relative O 0 0.004372131545096636
effects O 0 0.0042480104602873325
of O 0 0.0028428607620298862
genetic O 0 0.005725999362766743
and O 0 0.001949070836417377
environmental O 0 0.004927119240164757
factors O 0 0.0032226406037807465
in O 0 0.003181001404300332
susceptibility O 1 0.9945374131202698
to O 0 0.20836886763572693
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9996073842048645
AS B-Disease 1 0.9956852197647095
) O 0 0.011137699708342552
. O 0 0.011954821646213531

METHODS O 0 0.017171364277601242
Twins O 0 0.014891134575009346
with O 0 0.002903267042711377
AS B-Disease 0 0.004000420682132244
were O 0 0.0017436592606827617
identified O 0 0.0020752206910401583
from O 0 0.00124274508561939
the O 0 0.002546027535572648
Royal O 0 0.46353062987327576
National O 1 0.9824124574661255
Hospital O 1 0.9999994039535522
for O 1 0.9985625147819519
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9879130721092224
. O 0 0.022739065811038017

Clinical O 0 0.2825140655040741
and O 0 0.008703363128006458
radiographic O 1 0.9539713859558105
examinations O 0 0.019573194906115532
were O 0 0.00280859530903399
performed O 0 0.0027921651490032673
to O 0 0.0013575939228758216
establish O 0 0.0038465172983705997
diagnoses O 1 0.9966350197792053
, O 0 0.004326676018536091
and O 0 0.04113597422838211
disease O 1 0.9999996423721313
severity O 1 0.9999575614929199
was O 1 0.50555020570755
assessed O 0 0.004508613608777523
using O 0 0.0019377890275791287
a O 0 0.002345782471820712
combination O 0 0.004077005200088024
of O 0 0.004014314152300358
validated O 0 0.011380921117961407
scoring O 0 0.008791856467723846
systems O 0 0.0171964168548584
. O 0 0.014411883428692818

HLA O 1 0.9965516328811646
typing O 0 0.032740555703639984
for O 0 0.01120737288147211
HLA O 1 0.9999591112136841
- O 0 0.14618414640426636
B27 O 0 0.3414907455444336
, O 0 0.005952196661382914
HLA O 1 0.999786913394928
- O 0 0.015530277043581009
B60 O 0 0.025861740112304688
, O 0 0.0026686061173677444
and O 0 0.004372662398964167
HLA O 1 0.9999884366989136
- O 1 0.8482614755630493
DR1 O 1 0.9954492449760437
was O 0 0.006098804995417595
performed O 0 0.0031828375067561865
by O 0 0.0019393251277506351
polymerase O 0 0.006049769464880228
chain O 0 0.003738951403647661
reaction O 0 0.002539504086598754
with O 0 0.0013189467135816813
sequence O 0 0.0024090572260320187
- O 0 0.0034349337220191956
specific O 0 0.0018622508505359292
primers O 0 0.0068158251233398914
, O 0 0.0020718341693282127
and O 0 0.002236885717138648
zygosity O 0 0.05231700465083122
was O 0 0.007213826756924391
assessed O 0 0.008449194021522999
using O 0 0.006628390867263079
microsatellite O 0 0.04159015044569969
markers O 0 0.030001109465956688
. O 0 0.01520082913339138

Genetic O 0 0.015458029694855213
and O 0 0.004095626994967461
environmental O 0 0.006300610955804586
variance O 0 0.004820576868951321
components O 0 0.0038499573711305857
were O 0 0.002129335654899478
assessed O 0 0.003964835777878761
with O 0 0.0014724545180797577
the O 0 0.0026726461946964264
program O 0 0.004414151422679424
Mx O 0 0.035689711570739746
, O 0 0.0014436205383390188
using O 0 0.0011054753558710217
data O 0 0.0011071006301790476
from O 0 0.0009643886005505919
this O 0 0.0007275447132997215
and O 0 0.0009625637903809547
previous O 0 0.001746209105476737
studies O 0 0.0021233358420431614
of O 0 0.0030390832107514143
twins O 0 0.37033388018608093
with O 0 0.003989283461123705
AS B-Disease 1 0.8179917335510254
. O 0 0.01050524227321148

RESULTS O 0 0.010031293146312237
Six O 0 0.004470265936106443
of O 0 0.00419288594275713
8 O 0 0.006920747458934784
monozygotic O 1 0.5493655800819397
( O 0 0.008799880743026733
MZ O 1 0.9997898936271667
) O 0 0.0029952870681881905
twin O 0 0.006086598616093397
pairs O 0 0.00348714180290699
were O 0 0.002934524789452553
disease O 1 0.9999686479568481
concordant O 1 0.9709169864654541
, O 0 0.002607249189168215
compared O 0 0.0025166389532387257
with O 0 0.0012547197984531522
4 O 0 0.0021679881028831005
of O 0 0.0017881595995277166
15 O 0 0.003664234187453985
B27 O 0 0.019739391282200813
- O 0 0.007043990772217512
positive O 0 0.004545101895928383
dizygotic O 0 0.028686916455626488
( O 0 0.004804252181202173
DZ O 1 0.8742284178733826
) O 0 0.0025912760756909847
twin O 0 0.005090594757348299
pairs O 0 0.002768144477158785
( O 0 0.002245417796075344
27 O 0 0.0027981791645288467
% O 0 0.001705275266431272
) O 0 0.0010313709499314427
and O 0 0.0010216906666755676
4 O 0 0.0018775281496345997
of O 0 0.0018541356548666954
32 O 0 0.004818136338144541
DZ O 1 0.9258729219436646
twin O 0 0.006289890967309475
pairs O 0 0.003033081768080592
overall O 0 0.0033463845029473305
( O 0 0.001920832903124392
12 O 0 0.0018004957819357514
. O 0 0.0013965658145025373
5 O 0 0.0030126499477773905
% O 0 0.0036188748199492693
) O 0 0.005254924297332764
. O 0 0.008751243352890015

Nonsignificant O 1 0.6233196258544922
increases O 0 0.011333687230944633
in O 0 0.0034230276942253113
similarity O 0 0.003949675243347883
with O 0 0.0015722803073003888
regard O 0 0.0025341419968754053
to O 0 0.0014617332490161061
age O 0 0.004419906064867973
at O 0 0.11109814792871475
disease O 1 0.9999990463256836
onset O 1 0.9999803304672241
and O 0 0.0020549616310745478
all O 0 0.0011398678179830313
of O 0 0.005458014085888863
the O 1 0.9096733331680298
disease O 1 0.9999998807907104
severity O 1 0.9993133544921875
scores O 0 0.0032856022007763386
assessed O 0 0.0027229164261370897
were O 0 0.001400251523591578
noted O 0 0.002827494405210018
in O 0 0.003363601164892316
disease O 1 0.9999977350234985
- O 1 0.9981258511543274
concordant O 1 0.9997324347496033
MZ O 1 0.9999943971633911
twins O 0 0.25618278980255127
compared O 0 0.00876589771360159
with O 0 0.008333634585142136
concordant O 1 0.950638473033905
DZ O 1 0.9999138116836548
twins O 1 0.622198760509491
. O 0 0.022084888070821762

HLA O 1 0.9999500513076782
- O 0 0.3873137831687927
B27 O 0 0.22790828347206116
and O 0 0.00469153793528676
B60 O 0 0.07561421394348145
were O 0 0.0020987559109926224
associated O 0 0.002228147815912962
with O 0 0.001628893194720149
the O 0 0.08600808680057526
disease O 1 0.9999990463256836
in O 0 0.008613385260105133
probands O 1 0.9965927004814148
, O 0 0.0014155282406136394
and O 0 0.0008914659265428782
the O 0 0.001491499482654035
rate O 0 0.002558289561420679
of O 0 0.004091513808816671
disease O 1 0.9999978542327881
concordance O 1 0.929414689540863
was O 0 0.19946639239788055
significantly O 0 0.0029049015138298273
increased O 0 0.0021634118165820837
among O 0 0.002404203172773123
DZ O 1 0.9981791973114014
twin O 0 0.006881408393383026
pairs O 0 0.002004859270527959
in O 0 0.0010395528515800834
which O 0 0.0009606576641090214
the O 0 0.0020877178758382797
co O 0 0.2393127679824829
- O 0 0.1086682602763176
twin O 0 0.019292954355478287
was O 0 0.004436898045241833
positive O 0 0.0022932314313948154
for O 0 0.0017889905720949173
both O 0 0.0027347560971975327
B27 O 0 0.328799307346344
and O 0 0.010021988302469254
DR1 O 1 0.9970486760139465
. O 0 0.0170977171510458

Additive O 0 0.06397967785596848
genetic O 0 0.014739038422703743
effects O 0 0.00860566459596157
were O 0 0.0028882897458970547
estimated O 0 0.0032795490697026253
to O 0 0.0016929695848375559
contribute O 0 0.002952690003439784
97 O 0 0.004796145483851433
% O 0 0.002178498078137636
of O 0 0.0022696242667734623
the O 0 0.0038714315742254257
population O 0 0.005102453287690878
variance O 0 0.012022333219647408
. O 0 0.011796127073466778

CONCLUSION O 0 0.025129474699497223
Susceptibility O 0 0.0804217979311943
to O 0 0.003566437866538763
AS B-Disease 0 0.005165026057511568
is O 0 0.001822368591092527
largely O 0 0.0022745728492736816
genetically O 0 0.002536722458899021
determined O 0 0.001790383248589933
, O 0 0.001113169826567173
and O 0 0.0009146084194071591
the O 0 0.001588017214089632
environmental O 0 0.004719990771263838
trigger O 0 0.006324185524135828
for O 0 0.0019074867013841867
the O 0 0.14701233804225922
disease O 1 0.9999996423721313
is O 0 0.09774050116539001
probably O 0 0.021919049322605133
ubiquitous O 0 0.07912123203277588
. O 0 0.01203521341085434

HLA O 1 0.9998757839202881
- O 0 0.054179247468709946
B27 O 0 0.01985209807753563
accounts O 0 0.003798191901296377
for O 0 0.0021194375585764647
a O 0 0.0025891168043017387
minority O 0 0.002581711858510971
of O 0 0.002283602487295866
the O 0 0.004149171989411116
overall O 1 0.5295345187187195
genetic O 0 0.09406347572803497
susceptibility O 1 0.5071728229522705
to O 0 0.0035857022739946842
AS B-Disease 0 0.03378463163971901
. O 0 0.00975805800408125

Cell O 0 0.02922423556447029
cycle O 0 0.03207511454820633
- O 0 0.021469345316290855
dependent O 0 0.009815813042223454
colocalization O 0 0.1234547570347786
of O 0 0.008114393800497055
BARD1 O 1 0.9999140501022339
and O 0 0.0063264514319598675
BRCA1 O 1 0.7914237976074219
proteins O 0 0.0033535712864249945
in O 0 0.002887741895392537
discrete O 0 0.008468289859592915
nuclear O 0 0.008835896849632263
domains O 0 0.014205501414835453
. O 0 0.011691438965499401

Germ O 1 0.9979410767555237
- O 0 0.038801420480012894
line O 0 0.010949450545012951
mutations O 0 0.005547696258872747
of O 0 0.0038127151783555746
the O 0 0.006686820648610592
BRCA1 O 1 0.9826291799545288
gene O 0 0.004489454440772533
predispose O 0 0.006406816188246012
women O 0 0.0018777265213429928
to O 0 0.0012661608634516597
early O 0 0.006744970101863146
- O 1 0.9998213648796082
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999699592590332
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.008201698772609234
compromising O 1 0.7972174286842346
the O 0 0.006003481335937977
genes O 0 0.004749899730086327
presumptive O 1 0.9263845682144165
function O 0 0.0046592699363827705
as O 0 0.004764705430716276
a O 0 0.03773884475231171
tumor B-Disease 1 0.9999908208847046
suppressor O 1 0.9756296277046204
. O 0 0.01653585396707058

Although O 0 0.010422724299132824
the O 0 0.007620229385793209
biochemical O 0 0.01229393482208252
properties O 0 0.007193358615040779
of O 0 0.009630287066102028
BRCA1 O 1 0.9993277788162231
polypeptides O 0 0.009708540514111519
are O 0 0.0015527671203017235
not O 0 0.0013354758266359568
understood O 0 0.0028512717690318823
, O 0 0.0017554882215335965
their O 0 0.0013058639597147703
expression O 0 0.002710794797167182
pattern O 0 0.00411258265376091
and O 0 0.0023361314088106155
subcellular O 0 0.011135924607515335
localization O 0 0.007286283187568188
suggest O 0 0.0030076252296566963
a O 0 0.0022674568463116884
role O 0 0.003296692157164216
in O 0 0.0027870568446815014
cell O 0 0.0247506033629179
- O 0 0.1205221638083458
cycle O 0 0.016331898048520088
regulation O 0 0.012192759662866592
. O 0 0.011364123784005642

When O 0 0.014126909896731377
resting O 1 0.7818310856819153
cells O 0 0.0074232094921171665
are O 0 0.001954209990799427
induced O 0 0.06505105644464493
to O 0 0.001832451787777245
proliferate O 0 0.004524660762399435
, O 0 0.0014804797247052193
the O 0 0.002027123933658004
steady O 0 0.0066284723579883575
- O 0 0.0033768017310649157
state O 0 0.0014433014439418912
levels O 0 0.0018347558798268437
of O 0 0.0018765113782137632
BRCA1 O 0 0.23964561522006989
increase O 0 0.0015951654640957713
in O 0 0.001359528978355229
late O 0 0.00425063306465745
G1 O 1 0.8771077990531921
and O 0 0.0011301090708002448
reach O 0 0.0018715513870120049
a O 0 0.002139796270057559
maximum O 0 0.004238219000399113
during O 0 0.006495912093669176
S O 0 0.43581220507621765
phase O 0 0.022708948701620102
. O 0 0.011682516895234585

Moreover O 0 0.016408825293183327
, O 0 0.005247390363365412
in O 0 0.004760619252920151
S O 1 0.7772471904754639
phase O 0 0.1424665004014969
cells O 0 0.006669420748949051
, O 0 0.0033580383751541376
BRCA1 O 0 0.08719340711832047
polypeptides O 0 0.007418018765747547
are O 0 0.0019591208547353745
hyperphosphorylated O 0 0.01318284310400486
and O 0 0.0029322290793061256
accumulate O 0 0.006012588739395142
into O 0 0.002946827793493867
discrete O 0 0.008176501840353012
subnuclear O 0 0.03654473274946213
foci O 0 0.06355758756399155
termed O 0 0.14512836933135986
" O 0 0.021908996626734734
BRCA1 O 1 0.8560857772827148
nuclear O 0 0.018512515351176262
dots O 0 0.03584790974855423
. O 0 0.016864826902747154

" O 0 0.03156779333949089
BRCA1 O 1 0.8989859819412231
associates O 0 0.020135043188929558
in O 0 0.0039295111782848835
vivo O 0 0.0114796943962574
with O 0 0.002376875141635537
a O 0 0.005640239454805851
structurally O 1 0.6958525776863098
related O 0 0.009719284251332283
protein O 0 0.011905527673661709
termed O 0 0.06287234276533127
BARD1 O 1 0.9920910596847534
. O 0 0.018378768116235733

Here O 0 0.009693954139947891
we O 0 0.003468097187578678
show O 0 0.003134452970698476
that O 0 0.001303125754930079
the O 0 0.002131636720150709
steady O 0 0.006423636805266142
- O 0 0.004074289929121733
state O 0 0.001819228520616889
levels O 0 0.002384816762059927
of O 0 0.002223505172878504
BARD1 O 1 0.9723548293113708
, O 0 0.0014928727177903056
unlike O 0 0.0014592930674552917
those O 0 0.0009209912386722863
of O 0 0.0019761051516979933
BRCA1 O 1 0.7596728205680847
, O 0 0.0018284433754161
remain O 0 0.002566687297075987
relatively O 0 0.0025482079945504665
constant O 0 0.004604435991495848
during O 0 0.006197998765856028
cell O 0 0.0258973129093647
cycle O 0 0.19417643547058105
progression O 1 0.8614017963409424
. O 0 0.014782755635678768

However O 0 0.010077263228595257
, O 0 0.006549426820129156
immunostaining O 0 0.24871371686458588
revealed O 0 0.010785742662847042
that O 0 0.00410683685913682
BARD1 O 1 0.9529301524162292
resides O 0 0.010659628547728062
within O 0 0.0032385853119194508
BRCA1 O 0 0.0917106568813324
nuclear O 0 0.004138623364269733
dots O 0 0.005680379923433065
during O 0 0.002760663628578186
S O 0 0.020165424793958664
phase O 0 0.0033496746327728033
of O 0 0.0016039899783208966
the O 0 0.0024503329768776894
cell O 0 0.00627869414165616
cycle O 0 0.0031511622946709394
, O 0 0.0009524449124000967
but O 0 0.0007727944757789373
not O 0 0.0008413385367020965
during O 0 0.0025001834146678448
the O 0 0.004886170849204063
G1 O 1 0.9976809024810791
phase O 0 0.03259950131177902
. O 0 0.011028852313756943

Nevertheless O 0 0.028687823563814163
, O 0 0.009068503975868225
BARD1 O 1 0.8714985847473145
polypeptides O 0 0.009095513261854649
are O 0 0.0014817520277574658
found O 0 0.001803054939955473
exclusively O 0 0.001992798177525401
in O 0 0.001249487977474928
the O 0 0.0016623192932456732
nuclear O 0 0.00261502037756145
fractions O 0 0.0032570315524935722
of O 0 0.002106614178046584
both O 0 0.0030546828638762236
G1 O 1 0.9982277750968933
- O 0 0.017658155411481857
and O 0 0.0040548332035541534
S O 1 0.9732303619384766
- O 0 0.33464568853378296
phase O 0 0.1371355950832367
cells O 0 0.014855628833174706
. O 0 0.010843737050890923

Therefore O 0 0.013636899180710316
, O 0 0.006813123822212219
progression O 0 0.13015344738960266
to O 0 0.004359576851129532
S O 0 0.36471667885780334
phase O 0 0.008528514765202999
is O 0 0.002296611201018095
accompanied O 0 0.003901920048519969
by O 0 0.001423718174919486
the O 0 0.0019866167567670345
aggregation O 0 0.004450571723282337
of O 0 0.0032304003834724426
nuclear O 0 0.00760993454605341
BARD1 O 1 0.7822833061218262
polypeptides O 0 0.013510892167687416
into O 0 0.006742172408849001
BRCA1 O 0 0.16694079339504242
nuclear O 0 0.01675502397119999
dots O 0 0.03095783106982708
. O 0 0.01503785327076912

This O 0 0.00866091437637806
cell O 0 0.012454736046493053
cycle O 0 0.01882755197584629
- O 0 0.01488435734063387
dependent O 0 0.006789748556911945
colocalization O 0 0.07306215912103653
of O 0 0.005678202491253614
BARD1 O 1 0.9997803568840027
and O 0 0.0049090757966041565
BRCA1 O 1 0.8794065713882446
indicates O 0 0.004370888229459524
a O 0 0.0021121427416801453
role O 0 0.002845112234354019
for O 0 0.0022588090505450964
BARD1 O 1 0.9966922998428345
in O 0 0.009371570311486721
BRCA1 O 1 0.9999717473983765
- O 1 0.995784342288971
mediated O 1 0.9846314787864685
tumor B-Disease 1 0.999966025352478
suppression O 1 0.9995424747467041
. O 0 0.02203020453453064

Ethnic O 0 0.014691336080431938
differences O 0 0.009259602054953575
in O 0 0.005320604424923658
the O 0 0.009238139726221561
HFE O 1 0.9991408586502075
codon O 0 0.029973609372973442
282 O 1 0.7103899121284485
( O 0 0.03286285325884819
Cys O 1 0.9999368190765381
/ O 1 0.997365415096283
Tyr O 1 0.9996053576469421
) O 0 0.011398563161492348
polymorphism O 0 0.027785276994109154
. O 0 0.014523535035550594

Recent O 0 0.00944647565484047
studies O 0 0.005107241217046976
have O 0 0.0024557539727538824
shown O 0 0.003908421378582716
that O 0 0.0037640901282429695
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
( O 1 0.9999985694885254
HH B-Disease 1 1.0
) O 0 0.016413936391472816
is O 0 0.0016510841669514775
likely O 0 0.001275675487704575
to O 0 0.0007837819284759462
be O 0 0.0008042245754040778
caused O 0 0.002320637460798025
by O 0 0.0011291836854070425
homozygosity O 0 0.0326913520693779
for O 0 0.0014277860755100846
a O 0 0.0029079997912049294
Cys282Tyr O 0 0.48530977964401245
mutation O 0 0.004071393981575966
in O 0 0.0019576966296881437
the O 0 0.004780883900821209
HFE O 1 0.9983311295509338
gene O 0 0.0071867890655994415
located O 0 0.009954528883099556
4 O 0 0.01182013563811779
. O 0 0.012243027798831463

5 O 0 0.033431582152843475
Mb O 1 0.6201741099357605
telomeric O 1 0.5862099528312683
to O 0 0.014100157655775547
HLA O 1 0.9999333620071411
- O 0 0.351482629776001
A O 0 0.025253256782889366
. O 0 0.017389189451932907

Population O 0 0.00745226489380002
studies O 0 0.005219385027885437
of O 0 0.00312069826759398
this O 0 0.002285526366904378
polymorphism O 0 0.004623262211680412
are O 0 0.0009592176065780222
facilitated O 0 0.0031270147301256657
by O 0 0.0011483118869364262
the O 0 0.0017809541895985603
fact O 0 0.0019135780166834593
that O 0 0.0012349806493148208
the O 0 0.002894663019105792
Cys282Tyr O 1 0.9569801092147827
mutation O 0 0.0074368189089000225
creates O 0 0.0065307579934597015
a O 0 0.005269108340144157
Rsal O 1 0.7905824780464172
restriction O 0 0.013130641542375088
site O 0 0.012886862270534039
. O 0 0.012592114508152008

We O 0 0.006122766528278589
have O 0 0.002935942495241761
studied O 0 0.004962975159287453
the O 0 0.004132146947085857
codon O 0 0.013597975485026836
282 O 0 0.1004224345088005
( O 0 0.011683964170515537
Cys O 1 0.9996974468231201
/ O 1 0.8142498731613159
Tyr O 1 0.983338475227356
) O 0 0.003983096685260534
polymorphism O 0 0.005161221604794264
in O 0 0.001970360055565834
different O 0 0.0016053183935582638
ethnic O 0 0.004742437042295933
groups O 0 0.006030946504324675
. O 0 0.01057455874979496

In O 0 0.00599927781149745
agreement O 0 0.004123055841773748
with O 0 0.0018586753867566586
previous O 0 0.002900096122175455
observations O 0 0.0039438907988369465
the O 0 0.003769512055441737
Tyr O 1 0.9981963038444519
allele O 0 0.006274583283811808
appeared O 0 0.002320116152986884
to O 0 0.0011475769570097327
be O 0 0.0011533073848113418
rare O 0 0.001937924767844379
or O 0 0.0014606632757931948
absent O 0 0.0050210789777338505
in O 0 0.0028335140086710453
Asiatic O 1 0.9943886399269104
( O 0 0.003795742755755782
Indian O 0 0.0036921934224665165
, O 0 0.0032293382100760937
Chinese O 0 0.007762284018099308
) O 0 0.005753690376877785
populations O 0 0.009478932246565819
. O 0 0.011235060170292854

The O 0 0.01026901789009571
highest O 0 0.013683530502021313
allele O 0 0.008118839003145695
frequency O 0 0.0036018826067447662
( O 0 0.0021862564608454704
7 O 0 0.002299866173416376
. O 0 0.0012250854633748531
5 O 0 0.0018586487276479602
% O 0 0.001671384321525693
) O 0 0.001567638712003827
was O 0 0.0026779172476381063
found O 0 0.0024937086272984743
in O 0 0.004522338043898344
Swedes O 0 0.02382432483136654
. O 0 0.011053754948079586

Saamis O 0 0.25745677947998047
( O 0 0.009014168754220009
2 O 0 0.005717904306948185
% O 0 0.002372829709202051
) O 0 0.001861058408394456
and O 0 0.0016010022955015302
Mordvinians O 0 0.01579246111214161
( O 0 0.0021650646813213825
1 O 0 0.0021538627333939075
. O 0 0.0010303161107003689
8 O 0 0.0019726697355508804
% O 0 0.0015405502635985613
) O 0 0.001461411127820611
had O 0 0.002010917291045189
significantly O 0 0.0025148200802505016
lower O 0 0.0030624396167695522
frequencies O 0 0.002853787736967206
of O 0 0.003966163843870163
the O 0 0.009704278782010078
Tyr O 1 0.9982894062995911
allele O 0 0.032488733530044556
. O 0 0.015419033356010914

Comparisons O 0 0.013933319598436356
with O 0 0.00510810874402523
allele O 0 0.0068713524378836155
frequencies O 0 0.002561794361099601
based O 0 0.0018034118693321943
on O 0 0.0021172582637518644
prevalence O 0 0.2023080587387085
estimates O 0 0.004034251905977726
of O 0 0.005705517716705799
HH B-Disease 1 0.9999971389770508
showed O 0 0.005100447218865156
some O 0 0.001392850186675787
disagreements O 0 0.003420824185013771
with O 0 0.0014012219617143273
the O 0 0.002604193054139614
RFLP O 0 0.022660406306385994
data O 0 0.0020265376660972834
, O 0 0.0021538627333939075
particularly O 0 0.003439098596572876
in O 0 0.00487675704061985
Finns O 0 0.03582792729139328
. O 0 0.013149073347449303

The O 0 0.01412020344287157
newly O 0 0.10893259197473526
described O 0 0.4791669547557831
HFE O 1 0.9999810457229614
marker O 0 0.4060971736907959
provides O 0 0.003706233110278845
a O 0 0.002243433613330126
new O 0 0.0014056171057745814
approach O 0 0.001755376229993999
to O 0 0.0009457236155867577
the O 0 0.0015486483462154865
screening O 0 0.0036443553399294615
of O 0 0.004788133781403303
HH B-Disease 1 0.9999958276748657
as O 0 0.001714771380648017
well O 0 0.000996121671050787
as O 0 0.0008976163808256388
studies O 0 0.001000452903099358
of O 0 0.001029939274303615
the O 0 0.0015805321745574474
relationship O 0 0.002240413101390004
between O 0 0.0020052753388881683
the O 0 0.054260239005088806
HFE O 1 0.9999980926513672
Tyr O 1 0.9999887943267822
allele O 0 0.012361782602965832
and O 0 0.0033937206026166677
different O 0 0.004208947531878948
disorders O 1 0.999985933303833
including O 1 0.9550220370292664
cancer B-Disease 1 0.9999995231628418

Autosomal B-Disease 1 0.9999585151672363
dominant I-Disease 1 0.9999866485595703
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
associated O 0 0.23370106518268585
with O 0 0.0034521978814154863
a O 0 0.005725271068513393
missense O 0 0.02366519160568714
mutation O 0 0.007709423545747995
encoding O 0 0.00783455464988947
Gly23 O 1 0.9482214450836182
- O 1 0.6021791100502014
- O 0 0.4815997779369354
> O 0 0.03944991156458855
Val O 1 0.7183775901794434
in O 0 0.01014726608991623
neurophysin O 1 0.979552686214447
II O 1 0.9989299178123474
. O 0 0.020345840603113174

Autosomal B-Disease 1 0.9991031885147095
dominant I-Disease 1 0.998935878276825
neurohypophyseal I-Disease 1 0.9999994039535522
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9971811771392822
ADNDI B-Disease 1 0.9999880790710449
) O 0 0.004086553584784269
is O 0 0.0024844594299793243
an O 0 0.06749504804611206
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999988079071045
by O 1 0.995518684387207
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.9994144439697266
the O 1 0.9998912811279297
magnocellular O 1 0.9999990463256836
neurons O 0 0.045341793447732925
of O 0 0.0029836981557309628
the O 0 0.005117729306221008
hypothalamus O 0 0.15101605653762817
leading O 0 0.004153065383434296
to O 0 0.0017648148350417614
decreased O 0 0.003958756569772959
ability O 0 0.0016741784056648612
to O 0 0.0010856339940801263
produce O 0 0.002144974423572421
the O 0 0.003819182747974992
hormone O 1 0.7315227389335632
arginine O 0 0.13790789246559143
vasopressin O 1 0.600892186164856
( O 0 0.013137699104845524
AVP O 1 0.9970122575759888
) O 0 0.009440845809876919
. O 0 0.010718555189669132

Affected O 0 0.010101456195116043
individuals O 0 0.002909198636189103
are O 0 0.0015838510589674115
not O 0 0.0016947491094470024
symptomatic O 1 0.9934172630310059
at O 0 0.007517337333410978
birth O 0 0.4712417721748352
, O 0 0.0022202800028026104
but O 0 0.0012912650126963854
usually O 0 0.0026648726779967546
develop O 0 0.02870974689722061
diabetes B-Disease 1 0.9999979734420776
insipidus I-Disease 1 0.9999728202819824
at O 0 0.014532689936459064
1 O 0 0.011064080521464348
- O 0 0.013525797054171562
6 O 0 0.008260906673967838
yr O 0 0.13240817189216614
of O 0 0.005454360041767359
age O 0 0.014982075430452824
. O 0 0.012644502334296703

The O 0 0.012672661803662777
genetic O 0 0.011422144249081612
locus O 0 0.013837856240570545
of O 0 0.0053457701578736305
the O 0 0.09946788847446442
disease O 1 0.9999923706054688
is O 0 0.004652099683880806
the O 0 0.017881318926811218
AVP O 1 0.9999936819076538
- O 1 0.9241557717323303
neurophysin O 1 0.9927859902381897
II O 1 0.999925971031189
( O 0 0.008800083771348
NPII O 1 0.9838322401046753
) O 0 0.002290917094796896
gene O 0 0.0017403092933818698
, O 0 0.0009956912836059928
and O 0 0.0010058925254270434
mutations O 0 0.0020874913316220045
that O 0 0.001333001651801169
cause O 1 0.8648244142532349
ADNDI B-Disease 1 0.9999496936798096
have O 0 0.0011115294182673097
been O 0 0.0012246770784258842
found O 0 0.001006023259833455
in O 0 0.0008368594571948051
both O 0 0.0008999062119983137
the O 0 0.0014726774534210563
signal O 0 0.003090056125074625
peptide O 0 0.003149519208818674
of O 0 0.0018880482530221343
the O 0 0.003762459848076105
prepro O 1 0.9894630312919617
- O 1 0.9237593412399292
AVP O 1 0.999944806098938
- O 1 0.7100816965103149
NPII O 1 0.9828063249588013
precursor O 0 0.011377262882888317
and O 0 0.0030281601939350367
within O 0 0.004487055353820324
NPII O 1 0.9942982792854309
itself O 0 0.014418399892747402
. O 0 0.011768588796257973

An O 0 0.00952229555696249
affected O 0 0.012013779021799564
girl O 0 0.05520639941096306
who O 0 0.0033630765974521637
presented O 0 0.0032738707959651947
at O 0 0.0022230567410588264
9 O 0 0.002212515566498041
months O 0 0.0013313433155417442
of O 0 0.0013535692123696208
age O 0 0.002520716516301036
and O 0 0.0015210434794425964
her O 0 0.012721342034637928
similarly O 0 0.019040685147047043
affected O 0 0.0112084299325943
younger O 0 0.00826291088014841
brother O 0 0.016077352687716484
and O 0 0.0015064878389239311
father O 0 0.006325240712612867
were O 0 0.001177891856059432
all O 0 0.000737333670258522
found O 0 0.0010583300609141588
to O 0 0.0008534331573173404
have O 0 0.0007596612558700144
a O 0 0.0016310224309563637
novel O 0 0.004792443942278624
missense O 0 0.009455077350139618
mutation O 0 0.004995505791157484
( O 0 0.003733860794454813
G1758 O 0 0.46369656920433044
- O 1 0.532856285572052
- O 0 0.4451889097690582
> O 0 0.01991724781692028
T O 0 0.010272600688040257
) O 0 0.0016287046018987894
encoding O 0 0.0021270045544952154
the O 0 0.0017241825116798282
amino O 0 0.0031846475321799517
acid O 0 0.005241975653916597
substitution O 0 0.00936763547360897
Gly23 O 1 0.9040349125862122
- O 1 0.7321082353591919
- O 1 0.5869681239128113
> O 0 0.06021396070718765
Val O 1 0.6298493146896362
within O 0 0.011844929307699203
NPII O 1 0.9764639139175415
. O 0 0.018648456782102585

The O 0 0.012915694154798985
mutation O 0 0.015221908688545227
was O 0 0.009991614148020744
confirmed O 0 0.008843936026096344
by O 0 0.005102186929434538
restriction O 0 0.015928111970424652
endonuclease O 0 0.04675012826919556
analysis O 0 0.014266402460634708
. O 0 0.016666360199451447

A O 0 0.05093688145279884
T1 O 1 0.9991408586502075
- O 0 0.01806645095348358
weighted O 0 0.010149029083549976
magnetic O 0 0.008300079964101315
resonance O 0 0.006415497045964003
imaging O 0 0.006029482465237379
of O 0 0.003500375198200345
the O 0 0.009707129560410976
fathers O 1 0.9702553153038025
pituitary O 1 0.999991774559021
gland O 1 0.9999687671661377
demonstrates O 1 0.9589633941650391
an O 0 0.2296186089515686
attenuated O 1 0.999900221824646
posterior O 1 0.9998464584350586
pituitary O 1 0.9999790191650391
bright O 1 0.985372006893158
spot O 0 0.35412436723709106
. O 0 0.02081436663866043

This O 0 0.008704744279384613
mutation O 0 0.010987159796059132
may O 0 0.0032038595527410507
be O 0 0.0014107143506407738
valuable O 0 0.0023896200582385063
for O 0 0.0014694260898977518
developing O 0 0.002649745438247919
models O 0 0.002458439441397786
of O 0 0.004484775010496378
dominantly B-Disease 1 0.9999912977218628
inherited I-Disease 1 0.9999996423721313
neurodegeneration I-Disease 1 1.0
, O 0 0.0037477537989616394
as O 0 0.0016871545230969787
the O 0 0.0016380458837375045
early O 0 0.0018589736428111792
age O 0 0.0027752630412578583
of O 0 0.00812716968357563
onset O 1 0.9999994039535522
of O 1 0.9987136125564575
symptoms O 1 1.0
suggests O 1 0.7789909839630127
that O 0 0.0017725990619510412
this O 0 0.0015886318869888783
mutation O 0 0.0032857211772352457
may O 0 0.001653238432481885
be O 0 0.0012000958668068051
particularly O 0 0.002826460637152195
deleterious O 0 0.009733655489981174
to O 0 0.0033301671501249075
the O 0 0.007674803026020527
magnocellular O 1 0.9983506202697754
neuron O 1 0.8949971795082092
. O 0 0.009922589175403118
. O 0 0.015650274232029915

Frequent O 0 0.0265286136418581
inactivation O 1 0.563317060470581
of O 0 0.15063749253749847
PTEN O 1 0.9999936819076538
/ O 1 0.9982514977455139
MMAC1 O 1 0.9996366500854492
in O 0 0.05682037025690079
primary O 1 0.9998971223831177
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.5728083252906799

Sporadic B-Disease 1 0.9999468326568604
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.3176102638244629
the O 0 0.02060100995004177
most O 0 0.0026571631897240877
common O 0 0.12387803196907043
male B-Disease 1 0.9413591623306274
cancer I-Disease 1 0.9999802112579346
in O 0 0.002054661512374878
the O 0 0.0028570203576236963
Western O 0 0.0023327399976551533
world O 0 0.0023148839827626944
, O 0 0.0010054819285869598
yet O 0 0.0008595841354690492
many O 0 0.0006004920578561723
of O 0 0.0008888086886145175
the O 0 0.0013740197755396366
major O 0 0.0022654880303889513
genetic O 0 0.0018574533751234412
events O 0 0.001136384322308004
involved O 0 0.00109867041464895
in O 0 0.0010314799146726727
the O 0 0.0021966707427054644
progression O 1 0.8867555260658264
of O 0 0.003992769401520491
this O 0 0.0027043954469263554
often O 0 0.01599160209298134
fatal O 1 0.9999988079071045
cancer B-Disease 1 0.9999991655349731
remain O 0 0.02466023899614811
to O 0 0.0031242487020790577
be O 0 0.004796152003109455
elucidated O 0 0.11552181839942932
. O 0 0.010855947621166706

Numerous O 0 0.016023462638258934
cytogenetic O 0 0.4004271924495697
and O 0 0.005317493807524443
allelotype O 1 0.7503102421760559
studies O 0 0.0039339326322078705
have O 0 0.00188502948731184
reported O 0 0.0034695311915129423
frequent O 0 0.004318824037909508
loss O 0 0.01609504222869873
of O 0 0.006084703840315342
heterozygosity O 1 0.9992703795433044
on O 0 0.00659598596394062
chromosomal O 1 0.9353281259536743
arm O 1 0.9175127744674683
10q O 1 0.986924409866333
in O 0 0.029394138604402542
sporadic B-Disease 1 0.9999219179153442
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.4085145592689514

Deletion O 0 0.03413406386971474
mapping O 0 0.014547660946846008
studies O 0 0.0056481449864804745
have O 0 0.0026632838416844606
unambiguously O 0 0.00828070379793644
identified O 0 0.003265606239438057
a O 0 0.0023713521659374237
region O 0 0.002963230013847351
of O 0 0.00360061670653522
chromosome O 0 0.023052841424942017
10q23 O 0 0.031990114599466324
to O 0 0.001384077942930162
be O 0 0.0012335769133642316
the O 0 0.002069144742563367
minimal O 0 0.005677490960806608
area O 0 0.004286943934857845
of O 0 0.007461215369403362
loss O 1 0.9475383162498474
. O 0 0.014418840408325195

A O 0 0.021500451490283012
new O 0 0.019313674420118332
tumor B-Disease 1 0.9999676942825317
suppressor O 1 0.9321469664573669
gene O 0 0.009079329669475555
, O 0 0.005968577228486538
PTEN O 1 0.9998798370361328
/ O 1 0.9791345596313477
MMAC1 O 1 0.9991267323493958
, O 0 0.0034050126560032368
was O 0 0.007993695326149464
isolated O 0 0.004353892523795366
recently O 0 0.002496525878086686
at O 0 0.001838045776821673
this O 0 0.0010261069983243942
region O 0 0.0015547925140708685
of O 0 0.0019697092939168215
chromosome O 0 0.00799088180065155
10q23 O 0 0.03325046971440315
and O 0 0.00109020562376827
found O 0 0.0010817935690283775
to O 0 0.0008471813634969294
be O 0 0.0008626200724393129
inactivated O 0 0.0041754296980798244
by O 0 0.0010669633047655225
mutation O 0 0.002265940885990858
in O 0 0.00174144865013659
three O 0 0.032965511083602905
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.998896598815918
lines O 0 0.06037221476435661
. O 0 0.014230496250092983

We O 0 0.01065754797309637
screened O 0 0.02181471325457096
80 O 0 0.18029867112636566
prostate B-Disease 1 0.9999996423721313
tumors I-Disease 1 0.999981164932251
by O 0 0.0032039068173617125
microsatellite O 0 0.27602463960647583
analysis O 0 0.002639414742588997
and O 0 0.0018816431984305382
found O 0 0.0027087435591965914
chromosome O 0 0.005226872395724058
10q23 O 0 0.008417720906436443
to O 0 0.0015791120240464807
be O 0 0.0015646093524992466
deleted O 0 0.004730370827019215
in O 0 0.002466564066708088
23 O 0 0.00655102264136076
cases O 0 0.008165133185684681
. O 0 0.01178888138383627

We O 0 0.007435200270265341
then O 0 0.005301311146467924
proceeded O 0 0.005678918212652206
with O 0 0.0019415137358009815
sequence O 0 0.0021632129792124033
analysis O 0 0.001759872306138277
of O 0 0.001960077788680792
the O 0 0.0035551891196519136
entire O 0 0.10869546979665756
PTEN O 1 0.9999755620956421
/ O 1 0.9960980415344238
MMAC1 O 1 0.9983654618263245
coding O 0 0.010969562456011772
region O 0 0.003412171034142375
and O 0 0.001999101135879755
tested O 0 0.0036170165985822678
for O 0 0.0016967374831438065
homozygous O 0 0.0047915843315422535
deletion O 0 0.004186186008155346
with O 0 0.0013756543630734086
new O 0 0.0022799107246100903
intragenic O 0 0.21024039387702942
markers O 0 0.00465372484177351
in O 0 0.0013429921818897128
these O 0 0.0010747612686827779
23 O 0 0.002618888858705759
cases O 0 0.0023074501659721136
with O 0 0.002896393882110715
10q23 O 1 0.9524121284484863
loss O 1 0.6761181354522705
of O 0 0.13028307259082794
heterozygosity O 1 0.9998462200164795
. O 0 0.022729501128196716

The O 0 0.009348314255475998
identification O 0 0.006368930451571941
of O 0 0.004021779168397188
the O 0 0.004140675533562899
second O 0 0.005421276204288006
mutational O 0 0.06141640245914459
event O 0 0.002980971708893776
in O 0 0.0012993853306397796
10 O 0 0.0014778142794966698
( O 0 0.0017642882885411382
43 O 0 0.0028501993510872126
% O 0 0.0024641635827720165
) O 0 0.0035894045140594244
tumors B-Disease 1 0.9974097609519958
establishes O 1 0.9896971583366394
PTEN O 1 0.9999923706054688
/ O 1 0.9726167321205139
MMAC1 O 1 0.8043040633201599
as O 0 0.002577256178483367
a O 0 0.002449441235512495
main O 0 0.004168547224253416
inactivation O 0 0.012116070836782455
target O 0 0.00249553588218987
of O 0 0.0027166148647665977
10q O 1 0.583095371723175
loss O 0 0.48990267515182495
in O 0 0.010646642185747623
sporadic B-Disease 1 0.9999351501464844
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.09140811860561371
. O 0 0.01783622056245804

Risk O 0 0.11546625941991806
reversals O 0 0.06423180550336838
in O 0 0.0067145247012376785
predictive O 0 0.021559998393058777
testing O 0 0.018248602747917175
for O 0 0.11602812260389328
Huntington B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999998807907104
. O 0 0.09647215157747269

The O 0 0.008682278916239738
first O 0 0.005641629919409752
predictive O 0 0.00839054025709629
testing O 0 0.005610449239611626
for O 0 0.007937813177704811
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9415442943572998
HD B-Disease 1 0.8208109736442566
) O 0 0.0016840805765241385
was O 0 0.001845069113187492
based O 0 0.0010863457573577762
on O 0 0.000989919644780457
analysis O 0 0.0014852560125291348
of O 0 0.0017768633551895618
linked O 0 0.00480297626927495
polymorphic O 0 0.0077958060428500175
DNA O 0 0.0032418034970760345
markers O 0 0.003780616447329521
to O 0 0.0012396193342283368
estimate O 0 0.0022605580743402243
the O 0 0.0016938564367592335
likelihood O 0 0.003474827390164137
of O 0 0.002939303172752261
inheriting O 1 0.7950230836868286
the O 0 0.007049177307635546
mutation O 0 0.015086465515196323
for O 0 0.005994991399347782
HD B-Disease 0 0.0733618214726448
. O 0 0.010793227702379227

Limits O 0 0.012731648050248623
to O 0 0.0038507606368511915
accuracy O 0 0.004997037351131439
included O 0 0.0030462066642940044
recombination O 0 0.00440386775881052
between O 0 0.0016183701809495687
the O 0 0.0019010810647159815
DNA O 0 0.0027300813235342503
markers O 0 0.003283803816884756
and O 0 0.0012250065337866545
the O 0 0.0018483573803678155
mutation O 0 0.003450628137215972
, O 0 0.0016793980030342937
pedigree O 0 0.006174874026328325
structure O 0 0.0026913529727607965
, O 0 0.0014159077545627952
and O 0 0.0010417401790618896
whether O 0 0.0013733007945120335
DNA O 0 0.001968322554603219
samples O 0 0.0014429339207708836
were O 0 0.0011310729896649718
available O 0 0.0015204866649582982
from O 0 0.002299834508448839
family O 0 0.0055482042953372
members O 0 0.005411958787590265
. O 0 0.010359412059187889

With O 0 0.0052445922046899796
direct O 0 0.0044915261678397655
tests O 0 0.003665937576442957
for O 0 0.0023266642820090055
the O 0 0.003676772117614746
HD B-Disease 0 0.22682122886180878
mutation O 0 0.0034732113126665354
, O 0 0.001256492338143289
we O 0 0.0009332022164016962
have O 0 0.0007590193417854607
assessed O 0 0.002000482752919197
the O 0 0.0011868230067193508
accuracy O 0 0.001838365918956697
of O 0 0.0012807863531634212
results O 0 0.0014250556705519557
obtained O 0 0.0014548939652740955
by O 0 0.0010294002713635564
linkage O 0 0.003725097980350256
approaches O 0 0.002332187257707119
when O 0 0.0011488173622637987
requested O 0 0.0018335668137297034
to O 0 0.0009368819301016629
do O 0 0.0010152217000722885
so O 0 0.0009506135247647762
by O 0 0.0011609774082899094
the O 0 0.0027961963787674904
test O 0 0.004705881699919701
individuals O 0 0.004674295894801617
. O 0 0.009943874552845955

For O 0 0.005597999319434166
six O 0 0.0035005779936909676
such O 0 0.0017352261347696185
individuals O 0 0.0013178485678508878
, O 0 0.0016680124681442976
there O 0 0.0017030863091349602
was O 0 0.005051236599683762
significant O 0 0.003201541258022189
disparity O 0 0.025238752365112305
between O 0 0.003159812418743968
the O 0 0.006807876750826836
tests O 0 0.009364321827888489
. O 0 0.010226317681372166

Three O 0 0.005751628894358873
went O 0 0.006536458153277636
from O 0 0.002930414630100131
a O 0 0.004499686881899834
decreased O 0 0.22293418645858765
risk O 0 0.004314066842198372
to O 0 0.001272497233003378
an O 0 0.0015649282140657306
increased O 0 0.002520008245483041
risk O 0 0.004574949853122234
, O 0 0.0010577684734016657
while O 0 0.000888156471773982
in O 0 0.0007447063107974827
another O 0 0.0011723835486918688
three O 0 0.0012809502659365535
the O 0 0.0031119242776185274
risk O 0 0.19539164006710052
was O 0 0.28280994296073914
decreased O 0 0.23438996076583862
. O 0 0.011597848497331142

Knowledge O 0 0.010730423033237457
of O 0 0.005163437686860561
the O 0 0.0039878417737782
potential O 0 0.0032809427939355373
reasons O 0 0.0019110888242721558
for O 0 0.0009534513228572905
these O 0 0.0006934927660040557
changes O 0 0.0008625025511719286
in O 0 0.0008234084234572947
results O 0 0.0009699981892481446
and O 0 0.0007356916321441531
impact O 0 0.001381045556627214
of O 0 0.0011085189180448651
these O 0 0.000915722397621721
risk O 0 0.003125065704807639
reversals O 0 0.0076857274398207664
on O 0 0.0014432704774662852
both O 0 0.0014015549095347524
patients O 0 0.20344147086143494
and O 0 0.0013149261940270662
the O 0 0.0024262317456305027
counseling O 0 0.2305973768234253
team O 0 0.0020653472747653723
can O 0 0.0007580301025882363
assist O 0 0.00143211439717561
in O 0 0.000794715597294271
the O 0 0.0009813280776143074
development O 0 0.001286529004573822
of O 0 0.0012778686359524727
strategies O 0 0.0021949291694909334
for O 0 0.0010916739702224731
the O 0 0.0023066895082592964
prevention O 1 0.9948934316635132
and O 0 0.0013123751850798726
, O 0 0.0010847687954083085
where O 0 0.0010608859593048692
necessary O 0 0.001278723357245326
, O 0 0.0009675296605564654
management O 0 0.0016926779644563794
of O 0 0.0013333266833797097
a O 0 0.0030455824453383684
risk O 0 0.06288515776395798
reversal O 0 0.011414846405386925
in O 0 0.001345419674180448
any O 0 0.0014328777324408293
predictive O 0 0.005475289653986692
testing O 0 0.004825799725949764
program O 0 0.005389142781496048
. O 0 0.004375035874545574
. O 0 0.009679581969976425

A O 0 0.019077850505709648
novel O 0 0.01915588229894638
common O 0 0.009845016524195671
missense O 0 0.023295974358916283
mutation O 0 0.008878964930772781
G301C O 0 0.01361022423952818
in O 0 0.00268274312838912
the O 0 0.003852156223729253
N O 0 0.01325097307562828
- O 0 0.013916773721575737
acetylgalactosamine O 1 0.8821966052055359
- O 0 0.31655099987983704
6 O 0 0.02310076169669628
- O 1 0.849495530128479
sulfate O 1 0.9991672039031982
sulfatase O 1 0.9998082518577576
gene O 0 0.009598322212696075
in O 0 0.007428804878145456
mucopolysaccharidosis B-Disease 1 0.997569739818573
IVA I-Disease 1 0.9999598264694214
. O 0 0.025516008958220482

Mucopolysaccharidosis B-Disease 1 0.9958154559135437
IVA I-Disease 1 0.9999762773513794
( O 0 0.06427913904190063
MPS B-Disease 1 0.9792267680168152
IVA I-Disease 1 0.9999984502792358
) O 0 0.006094430573284626
is O 0 0.003479100065305829
an O 0 0.0064619253389537334
autosomal B-Disease 1 0.9999746084213257
recessive I-Disease 1 0.9999988079071045
lysosomal I-Disease 1 1.0
storage I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
caused O 1 0.9999033212661743
by O 0 0.009834442287683487
a O 0 0.10204009711742401
genetic B-Disease 1 0.8640695214271545
defect I-Disease 1 0.9985150694847107
in O 0 0.003619518131017685
N O 0 0.05475454777479172
- O 0 0.015505234710872173
acetylgalactosamine O 0 0.4211055636405945
- O 0 0.0272007267922163
6 O 0 0.011393627151846886
- O 1 0.5069128274917603
sulfate O 1 0.9990842342376709
sulfatase O 1 0.9998672008514404
( O 0 0.02891506999731064
GALNS O 1 0.9953411817550659
) O 0 0.011086340062320232
. O 0 0.01291685551404953

In O 0 0.00712774321436882
previous O 0 0.005414030980318785
studies O 0 0.003816895419731736
, O 0 0.0020800430793315172
we O 0 0.0013201242545619607
have O 0 0.0007669071783311665
found O 0 0.0009916276903823018
two O 0 0.0008588015916757286
common O 0 0.0016723847948014736
mutations O 0 0.0026377260219305754
in O 0 0.001923544448800385
Caucasians O 0 0.18681319057941437
and O 0 0.0030153379775583744
Japanese O 0 0.0524207279086113
, O 0 0.0050314185209572315
respectively O 0 0.01220683939754963
. O 0 0.010653581470251083

To O 0 0.008321057073771954
characterize O 0 0.014531631022691727
the O 0 0.0061226156540215015
mutational O 0 0.2248806208372116
spectrum O 0 0.003895130241289735
in O 0 0.001499853329733014
various O 0 0.0013613266637548804
ethnic O 0 0.0018560533644631505
groups O 0 0.0011347249383106828
, O 0 0.0016355343395844102
mutations O 0 0.0021425802260637283
in O 0 0.0013788193464279175
the O 0 0.0026379742193967104
GALNS O 1 0.9086246490478516
gene O 0 0.003044895129278302
in O 0 0.0019982813391834497
Colombian O 0 0.010686464607715607
MPS B-Disease 1 0.9714667797088623
IVA I-Disease 1 0.9999998807907104
patients O 1 0.9941060543060303
were O 0 0.0021967084612697363
investigated O 0 0.02711012214422226
, O 0 0.0014667537761852145
and O 0 0.0012362542329356074
genetic O 0 0.002171518746763468
backgrounds O 0 0.0017785996897146106
were O 0 0.0010589397279545665
extensively O 0 0.002277147490531206
analyzed O 0 0.0021802803967148066
to O 0 0.0010948131093755364
identify O 0 0.00201279460452497
racial O 0 0.003280066419392824
origin O 0 0.0016541050281375647
, O 0 0.0013623752165585756
based O 0 0.0015881819417700171
on O 0 0.002298082457855344
mitochondrial O 0 0.005653471685945988
DNA O 0 0.004800610709935427
( O 0 0.004894909914582968
mtDNA O 0 0.00880423653870821
) O 0 0.005385918542742729
lineages O 0 0.014324636198580265
. O 0 0.010747956112027168

Three O 0 0.010850152000784874
novel O 0 0.01699153706431389
missense O 0 0.03067810647189617
mutations O 0 0.007420182228088379
never O 0 0.004011840093880892
identified O 0 0.003046368947252631
previously O 0 0.0022495773155242205
in O 0 0.001039893482811749
other O 0 0.0008257364970631897
populations O 0 0.0014664513291791081
and O 0 0.0008556356187909842
found O 0 0.0010777100687846541
in O 0 0.0009653010638430715
16 O 0 0.0013657996896654367
out O 0 0.0010042450157925487
of O 0 0.0015522512840107083
19 O 0 0.003604731522500515
Colombian O 0 0.008836649358272552
MPS B-Disease 0 0.3293856382369995
IVA I-Disease 1 0.9999934434890747
unrelated O 0 0.020360460504889488
alleles O 0 0.006985093001276255
account O 0 0.004285480827093124
for O 0 0.004436083137989044
84 O 0 0.021627597510814667
. O 0 0.01320645771920681

2 O 0 0.012561221607029438
% O 0 0.0059350766241550446
of O 0 0.0035983454436063766
the O 0 0.00394347682595253
alleles O 0 0.005750960670411587
in O 0 0.0031529644038528204
this O 0 0.003651478560641408
study O 0 0.009151184931397438
. O 0 0.012251335196197033

The O 0 0.017189860343933105
G301C O 0 0.15093688666820526
and O 0 0.0069824340753257275
S162F O 0 0.2318633794784546
mutations O 0 0.008054978214204311
account O 0 0.005976824555546045
for O 0 0.006109155714511871
68 O 0 0.02127951756119728
. O 0 0.011841638013720512

4 O 0 0.020664334297180176
% O 0 0.010489284060895443
and O 0 0.0075659360736608505
10 O 0 0.012970923446118832
. O 0 0.013366310857236385

5 O 0 0.011370008811354637
% O 0 0.004987283609807491
of O 0 0.003320988267660141
mutations O 0 0.004507070407271385
, O 0 0.0021624083165079355
respectively O 0 0.003089239588007331
, O 0 0.0016525073442608118
whereas O 0 0.0021120000164955854
the O 0 0.0020168167538940907
remaining O 0 0.00403711898252368
F69V O 1 0.7467968463897705
is O 0 0.002196449087932706
limited O 0 0.0022196294739842415
to O 0 0.0019932857248932123
a O 0 0.004232173785567284
single O 0 0.0077486708760261536
allele O 0 0.01907690241932869
. O 0 0.012208880856633186

The O 0 0.0135195879265666
skewed O 0 0.019734997302293777
prevalence O 0 0.3811706006526947
of O 0 0.006151243112981319
G301C O 1 0.562378466129303
in O 0 0.0029207360930740833
only O 0 0.002135966205969453
Colombian O 0 0.015351813286542892
patients O 0 0.16643014550209045
and O 0 0.0016543633537366986
haplotype O 0 0.004752014763653278
analysis O 0 0.001433918485417962
by O 0 0.0012510736705735326
restriction O 0 0.0028392502572387457
fragment O 0 0.0036637187004089355
length O 0 0.002649995032697916
polymorphisms O 0 0.0035691179800778627
in O 0 0.0015311253955587745
the O 0 0.0027791031170636415
GALNS O 1 0.8638164401054382
gene O 0 0.003278666641563177
suggest O 0 0.0025505630765110254
that O 0 0.0016318223206326365
G301C O 0 0.009105497971177101
originated O 0 0.004690215922892094
from O 0 0.0026162697467952967
a O 0 0.004829708486795425
common O 0 0.008744784630835056
ancestor O 0 0.07141876965761185
. O 0 0.015111624263226986

Investigation O 0 0.01200057566165924
of O 0 0.006035590078681707
the O 0 0.005525663495063782
genetic O 0 0.004597397521138191
background O 0 0.0031894510611891747
by O 0 0.001656107953749597
means O 0 0.0022337075788527727
of O 0 0.0020773387514054775
mtDNA O 0 0.004085224121809006
lineages O 0 0.0030159298330545425
indicate O 0 0.0018963657785207033
that O 0 0.0008190231746993959
all O 0 0.0008945410372689366
our O 0 0.0019924433436244726
patients O 0 0.020480139181017876
are O 0 0.0009764364222064614
probably O 0 0.002682507038116455
of O 0 0.0031334892846643925
native O 0 0.009863374754786491
American O 0 0.017261121422052383
descent O 0 0.07596033066511154

Low O 0 0.018742918968200684
frequency O 0 0.009118335321545601
of O 0 0.006421929225325584
BRCA1 O 1 0.8462223410606384
germline O 0 0.035280242562294006
mutations O 0 0.004093576688319445
in O 0 0.0026959367096424103
45 O 0 0.00793860200792551
German O 1 0.9999499320983887
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9538522958755493
. O 0 0.018737927079200745

In O 0 0.004638511687517166
this O 0 0.0018881254363805056
study O 0 0.0018972450634464622
we O 0 0.0012911795638501644
investigated O 0 0.003925332333892584
45 O 0 0.0040317922830581665
German O 1 0.9942604303359985
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.013439693488180637
for O 0 0.00445425882935524
germline O 1 0.9545802474021912
mutations O 0 0.004840799607336521
in O 0 0.00296440115198493
the O 0 0.012268062680959702
BRCA1 O 1 0.9996223449707031
gene O 0 0.015274662524461746
. O 0 0.011897305957973003

We O 0 0.006451423745602369
identified O 0 0.006348582450300455
four O 0 0.003466957248747349
germline O 0 0.012834249995648861
mutations O 0 0.003233432536944747
in O 0 0.0019464865326881409
three O 0 0.004491104278713465
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999953508377075
families O 0 0.002473477041348815
and O 0 0.001249848515726626
in O 0 0.0020945039577782154
one O 1 0.5876134634017944
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.962846577167511
. O 0 0.0013588039437308908
among O 0 0.0009887861087918282
these O 0 0.0006054391851648688
were O 0 0.0009930951055139303
one O 0 0.0015316694043576717
frameshift O 0 0.03503890708088875
mutation O 0 0.0026969672180712223
, O 0 0.0015335549833253026
one O 0 0.0016843765042722225
nonsense O 0 0.008820884861052036
mutation O 0 0.003023893339559436
, O 0 0.0016348096542060375
one O 0 0.0018053159583359957
novel O 0 0.006306070368736982
splice O 0 0.011058214120566845
site O 0 0.00441877031698823
mutation O 0 0.0045578088611364365
, O 0 0.0023706709034740925
and O 0 0.0027656275779008865
one O 0 0.0055365716107189655
missense O 0 0.04179121553897858
mutation O 0 0.022121449932456017
. O 0 0.014300351962447166

The O 0 0.01725509576499462
missense O 0 0.0470065213739872
mutation O 0 0.019302615895867348
was O 0 0.010243766009807587
also O 0 0.004037387203425169
found O 0 0.004247621167451143
in O 0 0.005168137606233358
2 O 0 0.010591299273073673
. O 0 0.01228948961943388

8 O 0 0.010824737139046192
% O 0 0.00398914935067296
of O 0 0.002503772731870413
the O 0 0.0022096182219684124
general O 0 0.005727047100663185
population O 0 0.0017529315082356334
, O 0 0.0013596487697213888
suggesting O 0 0.0019657781813293695
that O 0 0.0008868909790180624
it O 0 0.0010722862789407372
is O 0 0.002165157115086913
not O 0 0.002842295914888382
disease O 1 0.9996846914291382
associated O 0 0.01979340985417366
. O 0 0.012748781591653824

The O 0 0.0072951423935592175
average O 0 0.006300616543740034
age O 0 0.006602926179766655
of O 1 0.5099177360534668
disease O 1 1.0
onset O 1 0.9999997615814209
in O 0 0.04216666519641876
those O 0 0.0029068333096802235
families O 0 0.007718825712800026
harbouring O 1 0.999697208404541
causative O 1 0.999301552772522
mutations O 0 0.007773861289024353
was O 0 0.007708635646849871
between O 0 0.004788111429661512
32 O 0 0.010182193480432034
. O 0 0.008902661502361298

3 O 0 0.024402284994721413
and O 0 0.012673753313720226
37 O 0 0.03366706147789955
. O 0 0.02515295334160328

4 O 0 0.010758176445960999
years O 0 0.004430644679814577
, O 0 0.0028815248515456915
whereas O 0 0.003368191886693239
the O 0 0.002470995532348752
family O 0 0.004775548819452524
harbouring O 1 0.9440438151359558
the O 0 0.004587873350828886
missense O 0 0.11225007474422455
mutation O 0 0.00414880970492959
had O 0 0.0020089764147996902
an O 0 0.001342981937341392
average O 0 0.0026749984826892614
age O 0 0.002963124541565776
of O 0 0.004972119815647602
onset O 1 0.9998805522918701
of O 0 0.14873088896274567
51 O 0 0.2660910189151764
. O 0 0.014349798671901226

2 O 0 0.038824353367090225
years O 0 0.024345938116312027
. O 0 0.028101302683353424

These O 0 0.006961153820157051
findings O 0 0.008646290749311447
show O 0 0.005965241231024265
that O 0 0.0030530686490237713
BRCA1 O 0 0.2989375591278076
is O 0 0.002662983722984791
implicated O 0 0.00586280319839716
in O 0 0.001468455302529037
a O 0 0.0017613889649510384
small O 0 0.0015689340652897954
fraction O 0 0.0038030706346035004
of O 1 0.7582626342773438
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.12630638480186462
suggesting O 0 0.006333265453577042
the O 0 0.0023985260631889105
involvement O 0 0.0047753541730344296
of O 0 0.004247800912708044
another O 0 0.0792035460472107
susceptibility O 1 0.9985861778259277
gene O 0 0.012249868363142014
( O 0 0.009048078209161758
s O 0 0.03818518668413162
) O 0 0.014735646545886993

Paternal O 1 0.9975433945655823
transmission O 1 0.9990857839584351
of O 1 0.9998860359191895
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9998916387557983

We O 0 0.007341898046433926
report O 0 0.0055895303376019
a O 0 0.004134289920330048
rare O 0 0.004433882888406515
case O 0 0.005767389200627804
of O 0 0.16717854142189026
paternally O 1 0.9999958276748657
transmitted O 1 0.9999978542327881
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DM B-Disease 1 1.0
) O 0 0.2078588455915451
. O 0 0.017495160922408104

The O 0 0.012726398184895515
proband O 0 0.03550127521157265
is O 0 0.0033531824592500925
a O 0 0.002739581512287259
23 O 0 0.00324851181358099
year O 0 0.0023392518050968647
old O 0 0.01829714886844158
, O 0 0.008565927855670452
mentally B-Disease 1 0.9999966621398926
retarded I-Disease 1 0.999984622001648
male O 1 0.9735497236251831
who O 1 0.9974820017814636
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9983633160591125

He O 0 0.011496437713503838
presented O 0 0.013887384906411171
with O 0 0.012874383479356766
respiratory O 1 1.0
and O 1 0.714958667755127
feeding O 1 0.9978383183479309
difficulties O 1 0.9999206066131592
at O 1 0.9694252014160156
birth O 1 0.9971765279769897
. O 0 0.016231872141361237

His O 0 0.014989880844950676
two O 0 0.011060627177357674
sibs O 1 0.999951958656311
suffer O 1 0.9992684721946716
from O 1 0.6108243465423584
childhood O 1 0.9999997615814209
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.8921395540237427

Their O 0 0.008318373933434486
late O 0 0.009470420889556408
father O 0 0.009560600854456425
had O 0 0.0037563771475106478
the O 0 0.0030165521893650293
adult O 0 0.005316091701388359
type O 0 0.028264759108424187
of O 0 0.10436456650495529
DM B-Disease 1 1.0
, O 0 0.004014989361166954
with O 0 0.002981517231091857
onset O 1 0.998058021068573
around O 0 0.0038904256653040648
30 O 0 0.0049993800930678844
years O 0 0.0057519832625985146
. O 0 0.009236324578523636

Only O 0 0.004068761598318815
six O 0 0.0028107701800763607
other O 0 0.0013385675847530365
cases O 0 0.0023733116686344147
of O 0 0.005282148253172636
paternal O 1 0.9999679327011108
transmission O 1 0.9999310970306396
of O 1 0.9999583959579468
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.10248704254627228
been O 0 0.010102282278239727
reported O 0 0.014880911447107792
recently O 0 0.017863623797893524
. O 0 0.01122025866061449

We O 0 0.008448614738881588
review O 0 0.006112596020102501
the O 0 0.003931940998882055
sex O 0 0.005101328250020742
related O 0 0.004332633689045906
effects O 0 0.06341169029474258
on O 0 0.007934133522212505
transmission O 1 0.9966071844100952
of O 1 0.99922776222229
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8545487523078918

Decreased O 0 0.12957805395126343
fertility O 0 0.0562734454870224
of O 0 0.006100845523178577
males O 0 0.004938526079058647
with O 0 0.003067354205995798
adult O 0 0.3270564377307892
onset O 1 0.9999996423721313
DM B-Disease 1 1.0
and O 0 0.005194293800741434
contraction O 0 0.2819121181964874
of O 0 0.0025863724295049906
the O 0 0.002945354674011469
repeat O 0 0.008879774250090122
upon O 0 0.002524835057556629
male O 0 0.0041750711388885975
transmission O 0 0.004157939460128546
contribute O 0 0.0016541286604478955
to O 0 0.0010567628778517246
the O 0 0.001461852341890335
almost O 0 0.0017118480755016208
absent O 0 0.003946632146835327
occurrence O 0 0.005636256188154221
of O 0 0.005714012775570154
paternal O 1 0.999377429485321
transmission O 1 0.9995942711830139
of O 1 0.9998169541358948
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8933794498443604

Also O 0 0.007119176909327507
the O 0 0.004701717756688595
fathers O 0 0.005428611300885677
of O 0 0.003024735953658819
the O 0 0.005616818554699421
reported O 1 0.5272250175476074
congenitally O 1 0.9996008276939392
affected O 0 0.01696961559355259
children O 0 0.00359053211286664
showed O 0 0.0027651095297187567
, O 0 0.0011510200565680861
on O 0 0.0014201257145032287
average O 0 0.0022084915544837713
, O 0 0.0017780782654881477
shorter O 0 0.004674266558140516
CTG O 0 0.18500898778438568
repeat O 0 0.006351218093186617
lengths O 0 0.0051614344120025635
and O 0 0.0016682666027918458
hence O 0 0.004020939115434885
less O 0 0.0034028016962110996
severe O 1 0.9999614953994751
clinical O 1 0.9999874830245972
symptoms O 1 0.9999983310699463
than O 0 0.002310186391696334
the O 0 0.003805199172347784
mothers O 0 0.1654054969549179
of O 0 0.006853565573692322
children O 1 0.964686393737793
with O 1 0.9819090366363525
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8535823822021484

We O 0 0.008491335436701775
conclude O 0 0.010496486909687519
that O 0 0.004418869037181139
paternal O 0 0.2626785337924957
transmission O 1 0.9418402910232544
of O 1 0.9996812343597412
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9640794992446899
rare O 0 0.16510075330734253
and O 0 0.0025174121838063
preferentially O 0 0.00527577567845583
occurs O 0 0.0019917436875402927
with O 0 0.0015093609690666199
onset O 1 0.9973701238632202
of O 0 0.25450634956359863
DM B-Disease 1 0.9999998807907104
past O 0 0.002633772324770689
30 O 0 0.0016337166307494044
years O 0 0.001446070265956223
in O 0 0.001529874512925744
the O 0 0.0032212408259510994
father O 0 0.03518106788396835
. O 0 0.004925660323351622
. O 0 0.008869309909641743

The O 0 0.028999824076890945
RB1 O 1 0.9937980771064758
gene O 0 0.012474305927753448
mutation O 0 0.007639982737600803
in O 0 0.0037489396054297686
a O 0 0.006467487197369337
child O 1 0.876181960105896
with O 0 0.4582507312297821
ectopic B-Disease 1 0.9999997615814209
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999988079071045
. O 0 0.13472089171409607

The O 0 0.023869222030043602
RB1 O 1 0.9995797276496887
gene O 0 0.010285587050020695
mutation O 0 0.006389718968421221
was O 0 0.004818787798285484
investigated O 0 0.005128738470375538
in O 0 0.0021459658164530993
a O 0 0.004347889684140682
child O 1 0.7454506754875183
with O 0 0.008983059786260128
ectopic B-Disease 1 0.9999951124191284
intracranial I-Disease 1 0.9999990463256836
retinoblastoma I-Disease 1 0.9995542168617249
using O 0 0.002838488668203354
DNA O 0 0.00232513714581728
obtained O 0 0.0017672046087682247
from O 0 0.0011512810597196221
both O 0 0.0011540001723915339
the O 0 0.003414684906601906
pineal B-Disease 1 0.9998414516448975
and I-Disease 0 0.19292038679122925
retinal I-Disease 1 0.9999995231628418
tumours I-Disease 1 0.9999990463256836
of O 1 0.9460019469261169
the O 1 0.9968309998512268
patient O 1 0.9999738931655884
. O 0 0.016340764239430428

A O 0 0.019272463396191597
nonsense O 0 0.039897456765174866
mutation O 0 0.010385672561824322
in O 0 0.004642912652343512
exon O 0 0.015748687088489532
17 O 0 0.005114442203193903
( O 0 0.003367590019479394
codon O 0 0.0067362613044679165
556 O 0 0.008877084590494633
) O 0 0.00191028683912009
of O 0 0.0022166648413985968
the O 0 0.00561030488461256
RB1 O 1 0.9998774528503418
gene O 0 0.0032755890861153603
was O 0 0.0025453229900449514
found O 0 0.0012298121582716703
to O 0 0.0008810053113847971
be O 0 0.0008370803552679718
present O 0 0.001532149501144886
homozygously O 0 0.009760352782905102
in O 0 0.0013088361592963338
both O 0 0.0016846409998834133
the O 0 0.005023328121751547
retinal B-Disease 1 0.9999080896377563
and I-Disease 0 0.008359753526747227
the I-Disease 1 0.7607768774032593
pineal I-Disease 1 0.9999908208847046
tumours I-Disease 1 0.9999974966049194
. O 0 0.021810561418533325

The O 0 0.011334468610584736
same O 0 0.005697694607079029
mutation O 0 0.007051317021250725
was O 0 0.0060099391266703606
present O 0 0.003534446470439434
heterozygously O 0 0.039828959852457047
in O 0 0.001668810728006065
the O 0 0.0016469471156597137
DNA O 0 0.0019832709804177284
from O 0 0.0009890306973829865
the O 0 0.0013235642109066248
constitutional O 0 0.0022971511352807283
cells O 0 0.0016197344521060586
of O 0 0.0013871440896764398
the O 0 0.003718034364283085
patient O 1 0.993077278137207
, O 0 0.0018234574235975742
proving O 0 0.005730980075895786
it O 0 0.0009780862601473927
to O 0 0.0010901786154136062
be O 0 0.0013451158301904798
of O 0 0.0031212514732033014
germline O 0 0.09704319387674332
origin O 0 0.007918529212474823
. O 0 0.010003139264881611

The O 0 0.01141998078674078
initial O 0 0.011915797367691994
mutation O 0 0.009152469225227833
was O 0 0.005300476215779781
shown O 0 0.002276898128911853
to O 0 0.0010910596465691924
have O 0 0.0010122599778696895
occurred O 0 0.0022561775986105204
in O 0 0.0020676760468631983
the O 0 0.005914479494094849
paternally O 1 0.9666684865951538
derived O 0 0.02785216085612774
RB1 O 1 0.9936980605125427
allele O 0 0.03373520448803902
. O 0 0.01881297118961811

The O 0 0.01153514999896288
mutation O 0 0.00901030283421278
is O 0 0.0028234717901796103
in O 0 0.0017996543319895864
an O 0 0.0015340909594669938
area O 0 0.0019492380088195205
of O 0 0.0018021718133240938
the O 0 0.002432830398902297
gene O 0 0.0019868628587573767
that O 0 0.0009034451213665307
encodes O 0 0.002551498357206583
the O 0 0.0018188564572483301
protein O 0 0.002761327661573887
- O 0 0.0030688070692121983
binding O 0 0.0015386994928121567
region O 0 0.001980978762730956
known O 0 0.0019370614318177104
as O 0 0.001624701777473092
the O 0 0.0026220730505883694
pocket O 0 0.41006672382354736
region O 0 0.0029271841049194336
and O 0 0.001345187658444047
has O 0 0.0014098038664087653
been O 0 0.0013815481215715408
detected O 0 0.0022680775728076696
in O 0 0.0010878598550334573
other O 0 0.0010568529833108187
cases O 0 0.0027564421761780977
of O 0 0.016233813017606735
retinoblastoma B-Disease 1 0.9999581575393677
. O 0 0.009120064787566662
. O 0 0.012611528858542442

Low O 0 0.015143650583922863
levels O 0 0.006763789802789688
of O 0 0.0047586760483682156
beta O 0 0.011510160751640797
hexosaminidase O 0 0.23612281680107117
A O 0 0.004164218902587891
in O 0 0.0020904913544654846
healthy O 0 0.006184643600136042
individuals O 0 0.0014499338576570153
with O 0 0.0026625555474311113
apparent O 1 0.9999057054519653
deficiency O 1 1.0
of O 1 0.9963125586509705
this O 1 0.6725339293479919
enzyme O 1 0.6577634215354919
. O 0 0.01235035341233015

Appreciable O 0 0.09729348868131638
beta O 0 0.030109290033578873
hexosaminidase O 0 0.3082183599472046
A O 0 0.010667400434613228
( O 0 0.0060447994619607925
hex O 0 0.010647245682775974
A O 0 0.003972067963331938
) O 0 0.00200284318998456
activity O 0 0.0015375108923763037
has O 0 0.0011250944808125496
been O 0 0.001307031256146729
detected O 0 0.002779573667794466
in O 0 0.0022397353313863277
cultured O 1 0.9945091605186462
skin O 1 0.9999974966049194
fibroblasts O 1 0.9999661445617676
and O 1 0.9789326786994934
melanoma B-Disease 1 1.0
tissue O 1 0.9998984336853027
from O 0 0.005183802917599678
healthy O 0 0.057169098407030106
individuals O 0 0.001266934210434556
previously O 0 0.0022219084203243256
reported O 0 0.0029951557517051697
as O 0 0.0022050216794013977
having O 0 0.13987404108047485
deficiency B-Disease 1 0.9999988079071045
of I-Disease 0 0.1061161458492279
hex I-Disease 1 0.8386817574501038
A I-Disease 0 0.0034577238839119673
activity O 0 0.0016477650497108698
indistinguishable O 0 0.0022024977952241898
from O 0 0.0008855195483192801
that O 0 0.0007122413371689618
of O 0 0.0018813905771821737
patients O 1 0.9781888127326965
with O 1 0.8444717526435852
Tay B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9802014231681824
TSD B-Disease 1 0.9999911785125732
) O 0 0.011157683096826077
. O 0 0.011507964693009853

Identification O 0 0.015146730467677116
and O 0 0.006413017399609089
quantitation O 0 0.06774391233921051
of O 0 0.009231063537299633
hex O 0 0.22788295149803162
A O 0 0.008683543652296066
, O 0 0.00434122746810317
amounting O 0 0.011954832822084427
to O 0 0.004532315768301487
3 O 0 0.009822113439440727
. O 0 0.010317444801330566

5 O 0 0.021763276308774948
% O 0 0.016297217458486557
- O 0 0.026837367564439774
6 O 0 0.02287973277270794
. O 0 0.017796151340007782

9 O 0 0.012856852263212204
% O 0 0.0044784885831177235
of O 0 0.0029489581938833
total O 0 0.004468990955501795
beta O 0 0.024289054796099663
hexosaminidase O 1 0.6829859018325806
activity O 0 0.0024623838253319263
, O 0 0.001581396209076047
has O 0 0.001370066311210394
been O 0 0.0011894350172951818
obtained O 0 0.001948487595655024
by O 0 0.002207439159974456
cellulose O 1 0.9693063497543335
acetate O 1 0.9988352656364441
gel O 1 0.9241222739219666
electrophoresis O 0 0.027456769719719887
, O 0 0.004666829947382212
DEAE O 1 0.9979615211486816
- O 0 0.41039788722991943
cellulose O 1 0.8473718166351318
ion O 0 0.10798473656177521
- O 0 0.009168184362351894
exchange O 0 0.004993666894733906
chromatography O 0 0.05257746949791908
, O 0 0.006139503326267004
radial O 1 0.9054300785064697
immunodiffusion O 1 0.9719750285148621
, O 0 0.0062052286230027676
and O 0 0.008948728442192078
radioimmunoassay O 1 0.7680853009223938
. O 0 0.01778402179479599

Previous O 0 0.011408304795622826
family O 0 0.007944530807435513
studies O 0 0.0044617922976613045
suggested O 0 0.0035964036360383034
that O 0 0.00153974664863199
these O 0 0.0011567312758415937
individuals O 0 0.0013622259721159935
may O 0 0.0017295359866693616
be O 0 0.0012875671964138746
compound O 0 0.004597637336701155
heterozygotes O 0 0.01200826745480299
for O 0 0.0015361286932602525
the O 0 0.0023626452311873436
common O 0 0.005815918557345867
mutant O 1 0.8695477247238159
TSD B-Disease 1 0.999932050704956
gene O 0 0.003218690864741802
and O 0 0.0014047820586711168
a O 0 0.002466880949214101
rare O 0 0.006722473073750734
( O 0 0.008232546970248222
allelic O 1 0.8471952676773071
) O 0 0.007128539495170116
mutant O 0 0.02913161925971508
gene O 0 0.013030830770730972
. O 0 0.012100282125175

Thus O 0 0.010148420929908752
, O 0 0.004901550244539976
the O 0 0.00435891468077898
postulated O 0 0.016368955373764038
rate O 0 0.007606923580169678
mutant O 0 0.012647777795791626
gene O 0 0.003322947071865201
appears O 0 0.0023060753010213375
to O 0 0.0009310906752943993
code O 0 0.0013957361225038767
for O 0 0.0010670069605112076
the O 0 0.0015677036717534065
expression O 0 0.0020794509910047054
of O 0 0.0021184857469052076
low O 0 0.005141188856214285
amounts O 0 0.004259745590388775
of O 0 0.0053641838021576405
hex O 0 0.044149402529001236
A O 0 0.016226552426815033
. O 0 0.015454393811523914

Heterozygotes O 0 0.05050981417298317
for O 0 0.0068651526235044
the O 0 0.006368423346430063
rare O 0 0.021017886698246002
mutant O 0 0.3459503948688507
may O 0 0.0027112411335110664
be O 0 0.0014824471436440945
indistinguishable O 0 0.004243201110512018
from O 0 0.002518428023904562
heterozygotes O 0 0.012848545797169209
for O 0 0.0028018353041261435
the O 0 0.006151269190013409
common O 0 0.03374975174665451
TSD B-Disease 1 0.9999783039093018
mutant O 1 0.7117128372192383
. O 0 0.01677951030433178

However O 0 0.011139480397105217
, O 0 0.005270997527986765
direct O 0 0.0049590771086514
visualization O 0 0.012269028462469578
and O 0 0.003795734141021967
quantitation O 0 0.15130221843719482
of O 0 0.005012905225157738
hex O 0 0.031064175069332123
A O 0 0.0031632266473025084
by O 0 0.0013512017903849483
the O 0 0.001505074673332274
methods O 0 0.0020677291322499514
described O 0 0.0030137556605041027
may O 0 0.0022356256376951933
prevent O 0 0.0036654321011155844
false O 0 0.007148316595703363
- O 0 0.1049899160861969
positive O 0 0.007442368194460869
prenatal O 1 0.9833364486694336
diagnosis O 1 0.9653676748275757
of O 0 0.015402719378471375
TSD B-Disease 1 0.9999922513961792
in O 0 0.004218727815896273
fetuses O 0 0.1521151065826416
having O 0 0.0025175907649099827
the O 0 0.002052964875474572
incomplete O 0 0.007538434583693743
hex B-Disease 1 0.7059159278869629
A I-Disease 1 0.7159069180488586
deficiency I-Disease 1 0.9999990463256836
of O 0 0.03028358705341816
the O 0 0.3545137643814087
type O 1 0.8428871035575867
described O 0 0.005395214073359966
in O 0 0.002117979573085904
the O 0 0.0036363478284329176
four O 0 0.004851564299315214
healthy O 0 0.01888875663280487
individuals O 0 0.01224775705486536

The O 0 0.045595426112413406
tumor B-Disease 1 0.9999421834945679
suppressor O 1 0.9929064512252808
gene O 0 0.017328571528196335
Smad4 O 1 0.9897275567054749
/ O 1 0.7838332653045654
Dpc4 O 0 0.19825372099876404
is O 0 0.002910427050665021
required O 0 0.0020461941603571177
for O 0 0.001989994663745165
gastrulation O 1 0.8516187071800232
and O 0 0.0017419651849195361
later O 0 0.0025139274075627327
for O 0 0.0022428191732615232
anterior O 1 0.978440523147583
development O 0 0.006463431287556887
of O 0 0.010200364515185356
the O 0 0.303608238697052
mouse O 1 0.587730884552002
embryo O 0 0.02371424250304699
. O 0 0.010865665040910244

Mutations O 0 0.012569598853588104
in O 0 0.005241772159934044
the O 0 0.010294502601027489
SMAD4 O 1 0.9999940395355225
/ O 1 0.9999786615371704
DPC4 O 1 0.9999990463256836
tumor B-Disease 1 0.9999994039535522
suppressor O 1 0.9925795197486877
gene O 0 0.0038413722068071365
, O 0 0.0013670269399881363
a O 0 0.0016953101148828864
key O 0 0.0024237907491624355
signal O 0 0.0031579039059579372
transducer O 0 0.004501682240515947
in O 0 0.0013258889084681869
most O 0 0.0018788392189890146
TGFbeta O 1 0.9871370792388916
- O 0 0.07165459543466568
related O 0 0.003380353096872568
pathways O 0 0.0036133185494691133
, O 0 0.001168360118754208
are O 0 0.0007303303573280573
involved O 0 0.0012034605024382472
in O 0 0.0013253390789031982
50 O 0 0.002306981710717082
% O 0 0.003216818906366825
of O 0 0.02556149661540985
pancreatic B-Disease 1 0.9999998807907104
cancers I-Disease 1 0.999998927116394
. O 0 0.059073206037282944

Homozygous O 0 0.06571494042873383
Smad4 O 1 0.8753182291984558
mutant O 1 0.5929361581802368
mice O 0 0.1488027572631836
die O 0 0.08106797188520432
before O 0 0.005920788273215294
day O 0 0.008491836488246918
7 O 0 0.014213521964848042
. O 0 0.012130067683756351

5 O 0 0.0304291769862175
of O 0 0.027171147987246513
embryogenesis O 0 0.48837366700172424
. O 0 0.03758598119020462

Mutant O 0 0.03770872950553894
embryos O 0 0.01139016356319189
have O 0 0.003615784924477339
reduced O 0 0.004499252885580063
size O 0 0.002945082960650325
, O 0 0.0021238450426608324
fail O 0 0.0036958190612494946
to O 0 0.0019035093719139695
gastrulate O 0 0.01885615848004818
or O 0 0.002190076280385256
express O 0 0.0038460318464785814
a O 0 0.003946482669562101
mesodermal O 1 0.8887335062026978
marker O 0 0.16879260540008545
, O 0 0.003359176218509674
and O 0 0.0037685702554881573
show O 0 0.011544287204742432
abnormal O 1 0.9942837357521057
visceral O 1 0.9994882345199585
endoderm O 1 0.9993467926979065
development O 0 0.05607334524393082
. O 0 0.019357725977897644

Growth B-Disease 0 0.43918249011039734
retardation I-Disease 1 0.9991452693939209
of O 0 0.027380703017115593
the O 1 0.92696613073349
Smad4 O 1 0.9999991655349731
- O 1 0.9999301433563232
deficient O 1 0.9965360164642334
embryos O 0 0.0034786202013492584
results O 0 0.0017581726424396038
from O 0 0.0017182260053232312
reduced O 0 0.004432413727045059
cell O 0 0.005133734084665775
proliferation O 0 0.006384260021150112
rather O 0 0.002838399726897478
than O 0 0.0029927988070994616
increased O 0 0.0090835215523839
apoptosis O 0 0.028838371858000755
. O 0 0.0143966656178236

Aggregation O 0 0.027810418978333473
of O 0 0.015498227439820766
mutant O 1 0.9452747106552124
Smad4 O 1 0.9996951818466187
ES O 1 0.9991186261177063
cells O 0 0.006320158950984478
with O 0 0.0029462578240782022
wild O 0 0.00957345962524414
- O 0 0.20015540719032288
type O 0 0.11188672482967377
tetraploid O 1 0.5059425830841064
morulae O 1 0.7908363342285156
rescues O 0 0.42674487829208374
the O 0 0.019457152113318443
gastrulation B-Disease 1 0.998677670955658
defect I-Disease 1 0.9982490539550781
. O 0 0.027857910841703415

These O 0 0.0056563182733953
results O 0 0.004933416377753019
indicate O 0 0.004706383682787418
that O 0 0.0020623893942683935
Smad4 O 0 0.1942400485277176
is O 0 0.0021050390787422657
initially O 0 0.0025282956194132566
required O 0 0.0011871724855154753
for O 0 0.0009344139252789319
the O 0 0.0016320879803970456
differentiation O 0 0.00277702952735126
of O 0 0.0022192716132849455
the O 0 0.006200639996677637
visceral O 1 0.9985390901565552
endoderm O 1 0.9831453561782837
and O 0 0.0023011171724647284
that O 0 0.0017781509086489677
the O 0 0.0036715217866003513
gastrulation B-Disease 1 0.9982189536094666
defect I-Disease 1 0.9885509610176086
in O 0 0.002194336149841547
the O 0 0.005897005554288626
epiblast O 1 0.9998176693916321
is O 0 0.0030498031992465258
secondary O 0 0.009995103813707829
and O 0 0.0033026342280209064
non O 0 0.14610663056373596
- O 1 0.8373188972473145
cell O 0 0.015055733732879162
autonomous O 0 0.012805844657123089
. O 0 0.011226708069443703

Rescued O 0 0.17550380527973175
embryos O 0 0.023050397634506226
show O 0 0.021163128316402435
severe O 1 0.9999576807022095
anterior O 1 0.9999840259552002
truncations O 1 0.9999719858169556
, O 0 0.0369669646024704
indicating O 0 0.05592942237854004
a O 0 0.0033329003490507603
second O 0 0.0035315793938934803
important O 0 0.0021162957418709993
role O 0 0.00335522904060781
for O 0 0.002865147078409791
Smad4 O 1 0.9898423552513123
in O 0 0.008779561147093773
anterior O 1 0.999879002571106
patterning O 1 0.9968026876449585
during O 1 0.5255787372589111
embryogenesis O 1 0.9920807480812073
. O 0 0.01965641789138317

Prevalence O 1 0.7553216218948364
of O 0 0.015955833718180656
p16 O 1 0.9246652126312256
and O 0 0.007643736433237791
CDK4 O 1 0.9992918968200684
germline O 1 0.5612581968307495
mutations O 0 0.005630708299577236
in O 0 0.004159665200859308
48 O 0 0.4185333847999573
melanoma B-Disease 1 1.0
- O 1 0.9969648718833923
prone O 1 0.9655303955078125
families O 0 0.005786116234958172
in O 0 0.0052450597286224365
France O 0 0.01814572513103485
. O 0 0.012659948319196701

The O 0 0.023138858377933502
French O 1 0.9611597061157227
Familial B-Disease 1 0.9999979734420776
Melanoma I-Disease 1 1.0
Study O 1 0.9217272996902466
Group O 0 0.06924686580896378
. O 0 0.019993940368294716

Germline O 0 0.1885249763727188
mutations O 0 0.010133873671293259
in O 0 0.0037643963005393744
the O 0 0.005237288773059845
p16 O 0 0.41189417243003845
and O 0 0.004640986677259207
CDK4 O 1 0.9983319640159607
genes O 0 0.002794174477458
have O 0 0.0012245172401890159
been O 0 0.0012330296449363232
reported O 0 0.0016597581561654806
in O 0 0.001048763981088996
a O 0 0.0015790353063493967
subset O 0 0.005295761860907078
of O 0 0.010603784583508968
melanoma B-Disease 1 0.9999998807907104
pedigrees O 1 0.7903962135314941
, O 0 0.002409433014690876
but O 0 0.0012911168159916997
their O 0 0.0015498283319175243
prevalence O 1 0.9873485565185547
is O 0 0.002043107058852911
not O 0 0.001583299832418561
well O 0 0.0028424649499356747
known O 0 0.008303839713335037
. O 0 0.01101022120565176

We O 0 0.0093535790219903
searched O 0 0.011615741066634655
for O 0 0.003796871518716216
such O 0 0.0033905773889273405
germline O 0 0.01621302217245102
mutations O 0 0.003965802490711212
in O 0 0.002393522532656789
48 O 0 0.007048577535897493
French O 1 0.9922229647636414
melanoma B-Disease 1 1.0
- O 1 0.9997932314872742
prone O 1 0.9960103034973145
families O 0 0.0027085840702056885
selected O 0 0.002062919083982706
according O 0 0.0012730155140161514
to O 0 0.000857235980220139
two O 0 0.0006428570486605167
major O 0 0.0013880095211789012
criteria O 0 0.0016671281773597002
families O 0 0.0009907890344038606
with O 0 0.0006366667221300304
at O 0 0.0011069318279623985
least O 0 0.0008133217343129218
three O 0 0.000712184642907232
affected O 0 0.001227727741934359
members O 0 0.0009250904549844563
( O 0 0.0013802946778014302
n O 0 0.0026474532205611467
= O 0 0.002682554302737117
20 O 0 0.00118353555444628
) O 0 0.0009139890316873789
or O 0 0.0007408048259094357
families O 0 0.0007890249835327268
with O 0 0.000670370296575129
two O 0 0.0007664600270800292
affected O 0 0.0013387511717155576
members O 0 0.0008401568629778922
, O 0 0.0008531761704944074
one O 0 0.0008290245314128697
of O 0 0.0009979278547689319
them O 0 0.0008154868264682591
affected O 0 0.0013674201909452677
before O 0 0.0010645051952451468
the O 0 0.0010662224376574159
age O 0 0.00143937929533422
of O 0 0.00118330679833889
50 O 0 0.0017174456734210253
( O 0 0.0017173034138977528
n O 0 0.0027980278246104717
= O 0 0.00270522921346128
28 O 0 0.0015751527389511466
) O 0 0.0011162348091602325
, O 0 0.001055041211657226
and O 0 0.0011002800893038511
one O 0 0.001986972289159894
additional O 0 0.0036151388194411993
minor O 0 0.012782322242856026
criterion O 0 0.4084632992744446
. O 0 0.015864184126257896

Sixteen O 0 0.02163580246269703
different O 0 0.005941581446677446
p16 O 0 0.08407053351402283
germline O 0 0.08791688829660416
mutations O 0 0.0044684819877147675
were O 0 0.0016463497886434197
found O 0 0.0016000819159671664
in O 0 0.0014076123479753733
21 O 0 0.002094193361699581
families O 0 0.001473603188060224
, O 0 0.0013667228631675243
while O 0 0.001545246341265738
one O 0 0.002172390930354595
germline O 0 0.02578463777899742
mutation O 0 0.003992092330008745
, O 0 0.002230664948001504
Arg24His O 0 0.2863573729991913
, O 0 0.0025790464133024216
was O 0 0.005199579522013664
detected O 0 0.0047903843224048615
in O 0 0.0029444468673318624
the O 0 0.007451884914189577
CDK4 O 1 0.9983221888542175
gene O 0 0.01627456210553646
. O 0 0.01302623376250267

The O 0 0.012362155131995678
frequency O 0 0.00786394253373146
of O 0 0.005754244513809681
p16 O 0 0.03189914673566818
gene O 0 0.004751897417008877
mutation O 0 0.003044343553483486
in O 0 0.001277207164093852
our O 0 0.0013977494090795517
sample O 0 0.0017643378814682364
( O 0 0.001577297574840486
44 O 0 0.002041520783677697
% O 0 0.001305345562286675
) O 0 0.0009637668263167143
is O 0 0.0008963147993199527
among O 0 0.0008294035214930773
the O 0 0.0012368125608190894
highest O 0 0.004306505434215069
rates O 0 0.0021560867317020893
yet O 0 0.0012052612146362662
reported O 0 0.0015614317962899804
and O 0 0.001003430224955082
the O 0 0.0019389053341001272
CDK4 O 1 0.9781826734542847
mutation O 0 0.003181290114298463
is O 0 0.0013766138581559062
the O 0 0.001497256220318377
second O 0 0.002739137038588524
mutation O 0 0.003444189904257655
detected O 0 0.0035650539211928844
in O 0 0.001837524469010532
this O 0 0.00226394971832633
gene O 0 0.005530515685677528
worldwide O 0 0.006865282543003559
. O 0 0.010379176586866379

In O 0 0.008302297443151474
summary O 0 0.010466202162206173
, O 0 0.00401463033631444
our O 0 0.0030373353511095047
results O 0 0.0027232568245381117
show O 0 0.0027031060308218002
frequent O 0 0.003081744769588113
involvement O 0 0.0034799298737198114
of O 0 0.0025013291742652655
the O 0 0.005331514403223991
p16 O 1 0.8013642430305481
gene O 0 0.0036920493002980947
in O 0 0.003020919393748045
familial B-Disease 1 0.9999942779541016
melanoma I-Disease 1 1.0
and O 0 0.0030175892170518637
confirm O 0 0.002307034097611904
the O 0 0.001402988564223051
role O 0 0.00166179402731359
of O 0 0.0015796964289620519
the O 0 0.0030506018083542585
CDK4 O 1 0.9982678890228271
gene O 0 0.0028473492711782455
as O 0 0.001850662985816598
a O 0 0.009558514691889286
melanoma B-Disease 1 0.9999998807907104
- O 1 0.9977737069129944
predisposing O 1 0.9912699460983276
gene O 0 0.008488941937685013
. O 0 0.005019668489694595
. O 0 0.009458481334149837

Progression O 1 0.5323829650878906
of O 0 0.013883193023502827
somatic O 1 0.9076138138771057
CTG O 1 0.998955488204956
repeat O 0 0.016112178564071655
length O 0 0.005096968729048967
heterogeneity O 0 0.006963732186704874
in O 0 0.002611154457554221
the O 0 0.007623536512255669
blood O 1 0.9977411031723022
cells O 1 0.5094705820083618
of O 1 0.9963595271110535
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999992847442627
. O 0 0.3590451180934906

The O 0 0.00880068726837635
genetic O 0 0.007693644613027573
basis O 0 0.005627412348985672
of O 0 0.31524890661239624
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999972581863403
DM B-Disease 1 1.0
) O 0 0.004336083773523569
is O 0 0.001749713788740337
the O 0 0.0015664190286770463
expansion O 0 0.0026882831007242203
of O 0 0.002425913233309984
an O 0 0.003999311476945877
unstable O 1 0.9926608800888062
CTG O 1 0.9973813891410828
repeat O 0 0.008079574443399906
in O 0 0.002300997730344534
the O 0 0.002929066075012088
34 O 0 0.004799864254891872
UTR O 0 0.015006541274487972
of O 0 0.004464334808290005
the O 0 0.009254751726984978
DM B-Disease 1 0.9999955892562866
protein O 0 0.008935429155826569
kinase O 0 0.010784800164401531
gene O 0 0.005609769839793444
on O 0 0.004544803872704506
chromosome O 0 0.013112382963299751
19 O 0 0.01454168651252985
. O 0 0.013412957079708576

One O 0 0.0074499305337667465
of O 0 0.005015726201236248
the O 0 0.00420149601995945
principal O 0 0.0061445352621376514
features O 0 0.003378255758434534
of O 0 0.004084174986928701
the O 1 0.6282231211662292
DM B-Disease 1 1.0
mutation O 0 0.029981525614857674
is O 0 0.0016629985766485333
an O 0 0.001495218719355762
extraordinarily O 0 0.0080350236967206
high O 0 0.0027936112601310015
level O 0 0.002386335050687194
of O 0 0.0034263001289218664
somatic O 1 0.9493879675865173
mosaicism O 1 0.9883387088775635
, O 0 0.001830338966101408
due O 0 0.0017541724955663085
to O 0 0.0010303643066436052
an O 0 0.0013013948919251561
extremely O 0 0.002772635780274868
high O 0 0.0026567219756543636
degree O 0 0.0029525847639888525
of O 0 0.0041867271065711975
somatic O 1 0.8081269264221191
instability O 0 0.22839997708797455
both O 0 0.0015029687201604247
within O 0 0.001447672606445849
and O 0 0.0017057363875210285
between O 0 0.0024984311312437057
different O 0 0.0031344720628112555
tissues O 0 0.02755649760365486
. O 0 0.012105202302336693

This O 0 0.009454455226659775
instability O 0 0.10629784315824509
appears O 0 0.006467308849096298
to O 0 0.0020155885722488165
be O 0 0.0015455348184332252
biased O 0 0.0031639544758945704
towards O 0 0.0020937048830091953
further O 0 0.0016427766531705856
expansion O 0 0.0021375417709350586
and O 0 0.0010951010044664145
continuous O 0 0.002205515978857875
throughout O 0 0.0012891299556940794
the O 0 0.0013436396839097142
life O 0 0.0016623114934191108
of O 0 0.001367319142445922
an O 0 0.0013735780958086252
individual O 0 0.0012921434827148914
, O 0 0.0012395065277814865
features O 0 0.001345295226201415
that O 0 0.0007966012344695628
could O 0 0.0008631195523776114
be O 0 0.0006713017937727273
associated O 0 0.0009933164110407233
with O 0 0.0009135332657024264
the O 0 0.0021530124358832836
progressive O 1 0.8174924254417419
nature O 0 0.006404582876712084
of O 0 0.19026248157024384
the O 1 0.9969831109046936
disease O 1 0.9999997615814209
. O 0 0.052968546748161316

Although O 0 0.010969598777592182
increasing O 0 0.008889015763998032
measured O 0 0.006334183271974325
allele O 0 0.005936660338193178
size O 0 0.0032879202626645565
between O 0 0.0028589090798050165
patients O 0 0.09735900163650513
clearly O 0 0.003125603310763836
correlates O 0 0.004911642987281084
with O 0 0.001156063168309629
an O 0 0.0016681475099176168
increased O 0 0.0061000678688287735
severity O 1 0.9804555177688599
of O 0 0.1809397041797638
symptoms O 1 0.999995231628418
and O 0 0.0014283572090789676
an O 0 0.0012250515865162015
earlier O 0 0.001799668068997562
age O 0 0.00249673705548048
of O 0 0.013415196910500526
onset O 1 0.9999985694885254
, O 0 0.0018482889281585813
this O 0 0.0009286617860198021
correlation O 0 0.0017821225337684155
is O 0 0.0008629077929072082
not O 0 0.0005906541482545435
precise O 0 0.001297741662710905
and O 0 0.000936552241910249
measured O 0 0.002058652462437749
allele O 0 0.002441337099298835
length O 0 0.0015408516628667712
cannot O 0 0.0011001492384821177
be O 0 0.0006529334932565689
used O 0 0.0008332862635143101
as O 0 0.0008536298992112279
an O 0 0.0010175268398597836
accurate O 0 0.002304642926901579
predictor O 0 0.0071674492210149765
of O 0 0.0020887888967990875
age O 0 0.005831779912114143
of O 0 0.023525061085820198
onset O 1 0.9999969005584717
. O 0 0.023038551211357117

In O 0 0.00568525493144989
order O 0 0.0036620935425162315
to O 0 0.0018442341824993491
further O 0 0.0020423855166882277
characterize O 0 0.004488998558372259
the O 0 0.002667391672730446
dynamics O 0 0.010268615558743477
of O 0 0.24734100699424744
DM B-Disease 1 1.0
CTG O 1 0.9999964237213135
repeat O 1 0.9407038688659668
somatic O 1 0.6693967580795288
instability O 0 0.19100624322891235
, O 0 0.0019159738440066576
we O 0 0.0011964177247136831
have O 0 0.0008840492810122669
studied O 0 0.0022997402120381594
repeat O 0 0.003210747381672263
length O 0 0.0017168620834127069
changes O 0 0.0008928617462515831
over O 0 0.001003572717308998
time O 0 0.001287946361117065
in O 0 0.0023433309979736805
111 O 1 0.9995077848434448
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9998774528503418
with O 0 0.0037917958106845617
varying O 0 0.0062845246866345406
clinical O 1 0.9964409470558167
severity O 1 0.9996234178543091
and O 0 0.005774207413196564
CTG O 1 0.9990342855453491
repeat O 0 0.006278764922171831
size O 0 0.002076836535707116
over O 0 0.001376272295601666
time O 0 0.0012372012715786695
intervals O 0 0.0019954401068389416
of O 0 0.0020086083095520735
1 O 0 0.0037266165018081665
- O 0 0.006208846345543861
7 O 0 0.005195343866944313
years O 0 0.005549377761781216
. O 0 0.0075897942297160625

We O 0 0.006125900894403458
have O 0 0.0023020885419100523
found O 0 0.0020918785594403744
a O 0 0.002213042927905917
direct O 0 0.002303598914295435
progression O 0 0.05068289116024971
of O 0 0.0020301039330661297
the O 0 0.002570844953879714
size O 0 0.0022260139230638742
heterogeneity O 0 0.003982196096330881
over O 0 0.0013230884214863181
time O 0 0.0013042307691648602
related O 0 0.0016151622403413057
to O 0 0.001405435148626566
initial O 0 0.004340456798672676
CTG O 1 0.9050759673118591
repeat O 0 0.004826385993510485
size O 0 0.0016155312769114971
and O 0 0.0008778320625424385
the O 0 0.0010620246175676584
time O 0 0.0012074940605089068
interval O 0 0.002510711085051298
and O 0 0.0014630681835114956
always O 0 0.0031316797249019146
biased O 0 0.005616733338683844
towards O 0 0.004938179161399603
further O 0 0.006085546221584082
expansion O 0 0.01407384593039751
. O 0 0.011449269019067287

Attempts O 0 0.011160667054355145
to O 0 0.003917913418263197
mathematically O 0 0.007342919707298279
model O 0 0.004910915624350309
the O 0 0.0031107633840292692
dynamics O 0 0.005225298460572958
have O 0 0.0014372097793966532
proved O 0 0.003727769013494253
only O 0 0.0013785910559818149
partially O 0 0.004296035040169954
successful O 0 0.0025617501232773066
suggesting O 0 0.002172167645767331
that O 0 0.000811214093118906
individual O 0 0.0009623720543459058
specific O 0 0.001119691296480596
genetic O 0 0.0026628735940903425
and O 0 0.0018192147836089134
/ O 0 0.2803008556365967
or O 0 0.0017071692273020744
environmental O 0 0.003227602457627654
factors O 0 0.0017998615512624383
also O 0 0.0013456637971103191
play O 0 0.0013090656138956547
a O 0 0.0018585905199870467
role O 0 0.0034147531259804964
in O 0 0.003664584131911397
somatic O 0 0.4938785433769226
mosaicism O 1 0.9954748749732971
. O 0 0.00696930754929781
. O 0 0.011137930676341057

Aspartylglucosaminuria B-Disease 1 0.9802242517471313
among O 0 0.02157818339765072
Palestinian O 0 0.03350347280502319
Arabs O 0 0.03427348658442497
. O 0 0.021774882450699806

Aspartylglucosaminuria B-Disease 1 0.9997110962867737
( O 1 0.8032177686691284
AGU B-Disease 1 0.9999922513961792
) O 0 0.00655971048399806
is O 0 0.0035555858630687
a O 0 0.0046814316883683205
rare O 1 0.5482229590415955
disorder B-Disease 1 0.9999973773956299
of I-Disease 1 0.9967964291572571
glycoprotein I-Disease 1 0.9999995231628418
metabolism I-Disease 1 0.999586284160614
caused O 1 0.9175505638122559
by O 0 0.0031325703021138906
the O 1 0.6333263516426086
deficiency B-Disease 1 0.9999998807907104
of I-Disease 1 0.7208032608032227
the I-Disease 1 0.9943357110023499
lysosomal I-Disease 1 0.9999997615814209
enzyme I-Disease 1 0.995762050151825
aspartylglucosaminidase I-Disease 1 0.9998331069946289
( O 0 0.04777153953909874
AGA O 1 0.9982483386993408
) O 0 0.010395954363048077
. O 0 0.011861048638820648

AGU B-Disease 1 0.9999445676803589
is O 0 0.018410474061965942
inherited O 1 0.9973303079605103
as O 0 0.008093898184597492
an O 0 0.2125074416399002
autosomal O 1 0.9999974966049194
recessive O 1 0.9999990463256836
trait O 1 0.9998605251312256
and O 0 0.010269885882735252
occurs O 0 0.003773611504584551
with O 0 0.0014059679815545678
a O 0 0.0026881094090640545
high O 0 0.0038059386424720287
frequency O 0 0.0017595296958461404
in O 0 0.0010926895774900913
Finland O 0 0.002885391004383564
because O 0 0.001168671646155417
of O 0 0.0020085645373910666
a O 0 0.004914542660117149
founder O 1 0.8022664785385132
effect O 0 0.013099313713610172
. O 0 0.011579850688576698

While O 0 0.007760227657854557
very O 0 0.005153348669409752
few O 0 0.00424482487142086
patients O 1 0.8960625529289246
with O 0 0.0055693755857646465
AGU B-Disease 1 0.9999995231628418
have O 0 0.0017568281618878245
been O 0 0.0015786504372954369
reported O 0 0.001962297596037388
from O 0 0.0012222862569615245
non O 0 0.002912507625296712
- O 0 0.004092661663889885
Finnish O 0 0.011183482594788074
origin O 0 0.0020116083323955536
, O 0 0.0016223459970206022
we O 0 0.001953499624505639
diagnosed O 1 0.9999697208404541
the O 0 0.02853996679186821
disorder O 1 0.9999988079071045
in O 0 0.018394403159618378
8 O 0 0.046411093324422836
patients O 0 0.22642676532268524
originating O 0 0.002789980499073863
from O 0 0.001317077549174428
3 O 0 0.00197585322894156
unrelated O 0 0.002388960914686322
families O 0 0.0014936263905838132
, O 0 0.0011592269875109196
all O 0 0.0008805092074908316
Palestinian O 0 0.0024351163301616907
Arabs O 0 0.0026866125408560038
from O 0 0.0017000723164528608
the O 0 0.0025143332313746214
region O 0 0.004749737214297056
of O 0 0.006439819931983948
Jerusalem O 0 0.11463364958763123
. O 0 0.015911869704723358

The O 0 0.016071181744337082
clinical O 1 0.9988477230072021
diagnosis O 1 0.999995231628418
of O 1 0.9994456171989441
AGU B-Disease 1 1.0
is O 0 0.02545894868671894
often O 0 0.0019801510497927666
difficult O 0 0.0019339342834427953
, O 0 0.0012053949758410454
in O 0 0.0009072492248378694
particular O 0 0.0011308726388961077
early O 0 0.0010744131868705153
in O 0 0.0008324930095113814
the O 0 0.0011447230353951454
course O 0 0.002166381338611245
of O 0 0.0020942070987075567
the O 0 0.40694770216941833
disease O 1 0.9999994039535522
, O 0 0.0017553468933328986
and O 0 0.000807429663836956
most O 0 0.0006928499205969274
of O 0 0.0012728329747915268
the O 0 0.027709539979696274
patients O 1 0.9967700242996216
are O 0 0.0015238196356222034
diagnosed O 1 0.9999901056289673
after O 0 0.003937487956136465
the O 0 0.0025333394296467304
age O 0 0.004261513240635395
of O 0 0.003333698259666562
5 O 0 0.00545753026381135
years O 0 0.005642234813421965
. O 0 0.007674893364310265

However O 0 0.007218636106699705
, O 0 0.0038395915180444717
since O 0 0.0030199973843991756
these O 0 0.0021043680608272552
patients O 1 0.6772294044494629
excrete O 0 0.30010324716567993
early O 0 0.0022298747207969427
large O 0 0.0018717857310548425
amounts O 0 0.002345829037949443
of O 0 0.0023408636916428804
aspartylglucosamine O 1 0.9565275311470032
in O 0 0.0020750239491462708
urine O 0 0.007287359330803156
, O 0 0.0019242310663685203
biochemical O 0 0.005074535962194204
screening O 0 0.003833807073533535
is O 0 0.0020580305717885494
easy O 0 0.003274340881034732
by O 0 0.0026918677613139153
urine O 0 0.013433664105832577
chromatography O 0 0.05754100903868675
. O 0 0.007422148250043392
. O 0 0.012790484353899956

Detection O 0 0.019675305113196373
of O 0 0.008485215716063976
heterozygous O 0 0.011022274382412434
carriers O 0 0.0064535667188465595
of O 0 0.0045885201543569565
the O 0 0.21794965863227844
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999929666519165
telangiectasia I-Disease 1 0.9999995231628418
( O 0 0.0201572198420763
ATM O 0 0.018003180623054504
) O 0 0.003083142451941967
gene O 0 0.002951213391497731
by O 0 0.0024066383484750986
G2 O 1 0.9817173480987549
phase O 0 0.04002586007118225
chromosomal O 1 0.6897417306900024
radiosensitivity O 1 0.9904809594154358
of O 1 0.9222018122673035
peripheral O 1 0.9999985694885254
blood O 1 0.9999790191650391
lymphocytes O 1 0.9970961809158325
. O 0 0.02234026789665222

In O 0 0.021746495738625526
ataxia B-Disease 1 0.9999988079071045
- I-Disease 1 0.9997982382774353
telangiectasia I-Disease 1 0.9999979734420776
( O 0 0.17509061098098755
A B-Disease 1 0.9959536790847778
- I-Disease 1 0.9999300241470337
T I-Disease 1 0.9999852180480957
) O 0 0.0032444673124700785
patients O 0 0.01895570009946823
, O 0 0.001170070841908455
mutations O 0 0.001299380324780941
in O 0 0.0006762307020835578
a O 0 0.0012355372309684753
single O 0 0.0015306515851989388
gene O 0 0.0015941907186061144
, O 0 0.0011119403643533587
ATM O 0 0.0034459528978914022
, O 0 0.0011355841998010874
result O 0 0.001505098189227283
in O 0 0.0017775046871975064
an O 0 0.017368746921420097
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.4849318861961365
embraces O 1 0.9249055981636047
a O 0 0.003433811478316784
variety O 0 0.002288500079885125
of O 0 0.004807516001164913
clinical O 1 0.9987673759460449
features O 0 0.007747204042971134
and O 0 0.0030578295700252056
manifests O 1 0.9668959975242615
extreme O 1 0.7738024592399597
radiosensitivity O 1 0.9186320304870605
and O 0 0.0018703091191127896
a O 0 0.0025302660651504993
strong O 0 0.004432178568094969
pre O 0 0.2808249294757843
- O 0 0.40545785427093506
disposition O 1 0.608268678188324
to O 0 0.007578668650239706
malignancy B-Disease 1 0.9994100332260132
. O 0 0.015060881152749062

Heterozygotes O 0 0.05099649354815483
for O 0 0.00702135032042861
the O 0 0.007240321021527052
ATM O 0 0.021459799259901047
gene O 0 0.0038288498762995005
have O 0 0.0012534453999251127
no O 0 0.0014313734136521816
clinical O 0 0.003837771713733673
expression O 0 0.002291017211973667
of O 0 0.0028636353090405464
A B-Disease 1 0.9987952709197998
- I-Disease 1 0.9998155236244202
T I-Disease 1 0.9997397065162659
but O 0 0.0012116674333810806
may O 0 0.0019423419144004583
be O 0 0.0017450142186135054
cancer B-Disease 1 0.9986610412597656
prone O 1 0.7307993173599243
with O 0 0.0014890111051499844
a O 0 0.004137409385293722
moderate O 0 0.08392542600631714
increase O 0 0.0020869611762464046
in O 0 0.001918274792842567
in O 0 0.0038572652265429497
vitro O 0 0.05450756102800369
radiosensitivity O 1 0.8448595404624939
. O 0 0.013497551903128624

We O 0 0.009924781508743763
performed O 0 0.008420045487582684
a O 0 0.0056485566310584545
blind O 0 0.022380448877811432
chromosomal O 0 0.011490494944155216
analysis O 0 0.0038287206552922726
on O 0 0.004285863135010004
G2 O 1 0.9998946189880371
- O 0 0.01765373721718788
phase O 0 0.009044529870152473
lymphocytes O 0 0.006963291205465794
from O 0 0.0017655828269198537
7 O 0 0.002733566565439105
unrelated O 0 0.004917335230857134
A B-Disease 1 0.7798304557800293
- I-Disease 1 0.999299168586731
T I-Disease 1 0.9998384714126587
patients O 0 0.03314048796892166
, O 0 0.0018375191139057279
13 O 0 0.002901657484471798
obligate O 0 0.005744831170886755
A B-Disease 0 0.25837448239326477
- I-Disease 1 0.9798992872238159
T I-Disease 1 0.9984742999076843
heterozygotes O 0 0.06834835559129715
( O 0 0.002257018117234111
parents O 0 0.0016838182928040624
of O 0 0.0015496904961764812
the O 0 0.0028308520559221506
patients O 1 0.6097649931907654
) O 0 0.0014197496930137277
, O 0 0.0010437468299642205
and O 0 0.0008679304737597704
14 O 0 0.0016925070667639375
normal O 0 0.0015076329000294209
controls O 0 0.0017877782229334116
following O 0 0.0020100458059459925
X O 0 0.006898422725498676
- O 0 0.0036895140074193478
irradiation O 0 0.00470918882638216
with O 0 0.0012854854576289654
1 O 0 0.003028194885700941
Gy O 0 0.018882056698203087
in O 0 0.0013608593726530671
order O 0 0.0013761194422841072
to O 0 0.0011243964545428753
evaluate O 0 0.0027487666811794043
this O 0 0.0013286239700391889
cytogenetic O 0 0.0074166287668049335
method O 0 0.0024957233108580112
as O 0 0.0017692095134407282
a O 0 0.002268136478960514
tool O 0 0.004744623322039843
for O 0 0.0026811754796653986
detection O 0 0.0076264371164143085
of O 0 0.007749873213469982
ATM O 1 0.6912983059883118
carriers O 0 0.02655339054763317
. O 0 0.013353263959288597

Both O 0 0.011161903850734234
A B-Disease 1 0.9584973454475403
- I-Disease 1 0.9996596574783325
T I-Disease 1 0.9999836683273315
homozygotes O 1 0.9979828596115112
and O 0 0.004991134628653526
heterozygotes O 1 0.8064243197441101
showed O 0 0.006754342932254076
significantly O 0 0.0029735108837485313
increased O 0 0.002486131154000759
levels O 0 0.0031339998822659254
of O 0 0.004380641505122185
radiation O 1 0.9994550347328186
- O 1 0.9989526271820068
induced O 1 0.9999179840087891
chromatid O 1 0.9999630451202393
damage O 0 0.45658209919929504
relative O 0 0.0044759418815374374
to O 0 0.0017971358029171824
that O 0 0.0016515053575858474
of O 0 0.003863178426399827
normal O 0 0.008747834712266922
controls O 0 0.011395576409995556
. O 0 0.011931043118238449

These O 0 0.0055089425295591354
results O 0 0.004772394895553589
show O 0 0.003822874277830124
that O 0 0.0020424635149538517
the O 0 0.004532556515187025
G2 O 1 0.9999521970748901
- O 0 0.3098101317882538
phase O 0 0.17522524297237396
chromosomal O 1 0.6242718696594238
radiosensitivity O 1 0.564745306968689
assay O 0 0.00655503012239933
can O 0 0.0010792597895488143
be O 0 0.0007537861820310354
used O 0 0.0008482852717861533
for O 0 0.0009130642283707857
the O 0 0.0015149449463933706
detection O 0 0.004178306087851524
of O 0 0.004490737337619066
A B-Disease 1 0.999578058719635
- I-Disease 1 0.9999574422836304
T I-Disease 1 0.999930739402771
heterozygotes O 1 0.7935728430747986
. O 0 0.013082020916044712

In O 0 0.007618235889822245
combination O 0 0.007241061422973871
with O 0 0.002364498795941472
molecular O 0 0.005126379430294037
genetic O 0 0.0037767677567899227
analyses O 0 0.0029948498122394085
, O 0 0.001239823643118143
this O 0 0.0008623003959655762
test O 0 0.0012606183299794793
may O 0 0.0008183417376130819
be O 0 0.0004824940988328308
of O 0 0.0006102783954702318
value O 0 0.0009292326285503805
in O 0 0.0007303981110453606
studies O 0 0.0012955056736245751
of O 0 0.0019935527816414833
familial B-Disease 1 0.9994366765022278
and I-Disease 0 0.012578189373016357
sporadic I-Disease 1 0.9599006175994873
cancers I-Disease 1 0.9997218251228333
aimed O 0 0.004626621026545763
at O 0 0.0028248815797269344
determination O 0 0.003984682261943817
of O 0 0.0019356368575245142
the O 0 0.002060903934761882
potential O 0 0.0023253385443240404
involvement O 0 0.00319675006903708
of O 0 0.0038001772481948137
ATM O 1 0.9325263500213623
mutations O 0 0.010132046416401863
in O 0 0.007307872176170349
tumor B-Disease 1 0.9999951124191284
risk O 1 0.6944236159324646
or O 0 0.004143114201724529
development O 0 0.007910328917205334
. O 0 0.005285658873617649
. O 0 0.00995057262480259

Ataxia B-Disease 1 0.999998927116394
- I-Disease 1 0.9998824596405029
telangiectasia I-Disease 1 0.9999867677688599
: O 0 0.007437685038894415
identification O 0 0.004809398669749498
and O 0 0.0020967316813766956
detection O 0 0.004897387232631445
of O 0 0.00407231692224741
founder O 1 0.9937199354171753
- O 0 0.10654211044311523
effect O 0 0.0026609620545059443
mutations O 0 0.002002682536840439
in O 0 0.0011995101813226938
the O 0 0.0023450437001883984
ATM O 0 0.024840595200657845
gene O 0 0.0034522302448749542
in O 0 0.00212225504219532
ethnic O 0 0.005827706307172775
populations O 0 0.009705277159810066
. O 0 0.01188765186816454

To O 0 0.0063501945696771145
facilitate O 0 0.006760456133633852
the O 0 0.0039754160679876804
evaluation O 0 0.005734654609113932
of O 0 0.003931089770048857
ATM O 0 0.09927764534950256
heterozygotes O 0 0.1460568755865097
for O 0 0.002051153453066945
susceptibility O 0 0.010433737188577652
to O 0 0.0013934014132246375
other O 0 0.001455712947063148
diseases O 1 0.9998003840446472
, O 0 0.0019328860798850656
such O 0 0.0020895982161164284
as O 1 0.9738616943359375
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 0.002394638257101178
we O 0 0.000858717190567404
have O 0 0.0005418385262601078
attempted O 0 0.0012865252792835236
to O 0 0.0006260640802793205
define O 0 0.001508185756392777
the O 0 0.0010235074441879988
most O 0 0.0009641157812438905
common O 0 0.001489632180891931
mutations O 0 0.001608680933713913
and O 0 0.0008029878954403102
their O 0 0.0009052605601027608
frequencies O 0 0.0017151860520243645
in O 0 0.0024347223807126284
ataxia B-Disease 1 0.9999979734420776
- I-Disease 1 0.9991698265075684
telangiectasia I-Disease 1 0.9999983310699463
( O 0 0.0967312902212143
A B-Disease 1 0.9932531714439392
- I-Disease 1 0.9992097616195679
T I-Disease 1 0.9994851350784302
) O 0 0.0027330454904586077
homozygotes O 0 0.010606671683490276
from O 0 0.0025105439126491547
10 O 0 0.0036925547756254673
ethnic O 0 0.005817791447043419
populations O 0 0.00997573509812355
. O 0 0.011132454499602318

Both O 0 0.009338978677988052
genomic O 0 0.015804409980773926
mutations O 0 0.0073348055593669415
and O 0 0.002801896771416068
their O 0 0.0026788737159222364
effects O 0 0.007703213486820459
on O 0 0.004991617985069752
cDNA O 0 0.017839444801211357
were O 0 0.006856445223093033
characterized O 0 0.02375265769660473
. O 0 0.01405105646699667

Protein O 0 0.022612426429986954
- O 0 0.01579975336790085
truncation O 0 0.018279315903782845
testing O 0 0.005867045372724533
of O 0 0.0033175775315612555
the O 0 0.003835235256701708
entire O 0 0.007066684775054455
ATM O 0 0.01364790927618742
cDNA O 0 0.011057003401219845
detected O 0 0.005572590511292219
92 O 0 0.00678492384031415
( O 0 0.0029279466252774
66 O 0 0.005627279169857502
% O 0 0.002889482071623206
) O 0 0.003401120426133275
truncating O 0 0.01350763812661171
mutations O 0 0.005536448210477829
in O 0 0.0036460733972489834
140 O 0 0.011407960206270218
mutant O 0 0.022098533809185028
alleles O 0 0.020155232399702072
screened O 0 0.022950446233153343
. O 0 0.014652400277554989

The O 0 0.012167253531515598
haplotyping O 1 0.6272695660591125
of O 0 0.01072500366717577
patients O 1 0.9610368609428406
with O 0 0.0022968975827097893
identical O 0 0.00646949140354991
mutations O 0 0.004144889302551746
indicates O 0 0.0031138197518885136
that O 0 0.0007071131258271635
almost O 0 0.0008036619401536882
all O 0 0.0005349645507521927
of O 0 0.0008340477361343801
these O 0 0.0006224303506314754
represent O 0 0.0013143551768735051
common O 0 0.0017728235106915236
ancestry O 0 0.002707220148295164
and O 0 0.0011015114141628146
that O 0 0.0010371104581281543
very O 0 0.0017000860534608364
few O 0 0.0021857989486306906
spontaneously O 0 0.021811680868268013
recurring O 1 0.9974862337112427
ATM O 1 0.8708665370941162
mutations O 0 0.010614280588924885
exist O 0 0.008073767647147179
. O 0 0.01120696123689413

Assays O 0 0.02853552997112274
requiring O 0 0.013711224310100079
minimal O 0 0.012021330185234547
amounts O 0 0.006021994631737471
of O 0 0.003952736500650644
genomic O 0 0.008107719011604786
DNA O 0 0.004113161005079746
were O 0 0.0018215714953839779
designed O 0 0.0024718516506254673
to O 0 0.0012333136983215809
allow O 0 0.0015205786330625415
rapid O 0 0.004877395927906036
screening O 0 0.004256825428456068
for O 0 0.0020297723822295666
common O 0 0.004534757696092129
ethnic O 0 0.007936169393360615
mutations O 0 0.01678067445755005
. O 0 0.011808340437710285

These O 0 0.008561345748603344
rapid O 0 0.01498942356556654
assays O 0 0.010880885645747185
detected O 0 0.007711323909461498
mutations O 0 0.004391876049339771
in O 0 0.0020878096111118793
76 O 0 0.005331358406692743
% O 0 0.002008983399719
of O 0 0.002261510118842125
Costa O 0 0.011236399412155151
Rican O 0 0.13145938515663147
patients O 0 0.29880860447883606
( O 0 0.0025707895401865244
3 O 0 0.0020046704448759556
) O 0 0.0009516575373709202
, O 0 0.0007398495799861848
50 O 0 0.001008522231131792
% O 0 0.0009044570615515113
of O 0 0.0010952468728646636
Norwegian O 0 0.00400415388867259
patients O 0 0.0202172938734293
( O 0 0.001591273583471775
1 O 0 0.0015313078183680773
) O 0 0.0007883135695010424
, O 0 0.000690322951413691
25 O 0 0.0011597588891163468
% O 0 0.0009721830720081925
of O 0 0.0014364414382725954
Polish O 1 0.9382959604263306
patients O 1 0.8694267272949219
( O 0 0.0022088070400059223
4 O 0 0.0020362602081149817
) O 0 0.0009291714522987604
, O 0 0.0006848524208180606
and O 0 0.0006153545691631734
14 O 0 0.0011793054873123765
% O 0 0.0009664517128840089
of O 0 0.0012774798087775707
Italian O 0 0.4706447422504425
patients O 1 0.9947025179862976
( O 0 0.0037469547241926193
1 O 0 0.0024457077961415052
) O 0 0.0010651473421603441
, O 0 0.0008156616822816432
as O 0 0.0007550989976152778
well O 0 0.000849271600600332
as O 0 0.0010261449497193098
in O 0 0.001542782294563949
patients O 0 0.00883036945015192
of O 0 0.004480554722249508
Amish O 1 0.874228298664093
/ O 0 0.4241601228713989
Mennonite O 0 0.01929398812353611
and O 0 0.003986029420047998
Irish O 0 0.009552935138344765
English O 0 0.009876087307929993
backgrounds O 0 0.018668506294488907
. O 0 0.014471227303147316

Additional O 0 0.011774878948926926
mutations O 0 0.0061775813810527325
were O 0 0.002217538421973586
observed O 0 0.002419443801045418
in O 0 0.0015934760449454188
Japanese O 0 0.005432808771729469
, O 0 0.001965396571904421
Utah O 0 0.005259407684206963
Mormon O 0 0.005297907628118992
, O 0 0.0020938345696777105
and O 0 0.0024169727694243193
African O 0 0.009073586203157902
American O 0 0.02848774567246437
patients O 1 0.9710144996643066
. O 0 0.0138922818005085

These O 0 0.00660345796495676
assays O 0 0.00925125926733017
should O 0 0.0035793669521808624
facilitate O 0 0.004758279304951429
screening O 0 0.0054474323987960815
for O 0 0.0032970195170491934
A B-Disease 1 0.938922643661499
- I-Disease 1 0.9987516403198242
T I-Disease 1 0.9995736479759216
heterozygotes O 0 0.0325816348195076
in O 0 0.002292279852554202
the O 0 0.003029729938134551
populations O 0 0.0042138369753956795
studied O 0 0.0074440655298531055
. O 0 0.00592205673456192
. O 0 0.010102854110300541

The O 0 0.022435829043388367
von B-Disease 1 0.9954040050506592
Hippel I-Disease 1 0.999976634979248
- I-Disease 1 0.9999728202819824
Lindau I-Disease 1 0.9999994039535522
tumor I-Disease 1 0.9999990463256836
suppressor O 1 0.991081178188324
gene O 0 0.004339741542935371
is O 0 0.001841469551436603
required O 0 0.001634062733501196
for O 0 0.0018822612473741174
cell O 0 0.004729161038994789
cycle O 0 0.008174514397978783
exit O 0 0.010204719379544258
upon O 0 0.009365029633045197
serum O 1 0.9655543565750122
withdrawal O 0 0.027316344901919365
. O 0 0.012787341140210629

The O 0 0.013711308129131794
inactivation O 0 0.038095030933618546
of O 0 0.00695520406588912
the O 0 0.01039616484194994
von B-Disease 1 0.998557984828949
Hippel I-Disease 1 0.9999639987945557
- I-Disease 1 0.9990891218185425
Lindau I-Disease 1 0.9999827146530151
( I-Disease 0 0.4708242416381836
VHL I-Disease 1 0.9999948740005493
) I-Disease 0 0.1658092588186264
tumor I-Disease 1 0.9999790191650391
suppressor O 1 0.9926735758781433
gene O 0 0.007465207017958164
predisposes O 0 0.03807980567216873
affected O 0 0.0024059743154793978
individuals O 0 0.0009719617664813995
to O 0 0.0014229441294446588
the O 0 0.0038723989855498075
human O 1 0.9941831231117249
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.8170354962348938
is O 0 0.08560101687908173
associated O 0 0.015236468985676765
with O 0 0.006741488818079233
sporadic B-Disease 1 0.9998950958251953
renal I-Disease 1 1.0
cell I-Disease 1 0.9999977350234985
carcinomas I-Disease 1 1.0
( O 1 0.9997923970222473
RCC B-Disease 1 1.0
) O 0 0.013104313984513283
and O 0 0.007488231640309095
brain B-Disease 1 0.9893613457679749
hemangioblastomas I-Disease 1 0.988283097743988
. O 0 0.014584469608962536

VHL O 1 0.9962549209594727
- O 0 0.03893950581550598
negative O 0 0.015390410088002682
786 O 1 0.9875013828277588
- O 1 0.7335004210472107
0 O 0 0.014698135666549206
RCC B-Disease 1 0.9999288320541382
cells O 0 0.0034544586669653654
are O 0 0.0013167933793738484
tumorigenic O 0 0.013048842549324036
in O 0 0.0026102131232619286
nude O 1 0.7915220856666565
mice O 0 0.008864674717187881
which O 0 0.001628279103897512
is O 0 0.0022242628037929535
suppressed O 0 0.006603239569813013
by O 0 0.0023459685035049915
the O 0 0.005690691061317921
reintroduction O 0 0.22946979105472565
of O 0 0.024604663252830505
VHL B-Disease 1 0.9999544620513916
. O 0 0.016196008771657944

Remarkably O 0 0.1583467721939087
, O 0 0.004695062059909105
this O 0 0.0022729416377842426
occurs O 0 0.0024047591723501682
without O 0 0.0013964761747047305
affecting O 0 0.0025635543279349804
the O 0 0.002174593508243561
growth O 0 0.004147919826209545
rate O 0 0.0020841644145548344
and O 0 0.0011643768521025777
cell O 0 0.0027265858370810747
cycle O 0 0.003445402951911092
profile O 0 0.0021272473968565464
of O 0 0.0017418499337509274
these O 0 0.0014477857621386647
cells O 0 0.0034340396523475647
in O 0 0.003233199007809162
culture O 0 0.010710427537560463
. O 0 0.011851757764816284

The O 0 0.015616564080119133
786 O 0 0.4973942041397095
- O 0 0.017581000924110413
0 O 0 0.007332764100283384
cell O 0 0.004499349277466536
line O 0 0.003383840899914503
, O 0 0.0018636803142726421
like O 0 0.0021395240910351276
many O 0 0.002416684292256832
cancer B-Disease 1 0.9999735355377197
cells O 0 0.004711401183158159
, O 0 0.0017949423054233193
fails O 0 0.0030061074066907167
to O 0 0.0011564040323719382
exit O 0 0.004043036140501499
the O 0 0.0026353709399700165
cell O 0 0.005178723018616438
cycle O 0 0.007614342495799065
upon O 0 0.006882828660309315
serum O 1 0.9121565818786621
withdrawal O 0 0.023890351876616478
. O 0 0.013035733252763748

Here O 0 0.0097696203738451
, O 0 0.004046635702252388
it O 0 0.0019618324004113674
is O 0 0.001803748426027596
shown O 0 0.001981817651540041
that O 0 0.001147788600064814
reintroduction O 0 0.005009036976844072
of O 0 0.0020192540250718594
the O 0 0.003507040673866868
wild O 0 0.010333173908293247
- O 0 0.27453574538230896
type O 0 0.36501723527908325
VHL B-Disease 1 0.999042809009552
gene O 0 0.004862597212195396
restores O 0 0.006926590111106634
the O 0 0.002003352390602231
ability O 0 0.0021661382634192705
of O 0 0.004057076759636402
VHL O 1 0.9999961853027344
- O 1 0.9985994696617126
negative O 1 0.9751739501953125
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9999901056289673
cells O 0 0.0034025395289063454
to O 0 0.0016471345443278551
exit O 0 0.003769471077248454
the O 0 0.002481223549693823
cell O 0 0.004686548840254545
cycle O 0 0.006441302597522736
and O 0 0.0029026747215539217
enter O 0 0.009825242683291435
G0 O 1 0.9998698234558105
/ O 1 0.5990374684333801
quiescence O 0 0.10191495716571808
in O 0 0.008490162901580334
low O 0 0.029569558799266815
serum O 1 0.8855308294296265
. O 0 0.016593988984823227

Both O 0 0.01618504896759987
VHL O 1 0.999407172203064
- O 0 0.03748120740056038
positive O 0 0.0077438028529286385
and O 0 0.005406951066106558
VHL O 1 0.9999696016311646
- O 1 0.9538402557373047
negative O 0 0.085398830473423
RCC B-Disease 1 0.9999918937683105
cells O 0 0.0054650926031172276
exit O 0 0.005979405716061592
the O 0 0.0034639898221939802
cell O 0 0.006379059981554747
cycle O 0 0.0066617075353860855
by O 0 0.004085478838533163
contact O 0 0.010668749921023846
inhibition O 0 0.028797572478652
. O 0 0.013952948153018951

The O 0 0.026802027598023415
cyclin O 1 0.9882120490074158
- O 1 0.719211995601654
dependent O 0 0.020313074812293053
kinase O 0 0.09411847591400146
inhibitor O 1 0.804124653339386
, O 0 0.004955859389156103
p27 O 1 0.7526156306266785
, O 0 0.0037978587206453085
accumulates O 0 0.023755155503749847
upon O 0 0.00496954470872879
serum O 1 0.8671966195106506
withdrawal O 0 0.004851713310927153
, O 0 0.0012576250592246652
only O 0 0.0008561959839425981
in O 0 0.0008163771126419306
the O 0 0.0012472381349653006
presence O 0 0.001927891280502081
of O 0 0.003019618568941951
VHL B-Disease 1 0.9999618530273438
, O 0 0.0014858157373964787
as O 0 0.0010114627657458186
a O 0 0.001071354141458869
result O 0 0.001151503762230277
of O 0 0.0016439673490822315
the O 0 0.0031370879150927067
stabilization O 0 0.40849536657333374
of O 0 0.005004634615033865
the O 0 0.007419872563332319
protein O 0 0.011266147717833519
. O 0 0.009644810110330582

We O 0 0.007609529886394739
propose O 0 0.008121738210320473
that O 0 0.0024211269337683916
the O 0 0.0024431380443274975
loss O 0 0.005008986219763756
of O 0 0.004090371076017618
wild O 1 0.6376239657402039
- O 1 0.996065080165863
type O 1 0.980231761932373
VHL B-Disease 1 0.999836802482605
gene O 0 0.003186635673046112
results O 0 0.0014840353978797793
in O 0 0.001195581629872322
a O 0 0.0019243565620854497
specific O 0 0.002048073336482048
cellular O 0 0.005254966206848621
defect O 1 0.8196114897727966
in O 0 0.004540607798844576
serum O 1 0.9998378753662109
- O 1 0.5057567954063416
dependent O 0 0.0040041618049144745
growth O 0 0.0026426350232213736
control O 0 0.00232920260168612
, O 0 0.0020573022775352
which O 0 0.0019335228716954589
may O 0 0.004500695504248142
initiate O 0 0.046956416219472885
tumor B-Disease 1 0.9991105198860168
formation O 0 0.08517301082611084
. O 0 0.016233736649155617

This O 0 0.006666736211627722
is O 0 0.0050788442604243755
corrected O 0 0.008762999437749386
by O 0 0.00187025242485106
the O 0 0.0024372159969061613
reintroduction O 0 0.007223248016089201
of O 0 0.0030097640119493008
wild O 0 0.01865672506392002
- O 1 0.6854273676872253
type O 1 0.7300753593444824
VHL B-Disease 1 0.9998182654380798
, O 0 0.005349934566766024
implicating O 1 0.984522819519043
VHL B-Disease 1 0.9996297359466553
as O 0 0.0032230846118181944
the O 0 0.0038322594482451677
first O 0 0.23879320919513702
tumor B-Disease 1 0.9999905824661255
suppressor O 0 0.14013700187206268
involved O 0 0.0017714359564706683
in O 0 0.0010644535068422556
the O 0 0.0016045001102611423
regulation O 0 0.0020020809024572372
of O 0 0.0018941774033010006
cell O 0 0.0077506243251264095
cycle O 0 0.006151618901640177
exit O 0 0.003937458619475365
, O 0 0.0012468285858631134
which O 0 0.0007515749312005937
is O 0 0.0009685838595032692
consistent O 0 0.0016767092747613788
with O 0 0.0009033779497258365
its O 0 0.0014925046125426888
gatekeeper O 1 0.8809377551078796
function O 0 0.0024842126294970512
in O 0 0.0023821815848350525
the O 0 0.04564930126070976
kidney O 1 0.9999982118606567
. O 0 0.008271735161542892
. O 0 0.010611831210553646

Piebaldism B-Disease 1 0.9977619647979736
with O 0 0.019077248871326447
deafness B-Disease 1 0.9999938011169434
: O 0 0.007707002107053995
molecular O 0 0.006337570026516914
evidence O 0 0.004137835465371609
for O 0 0.0037243016995489597
an O 0 0.00781292375177145
expanded O 1 0.8836265802383423
syndrome O 1 0.9999997615814209
. O 0 0.023677794262766838

In O 0 0.007219067309051752
a O 0 0.005960554350167513
South O 0 0.005713704042136669
African O 0 0.004967594984918833
girl O 0 0.029621893540024757
of O 0 0.005280627403408289
Xhosa O 1 0.9998071789741516
stock O 0 0.01732529327273369
with O 0 0.004771430045366287
severe O 1 0.9999984502792358
piebaldism B-Disease 1 0.9999982118606567
and O 1 0.9943407773971558
profound O 1 0.9999998807907104
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.24515238404273987
identified O 0 0.010951042175292969
a O 0 0.003503386629745364
novel O 0 0.0066300928592681885
missense O 0 0.007146209012717009
substitution O 0 0.0035867588594555855
at O 0 0.0019917436875402927
a O 0 0.0021182054188102484
highly O 0 0.002861103741452098
conserved O 0 0.0036703150253742933
residue O 0 0.005346326157450676
in O 0 0.002069140551611781
the O 0 0.0027730257716029882
intracellular O 0 0.008794757537543774
kinase O 0 0.0061309197917580605
domain O 0 0.0028720428235828876
of O 0 0.002888806164264679
the O 0 0.007237277925014496
KIT O 1 0.9999542236328125
proto O 1 0.9999336004257202
- O 1 0.9789468050003052
oncogene O 1 0.989306628704071
, O 0 0.010914567857980728
R796G O 0 0.07851681113243103
. O 0 0.018036620691418648

Though O 0 0.01994730718433857
auditory B-Disease 1 0.6133827567100525
anomalies I-Disease 0 0.13998113572597504
have O 0 0.0026397774927318096
been O 0 0.0020661386661231518
observed O 0 0.002278415486216545
in O 0 0.0016965032555162907
mice O 0 0.003344333963468671
with O 0 0.0013045042287558317
dominant O 0 0.005617537070065737
white O 0 0.048065654933452606
spotting O 1 0.9739575982093811
( O 0 0.034601375460624695
W O 1 0.9458582997322083
) O 0 0.0015672281151637435
due O 0 0.001824784092605114
to O 0 0.0018061641603708267
KIT O 1 0.9995002746582031
mutations O 0 0.01081192959100008
, O 0 0.004758153110742569
deafness B-Disease 1 0.9999932050704956
is O 0 0.0027330140583217144
not O 0 0.0015549081144854426
typical O 0 0.0042470828630030155
in O 0 0.003890961641445756
human O 0 0.01118495687842369
piebaldism B-Disease 1 0.9537346959114075
. O 0 0.015946507453918457

Thus O 0 0.00911322794854641
, O 0 0.003972558304667473
the O 0 0.004332373850047588
occurrence O 0 0.06554242968559265
of O 1 0.8998674750328064
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.642232358455658
this O 0 0.007848103530704975
patient O 1 0.9527885913848877
extends O 0 0.004941979423165321
considerably O 0 0.003148336661979556
the O 0 0.0018281255615875125
phenotypic O 0 0.003570673754438758
range O 0 0.002014990197494626
of O 0 0.0025347615592181683
piebaldism B-Disease 1 0.5395542979240417
due O 0 0.0035393170546740294
to O 0 0.00263143889605999
KIT O 1 0.9629110097885132
gene O 0 0.003149438416585326
mutation O 0 0.002341723535209894
in O 0 0.0012436333345249295
humans O 0 0.0020218135323375463
and O 0 0.0018304467666894197
tightens O 0 0.033155929297208786
the O 0 0.002300405642017722
clinical O 0 0.012526609934866428
similarity O 0 0.00361764058470726
between O 0 0.0020005018450319767
piebaldism B-Disease 0 0.01545712910592556
and O 0 0.0015085821505635977
the O 0 0.0017849095165729523
various O 0 0.0019440803444013
forms O 0 0.006027956958860159
of O 1 0.997751772403717
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.6491963267326355
. O 0 0.017349697649478912

Cycloheximide O 0 0.2200320065021515
facilitates O 0 0.02303164079785347
the O 0 0.006609534844756126
identification O 0 0.006490150932222605
of O 0 0.00495165167376399
aberrant O 0 0.030658621340990067
transcripts O 0 0.005419556982815266
resulting O 0 0.003617473877966404
from O 0 0.0020228144712746143
a O 0 0.003205591579899192
novel O 0 0.008987246081233025
splice O 0 0.016993654891848564
- O 0 0.005811779294162989
site O 0 0.0035521239042282104
mutation O 0 0.0035942818503826857
in O 0 0.0019531473517417908
COL17A1 O 1 0.5592811703681946
in O 0 0.002260307315737009
a O 0 0.004879549145698547
patient O 1 0.9896935820579529
with O 0 0.050050295889377594
generalized O 1 0.9999946355819702
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999991655349731
. O 0 0.11935049295425415

Patients O 1 0.9590967297554016
with O 0 0.022700583562254906
generalized O 1 0.9999531507492065
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
often O 0 0.015876593068242073
show O 0 0.007207539398223162
decreased O 0 0.010335699655115604
expression O 0 0.004150420427322388
of O 0 0.009654383175075054
type O 1 0.9999524354934692
XVII O 1 1.0
collagen O 1 0.9999945163726807
, O 0 0.004908404313027859
a O 0 0.006396552547812462
transmembrane O 0 0.04449034109711647
hemidesmosomal O 0 0.18913505971431732
protein O 0 0.005868592299520969
encoded O 0 0.004476564470678568
by O 0 0.004962967708706856
COL17A1 O 1 0.691961944103241
. O 0 0.014827504754066467

This O 0 0.006571454927325249
report O 0 0.0050110784359276295
documents O 0 0.004449968226253986
a O 0 0.0039018290117383003
novel O 0 0.00945353601127863
splice O 0 0.02605314552783966
- O 0 0.007393551990389824
site O 0 0.003849196946248412
mutation O 0 0.0034137957263737917
in O 0 0.0019069522386416793
COL17A1 O 1 0.6233993768692017
in O 0 0.0020270217210054398
a O 0 0.0035278426948934793
patient O 1 0.7832313179969788
with O 0 0.005750597454607487
generalized O 1 0.9999752044677734
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.015616246499121189
and O 0 0.0024238992482423782
applies O 0 0.0030699537601321936
a O 0 0.002113903174176812
new O 0 0.0018398058600723743
methodology O 0 0.0030408070888370275
to O 0 0.0013069864362478256
define O 0 0.002743579912930727
and O 0 0.001989339478313923
characterize O 0 0.006467585451900959
the O 0 0.003913321532309055
resulting O 0 0.008457547053694725
mRNA O 0 0.01599787548184395
splice O 0 0.032997023314237595
variants O 0 0.018643192946910858
. O 0 0.015615052543580532

Mutational O 0 0.05713963881134987
analysis O 0 0.009186452254652977
of O 0 0.007428752724081278
COL17A1 O 1 0.9544244408607483
identified O 0 0.007498441729694605
a O 0 0.006097677629441023
maternally O 1 0.9307184219360352
inherited O 1 0.9997150301933289
G O 1 0.9562358856201172
- O 0 0.020474176853895187
to O 0 0.0032406081445515156
- O 0 0.07087969779968262
T O 0 0.19529742002487183
transversion O 0 0.011636102572083473
at O 0 0.0030784502159804106
the O 0 0.0025440228637307882
- O 0 0.004589487332850695
1 O 0 0.0032990777399390936
position O 0 0.00368161010555923
of O 0 0.004361634608358145
exon O 0 0.028961261734366417
32 O 0 0.013665329664945602
. O 0 0.013353388756513596

This O 0 0.012603935785591602
acceptor O 0 0.03467931970953941
splice O 0 0.1570136696100235
- O 0 0.023130567744374275
site O 0 0.00586657552048564
mutation O 0 0.004264314658939838
led O 0 0.00237961090169847
to O 0 0.0011701025068759918
the O 0 0.0018086608033627272
formation O 0 0.0034541867207735777
of O 0 0.003093771869316697
aberrant O 0 0.0762077048420906
transcripts O 0 0.005889043677598238
present O 0 0.003734392812475562
at O 0 0.004227514378726482
extremely O 0 0.008503302931785583
low O 0 0.011707434430718422
levels O 0 0.012009421363472939
. O 0 0.010597363114356995

Based O 0 0.007639551535248756
on O 0 0.004550975747406483
our O 0 0.003323852550238371
recent O 0 0.003156099934130907
finding O 0 0.00447488809004426
that O 0 0.003221586812287569
cycloheximide O 1 0.8598037362098694
stabilized O 1 0.7116675972938538
mutant O 0 0.018481815233826637
COL17A1 O 0 0.13794758915901184
transcripts O 0 0.006512915249913931
in O 0 0.00282344501465559
keratinocytes O 0 0.01203934196382761
homozygous O 0 0.004741661250591278
for O 0 0.0018921681912615895
a O 0 0.0029212194494903088
frameshift O 0 0.26622164249420166
mutation O 0 0.004032313358038664
, O 0 0.0015357433585450053
the O 0 0.0017668657237663865
effects O 0 0.003431654768064618
of O 0 0.002391961868852377
the O 0 0.005046363919973373
splice O 0 0.2208561897277832
- O 0 0.006596758496016264
site O 0 0.003442399902269244
mutation O 0 0.0027632706332951784
on O 0 0.0016582750249654055
splicing O 0 0.003952353727072477
of O 0 0.0023748325183987617
COL17A1 O 0 0.06126035749912262
transcripts O 0 0.0046066767536103725
were O 0 0.0021258580964058638
determined O 0 0.0035352965351194143
using O 0 0.003287065541371703
reverse O 0 0.0092240609228611
transcriptase O 0 0.06778915971517563
polymerase O 0 0.009423302486538887
chain O 0 0.006083014886826277
reaction O 0 0.003540205070748925
of O 0 0.002536243526265025
total O 0 0.0044237724505364895
RNA O 0 0.006701418664306402
from O 0 0.002935962053015828
keratinocytes O 0 0.014560133218765259
incubated O 0 0.012140362523496151
for O 0 0.0049331309273839
2 O 0 0.011199872009456158
. O 0 0.011038977652788162

5 O 0 0.013479177840054035
h O 0 0.01256660558283329
in O 0 0.0030742210801690817
the O 0 0.003015652997419238
presence O 0 0.002919689519330859
or O 0 0.002091486705467105
absence O 0 0.0040969243273139
of O 0 0.0038159943651407957
10 O 0 0.005600346252322197
microg O 1 0.7334784269332886
cycloheximide O 1 0.6199299097061157
per O 0 0.009459950029850006
ml O 0 0.08500585705041885
. O 0 0.012157691642642021

Using O 0 0.006061091553419828
this O 0 0.0027453547809273005
approach O 0 0.003138709580525756
, O 0 0.001960413996130228
an O 0 0.0023234698455780745
abnormally O 1 0.6903420090675354
spliced O 0 0.009041184559464455
transcript O 0 0.006190918385982513
was O 0 0.003760387422516942
identified O 0 0.0019592249300330877
that O 0 0.0008590146899223328
contains O 0 0.0013129051076248288
an O 0 0.0011655932758003473
extra O 0 0.002396744443103671
264 O 0 0.003947931807488203
bases O 0 0.0019898999016731977
upstream O 0 0.0036070956848561764
from O 0 0.0019551010336726904
exon O 0 0.00784424226731062
32 O 0 0.003189304145053029
, O 0 0.0021165632642805576
resulting O 0 0.0027804092969745398
in O 0 0.002135827671736479
a O 0 0.00464979512616992
premature O 0 0.2854800224304199
termination O 0 0.03196171671152115
codon O 0 0.011694619432091713
27 O 0 0.0063643185421824455
bp O 0 0.007783013861626387
downstream O 0 0.00605805916711688
from O 0 0.0032987797167152166
the O 0 0.005225794389843941
cryptic O 0 0.02757485955953598
splice O 0 0.03703448921442032
site O 0 0.01858467049896717
. O 0 0.01601712591946125

Three O 0 0.007337677292525768
other O 0 0.00400279788300395
splice O 0 0.014304452575743198
variants O 0 0.004515040200203657
, O 0 0.001833931659348309
including O 0 0.0014940367545932531
one O 0 0.0013207315932959318
derived O 0 0.001971110003069043
from O 0 0.0011794547317549586
the O 0 0.0018273280002176762
skipping O 0 0.005123022012412548
of O 0 0.002700679237022996
exon O 0 0.024530205875635147
32 O 0 0.002887559123337269
, O 0 0.0017111311899498105
were O 0 0.002090996829792857
also O 0 0.003562272060662508
identified O 0 0.008152793161571026
. O 0 0.010256991721689701

These O 0 0.007222232408821583
results O 0 0.0057941316626966
indicate O 0 0.004988797940313816
the O 0 0.0036319259088486433
usefulness O 0 0.009103665128350258
of O 0 0.005220888182520866
cycloheximide O 1 0.9983319640159607
treatment O 1 0.8695036768913269
in O 0 0.0026039788499474525
evaluating O 0 0.005529867950826883
the O 0 0.0031104895751923323
abnormal O 0 0.013212323188781738
processing O 0 0.0028581318911165
of O 0 0.0021909072529524565
mRNA O 0 0.003504315624013543
due O 0 0.0018732312601059675
to O 0 0.0016876800218597054
splice O 0 0.007467471994459629
- O 0 0.0035563698038458824
site O 0 0.0028532708529382944
mutations O 0 0.0023426308762282133
, O 0 0.0016019173199310899
because O 0 0.001566037186421454
( O 0 0.0020929835736751556
i O 0 0.002344129141420126
) O 0 0.0019166376441717148
aberrant O 0 0.005538436118513346
splicing O 0 0.0038376222364604473
often O 0 0.002058308571577072
generates O 0 0.0037333641666918993
a O 0 0.0029285899363458157
premature O 0 0.012211019173264503
termination O 0 0.01762150228023529
codon O 0 0.007417840417474508
, O 0 0.0026648156344890594
( O 0 0.0035666655749082565
ii O 0 0.023063626140356064
) O 0 0.0023722052574157715
transcripts O 0 0.004381005652248859
with O 0 0.002889740513637662
premature O 0 0.05174298956990242
termination O 0 0.0766536220908165
codons O 0 0.006000261753797531
can O 0 0.0014231353998184204
occur O 0 0.00136942055542022
at O 0 0.0021681394428014755
low O 0 0.003905582008883357
or O 0 0.0023487815633416176
undetectable O 0 0.4095674753189087
levels O 0 0.003464865731075406
due O 0 0.0021293172612786293
to O 0 0.001542288693599403
nonsense O 0 0.021718237549066544
- O 0 0.00644893990829587
mediated O 0 0.004611171316355467
mRNA O 0 0.0031839043367654085
decay O 0 0.0038512598257511854
, O 0 0.0013530014548450708
and O 0 0.0013329902430996299
( O 0 0.0027384755667299032
iii O 0 0.11866071075201035
) O 0 0.0013283871812745929
the O 0 0.0012857853434979916
levels O 0 0.0016804687911644578
of O 0 0.0012196180177852511
these O 0 0.0009391677449457347
transcripts O 0 0.002479781862348318
can O 0 0.0011666718637570739
be O 0 0.001466215355321765
increased O 0 0.003865551669150591
by O 0 0.005353651475161314
cycloheximide O 0 0.19343942403793335
. O 0 0.01596754975616932

A O 0 0.022249020636081696
deletion O 0 0.031247751787304878
mutation O 0 0.00968257337808609
in O 0 0.0039151506498456
COL17A1 O 1 0.5269014239311218
in O 0 0.0026955504436045885
five O 0 0.0026716284919530153
Austrian O 0 0.10558433830738068
families O 0 0.005437536630779505
with O 0 0.006742319092154503
generalized O 1 0.9999667406082153
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999994039535522
represents O 0 0.23120704293251038
propagation O 0 0.03282926231622696
of O 0 0.0074280244298279285
an O 0 0.012718629091978073
ancestral O 1 0.8986217379570007
allele O 0 0.034741275012493134
. O 0 0.016211800277233124

Patients O 1 0.9468974471092224
with O 0 0.02440738119184971
generalized O 1 0.9999915361404419
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 0.025672614574432373
a O 0 0.00736171193420887
usually O 0 0.004343152977526188
nonlethal O 0 0.021092547103762627
form O 0 0.0049948920495808125
of O 0 0.01979142613708973
junctional B-Disease 1 0.9999986886978149
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999986886978149
, O 0 0.008151344023644924
have O 0 0.0036215547006577253
generalized O 1 0.8774305582046509
blistering B-Disease 1 0.9998145699501038
, O 1 0.9190372228622437
nail B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 1.0
, O 1 0.9972793459892273
patchy B-Disease 1 0.999998927116394
alopecia I-Disease 1 1.0
, O 1 0.9514265656471252
and O 1 0.9289606809616089
dental B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 0.9999967813491821
. O 0 0.0626940056681633

Skin B-Disease 1 0.9999842643737793
fragility I-Disease 1 0.999764621257782
in O 0 0.006490285973995924
most O 0 0.002953605493530631
cases O 0 0.004162983037531376
is O 0 0.0019367685308679938
due O 0 0.002078823745250702
to O 0 0.0011128506157547235
mutations O 0 0.0016098621999844909
in O 0 0.0010893646394833922
the O 0 0.002070816233754158
gene O 0 0.003927287179976702
encoding O 0 0.0066610416397452354
type O 0 0.40536996722221375
XVII O 1 0.9999966621398926
collagen O 1 0.9999585151672363
( O 0 0.04028763994574547
COL17A1 O 1 0.9938188195228577
) O 0 0.012516822665929794
. O 0 0.013988793827593327

Recently O 0 0.016277216374874115
, O 0 0.0052272845059633255
we O 0 0.0025595531333237886
reported O 0 0.0032565828878432512
five O 0 0.0022998431231826544
Austrian O 0 0.012459582649171352
families O 0 0.004249418154358864
with O 0 0.004954678937792778
generalized O 1 0.9998173117637634
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999994039535522
who O 0 0.053901560604572296
share O 0 0.005595069844275713
the O 0 0.005598790477961302
same O 0 0.0073835160583257675
COL17A1 O 1 0.9988025426864624
mutation O 0 0.031638484448194504
. O 0 0.013476470485329628

Affected O 0 0.011514649726450443
individuals O 0 0.002955771517008543
in O 0 0.0019238429376855493
three O 0 0.0015554692363366485
families O 0 0.0016704106237739325
are O 0 0.0011597488773986697
homozygous O 0 0.0037706675939261913
for O 0 0.001793965115211904
4003delTC O 0 0.12965784966945648
, O 0 0.0020479620434343815
whereas O 0 0.00225532753393054
those O 0 0.0009218657505698502
in O 0 0.0012843754375353456
two O 0 0.0013817514991387725
others O 0 0.002354500349611044
are O 0 0.0024627915117889643
compound O 0 0.02443758025765419
heterozygotes O 1 0.6472864151000977
. O 0 0.016537697985768318

To O 0 0.005597213748842478
determine O 0 0.003721139393746853
if O 0 0.0018821714911609888
the O 0 0.0018691112054511905
occurrence O 0 0.0035272527020424604
of O 0 0.0023936955258250237
4003delTC O 1 0.6916142106056213
in O 0 0.0014750971458852291
these O 0 0.001144003588706255
unrelated O 0 0.0037351560313254595
families O 0 0.0021703308448195457
signifies O 0 0.009019247256219387
propagation O 0 0.00414579501375556
of O 0 0.002102938713505864
an O 0 0.0026245745830237865
ancestral O 0 0.0700051486492157
allele O 0 0.004747321829199791
or O 0 0.0018891895888373256
a O 0 0.0030409181490540504
mutational O 0 0.3505398631095886
hot O 0 0.018357357010245323
spot O 0 0.005723676178604364
, O 0 0.0021925796754658222
haplotypes O 0 0.004549058154225349
were O 0 0.0013406905345618725
determined O 0 0.0021076940465718508
for O 0 0.0014730786206200719
polymorphisms O 0 0.0042465501464903355
both O 0 0.0015925520565360785
within O 0 0.0026451435405761003
and O 0 0.005201108753681183
flanking O 1 0.9432306885719299
COL17A1 O 1 0.9992314577102661
. O 0 0.021058322861790657

Five O 0 0.01403909269720316
intragenic O 0 0.04346984997391701
polymorphisms O 0 0.01237593125551939
were O 0 0.003796146484091878
chosen O 0 0.004173393826931715
based O 0 0.0028773245867341757
on O 0 0.0033138743601739407
their O 0 0.004943702835589647
informativeness O 1 0.7041863203048706
. O 0 0.013561573810875416

One O 0 0.005627043545246124
of O 0 0.003919743001461029
these O 0 0.0016666853334754705
, O 0 0.0016368234064429998
not O 0 0.0010387601796537638
previously O 0 0.001877421629615128
reported O 0 0.0022127008996903896
, O 0 0.0013246251037344337
was O 0 0.004920226987451315
2988 O 0 0.1235741376876831
A O 0 0.003841523779556155
or O 0 0.0020315179135650396
C O 0 0.004899815656244755
that O 0 0.0012465756153687835
introduces O 0 0.003734839614480734
a O 0 0.0018789618043228984
new O 0 0.0020320662297308445
restriction O 0 0.0038518854416906834
site O 0 0.004409085027873516
for O 0 0.004000348504632711
Eco0109 O 0 0.046019308269023895
I O 0 0.01869964972138405
. O 0 0.012906881980597973

All O 0 0.008826914243400097
the O 0 0.009001901373267174
4003delTC O 0 0.32134106755256653
alleles O 0 0.00921557191759348
showed O 0 0.005258866585791111
the O 0 0.0028006844222545624
same O 0 0.0023292910773307085
haplotype O 0 0.006001825910061598
for O 0 0.0017947168089449406
these O 0 0.0017669061198830605
five O 0 0.004041154868900776
polymorphic O 0 0.024317819625139236
markers O 0 0.02781868167221546
. O 0 0.014918943867087364

Fourteen O 0 0.030107276514172554
microsatellite O 0 0.04691910371184349
polymorphisms O 0 0.012111585587263107
were O 0 0.0028788105119019747
selected O 0 0.002432881621643901
based O 0 0.0017428061692044139
on O 0 0.001640533679164946
their O 0 0.0015485221520066261
high O 0 0.004822293296456337
heterozygosity O 0 0.1216917410492897
and O 0 0.0019810860976576805
their O 0 0.001620505703613162
location O 0 0.00321949296630919
within O 0 0.0036315477918833494
10q23 O 0 0.3224223554134369
- O 0 0.033301834017038345
q25 O 0 0.18196235597133636
near O 0 0.028301600366830826
COL17A1 O 1 0.9886761903762817
. O 0 0.01746794953942299

Three O 0 0.007835577242076397
families O 0 0.006128729321062565
shared O 0 0.007630739826709032
microsatellite O 0 0.06538475304841995
polymorphisms O 0 0.011233390308916569
covering O 0 0.005744516383856535
at O 0 0.0028982325457036495
most O 0 0.0016525436658412218
19 O 0 0.0031346359755843878
cM O 0 0.0047598062083125114
, O 0 0.0013915164163336158
whereas O 0 0.0017805470852181315
the O 0 0.0012683032546192408
others O 0 0.0012100528692826629
shared O 0 0.001517035299912095
smaller O 0 0.0012014060048386455
regions O 0 0.0012843888252973557
consistent O 0 0.002073141746222973
with O 0 0.0012586843222379684
cross O 0 0.0036873763892799616
- O 0 0.003569577820599079
over O 0 0.0013091890141367912
events O 0 0.0013049651170149446
during O 0 0.0015177774475887418
passage O 0 0.0020825755782425404
of O 0 0.0017722008051350713
this O 0 0.0015021087601780891
mutation O 0 0.0030555890407413244
through O 0 0.001828478300012648
several O 0 0.0033265738748013973
generations O 0 0.011300032958388329
. O 0 0.011271471157670021

These O 0 0.00620975811034441
results O 0 0.005995775107294321
indicate O 0 0.0050230990163981915
that O 0 0.002066647866740823
4003delTC O 0 0.015773452818393707
occurs O 0 0.002519357716664672
on O 0 0.0021158182062208652
a O 0 0.0030328540597110987
single O 0 0.005153678823262453
ancestral O 0 0.01785154640674591
allele O 0 0.011340025812387466
. O 0 0.005180419888347387
. O 0 0.010153167881071568

The O 0 0.02367374859750271
haptoglobin O 1 0.983640730381012
- O 0 0.29641494154930115
gene O 0 0.011120082810521126
deletion O 0 0.014457312412559986
responsible O 0 0.009708881378173828
for O 0 0.008997078984975815
anhaptoglobinemia B-Disease 1 0.9900093674659729
. O 0 0.018270248547196388

We O 0 0.007684963755309582
have O 0 0.0035005779936909676
found O 0 0.003723839530721307
an O 0 0.003219942795112729
allelic O 0 0.014629961922764778
deletion O 0 0.008606217801570892
of O 0 0.004151847213506699
the O 0 0.009207751601934433
haptoglobin O 1 0.9984135627746582
( O 0 0.006733405869454145
Hp O 0 0.0302144605666399
) O 0 0.0026161365676671267
gene O 0 0.0020159916020929813
from O 0 0.0014140151906758547
an O 0 0.0018907916964963078
individual O 0 0.002883010543882847
with O 0 0.004737197887152433
anhaptoglobinemia B-Disease 1 0.988353431224823
. O 0 0.015707558020949364

The O 0 0.016622209921479225
Hp O 0 0.25258469581604004
gene O 0 0.0070558758452534676
cluster O 0 0.004741305951029062
consists O 0 0.0029849752318114042
of O 0 0.002753581153228879
coding O 0 0.00538644939661026
regions O 0 0.0019269712502136827
of O 0 0.002126674633473158
the O 0 0.0032027389388531446
alpha O 0 0.007432448212057352
chain O 0 0.003992192912846804
and O 0 0.0018723612884059548
beta O 0 0.00433762650936842
chain O 0 0.003511756658554077
of O 0 0.002427098574116826
the O 0 0.004872691351920366
haptoglobin O 1 0.9837144017219543
gene O 0 0.00452827475965023
( O 0 0.0025458531454205513
Hp O 0 0.005528947804123163
) O 0 0.001445841626264155
and O 0 0.000965431216172874
of O 0 0.0014966249000281096
the O 0 0.0032728936057537794
alpha O 0 0.00666797487065196
chain O 0 0.003532210597768426
and O 0 0.0015764455311000347
beta O 0 0.004042163956910372
chain O 0 0.0032666451297700405
of O 0 0.0024308087304234505
the O 0 0.004747506231069565
haptoglobin O 1 0.9721174836158752
- O 0 0.01739770732820034
related O 0 0.004153648857027292
gene O 0 0.004707096144556999
( O 0 0.0035462251398712397
Hpr O 0 0.12537965178489685
) O 0 0.0017942608101293445
, O 0 0.0014392971061170101
in O 0 0.0015023978194221854
tandem O 0 0.004446627106517553
from O 0 0.0020148376934230328
the O 0 0.0032822745852172375
5 O 0 0.005698353983461857
side O 0 0.008518227376043797
. O 0 0.009588799439370632

Southern O 0 0.024422986432909966
blot O 0 0.18008717894554138
and O 0 0.0056195673532783985
PCR O 0 0.011988743208348751
analyses O 0 0.00405599782243371
have O 0 0.0013587477151304483
indicated O 0 0.002149277599528432
that O 0 0.0008574515813961625
the O 0 0.0010869794059544802
individual O 0 0.0011142275761812925
with O 0 0.0011463816044852138
anhaptoglobinemia B-Disease 1 0.6712592244148254
was O 0 0.004410295281559229
homozygous O 0 0.0029332246631383896
for O 0 0.0010269255144521594
the O 0 0.0016609540907666087
gene O 0 0.0024763166438788176
deletion O 0 0.0031049633398652077
and O 0 0.001056799665093422
that O 0 0.0009163254871964455
the O 0 0.0016784166218712926
gene O 0 0.0022254441864788532
deletion O 0 0.0035096919164061546
was O 0 0.0019290897762402892
included O 0 0.0013033435679972172
at O 0 0.0013675717636942863
least O 0 0.0010605676798149943
from O 0 0.0010698344558477402
the O 0 0.0016163127729669213
promoter O 0 0.028226442635059357
region O 0 0.0027976869605481625
of O 0 0.0027677167672663927
Hp O 0 0.18825948238372803
to O 0 0.001981953624635935
Hpr O 0 0.17324241995811462
alpha O 0 0.0038783703930675983
but O 0 0.000900029728654772
not O 0 0.0008369982242584229
to O 0 0.0016233517089858651
Hpr O 0 0.1889657974243164
beta O 0 0.01126123033463955
( O 0 0.00687682768329978
Hpdel O 0 0.12630733847618103
) O 0 0.009454965591430664
. O 0 0.012403418309986591

In O 0 0.006503373384475708
addition O 0 0.004053329583257437
, O 0 0.002132801804691553
we O 0 0.001345561700873077
found O 0 0.001093531958758831
seven O 0 0.0011096515227109194
individuals O 0 0.0008258994203060865
with O 0 0.0009877401171252131
hypohaptoglobinemia B-Disease 0 0.2850026786327362
in O 0 0.0010209846077486873
three O 0 0.0008612221572548151
families O 0 0.0011033271439373493
, O 0 0.0009704738040454686
and O 0 0.0008173718815669417
the O 0 0.0013970986474305391
genotypes O 0 0.003303150413557887
of O 0 0.00110987841617316
six O 0 0.001014653709717095
of O 0 0.0011783173540607095
the O 0 0.0013816691935062408
seven O 0 0.0013880127808079123
individuals O 0 0.0007899465272203088
were O 0 0.0009185829549096525
found O 0 0.0015089391963556409
to O 0 0.0017531116027384996
be O 0 0.00327053340151906
Hp2 O 1 0.9878185987472534
/ O 1 0.77419513463974
Hpdel O 1 0.7392653822898865
. O 0 0.015462305396795273

The O 0 0.013551219366490841
phenotypes O 0 0.020643087103962898
and O 0 0.004094022326171398
genotypes O 0 0.011444187723100185
in O 0 0.001966014737263322
one O 0 0.001367365475744009
of O 0 0.0012878486886620522
these O 0 0.0007558384095318615
three O 0 0.0008963019936345518
families O 0 0.0012935916893184185
showed O 0 0.0019057864556089044
the O 0 0.001591685926541686
father O 0 0.00320735783316195
to O 0 0.0011867948342114687
be O 0 0.0012980927713215351
hypohaptoglobinemic B-Disease 0 0.012311329133808613
( O 0 0.0031989645212888718
Hp2 O 0 0.027967922389507294
) O 0 0.0016651451587677002
and O 0 0.0014944487484171987
Hp2 O 1 0.9705716371536255
/ O 1 0.5499394536018372
Hpdel O 0 0.06164616346359253
, O 0 0.0017334520816802979
the O 0 0.001809811219573021
mother O 0 0.003513549454510212
to O 0 0.001085994066670537
be O 0 0.00120847939979285
Hp2 O 0 0.011838825419545174
- O 0 0.004499733913689852
1 O 0 0.002907063812017441
and O 0 0.0021716675255447626
Hp1 O 1 0.9135900735855103
/ O 0 0.34225478768348694
Hp2 O 0 0.06220777705311775
, O 0 0.0013536253245547414
one O 0 0.0008498146780766547
of O 0 0.0009241908555850387
the O 0 0.0011107451282441616
two O 0 0.0006932311225682497
children O 0 0.0012385594891384244
to O 0 0.0007872810238040984
be O 0 0.0010781802702695131
hypohaptoglobinemic B-Disease 0 0.0939159244298935
( O 0 0.0025330837815999985
Hp2 O 0 0.03901238739490509
) O 0 0.0017313541611656547
and O 0 0.0020535090006887913
Hp2 O 1 0.9771061539649963
/ O 1 0.7304661870002747
Hpdel O 0 0.27516409754753113
, O 0 0.0015580249018967152
and O 0 0.0009926995262503624
the O 0 0.001368061057291925
other O 0 0.0010469142580404878
child O 0 0.0035999545361846685
to O 0 0.0010940731735900044
be O 0 0.0013825813075527549
Hp1 O 0 0.061651915311813354
and O 0 0.0026266847271472216
Hp1 O 1 0.9972034692764282
/ O 1 0.808773934841156
Hpdel O 0 0.3484475612640381
, O 0 0.002221885370090604
showing O 0 0.003183302003890276
an O 0 0.0019146723207086325
anomalous O 0 0.013953951187431812
inheritance O 0 0.008945278823375702
of O 0 0.005157623440027237
Hp O 1 0.977143406867981
phenotypes O 0 0.02215556986629963
in O 0 0.002397158183157444
the O 0 0.004184695426374674
child O 0 0.44682878255844116
with O 0 0.006785084959119558
Hp1 O 1 0.9986007809638977
. O 0 0.012750349007546902

The O 0 0.02856859564781189
Hp2 O 1 0.9984026551246643
/ O 1 0.9801667332649231
Hpdel O 1 0.5856822729110718
individuals O 0 0.003464733948931098
had O 0 0.002993678441271186
an O 0 0.0020627884659916162
extremely O 0 0.0034858679864555597
low O 0 0.0037533878348767757
level O 0 0.0028530575800687075
of O 0 0.0024891768116503954
Hp O 0 0.07253206521272659
( O 0 0.0038281772285699844
mean O 0 0.004890262149274349
+ O 0 0.008475756272673607
/ O 0 0.00955703854560852
- O 0 0.008139378391206264
SD O 0 0.018467320129275322
= O 0 0.006245987489819527
0 O 0 0.0037305911537259817
. O 0 0.0021755313500761986
049 O 0 0.021323662251234055
+ O 0 0.00826373603194952
/ O 0 0.007680739276111126
- O 0 0.004558696877211332
0 O 0 0.003405972383916378
. O 0 0.0021025745663791895
043 O 0 0.022184330970048904
mg O 0 0.04736091196537018
/ O 0 0.011266498826444149
ml O 0 0.009670627303421497
; O 0 0.0019724464509636164
n O 0 0.003984186798334122
= O 0 0.0042016468942165375
6 O 0 0.0021763606928288937
) O 0 0.0010584505507722497
, O 0 0.0008507366292178631
compared O 0 0.0012163786450400949
with O 0 0.000711125903762877
the O 0 0.001185877132229507
level O 0 0.0018892509397119284
( O 0 0.00152049760799855
1 O 0 0.0016242950223386288
. O 0 0.0010508911218494177
64 O 0 0.0034595858305692673
+ O 0 0.005266684573143721
/ O 0 0.005159777123481035
- O 0 0.0034495904110372066
1 O 0 0.0026313336566090584
. O 0 0.001977676060050726
07 O 0 0.017417967319488525
mg O 0 0.2649802267551422
/ O 0 0.01733621396124363
ml O 0 0.00855011772364378
) O 0 0.0015063465107232332
obtained O 0 0.0018165757646784186
from O 0 0.001728868461214006
52 O 0 0.0048344614915549755
healthy O 0 0.0059210690669715405
volunteers O 0 0.005407689604908228
having O 0 0.004319238010793924
phenotype O 0 0.011830237694084644
Hp2 O 0 0.2177114337682724
, O 0 0.002221922157332301
whereas O 0 0.0030753437895327806
the O 0 0.0031604429241269827
serum O 1 0.8531630635261536
Hp O 0 0.006469288375228643
level O 0 0.0018619761103764176
of O 0 0.0012472182279452682
an O 0 0.0012303149560466409
individual O 0 0.00154916662722826
with O 0 0.002179299248382449
Hp1 O 1 0.9964374303817749
/ O 1 0.9105480909347534
Hpdel O 1 0.7193086743354797
was O 0 0.012990681454539299
0 O 0 0.010413275100290775
. O 0 0.008869955316185951

50 O 0 0.02171448990702629
mg O 1 0.9913784265518188
/ O 1 0.956260085105896
ml O 1 0.5344617962837219
, O 0 0.0022222669795155525
which O 0 0.0012557911686599255
was O 0 0.0021087254863232374
approximately O 0 0.00145125319249928
half O 0 0.0012833683285862207
the O 0 0.001277170842513442
level O 0 0.001913573476485908
of O 0 0.0015027496265247464
Hp O 0 0.006415409501641989
in O 0 0.001573918154463172
control O 0 0.0028617214411497116
sera O 0 0.3637917935848236
from O 0 0.0020249467343091965
the O 0 0.002728590974584222
Hp1 O 1 0.5705336332321167
phenotype O 0 0.0050940243527293205
( O 0 0.0015708849532529712
1 O 0 0.0017156237736344337
. O 0 0.0011436108034104109
26 O 0 0.002817652653902769
+ O 0 0.005103627685457468
/ O 0 0.005421803332865238
- O 0 0.002873013960197568
0 O 0 0.0024936560075730085
. O 0 0.0012502665631473064
33 O 0 0.004134231712669134
mg O 0 0.016152728348970413
/ O 0 0.010306291282176971
ml O 0 0.010490705259144306
; O 0 0.0018797562224790454
n O 0 0.003727742237970233
= O 0 0.003981791436672211
9 O 0 0.002355171600356698
) O 0 0.001343140029348433
, O 0 0.0015321887331083417
showing O 0 0.00342913088388741
a O 0 0.00389268109574914
gene O 0 0.007737269625067711
- O 0 0.015899086371064186
dosage O 0 0.07117772102355957
effect O 0 0.012380752712488174
. O 0 0.013050390407443047

The O 0 0.008930624462664127
other O 0 0.004468104802072048
allele O 0 0.0096471281722188
( O 0 0.004658544901758432
Hp2 O 0 0.013740865513682365
) O 0 0.0018115133279934525
of O 0 0.0014545945450663567
individuals O 0 0.0012246420374140143
with O 0 0.0020242840982973576
Hp2 O 1 0.9998656511306763
/ O 1 0.987924337387085
Hpdel O 1 0.9173915386199951
was O 0 0.007144175004214048
found O 0 0.0015852692304179072
to O 0 0.0009048657375387847
have O 0 0.0007045993115752935
, O 0 0.0009383613942191005
in O 0 0.0009056972339749336
all O 0 0.0008641173481009901
exons O 0 0.0034041183535009623
, O 0 0.0014375459868460894
no O 0 0.002085313433781266
mutation O 0 0.003403176786378026
, O 0 0.0022383525501936674
by O 0 0.003061427967622876
DNA O 0 0.008901559747755527
sequencing O 0 0.015713021159172058
. O 0 0.009869858622550964

On O 0 0.007035503163933754
the O 0 0.003796972567215562
basis O 0 0.0025481937918812037
of O 0 0.00207651243545115
the O 0 0.0019187440630048513
present O 0 0.0017089326865971088
study O 0 0.001599341630935669
, O 0 0.0011060895631089807
the O 0 0.0014669708907604218
mechanism O 0 0.002244067844003439
of O 0 0.002013441175222397
anhaptoglobinemia B-Disease 0 0.18413595855236053
and O 0 0.0012783671263605356
the O 0 0.001631328254006803
mechanism O 0 0.0029433025047183037
of O 0 0.002271901350468397
anomalous O 0 0.4045378565788269
inheritance O 0 0.014534514397382736
of O 0 0.006231872830539942
Hp O 1 0.9631721377372742
phenotypes O 0 0.02661081589758396
were O 0 0.0031237376388162374
well O 0 0.004463092889636755
explained O 0 0.015504411421716213
. O 0 0.011125857010483742

However O 0 0.010326525196433067
, O 0 0.005393937695771456
the O 0 0.005723333917558193
mechanism O 0 0.012161007151007652
of O 0 0.013022401370108128
hypohaptoglobinemia B-Disease 1 0.9973896145820618
remains O 0 0.3169487416744232
unknown O 0 0.042777497321367264

ATM O 0 0.04984017834067345
mutations O 0 0.011577165685594082
and O 0 0.004368734546005726
phenotypes O 0 0.08797048032283783
in O 0 0.035814132541418076
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999889135360718
telangiectasia I-Disease 1 0.9999980926513672
families O 0 0.00478747533634305
in O 0 0.002106384839862585
the O 0 0.002828217577189207
British O 0 0.004531065933406353
Isles O 0 0.006418957374989986
: O 0 0.0020377144683152437
expression O 0 0.001996460137888789
of O 0 0.0021969927474856377
mutant O 0 0.0061170123517513275
ATM O 0 0.0048012216575443745
and O 0 0.0012299458030611277
the O 0 0.001957694999873638
risk O 0 0.011329228058457375
of O 1 0.82984459400177
leukemia B-Disease 1 1.0
, O 1 0.9999009370803833
lymphoma B-Disease 1 1.0
, O 1 0.9956895709037781
and O 1 0.9994339346885681
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.1058509349822998

We O 0 0.00752783939242363
report O 0 0.00542496656998992
the O 0 0.0036265752278268337
spectrum O 0 0.004771654959768057
of O 0 0.0032411599531769753
59 O 0 0.007139259483665228
ATM O 0 0.008236611261963844
mutations O 0 0.003127841278910637
observed O 0 0.0023216400295495987
in O 0 0.0027992124669253826
ataxia B-Disease 1 0.999998927116394
- I-Disease 1 0.999196469783783
telangiectasia I-Disease 1 0.9999991655349731
( O 0 0.46937161684036255
A B-Disease 1 0.9994124174118042
- I-Disease 1 0.9999784231185913
T I-Disease 1 0.9999961853027344
) O 0 0.002606160705909133
patients O 0 0.0042855702340602875
in O 0 0.0017735578585416079
the O 0 0.0035823939833790064
British O 0 0.01010807603597641
Isles O 0 0.0294385626912117
. O 0 0.011694145388901234

Of O 0 0.011883541941642761
51 O 0 0.017106221988797188
ATM O 0 0.030591482296586037
mutations O 0 0.004947480745613575
identified O 0 0.002663993276655674
in O 0 0.001522570033557713
families O 0 0.0015730821760371327
native O 0 0.0016670566983520985
to O 0 0.0009493636316619813
the O 0 0.0015407444443553686
British O 0 0.002751491963863373
Isles O 0 0.004477274604141712
, O 0 0.0017761429771780968
11 O 0 0.002273443154990673
were O 0 0.001715425169095397
founder O 0 0.011035224422812462
mutations O 0 0.0027994103729724884
, O 0 0.0014205308398231864
and O 0 0.0012039291905239224
2 O 0 0.0018198424950242043
of O 0 0.0013143501710146666
these O 0 0.0009921342134475708
11 O 0 0.002485679229721427
conferred O 0 0.006675506941974163
a O 0 0.003874253248795867
milder O 0 0.23486046493053436
clinical O 1 0.5957819223403931
phenotype O 0 0.007748853415250778
with O 0 0.0015604804502800107
respect O 0 0.00236909044906497
to O 0 0.0023715777788311243
both O 0 0.00845613144338131
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
and O 1 0.9679103493690491
cellular O 1 0.964576780796051
features O 0 0.05090505629777908
. O 0 0.01428220234811306

We O 0 0.006311756558716297
report O 0 0.004203371703624725
, O 0 0.002058514393866062
in O 0 0.0014788819244131446
two O 0 0.0014912247424945235
A B-Disease 0 0.4390804171562195
- I-Disease 1 0.9610556364059448
T I-Disease 1 0.8428595066070557
families O 0 0.001527128741145134
, O 0 0.001361461472697556
an O 0 0.001473490265198052
ATM O 0 0.0058934930711984634
mutation O 0 0.003514618147164583
( O 0 0.0025193034671247005
7271T O 0 0.02932787872850895
- O 0 0.10616129636764526
- O 0 0.20003652572631836
> O 0 0.034746572375297546
G O 0 0.009680427610874176
) O 0 0.0013685203157365322
that O 0 0.0007112018065527081
may O 0 0.0008491893531754613
be O 0 0.0005656707216985524
associated O 0 0.0007554826443083584
with O 0 0.0006165821105241776
an O 0 0.001175457495264709
increased O 0 0.0030904351733624935
risk O 0 0.1277177780866623
of O 1 0.8987652063369751
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
in O 0 0.005054738838225603
both O 0 0.003033811692148447
homozygotes O 1 0.9886779189109802
and O 0 0.002413911744952202
heterozygotes O 0 0.30860674381256104
( O 0 0.0022166185081005096
relative O 0 0.002296670340001583
risk O 0 0.002239566994830966
12 O 0 0.001240244717337191
. O 0 0.0007479659398086369
7 O 0 0.001775635639205575
; O 0 0.0013044917723163962
P O 0 0.005709351971745491
= O 0 0.003969746641814709
. O 0 0.0016049109399318695
0025 O 0 0.03632063418626785
) O 0 0.0015901747392490506
, O 0 0.0012914851540699601
although O 0 0.0009896032279357314
there O 0 0.0009080210002139211
is O 0 0.001016016467474401
a O 0 0.0013925830135121942
less O 0 0.002016611397266388
severe O 1 0.9997349381446838
A B-Disease 1 0.9999752044677734
- I-Disease 1 0.9999957084655762
T I-Disease 1 0.9999756813049316
phenotype O 0 0.0037972053978592157
in O 0 0.0009807486785575747
terms O 0 0.001153839286416769
of O 0 0.0015291892923414707
the O 0 0.003083085175603628
degree O 0 0.05269145593047142
of O 1 0.9877210259437561
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9209181070327759

This O 0 0.007987330667674541
mutation O 0 0.010023265145719051
( O 0 0.007266222964972258
7271T O 0 0.4384269416332245
- O 1 0.6383144855499268
- O 1 0.6174589991569519
> O 0 0.08605513721704483
G O 0 0.012012352235615253
) O 0 0.0017723197815939784
also O 0 0.0011626733466982841
allows O 0 0.0012018776033073664
expression O 0 0.0016225235303863883
of O 0 0.0015743812546133995
full O 0 0.0027873986400663853
- O 0 0.005815761163830757
length O 0 0.002964964834973216
ATM O 0 0.0051375338807702065
protein O 0 0.0018143495544791222
at O 0 0.0015778050292283297
a O 0 0.0014908333541825414
level O 0 0.0019807713106274605
comparable O 0 0.0027790875174105167
with O 0 0.001336016459390521
that O 0 0.001588268089108169
in O 0 0.002924388274550438
unaffected O 0 0.018041813746094704
individuals O 0 0.005639121402055025
. O 0 0.010356689803302288

In O 0 0.006041863467544317
addition O 0 0.003939467016607523
, O 0 0.0022362363524734974
we O 0 0.0013041258789598942
have O 0 0.0008758568437770009
studied O 0 0.002501672599464655
18 O 0 0.003048060927540064
A B-Disease 1 0.9584668278694153
- I-Disease 1 0.9998273849487305
T I-Disease 1 0.9999707937240601
patients O 0 0.09530641883611679
, O 0 0.0012698140926659107
in O 0 0.0010878687025979161
15 O 0 0.0013731864746659994
families O 0 0.001095592393539846
, O 0 0.0013406663201749325
who O 0 0.0030220395419746637
developed O 1 0.816945493221283
leukemia B-Disease 1 1.0
, O 1 0.9957655668258667
lymphoma B-Disease 1 1.0
, O 1 0.9819439649581909
preleukemic O 1 0.9999979734420776
T O 1 0.9999682903289795
- O 1 0.6370643973350525
cell O 0 0.007686548866331577
proliferation O 0 0.10870230942964554
, O 0 0.003979505505412817
or O 1 0.6385105848312378
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.26836708188056946
mostly O 0 0.005081338342279196
in O 0 0.008940676227211952
childhood O 1 0.9999123811721802
. O 0 0.01677367463707924

A O 0 0.013616133481264114
wide O 0 0.007046635262668133
variety O 0 0.005039289593696594
of O 0 0.005413399077951908
ATM O 0 0.4196282625198364
mutation O 0 0.0063685146160423756
types O 0 0.0025213148910552263
, O 0 0.0017324836226180196
including O 0 0.0015929206274449825
missense O 0 0.007288842927664518
mutations O 0 0.002477365080267191
and O 0 0.001212051953189075
in O 0 0.0019916214514523745
- O 0 0.09746772050857544
frame O 0 0.01430917251855135
deletions O 0 0.004616556689143181
, O 0 0.0014710782561451197
were O 0 0.0015163782518357038
seen O 0 0.002507722470909357
in O 0 0.002070621820166707
these O 0 0.002839449793100357
patients O 0 0.3051275610923767
. O 0 0.013049604371190071

We O 0 0.007774336263537407
also O 0 0.003786534769460559
show O 0 0.0032510061282664537
that O 0 0.0013124251272529364
25 O 0 0.0016980433138087392
% O 0 0.0011857495410367846
of O 0 0.0010763079626485705
all O 0 0.0011858196230605245
A B-Disease 1 0.9467701315879822
- I-Disease 1 0.9994670748710632
T I-Disease 1 0.9999381303787231
patients O 0 0.06953857094049454
carried O 0 0.002187396865338087
in O 0 0.0018384142313152552
- O 0 0.006832627113908529
frame O 0 0.005381077527999878
deletions O 0 0.004796912893652916
or O 0 0.002037840196862817
missense O 0 0.006810588762164116
mutations O 0 0.0028058537282049656
, O 0 0.0013567348942160606
many O 0 0.000853345321957022
of O 0 0.0013401506002992392
which O 0 0.0012895222753286362
were O 0 0.0015138851013034582
also O 0 0.0016748830676078796
associated O 0 0.0017782136565074325
with O 0 0.0013522200752049685
expression O 0 0.003279732773080468
of O 0 0.005266529507935047
mutant O 0 0.48785826563835144
ATM O 0 0.04860036075115204
protein O 0 0.011291617527604103
. O 0 0.01023759413510561

The O 0 0.016089726239442825
DMPK O 1 0.9417572021484375
gene O 0 0.01302348729223013
of O 0 0.2352796494960785
severely O 1 0.9999984502792358
affected O 1 0.9999974966049194
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999998807907104
is O 1 0.9890753030776978
hypermethylated O 1 0.9999760389328003
proximal O 1 0.9972226619720459
to O 0 0.002393611241132021
the O 0 0.0032182903960347176
largely O 0 0.005891959182918072
expanded O 0 0.013334316201508045
CTG O 1 0.9976262450218201
repeat O 0 0.04746653512120247
. O 0 0.013862892054021358

Using O 0 0.013993923552334309
methylation O 0 0.016427254304289818
- O 0 0.012359687127172947
sensitive O 0 0.007898185402154922
restriction O 0 0.006905008107423782
enzymes O 0 0.0038685230538249016
, O 0 0.0020844044629484415
we O 0 0.0017434732289984822
characterized O 0 0.003436674363911152
the O 0 0.00223929388448596
methylation O 0 0.003813098883256316
pattern O 0 0.002780018374323845
on O 0 0.001523287151940167
the O 0 0.0016099249478429556
5 O 0 0.0020418562926352024
side O 0 0.0016774795949459076
of O 0 0.0017589878989383578
the O 0 0.0029211502987891436
CTG O 1 0.994587779045105
repeat O 0 0.004901627078652382
in O 0 0.0015501492889598012
the O 0 0.0021763055119663477
DMPK O 1 0.6638007164001465
gene O 0 0.0018618088215589523
of O 0 0.0013527172850444913
normal O 0 0.0016586357960477471
individuals O 0 0.0007615537033416331
and O 0 0.0009674126049503684
of O 0 0.004403307568281889
patients O 1 0.9998506307601929
affected O 1 0.9628651142120361
with O 1 0.929144561290741
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.05054346099495888
showing O 0 0.011507052928209305
expansions O 0 0.009160671383142471
of O 0 0.003969166427850723
the O 0 0.007429803721606731
repetitive O 1 0.8417421579360962
sequence O 0 0.011518209241330624
. O 0 0.011796237900853157

The O 0 0.013689013198018074
gene O 0 0.01088044885545969
segment O 0 0.008226277306675911
analyzed O 0 0.005217061378061771
corresponds O 0 0.006094637792557478
to O 0 0.0024235083255916834
the O 0 0.004242294002324343
genomic O 0 0.012918392196297646
SacI O 1 0.7584535479545593
- O 0 0.012243743985891342
HindIII O 0 0.022922268137335777
fragment O 0 0.009368471801280975
carrying O 0 0.0070943585596978664
exons O 0 0.01185198687016964
11 O 0 0.007461193483322859
- O 0 0.012616421096026897
15 O 0 0.010522490367293358
. O 0 0.0125212911516428

There O 0 0.009284043684601784
is O 0 0.006140754092484713
constitutive O 0 0.013827065005898476
methylation O 0 0.007008741144090891
in O 0 0.0035098388325423002
intron O 0 0.029057899489998817
12 O 0 0.00296345679089427
at O 0 0.0025388591457158327
restriction O 0 0.002835101680830121
sites O 0 0.0016754423268139362
of O 0 0.002425839425995946
SacII O 0 0.37334591150283813
and O 0 0.0031544757075607777
HhaI O 0 0.2356274127960205
, O 0 0.0029153090436011553
localized O 0 0.0064099072478711605
1 O 0 0.0033678526524454355
, O 0 0.002297894097864628
159 O 0 0.0069458079524338245
- O 0 0.005374078638851643
1 O 0 0.003213505959138274
, O 0 0.0022278467658907175
232 O 0 0.0066555095836520195
bp O 0 0.0067103211767971516
upstream O 0 0.004284267779439688
of O 0 0.002118124859407544
the O 0 0.0037331441417336464
CTG O 1 0.9950860142707825
repeat O 0 0.013484656810760498
, O 0 0.0023917625658214092
whereas O 0 0.002216846216470003
most O 0 0.0009929683292284608
, O 0 0.0011147476034238935
if O 0 0.0007161391549743712
not O 0 0.0005299457698129117
all O 0 0.0004927832633256912
, O 0 0.0007261310238391161
of O 0 0.0008510748157277703
the O 0 0.0009267278364859521
other O 0 0.0005421459209173918
sites O 0 0.0009661249350756407
of O 0 0.0016539759235456586
SacII O 1 0.8296915292739868
, O 0 0.0021381869446486235
HhaI O 1 0.513888955116272
, O 0 0.0016287596663460135
and O 0 0.0015030945651233196
HpaII O 0 0.20538198947906494
in O 0 0.0014843845274299383
this O 0 0.0011651237728074193
region O 0 0.00189758010674268
are O 0 0.0009600715711712837
unmethylated O 0 0.025137290358543396
, O 0 0.0013834519777446985
in O 0 0.001233116490766406
normal O 0 0.001750339986756444
individuals O 0 0.0008263245690613985
and O 0 0.0008946871967054904
most O 0 0.0011159568093717098
of O 0 0.0034257564693689346
the O 0 0.1513737142086029
patients O 1 0.9994367957115173
. O 0 0.014231559820473194

In O 0 0.00487530929967761
a O 0 0.003156098537147045
number O 0 0.0018241971265524626
of O 0 0.0026918291114270687
young O 0 0.4641980826854706
and O 0 0.04880794137716293
severely O 1 0.9999451637268066
affected O 1 0.9060643315315247
patients O 1 0.9919307827949524
, O 0 0.0022360384464263916
however O 0 0.001472086412832141
, O 0 0.0013345604529604316
complete O 0 0.0019708829931914806
methylation O 0 0.0022397625725716352
of O 0 0.0012892853701487184
these O 0 0.0008173967944458127
restriction O 0 0.0018883626908063889
sites O 0 0.0014767830725759268
was O 0 0.0028748263139277697
found O 0 0.001983500085771084
in O 0 0.0023639751598238945
the O 0 0.006376968696713448
mutated O 0 0.09787467867136002
allele O 0 0.01902982033789158
. O 0 0.012170284986495972

In O 0 0.005561060272157192
most O 0 0.002693629590794444
of O 0 0.0030530798248946667
these O 0 0.001895200228318572
patients O 0 0.18788689374923706
, O 0 0.002226924989372492
the O 0 0.004233830608427525
onset O 1 0.9999661445617676
of O 1 0.8955944776535034
the O 1 0.9999496936798096
disease O 1 1.0
was O 1 0.9999986886978149
congenital O 1 1.0
. O 1 0.8611005544662476

Preliminary O 0 0.01485750637948513
in O 0 0.007797565311193466
vivo O 0 0.022980481386184692
footprinting O 0 0.054001688957214355
data O 0 0.0038712366949766874
gave O 0 0.0030949751380831003
evidence O 0 0.002301156520843506
for O 0 0.0019543515518307686
protein O 0 0.0032734943088144064
- O 0 0.003894183086231351
DNA O 0 0.002214582171291113
contact O 0 0.001729181152768433
in O 0 0.0012136803707107902
normal O 0 0.0023998157121241093
genes O 0 0.0016987319104373455
at O 0 0.0019213376799598336
an O 0 0.0019952927250415087
Sp1 O 0 0.23498162627220154
consensus O 0 0.002805320080369711
binding O 0 0.0019858432933688164
site O 0 0.0026717681903392076
upstream O 0 0.0032779406756162643
of O 0 0.0019382454920560122
the O 0 0.003507212968543172
CTG O 1 0.9976767897605896
repeat O 0 0.007745261769741774
and O 0 0.0011989617487415671
for O 0 0.001028519938699901
a O 0 0.0013779016444459558
significant O 0 0.0017945622093975544
reduction O 0 0.0024710476864129305
of O 0 0.0011698455782607198
this O 0 0.0009618422482162714
interaction O 0 0.001363286399282515
in O 0 0.0011154228122904897
cells O 0 0.0017683180049061775
with O 0 0.0013658178504556417
a O 0 0.004579368978738785
hypermethylated O 1 0.9945865869522095
DMPK O 1 0.9988601207733154
gene O 0 0.009165113791823387
. O 0 0.005390829872339964
. O 0 0.01002336572855711

The O 0 0.12898629903793335
hemochromatosis B-Disease 1 0.9999990463256836
gene O 0 0.02135995589196682
product O 0 0.009255323559045792
complexes O 0 0.010420728474855423
with O 0 0.0034207687713205814
the O 0 0.008774313144385815
transferrin O 1 0.9986806511878967
receptor O 0 0.01368486788123846
and O 0 0.004176996648311615
lowers O 0 0.4556044340133667
its O 0 0.003338718321174383
affinity O 0 0.007337548304349184
for O 0 0.004494631662964821
ligand O 0 0.017282893881201744
binding O 0 0.012347168289124966
. O 0 0.014339955523610115

We O 0 0.009248733520507812
recently O 0 0.00835852138698101
reported O 0 0.005241046193987131
the O 0 0.003341326490044594
positional O 0 0.007321998942643404
cloning O 0 0.004506875295192003
of O 0 0.002351657021790743
a O 0 0.0037454580888152122
candidate O 0 0.008563441224396229
gene O 0 0.006806229241192341
for O 0 0.007344469893723726
hereditary B-Disease 1 0.9999996423721313
hemochromatosis I-Disease 1 1.0
called O 1 0.9999510049819946
HFE O 1 0.9999969005584717
. O 0 0.03143525496125221

The O 0 0.011806514114141464
gene O 0 0.008172783069312572
product O 0 0.0038654429372400045
, O 0 0.002334309509024024
a O 0 0.002072475152090192
member O 0 0.0020755729638040066
of O 0 0.001937450491823256
the O 0 0.003764229826629162
major O 0 0.13652025163173676
histocompatibility O 1 0.9999940395355225
complex O 1 0.5351582169532776
class O 1 0.9285658597946167
I O 0 0.4002254605293274
- O 0 0.014000782743096352
like O 0 0.0018062141025438905
family O 0 0.0023238875437527895
, O 0 0.0014000881928950548
was O 0 0.0021359212696552277
found O 0 0.0010653112549334764
to O 0 0.0008311201818287373
have O 0 0.0007602818077430129
a O 0 0.0015676663024351
mutation O 0 0.0026461791712790728
, O 0 0.002263832138851285
Cys O 1 0.7701578140258789
- O 0 0.011089068837463856
282 O 0 0.03622470051050186
- O 0 0.030629554763436317
- O 0 0.021388016641139984
> O 0 0.01446712575852871
Tyr O 1 0.6198822855949402
( O 0 0.004815738648176193
C282Y O 0 0.010365564376115799
) O 0 0.001867490354925394
, O 0 0.0012814183719456196
in O 0 0.0015508197247982025
85 O 0 0.004234145861119032
% O 0 0.002572221914306283
of O 0 0.004682555794715881
patient O 1 0.9524210095405579
chromosomes O 0 0.02096737176179886
. O 0 0.011807895265519619

This O 0 0.010415497235953808
mutation O 0 0.013520631939172745
eliminates O 0 0.012322710826992989
the O 0 0.0036630122922360897
ability O 0 0.0032808706164360046
of O 0 0.003300872165709734
HFE O 1 0.982297420501709
to O 0 0.00215481617487967
associate O 0 0.004209917038679123
with O 0 0.00231153704226017
beta2 O 1 0.9593236446380615
- O 0 0.28065377473831177
microglobulin O 1 0.9244317412376404
( O 0 0.004977189935743809
beta2m O 0 0.2408660352230072
) O 0 0.0024135331623256207
and O 0 0.002271905541419983
prevents O 0 0.009224270470440388
cell O 0 0.013126631267368793
- O 0 0.03349196910858154
surface O 0 0.010708760470151901
expression O 0 0.014562221243977547
. O 0 0.012116242200136185

A O 0 0.018871769309043884
second O 0 0.015683239325881004
mutation O 0 0.007879121229052544
that O 0 0.0016445418586954474
has O 0 0.0017830992583185434
no O 0 0.0016776464181020856
effect O 0 0.0020070530008524656
on O 0 0.0018620506161823869
beta2m O 1 0.5794544816017151
association O 0 0.007766801863908768
, O 0 0.0036654251161962748
H63D O 1 0.9942634701728821
, O 0 0.002076965058222413
was O 0 0.002690577646717429
found O 0 0.0012212115107104182
in O 0 0.0008489200263284147
eight O 0 0.0011661418247967958
out O 0 0.0009577915770933032
of O 0 0.0015198912005871534
nine O 0 0.0028205905109643936
patients O 0 0.07236974686384201
heterozygous O 0 0.003944052383303642
for O 0 0.00216362695209682
the O 0 0.005280011799186468
C282Y O 1 0.6412249803543091
mutant O 0 0.03337576240301132
. O 0 0.013162915594875813

In O 0 0.007683712523430586
this O 0 0.004061946179717779
report O 0 0.0036188780795782804
, O 0 0.0023733105044811964
we O 0 0.0016529542626813054
demonstrate O 0 0.003006997751072049
in O 0 0.0021952539682388306
cultured O 0 0.008539133705198765
293 O 0 0.015585262328386307
cells O 0 0.00585739454254508
overexpressing O 0 0.1090509295463562
wild O 0 0.0067313970066607
- O 0 0.023544471710920334
type O 0 0.01171024702489376
or O 0 0.0032359138131141663
mutant O 0 0.019170062616467476
HFE O 1 0.8910736441612244
proteins O 0 0.002332653384655714
that O 0 0.0010543946409597993
both O 0 0.001053109299391508
the O 0 0.0015926060732454062
wild O 0 0.005602497141808271
- O 0 0.2951495945453644
type O 0 0.03492967039346695
and O 0 0.003600254189223051
H63D O 1 0.9993743300437927
HFE O 1 0.9988712668418884
proteins O 0 0.003756588092073798
form O 0 0.002839739201590419
stable O 0 0.007060318253934383
complexes O 0 0.005804614629596472
with O 0 0.0024798878002911806
the O 0 0.007474660407751799
transferrin O 1 0.9982340335845947
receptor O 0 0.0348169282078743
( O 0 0.012847506441175938
TfR O 1 0.9875972867012024
) O 0 0.010377687402069569
. O 0 0.011988404206931591

The O 0 0.01913546398282051
C282Y O 0 0.07498062402009964
mutation O 0 0.012694253586232662
nearly O 0 0.006923920474946499
completely O 0 0.006522811017930508
prevents O 0 0.0052629439160227776
the O 0 0.0031497932504862547
association O 0 0.004997340962290764
of O 0 0.004548205528408289
the O 0 0.018630966544151306
mutant O 1 0.9006566405296326
HFE O 1 0.9994425177574158
protein O 0 0.00615239143371582
with O 0 0.004316039849072695
the O 0 0.011820532381534576
TfR O 1 0.9995189905166626
. O 0 0.019822990521788597

Studies O 0 0.013427476398646832
on O 0 0.00850349199026823
cell O 0 0.012710267677903175
- O 0 0.012007713317871094
associated O 0 0.005513248965144157
transferrin O 0 0.015841828659176826
at O 0 0.003978042863309383
37 O 0 0.004287780728191137
degrees O 0 0.003734252415597439
C O 0 0.004715562332421541
suggest O 0 0.002643667394295335
that O 0 0.0013557677157223225
the O 0 0.0026388776022940874
overexpressed O 0 0.01627950184047222
wild O 0 0.007136170286685228
- O 0 0.29314225912094116
type O 0 0.4673477113246918
HFE O 1 0.9994779229164124
protein O 0 0.005281142890453339
decreases O 0 0.004860982298851013
the O 0 0.002574102720245719
affinity O 0 0.0043019382283091545
of O 0 0.003693591570481658
the O 0 0.012767840176820755
TfR O 1 0.9998849630355835
for O 0 0.013022242113947868
transferrin O 1 0.9643054604530334
. O 0 0.01732129044830799

The O 0 0.023415250703692436
overexpressed O 1 0.9383515119552612
H63D O 1 0.9933204650878906
protein O 0 0.00881512463092804
does O 0 0.0027852680068463087
not O 0 0.0011669707018882036
have O 0 0.0008178752032108605
this O 0 0.0009192537399940193
effect O 0 0.0012798942625522614
, O 0 0.001144146779552102
providing O 0 0.0014494039351120591
the O 0 0.0012563661439344287
first O 0 0.0011963037541136146
direct O 0 0.0012217763578519225
evidence O 0 0.0012960616732016206
for O 0 0.0010210250038653612
a O 0 0.0020020906813442707
functional O 0 0.004147421568632126
consequence O 0 0.006199860945343971
of O 0 0.0043953461572527885
the O 0 0.02486187405884266
H63D O 1 0.9998886585235596
mutation O 0 0.04968385398387909
. O 0 0.012753291055560112

Addition O 0 0.013760519213974476
of O 0 0.009831772185862064
soluble O 0 0.41961362957954407
wild O 0 0.02508099563419819
- O 1 0.7693261504173279
type O 1 0.9422599673271179
HFE O 1 0.9999934434890747
/ O 1 0.9900583624839783
beta2m O 1 0.8988790512084961
heterodimers O 1 0.7207316160202026
to O 0 0.003453322919085622
cultured O 0 0.059709422290325165
cells O 0 0.003423894988372922
also O 0 0.0019252278143540025
decreased O 0 0.0042089298367500305
the O 0 0.0022347024641931057
apparent O 0 0.011199764907360077
affinity O 0 0.0032154216896742582
of O 0 0.002178841968998313
the O 0 0.004381463397294283
TfR O 1 0.9885479211807251
for O 0 0.0014795904280617833
its O 0 0.0013543840032070875
ligand O 0 0.0036474214866757393
under O 0 0.0024618052411824465
steady O 0 0.010834017768502235
- O 0 0.0037099486216902733
state O 0 0.0013068376574665308
conditions O 0 0.0017093581845983863
, O 0 0.0010653595672920346
both O 0 0.0009040451841428876
in O 0 0.0016722430009394884
293 O 0 0.0712176114320755
cells O 0 0.003525620326399803
and O 0 0.002256122650578618
in O 0 0.005645692348480225
HeLa O 1 0.9996563196182251
cells O 0 0.015316498465836048
. O 0 0.012161803431808949

Furthermore O 0 0.01299951784312725
, O 0 0.003869800828397274
at O 0 0.0034334948286414146
4 O 0 0.0028925666119903326
degrees O 0 0.0025728102773427963
C O 0 0.003506797831505537
, O 0 0.0013327401829883456
the O 0 0.0015371799236163497
added O 0 0.0029354735743254423
soluble O 0 0.005980284884572029
complex O 0 0.003992898389697075
of O 0 0.020179901272058487
HFE O 1 0.9999995231628418
/ O 1 0.9982286095619202
beta2m O 1 0.9577342867851257
inhibited O 0 0.008181191049516201
binding O 0 0.0027093617245554924
of O 0 0.0031615218613296747
transferrin O 0 0.12867280840873718
to O 0 0.0037484944332391024
HeLa O 1 0.9952707886695862
cell O 0 0.00810498557984829
TfR O 1 0.5921966433525085
in O 0 0.0025648982264101505
a O 0 0.004868572577834129
concentration O 1 0.9107728600502014
- O 0 0.24082475900650024
dependent O 0 0.010113642551004887
manner O 0 0.011051076464354992
. O 0 0.01075031328946352

Scatchard O 0 0.039725858718156815
plots O 0 0.011084700003266335
of O 0 0.004547073971480131
these O 0 0.0019503633957356215
data O 0 0.002248250413686037
indicate O 0 0.0028597780037671328
that O 0 0.001371437101624906
the O 0 0.002241445006802678
added O 0 0.005171939264982939
heterodimer O 1 0.5256010293960571
substantially O 0 0.006200713105499744
reduced O 0 0.0044783055782318115
the O 0 0.003569214604794979
affinity O 0 0.007256516255438328
of O 0 0.007570316549390554
TfR O 1 0.9996603727340698
for O 0 0.014313342981040478
transferrin O 1 0.9729217290878296
. O 0 0.018863705918192863

These O 0 0.005125494208186865
results O 0 0.004393890034407377
establish O 0 0.00436185859143734
a O 0 0.00277087464928627
molecular O 0 0.004425001330673695
link O 0 0.004868436139076948
between O 0 0.00286157988011837
HFE O 1 0.9957659244537354
and O 0 0.0019197746878489852
a O 0 0.0022551496513187885
key O 0 0.002651164773851633
protein O 0 0.001852348679676652
involved O 0 0.001293053268454969
in O 0 0.0016412725672125816
iron O 1 0.9705734252929688
transport O 0 0.023739513009786606
, O 0 0.002716351766139269
the O 0 0.00590141536667943
TfR O 1 0.9999535083770752
, O 0 0.002089936286211014
and O 0 0.0014421673258766532
raise O 0 0.0021100270096212626
the O 0 0.0015614667208865285
possibility O 0 0.0022899408359080553
that O 0 0.001172378077171743
alterations O 0 0.003234550356864929
in O 0 0.0010057645849883556
this O 0 0.0011568514164537191
regulatory O 0 0.003126111114397645
mechanism O 0 0.003222052473574877
may O 0 0.0012570795370265841
play O 0 0.0009734978666529059
a O 0 0.001235681469552219
role O 0 0.0019112670561298728
in O 0 0.0015596650773659348
the O 0 0.005156463943421841
pathogenesis O 1 0.999975323677063
of O 1 0.9984729886054993
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9596686959266663
. O 0 0.02443460188806057

Genomic O 0 0.021532004699110985
organization O 0 0.007875341922044754
of O 0 0.0058152819983661175
the O 0 0.027585690841078758
UBE3A O 1 0.9999978542327881
/ O 1 0.9997748732566833
E6 O 1 0.9997984766960144
- O 1 0.7817674875259399
AP O 0 0.02541343867778778
gene O 0 0.005530261434614658
and O 0 0.003614105051383376
related O 0 0.010033756494522095
pseudogenes O 0 0.10327523946762085
. O 0 0.01751483418047428

The O 0 0.02455761469900608
UBE3A O 1 0.9747918248176575
gene O 0 0.014192845672369003
encodes O 0 0.012550177983939648
the O 0 0.007883350364863873
E6 O 1 0.9344059824943542
- O 0 0.027589373290538788
AP O 0 0.01482967659831047
ubiquitin O 0 0.021552806720137596
- O 0 0.011495840735733509
protein O 0 0.003965007606893778
ligase O 0 0.007579292636364698
and O 0 0.0019665781874209642
has O 0 0.0018208763794973493
recently O 0 0.002624921500682831
been O 0 0.001345878466963768
shown O 0 0.0014378874329850078
to O 0 0.0009600577759556472
be O 0 0.001271208981052041
mutated O 0 0.013937873765826225
in O 0 0.12136851996183395
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999988079071045
who O 1 0.9474910497665405
lack O 1 0.9983296990394592
15q11 O 1 0.9999682903289795
- O 1 0.9774927496910095
q13 O 1 0.7607516050338745
deletions O 0 0.014329317957162857
or O 0 0.005342009011656046
chromosome O 0 0.013510326854884624
15 O 0 0.01084839180111885
paternal O 1 0.9512264132499695
uniparental B-Disease 1 0.9999420642852783
disomy I-Disease 1 0.9986541271209717
. O 0 0.025940898805856705

Previous O 0 0.02546961046755314
UBE3A O 1 0.9841132760047913
cDNA O 0 0.020324651151895523
analysis O 0 0.00445572379976511
has O 0 0.0026785514783114195
shown O 0 0.002417095936834812
a O 0 0.00268648867495358
coding O 0 0.006241714581847191
region O 0 0.003098605200648308
of O 0 0.0034726522862911224
approximately O 0 0.005737101659178734
2 O 0 0.008803628385066986
. O 0 0.00801403634250164

6 O 0 0.01804175227880478
kb O 0 0.022415006533265114
and O 0 0.0033852208871394396
a O 0 0.004526529926806688
3 O 0 0.005905803292989731
- O 0 0.010774976573884487
untranslated O 0 0.02050422690808773
region O 0 0.0048950910568237305
( O 0 0.004230000544339418
UTR O 0 0.016802992671728134
) O 0 0.002187199192121625
of O 0 0.0021955864503979683
< O 0 0.007277094293385744
50 O 0 0.002812517574056983
bp O 0 0.004435171373188496
, O 0 0.002036606427282095
whereas O 0 0.0025641333777457476
Northern O 0 0.0021617847960442305
analysis O 0 0.0021880087442696095
has O 0 0.002038913080468774
indicated O 0 0.0034231203608214855
mRNA O 0 0.0034966496750712395
sizes O 0 0.0026664750184863806
of O 0 0.0030722562223672867
5 O 0 0.006223155651241541
- O 0 0.011994567699730396
8 O 0 0.011443479917943478
kb O 0 0.043308425694704056
. O 0 0.013615096919238567

We O 0 0.0058741788379848
have O 0 0.0029511714819818735
analyzed O 0 0.005413139704614878
additional O 0 0.004080863669514656
cDNA O 0 0.011314467526972294
clones O 0 0.006618407554924488
and O 0 0.0017634377581998706
provide O 0 0.001738669816404581
evidence O 0 0.002043883316218853
for O 0 0.0017270540120080113
an O 0 0.002674153773114085
additional O 0 0.005005152430385351
0 O 0 0.010380263440310955
. O 0 0.009240321815013885

5 O 0 0.015370797365903854
kb O 0 0.024228163063526154
of O 0 0.006139165721833706
5 O 0 0.008553165011107922
- O 0 0.012236548587679863
UTR O 0 0.02916646935045719
and O 0 0.0036565859336405993
> O 0 0.00893013272434473
2 O 0 0.004935495089739561
kb O 0 0.01433492824435234
of O 0 0.005829386413097382
3 O 0 0.012780287303030491
- O 0 0.03159487619996071
UTR O 0 0.17470189929008484
. O 0 0.016215823590755463

We O 0 0.006881241220980883
have O 0 0.0026530721224844456
established O 0 0.003923893440514803
the O 0 0.003255514893680811
genomic O 0 0.0061479005962610245
organization O 0 0.0031053349375724792
of O 0 0.0036271782591938972
UBE3A O 1 0.9961536526679993
and O 0 0.002204739488661289
the O 0 0.0026245620101690292
sequence O 0 0.003814196912571788
of O 0 0.005747092422097921
intron O 1 0.9994066953659058
- O 0 0.37966999411582947
exon O 0 0.04039446637034416
borders O 0 0.013614365831017494
. O 0 0.012644734233617783

We O 0 0.0066884043626487255
have O 0 0.002832637634128332
also O 0 0.0025310341734439135
mapped O 0 0.004278665408492088
two O 0 0.0014855015324428678
highly O 0 0.003442757995799184
homologous O 0 0.00698473583906889
processed O 0 0.005373113788664341
pseudogenes O 0 0.01412199530750513
, O 0 0.0035329086240381002
UBE3AP1 O 1 0.9014944434165955
and O 0 0.002926454646512866
UBE3AP2 O 0 0.4172547161579132
, O 0 0.0017766925739124417
to O 0 0.0012693027965724468
chromosomes O 0 0.0024572541005909443
2 O 0 0.0016895801527425647
and O 0 0.0009308002190664411
21 O 0 0.001966899959370494
, O 0 0.0014005049597471952
respectively O 0 0.0022852772381156683
, O 0 0.0013696679379791021
and O 0 0.0016896171728149056
determined O 0 0.0037711460608989
their O 0 0.00252692773938179
genomic O 0 0.012272835709154606
organization O 0 0.010569910518825054
. O 0 0.011349814012646675

These O 0 0.006568634882569313
results O 0 0.004805643577128649
will O 0 0.0018538550939410925
form O 0 0.001774062868207693
the O 0 0.001427306910045445
basis O 0 0.001492779003456235
for O 0 0.0012945837806910276
studies O 0 0.0020594685338437557
of O 0 0.0024734227918088436
mutation O 0 0.00645780935883522
and O 0 0.004242958966642618
imprinting O 0 0.25511810183525085
of O 0 0.05009074881672859
UBE3A O 1 0.9998840093612671
. O 0 0.01949280872941017

Mutation O 0 0.022593896836042404
spectrum O 0 0.012667005881667137
and O 0 0.005625392775982618
genotype O 0 0.02256121300160885
- O 0 0.010359480045735836
phenotype O 0 0.007804241497069597
analyses O 0 0.004682555794715881
in O 0 0.004065562970936298
Cowden B-Disease 1 0.9999986886978149
disease I-Disease 1 0.9999994039535522
and O 1 0.6996418237686157
Bannayan B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999926090240479
Zonana I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.03677590191364288
two O 0 0.010053853504359722
hamartoma B-Disease 1 0.9999969005584717
syndromes I-Disease 1 0.9999958276748657
with O 1 0.7497458457946777
germline O 1 0.9999783039093018
PTEN O 1 0.9999693632125854
mutation O 0 0.25224393606185913
. O 0 0.020151691511273384

The O 0 0.4890994727611542
tumour B-Disease 1 0.9999995231628418
suppressor O 1 0.9999150037765503
gene O 0 0.24894855916500092
PTEN O 1 0.9945685863494873
, O 0 0.0043516443111002445
which O 0 0.0032303081825375557
maps O 0 0.007716564927250147
to O 0 0.00673846947029233
10q23 O 0 0.048673637211322784
. O 0 0.015517795458436012

3 O 0 0.012878898531198502
and O 0 0.00552389258518815
encodes O 0 0.008793859742581844
a O 0 0.004282661247998476
403 O 0 0.014191911555826664
amino O 0 0.00642465939745307
acid O 0 0.00909052137285471
dual O 0 0.009626866318285465
specificity O 0 0.01091177761554718
phosphatase O 0 0.27713945508003235
( O 0 0.004972427152097225
protein O 0 0.004720170516520739
tyrosine O 0 0.008135074749588966
phosphatase O 0 0.021385228261351585
; O 0 0.0025729427579790354
PTPase O 0 0.09991221874952316
) O 0 0.0021140631288290024
, O 0 0.0014960869448259473
was O 0 0.002960727782920003
shown O 0 0.001772248768247664
recently O 0 0.001834974274970591
to O 0 0.0009807177120819688
play O 0 0.001429739873856306
a O 0 0.0019494523294270039
broad O 0 0.004022157285362482
role O 0 0.004428523126989603
in O 0 0.004494273103773594
human O 0 0.31058475375175476
malignancy B-Disease 1 0.9999939203262329
. O 0 0.01925716921687126

Somatic O 1 0.9599352478981018
PTEN O 1 0.9979343414306641
deletions O 0 0.02070639096200466
and O 0 0.004607401788234711
mutations O 0 0.004145820625126362
were O 0 0.0018220258643850684
observed O 0 0.0022749926429241896
in O 0 0.0019548721611499786
sporadic B-Disease 0 0.3882802426815033
breast I-Disease 1 0.9999985694885254
, I-Disease 1 0.5570774078369141
brain I-Disease 1 0.9999291896820068
, I-Disease 1 0.938770592212677
prostate I-Disease 1 1.0
and I-Disease 1 0.9999598264694214
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9888561367988586
lines O 0 0.003602017881348729
and O 0 0.0009942452888935804
in O 0 0.0009800326079130173
several O 0 0.00122284353710711
primary O 0 0.05074901133775711
tumours B-Disease 1 0.9994742274284363
such O 0 0.0019784255418926477
as O 0 0.03534788265824318
endometrial B-Disease 1 0.9999995231628418
carcinomas I-Disease 1 1.0
, O 1 0.9999979734420776
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9985581040382385

In O 0 0.008206339552998543
addition O 0 0.008871941827237606
, O 0 0.007739173714071512
PTEN O 1 0.9914348721504211
was O 0 0.007900983095169067
identified O 0 0.003604942001402378
as O 0 0.001944311778061092
the O 0 0.0026201095897704363
susceptibility O 0 0.021449550986289978
gene O 0 0.002396468771621585
for O 0 0.0015167267993092537
two O 0 0.003031520638614893
hamartoma B-Disease 1 0.9999972581863403
syndromes I-Disease 1 0.9999997615814209
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.961493968963623
CD B-Disease 1 0.9600788354873657
; O 0 0.004985840525478125
MIM O 1 0.9992138147354126
158350 O 0 0.24904295802116394
) O 0 0.002919431310147047
and O 0 0.0026427810080349445
Bannayan B-Disease 1 0.7420383095741272
- I-Disease 0 0.05513150990009308
Zonana I-Disease 1 0.9783796072006226
( I-Disease 0 0.007074375171214342
BZS I-Disease 0 0.24541828036308289
) I-Disease 0 0.003507674438878894
or I-Disease 0 0.003744949121028185
Ruvalcaba I-Disease 1 0.9826535582542419
- I-Disease 0 0.21461713314056396
Riley I-Disease 1 0.9825729131698608
- I-Disease 1 0.982448160648346
Smith I-Disease 1 0.9928644895553589
syndrome I-Disease 1 1.0
( O 1 0.9752768874168396
MIM O 1 0.9999963045120239
153480 O 1 0.9996424913406372
) O 0 0.014099725522100925
. O 0 0.012284106574952602

Constitutive O 0 0.04138227924704552
DNA O 0 0.011225808411836624
from O 0 0.004629445727914572
37 O 0 0.005842660553753376
CD B-Disease 0 0.005907517392188311
families O 0 0.00238732504658401
and O 0 0.0022955494932830334
seven O 0 0.003830305067822337
BZS B-Disease 1 0.9720163345336914
families O 0 0.00418740464374423
was O 0 0.008493748493492603
screened O 0 0.013237793929874897
for O 0 0.0075901891104876995
germline O 1 0.9923146367073059
PTEN O 1 0.9992352724075317
mutations O 0 0.023807507008314133
. O 0 0.01400294154882431

PTEN O 1 0.9884023070335388
mutations O 0 0.009396607056260109
were O 0 0.003072768449783325
identified O 0 0.00287891598418355
in O 0 0.001416713697835803
30 O 0 0.0016749190399423242
of O 0 0.0015936974668875337
37 O 0 0.003055019536986947
( O 0 0.0020403945818543434
81 O 0 0.003918212838470936
% O 0 0.001603982294909656
) O 0 0.0013236745726317167
CD B-Disease 0 0.0028296876698732376
families O 0 0.001306324265897274
, O 0 0.0012579802423715591
including O 0 0.0013376863207668066
missense O 0 0.006053323391824961
and O 0 0.0019542898517102003
nonsense O 0 0.010391569696366787
point O 0 0.0038547299336642027
mutations O 0 0.00339732738211751
, O 0 0.0019203630508854985
deletions O 0 0.004744064994156361
, O 0 0.002010118216276169
insertions O 0 0.006664645858108997
, O 0 0.002284036949276924
a O 0 0.0041581327095627785
deletion O 0 0.388018399477005
/ O 0 0.16496361792087555
insertion O 0 0.012443657964468002
and O 0 0.004271224606782198
splice O 0 0.024156367406249046
site O 0 0.011599582619965076
mutations O 0 0.014448709785938263
. O 0 0.01128518395125866

These O 0 0.006194680463522673
mutations O 0 0.005426876246929169
were O 0 0.0024531434755772352
scattered O 0 0.0028828196227550507
over O 0 0.0020013151224702597
the O 0 0.0024439608678221703
entire O 0 0.003807538654655218
length O 0 0.0032278234139084816
of O 0 0.0035942464601248503
PTEN O 1 0.9955354928970337
, O 0 0.001761194784194231
with O 0 0.0010397250298410654
the O 0 0.0012453258968889713
exception O 0 0.0018214622978121042
of O 0 0.0014076982624828815
the O 0 0.0017410930013284087
first O 0 0.0019643642008304596
, O 0 0.0018542425241321325
fourth O 0 0.004417667165398598
and O 0 0.003072792198508978
last O 0 0.0070768133737146854
exons O 0 0.023769017308950424
. O 0 0.011338894255459309

A O 0 0.01829165406525135
hot O 0 0.02398516982793808
spot O 0 0.01135662104934454
for O 0 0.005074538290500641
PTEN O 1 0.9874843955039978
mutation O 0 0.00573561480268836
in O 0 0.00215791049413383
CD B-Disease 0 0.006598073989152908
was O 0 0.003995571285486221
identified O 0 0.002436550799757242
in O 0 0.001496202894486487
exon O 0 0.0057866210117936134
5 O 0 0.0017549884505569935
that O 0 0.0008640374871902168
contains O 0 0.00156819773837924
the O 0 0.0020928902085870504
PTPase O 0 0.11416584253311157
core O 0 0.004642092622816563
motif O 0 0.004322105553001165
, O 0 0.0010383145418018103
with O 0 0.0007425308576785028
13 O 0 0.001289669657126069
of O 0 0.0010090478463098407
30 O 0 0.0013582075480371714
( O 0 0.0014840967487543821
43 O 0 0.002264992333948612
% O 0 0.0015168605605140328
) O 0 0.001560036325827241
CD B-Disease 0 0.004521728027611971
mutations O 0 0.0028211192693561316
identified O 0 0.0027855478692799807
in O 0 0.0024812992196530104
this O 0 0.004025906790047884
exon O 0 0.027925683185458183
. O 0 0.011211009696125984

Seven O 0 0.00804657768458128
of O 0 0.004370373673737049
30 O 0 0.003942795563489199
( O 0 0.0029860681388527155
23 O 0 0.0029651764780282974
% O 0 0.0016583721153438091
) O 0 0.0011287975357845426
were O 0 0.0008338085608556867
within O 0 0.000977727584540844
the O 0 0.0015197782777249813
core O 0 0.004273512400686741
motif O 0 0.004935146775096655
, O 0 0.001177544123493135
the O 0 0.0011723164934664965
majority O 0 0.0011324260849505663
( O 0 0.0011309566907584667
five O 0 0.0007417136221192777
of O 0 0.0008005324052646756
seven O 0 0.0011057903757318854
) O 0 0.000853423320222646
of O 0 0.0007488781120628119
which O 0 0.0007753540994599462
were O 0 0.0011774118756875396
missense O 0 0.005787191446870565
mutations O 0 0.002361585386097431
, O 0 0.0013169239973649383
possibly O 0 0.0017611393705010414
pointing O 0 0.002560364082455635
to O 0 0.0011188682401552796
the O 0 0.0015149075770750642
functional O 0 0.0026864660903811455
significance O 0 0.0034165061078965664
of O 0 0.002789833350107074
this O 0 0.0033172087278217077
region O 0 0.009929580613970757
. O 0 0.009370874613523483

Germline O 1 0.9988583326339722
PTEN O 1 0.9986605644226074
mutations O 0 0.008188138715922832
were O 0 0.002673577982932329
identified O 0 0.002093378221616149
in O 0 0.001151406206190586
four O 0 0.0010204390855506063
of O 0 0.0012867054902017117
seven O 0 0.0019343956373631954
( O 0 0.002654643263667822
57 O 0 0.004659508354961872
% O 0 0.002916445955634117
) O 0 0.004223542287945747
BZS B-Disease 0 0.15006648004055023
families O 0 0.0058119832538068295
studied O 0 0.01169601920992136
. O 0 0.013106977567076683

Interestingly O 0 0.027156468480825424
, O 0 0.006077890750020742
none O 0 0.004202460870146751
of O 0 0.002595125464722514
these O 0 0.0017994402442127466
mutations O 0 0.0030422371346503496
was O 0 0.0037085670046508312
observed O 0 0.002729307394474745
in O 0 0.0022392706014215946
the O 0 0.005312653724104166
PTPase O 1 0.97056645154953
core O 0 0.04755016416311264
motif O 0 0.10770430415868759
. O 0 0.013387848623096943

It O 0 0.006069260649383068
is O 0 0.004004247020930052
also O 0 0.0026820909697562456
worthy O 0 0.00513707147911191
of O 0 0.002181912772357464
note O 0 0.002597486600279808
that O 0 0.0011164065217599273
a O 0 0.0016646895091980696
single O 0 0.0020136269740760326
nonsense O 0 0.006002633832395077
point O 0 0.0031310042832046747
mutation O 0 0.0028724446892738342
, O 0 0.0016271709464490414
R233X O 0 0.007567143067717552
, O 0 0.001776376273483038
was O 0 0.0023261241149157286
observed O 0 0.0017618670826777816
in O 0 0.0011559195118024945
the O 0 0.00190520950127393
germline O 0 0.011063110083341599
DNA O 0 0.0022640679962933064
from O 0 0.0012201092904433608
two O 0 0.0010095714824274182
unrelated O 0 0.0034066170919686556
CD B-Disease 0 0.004997383337467909
families O 0 0.002494394313544035
and O 0 0.0024550778325647116
one O 0 0.005395951215177774
BZS B-Disease 1 0.9984473586082458
family O 0 0.015687577426433563
. O 0 0.012200487777590752

Genotype O 1 0.6896896362304688
- O 0 0.1133943721652031
phenotype O 0 0.011760417371988297
studies O 0 0.0032665347680449486
were O 0 0.001950696692802012
not O 0 0.0013421623734757304
performed O 0 0.002331631723791361
on O 0 0.0015116854337975383
this O 0 0.001271100016310811
small O 0 0.0019720953423529863
group O 0 0.0029971743933856487
of O 0 0.0070135812275111675
BZS B-Disease 1 0.9997156262397766
families O 0 0.01254945807158947
. O 0 0.013000087812542915

However O 0 0.013055982068181038
, O 0 0.009178617037832737
genotype O 0 0.022977156564593315
- O 0 0.010702932253479958
phenotype O 0 0.00821409747004509
analysis O 0 0.0035232275258749723
inthe O 0 0.012065459042787552
group O 0 0.0023965302389115095
of O 0 0.002456217771396041
CD B-Disease 0 0.00905699748545885
families O 0 0.002441994845867157
revealed O 0 0.0027840498369187117
two O 0 0.0009278379729948938
possible O 0 0.0014789876295253634
associations O 0 0.0021034087985754013
worthy O 0 0.003967199940234423
of O 0 0.00215046014636755
follow O 0 0.0030359886586666107
- O 0 0.004981187637895346
up O 0 0.0022684691939502954
in O 0 0.0024663200601935387
independent O 0 0.004570656921714544
analyses O 0 0.012668665498495102
. O 0 0.011058478616178036

The O 0 0.008143694140017033
first O 0 0.005437704734504223
was O 0 0.005895102396607399
an O 0 0.0021227833349257708
association O 0 0.0038726013153791428
noted O 0 0.0023112327326089144
in O 0 0.001237104763276875
the O 0 0.0015474993269890547
group O 0 0.0015396943781524897
of O 0 0.002267012605443597
CD B-Disease 0 0.10470321774482727
families O 0 0.0054019480012357235
with O 0 0.04756702110171318
breast B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999996423721313
. O 0 0.10188991576433182

A O 0 0.013774619437754154
correlation O 0 0.010699146427214146
was O 0 0.005638212896883488
observed O 0 0.00289283343590796
between O 0 0.0017490364843979478
the O 0 0.002348985057324171
presence O 0 0.004720248747617006
/ O 0 0.1608894318342209
absence O 0 0.0043170154094696045
of O 0 0.0032894378527998924
a O 0 0.03818853572010994
PTEN O 1 0.9997767806053162
mutation O 0 0.0036520615685731173
and O 0 0.0013426955556496978
the O 0 0.0022320374846458435
type O 0 0.006566257681697607
of O 0 0.02192971482872963
breast O 1 0.9999992847442627
involvement O 1 0.9933698177337646
( O 0 0.48966100811958313
unaffected O 1 0.9807689189910889
versus O 1 0.9826347231864929
benign O 1 0.9999376535415649
versus O 1 0.9990382194519043
malignant O 1 0.9999990463256836
) O 0 0.0165215115994215
. O 0 0.014771716669201851

Specifically O 0 0.0106880534440279
and O 0 0.0038170244079083204
more O 0 0.0018647672841325402
directly O 0 0.0022578698117285967
, O 0 0.0018555657006800175
an O 0 0.0019373409450054169
association O 0 0.005227515008300543
was O 0 0.007019934244453907
also O 0 0.0014041174435988069
observed O 0 0.00136494729667902
between O 0 0.0008626339840702713
the O 0 0.0011049638269469142
presence O 0 0.0014288007514551282
of O 0 0.0018861836288124323
a O 0 0.04282844066619873
PTEN O 1 0.9999901056289673
mutation O 1 0.930288553237915
and O 1 0.8411737084388733
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.8700151443481445

Secondly O 0 0.04459916800260544
, O 0 0.004178634844720364
there O 0 0.002477111527696252
appeared O 0 0.002516495529562235
to O 0 0.0009923529578372836
be O 0 0.0009175149607472122
an O 0 0.0013984603574499488
interdependent O 0 0.01624816656112671
association O 0 0.0038470877334475517
between O 0 0.0019689607433974743
mutations O 0 0.0032218992710113525
upstream O 0 0.002732192864641547
and O 0 0.001096214633435011
within O 0 0.0012585950316861272
the O 0 0.0025739853736013174
PTPase O 1 0.9389374256134033
core O 0 0.01179105881601572
motif O 0 0.007522041909396648
, O 0 0.001935262931510806
the O 0 0.002429794752970338
core O 0 0.004686557687819004
motif O 0 0.0048280213959515095
containing O 0 0.0025190699379891157
the O 0 0.0020278533920645714
majority O 0 0.0019060419872403145
of O 0 0.0026094636414200068
missense O 0 0.21713431179523468
mutations O 0 0.0033142869360744953
, O 0 0.0014094064245000482
and O 0 0.0009995506843551993
the O 0 0.0012747086584568024
involvement O 0 0.002583414316177368
of O 0 0.001684629707597196
all O 0 0.0013371811946853995
major O 0 0.004964679945260286
organ O 1 0.9967306852340698
systems O 0 0.12041251361370087
( O 0 0.004225921351462603
central O 0 0.007996470667421818
nervous O 1 0.8771606087684631
system O 0 0.008676634170114994
, O 0 0.008156712166965008
thyroid O 1 0.9999997615814209
, O 1 0.8551799654960632
breast O 1 0.9999998807907104
, O 1 0.9972848892211914
skin O 1 0.9999998807907104
and O 1 0.9983250498771667
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9275890588760376
. O 0 0.021620748564600945

However O 0 0.008136621676385403
, O 0 0.0033415472134947777
these O 0 0.0016062548384070396
observations O 0 0.0031221683602780104
would O 0 0.0014282838674262166
need O 0 0.001312463777139783
to O 0 0.0008627307252027094
be O 0 0.0008642078610137105
confirmed O 0 0.0014400100335478783
by O 0 0.0009254201431758702
studying O 0 0.0020863316021859646
a O 0 0.001780532649718225
larger O 0 0.002043284010142088
number O 0 0.0017318939790129662
of O 0 0.0035693729296326637
CD B-Disease 0 0.01689968630671501
families O 0 0.00929610338062048
. O 0 0.011390508152544498

Molecular O 0 0.0367794968187809
defects O 1 0.9766334891319275
leading O 0 0.008440956473350525
to O 0 0.0032894646283239126
human O 0 0.0103843342512846
complement B-Disease 1 0.9151312112808228
component I-Disease 1 0.9999622106552124
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0045098611153662205
an O 0 0.0060292743146419525
African O 0 0.35369887948036194
- O 1 0.5710292458534241
American O 0 0.00883431825786829
family O 0 0.011909005232155323
. O 0 0.011367709375917912

Complement B-Disease 0 0.2913837134838104
component I-Disease 1 0.9996569156646729
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9706560969352722
C6D B-Disease 1 0.999969482421875
) O 0 0.0056663574650883675
was O 0 0.13992172479629517
diagnosed O 1 0.9996596574783325
in O 0 0.0016797353746369481
a O 0 0.002035880461335182
16 O 0 0.0023058729711920023
- O 0 0.003991239238530397
year O 0 0.0017347481334581971
- O 0 0.004386166576296091
old O 0 0.0048602186143398285
African O 0 0.004981716629117727
- O 0 0.013669184409081936
American O 0 0.004492080770432949
male O 0 0.011057869531214237
with O 0 0.04464991018176079
meningococcal B-Disease 1 0.9999998807907104
meningitis I-Disease 1 0.9999998807907104
. O 0 0.4850631356239319

The O 0 0.0175647996366024
patients O 1 0.8939450979232788
father O 0 0.03188116103410721
and O 0 0.0022706936579197645
two O 0 0.001460492261685431
brothers O 0 0.028462087735533714
also O 0 0.002492434810847044
had O 0 0.005635953973978758
C6D B-Disease 1 0.9904878735542297
, O 0 0.0015065682819113135
but O 0 0.0009781245607882738
gave O 0 0.001561653334647417
no O 0 0.001134749734774232
history O 0 0.002647991990670562
of O 0 0.07697079330682755
meningitis B-Disease 1 0.9999998807907104
or O 0 0.06263891607522964
other O 0 0.007848801091313362
neisserial B-Disease 1 0.9999791383743286
infection I-Disease 1 0.9999935626983643
. O 0 0.019071562215685844

By O 0 0.007556036114692688
using O 0 0.0073233712464571
exon O 0 0.02832433395087719
- O 0 0.008186504244804382
specific O 0 0.003506231354549527
polymerase O 0 0.009263578802347183
chain O 0 0.006609328556805849
reaction O 0 0.005507816094905138
( O 0 0.004128498490899801
PCR O 0 0.009839300066232681
) O 0 0.003246548119932413
/ O 0 0.0074484930373728275
single O 0 0.003778856247663498
- O 0 0.00649432186037302
strand O 0 0.006065045483410358
conformation O 0 0.0062627228908240795
polymorphism O 0 0.004550548270344734
as O 0 0.0019712650682777166
a O 0 0.0026362836360931396
screening O 0 0.004430289380252361
step O 0 0.0029435190372169018
and O 0 0.0016813313122838736
nucleotide O 0 0.003058510133996606
sequencing O 0 0.0030656764283776283
of O 0 0.001506393076851964
target O 0 0.002154867397621274
exons O 0 0.003456961363554001
, O 0 0.0013089609565213323
we O 0 0.0010319016873836517
determined O 0 0.001622154377400875
that O 0 0.0009465925977565348
the O 0 0.0016849313396960497
proband O 0 0.28178125619888306
was O 0 0.004409700632095337
a O 0 0.002532699378207326
compound O 0 0.007306594867259264
heterozygote O 0 0.016249211505055428
for O 0 0.002737201051786542
two O 0 0.004676235374063253
C6 O 1 0.9992948770523071
gene O 0 0.014927874319255352
mutations O 0 0.015534020029008389
. O 0 0.014061578549444675

The O 0 0.009037114679813385
first O 0 0.005747022572904825
, O 0 0.003504781983792782
1195delC O 0 0.017207438126206398
located O 0 0.003957797773182392
in O 0 0.002133243950083852
exon O 0 0.010178464464843273
7 O 0 0.002643314888700843
, O 0 0.0013687217142432928
is O 0 0.0011736539890989661
a O 0 0.0016184765845537186
novel O 0 0.004406256135553122
mutation O 0 0.002663995837792754
, O 0 0.0011874476913362741
while O 0 0.0010914972517639399
the O 0 0.0013297910336405039
second O 0 0.002208002144470811
, O 0 0.0018809017492458224
1936delG O 0 0.00970161147415638
in O 0 0.002025091554969549
exon O 0 0.007240166421979666
12 O 0 0.0018872924847528338
, O 0 0.0013007053639739752
has O 0 0.0011492742924019694
been O 0 0.0010822758777067065
described O 0 0.0020775424782186747
before O 0 0.0014571623178198934
to O 0 0.0012526523787528276
cause O 0 0.0052399649284780025
C6D B-Disease 1 0.6434003114700317
in O 0 0.0015369773609563708
an O 0 0.0019079090561717749
unrelated O 0 0.016192225739359856
African O 0 0.012549233622848988
- O 0 0.02201194129884243
American O 0 0.006262362934648991
individual O 0 0.006369503680616617
. O 0 0.009264882653951645

Both O 0 0.010008258745074272
mutations O 0 0.009964519180357456
result O 0 0.005905349738895893
in O 0 0.005097636487334967
premature O 1 0.9214158058166504
termination O 1 0.977510392665863
codons O 0 0.11554495990276337
and O 0 0.011147229932248592
C6 O 1 0.9996694326400757
null O 0 0.04216959327459335
alleles O 0 0.033524077385663986
. O 0 0.01747717708349228

Allele O 0 0.03221287205815315
- O 0 0.013501198962330818
specific O 0 0.004724943079054356
PCR O 0 0.009868658147752285
indicated O 0 0.004145584534853697
that O 0 0.0013565929839387536
the O 0 0.0017727609956637025
probands O 0 0.019444532692432404
two O 0 0.0013156734639778733
brothers O 0 0.005392369348555803
also O 0 0.002400114666670561
inherited O 1 0.8860994577407837
the O 0 0.004436763469129801
1195delC O 1 0.9431838393211365
mutation O 0 0.0034179138019680977
from O 0 0.0011486827861517668
their O 0 0.0011591038201004267
heterozygous O 0 0.0034470076207071543
mother O 0 0.004062976688146591
and O 0 0.0016233238857239485
the O 0 0.0028012108523398638
1936delG O 1 0.5225420594215393
mutation O 0 0.0033399879466742277
from O 0 0.0019070056732743979
their O 0 0.0021336826030164957
homozygous O 0 0.008775494992733002
father O 0 0.011681278236210346
. O 0 0.005503957159817219
. O 0 0.008494571782648563

PAX6 O 1 0.9987362027168274
mutations O 0 0.062177624553442
reviewed O 0 0.04696793481707573
. O 0 0.029243387281894684

Mutations O 0 0.019097499549388885
in O 0 0.006792009342461824
PAX6 O 1 0.9945992231369019
are O 0 0.0019802360329777002
responsible O 0 0.003570463042706251
for O 0 0.0020666292402893305
human O 0 0.05546817556023598
aniridia B-Disease 1 0.999825656414032
and O 0 0.0015778240049257874
have O 0 0.0008964574080891907
also O 0 0.0009738675435073674
been O 0 0.0010179659584537148
found O 0 0.0009996898006647825
in O 0 0.0011494193458929658
patients O 0 0.12426082044839859
with O 0 0.0018669101409614086
Peters B-Disease 1 0.9999443292617798
anomaly I-Disease 1 0.9998981952667236
, O 0 0.0464191809296608
with O 1 0.9695243835449219
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9992862343788147
with O 1 0.9965865612030029
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999967813491821
keratitis I-Disease 1 1.0
, O 0 0.18613135814666748
and O 0 0.011266051791608334
with O 0 0.02498813532292843
isolated B-Disease 1 0.9995115995407104
foveal I-Disease 1 0.9999969005584717
hypoplasia I-Disease 1 0.9999995231628418
. O 0 0.07295370101928711

No O 0 0.011055871844291687
locus O 0 0.01396935060620308
other O 0 0.0024068213533610106
than O 0 0.0024910152424126863
chromosome O 0 0.006624517496675253
11p13 O 0 0.01218764390796423
has O 0 0.002402184298262
been O 0 0.0021000937558710575
implicated O 0 0.021758588030934334
in O 0 0.0034673952031880617
aniridia B-Disease 1 0.9999463558197021
, O 0 0.0033121940214186907
and O 0 0.003009085776284337
PAX6 O 1 0.999883770942688
is O 0 0.0021190543193370104
clearly O 0 0.002263858914375305
the O 0 0.0014432019088417292
major O 0 0.0020560689736157656
, O 0 0.0013993170578032732
if O 0 0.0010021576890721917
not O 0 0.0008409289875999093
only O 0 0.001319955219514668
, O 0 0.0025412729009985924
gene O 0 0.005426845513284206
responsible O 0 0.008468146435916424
. O 0 0.010857411660254002

Twenty O 0 0.019313815981149673
- O 0 0.010630832985043526
eight O 0 0.004145657178014517
percent O 0 0.0037870327942073345
of O 0 0.003583107143640518
identified O 0 0.00885213166475296
PAX6 O 1 0.9983354210853577
mutations O 0 0.004526573233306408
are O 0 0.0015930571826174855
C O 0 0.01884762942790985
- O 0 0.01106638740748167
T O 0 0.008808601647615433
changes O 0 0.0015677977353334427
at O 0 0.0022908125538378954
CpG O 0 0.00948907807469368
dinucleotides O 0 0.01614668220281601
, O 0 0.0014555375091731548
20 O 0 0.0015821242704987526
% O 0 0.0012462165905162692
are O 0 0.000760908704251051
splicing O 0 0.0028591908048838377
errors O 0 0.002813836792483926
, O 0 0.0013635681243613362
and O 0 0.0009639670024625957
more O 0 0.0006978172459639609
than O 0 0.0008059692336246371
30 O 0 0.0017155345994979143
% O 0 0.0016881001647561789
are O 0 0.0015037673292681575
deletion O 0 0.008218923583626747
or O 0 0.0039859311655163765
insertion O 0 0.018943898379802704
events O 0 0.012447004206478596
. O 0 0.015330910682678223

There O 0 0.0076524438336491585
is O 0 0.005621603690087795
a O 0 0.005399294663220644
noticeably O 0 0.026635393500328064
elevated O 1 0.8010973334312439
level O 0 0.003881969954818487
of O 0 0.0028830403462052345
mutation O 0 0.004126174375414848
in O 0 0.0014241586904972792
the O 0 0.001976093975827098
paired O 0 0.003681711619719863
domain O 0 0.002175471279770136
compared O 0 0.0017507215961813927
with O 0 0.0009195366292260587
the O 0 0.001868496066890657
rest O 0 0.0027282044757157564
of O 0 0.0034737843088805676
the O 0 0.008923335932195187
gene O 0 0.011593470349907875
. O 0 0.009978707879781723

Increased O 0 0.014232450164854527
mutation O 0 0.010398456826806068
in O 0 0.003558112308382988
the O 0 0.004934268072247505
homeodomain O 1 0.820800244808197
is O 0 0.0031520549673587084
accounted O 0 0.0034585357643663883
for O 0 0.001776520861312747
by O 0 0.0024995654821395874
the O 0 0.005269635934382677
hypermutable O 1 0.9174348711967468
CpG O 0 0.1710684895515442
dinucleotide O 0 0.09238943457603455
in O 0 0.007964586839079857
codon O 0 0.027051135897636414
240 O 0 0.022986246272921562
. O 0 0.017000801861286163

Very O 0 0.008811196312308311
nearly O 0 0.005555093288421631
all O 0 0.0026170797646045685
mutations O 0 0.0036857931409031153
appear O 0 0.002364339306950569
to O 0 0.0018173791468143463
cause O 0 0.008430944755673409
loss O 0 0.007265772204846144
of O 0 0.0026003418024629354
function O 0 0.00266420585103333
of O 0 0.0031845036428421736
the O 0 0.08134138584136963
mutant O 1 0.6170691251754761
allele O 0 0.00277209491468966
, O 0 0.0008843442192301154
and O 0 0.0006700103986077011
more O 0 0.0005205641500651836
than O 0 0.0006582415662705898
80 O 0 0.0015344256535172462
% O 0 0.0012205898528918624
of O 0 0.0015795858344063163
exonic O 0 0.18248285353183746
substitutions O 0 0.005198336206376553
result O 0 0.003343521384522319
in O 0 0.004135214723646641
nonsense O 0 0.234939306974411
codons O 0 0.02732730470597744
. O 0 0.012458156794309616

In O 0 0.007557516451925039
a O 0 0.00588950514793396
gene O 0 0.003928244113922119
with O 0 0.0016680093249306083
such O 0 0.0017389528220519423
extraordinarily O 0 0.02827153354883194
high O 0 0.004485956393182278
sequence O 0 0.0024971100501716137
conservation O 0 0.0028426297940313816
throughout O 0 0.0014298760797828436
evolution O 0 0.002299998886883259
, O 0 0.0013926964020356536
there O 0 0.0010810632957145572
are O 0 0.0010361969470977783
presumed O 0 0.006639054976403713
undiscovered O 0 0.35337814688682556
missense O 0 0.0394817553460598
mutations O 0 0.0032279291190207005
, O 0 0.001288316329009831
these O 0 0.0008332318975590169
are O 0 0.0008115402888506651
hypothesized O 0 0.003148088464513421
to O 0 0.0009512142860330641
exist O 0 0.0011930150212720037
in O 0 0.0013938479823991656
as O 0 0.0023901648819446564
- O 0 0.007352867163717747
yet O 0 0.004909774288535118
unidentified O 0 0.014839621260762215
phenotypes O 0 0.018864020705223083
. O 0 0.005462851841002703
. O 0 0.011562463827431202

Genetic O 0 0.031056609004735947
heterogeneity O 0 0.030099913477897644
and O 0 0.00589995551854372
penetrance O 0 0.038027409464120865
analysis O 0 0.003289727261289954
of O 0 0.0031471969559788704
the O 0 0.005979910027235746
BRCA1 O 1 0.9968156218528748
and O 0 0.00420019356533885
BRCA2 O 1 0.9984815716743469
genes O 0 0.010165338404476643
in O 0 0.33707383275032043
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
families O 0 0.1385316550731659
. O 0 0.014316681772470474

The O 1 0.9779690504074097
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9997791647911072
Consortium O 1 0.6399140357971191
. O 0 0.021938353776931763

The O 0 0.010350733995437622
contribution O 0 0.011304476298391819
of O 0 0.008173815906047821
BRCA1 O 1 0.9935562014579773
and O 0 0.0058462955057621
BRCA2 O 1 0.9993996620178223
to O 0 0.031703412532806396
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9994713664054871
assessed O 0 0.09668266028165817
by O 0 0.0017803293885663152
linkage O 0 0.00523923197761178
and O 0 0.001378292916342616
mutation O 0 0.002041761763393879
analysis O 0 0.00119523995090276
in O 0 0.0011791526339948177
237 O 0 0.003973162733018398
families O 0 0.0011846070410683751
, O 0 0.0008697187295183539
each O 0 0.0006393658695742488
with O 0 0.0006257783388718963
at O 0 0.0011995797976851463
least O 0 0.0007947785197757185
four O 0 0.0008914718637242913
cases O 0 0.001767619512975216
of O 0 0.09703460335731506
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999904632568359
, O 0 0.0022101590875536203
collected O 0 0.0024457124527543783
by O 0 0.0024622853379696608
the O 1 0.6715327501296997
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9994974136352539
Consortium O 0 0.11127811670303345
. O 0 0.015093297697603703

Families O 0 0.010089335031807423
were O 0 0.004168397281318903
included O 0 0.0035794181749224663
without O 0 0.0022428850643336773
regard O 0 0.0027286612894386053
to O 0 0.001428984571248293
the O 0 0.0022264691069722176
occurrence O 0 0.06095822900533676
of O 1 0.849960446357727
ovarian B-Disease 1 1.0
or I-Disease 0 0.48586636781692505
other I-Disease 0 0.011112667620182037
cancers I-Disease 1 0.9999324083328247
. O 0 0.017664344981312752

Overall O 1 0.7507659196853638
, O 0 0.2131708413362503
disease O 1 0.9999979734420776
was O 1 0.9350247383117676
linked O 0 0.34492552280426025
to O 0 0.0022353376261889935
BRCA1 O 0 0.18147900700569153
in O 0 0.0012849468039348722
an O 0 0.0011582671431824565
estimated O 0 0.0021860068663954735
52 O 0 0.0023724809288978577
% O 0 0.001078753499314189
of O 0 0.0010779809672385454
families O 0 0.0013754015089944005
, O 0 0.0011678360169753432
to O 0 0.001124963047914207
BRCA2 O 0 0.006556538864970207
in O 0 0.0010488758562132716
32 O 0 0.0017321126069873571
% O 0 0.0009934034897014499
of O 0 0.0009348379098810256
families O 0 0.0011754893930628896
, O 0 0.0008775184396654367
and O 0 0.0007166536524891853
to O 0 0.0007845317595638335
neither O 0 0.0013870984548702836
gene O 0 0.0010163815459236503
in O 0 0.0007955422624945641
16 O 0 0.0016253191279247403
% O 0 0.0013414243003353477
( O 0 0.001705867936834693
95 O 0 0.0022348109632730484
% O 0 0.0017365028616040945
confidence O 0 0.0038387198001146317
interval O 0 0.005038211587816477
[ O 0 0.006927521899342537
CI O 1 0.5340203046798706
] O 0 0.005669733043760061
6 O 0 0.003150266595184803
% O 0 0.0022047667298465967
- O 0 0.003379289759323001
28 O 0 0.0026545915752649307
% O 0 0.002112718764692545
) O 0 0.0018750490853562951
, O 0 0.0020105610601603985
suggesting O 0 0.004251331556588411
other O 0 0.0027786537539213896
predisposition O 1 0.8551084399223328
genes O 0 0.01087602786719799
. O 0 0.010778484866023064

The O 0 0.007767332252115011
majority O 0 0.004644261207431555
( O 0 0.0035579027608036995
81 O 0 0.004804421216249466
% O 0 0.001732543809339404
) O 0 0.0012847675243392587
of O 0 0.0020006485283374786
the O 0 0.48352673649787903
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.011500698514282703
were O 0 0.002028121380135417
due O 0 0.0027611074037849903
to O 0 0.0017389992717653513
BRCA1 O 0 0.2910316288471222
, O 0 0.0011725856456905603
with O 0 0.0008084737928584218
most O 0 0.000814391125459224
others O 0 0.0012797839008271694
( O 0 0.0016878567403182387
14 O 0 0.0019237915985286236
% O 0 0.0021990465465933084
) O 0 0.0023364361841231585
due O 0 0.0037168427370488644
to O 0 0.005273513961583376
BRCA2 O 1 0.8992592096328735
. O 0 0.014328138902783394

Conversely O 0 0.02008783258497715
, O 0 0.005038674920797348
the O 0 0.002971091540530324
majority O 0 0.0021736605558544397
of O 0 0.0018263617530465126
families O 0 0.0017862642416730523
with O 0 0.0012195969466120005
male B-Disease 0 0.007172779180109501
and I-Disease 0 0.0034547261893749237
female I-Disease 1 0.9984421133995056
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
were O 0 0.0034870377276092768
due O 0 0.003279698546975851
to O 0 0.0022678938694298267
BRCA2 O 1 0.9404645562171936
( O 0 0.0038515820633620024
76 O 0 0.009504907764494419
% O 0 0.004330778494477272
) O 0 0.005353372078388929
. O 0 0.00830583181232214

The O 0 0.008644030429422855
largest O 0 0.008238252252340317
proportion O 0 0.006305300164967775
( O 0 0.0034349567722529173
67 O 0 0.004096721764653921
% O 0 0.0017618236597627401
) O 0 0.0011124287266284227
of O 0 0.0010491696884855628
families O 0 0.0012469651410356164
due O 0 0.0012553558917716146
to O 0 0.0007707226905040443
other O 0 0.000712377717718482
genes O 0 0.0011365489335730672
was O 0 0.001518038916401565
found O 0 0.0008405103581026196
in O 0 0.000716758833732456
families O 0 0.0007176613435149193
with O 0 0.0005188318900763988
four O 0 0.0005693765706382692
or O 0 0.0006379900150932372
five O 0 0.0007853062124922872
cases O 0 0.0015254486352205276
of O 0 0.09719666093587875
female O 1 0.9999910593032837
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
only O 0 0.011445904150605202
. O 0 0.012135193683207035

These O 0 0.005588838364928961
estimates O 0 0.005885252263396978
were O 0 0.0029068770818412304
not O 0 0.0022442021872848272
substantially O 0 0.004481843672692776
affected O 0 0.0020198749843984842
either O 0 0.0012989201350137591
by O 0 0.001139687024988234
changing O 0 0.0022212110925465822
the O 0 0.0019523267401382327
assumed O 0 0.020202457904815674
penetrance O 1 0.6195976734161377
model O 0 0.002723087090998888
for O 0 0.0015776745276525617
BRCA1 O 0 0.056437648832798004
or O 0 0.0012311114696785808
by O 0 0.001165445544756949
including O 0 0.0018783645937219262
or O 0 0.003654185915365815
excluding O 0 0.021862933412194252
BRCA1 O 1 0.9892523884773254
mutation O 0 0.011236188001930714
data O 0 0.007603699807077646
. O 0 0.011155979707837105

Among O 0 0.007021362893283367
those O 0 0.0026987981982529163
families O 0 0.003906513098627329
with O 0 0.004987051710486412
disease O 1 0.999997615814209
due O 0 0.4892248213291168
to O 0 0.0032266713678836823
BRCA1 O 1 0.8833154439926147
that O 0 0.0010691381758078933
were O 0 0.001051617320626974
tested O 0 0.001957847736775875
by O 0 0.0006840549758635461
one O 0 0.0007871366105973721
of O 0 0.0010707805631682277
the O 0 0.0017800478963181376
standard O 0 0.0028996330220252275
screening O 0 0.0024278131313622
methods O 0 0.0017181049333885312
, O 0 0.001169457333162427
mutations O 0 0.0015204164665192366
were O 0 0.0010628873715177178
detected O 0 0.002106303349137306
in O 0 0.0011384793324396014
the O 0 0.0016409398522228003
coding O 0 0.0038248542696237564
sequence O 0 0.0019992399029433727
or O 0 0.0012448496418073773
splice O 0 0.0036857195664197206
sites O 0 0.0012605618685483932
in O 0 0.001008510123938322
an O 0 0.0012160033220425248
estimated O 0 0.002117564668878913
63 O 0 0.0035756819415837526
% O 0 0.0018166655208915472
( O 0 0.0019784902688115835
95 O 0 0.0031727280002087355
% O 0 0.0030113353859633207
CI O 0 0.1527504324913025
51 O 0 0.005849101115018129
% O 0 0.00360660208389163
- O 0 0.006832666229456663
77 O 0 0.008840031921863556
% O 0 0.005595229100435972
) O 0 0.006131832487881184
. O 0 0.008977670222520828

The O 0 0.0115659786388278
estimated O 0 0.00951556209474802
sensitivity O 0 0.01043946947902441
was O 0 0.005192357115447521
identical O 0 0.003254840150475502
for O 0 0.0018062690505757928
direct O 0 0.0028455720748752356
sequencing O 0 0.004668287932872772
and O 0 0.002198830945417285
other O 0 0.002543483395129442
techniques O 0 0.011339619755744934
. O 0 0.011330588720738888

The O 0 0.01940973289310932
penetrance O 1 0.7445797324180603
of O 0 0.019150450825691223
BRCA2 O 1 0.9983036518096924
was O 0 0.019001133739948273
estimated O 0 0.004557411652058363
by O 0 0.0020096092484891415
maximizing O 0 0.007159873377531767
the O 0 0.0035985694266855717
LOD O 0 0.4790443778038025
score O 0 0.003597292583435774
in O 0 0.003071422455832362
BRCA2 O 1 0.9467225074768066
- O 0 0.015353349968791008
mutation O 0 0.004197276663035154
families O 0 0.001968586817383766
, O 0 0.0016937885666266084
over O 0 0.001968828495591879
all O 0 0.0021062353625893593
possible O 0 0.005647973623126745
penetrance O 0 0.10145978629589081
functions O 0 0.011257386766374111
. O 0 0.015389802865684032

The O 0 0.011392585933208466
estimated O 0 0.009853907860815525
cumulative O 0 0.01870160922408104
risk O 0 0.02083250880241394
of O 0 0.19196273386478424
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999934434890747
reached O 0 0.009670435450971127
28 O 0 0.0035088162403553724
% O 0 0.0017509299796074629
( O 0 0.0016140438383445144
95 O 0 0.0025481744669377804
% O 0 0.002186751691624522
CI O 0 0.19009894132614136
9 O 0 0.0029547656886279583
% O 0 0.001808714121580124
- O 0 0.0026306076906621456
44 O 0 0.0022442450281232595
% O 0 0.00137202104087919
) O 0 0.0009074831032194197
by O 0 0.0007171100005507469
age O 0 0.0015379274263978004
50 O 0 0.0012830706546083093
years O 0 0.0012433418305590749
and O 0 0.0011491314508020878
84 O 0 0.0037007525097578764
% O 0 0.0018296439666301012
( O 0 0.0019429039675742388
95 O 0 0.0028779921121895313
% O 0 0.002606666646897793
CI O 0 0.07828337699174881
43 O 0 0.003998315893113613
% O 0 0.002067788038402796
- O 0 0.0031125470995903015
95 O 0 0.0025587331037968397
% O 0 0.0016802374739199877
) O 0 0.001248957240022719
by O 0 0.0012917054118588567
age O 0 0.003608088241890073
70 O 0 0.005971857346594334
years O 0 0.007389976643025875
. O 0 0.009640233591198921

The O 0 0.032832738012075424
corresponding O 1 0.9996709823608398
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.999934196472168
were O 0 0.04630259796977043
0 O 0 0.01875416934490204
. O 0 0.012198693118989468

4 O 0 0.01153106801211834
% O 0 0.0056053935550153255
( O 0 0.004018193576484919
95 O 0 0.005008306819945574
% O 0 0.003928799647837877
CI O 0 0.27115675806999207
0 O 0 0.004172710236161947
% O 0 0.0023044715635478497
- O 0 0.0032397303730249405
1 O 0 0.0024823746643960476
% O 0 0.0015740350354462862
) O 0 0.0010777361458167434
by O 0 0.0008177388226613402
age O 0 0.001528184744529426
50 O 0 0.0014169227797538042
years O 0 0.0012440216960385442
and O 0 0.0011862912215292454
27 O 0 0.002012995770201087
% O 0 0.0013483738293871284
( O 0 0.0016735539538785815
95 O 0 0.0028164188843220472
% O 0 0.0026461442466825247
CI O 0 0.04513603076338768
0 O 0 0.0038279113359749317
% O 0 0.002191564766690135
- O 0 0.0032433082815259695
47 O 0 0.003891394240781665
% O 0 0.0022868781816214323
) O 0 0.0018342197872698307
by O 0 0.0017611193470656872
age O 0 0.005079022608697414
70 O 0 0.007277283351868391
years O 0 0.00846222322434187
. O 0 0.01159873977303505

The O 0 0.011337155476212502
lifetime O 1 0.6075112819671631
risk O 1 0.9642908573150635
of O 1 0.9996864795684814
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.37118253111839294
similar O 0 0.0018115158891305327
to O 0 0.0012651843717321754
the O 0 0.0022077634930610657
risk O 0 0.0331035852432251
in O 0 0.002876626793295145
BRCA1 O 1 0.9991195797920227
carriers O 0 0.0033717297483235598
, O 0 0.0010457320604473352
but O 0 0.000756042602006346
there O 0 0.0009082863107323647
was O 0 0.0016104922397062182
some O 0 0.0008437944925390184
suggestion O 0 0.0026252514217048883
of O 0 0.0015477800043299794
a O 0 0.002678485354408622
lower O 0 0.0073620956391096115
risk O 0 0.006134564522653818
in O 0 0.0026486972346901894
BRCA2 O 1 0.9471235871315002
carriers O 0 0.006307806819677353
< O 0 0.00850793905556202
50 O 0 0.0029657066334038973
years O 0 0.0026950493920594454
of O 0 0.004427854437381029
age O 0 0.013412307016551495
. O 0 0.011954096145927906

Eye B-Disease 1 0.9965180158615112
movement I-Disease 0 0.07628347724676132
abnormalities I-Disease 1 0.9709830284118652
correlate O 0 0.01324169896543026
with O 0 0.004548580851405859
genotype O 0 0.24305827915668488
in O 0 0.006109190173447132
autosomal O 1 0.999904990196228
dominant O 1 0.9999585151672363
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999996423721313
I I-Disease 1 0.9999321699142456
. O 0 0.02329649217426777

We O 0 0.008419790305197239
compared O 0 0.008425971493124962
horizontal O 0 0.013330351561307907
eye O 0 0.024141307920217514
movements O 0 0.004546985495835543
( O 0 0.004390299320220947
visually O 0 0.00606116047129035
guided O 0 0.008733256720006466
saccades O 1 0.9348494410514832
, O 0 0.0035570389591157436
antisaccades O 0 0.09835266321897507
, O 0 0.0020765045192092657
and O 0 0.001767629524692893
smooth O 0 0.004802447743713856
pursuit O 0 0.0057222130708396435
) O 0 0.0013978678034618497
in O 0 0.001171753858216107
control O 0 0.0017995737725868821
subjects O 0 0.00245454628020525
( O 0 0.0022409469820559025
n O 0 0.003518778830766678
= O 0 0.003393093589693308
14 O 0 0.0018547254148870707
) O 0 0.0011710462858900428
and O 0 0.0009821323910728097
patients O 0 0.0020026182755827904
with O 0 0.0008588355267420411
three O 0 0.0012134738499298692
forms O 0 0.0023043181281536818
of O 0 0.020637433975934982
autosomal O 1 0.9999860525131226
dominant O 1 0.9997753500938416
cerebellar B-Disease 1 0.9999998807907104
ataxias I-Disease 1 0.9999990463256836
type I-Disease 1 0.9999263286590576
I I-Disease 1 0.9971505999565125
spinocerebellar B-Disease 1 0.9999918937683105
ataxias I-Disease 1 0.8833644390106201
1 I-Disease 0 0.004065678920596838
and I-Disease 0 0.0018773834453895688
2 I-Disease 0 0.0028501737397164106
( O 0 0.002673402661457658
SCA1 B-Disease 0 0.012610786594450474
, O 0 0.002312000375241041
n O 0 0.00447981059551239
= O 0 0.004347596317529678
11 O 0 0.002214891603216529
; O 0 0.0017575901001691818
SCA2 B-Disease 0 0.010106206871569157
, O 0 0.002075479133054614
n O 0 0.004399549216032028
= O 0 0.003554734168574214
10 O 0 0.0016936594620347023
) O 0 0.0015653856098651886
and O 0 0.0019596281927078962
SCA3 B-Disease 1 0.9983306527137756
/ O 0 0.45519623160362244
Machado B-Disease 1 0.9650518298149109
- I-Disease 0 0.4482017159461975
Joseph I-Disease 1 0.9797812700271606
disease I-Disease 1 0.9999961853027344
( O 0 0.05769968777894974
MJD B-Disease 1 0.9999017715454102
) O 0 0.0037862109020352364
( O 0 0.0034795827232301235
n O 0 0.006725900340825319
= O 0 0.008593453094363213
16 O 0 0.0060585360042750835
) O 0 0.00648570666089654
. O 0 0.010113350115716457

In O 0 0.012694277800619602
SCA1 B-Disease 1 0.9650937914848328
, O 0 0.008930177427828312
saccade O 0 0.08740296959877014
amplitude O 0 0.014270264655351639
was O 0 0.009816475212574005
significantly O 0 0.004897716920822859
increased O 0 0.0037207892164587975
, O 0 0.0037342968862503767
resulting O 0 0.007517575286328793
in O 0 0.008218527771532536
hypermetria B-Disease 1 0.9620091319084167
. O 0 0.016692347824573517

The O 0 0.017331747338175774
smooth O 0 0.022533271461725235
pursuit O 0 0.052198514342308044
gain O 0 0.01587999053299427
was O 1 0.5580012202262878
decreased O 1 0.737616777420044
. O 0 0.01952245458960533

In O 0 0.0164806991815567
SCA2 B-Disease 1 0.9812151193618774
, O 0 0.01233295165002346
saccade O 0 0.250722199678421
velocity O 0 0.019028056412935257
was O 0 0.11539853364229202
markedly O 0 0.12323977053165436
decreased O 0 0.06377150863409042
. O 0 0.019233908504247665

The O 0 0.008389366790652275
percentage O 0 0.006927311420440674
of O 0 0.0035279865842312574
errors O 0 0.013305902481079102
in O 0 0.004617823753505945
antisaccades O 1 0.9996660947799683
was O 1 0.5653931498527527
greatly O 0 0.006688440218567848
increased O 0 0.002475944347679615
and O 0 0.0017319524195045233
was O 0 0.004401462618261576
significantly O 0 0.0025448217056691647
correlated O 0 0.003447078401222825
with O 0 0.0020495124626904726
age O 0 0.0274505577981472
at O 1 0.6995001435279846
disease O 1 0.9999997615814209
onset O 1 0.9999994039535522
. O 0 0.12940962612628937

In O 0 0.0074974484741687775
addition O 0 0.004827604629099369
, O 0 0.0031040553003549576
a O 0 0.0028203909751027822
correlation O 0 0.0037276255898177624
between O 0 0.0019113380694761872
smooth O 0 0.005303054582327604
pursuit O 0 0.007703020703047514
gain O 0 0.002514687366783619
and O 0 0.0013680740958079696
the O 0 0.0018437567632645369
number O 0 0.0020508274901658297
of O 0 0.0044201635755598545
trinucleotide O 1 0.9989737272262573
repeats O 0 0.031920671463012695
was O 0 0.015141922049224377
found O 0 0.00902258139103651
. O 0 0.011164315044879913

In O 0 0.013364323414862156
SCA3 B-Disease 1 0.9979129433631897
, O 0 0.009534730575978756
gaze B-Disease 1 0.6809081435203552
- I-Disease 1 0.7918440103530884
evoked I-Disease 1 0.938908040523529
nystagmus I-Disease 1 0.9968506693840027
was O 0 0.011565581895411015
often O 0 0.0019016818841919303
present O 0 0.002300208667293191
as O 0 0.0021625629160553217
was O 0 0.01678534783422947
saccade O 1 0.7338023781776428
hypometria O 0 0.16343380510807037
and O 0 0.0030443898867815733
smooth O 0 0.009307238273322582
pursuit O 0 0.020559433847665787
gain O 0 0.00986990612000227
was O 0 0.1036236509680748
markedly O 0 0.17543978989124298
decreased O 0 0.08981264382600784
. O 0 0.015512567013502121

Three O 0 0.009398853406310081
major O 0 0.010453211143612862
criteria O 0 0.009348074905574322
, O 0 0.006155380047857761
saccade O 0 0.040324218571186066
amplitude O 0 0.011645643040537834
, O 0 0.004248230252414942
saccade O 0 0.016954001039266586
velocity O 0 0.004807158373296261
, O 0 0.001923709292896092
and O 0 0.0014911748003214598
presence O 0 0.0024376078508794308
of O 0 0.0036327142734080553
gaze B-Disease 1 0.9609823226928711
- I-Disease 1 0.6637392044067383
evoked I-Disease 1 0.7622221112251282
nystagmus I-Disease 1 0.7494910359382629
, O 0 0.0020708260126411915
permitted O 0 0.0020967216696590185
the O 0 0.0016829009400680661
correct O 0 0.0028499651234596968
assignment O 0 0.002776209730654955
of O 0 0.0011498377425596118
90 O 0 0.0016991186421364546
% O 0 0.0009745092829689384
of O 0 0.0010006431257352233
the O 0 0.00177362363319844
SCA1 B-Disease 1 0.5206252932548523
, O 0 0.0012993939453735948
90 O 0 0.0015015811659395695
% O 0 0.0010697677498683333
of O 0 0.0011193963000550866
the O 0 0.0018265793332830071
SCA2 B-Disease 1 0.7228957414627075
, O 0 0.0013168386649340391
and O 0 0.0009956227149814367
93 O 0 0.003051312640309334
% O 0 0.0012004964519292116
of O 0 0.0012656677281484008
the O 0 0.002508698496967554
patients O 0 0.32816749811172485
with O 0 0.0017416581977158785
SCA3 B-Disease 1 0.9990918636322021
to O 0 0.0011907019652426243
their O 0 0.0010495006572455168
genetically O 0 0.0023371886927634478
confirmed O 0 0.002843787195160985
patient O 0 0.21112343668937683
group O 0 0.001306908088736236
and O 0 0.0009301964892074466
, O 0 0.0011732772691175342
therefore O 0 0.0013588026631623507
, O 0 0.0012036246480420232
may O 0 0.0013649479951709509
help O 0 0.001692805322818458
orient O 0 0.006723804399371147
diagnoses O 0 0.11693567037582397
of O 0 0.005312063731253147
SCA1 B-Disease 1 0.9997116923332214
, O 0 0.004683511331677437
SCA2 B-Disease 1 0.9957228899002075
, O 0 0.0024255565367639065
and O 0 0.0020164980087429285
SCA3 B-Disease 1 0.9759160280227661
at O 0 0.00270929210819304
early O 0 0.0024189832620322704
clinical O 0 0.014901995658874512
stages O 0 0.0061090742237865925
of O 0 0.008389707654714584
the O 1 0.8827536106109619
diseases O 1 0.9999995231628418
. O 0 0.011327112093567848
. O 0 0.010606816969811916

Genetic O 0 0.01310055423527956
basis O 0 0.006409190595149994
and O 0 0.004397784359753132
molecular O 0 0.01256813108921051
mechanism O 0 0.358242928981781
for O 1 0.8660939335823059
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9901851415634155

Ventricular B-Disease 1 0.999997615814209
fibrillation I-Disease 1 0.9999977350234985
causes O 1 0.8795753121376038
more O 0 0.0026386945974081755
than O 0 0.0019767293706536293
300 O 0 0.0034715398214757442
, O 0 0.002644156338647008
000 O 0 0.0061247339472174644
sudden O 0 0.008222951553761959
deaths O 0 0.003200320992618799
each O 0 0.0010430196998640895
year O 0 0.0014930192846804857
in O 0 0.0018233098089694977
the O 0 0.003965007606893778
USA O 0 0.017842350527644157
alone O 0 0.010035413317382336
. O 0 0.010267889127135277

In O 0 0.005613537505269051
approximately O 0 0.0038732176180928946
5 O 0 0.003473907709121704
- O 0 0.003862468060106039
12 O 0 0.001800747588276863
% O 0 0.0012428422924131155
of O 0 0.0009323751437477767
these O 0 0.0006571859121322632
cases O 0 0.0011987906182184815
, O 0 0.0011953366920351982
there O 0 0.0009608186664991081
are O 0 0.0007030931883491576
no O 0 0.0021786552388221025
demonstrable O 1 0.987762987613678
cardiac O 1 0.999982476234436
or O 0 0.021647565066814423
non O 1 0.9950281977653503
- O 1 0.9999390840530396
cardiac O 1 0.9999995231628418
causes O 1 0.7489273548126221
to O 0 0.001070080092176795
account O 0 0.00113885966129601
for O 0 0.0009011083748191595
the O 0 0.001475274097174406
episode O 0 0.0032431490253657103
, O 0 0.0010014261351898313
which O 0 0.0007613693014718592
is O 0 0.0011314329458400607
therefore O 0 0.001772887771949172
classified O 0 0.006202808581292629
as O 0 0.08118677139282227
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999837875366211
IVF B-Disease 1 0.9999984502792358
) O 0 0.020751625299453735
. O 0 0.01651337929069996

A O 0 0.010787680745124817
distinct O 0 0.005633645690977573
group O 0 0.004468388855457306
of O 0 0.1384197622537613
IVF B-Disease 1 0.9999998807907104
patients O 1 0.9998537302017212
has O 0 0.003323880722746253
been O 0 0.0016537138726562262
found O 0 0.0012428954942151904
to O 0 0.0008815032779239118
present O 0 0.001457237172871828
with O 0 0.0014570326311513782
a O 0 0.004225441720336676
characteristic O 1 0.6045168042182922
electrocardiographic O 1 0.9988011121749878
pattern O 0 0.3735208511352539
. O 0 0.013242608867585659

Because O 0 0.00656113401055336
of O 0 0.004419672768563032
the O 0 0.0032758773304522038
small O 0 0.002216283231973648
size O 0 0.0020770917180925608
of O 0 0.0016250646440312266
most O 0 0.0015462059527635574
pedigrees O 0 0.00486916396766901
and O 0 0.0014594786334782839
the O 0 0.0021649140398949385
high O 0 0.01566220633685589
incidence O 1 0.9986238479614258
of O 0 0.14742781221866608
sudden B-Disease 1 0.9999679327011108
death I-Disease 1 0.9844075441360474
, O 0 0.0019596938509494066
however O 0 0.0012113640550523996
, O 0 0.0010389634408056736
molecular O 0 0.0020750644616782665
genetic O 0 0.0019734257366508245
studies O 0 0.0018115469720214605
of O 0 0.003968136850744486
IVF B-Disease 1 0.9998905658721924
have O 0 0.0015804386930540204
not O 0 0.0013785227201879025
yet O 0 0.0021368118468672037
been O 0 0.0035268922802060843
done O 0 0.007238662336021662
. O 0 0.009351758286356926

Because O 0 0.12462951987981796
IVF B-Disease 1 0.999996542930603
causes O 1 0.9999785423278809
cardiac O 1 0.9999998807907104
rhythm O 1 0.9999568462371826
disturbance O 1 0.9993917942047119
, O 0 0.0035021984949707985
we O 0 0.0018659454071894288
investigated O 0 0.004075251054018736
whether O 0 0.0021764938719570637
malfunction O 0 0.4486004710197449
of O 0 0.0032521840184926987
ion O 0 0.0761977955698967
channels O 0 0.002279886743053794
could O 0 0.0018614500295370817
cause O 0 0.008275060914456844
the O 0 0.003325675381347537
disorder O 1 0.9998899698257446
by O 0 0.002172175794839859
studying O 0 0.004388623870909214
mutations O 0 0.0035414095036685467
in O 0 0.0023615944664925337
the O 0 0.006623024120926857
cardiac O 1 0.9999864101409912
sodium O 1 0.5497631430625916
channel O 0 0.016486598178744316
gene O 0 0.01585560478270054
SCN5A O 1 0.5743032693862915
. O 0 0.01890273205935955

We O 0 0.006694981828331947
have O 0 0.0028788186609745026
now O 0 0.002890298143029213
identified O 0 0.0032499355729669333
a O 0 0.002948456211015582
missense O 0 0.009458056651055813
mutation O 0 0.003707024035975337
, O 0 0.00221121683716774
a O 0 0.00347979087382555
splice O 0 0.25484198331832886
- O 0 0.13878591358661652
donor O 0 0.007631357293576002
mutation O 0 0.003369927406311035
, O 0 0.0013347401982173324
and O 0 0.0013481912901625037
a O 0 0.002564000431448221
frameshift O 1 0.6021134257316589
mutation O 0 0.003268811386078596
in O 0 0.0014451988972723484
the O 0 0.002070916583761573
coding O 0 0.004682660102844238
region O 0 0.002813696162775159
of O 0 0.0031385512556880713
SCN5A O 1 0.97203528881073
in O 0 0.003220995655283332
three O 0 0.004585785325616598
IVF B-Disease 1 0.9994100332260132
families O 0 0.009632697328925133
. O 0 0.011767813004553318

We O 0 0.007826763205230236
show O 0 0.004880891647189856
that O 0 0.00233841291628778
sodium O 0 0.004734132904559374
channels O 0 0.0019582207314670086
with O 0 0.0012085255002602935
the O 0 0.0023253662511706352
missense O 0 0.01488634292036295
mutation O 0 0.00680445646867156
recover O 0 0.014826320111751556
from O 0 0.0020455156918615103
inactivation O 0 0.27541878819465637
more O 0 0.001114616054110229
rapidly O 0 0.0023694352712482214
than O 0 0.0008750669658184052
normal O 0 0.0014291980769485235
and O 0 0.0008161498699337244
that O 0 0.0009232087177224457
the O 0 0.0025011610705405474
frameshift O 0 0.41889411211013794
mutation O 0 0.006168401800096035
causes O 0 0.00411798432469368
the O 0 0.0023451063316315413
sodium O 0 0.005047302693128586
channel O 0 0.0026032140012830496
to O 0 0.001581252901814878
be O 0 0.002130641136318445
non O 0 0.005933062639087439
- O 0 0.013972477987408638
functional O 0 0.015204692259430885
. O 0 0.01102444063872099

Our O 0 0.011342751793563366
results O 0 0.0053142160177230835
indicate O 0 0.004254692234098911
that O 0 0.002111525507643819
mutations O 0 0.0038636389654129744
in O 0 0.002892902120947838
cardiac O 1 0.9999821186065674
ion O 1 0.9456490874290466
- O 0 0.18324439227581024
channel O 0 0.003883316181600094
genes O 0 0.0021202322095632553
contribute O 0 0.002045034896582365
to O 0 0.0012403669534251094
the O 0 0.0021024683956056833
risk O 0 0.004544487223029137
of O 0 0.004961041733622551
developing O 1 0.6594411730766296
IVF B-Disease 1 0.9999219179153442
. O 0 0.008559215813875198
. O 0 0.011005404405295849

Molecular O 0 0.019495045766234398
heterogeneity O 0 0.026716893538832664
in O 0 0.007711802143603563
mucopolysaccharidosis B-Disease 1 0.9994832277297974
IVA I-Disease 1 0.999993085861206
in O 0 0.0033576537389308214
Australia O 0 0.002800751244649291
and O 0 0.0014052370097488165
Northern O 0 0.0018995580030605197
Ireland O 0 0.001945072552189231
: O 0 0.0014588964404538274
nine O 0 0.0018499133875593543
novel O 0 0.0034623572137206793
mutations O 0 0.002108467509970069
including O 0 0.001312032574787736
T312S O 0 0.0817144587635994
, O 0 0.0019817347638309
a O 0 0.002723455196246505
common O 0 0.00405809236690402
allele O 0 0.00625613471493125
that O 0 0.0025561214424669743
confers O 1 0.5468756556510925
a O 0 0.053476568311452866
mild O 1 0.9999252557754517
phenotype O 1 0.9386726021766663
. O 0 0.015740979462862015

Mucopolysaccharidosis B-Disease 1 0.9977816939353943
IVA I-Disease 1 0.9999730587005615
( O 0 0.10067293792963028
MPS B-Disease 1 0.972736120223999
IVA I-Disease 1 0.999998927116394
) O 0 0.00542108342051506
is O 0 0.0032215197570621967
an O 0 0.005301251076161861
autosomal B-Disease 1 0.9999438524246216
recessive I-Disease 1 0.9999986886978149
lysosomal I-Disease 1 1.0
storage I-Disease 1 0.9999995231628418
disorder I-Disease 1 1.0
caused O 1 0.9999513626098633
by O 0 0.010487803258001804
a O 0 0.1398715227842331
genetic B-Disease 1 0.9423484802246094
defect I-Disease 1 0.9998331069946289
in O 0 0.0039995694532990456
N O 0 0.13465511798858643
- O 0 0.04234720766544342
acetylgalactosamine O 1 0.5848633050918579
- O 0 0.03529895469546318
6 O 0 0.010984166525304317
- O 0 0.24711455404758453
sulfate O 1 0.9965543746948242
sulfatase O 1 0.9996439218521118
( O 0 0.025031674653291702
GALNS O 1 0.9980130195617676
) O 0 0.01493803784251213
. O 0 0.015513329766690731

Previous O 0 0.009380809962749481
studies O 0 0.004541392438113689
of O 0 0.0044189151376485825
patients O 1 0.6268222332000732
from O 0 0.0021005242597311735
a O 0 0.0031304415315389633
British O 0 0.02533353492617607
- O 0 0.08258672803640366
Irish O 0 0.004154917784035206
population O 0 0.0015137469163164496
showed O 0 0.0019641912076622248
that O 0 0.0009489268413744867
the O 0 0.0018737207865342498
I113F O 0 0.13040794432163239
mutation O 0 0.0024055233225226402
is O 0 0.0009898069547489285
the O 0 0.0009121681796386838
most O 0 0.0007994392071850598
common O 0 0.0013245820300653577
single O 0 0.0017611972289159894
mutation O 0 0.0032380246557295322
among O 0 0.003049706108868122
MPS B-Disease 1 0.999735414981842
IVA I-Disease 1 1.0
patients O 1 0.999981164932251
and O 0 0.013518126681447029
produces O 0 0.1479290872812271
a O 0 0.4301624298095703
severe O 1 0.9999990463256836
clinical O 1 0.9999955892562866
phenotype O 1 0.998619556427002
. O 0 0.014141234569251537

We O 0 0.007990208454430103
studied O 0 0.007900037802755833
mutations O 0 0.005077413283288479
in O 0 0.0023873320315033197
the O 0 0.0032500973902642727
GALNS O 1 0.8473340272903442
gene O 0 0.0028210750315338373
from O 0 0.0015316300559788942
23 O 0 0.0029088626615703106
additional O 0 0.002919410588219762
MPS B-Disease 1 0.616948127746582
IVA I-Disease 1 0.9999997615814209
patients O 1 0.9778568148612976
( O 0 0.002490878803655505
15 O 0 0.0013771802186965942
from O 0 0.0009116771980188787
Australia O 0 0.0013826932990923524
, O 0 0.0008057373343035579
8 O 0 0.0011267253430560231
from O 0 0.0006706028361804783
Northern O 0 0.001202479936182499
Ireland O 0 0.001517358236014843
) O 0 0.0008897993247956038
, O 0 0.0007252147188410163
with O 0 0.0007322430028580129
various O 0 0.0011631277156993747
clinical O 1 0.7396928668022156
phenotypes O 1 0.9877177476882935
( O 0 0.0917840227484703
severe O 1 0.9992460012435913
, O 0 0.002456609159708023
16 O 0 0.002514584455639124
cases O 0 0.0019862784538418055
; O 0 0.0013480129418894649
intermediate O 0 0.003345729783177376
, O 0 0.0013099893694743514
4 O 0 0.001976398518308997
cases O 0 0.0018244809471070766
; O 0 0.0017372253350913525
mild O 0 0.07036477327346802
, O 0 0.002350118011236191
3 O 0 0.004125941079109907
cases O 0 0.004917304962873459
) O 0 0.006122360937297344
. O 0 0.008709786459803581

We O 0 0.006614665500819683
found O 0 0.003519524587318301
two O 0 0.001995147205889225
common O 0 0.0026330335531383753
mutations O 0 0.002471908461302519
that O 0 0.0010264696320518851
together O 0 0.0010452280985191464
accounted O 0 0.0019278775434941053
for O 0 0.0010971982264891267
32 O 0 0.0020007228013128042
% O 0 0.0010662529384717345
of O 0 0.0010392764816060662
the O 0 0.0017101347912102938
44 O 0 0.0040774038061499596
unrelated O 0 0.0055855801329016685
alleles O 0 0.004241198301315308
in O 0 0.0023048061411827803
these O 0 0.002943598898127675
patients O 0 0.4310615062713623
. O 0 0.010495164431631565

One O 0 0.006594748701900244
is O 0 0.004575536120682955
the O 0 0.005617649760097265
T312S O 0 0.36512094736099243
mutation O 0 0.006755037233233452
, O 0 0.0024035009555518627
a O 0 0.0031689691822975874
novel O 0 0.008672591298818588
mutation O 0 0.0053036026656627655
found O 0 0.003372862935066223
exclusively O 0 0.005257160868495703
in O 0 0.007055509369820356
milder O 0 0.4837340712547302
patients O 1 0.8666248321533203
. O 0 0.01800617389380932

The O 0 0.007557058706879616
other O 0 0.0024284878745675087
is O 0 0.002583662513643503
the O 0 0.0027883558068424463
previously O 0 0.00450523104518652
described O 0 0.006219733506441116
I113F O 0 0.2761489152908325
that O 0 0.003096005180850625
produces O 0 0.008120428770780563
a O 0 0.01476212963461876
severe O 1 0.9999926090240479
phenotype O 1 0.9975284934043884
. O 0 0.01717216894030571

The O 0 0.013621808961033821
I113F O 0 0.051270656287670135
and O 0 0.005824143532663584
T312S O 0 0.11636147648096085
mutations O 0 0.0042980448342859745
accounted O 0 0.0033811437897384167
for O 0 0.0016453115968033671
8 O 0 0.0027230223640799522
( O 0 0.0016274142544716597
18 O 0 0.0014155963435769081
% O 0 0.0011953185312449932
) O 0 0.0009381517884321511
and O 0 0.0009706808486953378
6 O 0 0.002271142788231373
( O 0 0.0014717277372255921
14 O 0 0.0014343971852213144
% O 0 0.0011810642899945378
) O 0 0.0011022628750652075
of O 0 0.0015920683508738875
44 O 0 0.004296727012842894
unrelated O 0 0.007289960980415344
alleles O 0 0.007803836837410927
, O 0 0.005096964072436094
respectively O 0 0.01244240440428257
. O 0 0.011086434125900269

The O 0 0.012902095913887024
relatively O 0 0.010748809203505516
high O 0 0.014378165826201439
residual O 1 0.8607811331748962
GALNS O 1 0.9880578517913818
activity O 0 0.003975257743149996
seen O 0 0.0030837813392281532
when O 0 0.0020132362842559814
the O 0 0.0026194120291620493
T312S O 0 0.1260634809732437
mutant O 0 0.010277382098138332
cDNA O 0 0.008697954937815666
is O 0 0.0025457090232521296
overexpressed O 0 0.009228856302797794
in O 0 0.002238128799945116
mutant O 0 0.007593824993818998
cells O 0 0.002219417365267873
provides O 0 0.0017774115549400449
an O 0 0.0012171128764748573
explanation O 0 0.001959478948265314
for O 0 0.0013799353037029505
the O 0 0.0034579522907733917
mild O 1 0.9991950392723083
phenotype O 1 0.5861697793006897
in O 0 0.003046776168048382
patients O 1 0.6779922246932983
with O 0 0.0027518977876752615
this O 0 0.004318286199122667
mutation O 0 0.015435274690389633
. O 0 0.00997017603367567

The O 0 0.00989872682839632
distribution O 0 0.0058510140515863895
and O 0 0.0033606612123548985
relative O 0 0.004269550088793039
frequencies O 0 0.0024647051468491554
of O 0 0.002019676845520735
the O 0 0.0026130438782274723
I113F O 0 0.21186232566833496
and O 0 0.002703485544770956
T312S O 0 0.05532783642411232
mutations O 0 0.002712311688810587
in O 0 0.0012360122054815292
Australia O 0 0.0017621624283492565
corresponded O 0 0.002337080892175436
to O 0 0.0008458223310299218
those O 0 0.0007957796333357692
observed O 0 0.0013859589817002416
in O 0 0.000938211684115231
Northern O 0 0.0014698997838422656
Ireland O 0 0.0015393029898405075
and O 0 0.0007048051338642836
are O 0 0.000427249789936468
unique O 0 0.0007511266157962382
to O 0 0.00048689593677408993
these O 0 0.0003591748245526105
two O 0 0.0004906693357042968
populations O 0 0.0009062651661224663
, O 0 0.0008250506361946464
suggesting O 0 0.0016151359304785728
that O 0 0.0008009013254195452
both O 0 0.0009303412516601384
mutations O 0 0.0017080616671591997
were O 0 0.0009802356362342834
probably O 0 0.001627076417207718
introduced O 0 0.0015295938355848193
to O 0 0.000789119687397033
Australia O 0 0.0014216777635738254
by O 0 0.0009527375223115087
Irish O 0 0.0028936616145074368
migrants O 0 0.0030161950271576643
during O 0 0.003002929501235485
the O 0 0.003901282325387001
19th O 0 0.01420897338539362
century O 0 0.019517946988344193
. O 0 0.012935076840221882

Haplotype O 0 0.032990291714668274
analysis O 0 0.007726297713816166
using O 0 0.005380853079259396
6 O 0 0.00753923412412405
RFLPs O 0 0.015276945196092129
provides O 0 0.0036129853688180447
additional O 0 0.0022577238269150257
data O 0 0.001530465204268694
that O 0 0.001259898766875267
the O 0 0.002223541494458914
I113F O 0 0.01754547283053398
mutation O 0 0.005076938308775425
originated O 0 0.00416056253015995
from O 0 0.0027008564211428165
a O 0 0.005079993046820164
common O 0 0.008049783296883106
ancestor O 0 0.026159724220633507
. O 0 0.015067561529576778

The O 0 0.00788209680467844
other O 0 0.0031499024480581284
9 O 0 0.005269543267786503
novel O 0 0.0061998083256185055
mutations O 0 0.002851675497367978
identified O 0 0.001684546354226768
in O 0 0.001096824649721384
these O 0 0.0009011694346554577
23 O 0 0.0021929522044956684
patients O 0 0.0035625288728624582
were O 0 0.0009967853548005223
each O 0 0.0008294966537505388
limited O 0 0.0012010324280709028
to O 0 0.001108670374378562
a O 0 0.002504620933905244
single O 0 0.004766302183270454
family O 0 0.009266253560781479
. O 0 0.010415006428956985

These O 0 0.006052285432815552
data O 0 0.004323180764913559
provide O 0 0.003213129937648773
further O 0 0.0021560529712587595
evidence O 0 0.0021027144975960255
for O 0 0.002031780546531081
extensive O 0 0.004984763916581869
allelic O 0 0.0880621001124382
heterogeneity O 0 0.01675652340054512
in O 0 0.0034665449056774378
MPS B-Disease 1 0.5095709562301636
IVA I-Disease 1 0.9999873638153076
in O 0 0.0031543499790132046
British O 0 0.20937465131282806
- O 1 0.9526242613792419
Irish O 1 0.5342453122138977
patients O 1 0.6722434759140015
and O 0 0.001172180287539959
provide O 0 0.0011356701143085957
evidence O 0 0.001235107658430934
for O 0 0.0008645921479910612
their O 0 0.0009095939458347857
transmission O 0 0.0019347361521795392
to O 0 0.0007514992612414062
Australia O 0 0.0013525678077712655
by O 0 0.0010938685154542327
British O 0 0.003379145637154579
- O 0 0.008994655683636665
Irish O 0 0.007320272736251354
migrants O 0 0.007012237329035997
. O 0 0.004817735869437456
. O 0 0.008925030007958412

Identification O 0 0.016565384343266487
of O 0 0.010240121744573116
constitutional O 0 0.01924331858754158
WT1 O 1 0.999768078327179
mutations O 0 0.008505824021995068
, O 0 0.0029860297217965126
in O 0 0.0027228700928390026
patients O 0 0.4010368585586548
with O 0 0.00405482342466712
isolated O 1 0.9986440539360046
diffuse B-Disease 1 0.9999992847442627
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.012814722023904324
and O 0 0.0020491280592978
analysis O 0 0.0024664397351443768
of O 0 0.004812631756067276
genotype O 1 0.9039052724838257
/ O 0 0.3273247480392456
phenotype O 0 0.0054650744423270226
correlations O 0 0.003421728266403079
by O 0 0.0012079471489414573
use O 0 0.0015614846488460898
of O 0 0.0025096985045820475
a O 0 0.0062723648734390736
computerized O 0 0.2866258919239044
mutation O 0 0.015467917546629906
database O 0 0.013441374525427818
. O 0 0.012876851484179497

Constitutional O 0 0.01862693578004837
mutations O 0 0.009968005120754242
of O 0 0.006213858723640442
the O 0 0.009365657344460487
WT1 O 1 0.999542236328125
gene O 0 0.0050873057916760445
, O 0 0.00241609918884933
encoding O 0 0.0038927255664020777
a O 0 0.004678184166550636
zinc O 1 0.9991306662559509
- O 0 0.18289907276630402
finger O 0 0.04149064049124718
transcription O 0 0.006799630355089903
factor O 0 0.004453940782696009
involved O 0 0.002908006776124239
in O 0 0.010745720006525517
renal O 1 1.0
and O 1 0.8904480934143066
gonadal O 1 0.9999991655349731
development O 0 0.3314014673233032
, O 0 0.0015828573377802968
are O 0 0.0006511103129014373
found O 0 0.0008839768124744296
in O 0 0.0008359641069546342
most O 0 0.0011930469190701842
patients O 0 0.030580585822463036
with O 0 0.003442048095166683
Denys B-Disease 1 0.9999973773956299
- I-Disease 1 0.9999815225601196
Drash I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
( O 1 0.9870031476020813
DDS B-Disease 1 0.9999994039535522
) O 0 0.0029275836423039436
, O 0 0.0023597583640366793
or O 0 0.004195339512079954
diffuse B-Disease 1 0.9998785257339478
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9983909130096436
DMS B-Disease 1 0.9999964237213135
) O 0 0.002757396548986435
associated O 0 0.0021992831025272608
with O 0 0.0017545918235555291
pseudohermaphroditism B-Disease 1 0.9973046779632568
and O 0 0.004793108440935612
/ O 1 0.9889003038406372
or O 0 0.13364000618457794
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999994039535522
( O 1 0.7763864994049072
WT B-Disease 1 0.9998812675476074
) O 0 0.009899414144456387
. O 0 0.010735648684203625

Most O 0 0.007956942543387413
mutations O 0 0.011102568358182907
in O 0 0.007947172969579697
DDS B-Disease 1 0.9999984502792358
patients O 1 0.9582004547119141
lie O 0 0.019327174872159958
in O 0 0.003236674005165696
exon O 0 0.020105866715312004
8 O 0 0.003517257748171687
or O 0 0.0021570913959294558
exon O 0 0.00812267605215311
9 O 0 0.0037223738618195057
, O 0 0.002322772517800331
encoding O 0 0.004734897054731846
zinc O 0 0.06575442105531693
finger O 0 0.009389586746692657
2 O 0 0.004434975329786539
or O 0 0.00298365973867476
zinc O 1 0.8503864407539368
finger O 0 0.012071246281266212
3 O 0 0.002738324459642172
, O 0 0.0015742974355816841
respectively O 0 0.0019282152643427253
, O 0 0.0011063815327361226
with O 0 0.0009497102000750601
a O 0 0.0019381126621738076
hot O 0 0.007486261893063784
spot O 0 0.005798225291073322
( O 0 0.00331430253572762
R394W O 0 0.011796711012721062
) O 0 0.0023878475185483694
in O 0 0.0029869384597986937
exon O 0 0.020093416795134544
9 O 0 0.012245369143784046
. O 0 0.01076964195817709

We O 0 0.006083040032535791
analyzed O 0 0.005772690754383802
a O 0 0.0030083246529102325
series O 0 0.0027594089042395353
of O 0 0.0022682207636535168
24 O 0 0.003580690361559391
patients O 0 0.008641672320663929
, O 0 0.0013105927500873804
10 O 0 0.0013135418994352221
with O 0 0.0013641812838613987
isolated B-Disease 0 0.01960877887904644
DMS I-Disease 1 0.9999606609344482
( O 0 0.0073056272231042385
IDMS B-Disease 1 0.9972586631774902
) O 0 0.0020328755490481853
, O 0 0.0014528544852510095
10 O 0 0.0015799949178472161
with O 0 0.001526635605841875
DDS B-Disease 1 0.9995936751365662
, O 0 0.0019900931511074305
and O 0 0.0017616205150261521
4 O 0 0.0033615748398005962
with O 0 0.002696941839531064
urogenital B-Disease 1 0.9999942779541016
abnormalities I-Disease 1 0.9999877214431763
and O 1 0.7173700332641602
/ O 1 0.9997944235801697
or O 0 0.04819765314459801
WT B-Disease 1 0.9996147155761719
. O 0 0.01702696643769741

We O 0 0.010622650384902954
report O 0 0.011415545828640461
WT1 O 0 0.33213329315185547
heterozygous O 0 0.010515021160244942
mutations O 0 0.004527561832219362
in O 0 0.002406631363555789
16 O 0 0.0037876085843890905
patients O 0 0.00975976325571537
, O 0 0.0017202268354594707
4 O 0 0.0023965323343873024
of O 0 0.002377284225076437
whom O 0 0.005499355494976044
presented O 0 0.00908290408551693
with O 0 0.008525155484676361
IDMS B-Disease 1 0.9999315738677979
. O 0 0.017492076382040977

One O 0 0.008585656993091106
male O 0 0.006995863746851683
and O 0 0.002827431308105588
two O 0 0.003301521297544241
female O 1 0.9633960127830505
IDMS B-Disease 1 0.9999995231628418
patients O 1 0.9996699094772339
with O 0 0.17061066627502441
WT1 O 1 0.9999978542327881
mutations O 1 0.7172031998634338
underwent O 1 0.9999455213546753
normal O 0 0.36531126499176025
puberty O 1 0.9794443845748901
. O 0 0.01700877957046032

Two O 0 0.0077316779643297195
mutations O 0 0.008598605170845985
associated O 0 0.004430638626217842
with O 0 0.0029384030494838953
IDMS B-Disease 1 0.9988577365875244
are O 0 0.0010664418805390596
different O 0 0.0008301652269437909
from O 0 0.0014168662019073963
those O 0 0.001525271451100707
described O 0 0.007798254489898682
in O 0 0.022714925929903984
DDS B-Disease 1 0.9999997615814209
patients O 1 0.9997852444648743
. O 0 0.020206818357110023

No O 0 0.020235424861311913
WT1 O 1 0.9678944945335388
mutations O 0 0.008556199260056019
were O 0 0.0031958066392689943
detected O 0 0.004187410697340965
in O 0 0.001799420453608036
the O 0 0.00212659384123981
six O 0 0.0024065054021775723
other O 0 0.002602830994874239
IDMS B-Disease 1 0.9999977350234985
patients O 1 0.9907630085945129
, O 0 0.003404156770557165
suggesting O 0 0.006314537953585386
genetic O 0 0.005929224658757448
heterogeneity O 0 0.017458803951740265
of O 0 0.01307395938783884
this O 0 0.08566037565469742
disease O 1 0.999997615814209
. O 0 0.02141273207962513

We O 0 0.01008458249270916
analyzed O 0 0.016528503969311714
genotype O 0 0.05208863317966461
/ O 0 0.04731806367635727
phenotype O 0 0.0095110684633255
correlations O 0 0.005352310836315155
, O 0 0.0016724953893572092
on O 0 0.0013433798449113965
the O 0 0.001366903306916356
basis O 0 0.0012732550967484713
of O 0 0.0014306142693385482
the O 0 0.0016939191846176982
constitution O 0 0.0021401471458375454
of O 0 0.0021604462526738644
a O 0 0.004256403539329767
WT1 O 1 0.9667754173278809
mutation O 0 0.003359706373885274
database O 0 0.0020930415485054255
of O 0 0.002260935492813587
84 O 0 0.015294242650270462
germ O 1 0.9994262456893921
- O 0 0.12206319719552994
line O 0 0.0038197487592697144
mutations O 0 0.0020807269029319286
, O 0 0.0008683506748639047
to O 0 0.0008073112112469971
compare O 0 0.001694669364951551
the O 0 0.0011494336649775505
distribution O 0 0.0012501153396442533
and O 0 0.0012568484526127577
type O 0 0.0033270511776208878
of O 0 0.0019180612871423364
mutations O 0 0.0027440206613391638
, O 0 0.0011437855428084731
according O 0 0.0013648687163367867
to O 0 0.0012902814196422696
the O 0 0.0026390645653009415
different O 0 0.0037464776542037725
symptoms O 1 0.9958276152610779
. O 0 0.014494320377707481

This O 0 0.0066346097737550735
demonstrated O 0 0.009617005474865437
( O 0 0.004947269801050425
1 O 0 0.003732183249667287
) O 0 0.0017799870111048222
the O 0 0.0018500392325222492
association O 0 0.002994355745613575
between O 0 0.0019348337082192302
mutations O 0 0.0024397619999945164
in O 0 0.0013470606645569205
exons O 0 0.0037278553936630487
8 O 0 0.0018548646476119757
and O 0 0.0010324523318558931
9 O 0 0.002016926184296608
and O 0 0.0013797020073980093
DMS B-Disease 1 0.8997215628623962
; O 0 0.0015527729410678148
( O 0 0.0017181114526465535
2 O 0 0.0016607200959697366
) O 0 0.0014188578352332115
among O 0 0.0014890246093273163
patients O 0 0.11877747625112534
with O 0 0.0029162655118852854
DMS B-Disease 1 0.9999759197235107
, O 0 0.0018449558410793543
a O 0 0.0017913850024342537
higher O 0 0.001787429442629218
frequency O 0 0.0015186852542683482
of O 0 0.0016267341561615467
exon O 0 0.006019255146384239
8 O 0 0.0026373083237558603
mutations O 0 0.0022564632818102837
among O 0 0.0018346640281379223
46 O 0 0.0038236931432038546
, O 0 0.003567264648154378
XY O 1 0.9966039657592773
patients O 0 0.07055801153182983
with O 0 0.0020319647155702114
female O 0 0.005545208230614662
phenotype O 0 0.004383564461022615
than O 0 0.0010270419297739863
among O 0 0.0013169320300221443
46 O 0 0.003639394650235772
, O 0 0.0029098389204591513
XY O 1 0.9859814643859863
patients O 0 0.007134552579373121
with O 0 0.0013300215359777212
sexual O 0 0.003834625007584691
ambiguity O 0 0.022200923413038254
or O 0 0.002461053431034088
male O 0 0.008071805350482464
phenotype O 0 0.010687040165066719
; O 0 0.0013563733082264662
and O 0 0.0011389782885089517
( O 0 0.002019288716837764
3 O 0 0.0019657148513942957
) O 0 0.001204331056214869
statistically O 0 0.0017511284677311778
significant O 0 0.0014331396669149399
evidence O 0 0.0013958930503576994
that O 0 0.0009486190392635763
mutations O 0 0.001849244348704815
in O 0 0.0014588214689865708
exons O 0 0.0047844815999269485
8 O 0 0.0023658694699406624
and O 0 0.0015902777668088675
9 O 0 0.003258113982155919
preferentially O 0 0.00418003648519516
affect O 0 0.0023657502606511116
amino O 0 0.0026715595740824938
acids O 0 0.0021769125014543533
with O 0 0.0014159833081066608
different O 0 0.001485083601437509
functions O 0 0.003986362833529711
. O 0 0.0054880850948393345
. O 0 0.01046886295080185

The O 0 0.027482086792588234
185delAG O 1 0.9845070838928223
BRCA1 O 1 0.9726164937019348
mutation O 0 0.010471021756529808
originated O 0 0.0059793260879814625
before O 0 0.0023756360169500113
the O 0 0.0018146035727113485
dispersion O 0 0.003645234974101186
of O 0 0.0017262559849768877
Jews O 0 0.0027575199492275715
in O 0 0.0016117463819682598
the O 0 0.0023009355645626783
diaspora O 0 0.0035380928311496973
and O 0 0.0014918652595952153
is O 0 0.0017592977965250611
not O 0 0.001362341339699924
limited O 0 0.0027468069456517696
to O 0 0.0037154867313802242
Ashkenazim O 0 0.03765038773417473
. O 0 0.014422609470784664

The O 0 0.016037415713071823
185delAG O 0 0.4083261489868164
mutation O 0 0.011450042948126793
in O 0 0.0038702567107975483
BRCA1 O 1 0.856904923915863
is O 0 0.002376784570515156
detected O 0 0.0034582759253680706
in O 0 0.0014986200258135796
Ashkenazi O 0 0.00686296122148633
Jews O 0 0.0021803767886012793
both O 0 0.00137364084366709
in O 0 0.0032699427101761103
familial B-Disease 1 0.9999995231628418
breast I-Disease 1 1.0
and I-Disease 1 0.9999985694885254
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8718336224555969
in O 0 0.031959421932697296
the O 0 0.05865492671728134
general O 0 0.08223817497491837
population O 0 0.007218192331492901
. O 0 0.009379100054502487

All O 0 0.010222341865301132
tested O 0 0.025923488661646843
Ashkenazi O 0 0.3894697427749634
mutation O 0 0.010616563260555267
carriers O 0 0.006121582817286253
share O 0 0.003237821627408266
the O 0 0.0031827178318053484
same O 0 0.0035290494561195374
allelic O 0 0.019975973293185234
pattern O 0 0.010331046767532825
at O 0 0.008336433209478855
the O 0 0.017141805961728096
BRCA1 O 1 0.9970452189445496
locus O 0 0.17462287843227386
. O 0 0.01696040853857994

Our O 0 0.010179828852415085
previous O 0 0.006017361301928759
study O 0 0.004576314240694046
showed O 0 0.004709371365606785
that O 0 0.0015954022528603673
this O 0 0.0017164634773507714
Ashkenazi O 0 0.16290602087974548
mutation O 0 0.004485734738409519
also O 0 0.00178150599822402
occurs O 0 0.0016244960715994239
in O 0 0.0014473100891336799
Iraqi O 0 0.0025998272467404604
Jews O 0 0.002524989889934659
with O 0 0.0014882185496389866
a O 0 0.0034124592784792185
similar O 0 0.005887140985578299
allelic O 0 0.45322099328041077
pattern O 0 0.051757801324129105
. O 0 0.017053676769137383

We O 0 0.007243913132697344
extended O 0 0.005194717552512884
our O 0 0.002420097589492798
analysis O 0 0.0020151627250015736
to O 0 0.001376634812913835
other O 0 0.0013575085904449224
non O 0 0.004257913213223219
- O 0 0.00737387640401721
Ashkenazi O 0 0.011946287006139755
subsets O 0 0.007814827375113964
354 O 0 0.009634305723011494
of O 0 0.0032499339431524277
Moroccan O 0 0.007799555081874132
origin O 0 0.0036860851105302572
, O 0 0.003310768399387598
200 O 0 0.005026307888329029
Yemenites O 0 0.019401054829359055
and O 0 0.003683380549773574
150 O 0 0.006929086521267891
Iranian O 0 0.010552499443292618
Jews O 0 0.012740880250930786
. O 0 0.013361645862460136

Heteroduplex O 0 0.06748592853546143
analysis O 0 0.00977427139878273
complemented O 0 0.012324880808591843
by O 0 0.0034641544334590435
direct O 0 0.004148195497691631
DNA O 0 0.005129371769726276
sequencing O 0 0.005861519370228052
of O 0 0.0038665374740958214
abnormally O 1 0.5599489212036133
migrating O 0 0.008575174026191235
bands O 0 0.0059347921051084995
were O 0 0.004470107611268759
employed O 0 0.013898344710469246
. O 0 0.012861919589340687

Four O 0 0.006275758147239685
of O 0 0.004889190662652254
Moroccan O 0 0.009004035964608192
origin O 0 0.002867508679628372
( O 0 0.002611808944493532
1 O 0 0.0019465596415102482
. O 0 0.0009035913972184062
1 O 0 0.0016899413894861937
% O 0 0.0011650597443804145
) O 0 0.0009505731868557632
and O 0 0.0007486551767215133
none O 0 0.0011576246470212936
of O 0 0.0013072167057543993
the O 0 0.0024527059867978096
Yemenites O 1 0.8861627578735352
or O 0 0.0020349188707768917
Iranians O 0 0.0028552913572639227
was O 0 0.0028955095913261175
a O 0 0.0024671342689543962
carrier O 0 0.006282327696681023
of O 0 0.0034926626831293106
the O 0 0.0101386196911335
185delAG O 1 0.9901593327522278
mutation O 0 0.023416630923748016
. O 0 0.012886316515505314

BRCA1 O 1 0.9688123464584351
allelic O 0 0.06251469254493713
patterns O 0 0.007707607466727495
were O 0 0.003085671691223979
determined O 0 0.0025830112863332033
for O 0 0.0011388963321223855
four O 0 0.0010293640661984682
of O 0 0.0011199451982975006
these O 0 0.000694549351464957
individuals O 0 0.0007302057929337025
and O 0 0.0007832294213585556
for O 0 0.0010313718812540174
12 O 0 0.0016485834494233131
additional O 0 0.0016850018873810768
non O 0 0.0035514167975634336
- O 0 0.008421988226473331
Ashkenazi O 0 0.02091696299612522
185delAG O 0 0.07182993739843369
mutation O 0 0.0059478310868144035
carriers O 0 0.005335238762199879
who O 0 0.006896679289638996
had O 1 0.9557269811630249
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6552556753158569

Six O 0 0.013112364336848259
non O 0 0.030642570927739143
- O 0 0.11983421444892883
Ashkenazi O 0 0.02041172794997692
individuals O 0 0.002466554520651698
shared O 0 0.004061086568981409
the O 0 0.003182037267833948
common O 0 0.006307654082775116
Ashkenazi O 1 0.8134443759918213
haplotype O 0 0.013478359207510948
, O 0 0.0016653221100568771
four O 0 0.001266210456378758
had O 0 0.0015943986363708973
a O 0 0.0013720080023631454
closely O 0 0.0014833586756139994
related O 0 0.0018412258941680193
pattern O 0 0.0035119520034641027
, O 0 0.0013329267967492342
and O 0 0.0010353645775467157
the O 0 0.0015961530152708292
rest O 0 0.002696102950721979
( O 0 0.0023095994256436825
n O 0 0.0035562312696129084
= O 0 0.00353830773383379
6 O 0 0.0022516287863254547
) O 0 0.001604833290912211
displayed O 0 0.0035245351027697325
a O 0 0.003428531577810645
distinct O 0 0.007781481370329857
BRCA1 O 1 0.9787994623184204
allelic O 1 0.756866455078125
pattern O 0 0.11697742342948914
. O 0 0.016258513554930687

We O 0 0.008236778900027275
conclude O 0 0.008297882042825222
that O 0 0.003052402287721634
the O 0 0.005880354903638363
185delAG O 1 0.984691321849823
BRCA1 O 1 0.9657220840454102
mutation O 0 0.004873597528785467
occurs O 0 0.0023392431903630495
in O 0 0.001562203629873693
some O 0 0.0017098026582971215
non O 0 0.010379113256931305
- O 0 0.2562027871608734
Ashkenazi O 0 0.08674204349517822
populations O 0 0.0027441957499831915
at O 0 0.002656882628798485
rates O 0 0.0029616274405270815
comparable O 0 0.0033443444408476353
with O 0 0.0017403746023774147
that O 0 0.0025438102893531322
of O 0 0.007640073075890541
Ashkenazim O 1 0.856017529964447
. O 0 0.015827450901269913

The O 0 0.007800712715834379
majority O 0 0.005184913985431194
of O 0 0.004438296891748905
Jewish O 0 0.017051054164767265
185delAG O 1 0.9965601563453674
mutation O 0 0.01938549056649208
carriers O 0 0.004076138138771057
have O 0 0.0011362583609297872
a O 0 0.002193823456764221
common O 0 0.003200707258656621
allelic O 0 0.2889389991760254
pattern O 0 0.012872348539531231
, O 0 0.0022507975809276104
supporting O 0 0.0031935968436300755
the O 0 0.0028226450085639954
founder O 1 0.5856969952583313
effect O 0 0.0028517732862383127
notion O 0 0.0036366689018905163
, O 0 0.0015979892341420054
but O 0 0.001244217506609857
dating O 0 0.0027585062198340893
the O 0 0.0019057556055486202
mutations O 0 0.002118685282766819
origin O 0 0.0014079830143600702
to O 0 0.0011445942800492048
an O 0 0.0013150488957762718
earlier O 0 0.0023199378047138453
date O 0 0.0027441394049674273
than O 0 0.0018703152891248465
currently O 0 0.005174520891159773
estimated O 0 0.00884146150201559
. O 0 0.010732267051935196

However O 0 0.008442360907793045
, O 0 0.004172470886260271
the O 0 0.003632265841588378
different O 0 0.0020119890104979277
allelic O 0 0.011998828500509262
pattern O 0 0.006401036400347948
at O 0 0.004074156284332275
the O 0 0.005806472152471542
BRCA1 O 1 0.9882165789604187
locus O 0 0.009530909359455109
even O 0 0.0013188706943765283
in O 0 0.0011938994284719229
some O 0 0.001233645249158144
Jewish O 0 0.0034306240268051624
mutation O 0 0.0058279442600905895
carriers O 0 0.0037876591086387634
, O 0 0.0017984820296987891
might O 0 0.001965377712622285
suggest O 0 0.002124790335074067
that O 0 0.0014418892096728086
the O 0 0.0029436605982482433
mutation O 0 0.00509778643026948
arose O 0 0.005861780606210232
independently O 0 0.0050108120776712894
. O 0 0.005081984214484692
. O 0 0.010269522666931152

Crystal O 0 0.0356626883149147
structure O 0 0.013683921657502651
of O 0 0.010833624750375748
the O 1 0.8230423927307129
hemochromatosis B-Disease 1 1.0
protein O 1 0.9329997301101685
HFE O 1 0.9997842907905579
and O 0 0.0040831780061125755
characterization O 0 0.00881724152714014
of O 0 0.0035613884683698416
its O 0 0.0035980476532131433
interaction O 0 0.006594674661755562
with O 0 0.006932017393410206
transferrin O 1 0.9517154097557068
receptor O 0 0.027146251872181892
. O 0 0.012600559741258621

HFE O 1 0.9988365769386292
is O 0 0.008483300916850567
an O 0 0.007381684146821499
MHC O 1 0.9997019171714783
- O 0 0.19227872788906097
related O 0 0.004717532079666853
protein O 0 0.003072085091844201
that O 0 0.0013761103618890047
is O 0 0.002079166006296873
mutated O 0 0.004572531674057245
in O 0 0.00231414707377553
the O 0 0.008091660216450691
iron B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999979734420776
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9983174800872803

HFE O 1 0.9902352094650269
binds O 0 0.026695266366004944
to O 0 0.009614473208785057
transferrin O 1 0.5314542651176453
receptor O 0 0.01795942895114422
( O 0 0.010253028012812138
TfR O 1 0.9961387515068054
) O 0 0.003802721621468663
and O 0 0.0018667856929823756
reduces O 0 0.0046742865815758705
its O 0 0.0016978296916931868
affinity O 0 0.0032565456349402666
for O 0 0.002487046644091606
iron O 1 0.9983957409858704
- O 0 0.46267297863960266
loaded O 0 0.015502273105084896
transferrin O 1 0.5658352971076965
, O 0 0.005929972510784864
implicating O 1 0.9970082640647888
HFE O 1 0.9999872446060181
in O 0 0.10859611630439758
iron O 1 0.99998939037323
metabolism O 1 0.9950443506240845
. O 0 0.017915330827236176

The O 0 0.027577253058552742
2 O 0 0.03454963117837906
. O 0 0.023446744307875633

6 O 0 0.015642885118722916
A O 0 0.009739791974425316
crystal O 0 0.014623072929680347
structure O 0 0.008376206271350384
of O 0 0.013772496953606606
HFE O 1 0.9999799728393555
reveals O 0 0.05878900736570358
the O 0 0.002768260659649968
locations O 0 0.0026298973243683577
of O 0 0.017569277435541153
hemochromatosis B-Disease 1 1.0
mutations O 0 0.18176864087581635
and O 0 0.00218823179602623
a O 0 0.019009659066796303
patch O 1 0.9998993873596191
of O 0 0.09007960557937622
histidines O 1 0.9965858459472656
that O 0 0.001486588385887444
could O 0 0.0011045776773244143
be O 0 0.0008638480794616044
involved O 0 0.0016116825863718987
in O 0 0.0025064467918127775
pH O 1 0.689439058303833
- O 0 0.028180211782455444
dependent O 0 0.008494459092617035
interactions O 0 0.009589196182787418
. O 0 0.011691972613334656

We O 0 0.008257829584181309
also O 0 0.005416234023869038
demonstrate O 0 0.008715083822607994
that O 0 0.004813486244529486
soluble O 0 0.3277041018009186
TfR O 1 0.9984411597251892
and O 0 0.005623677279800177
HFE O 1 0.997591495513916
bind O 0 0.006226601544767618
tightly O 0 0.004028536379337311
at O 0 0.0023748204112052917
the O 0 0.0022522415965795517
basic O 0 0.00446374760940671
pH O 0 0.006327896378934383
of O 0 0.0019026126246899366
the O 0 0.0020422982051968575
cell O 0 0.0029106305446475744
surface O 0 0.0020666136406362057
, O 0 0.0012486480409279466
but O 0 0.0008070417097769678
not O 0 0.0007261150749400258
at O 0 0.001785040250979364
the O 0 0.002841470530256629
acidic O 0 0.44801783561706543
pH O 0 0.11089056730270386
of O 0 0.009310492314398289
intracellular O 1 0.9047538638114929
vesicles O 1 0.8106590509414673
. O 0 0.015393847599625587

TfR O 1 0.9976339340209961
HFE O 1 0.9907264709472656
stoichiometry O 0 0.04337885603308678
( O 0 0.009567542932927608
2 O 0 0.0055551305413246155
1 O 0 0.004303174093365669
) O 0 0.0021616017911583185
differs O 0 0.0035878941416740417
from O 0 0.0024417114909738302
TfR O 1 0.9471463561058044
transferrin O 0 0.12842942774295807
stoichiometry O 0 0.010830742307007313
( O 0 0.002678938675671816
2 O 0 0.0024992201942950487
2 O 0 0.002197674475610256
) O 0 0.0012113560223951936
, O 0 0.001142796827480197
implying O 0 0.002927600173279643
a O 0 0.0012452288065105677
different O 0 0.0007268033223226666
mode O 0 0.0018159497994929552
of O 0 0.0013570673763751984
binding O 0 0.0019980319775640965
for O 0 0.002551288576796651
HFE O 1 0.9955226182937622
and O 0 0.0031736360397189856
transferrin O 0 0.23478493094444275
to O 0 0.003260779893025756
TfR O 1 0.9512143135070801
, O 0 0.00259093614295125
consistent O 0 0.0028807902708649635
with O 0 0.0013992497697472572
our O 0 0.002131145913153887
demonstration O 0 0.00454887468367815
that O 0 0.0025361482985317707
HFE O 1 0.9986935257911682
, O 0 0.005042032804340124
transferrin O 1 0.7829788327217102
, O 0 0.00342778698541224
and O 0 0.003914124798029661
TfR O 1 0.9876821637153625
form O 0 0.006475694011896849
a O 0 0.007686607073992491
ternary O 0 0.2063026875257492
complex O 0 0.03308992460370064
. O 0 0.0169578455388546

Identification O 0 0.011572876945137978
of O 0 0.005002080928534269
three O 0 0.003295373171567917
novel O 0 0.009987986646592617
mutations O 0 0.0036698582116514444
and O 0 0.0013840411556884646
a O 0 0.001914509804919362
high O 0 0.0026581238489598036
frequency O 0 0.00168743752874434
of O 0 0.0013690951745957136
the O 0 0.002315496327355504
Arg778Leu O 0 0.46198534965515137
mutation O 0 0.004326947499066591
in O 0 0.002091215690597892
Korean O 1 0.6153322458267212
patients O 1 0.9680359959602356
with O 0 0.012900516390800476
Wilson B-Disease 1 0.9998986721038818
disease I-Disease 1 0.999998927116394
. O 0 0.02430114895105362

Four O 0 0.01172846183180809
mutations O 0 0.014059282839298248
- O 0 0.051255002617836
- O 0 0.016630036756396294
R778L O 0 0.0500500351190567
, O 0 0.003785421373322606
A874V O 0 0.012784956023097038
, O 0 0.002917915815487504
L1083F O 0 0.009149909019470215
, O 0 0.0019693775102496147
and O 0 0.0019329063361510634
2304delC O 0 0.4118208587169647
- O 0 0.01041661761701107
- O 0 0.0037652563769370317
in O 0 0.0013588997535407543
the O 0 0.002429747488349676
copper O 1 0.9766947031021118
- O 0 0.016598422080278397
transporting O 0 0.010650133714079857
enzyme O 0 0.005011844448745251
, O 0 0.002762730699032545
P O 0 0.023097656667232513
- O 0 0.009620379656553268
type O 0 0.00850297324359417
ATPase O 0 0.035626139491796494
( O 0 0.004618555307388306
ATP7B O 0 0.0906624123454094
) O 0 0.0017293492564931512
, O 0 0.0012164782965555787
were O 0 0.0011559074046090245
identified O 0 0.001810629852116108
in O 0 0.0019735111854970455
Korean O 1 0.8564448356628418
Patients O 1 0.9973918199539185
with O 0 0.04501628503203392
Wilson B-Disease 1 0.999954104423523
disease I-Disease 1 0.9999992847442627
. O 0 0.02287682518362999

Arg778Leu O 0 0.45680326223373413
, O 0 0.00661433907225728
the O 0 0.0036343408282846212
most O 0 0.001808836474083364
frequently O 0 0.0025478422176092863
reported O 0 0.0031107692047953606
mutation O 0 0.002420751377940178
of O 0 0.0015950880479067564
this O 0 0.0014107183087617159
enzyme O 0 0.0030761242378503084
, O 0 0.0011622714810073376
was O 0 0.0017617462435737252
found O 0 0.001106691430322826
in O 0 0.0009773810161277652
six O 0 0.001056300476193428
of O 0 0.0014610515208914876
eight O 0 0.002314159180969
unrelated O 0 0.03987594693899155
patients O 1 0.5164461731910706
studied O 0 0.004339900799095631
, O 0 0.0024100751616060734
an O 0 0.0026169242337346077
allele O 0 0.0060780784115195274
frequency O 0 0.003997070249170065
of O 0 0.004373204428702593
37 O 0 0.014897487126290798
. O 0 0.01348133385181427

5 O 0 0.013513059355318546
% O 0 0.006826869677752256
, O 0 0.0032310420647263527
which O 0 0.0018097131978720427
is O 0 0.001974313287064433
considerably O 0 0.0029509596060961485
higher O 0 0.0018255666363984346
than O 0 0.0008984370506368577
those O 0 0.0009145360090769827
in O 0 0.0014395384350791574
other O 0 0.002056235447525978
Asian O 0 0.010144700296223164
populations O 0 0.008962258696556091
. O 0 0.011235779151320457

The O 0 0.012513947673141956
novel O 0 0.015592288225889206
single O 0 0.008271938189864159
nucleotide O 0 0.009730272926390171
deletion O 0 0.009738926775753498
, O 0 0.003557914402335882
2304delC O 0 0.030455388128757477
, O 0 0.003245028667151928
was O 0 0.0048070852644741535
found O 0 0.003174637444317341
in O 0 0.0037044186610728502
one O 0 0.005764179863035679
patient O 1 0.7658774256706238
. O 0 0.013368763960897923

Since O 0 0.010857135988771915
a O 0 0.007062634918838739
mutation O 0 0.00832288432866335
at O 0 0.00560195604339242
cDNA O 0 0.01492181047797203
nucleotide O 0 0.01051552314311266
2302 O 1 0.5259794592857361
( O 0 0.005210257135331631
2302insC O 0 0.017473239451646805
) O 0 0.002090844791382551
had O 0 0.0019679495599120855
been O 0 0.001589021529071033
previously O 0 0.0021945866756141186
described O 0 0.00250332267023623
, O 0 0.001190642942674458
this O 0 0.0008290897239930928
region O 0 0.0014420548686757684
of O 0 0.0016677877865731716
the O 0 0.004721353761851788
ATP7B O 1 0.9998542070388794
gene O 0 0.0034657116048038006
may O 0 0.0016236732481047511
be O 0 0.0013781117741018534
susceptible O 0 0.005594841204583645
to O 0 0.0019292000215500593
gene O 0 0.005700921174138784
rearrangements O 0 0.4543391764163971
causing O 1 0.9929156303405762
Wilson B-Disease 1 0.9998767375946045
disease I-Disease 1 0.9999984502792358
. O 0 0.02549438178539276

Disruption O 0 0.0311907846480608
of O 0 0.00888544600456953
splicing O 0 0.011036384850740433
regulated O 0 0.006183113902807236
by O 0 0.002493774751201272
a O 0 0.0052933162078261375
CUG O 1 0.9988313317298889
- O 0 0.071467824280262
binding O 0 0.007394805550575256
protein O 0 0.008424708619713783
in O 0 0.012952438555657864
myotonic B-Disease 1 0.999997615814209
dystrophy I-Disease 1 0.9999996423721313
. O 0 0.07511714845895767

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9999881982803345
DM B-Disease 1 1.0
) O 0 0.016622398048639297
is O 0 0.0036488668993115425
caused O 0 0.00862590316683054
by O 0 0.0017500000540167093
a O 0 0.003726859111338854
CTG O 1 0.9866880774497986
expansion O 0 0.0037760750856250525
in O 0 0.001640204107388854
the O 0 0.002344764769077301
3 O 0 0.003248784691095352
untranslated O 0 0.010364066809415817
region O 0 0.00398179329931736
of O 0 0.004449562635272741
the O 0 0.1547023355960846
DM B-Disease 1 0.9999996423721313
gene O 0 0.023785464465618134
. O 0 0.012605711817741394

One O 0 0.010539821349084377
model O 0 0.011933455243706703
of O 0 0.04604404792189598
DM B-Disease 1 0.9999998807907104
pathogenesis O 1 0.999976634979248
suggests O 0 0.009399909526109695
that O 0 0.002303136745467782
RNAs O 0 0.005677294451743364
from O 0 0.001867828075774014
the O 0 0.0020355975721031427
expanded O 0 0.002977791940793395
allele O 0 0.002972315065562725
create O 0 0.0015113515546545386
a O 0 0.0019006251823157072
gain O 0 0.0031428299844264984
- O 0 0.0038866065442562103
of O 0 0.0023817759938538074
- O 0 0.010915957391262054
function O 0 0.0023182507138699293
mutation O 0 0.0020773170981556177
by O 0 0.0009713239269331098
the O 0 0.001782467938028276
inappropriate O 0 0.0037392748054116964
binding O 0 0.002124887192621827
of O 0 0.002238360932096839
proteins O 0 0.002619706094264984
to O 0 0.0028245621360838413
the O 0 0.007497597020119429
CUG O 1 0.9676197171211243
repeats O 0 0.03339364752173424
. O 0 0.014581193216145039

Data O 0 0.01192747987806797
presented O 0 0.01012467872351408
here O 0 0.004655295982956886
indicate O 0 0.004073862452059984
that O 0 0.0020198519341647625
the O 0 0.0026964466087520123
conserved O 0 0.006083949003368616
heterogeneous O 0 0.008714831434190273
nuclear O 0 0.008122507482767105
ribonucleoprotein O 1 0.7380642294883728
, O 0 0.004800891038030386
CUG O 0 0.45520246028900146
- O 0 0.005288613494485617
binding O 0 0.0028780659195035696
protein O 0 0.0035718379076570272
( O 0 0.003501336555927992
CUG O 0 0.4184023439884186
- O 0 0.00900122057646513
BP O 0 0.009006696753203869
) O 0 0.001705643837340176
, O 0 0.001407082425430417
may O 0 0.0016209317836910486
mediate O 0 0.004043512046337128
the O 0 0.003024609526619315
trans O 0 0.07990160584449768
- O 0 0.01387855876237154
dominant O 0 0.004710399080067873
effect O 0 0.003449052572250366
of O 0 0.003919277805835009
the O 0 0.007789144292473793
RNA O 0 0.021336089819669724
. O 0 0.010237793438136578

CUG O 1 0.9988099336624146
- O 1 0.5775255560874939
BP O 0 0.0441279336810112
was O 0 0.005823127459734678
found O 0 0.0024927454069256783
to O 0 0.00165318395011127
bind O 0 0.0024883621372282505
to O 0 0.001349835772998631
the O 0 0.002496127039194107
human O 0 0.011172446422278881
cardiac O 1 0.9999986886978149
troponin O 1 0.9999988079071045
T O 1 0.9992868304252625
( O 0 0.005527113098651171
cTNT O 0 0.18422995507717133
) O 0 0.003155324375256896
pre O 0 0.013171427883207798
- O 0 0.033751480281353
messenger O 0 0.008093229494988918
RNA O 0 0.0042268261313438416
and O 0 0.0019954757299274206
regulate O 0 0.003950180485844612
its O 0 0.00326901045627892
alternative O 0 0.008467601612210274
splicing O 0 0.021457787603139877
. O 0 0.013549154624342918

Splicing O 0 0.022320767864584923
of O 0 0.009014833718538284
cTNT O 1 0.8219544291496277
was O 0 0.05671994015574455
disrupted O 1 0.5695268511772156
in O 0 0.4237285256385803
DM B-Disease 1 1.0
striated O 1 0.9999994039535522
muscle O 1 0.999749481678009
and O 0 0.003426854033023119
in O 0 0.0031312033534049988
normal O 0 0.007887317799031734
cells O 0 0.004198492504656315
expressing O 0 0.006039688363671303
transcripts O 0 0.007128512021154165
that O 0 0.0030750862788408995
contain O 0 0.010361133143305779
CUG O 1 0.7748465538024902
repeats O 0 0.031796880066394806
. O 0 0.017322978004813194

Altered O 0 0.01630357839167118
expression O 0 0.007379920221865177
of O 0 0.004354659467935562
genes O 0 0.005236836150288582
regulated O 0 0.005562447477132082
posttranscriptionally O 0 0.028368672356009483
by O 0 0.003175238147377968
CUG O 1 0.9994447827339172
- O 0 0.17188911139965057
BP O 0 0.02266741544008255
therefore O 0 0.002830216661095619
may O 0 0.0027067195624113083
contribute O 0 0.004866295028477907
to O 0 0.006040395703166723
DM B-Disease 1 0.9999995231628418
pathogenesis O 1 0.9999659061431885
. O 0 0.00982502568513155
. O 0 0.014442992396652699

Identification O 0 0.011255401186645031
of O 0 0.004968238528817892
a O 0 0.004940068814903498
novel O 0 0.05011586472392082
nonsense O 1 0.6728789210319519
mutation O 0 0.005087117664515972
and O 0 0.0017721401527523994
a O 0 0.002876041457056999
missense O 0 0.007767810020595789
substitution O 0 0.0035997682716697454
in O 0 0.0018436374375596642
the O 0 0.0042990101501345634
vasopressin O 1 0.8094556331634521
- O 0 0.3141666352748871
neurophysin O 1 0.9616199731826782
II O 1 0.992464542388916
gene O 0 0.0028850368689745665
in O 0 0.0013082666555419564
two O 0 0.0015266023110598326
Spanish O 0 0.006402944680303335
kindreds O 1 0.5321633219718933
with O 0 0.010699868202209473
familial B-Disease 1 0.9999994039535522
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
. O 1 0.7933494448661804

Familial B-Disease 1 0.9999896287918091
neurohypophyseal I-Disease 1 0.9999990463256836
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9996548891067505
FNDI B-Disease 1 0.9999986886978149
) O 0 0.005052971187978983
is O 0 0.0027741999365389347
an O 0 0.004468189552426338
autosomal B-Disease 1 0.9999749660491943
dominant I-Disease 1 0.9999966621398926
disease I-Disease 1 1.0
caused O 1 0.9999994039535522
by O 1 0.9983354210853577
deficiency O 1 1.0
in O 1 0.8638525605201721
the O 1 0.996745228767395
antidiuretic O 1 0.9999996423721313
hormone O 1 0.9997031092643738
arginine O 1 0.5310617685317993
vasopressin O 0 0.19897760450839996
( O 0 0.00542569300159812
AVP O 0 0.1360335499048233
) O 0 0.0022108592092990875
encoded O 0 0.0017650752561166883
by O 0 0.0013575247721746564
the O 0 0.0030792434699833393
AVP O 1 0.9971833825111389
- O 0 0.30923721194267273
neurophysin O 1 0.9862167835235596
II O 1 0.9999204874038696
( O 0 0.04046925902366638
AVP O 1 0.9998915195465088
- O 1 0.553473949432373
NPII O 1 0.9850874543190002
) O 0 0.004196292255073786
gene O 0 0.0047532059252262115
on O 0 0.004651757422834635
chromosome O 0 0.016501324251294136
20p13 O 0 0.05383514612913132
. O 0 0.016937000676989555

In O 0 0.0056198714300990105
this O 0 0.002544119954109192
study O 0 0.0023415610194206238
, O 0 0.0012706599663943052
we O 0 0.0009444422321394086
analyzed O 0 0.0015039881691336632
two O 0 0.000738313072361052
families O 0 0.0012623834190890193
with O 0 0.0015078039141371846
FNDI B-Disease 1 0.9543495178222656
using O 0 0.0019351319642737508
direct O 0 0.0024193054996430874
automated O 0 0.005796818528324366
fluorescent O 0 0.007040792610496283
, O 0 0.0020536594092845917
solid O 0 0.004425635561347008
phase O 0 0.005088638514280319
, O 0 0.0024552445393055677
single O 0 0.003445186885073781
- O 0 0.005841544363647699
stranded O 0 0.006301877088844776
DNA O 0 0.0038305269554257393
sequencing O 0 0.004598475527018309
of O 0 0.0033114796970039606
PCR O 0 0.0194158386439085
- O 0 0.02343161590397358
amplified O 0 0.02742251195013523
AVP O 1 0.9991415739059448
- O 0 0.3292253017425537
NPII O 1 0.9707932472229004
DNA O 0 0.019316619262099266
. O 0 0.014522197656333447

In O 0 0.005980369634926319
one O 0 0.0030247417744249105
of O 0 0.00296051986515522
the O 0 0.003735792590305209
families O 0 0.0034280819818377495
, O 0 0.0021615566220134497
affected O 0 0.0021656807512044907
individuals O 0 0.0010991331655532122
presented O 0 0.0023990690242499113
a O 0 0.0023291069082915783
novel O 0 0.011037904769182205
nonsense O 0 0.02574065886437893
mutation O 0 0.0036306369584053755
in O 0 0.0018396388040855527
exon O 0 0.007348636165261269
3 O 0 0.002054373035207391
of O 0 0.001408892683684826
the O 0 0.0017283156048506498
gene O 0 0.0021162359043955803
, O 0 0.0011687349760904908
consisting O 0 0.0018116118153557181
in O 0 0.001424877205863595
a O 0 0.002559239976108074
G O 0 0.00795487966388464
to O 0 0.0020436979830265045
T O 0 0.009422242641448975
transition O 0 0.00361418048851192
at O 0 0.0030175577849149704
nucleotide O 0 0.005362120922654867
2101 O 0 0.015344729647040367
, O 0 0.002193479100242257
which O 0 0.001476641045883298
produces O 0 0.0024910718202590942
a O 0 0.0021306390408426523
stop O 0 0.003035877598449588
signal O 0 0.0030111761298030615
in O 0 0.001658808090724051
codon O 0 0.00786199327558279
82 O 0 0.009007321670651436
( O 0 0.006771088112145662
Glu O 1 0.9720330238342285
) O 0 0.004962301813066006
of O 0 0.008232040330767632
NPII O 1 0.9938033819198608
. O 0 0.016312560066580772

The O 0 0.01882132701575756
premature O 1 0.7401854395866394
termination O 0 0.45013636350631714
eliminates O 0 0.01787315495312214
part O 0 0.004541192203760147
of O 0 0.003939530812203884
the O 0 0.008431886322796345
C O 1 0.9153158664703369
- O 0 0.026562882587313652
terminal O 0 0.009203890338540077
domain O 0 0.0028657736256718636
of O 0 0.0025466936640441418
NPII O 1 0.974753737449646
, O 0 0.001574855763465166
including O 0 0.0010905980598181486
a O 0 0.002003649715334177
cysteine O 0 0.0039374507032334805
residue O 0 0.004144849721342325
in O 0 0.0013285960303619504
position O 0 0.002109864726662636
85 O 0 0.0028839409351348877
, O 0 0.001228278735652566
which O 0 0.0007390850805677474
could O 0 0.0007523322128690779
be O 0 0.0006099877064116299
involved O 0 0.0009224798996001482
in O 0 0.00109388108830899
the O 0 0.00233731628395617
correct O 0 0.007055983878672123
folding O 0 0.08065621554851532
of O 0 0.0070162187330424786
the O 0 0.05391530692577362
prohormone O 1 0.9995942711830139
. O 0 0.019289234653115273

In O 0 0.0062762838788330555
the O 0 0.005289807915687561
second O 0 0.004820873960852623
family O 0 0.004467196762561798
, O 0 0.0025391706731170416
a O 0 0.0028319319244474173
G279A O 0 0.010859818197786808
substitution O 0 0.004025160800665617
at O 0 0.002679081168025732
position O 0 0.0025520347990095615
- O 0 0.003334376960992813
1 O 0 0.0020104849245399237
of O 0 0.001405034912750125
the O 0 0.0021168070379644632
signal O 0 0.003842282807454467
peptide O 0 0.003694305894896388
was O 0 0.002528259763494134
observed O 0 0.0021647883113473654
in O 0 0.0016234176000580192
all O 0 0.0019077373435720801
affected O 0 0.005046139471232891
individuals O 0 0.004792028106749058
. O 0 0.009750375524163246

This O 0 0.010318730026483536
missense O 0 0.023558683693408966
mutation O 0 0.00857618823647499
, O 0 0.0031566175166517496
which O 0 0.003182239830493927
replaces O 1 0.9527350068092346
Ala O 1 0.9995885491371155
with O 0 0.004552693571895361
Thr O 1 0.9998313188552856
, O 0 0.0027187191881239414
is O 0 0.002229626290500164
frequent O 0 0.004181886091828346
among O 0 0.021685505285859108
FNDI B-Disease 1 0.9999998807907104
patients O 1 0.9978671073913574
and O 0 0.0021613941062241793
is O 0 0.0018364936113357544
thought O 0 0.0018025054596364498
to O 0 0.0010406392393633723
reduce O 0 0.002283321227878332
the O 0 0.001775174168869853
efficiency O 0 0.0044356053695082664
of O 0 0.003555386560037732
cleavage O 0 0.4825938642024994
by O 0 0.0035101219546049833
signal O 0 0.011240649968385696
peptidases O 0 0.047935377806425095
. O 0 0.006654135882854462
. O 0 0.01131989061832428

Genetic O 0 0.02128407545387745
heterogeneity O 0 0.027080917730927467
of O 0 0.06412020325660706
Saethre B-Disease 1 0.9999984502792358
- I-Disease 1 0.999997615814209
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
, O 0 0.01609860733151436
due O 0 0.0065886229276657104
to O 0 0.0035651468206197023
TWIST O 1 0.5320717692375183
and O 0 0.007295874413102865
FGFR O 1 0.9987189769744873
mutations O 0 0.021021824330091476
. O 0 0.013405014760792255

Thirty O 0 0.025904929265379906
- O 0 0.011391549371182919
two O 0 0.003011260647326708
unrelated O 0 0.008252456784248352
patients O 0 0.009131628088653088
with O 0 0.0018221420468762517
features O 0 0.002982713980600238
of O 0 0.03909879922866821
Saethre B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999980926513672
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
, O 0 0.004178556147962809
a O 0 0.004588367883116007
common O 0 0.05563334375619888
autosomal B-Disease 1 0.9989602565765381
dominant I-Disease 1 0.9807480573654175
condition I-Disease 1 0.9998675584793091
of O 1 0.9995384216308594
craniosynostosis B-Disease 1 1.0
and O 1 0.9995381832122803
limb B-Disease 1 0.9999997615814209
anomalies I-Disease 1 0.9997466206550598
, O 0 0.0025960933417081833
were O 0 0.0014794071903452277
screened O 0 0.002952161943539977
for O 0 0.0013354502152651548
mutations O 0 0.0021798666566610336
in O 0 0.001662987400777638
TWIST O 0 0.06261100620031357
, O 0 0.004509719554334879
FGFR2 O 1 0.95937180519104
, O 0 0.005217150319367647
and O 0 0.007041112519800663
FGFR3 O 1 0.9918699264526367
. O 0 0.01658039167523384

Nine O 0 0.00990529078990221
novel O 0 0.012537362985312939
and O 0 0.0034770111087709665
three O 0 0.003859603311866522
recurrent O 1 0.9999755620956421
TWIST O 1 0.9973266124725342
mutations O 0 0.005505025386810303
were O 0 0.0017152210930362344
found O 0 0.002001975430175662
in O 0 0.002340006874874234
12 O 0 0.00529110012575984
families O 0 0.006858143489807844
. O 0 0.009804881177842617

Seven O 0 0.007963912561535835
families O 0 0.004158528055995703
were O 0 0.0022909543476998806
found O 0 0.0017641615122556686
to O 0 0.0010853847488760948
have O 0 0.0009795569349080324
the O 0 0.0024034681264311075
FGFR3 O 1 0.9994804263114929
P250R O 1 0.9572301506996155
mutation O 0 0.003892370732501149
, O 0 0.0013564404798671603
and O 0 0.0008761941571719944
one O 0 0.0010322665330022573
individual O 0 0.001157046528533101
was O 0 0.0023435032926499844
found O 0 0.0013256269739940763
to O 0 0.000941507110837847
have O 0 0.0011047322768718004
an O 0 0.002478388138115406
FGFR2 O 1 0.9539095163345337
VV269 O 1 0.7549377083778381
- O 0 0.03902893885970116
270 O 0 0.01644119620323181
deletion O 0 0.025598375126719475
. O 0 0.011184203438460827

To O 0 0.007226706016808748
date O 0 0.005885377526283264
, O 0 0.002860882319509983
our O 0 0.0023374808952212334
detection O 0 0.004050413612276316
rate O 0 0.0024521565064787865
for O 0 0.001599858165718615
TWIST O 0 0.00985849741846323
or O 0 0.002601628191769123
FGFR O 0 0.4678993225097656
mutations O 0 0.002780197886750102
is O 0 0.0014175503747537732
68 O 0 0.0030735605396330357
% O 0 0.0013578635407611728
in O 0 0.0012426588218659163
our O 0 0.0027689870912581682
Saethre B-Disease 1 0.9995303153991699
- I-Disease 1 0.9999196529388428
Chotzen I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 1 0.999931812286377
, O 0 0.002806592732667923
including O 0 0.0016021262854337692
our O 0 0.0020102912094444036
five O 0 0.0023072471376508474
patients O 1 0.725108802318573
elsewhere O 0 0.00292131956666708
reported O 0 0.0045920019038021564
with O 0 0.003809863468632102
TWIST O 1 0.7912296652793884
mutations O 0 0.017016004770994186
. O 0 0.01286175474524498

More O 0 0.004375921096652746
than O 0 0.0023592745419591665
35 O 0 0.0033546467311680317
different O 0 0.001711590914055705
TWIST O 0 0.009399416856467724
mutations O 0 0.0033507959451526403
are O 0 0.0009261579834856093
now O 0 0.0017897672951221466
known O 0 0.002226189710199833
in O 0 0.0018431320786476135
the O 0 0.00437808595597744
literature O 0 0.011498476378619671
. O 0 0.01221495307981968

The O 0 0.008861960843205452
most O 0 0.003919654060155153
common O 0 0.0041632698848843575
phenotypic O 0 0.007727296557277441
features O 0 0.003158091101795435
, O 0 0.0018666702089831233
present O 0 0.001602190313860774
in O 0 0.0009361151023767889
more O 0 0.0005823696847073734
than O 0 0.0005890958709642291
a O 0 0.001083959941752255
third O 0 0.0015957775758579373
of O 0 0.0016896509332582355
our O 0 0.0022064330987632275
patients O 0 0.083860382437706
with O 0 0.001783467479981482
TWIST O 1 0.5456869602203369
mutations O 0 0.0035290697123855352
, O 0 0.00162166403606534
are O 0 0.0013975524343550205
coronal B-Disease 0 0.044098641723394394
synostosis I-Disease 1 0.5685727000236511
, O 0 0.003925004042685032
brachycephaly B-Disease 1 0.717140257358551
, O 0 0.0045275697484612465
low B-Disease 0 0.1900365650653839
frontal I-Disease 1 0.9999366998672485
hairline I-Disease 1 0.9999995231628418
, O 1 0.783129096031189
facial B-Disease 1 0.9999980926513672
asymmetry I-Disease 1 0.9999183416366577
, O 1 0.8116961717605591
ptosis B-Disease 1 0.9999997615814209
, O 0 0.08713232725858688
hypertelorism B-Disease 1 0.9998617172241211
, O 0 0.004568608943372965
broad B-Disease 0 0.009966476820409298
great I-Disease 0 0.24816207587718964
toes I-Disease 1 0.9939188957214355
, O 0 0.006008207332342863
and O 0 0.008196284994482994
clinodactyly B-Disease 1 0.992283284664154
. O 0 0.016022108495235443

Significant O 0 0.021856071427464485
intra O 1 0.9241694211959839
- O 0 0.10597645491361618
and O 0 0.005700934212654829
interfamilial O 0 0.46085965633392334
phenotypic O 0 0.012476949952542782
variability O 0 0.007799514103680849
is O 0 0.0023258919827640057
present O 0 0.0019467042293399572
for O 0 0.0018802001141011715
either O 0 0.0035690823569893837
TWIST O 0 0.45404377579689026
mutations O 0 0.009677288122475147
or O 0 0.006905060727149248
FGFR O 1 0.9964050054550171
mutations O 0 0.024844279512763023
. O 0 0.014336020685732365

The O 0 0.009789093397557735
overlap O 0 0.0076802452094852924
in O 0 0.0036490573547780514
clinical O 0 0.20004355907440186
features O 0 0.0031822549644857645
and O 0 0.0015799496322870255
the O 0 0.001967964693903923
presence O 0 0.0015369376633316278
, O 0 0.0009168739779852331
in O 0 0.0008428269647993147
the O 0 0.0009164359653368592
same O 0 0.0008362974622286856
genes O 0 0.0008776571485213935
, O 0 0.0006230850704014301
of O 0 0.0008089191978797317
mutations O 0 0.0010225187288597226
for O 0 0.0005563475424423814
more O 0 0.000503093411680311
than O 0 0.0006018812418915331
one O 0 0.0011654938571155071
craniosynostotic B-Disease 1 0.7238558530807495
condition I-Disease 0 0.08355805277824402
- O 0 0.0037241389509290457
such O 0 0.0011288910172879696
as O 0 0.0023177778348326683
Saethre B-Disease 1 0.9862927198410034
- I-Disease 0 0.10957130044698715
Chotzen I-Disease 1 0.6099035739898682
, I-Disease 0 0.002354903845116496
Crouzon I-Disease 0 0.3085998594760895
, I-Disease 0 0.002938962308689952
and I-Disease 0 0.0039032716304063797
Pfeiffer I-Disease 1 0.9999977350234985
syndromes I-Disease 1 0.9999979734420776
- O 1 0.6053241491317749
support O 0 0.0025330428034067154
the O 0 0.0023994275834411383
hypothesis O 0 0.004188030492514372
that O 0 0.0013553349999710917
TWIST O 0 0.007788934279233217
and O 0 0.0015674668829888105
FGFRs O 0 0.01344353798776865
are O 0 0.0009325702558271587
components O 0 0.0015381235862150788
of O 0 0.0012815403752028942
the O 0 0.0014272694243118167
same O 0 0.0013779884902760386
molecular O 0 0.002555480692535639
pathway O 0 0.002307332819327712
involved O 0 0.0011130585335195065
in O 0 0.001048362348228693
the O 0 0.002178962342441082
modulation O 0 0.0174545980989933
of O 0 0.22004015743732452
craniofacial O 1 1.0
and O 1 0.9935342073440552
limb O 1 0.9999988079071045
development O 0 0.4699666202068329
in O 0 0.005147878080606461
humans O 0 0.005908051505684853
. O 0 0.004081356339156628
. O 0 0.008698242716491222

Mutation O 0 0.02312072366476059
analysis O 0 0.009747613221406937
of O 0 0.0169356856495142
UBE3A O 1 0.9999959468841553
in O 1 0.999464213848114
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 1 0.9699975848197937

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9988652467727661
AS B-Disease 1 0.9964358806610107
) O 0 0.0057415422052145
is O 0 0.0027312340680509806
caused O 0 0.011264374479651451
by O 0 0.0028896809089928865
chromosome O 0 0.021237598732113838
15q11 O 0 0.4893309473991394
- O 0 0.014018057845532894
q13 O 0 0.01959873177111149
deletions O 0 0.007639989722520113
of O 0 0.0038303888868540525
maternal O 0 0.2103434056043625
origin O 0 0.0033117393031716347
, O 0 0.002838850487023592
by O 0 0.0032367659732699394
paternal O 1 0.9616868495941162
uniparental B-Disease 1 0.9999949932098389
disomy I-Disease 1 0.9999618530273438
( O 0 0.3963346481323242
UPD B-Disease 1 0.9999896287918091
) O 0 0.002454492961987853
15 O 0 0.0018848159816116095
, O 0 0.001406740746460855
by O 0 0.0017026551067829132
imprinting O 1 0.8503186702728271
defects O 1 0.9990536570549011
, O 0 0.002039998071268201
and O 0 0.0013068257831037045
by O 0 0.0015462709125131369
mutations O 0 0.003292699344456196
in O 0 0.0027097174897789955
the O 0 0.008237328380346298
UBE3A O 1 0.9999558925628662
gene O 0 0.016022009775042534
. O 0 0.010585535317659378

UBE3A O 1 0.979145884513855
encodes O 0 0.02862425707280636
a O 0 0.01282693725079298
ubiquitin O 0 0.041961997747421265
- O 0 0.020163604989647865
protein O 0 0.008752517402172089
ligase O 0 0.017227139323949814
and O 0 0.004661255981773138
shows O 0 0.008146272040903568
brain O 1 0.5864883065223694
- O 0 0.018872298300266266
specific O 0 0.009556844830513
imprinting O 0 0.19483360648155212
. O 0 0.015774549916386604

Here O 0 0.010169561952352524
we O 0 0.005927443969994783
describe O 0 0.013462979346513748
UBE3A O 1 0.9981309771537781
coding O 0 0.046802181750535965
- O 0 0.013821116648614407
region O 0 0.005735279992222786
mutations O 0 0.00455555971711874
detected O 0 0.0040847728960216045
by O 0 0.0018644112860783935
SSCP O 0 0.024230992421507835
analysis O 0 0.0020544982980936766
in O 0 0.0014478022931143641
13 O 0 0.002777834888547659
AS B-Disease 0 0.004286819603294134
individuals O 0 0.0019866072107106447
or O 0 0.003610361833125353
families O 0 0.007709539961069822
. O 0 0.009830848313868046

Two O 0 0.007440825458616018
identical O 0 0.010125420987606049
de O 0 0.017719866707921028
novo O 0 0.02538948506116867
5 O 0 0.008169327862560749
- O 0 0.009449210949242115
bp O 0 0.01005172822624445
duplications O 0 0.010411050170660019
in O 0 0.0034712825436145067
exon O 0 0.014581919647753239
16 O 0 0.005355337634682655
were O 0 0.005047868471592665
found O 0 0.009838975965976715
. O 0 0.013653083704411983

Among O 0 0.006486056838184595
the O 0 0.00324050965718925
other O 0 0.001641585142351687
11 O 0 0.0025787840131670237
unique O 0 0.0023823357187211514
mutations O 0 0.002318485639989376
, O 0 0.0012751895701512694
8 O 0 0.0020560610573738813
were O 0 0.0011226251954212785
small O 0 0.0014972304925322533
deletions O 0 0.0040956889279186726
or O 0 0.0018979405285790563
insertions O 0 0.006490950472652912
predicted O 0 0.003737058723345399
to O 0 0.0018432935466989875
cause O 0 0.0075899274088442326
frameshifts O 1 0.5534740090370178
, O 0 0.0021995510905981064
1 O 0 0.0025823381729424
was O 0 0.0024699722416698933
a O 0 0.0016155544435605407
mutation O 0 0.0017664115875959396
to O 0 0.0007188540184870362
a O 0 0.0012366893934085965
stop O 0 0.0021435448434203863
codon O 0 0.003074504667893052
, O 0 0.0012827761238440871
1 O 0 0.0017866555135697126
was O 0 0.0020113689824938774
a O 0 0.0017501292750239372
missense O 0 0.0059873806312680244
mutation O 0 0.002599849598482251
, O 0 0.0010792211396619678
and O 0 0.0012018592096865177
1 O 0 0.0022647574078291655
was O 0 0.0027480050921440125
predicted O 0 0.003182596992701292
to O 0 0.0013168749865144491
cause O 0 0.0032297123689204454
insertion O 0 0.003938883543014526
of O 0 0.00206011557020247
an O 0 0.0028300548437982798
isoleucine O 1 0.637543261051178
in O 0 0.0020033419132232666
the O 0 0.002839809050783515
hect O 0 0.014316068962216377
domain O 0 0.0027173617854714394
of O 0 0.0020536312367767096
the O 0 0.004071962554007769
UBE3A O 1 0.9996634721755981
protein O 0 0.003168177092447877
, O 0 0.0013784386683255434
which O 0 0.000989768304862082
functions O 0 0.001693005091510713
in O 0 0.002254533814266324
E2 O 0 0.225440114736557
binding O 0 0.004719581454992294
and O 0 0.0042692213319242
ubiquitin O 0 0.01971728540956974
transfer O 0 0.011542982421815395
. O 0 0.015034465119242668

Eight O 0 0.0067536779679358006
of O 0 0.004499541595578194
the O 0 0.00389945600181818
cases O 0 0.0039038255345076323
were O 0 0.003040880663320422
familial O 1 0.9991223216056824
, O 0 0.0027776064816862345
and O 0 0.002082090824842453
five O 0 0.0025747809559106827
were O 0 0.004180218558758497
sporadic O 0 0.018263626843690872
. O 0 0.012460622005164623

In O 0 0.0061001405119895935
two O 0 0.003855447517707944
familial O 1 0.9805214405059814
cases O 0 0.006406264379620552
and O 0 0.0023098676465451717
one O 0 0.002324467059224844
sporadic O 0 0.0076691759750247
case O 0 0.004753054119646549
, O 0 0.0029509412124753
mosaicism O 1 0.9044479131698608
for O 0 0.003148534568026662
UBE3A O 1 0.9996649026870728
mutations O 0 0.004214531276375055
was O 0 0.002989616245031357
detected O 0 0.0024469527415931225
in O 0 0.0010809004306793213
the O 0 0.001314625726081431
mother O 0 0.0034179091453552246
of O 0 0.0013674970250576735
three O 0 0.0012217002222314477
AS B-Disease 0 0.07737524807453156
sons O 0 0.020698050037026405
, O 0 0.0011980392737314105
in O 0 0.0009796746307983994
the O 0 0.0019888784736394882
maternal O 1 0.5037127137184143
grandfather O 0 0.05002664774656296
of O 0 0.001462986576370895
two O 0 0.0008644838235341012
AS B-Disease 0 0.011243462562561035
first O 0 0.0014965477166697383
cousins O 0 0.002345440909266472
, O 0 0.000831331592053175
and O 0 0.0007255078526213765
in O 0 0.0009170478442683816
the O 0 0.0015325084095820785
mother O 0 0.01147730927914381
of O 0 0.0030584402848035097
an O 0 0.008571388199925423
AS B-Disease 1 0.9843558669090271
daughter O 1 0.9936421513557434
. O 0 0.012012907303869724

The O 0 0.009406722150743008
frequencies O 0 0.004749298095703125
with O 0 0.0021288758143782616
which O 0 0.0017796448664739728
we O 0 0.0017461766256019473
detected O 0 0.0034313532523810863
mutations O 0 0.0021392512135207653
were O 0 0.0012649320997297764
5 O 0 0.001839693053625524
( O 0 0.0014629029901698232
14 O 0 0.0014698710292577744
% O 0 0.001063086441718042
) O 0 0.00079256173921749
of O 0 0.0008005518466234207
35 O 0 0.0012117726728320122
in O 0 0.001039662747643888
sporadic O 0 0.0022071911953389645
cases O 0 0.0012267540441825986
and O 0 0.0010864896466955543
8 O 0 0.0016600711969658732
( O 0 0.0013111151056364179
80 O 0 0.0015574936987832189
% O 0 0.0009796811500564218
) O 0 0.0008506929152645171
of O 0 0.0010213650530204177
10 O 0 0.0017673780675977468
in O 0 0.0024451171047985554
familial O 1 0.9520832896232605
cases O 0 0.010614564642310143
. O 0 0.006941299885511398
. O 0 0.011869887821376324

The O 0 0.03844475373625755
hemochromatosis B-Disease 1 0.9999970197677612
845 O 1 0.9999064207077026
G O 1 0.9987010955810547
- O 1 0.5599584579467773
- O 0 0.01872986927628517
> O 0 0.0077543193474411964
A O 0 0.003809043439105153
and O 0 0.002242980059236288
187 O 0 0.007280807476490736
C O 0 0.010814999230206013
- O 0 0.009702976793050766
- O 0 0.010190578177571297
> O 0 0.011835088953375816
G O 0 0.010048544965684414
mutations O 0 0.003718202468007803
: O 0 0.0030686785466969013
prevalence O 0 0.05760122090578079
in O 0 0.003638829803094268
non O 0 0.28177785873413086
- O 1 0.990333616733551
Caucasian O 1 0.9848419427871704
populations O 0 0.013758266344666481
. O 0 0.013493774458765984

Hemochromatosis B-Disease 1 0.9999759197235107
, O 0 0.019229445606470108
the O 1 0.9401763677597046
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999972581863403
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999921321868896
, O 0 0.08491267263889313
leads O 0 0.08553869277238846
, O 0 0.0023180136922746897
if O 0 0.0019652824848890305
untreated O 1 0.9917280673980713
, O 0 0.0023554391227662563
to O 0 0.0027090979274362326
progressive O 1 0.9998972415924072
iron B-Disease 1 0.9999992847442627
overload I-Disease 1 0.9999967813491821
and O 0 0.28714340925216675
premature B-Disease 1 0.9984250068664551
death I-Disease 1 0.924003541469574
. O 0 0.016989560797810555

The O 0 0.1721734255552292
hemochromatosis B-Disease 1 0.9999996423721313
gene O 0 0.08291804045438766
, O 0 0.009297806769609451
HFE O 1 0.9999462366104126
, O 0 0.003836353775113821
recently O 0 0.005484970286488533
has O 0 0.002149507636204362
been O 0 0.0016304198652505875
identified O 0 0.0018477503908798099
, O 0 0.001161911292001605
and O 0 0.0011938255047425628
characterization O 0 0.0042867460288107395
of O 0 0.00211338116787374
this O 0 0.0017970212502405047
gene O 0 0.0024900578428059816
has O 0 0.0012973794946447015
shown O 0 0.0013674590736627579
that O 0 0.0007739813299849629
it O 0 0.0006288756849244237
contains O 0 0.0010093085002154112
two O 0 0.0006822762661613524
mutations O 0 0.0014935368672013283
that O 0 0.000733420776668936
result O 0 0.0012081721797585487
in O 0 0.001278915093280375
amino O 0 0.00275570061057806
acid O 0 0.004136006813496351
substitutions O 0 0.0048454515635967255
- O 0 0.006535090506076813
cDNA O 0 0.010558207519352436
nucleotides O 0 0.006839160341769457
845 O 0 0.019771423190832138
G O 0 0.026193374767899513
- O 0 0.009906118735671043
- O 0 0.008173711597919464
> O 0 0.006017857696861029
A O 0 0.003528368892148137
( O 0 0.002794015221297741
C282Y O 0 0.006510956212878227
) O 0 0.0015837785322219133
and O 0 0.001603496726602316
187 O 0 0.007138448301702738
C O 0 0.013136765919625759
- O 0 0.02123117633163929
- O 0 0.03143322467803955
> O 0 0.025929611176252365
G O 0 0.031367942690849304
( O 0 0.007966579869389534
H63D O 1 0.6100644469261169
) O 0 0.009497120976448059
. O 0 0.011626312509179115

Although O 0 0.04580986127257347
hemochromatosis B-Disease 1 0.9999973773956299
is O 0 0.0072420756332576275
common O 0 0.0045400457456707954
in O 0 0.0034526861272752285
Caucasians O 1 0.8572185039520264
, O 0 0.003184156958013773
affecting O 0 0.007801946252584457
> O 0 0.016080202534794807
= O 0 0.0068252962082624435
1 O 0 0.0035028508864343166
/ O 0 0.0043206168338656425
300 O 0 0.0017564812442287803
individuals O 0 0.0008483260171487927
of O 0 0.0012564229546114802
northern O 0 0.001656470587477088
European O 0 0.0014394157333299518
origin O 0 0.0014331083511933684
, O 0 0.0010796418646350503
it O 0 0.0007657584501430392
has O 0 0.0010379001032561064
not O 0 0.0007067876867949963
been O 0 0.0012254426255822182
recognized O 0 0.0018780516693368554
in O 0 0.00193740613758564
other O 0 0.0025863032788038254
populations O 0 0.007524228189140558
. O 0 0.009412065148353577

The O 0 0.008835687302052975
present O 0 0.005299189127981663
study O 0 0.004178659059107304
used O 0 0.0035459890495985746
PCR O 0 0.008849848061800003
and O 0 0.002680702367797494
restriction O 0 0.007422795053571463
- O 0 0.02390168607234955
enzyme O 0 0.005459606181830168
digestion O 0 0.0065493714064359665
to O 0 0.0014849004801362753
analyze O 0 0.0029044318944215775
the O 0 0.0017688937950879335
frequency O 0 0.0019111725268885493
of O 0 0.0016842863988131285
the O 0 0.0030117935966700315
845 O 1 0.9089171290397644
G O 0 0.20330287516117096
- O 0 0.009787474758923054
- O 0 0.0051263743080198765
> O 0 0.003903026692569256
A O 0 0.0019587723072618246
and O 0 0.0014522555284202099
187 O 0 0.005608041305094957
C O 0 0.008228810504078865
- O 0 0.008415189571678638
- O 0 0.009110757149755955
> O 0 0.009398301132023335
G O 0 0.0087287537753582
mutations O 0 0.0033056254032999277
in O 0 0.0027290352154523134
HLA O 1 0.9367581009864807
- O 0 0.004419622477144003
typed O 0 0.0041208164766430855
samples O 0 0.002221521455794573
from O 0 0.0016860273899510503
non O 0 0.004352247342467308
- O 0 0.035902734845876694
Caucasian O 0 0.03406766057014465
populations O 0 0.0021294045727699995
, O 0 0.0014518427196890116
comprising O 0 0.002675054594874382
Australian O 0 0.005278286524116993
Aboriginal O 0 0.008344652131199837
, O 0 0.002128013875335455
Chinese O 0 0.004757692106068134
, O 0 0.00323209585621953
and O 0 0.00405204389244318
Pacific O 0 0.016170820221304893
Islanders O 0 0.02698516473174095
. O 0 0.013138997368514538

Results O 0 0.012225095182657242
showed O 0 0.009211311116814613
that O 0 0.0030603441409766674
the O 0 0.004593246150761843
845 O 1 0.974526584148407
G O 1 0.9334095120429993
- O 0 0.23858878016471863
- O 0 0.02629080042243004
> O 0 0.007689968682825565
A O 0 0.0036241435445845127
mutation O 0 0.0029846844263374805
was O 0 0.002202461240813136
present O 0 0.0012935970444232225
in O 0 0.0010477761970832944
these O 0 0.0007699182024225593
populations O 0 0.0015017526457086205
( O 0 0.00159354112111032
allele O 0 0.0020677861757576466
frequency O 0 0.0012631543213501573
0 O 0 0.0012215349124744534
. O 0 0.0006773516652174294
32 O 0 0.0014128494076430798
% O 0 0.001217984943650663
) O 0 0.0010082983644679189
, O 0 0.0010142013197764754
and O 0 0.0008770489948801696
, O 0 0.001282690791413188
furthermore O 0 0.0021033419761806726
, O 0 0.0011474686907604337
it O 0 0.0007962415111251175
was O 0 0.002389758825302124
always O 0 0.0014814260648563504
seen O 0 0.0013382782926782966
in O 0 0.0011853629257529974
conjunction O 0 0.004275030456483364
with O 0 0.003308410756289959
HLA O 1 0.9999823570251465
haplotypes O 0 0.009075378999114037
common O 0 0.0020302149932831526
in O 0 0.001754457363858819
Caucasians O 0 0.009014058858156204
, O 0 0.0022354545071721077
suggesting O 0 0.0036231449339538813
that O 0 0.0021596180740743876
845 O 1 0.6756065487861633
G O 1 0.9041295647621155
- O 0 0.28798022866249084
- O 0 0.077963687479496
> O 0 0.009016920812427998
A O 0 0.002955441130325198
may O 0 0.0014005036791786551
have O 0 0.000661709695123136
been O 0 0.0009894599206745625
introduced O 0 0.001623834134079516
into O 0 0.0011647429782897234
these O 0 0.0011577355908229947
populations O 0 0.0030118394643068314
by O 0 0.0042208838276565075
Caucasian O 1 0.6812448501586914
admixture O 1 0.5396287441253662
. O 0 0.016284991055727005

187 O 0 0.035472575575113297
C O 0 0.08904444426298141
- O 0 0.11541901528835297
- O 0 0.05043281614780426
> O 0 0.019461188465356827
G O 0 0.0110665587708354
was O 0 0.003527597989886999
present O 0 0.002101676305755973
at O 0 0.002270388649776578
an O 0 0.0020575097296386957
allele O 0 0.00463167205452919
frequency O 0 0.0030130536761134863
of O 0 0.0037354042287915945
2 O 0 0.00808605458587408
. O 0 0.009808327071368694

68 O 0 0.01896502450108528
% O 0 0.004642178304493427
in O 0 0.002298447536304593
the O 0 0.0020428579300642014
two O 0 0.0012355678481981158
populations O 0 0.0020455275662243366
analyzed O 0 0.003578077768906951
( O 0 0.0028150572907179594
Australian O 0 0.004282812122255564
Aboriginal O 0 0.007582675665616989
and O 0 0.0029602462891489267
Chinese O 0 0.010628942400217056
) O 0 0.007948418147861958
. O 0 0.010193330235779285

In O 0 0.007449835538864136
the O 0 0.005514070391654968
Australian O 0 0.007421017624437809
Aboriginal O 0 0.007843641564249992
samples O 0 0.0033165684435516596
, O 0 0.0025340744759887457
187 O 0 0.006958122365176678
C O 0 0.011731076054275036
- O 0 0.015368306078016758
- O 0 0.03775320202112198
> O 0 0.01487251278012991
G O 0 0.00777116185054183
was O 0 0.0021946774795651436
found O 0 0.0012466468615457416
to O 0 0.0009208956034854054
be O 0 0.000990401254966855
associated O 0 0.0017334074946120381
with O 0 0.00223462819121778
HLA O 1 0.9999089241027832
haplotypes O 0 0.009262612089514732
common O 0 0.002309266710653901
in O 0 0.002003792906180024
Caucasians O 0 0.22269880771636963
, O 0 0.0020921393297612667
suggesting O 0 0.0028169734869152308
that O 0 0.001066741649992764
it O 0 0.0011195270344614983
was O 0 0.002794095082208514
introduced O 0 0.0032379261683672667
by O 0 0.0028363624587655067
recent O 0 0.007328142412006855
admixture O 0 0.05013246089220047
. O 0 0.015559430234134197

In O 0 0.007121675182133913
the O 0 0.004766946658492088
Chinese O 0 0.00595232704654336
samples O 0 0.003669298253953457
analyzed O 0 0.003350350074470043
, O 0 0.002153330948203802
187 O 0 0.006030471995472908
C O 0 0.009723657742142677
- O 0 0.011538565158843994
- O 0 0.01425072643905878
> O 0 0.012004426680505276
G O 0 0.0070328619331121445
was O 0 0.0024919419083744287
present O 0 0.001387229305692017
in O 0 0.001202707877382636
association O 0 0.0018592372070997953
with O 0 0.0009886495536193252
a O 0 0.0015788399614393711
wide O 0 0.0017836671322584152
variety O 0 0.0023549406323581934
of O 0 0.057136937975883484
HLA O 1 0.9999997615814209
haplotypes O 1 0.5789717435836792
, O 0 0.002187845529988408
showing O 0 0.002946038031950593
this O 0 0.0012887401971966028
mutation O 0 0.0021118430886417627
to O 0 0.000878725724760443
be O 0 0.0009721701499074697
widespread O 0 0.002392124617472291
and O 0 0.0014450309099629521
likely O 0 0.0019121550722047687
to O 0 0.0014081655535846949
predate O 0 0.004354177974164486
the O 0 0.0017717047594487667
more O 0 0.001380958128720522
genetically O 0 0.003581265453249216
restricted O 0 0.004223044961690903
845 O 0 0.37624046206474304
G O 1 0.5832533240318298
- O 0 0.2876364588737488
- O 0 0.2701377868652344
> O 0 0.021550366654992104
A O 0 0.012420731596648693
mutation O 0 0.018457936123013496
. O 0 0.012194408103823662

Genotype O 0 0.45265018939971924
- O 0 0.0833544209599495
phenotype O 0 0.03364114835858345
correlations O 0 0.023826828226447105
in O 0 0.017718706279993057
attenuated B-Disease 1 0.999911904335022
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
. O 0 0.4240524172782898

Germ O 1 0.9977574944496155
- O 0 0.04516991227865219
line O 0 0.01028104405850172
mutations O 0 0.0064969551749527454
of O 0 0.004933448508381844
the O 1 0.6649978756904602
tumor B-Disease 1 0.9999994039535522
suppressor O 1 0.9989907145500183
APC O 1 0.9095495343208313
are O 0 0.0022071555722504854
implicated O 0 0.04101403057575226
in O 0 0.008986778557300568
attenuated B-Disease 1 0.9999805688858032
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.999477207660675
AAPC B-Disease 1 0.9999988079071045
) O 0 0.003964890725910664
, O 0 0.0023675491102039814
a O 0 0.0037458776496350765
variant O 0 0.04925231263041496
of O 0 0.32815486192703247
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999951124191284
FAP B-Disease 1 0.9999998807907104
) O 0 0.062064897269010544
. O 0 0.016161641106009483

AAPC B-Disease 1 0.9991059899330139
is O 0 0.008047841489315033
recognized O 0 0.005103864707052708
by O 0 0.002528752665966749
the O 0 0.003114186692982912
occurrence O 0 0.00845442432910204
of O 0 0.006806719582527876
< O 1 0.7858898043632507
100 O 0 0.007021290250122547
colonic B-Disease 1 0.9996887445449829
adenomas I-Disease 1 0.975328803062439
and O 0 0.001774235744960606
a O 0 0.002426407067105174
later O 0 0.005927165038883686
onset O 1 0.9999903440475464
of O 1 0.9999680519104004
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9641385674476624
age O 0 0.49391505122184753
> O 0 0.022456079721450806
40 O 0 0.0036254418082535267
years O 0 0.004072945099323988
) O 0 0.00508924201130867
. O 0 0.007673941552639008

The O 0 0.009059038944542408
aim O 0 0.0071581508964300156
of O 0 0.0030110490042716265
this O 0 0.0016947048716247082
study O 0 0.0023767640814185143
was O 0 0.0033597603905946016
to O 0 0.0019989393185824156
assess O 0 0.007090671453624964
genotype O 0 0.01673232950270176
- O 0 0.011390851810574532
phenotype O 0 0.011821111664175987
correlations O 0 0.010888714343309402
in O 0 0.007781685795634985
AAPC B-Disease 1 0.9997733235359192
families O 0 0.017862167209386826
. O 0 0.016898982226848602

By O 0 0.00945575162768364
protein O 0 0.010089263319969177
- O 0 0.00879174005240202
truncation O 0 0.016492653638124466
test O 0 0.005127463955432177
( O 0 0.003821393009275198
PTT O 0 0.012285402975976467
) O 0 0.0019386413041502237
assay O 0 0.003701624693349004
, O 0 0.0015472951345145702
the O 0 0.0017564301379024982
entire O 0 0.0028218263760209084
coding O 0 0.004093985538929701
region O 0 0.0019346275366842747
of O 0 0.0017800427740439773
the O 0 0.003870210610330105
APC B-Disease 1 0.9919613003730774
gene O 0 0.0026716790162026882
was O 0 0.0029618260450661182
screened O 0 0.0028498617466539145
in O 0 0.0010444684885442257
affected O 0 0.0017894537886604667
individuals O 0 0.0009756097570061684
from O 0 0.0016204208368435502
11 O 0 0.005575355142354965
AAPC B-Disease 1 0.9999884366989136
kindreds O 1 0.5960143208503723
, O 0 0.0025794769171625376
and O 0 0.0018130160169675946
their O 0 0.002066795714199543
phenotypic O 0 0.007576718460768461
differences O 0 0.005359204951673746
were O 0 0.006045668385922909
examined O 0 0.026075297966599464
. O 0 0.015398712828755379

Five O 0 0.012450795620679855
novel O 0 0.16742029786109924
germ O 1 0.9999271631240845
- O 1 0.9241544604301453
line O 0 0.06415905058383942
APC B-Disease 1 0.9355247616767883
mutations O 0 0.0045850458554923534
were O 0 0.002248279517516494
identified O 0 0.0043991245329380035
in O 0 0.004016499035060406
seven O 0 0.00894841831177473
kindreds O 0 0.3268669545650482
. O 0 0.01790744438767433

Mutations O 0 0.016057871282100677
were O 0 0.004526082891970873
located O 0 0.003918976057320833
in O 0 0.0018807011656463146
three O 0 0.00114050367847085
different O 0 0.0007869452820159495
regions O 0 0.0013117027701810002
of O 0 0.0016291877254843712
the O 0 0.0039452495984733105
APC B-Disease 1 0.9966714382171631
gene O 0 0.002820600289851427
( O 0 0.001757536781951785
1 O 0 0.0016477437457069755
) O 0 0.0009263150277547538
at O 0 0.000998970470391214
the O 0 0.001103564747609198
5 O 0 0.001450608018785715
end O 0 0.0015712423482909799
spanning O 0 0.002674773335456848
exons O 0 0.003988593816757202
4 O 0 0.0019390168599784374
and O 0 0.0008885535062290728
5 O 0 0.001313952263444662
, O 0 0.001118663465604186
( O 0 0.0012932312674820423
2 O 0 0.0014683142071589828
) O 0 0.00093814916908741
within O 0 0.0009145857766270638
exon O 0 0.004355782642960548
9 O 0 0.0016980543732643127
, O 0 0.0009588151006028056
and O 0 0.0009446496260352433
( O 0 0.0015661573270335793
3 O 0 0.0014692596159875393
) O 0 0.0009717486682347953
at O 0 0.0013407646911218762
the O 0 0.0018647094257175922
3 O 0 0.003169137751683593
distal O 0 0.008357192389667034
end O 0 0.0028308492619544268
of O 0 0.0034713521599769592
the O 0 0.008136187680065632
gene O 0 0.012737564742565155
. O 0 0.010809481143951416

Variability O 0 0.014758550561964512
in O 0 0.003586326027289033
the O 0 0.0032678856514394283
number O 0 0.0026328933890908957
of O 1 0.9290577173233032
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9995077848434448
most O 0 0.002972010290250182
apparent O 0 0.049129582941532135
in O 0 0.0015475301770493388
individuals O 0 0.0010186508297920227
with O 0 0.0010195014765486121
mutations O 0 0.0016495881136506796
in O 0 0.000997592811472714
region O 0 0.0016989745199680328
1 O 0 0.0018469627248123288
, O 0 0.001297095324844122
and O 0 0.0018461978761479259
upper O 1 0.9955776929855347
- O 1 0.9997445940971375
gastrointestinal O 1 0.9999996423721313
manifestations O 1 0.999847412109375
were O 0 0.009910473600029945
more O 0 0.002173108048737049
severe O 1 0.9986193180084229
in O 0 0.003912533167749643
them O 0 0.004937369376420975
. O 0 0.008545849472284317

In O 0 0.005662060808390379
individuals O 0 0.0032888769637793303
with O 0 0.002117319032549858
mutations O 0 0.0026851273141801357
in O 0 0.0014989017508924007
either O 0 0.0017381187062710524
region O 0 0.002716746646910906
2 O 0 0.0023650210350751877
or O 0 0.0012309702578932047
region O 0 0.001731236930936575
3 O 0 0.0013495003804564476
, O 0 0.0008663234184496105
the O 0 0.0010479319607838988
average O 0 0.0015024006133899093
number O 0 0.0009934905683621764
of O 0 0.001906909397803247
adenomas B-Disease 1 0.9859030246734619
tended O 0 0.00378467352129519
to O 0 0.001244699931703508
be O 0 0.0010575872147455812
lower O 0 0.0019272903446108103
than O 0 0.0007101832306943834
those O 0 0.0005986596224829555
in O 0 0.000756891502533108
individuals O 0 0.0007010414265096188
with O 0 0.0009636226459406316
mutations O 0 0.0017363299848511815
in O 0 0.0009166839881800115
region O 0 0.0018915353575721383
1 O 0 0.0018415063386783004
, O 0 0.0011945366859436035
although O 0 0.0012504172045737505
age O 0 0.0025443448685109615
at O 0 0.004697790369391441
diagnosis O 1 0.9997267127037048
was O 0 0.12569080293178558
similar O 0 0.00714482506737113
. O 0 0.011192756704986095

In O 0 0.010035764425992966
all O 0 0.0076536815613508224
AAPC B-Disease 1 0.9997987151145935
kindreds O 0 0.19588233530521393
, O 0 0.00379022560082376
a O 0 0.004194843582808971
predominance O 0 0.4150029122829437
of O 0 0.08592011779546738
right O 1 0.9878595471382141
- O 1 0.9999980926513672
sided O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999580383300781
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.99998939037323
was O 1 0.9921878576278687
observed O 0 0.02212652750313282
. O 0 0.013064573518931866

No O 0 0.023908793926239014
desmoid B-Disease 1 0.9995248317718506
tumors I-Disease 1 0.9999206066131592
were O 0 0.004444871097803116
found O 0 0.00419408455491066
in O 0 0.00425496231764555
these O 0 0.00515896687284112
kindreds O 0 0.1826305091381073
. O 0 0.014186147600412369

Our O 0 0.008229253813624382
data O 0 0.0037783861625939608
suggest O 0 0.003435224760323763
that O 0 0.0014789144042879343
, O 0 0.001945794909261167
in O 0 0.0025475320871919394
AAPC B-Disease 1 0.9997486472129822
families O 0 0.0023145314771682024
, O 0 0.0016788033535704017
the O 0 0.0014774207957088947
location O 0 0.002098778961226344
of O 0 0.0023562840651720762
the O 0 0.006467155646532774
APC B-Disease 1 0.9993261098861694
mutation O 0 0.008570553734898567
may O 0 0.003346926998347044
partially O 0 0.006885880138725042
predict O 0 0.006188625004142523
specific O 0 0.004009472671896219
phenotypic O 0 0.016767172142863274
expression O 0 0.01486266404390335
. O 0 0.013902084901928902

This O 0 0.0066667706705629826
should O 0 0.0036937089171260595
help O 0 0.002942676655948162
in O 0 0.0016590054146945477
the O 0 0.001907254452817142
design O 0 0.0030571031384170055
of O 0 0.0030679928604513407
tailored O 1 0.6067758202552795
clinical O 1 0.9991158843040466
- O 1 0.766793966293335
management O 0 0.00797024741768837
protocols O 0 0.003404956543818116
in O 0 0.0016272987704724073
this O 0 0.0017366152023896575
subset O 0 0.007148170843720436
of O 0 0.04091799259185791
FAP B-Disease 1 0.9999997615814209
patients O 1 0.9994631409645081
. O 0 0.007593329064548016
. O 0 0.013227264396846294

Wilms B-Disease 1 0.9999784231185913
' I-Disease 1 0.5022085905075073
tumor I-Disease 1 0.9927027225494385
1 O 0 0.01018295157700777
and O 0 0.004964760504662991
Dax O 1 0.9983029365539551
- O 0 0.014117773622274399
1 O 0 0.005376771558076143
modulate O 0 0.007284192834049463
the O 0 0.003636271459981799
orphan O 1 0.6847673058509827
nuclear O 0 0.007646941114217043
receptor O 0 0.008624903857707977
SF O 1 0.979649543762207
- O 0 0.006505295634269714
1 O 0 0.002814911538735032
in O 0 0.002167467027902603
sex O 0 0.004475578665733337
- O 0 0.009024389088153839
specific O 0 0.0035536671057343483
gene O 0 0.007881373167037964
expression O 0 0.01042604073882103
. O 0 0.010638810694217682

Products O 0 0.015560656785964966
of O 0 0.01193230226635933
steroidogenic O 1 0.9991034865379333
factor O 0 0.014675067737698555
1 O 0 0.00795743241906166
( O 0 0.005646407138556242
SF O 1 0.9902593493461609
- O 0 0.006820565555244684
1 O 0 0.0037668843287974596
) O 0 0.0022568884305655956
and O 0 0.0028376898262649775
Wilms B-Disease 1 0.9999935626983643
tumor I-Disease 1 0.9998378753662109
1 O 0 0.009502887725830078
( O 0 0.006012770812958479
WT1 O 1 0.986706554889679
) O 0 0.0020207171328365803
genes O 0 0.0015636092284694314
are O 0 0.0007154198829084635
essential O 0 0.0020804970990866423
for O 0 0.0019288364564999938
mammalian O 0 0.0060465675778687
gonadogenesis O 0 0.021411338821053505
prior O 0 0.004401284269988537
to O 0 0.003295507747679949
sexual O 0 0.01310868002474308
differentiation O 0 0.16773290932178497
. O 0 0.014483828097581863

In O 0 0.007403073366731405
males O 0 0.00850033201277256
, O 0 0.006817623507231474
SF O 1 0.9999357461929321
- O 0 0.13909980654716492
1 O 0 0.004846605472266674
participates O 0 0.004000078421086073
in O 0 0.001666360185481608
sexual O 0 0.002624363638460636
development O 0 0.0021705743856728077
by O 0 0.001352227758616209
regulating O 0 0.0032716202549636364
expression O 0 0.0024322867393493652
of O 0 0.002693335060030222
the O 0 0.011424417607486248
polypeptide O 1 0.9917963743209839
hormone O 1 0.9949911236763
Mullerian O 1 0.999735414981842
inhibiting O 1 0.8677833080291748
substance O 1 0.9667744636535645
( O 0 0.3463749289512634
MIS O 1 0.9996223449707031
) O 0 0.011688259430229664
. O 0 0.011738481000065804

Here O 0 0.011116082780063152
, O 0 0.005022441036999226
we O 0 0.0029341254848986864
show O 0 0.004340679384768009
that O 0 0.003374360268935561
WT1 O 1 0.9931024312973022
- O 0 0.11569725722074509
KTS O 1 0.9706736207008362
isoforms O 0 0.006003222893923521
associate O 0 0.005660214461386204
and O 0 0.0028356611728668213
synergize O 0 0.18810652196407318
with O 0 0.005213107913732529
SF O 1 0.9999816417694092
- O 0 0.15198321640491486
1 O 0 0.005546859465539455
to O 0 0.0033208904787898064
promote O 0 0.011593514122068882
MIS O 1 0.9731112122535706
expression O 0 0.018699880689382553
. O 0 0.014284503646194935

In O 0 0.010276125743985176
contrast O 0 0.01301030907779932
, O 0 0.009173587895929813
WT1 O 1 0.9976995587348938
missense O 0 0.03168485313653946
mutations O 0 0.007107672281563282
, O 0 0.0025174361653625965
associated O 0 0.0025856243446469307
with O 0 0.0021803767886012793
male B-Disease 0 0.009001250378787518
pseudohermaphroditism I-Disease 1 0.9995484948158264
in O 0 0.053085390478372574
Denys B-Disease 1 0.999998927116394
- I-Disease 1 0.9999804496765137
Drash I-Disease 1 0.9999990463256836
syndrome I-Disease 1 1.0
, O 0 0.0059323059394955635
fail O 0 0.005864871200174093
to O 0 0.0025880602188408375
synergize O 1 0.6341439485549927
with O 0 0.006031406577676535
SF O 1 0.9999884366989136
- O 1 0.7347121238708496
1 O 0 0.013085606507956982
. O 0 0.010688209906220436

Additionally O 0 0.014754392206668854
, O 0 0.004648138303309679
the O 0 0.004788536578416824
X O 0 0.03175599128007889
- O 0 0.008549866266548634
linked O 0 0.004803563933819532
, O 0 0.0024006683379411697
candidate O 0 0.004786702338606119
dosage O 0 0.03217382729053497
- O 0 0.005868272390216589
sensitive O 0 0.004551561549305916
sex O 0 0.0045128315687179565
- O 0 0.006465538404881954
reversal O 0 0.007811963092535734
gene O 0 0.003194296732544899
, O 0 0.002546335104852915
Dax O 1 0.9923648834228516
- O 0 0.013289159163832664
1 O 0 0.0038920780643820763
, O 0 0.0024622268974781036
antagonizes O 0 0.01635442115366459
synergy O 0 0.009587164968252182
between O 0 0.003941653296351433
SF O 1 0.9999213218688965
- O 0 0.06537234783172607
1 O 0 0.004162976983934641
and O 0 0.0027766225393861532
WT1 O 1 0.9864687919616699
, O 0 0.0020226940978318453
most O 0 0.001247299020178616
likely O 0 0.0014926452422514558
through O 0 0.0012243716046214104
a O 0 0.0017445674166083336
direct O 0 0.0020280038006603718
interaction O 0 0.003658462781459093
with O 0 0.004715698305517435
SF O 1 0.9998993873596191
- O 0 0.16738948225975037
1 O 0 0.014964871108531952
. O 0 0.011518340557813644

We O 0 0.009820405393838882
propose O 0 0.012315347790718079
that O 0 0.004835573956370354
WT1 O 1 0.9291738867759705
and O 0 0.006241690833121538
Dax O 1 0.9998573064804077
- O 0 0.215767964720726
1 O 0 0.0052611869759857655
functionally O 0 0.006415832322090864
oppose O 0 0.0027874663937836885
each O 0 0.0011516090016812086
other O 0 0.0011753265280276537
in O 0 0.002211717888712883
testis O 0 0.20408545434474945
development O 0 0.003672402584925294
by O 0 0.003886595368385315
modulating O 1 0.9206659197807312
SF O 1 0.9999691247940063
- O 0 0.42901554703712463
1 O 0 0.012212607078254223
- O 0 0.023692557588219643
mediated O 0 0.018223436549305916
transactivation O 0 0.16093139350414276
. O 0 0.009280008263885975
. O 0 0.01456399355083704

A O 0 0.0183081217110157
mouse O 0 0.01587309129536152
model O 0 0.01144656166434288
for O 0 0.012923197820782661
Prader B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999994039535522
- O 1 0.9999531507492065
centre O 1 0.996967613697052
mutations O 0 0.2752920687198639
. O 0 0.016567599028348923

Imprinting O 0 0.031534239649772644
in O 0 0.005306595005095005
the O 0 0.006254160311073065
15q11 O 1 0.994659960269928
- O 1 0.7131996154785156
q13 O 0 0.2174263298511505
region O 0 0.004487417172640562
involves O 0 0.003768846159800887
an O 0 0.0028821108862757683
imprinting O 0 0.0820915699005127
centre O 0 0.018835773691534996
( O 0 0.005692715756595135
IC O 0 0.47322869300842285
) O 0 0.002142164623364806
, O 0 0.0014606855111196637
mapping O 0 0.0021715578623116016
in O 0 0.0011007908033207059
part O 0 0.0016732367221266031
to O 0 0.0013914699666202068
the O 0 0.002343050902709365
promoter O 0 0.016062725335359573
and O 0 0.0026929585728794336
first O 0 0.004737126640975475
exon O 0 0.023260194808244705
of O 0 0.010902276262640953
SNRPN O 1 0.9969610571861267
. O 0 0.01638379506766796

Deletion O 0 0.03258077800273895
of O 0 0.009245116263628006
this O 0 0.0061195008456707
IC O 1 0.9964338541030884
abolishes O 1 0.5376123785972595
local O 0 0.006079060025513172
paternally O 0 0.025382690131664276
derived O 0 0.004419746343046427
gene O 0 0.0032352220732718706
expression O 0 0.0022678205277770758
and O 0 0.0015933886170387268
results O 0 0.002786611672490835
in O 0 0.007596082054078579
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999916553497314
PWS B-Disease 1 1.0
) O 0 0.03772977367043495
. O 0 0.013392067514359951

We O 0 0.006026334594935179
have O 0 0.0023575893137604
created O 0 0.0032720461022108793
two O 0 0.002001011511310935
deletion O 0 0.008278793655335903
mutations O 0 0.0038517280481755733
in O 0 0.0020337579771876335
mice O 0 0.0048483582213521
to O 0 0.0019098503980785608
understand O 0 0.006175394635647535
PWS B-Disease 1 0.9999943971633911
and O 0 0.0024457494728267193
the O 0 0.0029607503674924374
mechanism O 0 0.005905478727072477
of O 0 0.005054615903645754
this O 0 0.005906133446842432
IC O 1 0.989119291305542
. O 0 0.013978767208755016

Mice O 0 0.12300647050142288
harbouring O 1 0.6478089690208435
an O 0 0.008567094802856445
intragenic O 1 0.8740242719650269
deletion O 0 0.022394834086298943
in O 0 0.004145260900259018
Snrpn O 1 0.7515950798988342
are O 0 0.0025221894029527903
phenotypically O 0 0.04572596773505211
normal O 0 0.003368028672412038
, O 0 0.0018330223392695189
suggesting O 0 0.002796631073579192
that O 0 0.0014200452715158463
mutations O 0 0.0024414975196123123
of O 0 0.0027738907374441624
SNRPN O 1 0.9626075625419617
are O 0 0.0015346702421084046
not O 0 0.001780727761797607
sufficient O 0 0.005448855925351381
to O 0 0.005337277892976999
induce O 0 0.0496392697095871
PWS B-Disease 1 0.9999698400497437
. O 0 0.02224210649728775

Mice O 0 0.01861516386270523
with O 0 0.004034061916172504
a O 0 0.004131259862333536
larger O 0 0.0031377533450722694
deletion O 0 0.005987119860947132
involving O 0 0.0032300075981765985
both O 0 0.002038267208263278
Snrpn O 1 0.7591092586517334
and O 0 0.002788781886920333
the O 0 0.008510586805641651
putative O 1 0.9998934268951416
PWS O 1 0.9999998807907104
- O 1 0.9958523511886597
IC O 1 0.9801295399665833
lack O 0 0.005402862560003996
expression O 0 0.00319458544254303
of O 0 0.0021187439560890198
the O 0 0.004086990375071764
imprinted O 0 0.48204654455184937
genes O 0 0.003912823740392923
Zfp127 O 0 0.13302336633205414
( O 0 0.003158838953822851
mouse O 0 0.005009794607758522
homologue O 0 0.00924542173743248
of O 0 0.0032027559354901314
ZNF127 O 1 0.9823280572891235
) O 0 0.003256983356550336
, O 0 0.0029429104179143906
Ndn O 1 0.881186306476593
and O 0 0.0027597525622695684
Ipw O 1 0.6078891754150391
, O 0 0.0027373856864869595
and O 0 0.0021786480210721493
manifest O 0 0.008031543344259262
several O 0 0.0031100858468562365
phenotypes O 0 0.029247133061289787
common O 0 0.008831175044178963
to O 0 0.010992685332894325
PWS B-Disease 1 0.9999996423721313
infants O 1 0.9999094009399414
. O 0 0.020938927307724953

These O 0 0.005049032159149647
data O 0 0.003765445901080966
demonstrate O 0 0.00380259333178401
that O 0 0.0011003221152350307
both O 0 0.001001254771836102
the O 0 0.0012627707328647375
position O 0 0.0017740802140906453
of O 0 0.0016404351918026805
the O 0 0.0031293362844735384
IC O 1 0.9841120839118958
and O 0 0.0015420186100527644
its O 0 0.0011308025568723679
role O 0 0.00151144212577492
in O 0 0.0009637668263167143
the O 0 0.0012970612151548266
coordinate O 0 0.0022685856092721224
expression O 0 0.001883288030512631
of O 0 0.0013790662633255124
genes O 0 0.0014367966214194894
is O 0 0.0010071905562654138
conserved O 0 0.0019618398509919643
between O 0 0.001203805790282786
mouse O 0 0.0028886604122817516
and O 0 0.0012017586268484592
human O 0 0.0018059012945741415
, O 0 0.0013984937686473131
and O 0 0.0012164019281044602
indicate O 0 0.0019137646304443479
that O 0 0.0009850600035861135
the O 0 0.0017694545676931739
mouse O 0 0.003087652614340186
is O 0 0.0012091329554095864
a O 0 0.0013296542456373572
suitable O 0 0.0022448119707405567
model O 0 0.002058263635262847
system O 0 0.0015275287441909313
in O 0 0.0008294089348055422
which O 0 0.0006133345304988325
to O 0 0.0007398368325084448
investigate O 0 0.0019358504796400666
the O 0 0.0013887095265090466
molecular O 0 0.002397914184257388
mechanisms O 0 0.0020562841091305017
of O 0 0.0017438001232221723
imprinting O 0 0.010290641337633133
in O 0 0.001441141706891358
this O 0 0.001149846357293427
region O 0 0.0020057372748851776
of O 0 0.0025260888505727053
the O 0 0.005298249423503876
genome O 0 0.01045969408005476
. O 0 0.005038469564169645
. O 0 0.009886452928185463

Mutations O 0 0.014128157868981361
of O 0 0.0061621577478945255
the O 0 0.006233190186321735
ATM O 0 0.021460430696606636
gene O 0 0.004643840249627829
detected O 0 0.0042318967171013355
in O 0 0.0030392417684197426
Japanese O 1 0.9556945562362671
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999970197677612
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.9991648197174072
: O 0 0.003428896190598607
possible O 0 0.0027163943741470575
preponderance O 0 0.01085036713629961
of O 0 0.0023849098943173885
the O 0 0.002737025497481227
two O 0 0.0023515273351222277
founder O 1 0.8127614855766296
mutations O 0 0.029980624094605446
4612del165 O 0 0.42003411054611206
and O 0 0.007330508437007666
7883del5 O 1 0.6378461122512817
. O 0 0.01683264598250389

The O 0 0.013226281851530075
ATM O 0 0.03231683745980263
( O 0 0.009578398428857327
A O 1 0.5445416569709778
- O 1 0.9797624945640564
T O 1 0.9979604482650757
, O 0 0.0033222667407244444
mutated O 0 0.0077588181011378765
) O 0 0.00246088276617229
gene O 0 0.0028679114766418934
on O 0 0.002875844482332468
human O 0 0.006865250412374735
chromosome O 0 0.01840587519109249
11q22 O 0 0.14334669709205627
. O 0 0.015329556539654732

3 O 0 0.010883842594921589
has O 0 0.00390555988997221
recently O 0 0.004534030798822641
been O 0 0.0020268980879336596
identified O 0 0.002032887190580368
as O 0 0.0013329926878213882
the O 0 0.001320341252721846
gene O 0 0.0013333483366295695
responsible O 0 0.0013688852777704597
for O 0 0.0009600883931852877
the O 0 0.002283031353726983
human O 1 0.7575153112411499
recessive B-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 1 0.9985711574554443
A B-Disease 1 0.9999810457229614
- I-Disease 1 0.9999923706054688
T I-Disease 1 0.9999587535858154
) O 0 0.007230333052575588
. O 0 0.009404491633176804

In O 0 0.007424313109368086
order O 0 0.004051314666867256
to O 0 0.001956431195139885
define O 0 0.002966922242194414
the O 0 0.001975529594346881
types O 0 0.002957759192213416
of O 0 0.4176880717277527
disease O 1 1.0
- O 1 0.9997637867927551
causing O 1 0.976379930973053
ATM O 0 0.08845897763967514
mutations O 0 0.0020286852959543467
in O 0 0.00123655388597399
Japanese O 0 0.015995249152183533
A B-Disease 1 0.9965875148773193
- I-Disease 1 0.9999719858169556
T I-Disease 1 0.999997615814209
patients O 1 0.6608413457870483
as O 0 0.0011854858603328466
well O 0 0.0009120377944782376
as O 0 0.0008573723607696593
to O 0 0.0006926077185198665
look O 0 0.001227364526130259
for O 0 0.0011086304439231753
possible O 0 0.002560082823038101
mutational O 0 0.022281186655163765
hotspots O 0 0.007111357059329748
, O 0 0.0022912758868187666
reverse O 0 0.005213928874582052
- O 0 0.005139001179486513
transcribed O 0 0.005001586861908436
RNA O 0 0.0037075167056173086
derived O 0 0.0018451446667313576
from O 0 0.0015351473120972514
ten O 0 0.002809485187754035
patients O 0 0.0033423826098442078
belonging O 0 0.002282238332554698
to O 0 0.0010700341081246734
eight O 0 0.0016861221520230174
unrelated O 0 0.003939246758818626
Japanese O 0 0.21952661871910095
A B-Disease 1 0.9908850789070129
- I-Disease 1 0.9977487921714783
T I-Disease 1 0.9962852001190186
families O 0 0.0022608302533626556
was O 0 0.0023674455005675554
analyzed O 0 0.002593531273305416
for O 0 0.0014829984866082668
mutations O 0 0.0027901888824999332
by O 0 0.0015940949087962508
the O 0 0.004189617931842804
restriction O 0 0.011491053737699986
endonuclease O 0 0.036590106785297394
fingerprinting O 0 0.019969364628195763
method O 0 0.014832206070423126
. O 0 0.017226172611117363

As O 0 0.008795647881925106
has O 0 0.004795735701918602
been O 0 0.0030320612713694572
reported O 0 0.00315120373852551
by O 0 0.001479739905335009
others O 0 0.0015719217481091619
, O 0 0.0015982806216925383
mutations O 0 0.0019173111068084836
that O 0 0.0009801100241020322
lead O 0 0.0018124018097296357
to O 0 0.0016602883115410805
exon O 0 0.010348116047680378
skipping O 0 0.006657616700977087
or O 0 0.002634915057569742
premature O 0 0.007908264175057411
protein O 0 0.003557816380634904
truncation O 0 0.008689990267157555
were O 0 0.0020399747882038355
also O 0 0.0025000267196446657
predominant O 0 0.006196318659931421
in O 0 0.0032978360541164875
our O 0 0.006329887546598911
mutants O 0 0.031034957617521286
. O 0 0.010870437137782574

Six O 0 0.007612346671521664
different O 0 0.0028600268997251987
mutations O 0 0.004120362922549248
were O 0 0.0015339894453063607
identified O 0 0.0021267274860292673
on O 0 0.0017544873990118504
12 O 0 0.001988929696381092
of O 0 0.0021806766744703054
the O 0 0.0033951131626963615
16 O 0 0.006282317917793989
alleles O 0 0.011636054143309593
examined O 0 0.01511143334209919
. O 0 0.011859098449349403

Four O 0 0.00747394934296608
were O 0 0.004263909999281168
deletions O 0 0.00791755598038435
involving O 0 0.004026499576866627
a O 0 0.00399717316031456
loss O 0 0.01798824407160282
of O 0 0.004010329023003578
a O 0 0.005344958510249853
single O 0 0.0059478310868144035
exon O 0 0.03198007866740227
exon O 0 0.01093212328851223
7 O 0 0.003211261471733451
, O 0 0.0024849725887179375
exon O 0 0.009097171947360039
16 O 0 0.003402761183679104
, O 0 0.002843448892235756
exon O 0 0.012077759951353073
33 O 0 0.006246244069188833
or O 0 0.004581395536661148
exon O 0 0.023053215816617012
35 O 0 0.01242950651794672
. O 0 0.012111430987715721

The O 0 0.010468187741935253
others O 0 0.00559206260368228
were O 0 0.0037826821208000183
minute O 0 0.005368396639823914
deletions O 0 0.008580324240028858
, O 0 0.0031882054172456264
4649delA O 0 0.01394264493137598
in O 0 0.002851964673027396
exon O 0 0.014007815159857273
33 O 0 0.0063904765993356705
and O 0 0.0036150291562080383
7883del5 O 0 0.020474014803767204
in O 0 0.007092169485986233
exon O 0 0.03718676045536995
55 O 0 0.017622509971261024
. O 0 0.015356196090579033

The O 0 0.01257654931396246
mutations O 0 0.009922702796757221
4612del165 O 0 0.03444964811205864
and O 0 0.0034891392569988966
7883del5 O 0 0.05294492840766907
were O 0 0.0015990623505786061
found O 0 0.0013713365187868476
in O 0 0.0008812949527055025
more O 0 0.0006003309390507638
than O 0 0.0005742590874433517
two O 0 0.0006798531976528466
unrelated O 0 0.0019581462256610394
families O 0 0.0012758017983287573
; O 0 0.0011649399530142546
44 O 0 0.0022144513204693794
% O 0 0.0013315026881173253
( O 0 0.0016370221273973584
7 O 0 0.0018170608673244715
of O 0 0.0013493570731952786
16 O 0 0.001988497097045183
) O 0 0.0011382878292351961
of O 0 0.0011954937363043427
the O 0 0.00186717149335891
mutant O 0 0.0059020365588366985
alleles O 0 0.00283964816480875
had O 0 0.0014412475284188986
one O 0 0.0010902523063123226
of O 0 0.0016172203468158841
the O 0 0.0028985277749598026
two O 0 0.0033235710579901934
mutations O 0 0.01269552018493414
. O 0 0.008727540262043476

The O 0 0.01655532605946064
4612del165 O 0 0.06564014405012131
mutations O 0 0.005562621168792248
in O 0 0.00210219225846231
three O 0 0.001368686673231423
different O 0 0.0008758348994888365
families O 0 0.001208707457408309
were O 0 0.0009283538674935699
all O 0 0.0008310322882607579
ascribed O 0 0.0029002095106989145
to O 0 0.0008770335116423666
the O 0 0.001666563330218196
same O 0 0.0026527035515755415
T O 1 0.9961526989936829
- O 0 0.3656430244445801
- O 0 0.011154127307236195
> O 0 0.004657108336687088
A O 0 0.0024289130233228207
substitution O 0 0.0038788660895079374
at O 0 0.00281842821277678
the O 0 0.0037596477195620537
splice O 0 0.01459663175046444
donor O 0 0.007465334143489599
site O 0 0.0066566066816449165
in O 0 0.006421445868909359
intron O 1 0.6028680205345154
33 O 0 0.02334175631403923
. O 0 0.016441991552710533

Microsatellite O 0 0.08712287992238998
genotyping O 0 0.04033065587282181
around O 0 0.008026445284485817
the O 0 0.007072007283568382
ATM O 0 0.04533171281218529
locus O 0 0.015501179732382298
also O 0 0.0028955719899386168
indicated O 0 0.0034569548442959785
that O 0 0.0013168028090149164
a O 0 0.0019400394521653652
common O 0 0.002519708825275302
haplotype O 0 0.0074338666163384914
was O 0 0.003313304390758276
shared O 0 0.002422221004962921
by O 0 0.0015067346394062042
the O 0 0.0030899355188012123
mutant O 0 0.013777988031506538
alleles O 0 0.005064529832452536
in O 0 0.002898555248975754
both O 0 0.004250016063451767
mutations O 0 0.012110398150980473
. O 0 0.010565591976046562

This O 0 0.0069120293483138084
suggests O 0 0.006247182842344046
that O 0 0.0017668335931375623
these O 0 0.001211832626722753
two O 0 0.0015784392599016428
founder O 0 0.0590553916990757
mutations O 0 0.004715065471827984
may O 0 0.002265363000333309
be O 0 0.0015567466616630554
predominant O 0 0.006265127100050449
among O 0 0.0035556312650442123
Japanese O 0 0.22477883100509644
ATM O 0 0.49500808119773865
mutant O 0 0.06494352221488953
alleles O 0 0.0217437744140625
. O 0 0.012371269054710865

W474C O 0 0.2902863025665283
amino O 0 0.01995173469185829
acid O 0 0.06714466214179993
substitution O 0 0.012559860944747925
affects O 0 0.006152021232992411
early O 0 0.002947033615782857
processing O 0 0.0030000326223671436
of O 0 0.0024598620366305113
the O 0 0.0029046419076621532
alpha O 0 0.006438858807086945
- O 0 0.004060558509081602
subunit O 0 0.003630402497947216
of O 0 0.0022031362168490887
beta O 0 0.008521405048668385
- O 0 0.009101196192204952
hexosaminidase O 0 0.022086597979068756
A O 0 0.0028722179122269154
and O 0 0.0015234611928462982
is O 0 0.0018094442784786224
associated O 0 0.002693216083571315
with O 0 0.004145893733948469
subacute O 1 0.9999997615814209
G B-Disease 1 0.9999247789382935
( I-Disease 0 0.22142046689987183
M2 I-Disease 1 0.998847246170044
) I-Disease 0 0.01014686282724142
gangliosidosis I-Disease 0 0.052612412720918655
. O 0 0.013965471647679806

Mutations O 0 0.01756671816110611
in O 0 0.006914507132023573
the O 0 0.0090419240295887
HEXA O 1 0.9997348189353943
gene O 0 0.005949049722403288
, O 0 0.0025451278779655695
encoding O 0 0.0036624781787395477
the O 0 0.0029105336870998144
alpha O 0 0.0060280258767306805
- O 0 0.004318167455494404
subunit O 0 0.004063308704644442
of O 0 0.0028815933037549257
beta O 0 0.007964967750012875
- O 0 0.007192970719188452
hexosaminidase O 0 0.016070211306214333
A O 0 0.0050729806534945965
( O 0 0.003390575759112835
Hex O 0 0.00788238737732172
A O 0 0.0032208184711635113
) O 0 0.001811952330172062
, O 0 0.001337283756583929
that O 0 0.0014297685120254755
abolish O 0 0.0064098890870809555
Hex O 0 0.00917988270521164
A O 0 0.004621739499270916
enzyme O 0 0.0057398066855967045
activity O 0 0.004271259065717459
cause O 1 0.9524162411689758
Tay B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999821186065674
Sachs I-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999997615814209
( O 1 0.5065441727638245
TSD B-Disease 1 0.9999665021896362
) O 0 0.0024809418246150017
, O 0 0.0014316870365291834
the O 0 0.002579684369266033
fatal O 1 0.9995421171188354
infantile B-Disease 1 0.9999935626983643
form I-Disease 0 0.006781960837543011
of I-Disease 1 0.7519638538360596
G I-Disease 1 0.9999544620513916
( I-Disease 0 0.08044707775115967
M2 I-Disease 1 0.9972805976867676
) I-Disease 0 0.003279238473623991
gangliosidosis I-Disease 0 0.024036338552832603
, I-Disease 0 0.0037677879445254803
Type I-Disease 0 0.01142894197255373
1 I-Disease 0 0.011724008247256279
. O 0 0.01003528106957674

Less O 0 0.016441388055682182
severe O 1 0.9991648197174072
, O 0 0.061587538570165634
subacute O 1 0.9999997615814209
( O 1 0.9649072289466858
juvenile O 1 0.9999902248382568
- O 1 0.9993390440940857
onset O 1 0.9999979734420776
) O 0 0.009541826322674751
and O 0 0.007284276653081179
chronic O 1 1.0
( O 1 0.9696122407913208
adult O 1 0.942122220993042
- O 1 0.9985673427581787
onset O 1 0.9999939203262329
) O 0 0.002447372069582343
variants O 0 0.0020855118054896593
are O 0 0.0008457127260044217
characterized O 0 0.0026919343508780003
by O 0 0.0010156468488276005
a O 0 0.0016467001987621188
broad O 0 0.0031256566289812326
spectrum O 0 0.0029152368661016226
of O 0 0.0035682329908013344
clinical O 1 0.9989836812019348
manifestations O 1 0.9988491535186768
and O 0 0.002019536681473255
are O 0 0.0009511172538623214
associated O 0 0.0020491338800638914
with O 0 0.001856491668149829
residual O 0 0.15504783391952515
levels O 0 0.004711454268544912
of O 0 0.004982965532690287
Hex O 0 0.3531379997730255
A O 0 0.012744611129164696
enzyme O 0 0.013718970119953156
activity O 0 0.011955639347434044
. O 0 0.012529140338301659

We O 0 0.00863795168697834
identified O 0 0.006826708558946848
a O 0 0.00807390920817852
1422 O 1 0.9794445037841797
G O 1 0.6756764650344849
- O 0 0.10331906378269196
- O 0 0.0641031488776207
> O 0 0.011371954344213009
C O 0 0.0068930708803236485
( O 0 0.0031292159110307693
amino O 0 0.003463663859292865
acid O 0 0.004931665491312742
W474C O 0 0.008877747692167759
) O 0 0.002009820891544223
substitution O 0 0.0032115941867232323
in O 0 0.0014009486185386777
the O 0 0.0015941876918077469
first O 0 0.0017602157313376665
position O 0 0.002533312886953354
of O 0 0.0020790998823940754
exon O 0 0.007772353012114763
13 O 0 0.0024881812278181314
of O 0 0.0024282822851091623
HEXA O 1 0.9893985986709595
of O 0 0.0028028683736920357
a O 0 0.004048173315823078
non O 0 0.007340418640524149
- O 0 0.010021297261118889
Jewish O 0 0.00504049239680171
proband O 0 0.3246541917324066
who O 0 0.004950538743287325
manifested O 0 0.021532665938138962
a O 0 0.006846179254353046
subacute O 1 0.9999819993972778
variant O 1 0.5813149809837341
of O 0 0.0858331099152565
G B-Disease 1 0.999722421169281
( I-Disease 0 0.12177101522684097
M2 I-Disease 1 0.9984269142150879
) I-Disease 0 0.008718420751392841
gangliosidosis I-Disease 0 0.050156790763139725
. O 0 0.013715887442231178

On O 0 0.01032939925789833
the O 0 0.00799246970564127
second O 0 0.015142186544835567
maternally O 1 0.9725951552391052
inherited O 1 0.9984960556030273
allele O 0 0.008840424939990044
, O 0 0.0022987592965364456
we O 0 0.0015050037764012814
identified O 0 0.0021363897249102592
the O 0 0.0021667915862053633
common O 0 0.12824267148971558
infantile O 1 0.9999998807907104
disease O 1 1.0
- O 1 0.9997661709785461
causing O 1 0.9961434006690979
4 O 0 0.017223555594682693
- O 0 0.022562779486179352
bp O 0 0.008448614738881588
insertion O 0 0.007281683385372162
, O 0 0.0038626512978225946
+ O 0 0.012428687885403633
TATC O 0 0.4103206396102905
1278 O 0 0.3036704361438751
, O 0 0.004551552701741457
in O 0 0.004842940717935562
exon O 0 0.031001660972833633
11 O 0 0.011463737115263939
. O 0 0.01287528220564127

Pulse O 0 0.23069743812084198
- O 0 0.01812739297747612
chase O 0 0.010513592511415482
analysis O 0 0.003884469158947468
using O 0 0.004021213389933109
proband O 0 0.08499059081077576
fibroblasts O 0 0.014430861920118332
revealed O 0 0.005307264160364866
that O 0 0.0017042203107848763
the O 0 0.0029154892545193434
W474C O 0 0.09378182142972946
- O 0 0.006144311744719744
containing O 0 0.004881070926785469
alpha O 0 0.009491951204836369
- O 0 0.0065461331978440285
subunit O 0 0.0062934053130447865
precursor O 0 0.005991151090711355
was O 0 0.0035596631933003664
normally O 0 0.002409969689324498
synthesized O 0 0.003720977110788226
, O 0 0.0012850093189626932
but O 0 0.0010041340719908476
not O 0 0.0010564322583377361
phosphorylated O 0 0.0034577876795083284
or O 0 0.001359101734124124
secreted O 0 0.00279924925416708
, O 0 0.0013299532001838088
and O 0 0.0015560530591756105
the O 0 0.0027301462832838297
mature O 0 0.008873695507645607
lysosomal O 1 0.9992702603340149
alpha O 0 0.08215612173080444
- O 0 0.010721387341618538
subunit O 0 0.006793379317969084
was O 0 0.005902839358896017
not O 0 0.003492878284305334
detected O 0 0.01229105144739151
. O 0 0.010257854126393795

When O 0 0.01134943962097168
the O 0 0.008105156943202019
W474C O 0 0.05938764289021492
- O 0 0.011395266279578209
containing O 0 0.007045164238661528
alpha O 0 0.011590974405407906
- O 0 0.007563963998109102
subunit O 0 0.0066179693676531315
was O 0 0.005569621454924345
transiently O 0 0.014501945115625858
co O 0 0.01060511451214552
- O 0 0.005066553130745888
expressed O 0 0.002840727102011442
with O 0 0.001396315055899322
the O 0 0.002455163048580289
beta O 0 0.005997156724333763
- O 0 0.00363893317990005
subunit O 0 0.0026760967448353767
to O 0 0.0009412217768840492
produce O 0 0.001518038916401565
Hex O 0 0.005779788829386234
A O 0 0.003145330585539341
( O 0 0.0027178737800568342
alphabeta O 0 0.008306818082928658
) O 0 0.0018519324949011207
in O 0 0.0022799507714807987
COS O 1 0.999873161315918
- O 0 0.0077539775520563126
7 O 0 0.0031319388654083014
cells O 0 0.0019229586469009519
, O 0 0.0012729784939438105
the O 0 0.0017570038326084614
mature O 0 0.003940960392355919
alpha O 0 0.006184599362313747
- O 0 0.003856755793094635
subunit O 0 0.0036995678674429655
was O 0 0.0026795121375471354
present O 0 0.001351423212327063
, O 0 0.0011020251549780369
but O 0 0.0008089792099781334
its O 0 0.0009001335129141808
level O 0 0.001620573690161109
was O 0 0.0020851355511695147
much O 0 0.0011976263485848904
lower O 0 0.0014804686652496457
than O 0 0.0006589684053324163
that O 0 0.0006343116401694715
from O 0 0.0010360073065385222
normal O 0 0.002357425633817911
alpha O 0 0.004762105643749237
- O 0 0.00377579010091722
subunit O 0 0.0040462324395775795
transfections O 0 0.0066537074744701385
, O 0 0.0013752536615356803
although O 0 0.0011557163670659065
higher O 0 0.0012526093050837517
than O 0 0.0006406914326362312
in O 0 0.0008102699066512287
those O 0 0.0011007634457200766
cells O 0 0.0026086261495947838
transfected O 0 0.007839743047952652
with O 0 0.0015464158495888114
an O 0 0.002152768662199378
alpha O 0 0.010111674666404724
- O 0 0.0073155895806849
subunit O 0 0.008200310170650482
associated O 0 0.005973248276859522
with O 0 0.007464126218110323
infantile O 1 0.9999840259552002
TSD B-Disease 1 0.9999837875366211
. O 0 0.028982041403651237

Furthermore O 0 0.016825033351778984
, O 0 0.0055268001742661
the O 0 0.0039589726366102695
precursor O 0 0.0065530273132026196
level O 0 0.0032681310549378395
of O 0 0.002684264210984111
the O 0 0.004533877596259117
W474C O 1 0.7623817920684814
alpha O 0 0.01567969098687172
- O 0 0.00635914271697402
subunit O 0 0.004377428907901049
was O 0 0.002561969216912985
found O 0 0.0012851879000663757
to O 0 0.0011356435716152191
accumulate O 0 0.002579881576821208
in O 0 0.0010627845767885447
comparison O 0 0.0017384610837325454
to O 0 0.0011046353029087186
the O 0 0.0020560570992529392
normal O 0 0.0043692821636796
alpha O 0 0.009841580875217915
- O 0 0.009283779188990593
subunit O 0 0.01351040881127119
precursor O 0 0.019042911008000374
levels O 0 0.01525195874273777
. O 0 0.014011330902576447

We O 0 0.007030038628727198
conclude O 0 0.007366194389760494
that O 0 0.002569684525951743
the O 0 0.00414713378995657
1422 O 1 0.992215096950531
G O 1 0.9155142307281494
- O 0 0.17007438838481903
- O 0 0.05980953946709633
> O 0 0.011846895329654217
C O 0 0.007525595836341381
mutation O 0 0.0031779694836586714
is O 0 0.0013625685824081302
the O 0 0.0015759803354740143
cause O 0 0.004585694056004286
of O 0 0.009957295842468739
Hex B-Disease 1 0.9993069171905518
A I-Disease 1 0.9977194666862488
enzyme I-Disease 1 0.9999121427536011
deficiency I-Disease 1 0.9999997615814209
in O 0 0.0073690228164196014
the O 0 0.09789633005857468
proband O 1 0.9989136457443237
. O 0 0.018773434683680534

The O 0 0.013894451782107353
resulting O 0 0.01465317141264677
W474C O 0 0.18224595487117767
substitution O 0 0.012853912077844143
clearly O 0 0.006062275264412165
interferes O 0 0.008753403089940548
with O 0 0.0025222734548151493
alpha O 0 0.008845853619277477
- O 0 0.0048393020406365395
subunit O 0 0.004041139502078295
processing O 0 0.0025424782652407885
, O 0 0.001404847833327949
but O 0 0.0009286671411246061
because O 0 0.0008602781454101205
the O 0 0.0013501907233148813
base O 0 0.0024993866682052612
substitution O 0 0.0038684424944221973
falls O 0 0.004559200722724199
at O 0 0.0016733721131458879
the O 0 0.001383250462822616
first O 0 0.001272460911422968
position O 0 0.0017260898603126407
of O 0 0.0020108637399971485
exon O 0 0.00975267868489027
13 O 0 0.002504773437976837
, O 0 0.001981558511033654
aberrant O 0 0.006881727371364832
splicing O 0 0.0045133777894079685
may O 0 0.0017625248292461038
also O 0 0.001438966835848987
contribute O 0 0.0024700395297259092
to O 0 0.0021500824950635433
Hex B-Disease 0 0.11353849619626999
A I-Disease 0 0.2807847261428833
deficiency I-Disease 1 0.9999970197677612
in O 0 0.003971660044044256
this O 0 0.0041460744105279446
proband O 1 0.9385157823562622
. O 0 0.005715448874980211
. O 0 0.011037602089345455

Two O 0 0.00970323383808136
frequent O 0 0.01769997365772724
missense O 0 0.10808730870485306
mutations O 0 0.06706340610980988
in O 0 0.45607462525367737
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 1 0.9423816204071045

Pendred B-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
is O 1 0.937029242515564
an O 1 0.9988686442375183
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999998807907104
by O 1 0.9995655417442322
early O 1 0.9999942779541016
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999958276748657
goiter B-Disease 1 1.0
. O 1 0.9882586002349854

A O 0 0.010840151458978653
century O 0 0.007268528454005718
after O 0 0.003790265182033181
its O 0 0.0020843863021582365
recognition O 0 0.0030422138515859842
as O 0 0.002433114219456911
a O 0 0.04454345256090164
syndrome O 1 0.9999997615814209
by O 0 0.004013726953417063
Vaughan O 1 0.898981511592865
Pendred O 1 0.8874644041061401
, O 0 0.002705718157812953
the O 0 0.005770321004092693
disease O 1 0.9999955892562866
gene O 0 0.011502865701913834
( O 0 0.005610031075775623
PDS O 1 0.9983534812927246
) O 0 0.002187613630667329
was O 0 0.002870317781344056
mapped O 0 0.004404838662594557
to O 0 0.0026566716842353344
chromosome O 0 0.011356530711054802
7q22 O 0 0.31208160519599915
- O 0 0.0882953330874443
q31 O 0 0.20834144949913025
. O 0 0.019661106169223785

1 O 0 0.013392824679613113
and O 0 0.004307785537093878
, O 0 0.0037227377761155367
recently O 0 0.0043043713085353374
, O 0 0.0024887435138225555
found O 0 0.002256806707009673
to O 0 0.0021339301019906998
encode O 0 0.006954327691346407
a O 0 0.008580777794122696
putative O 1 0.8594351410865784
sulfate O 1 0.9994695782661438
transporter O 1 0.9547275900840759
. O 0 0.021247589960694313

We O 0 0.007348267361521721
performed O 0 0.006333145312964916
mutation O 0 0.004611730109900236
analysis O 0 0.002272379118949175
of O 0 0.0024575584102422
the O 0 0.005899944342672825
PDS B-Disease 1 0.9999903440475464
gene O 0 0.004584590904414654
in O 0 0.002035506535321474
patients O 0 0.025068499147892
from O 0 0.0018540376331657171
14 O 0 0.0032141506671905518
Pendred B-Disease 0 0.08085200935602188
families O 0 0.002127065323293209
originating O 0 0.0023859108332544565
from O 0 0.0013559652725234628
seven O 0 0.0017987543251365423
countries O 0 0.0012884788447991014
and O 0 0.0019542824011296034
identified O 0 0.004244538489729166
all O 0 0.003403681330382824
mutations O 0 0.01150154322385788
. O 0 0.009402098134160042

The O 0 0.01061199139803648
mutations O 0 0.00638570636510849
include O 0 0.0032633135560899973
three O 0 0.00219027535058558
single O 0 0.00311490660533309
base O 0 0.003837436670437455
deletions O 0 0.00538257323205471
, O 0 0.001909435959532857
one O 0 0.002292262390255928
splice O 0 0.00847745593637228
site O 0 0.004701749421656132
mutation O 0 0.005011240020394325
and O 0 0.0025442384649068117
10 O 0 0.006193165667355061
missense O 0 0.02575175277888775
mutations O 0 0.015470110811293125
. O 0 0.011910631321370602

One O 0 0.01037640031427145
missense O 0 0.028023675084114075
mutation O 0 0.014099156484007835
( O 0 0.00683635612949729
L236P O 0 0.2198668271303177
) O 0 0.0026613466907292604
was O 0 0.0027140064630657434
found O 0 0.001475795404985547
in O 0 0.001084269373677671
a O 0 0.001487797824665904
homozygous O 0 0.002257194137200713
state O 0 0.000858486513607204
in O 0 0.0007454504957422614
two O 0 0.0008637765422463417
consanguineous O 0 0.09805524349212646
families O 0 0.0015513143735006452
and O 0 0.0010312815429642797
in O 0 0.001105122733861208
a O 0 0.0015907501801848412
heterozygous O 0 0.002081621438264847
state O 0 0.0008188078063540161
in O 0 0.000862886430695653
five O 0 0.0012848770711570978
additional O 0 0.0024067021440714598
non O 0 0.006231578066945076
- O 0 0.040881600230932236
consanguineous O 0 0.1963634490966797
families O 0 0.010125000961124897
. O 0 0.011470776982605457

Another O 0 0.013605915941298008
missense O 0 0.02741796150803566
mutation O 0 0.011957627721130848
( O 0 0.005902193486690521
T416P O 0 0.1566818505525589
) O 0 0.0022454860154539347
was O 0 0.002393861999735236
found O 0 0.0011750791454687715
in O 0 0.0010759301949292421
a O 0 0.001578566269017756
homozygous O 0 0.002345704473555088
state O 0 0.0008178852731361985
in O 0 0.0007120088557712734
one O 0 0.0009554055868647993
family O 0 0.0015917608980089426
and O 0 0.0008891187608242035
in O 0 0.0011307067470625043
a O 0 0.0018549433443695307
heterozygous O 0 0.0028803893364965916
state O 0 0.0014852554304525256
in O 0 0.002000244800001383
four O 0 0.0033007117453962564
families O 0 0.006496961694210768
. O 0 0.009621653705835342

Pendred B-Disease 1 0.8875760436058044
patients O 0 0.029943959787487984
in O 0 0.0034746890887618065
three O 0 0.002821439877152443
non O 0 0.0126265250146389
- O 0 0.42200708389282227
consanguineous O 0 0.4398713707923889
families O 0 0.0027581441681832075
were O 0 0.0016648361925035715
shown O 0 0.0017042778199538589
to O 0 0.0011121840216219425
be O 0 0.001472880714572966
compound O 0 0.005334559828042984
heterozygotes O 0 0.021002262830734253
for O 0 0.0036270152777433395
L236P O 0 0.38011646270751953
and O 0 0.00770067423582077
T416P O 0 0.31553488969802856
. O 0 0.018446248024702072

In O 0 0.006617667619138956
total O 0 0.004408415872603655
, O 0 0.0022621038369834423
one O 0 0.001334874308668077
or O 0 0.0010726102627813816
both O 0 0.0007392434636130929
of O 0 0.0011138827539980412
these O 0 0.0008037725929170847
mutations O 0 0.0015454215463250875
were O 0 0.0008328833500854671
found O 0 0.0009961548494175076
in O 0 0.0009337367373518646
nine O 0 0.0012627647956833243
of O 0 0.0015978090232238173
the O 0 0.0028051745612174273
14 O 0 0.0040003275498747826
families O 0 0.0039054688531905413
analyzed O 0 0.00996468961238861
. O 0 0.008309355936944485

The O 0 0.007817346602678299
identification O 0 0.0051659466698765755
of O 0 0.0031526407692581415
two O 0 0.002657913835719228
frequent O 0 0.11919185519218445
PDS B-Disease 1 0.9999520778656006
mutations O 0 0.00464977091178298
will O 0 0.0014618473360314965
facilitate O 0 0.003069284139201045
the O 0 0.0031723042484372854
molecular O 0 0.015359599143266678
diagnosis O 1 0.9996843338012695
of O 1 0.988241970539093
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 1 0.5100653767585754

Insertional O 1 0.7972689270973206
mutation O 0 0.018347449600696564
by O 0 0.005500875413417816
transposable O 1 0.709474503993988
element O 0 0.01300270576030016
, O 0 0.0055484590120613575
L1 O 0 0.3022850751876831
, O 0 0.0028286261949688196
in O 0 0.002941913204267621
the O 0 0.005654556676745415
DMD B-Disease 1 0.9999854564666748
gene O 0 0.00449985358864069
results O 0 0.003105276031419635
in O 0 0.003980623558163643
X B-Disease 1 0.8590814471244812
- I-Disease 1 0.9772262573242188
linked I-Disease 1 0.9882469773292542
dilated I-Disease 1 0.9999896287918091
cardiomyopathy I-Disease 1 1.0
. O 0 0.2955150604248047

X B-Disease 1 0.5513790249824524
- I-Disease 1 0.9026991128921509
linked I-Disease 1 0.9895533323287964
dilated I-Disease 1 0.999996542930603
cardiomyopathy I-Disease 1 1.0
( O 1 0.9977536797523499
XLDCM B-Disease 1 0.9999924898147583
) O 0 0.0035727457143366337
is O 0 0.002020928543061018
a O 0 0.0024680066853761673
clinical O 1 0.6725921034812927
phenotype O 0 0.024713650345802307
of O 0 0.0037954358849674463
dystrophinopathy B-Disease 1 0.9935581088066101
which O 0 0.001605143304914236
is O 0 0.002208138583227992
characterized O 0 0.039812907576560974
by O 0 0.0027626464143395424
preferential O 1 0.9631736874580383
myocardial B-Disease 1 0.9999997615814209
involvement I-Disease 1 0.5619665384292603
without O 0 0.002669850131496787
any O 0 0.0026151910424232483
overt O 0 0.04816257953643799
clinical O 1 0.9978302121162415
signs O 1 0.9988628625869751
of O 1 0.9998778104782104
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9300211071968079

To O 0 0.0067082783207297325
date O 0 0.0047491081058979034
, O 0 0.0023415526375174522
several O 0 0.001656877575442195
mutations O 0 0.003152711084112525
in O 0 0.0026009553112089634
the O 1 0.8557747006416321
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9983483552932739
, O 1 0.6075094938278198
DMD O 1 0.9999991655349731
, O 0 0.0019597031641751528
have O 0 0.000977790099568665
been O 0 0.0011052627814933658
identified O 0 0.001644997508265078
in O 0 0.00137801852542907
patients O 0 0.37507200241088867
with O 0 0.002362974686548114
XLDCM B-Disease 1 0.999962568283081
, O 0 0.002140544354915619
but O 0 0.0010961926309391856
a O 0 0.0015066383639350533
pathogenic O 0 0.003416246036067605
correlation O 0 0.0018531705718487501
of O 0 0.0011507761664688587
these O 0 0.0011092177592217922
cardiospecific O 0 0.2875352203845978
mutations O 0 0.0038777184672653675
in O 0 0.002856100909411907
DMD O 1 0.999968409538269
with O 0 0.0025539009366184473
the O 0 0.026785610243678093
XLDCM B-Disease 1 0.9999827146530151
phenotype O 0 0.2265445739030838
has O 0 0.0026326405350118876
remained O 0 0.005439465865492821
to O 0 0.003003868740051985
be O 0 0.0048692794516682625
elucidated O 0 0.03911558911204338
. O 0 0.01217279676347971

We O 0 0.008011724799871445
report O 0 0.00589907169342041
here O 0 0.0033336575143039227
the O 0 0.002442542929202318
identification O 0 0.0031736930832266808
of O 0 0.002403251826763153
a O 0 0.0029849864076822996
unique O 0 0.003910062834620476
de O 0 0.016818495467305183
novo O 0 0.16443376243114471
L1 O 0 0.2796610891819
insertion O 0 0.0075022149831056595
in O 0 0.0021754377521574497
the O 0 0.003418438835069537
muscle O 1 0.6523732542991638
exon O 0 0.102662093937397
1 O 0 0.003672317136079073
in O 0 0.0023092248011380434
DMD O 1 0.999640703201294
in O 0 0.0024571993853896856
three O 0 0.003107309341430664
XLDCM B-Disease 1 0.9994010925292969
patients O 0 0.04980776458978653
from O 0 0.002122228965163231
two O 0 0.0020501366816461086
unrelated O 0 0.010736123658716679
Japanese O 0 0.05930786579847336
families O 0 0.010352736338973045
. O 0 0.011746637523174286

The O 0 0.010053022764623165
insertion O 0 0.01496610976755619
was O 0 0.006728761829435825
a O 0 0.004027100279927254
5 O 0 0.0046711754985153675
- O 0 0.00659938994795084
truncated O 0 0.006187235005199909
form O 0 0.001864626188762486
of O 0 0.002503803698346019
human O 0 0.005032727029174566
L1 O 1 0.6834027767181396
inversely O 0 0.005748130846768618
integrated O 0 0.0036165094934403896
in O 0 0.0016931761056184769
the O 0 0.002626411383971572
5 O 0 0.0037513806018978357
- O 0 0.005405463743954897
untranslated O 0 0.008497183211147785
region O 0 0.0025430829264223576
in O 0 0.001784493331797421
the O 0 0.0030328973662108183
muscle O 1 0.6514174938201904
exon O 0 0.10443561524152756
1 O 0 0.003074456239119172
, O 0 0.0012902483576908708
which O 0 0.001060260459780693
affected O 0 0.001725816517136991
the O 0 0.0015938824508339167
transcription O 0 0.0029117048252373934
or O 0 0.0011704597854986787
the O 0 0.0013837715378031135
stability O 0 0.003618720220401883
of O 0 0.0025233100168406963
the O 0 0.02400285378098488
muscle O 1 0.9711196422576904
form O 0 0.0027433764189481735
of O 0 0.009465180337429047
dystrophin O 1 0.9780275821685791
transcripts O 0 0.0032866999972611666
but O 0 0.000927813642192632
not O 0 0.0005598926218226552
that O 0 0.0006132058915682137
of O 0 0.0012844554148614407
the O 0 0.0038619174156337976
brain O 1 0.9927729964256287
or O 0 0.004237627610564232
Purkinje O 1 0.999645471572876
cell O 0 0.013601412065327168
form O 0 0.002406714716926217
, O 0 0.0019438808085396886
probably O 0 0.001954943174496293
due O 0 0.0016542925732210279
to O 0 0.0011230551172047853
its O 0 0.001320156967267394
unique O 0 0.002163412980735302
site O 0 0.0035431969445198774
of O 0 0.004425079096108675
integration O 0 0.014608129858970642
. O 0 0.010631624609231949

We O 0 0.008165373466908932
speculate O 0 0.007128823548555374
that O 0 0.0020278438460081816
this O 0 0.0016517838230356574
insertion O 0 0.004424266051501036
of O 0 0.002108997432515025
an O 0 0.003137971041724086
L1 O 1 0.8101642727851868
sequence O 0 0.0031724050641059875
in O 0 0.0027212079148739576
DMD O 1 0.9999842643737793
is O 0 0.0020714171696454287
responsible O 0 0.0020348343532532454
for O 0 0.0009425373282283545
some O 0 0.0007309274515137076
of O 0 0.0009982212213799357
the O 0 0.0015927394852042198
population O 0 0.0014579645358026028
of O 0 0.0023176297545433044
Japanese O 1 0.7105427980422974
patients O 1 0.8835888504981995
with O 0 0.0043639871291816235
XLDCM B-Disease 1 0.9995430707931519
. O 0 0.005631613545119762
. O 0 0.008794889785349369

Severe O 1 0.9995935559272766
early O 1 0.9403796792030334
- O 1 0.9999960660934448
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999898672103882
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999327659606934
red O 1 0.9999997615814209
hair O 1 0.9999994039535522
pigmentation O 1 0.9999995231628418
caused O 1 0.9999209642410278
by O 1 0.5881679058074951
POMC O 1 0.9999990463256836
mutations O 0 0.035858869552612305
in O 0 0.0056038787588477135
humans O 0 0.010107981972396374
. O 0 0.011058988980948925

Sequential O 0 0.02828177995979786
cleavage O 0 0.021205998957157135
of O 0 0.005371856968849897
the O 0 0.005283769220113754
precursor O 0 0.020878005772829056
protein O 0 0.004566285293549299
pre O 0 0.011595798656344414
- O 0 0.029301034286618233
pro O 0 0.013160698115825653
- O 0 0.1254252940416336
opiomelanocortin O 1 0.873892068862915
( O 0 0.007363015320152044
POMC O 1 0.9671233296394348
) O 0 0.0031307628378272057
generates O 0 0.005460002459585667
the O 0 0.004963950719684362
melanocortin O 1 0.7733952403068542
peptides O 0 0.013061659410595894
adrenocorticotrophin O 0 0.2130182683467865
( O 0 0.008783292956650257
ACTH O 1 0.977886438369751
) O 0 0.0036806694697588682
, O 0 0.0042291004210710526
melanocyte O 1 0.9952731728553772
- O 0 0.3302963376045227
stimulating O 1 0.814144492149353
hormones O 1 0.7308489084243774
( O 0 0.013378830626606941
MSH O 1 0.9998767375946045
) O 0 0.004222961142659187
alpha O 0 0.006398813799023628
, O 0 0.0019388286164030433
beta O 0 0.0041732811369001865
and O 0 0.0015955299604684114
gamma O 0 0.0046080960892140865
as O 0 0.001706114737316966
well O 0 0.0016975697362795472
as O 0 0.0022457661107182503
the O 0 0.004750440828502178
opioid O 1 0.9711805582046509
- O 0 0.2396676391363144
receptor O 0 0.01604016311466694
ligand O 0 0.021667661145329475
beta O 0 0.044016800820827484
- O 0 0.3601435124874115
endorphin O 1 0.9471973776817322
. O 0 0.018589625135064125

While O 0 0.008182014338672161
a O 0 0.005345207639038563
few O 0 0.00309036485850811
cases O 0 0.004051966592669487
of O 0 0.054052721709012985
isolated O 1 0.9999737739562988
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.0022267382591962814
been O 0 0.0025760941207408905
reported O 0 0.005773621145635843
( O 0 0.005221668630838394
OMIM O 1 0.9984153509140015
201400 O 0 0.33455216884613037
) O 0 0.0020168223418295383
, O 0 0.0018511093221604824
an O 0 0.0038451547734439373
inherited O 1 0.9999988079071045
POMC O 1 1.0
defect O 1 0.9999885559082031
has O 0 0.003265097737312317
not O 0 0.0013260046252980828
been O 0 0.001889938022941351
described O 0 0.0037748699542135
so O 0 0.002700162585824728
far O 0 0.005079865921288729
. O 0 0.00855912733823061

Recent O 0 0.010974214412271976
studies O 0 0.006109554786235094
in O 0 0.0032004546374082565
animal O 0 0.0051671406254172325
models O 0 0.004149067681282759
elucidated O 0 0.00954072643071413
a O 0 0.002166441176086664
central O 0 0.0027304692193865776
role O 0 0.00256984937004745
of O 0 0.003143865382298827
alpha O 0 0.43805497884750366
- O 0 0.1929973065853119
MSH O 1 0.9892451763153076
in O 0 0.0015656808391213417
the O 0 0.0017021088860929012
regulation O 0 0.0022504946682602167
of O 0 0.0017604317981749773
food O 0 0.004207985009998083
intake O 0 0.005908693186938763
by O 0 0.001406113849952817
activation O 0 0.002704745391383767
of O 0 0.0018148119561374187
the O 0 0.003921631257981062
brain O 1 0.9823358654975891
melanocortin O 1 0.9996957778930664
- O 0 0.04459637776017189
4 O 0 0.004770588595420122
- O 0 0.007090309169143438
receptor O 0 0.005848296917974949
( O 0 0.004192328546196222
MC4 O 1 0.9370396733283997
- O 0 0.007835901342332363
R O 0 0.008850124664604664
; O 0 0.001957460306584835
refs O 0 0.006302772555500269
3 O 0 0.0028826757334172726
- O 0 0.003412381513044238
5 O 0 0.0018976983847096562
) O 0 0.0013329735957086086
and O 0 0.001069500227458775
the O 0 0.0016516721807420254
linkage O 0 0.0049006035551428795
of O 0 0.0025390509981662035
human O 0 0.04976556822657585
obesity B-Disease 1 0.9999736547470093
to O 0 0.0024182030465453863
chromosome O 0 0.0037208283320069313
2 O 0 0.001748298411257565
in O 0 0.0010207161540165544
close O 0 0.0015615849988535047
proximity O 0 0.002162595745176077
to O 0 0.0013432645937427878
the O 0 0.003262590616941452
POMC O 1 0.9997087121009827
locus O 0 0.00929505005478859
, O 0 0.0016872092382982373
led O 0 0.002001014305278659
to O 0 0.0008830656879581511
the O 0 0.0011920006945729256
proposal O 0 0.001839243806898594
of O 0 0.001241958816535771
an O 0 0.001865421305410564
association O 0 0.005965461488813162
of O 0 0.04008897393941879
POMC O 1 0.9999978542327881
with O 0 0.02728082984685898
human O 1 0.9147506356239319
obesity B-Disease 1 0.9999985694885254
. O 0 0.02008654735982418

The O 0 0.009949290193617344
dual O 0 0.011249715462327003
role O 0 0.007338319905102253
of O 0 0.007431513164192438
alpha O 1 0.8840779662132263
- O 1 0.8872410655021667
MSH O 1 0.9995549321174622
in O 0 0.0027808193117380142
regulating O 0 0.005507649388164282
food O 0 0.006453101988881826
intake O 0 0.013113955035805702
and O 0 0.0031271232292056084
influencing O 0 0.018867820501327515
hair O 1 0.9639176726341248
pigmentation O 1 0.999432384967804
predicts O 0 0.030060574412345886
that O 0 0.0014926360454410315
the O 0 0.0027674143202602863
phenotype O 0 0.006498553324490786
associated O 0 0.0016648933524265885
with O 0 0.0011428837897256017
a O 0 0.003627798752859235
defect O 1 0.9924840331077576
in O 0 0.0037457034923136234
POMC O 1 0.9998794794082642
function O 0 0.0027421112172305584
would O 0 0.0016746717737987638
include O 0 0.003267124993726611
obesity B-Disease 1 0.9999935626983643
, O 0 0.0063419342041015625
alteration O 1 0.9724835157394409
in O 0 0.08833842724561691
pigmentation O 1 0.9999985694885254
and O 1 0.9989196062088013
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.15991272032260895

The O 0 0.008414456620812416
observation O 0 0.011247370392084122
of O 0 0.004908162169158459
these O 0 0.0025213018525391817
symptoms O 1 0.9973830580711365
in O 0 0.0022702354472130537
two O 0 0.0017599693965166807
probands O 1 0.8168154358863831
prompted O 0 0.004271788522601128
us O 0 0.0017620902508497238
to O 0 0.0009785485453903675
search O 0 0.0017989116022363305
for O 0 0.0013527508126571774
mutations O 0 0.0027753766626119614
within O 0 0.0023875089827924967
their O 0 0.00390585302375257
POMC O 1 0.9997217059135437
genes O 0 0.014711546711623669
. O 0 0.013522934168577194

Patient O 1 0.8152157068252563
1 O 0 0.009089099243283272
was O 0 0.005305582657456398
found O 0 0.0019418001174926758
to O 0 0.001063002273440361
be O 0 0.0008361038053408265
a O 0 0.0016631584148854017
compound O 0 0.003965538460761309
heterozygote O 0 0.007405032869428396
for O 0 0.0011887780856341124
two O 0 0.001019759802147746
mutations O 0 0.001881000236608088
in O 0 0.0015663987724110484
exon O 0 0.008432682603597641
3 O 0 0.0030628342647105455
( O 0 0.002599522937089205
G7013T O 0 0.008630793541669846
, O 0 0.0026459023356437683
C7133delta O 0 0.07252226769924164
) O 0 0.002116482937708497
which O 0 0.0012113223783671856
interfere O 0 0.0023503575939685106
with O 0 0.0014750731643289328
appropriate O 0 0.003105600830167532
synthesis O 0 0.004784163553267717
of O 0 0.005777901038527489
ACTH O 1 0.9993764758110046
and O 0 0.009139683097600937
alpha O 0 0.32409965991973877
- O 0 0.4954781234264374
MSH O 1 0.9965895414352417
. O 0 0.022054987028241158

Patient O 0 0.35189366340637207
2 O 0 0.00875772349536419
was O 0 0.00580707797780633
homozygous O 0 0.004628593567758799
for O 0 0.001542445970699191
a O 0 0.0023314240388572216
mutation O 0 0.0033445737790316343
in O 0 0.0020179650746285915
exon O 0 0.010457444004714489
2 O 0 0.003750639269128442
( O 0 0.003972435835748911
C3804A O 0 0.018348919227719307
) O 0 0.004270344506949186
which O 0 0.0055864593014121056
abolishes O 0 0.43954944610595703
POMC O 1 0.9989004135131836
translation O 0 0.028281202539801598
. O 0 0.016835913062095642

These O 0 0.006156448274850845
findings O 0 0.005857430398464203
represent O 0 0.0034321537241339684
the O 0 0.0023138688411563635
first O 0 0.0018501562299206853
examples O 0 0.002559577813372016
of O 0 0.002695131581276655
a O 0 0.022755248472094536
genetic B-Disease 1 0.9364351034164429
defect I-Disease 1 0.9997628331184387
within O 0 0.002749677747488022
the O 0 0.03170408308506012
POMC O 1 0.9999865293502808
gene O 0 0.00307289557531476
and O 0 0.0013651923509314656
define O 0 0.002412164816632867
a O 0 0.00265903421677649
new O 0 0.004748872015625238
monogenic B-Disease 1 0.9999963045120239
endocrine I-Disease 1 0.9999971389770508
disorder I-Disease 1 0.9999964237213135
resulting O 1 0.6176610589027405
in O 0 0.05077424272894859
early O 1 0.9913141131401062
- O 1 0.9999957084655762
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999251365661621
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.999731719493866
red O 1 0.999998927116394
hair O 1 0.9999939203262329
pigmentation O 1 0.9999905824661255
. O 0 0.012237528339028358
. O 0 0.014942255802452564

A O 0 0.01558531541377306
European O 0 0.012028899043798447
multicenter O 0 0.3695673942565918
study O 0 0.010932361707091331
of O 0 0.09511126577854156
phenylalanine B-Disease 1 0.9999868869781494
hydroxylase I-Disease 1 0.999983549118042
deficiency I-Disease 1 0.9999998807907104
: O 0 0.006406585685908794
classification O 0 0.011182365007698536
of O 0 0.004645715933293104
105 O 0 0.012330860830843449
mutations O 0 0.00309400400146842
and O 0 0.0012353465426713228
a O 0 0.0016420541796833277
general O 0 0.0028694497887045145
system O 0 0.0024788056034594774
for O 0 0.0019241762347519398
genotype O 0 0.008113257586956024
- O 0 0.00483296811580658
based O 0 0.003604399273172021
prediction O 0 0.011151150800287724
of O 0 0.009013521485030651
metabolic O 1 0.9972448348999023
phenotype O 0 0.46498429775238037
. O 0 0.01588497683405876

Phenylketonuria B-Disease 1 0.9999481439590454
( O 1 0.679165244102478
PKU B-Disease 1 0.999982476234436
) O 0 0.008317014202475548
and O 0 0.005933605134487152
mild B-Disease 1 0.9998846054077148
hyperphenylalaninemia I-Disease 1 0.9999991655349731
( O 1 0.9971154928207397
MHP B-Disease 1 0.9999997615814209
) O 0 0.0042903549037873745
are O 0 0.0023586752358824015
allelic B-Disease 1 0.9898437261581421
disorders I-Disease 1 0.999998927116394
caused O 1 0.9960972666740417
by O 0 0.004013202618807554
mutations O 0 0.004897674545645714
in O 0 0.001941582071594894
the O 0 0.003629598766565323
gene O 0 0.006107565946877003
encoding O 0 0.008793888613581657
phenylalanine O 0 0.07996905595064163
hydroxylase O 1 0.9431072473526001
( O 0 0.08357930928468704
PAH O 1 0.9999808073043823
) O 0 0.016312099993228912
. O 0 0.017422767356038094

Previous O 0 0.010743647813796997
studies O 0 0.005114156287163496
have O 0 0.001949532888829708
suggested O 0 0.0031007418874651194
that O 0 0.001404491951689124
the O 0 0.0024526931811124086
highly O 0 0.00495087169110775
variable O 0 0.008425437845289707
metabolic O 1 0.9844356179237366
phenotypes O 1 0.9664146900177002
of O 1 0.9998260140419006
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.999885082244873
with O 1 0.9844180345535278
PAH O 1 1.0
genotypes O 1 0.9996090531349182
. O 0 0.02532576210796833

We O 0 0.00723554752767086
identified O 0 0.0070059578865766525
both O 0 0.0040649184957146645
causative O 0 0.40563076734542847
mutations O 0 0.006959566380828619
in O 0 0.0038157696835696697
686 O 1 0.9852631092071533
patients O 1 0.6442664861679077
from O 0 0.003221031278371811
seven O 0 0.004695120267570019
European O 0 0.00625759968534112
centers O 0 0.015496348962187767
. O 0 0.012621157802641392

On O 0 0.006452509202063084
the O 0 0.003437585895881057
basis O 0 0.0028089082334190607
of O 0 0.0025204697158187628
the O 0 0.0032719853334128857
phenotypic O 0 0.006555324885994196
characteristics O 0 0.004191954154521227
of O 0 0.0045793126337230206
297 O 1 0.982720673084259
functionally O 1 0.9574223160743713
hemizygous O 1 0.9888160228729248
patients O 0 0.21517716348171234
, O 0 0.0021116193383932114
105 O 0 0.004037682432681322
of O 0 0.0019715249072760344
the O 0 0.0021935978438705206
mutations O 0 0.0021965536288917065
were O 0 0.0011381919030100107
assigned O 0 0.0019055379088968039
to O 0 0.0009053400135599077
one O 0 0.0010389597155153751
of O 0 0.0014030092861503363
four O 0 0.002299700863659382
arbitrary O 0 0.006935714744031429
phenotype O 0 0.014426547102630138
categories O 0 0.011347807012498379
. O 0 0.012458267621695995

We O 0 0.007144209463149309
proposed O 0 0.005404933355748653
and O 0 0.0028655068017542362
tested O 0 0.004433651454746723
a O 0 0.002219580579549074
simple O 0 0.0028861071914434433
model O 0 0.002450736006721854
for O 0 0.0015283884713426232
correlation O 0 0.003956714645028114
between O 0 0.002458990551531315
genotype O 0 0.008342639543116093
and O 0 0.0030472190119326115
phenotypic O 0 0.016045475378632545
outcome O 0 0.012609266676008701
. O 0 0.012119267135858536

The O 0 0.010200539603829384
observed O 0 0.008329261094331741
phenotype O 0 0.010432003997266293
matched O 0 0.004990092944353819
the O 0 0.002923203632235527
predicted O 0 0.00463002547621727
phenotype O 0 0.003813736606389284
in O 0 0.0012159871403127909
79 O 0 0.003390227910131216
% O 0 0.0012097082799300551
of O 0 0.0010342637542635202
the O 0 0.0016431902768090367
cases O 0 0.0019163405522704124
, O 0 0.001014655688777566
and O 0 0.0006668916321359575
in O 0 0.0007102570380084217
only O 0 0.0006319016683846712
5 O 0 0.0009603358921594918
of O 0 0.0011183114256709814
184 O 0 0.010892619378864765
patients O 0 0.05804283916950226
was O 0 0.002441966673359275
the O 0 0.0012569805840030313
observed O 0 0.001695978338830173
phenotype O 0 0.002082566497847438
more O 0 0.0005041758995503187
than O 0 0.0005504789296537638
one O 0 0.0008219420560635626
category O 0 0.0023114217910915613
away O 0 0.001868899678811431
from O 0 0.002100166631862521
that O 0 0.0030277788173407316
expected O 0 0.007571423891931772
. O 0 0.010348712094128132

Among O 0 0.007682011462748051
the O 0 0.004438610747456551
seven O 0 0.0035024513490498066
contributing O 0 0.005521852057427168
centers O 0 0.0033884141594171524
, O 0 0.001710553071461618
the O 0 0.00175578729249537
proportion O 0 0.0027391305193305016
of O 0 0.002434288151562214
patients O 1 0.5920773148536682
for O 0 0.0016360724112018943
whom O 0 0.0024761089589446783
the O 0 0.0017793398583307862
observed O 0 0.0024524563923478127
phenotype O 0 0.0034986590035259724
did O 0 0.0012182268546894193
not O 0 0.0007468832773156464
match O 0 0.0017337258905172348
the O 0 0.0015789708122611046
predicted O 0 0.0034957577008754015
phenotype O 0 0.0038386874366551638
was O 0 0.002357571618631482
4 O 0 0.0020308576058596373
% O 0 0.0014396439073607326
- O 0 0.0026635245885699987
23 O 0 0.0023872116580605507
% O 0 0.0018474620301276445
( O 0 0.0026171181816607714
P O 0 0.010550539009273052
< O 0 0.007440114393830299
. O 0 0.0019390428205952048
0001 O 0 0.01936727948486805
) O 0 0.0017047736328095198
, O 0 0.0015619797632098198
suggesting O 0 0.0017842453671619296
that O 0 0.0007248602341860533
differences O 0 0.0010163591941818595
in O 0 0.000925207685213536
methods O 0 0.0013491411227732897
used O 0 0.0011258331360295415
for O 0 0.0013536560581997037
mutation O 0 0.003434685990214348
detection O 0 0.004128701984882355
or O 0 0.0019380094017833471
phenotype O 0 0.004940262995660305
classification O 0 0.004593226592987776
may O 0 0.001494492869824171
account O 0 0.0012509723892435431
for O 0 0.0008637798018753529
a O 0 0.0016749206697568297
considerable O 0 0.0031394779216498137
proportion O 0 0.004324708599597216
of O 0 0.006128773093223572
genotype O 1 0.892918050289154
- O 1 0.7982247471809387
phenotype O 0 0.08180740475654602
inconsistencies O 0 0.03412870690226555
. O 0 0.015119774267077446

Our O 0 0.0075090317986905575
data O 0 0.00397904310375452
indicate O 0 0.004256086423993111
that O 0 0.0026730261743068695
the O 0 0.008772273547947407
PAH O 1 0.9999998807907104
- O 1 0.8132324814796448
mutation O 0 0.007420448120683432
genotype O 0 0.006208846345543861
is O 0 0.0016262136632576585
the O 0 0.0019624088890850544
main O 0 0.0035898208152502775
determinant O 0 0.029980985447764397
of O 0 0.005865766666829586
metabolic O 1 0.999494194984436
phenotype O 0 0.09430021792650223
in O 0 0.0025543554220348597
most O 0 0.005074395798146725
patients O 1 0.9999880790710449
with O 1 0.9999302625656128
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.8675113916397095

In O 0 0.006414579227566719
the O 0 0.004213751293718815
present O 0 0.003166286274790764
study O 0 0.0024933835957199335
, O 0 0.0015767388977110386
the O 0 0.0019461724441498518
classification O 0 0.006773602217435837
of O 0 0.02957695908844471
105 O 1 0.9991668462753296
PAH O 1 0.9999998807907104
mutations O 0 0.004525657743215561
may O 0 0.001497112214565277
allow O 0 0.001045529730618
the O 0 0.0012703295797109604
prediction O 0 0.0028231064788997173
of O 0 0.0015922078164294362
the O 0 0.00205141119658947
biochemical O 0 0.006233544554561377
phenotype O 0 0.004435367416590452
in O 0 0.0015665980754420161
> O 0 0.0035467171110212803
10 O 0 0.0014107790775597095
, O 0 0.0013987148413434625
000 O 0 0.0038944375701248646
genotypes O 0 0.005695849657058716
, O 0 0.0012251051375642419
which O 0 0.0008918542880564928
may O 0 0.0010367685463279486
be O 0 0.0006769660976715386
useful O 0 0.0011412062449380755
for O 0 0.0011266468791291118
the O 0 0.0017287434311583638
management O 0 0.004965330474078655
of O 0 0.005899210926145315
hyperphenylalaninemia B-Disease 1 0.9997509121894836
in O 0 0.00979595072567463
newborns O 1 0.9900649189949036
. O 0 0.014552021399140358

Somatic O 0 0.050327885895967484
instability O 0 0.024995965883135796
of O 0 0.008402151986956596
the O 0 0.011922311969101429
CTG O 1 0.9994019269943237
repeat O 0 0.01699521765112877
in O 0 0.003108409931883216
mice O 0 0.0071773165836930275
transgenic O 0 0.008185556158423424
for O 0 0.002823461079970002
the O 1 0.8162452578544617
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9851148724555969
is O 0 0.0937223806977272
age O 0 0.10340287536382675
dependent O 0 0.0029033715836703777
but O 0 0.0010293792001903057
not O 0 0.0010364293120801449
correlated O 0 0.0029322123154997826
to O 0 0.0013172451872378588
the O 0 0.002624163869768381
relative O 0 0.0067282323725521564
intertissue O 0 0.297884464263916
transcription O 0 0.01491464301943779
levels O 0 0.012130004353821278
and O 0 0.010637018829584122
proliferative O 1 0.9998399019241333
capacities O 1 0.5919829607009888
. O 0 0.022713977843523026

A O 0 0.021300090476870537
( O 0 0.015324433334171772
CTG O 1 0.986017644405365
) O 0 0.004618714097887278
nexpansion O 0 0.009406096301972866
in O 0 0.002204105956479907
the O 0 0.0031556093599647284
3 O 0 0.004888424649834633
- O 0 0.008695931173861027
untranslated O 0 0.015261012129485607
region O 0 0.0044182706624269485
( O 0 0.0040985881350934505
UTR O 0 0.014435941353440285
) O 0 0.002111590001732111
of O 0 0.0023579124826937914
the O 0 0.006250137463212013
DM O 1 0.999998927116394
protein O 0 0.006067759823054075
kinase O 0 0.007099775597453117
gene O 0 0.003303260076791048
( O 0 0.0029837493784725666
DMPK O 0 0.05287700891494751
) O 0 0.0018745155539363623
is O 0 0.0018204549560323358
responsible O 0 0.004164230544120073
for O 0 0.005963572766631842
causing O 1 0.9999816417694092
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999977350234985
DM B-Disease 1 1.0
) O 0 0.030662477016448975
. O 0 0.015177697874605656

Major O 0 0.14577387273311615
instability O 1 0.9476192593574524
, O 0 0.003651152830570936
with O 0 0.0019070074195042253
very O 0 0.0017794143641367555
large O 0 0.0018316792557016015
expansions O 0 0.003846363862976432
between O 0 0.0014762796927243471
generations O 0 0.002198051894083619
and O 0 0.0012661031214520335
high O 0 0.003457034006714821
levels O 0 0.003167415037751198
of O 0 0.003690516809001565
somatic O 1 0.924118161201477
mosaicism O 1 0.9955117106437683
, O 0 0.002545797498896718
is O 0 0.0021459145937114954
observed O 0 0.0037215810734778643
in O 0 0.003982593305408955
patients O 1 0.5166842937469482
. O 0 0.012748212553560734

There O 0 0.006377536337822676
is O 0 0.003388255136087537
a O 0 0.0026635434478521347
good O 0 0.002524695824831724
correlation O 0 0.00284167961217463
between O 0 0.0015146479709073901
repeat O 0 0.00340938288718462
size O 0 0.0018134138081222773
( O 0 0.0014265356585383415
at O 0 0.0010253717191517353
least O 0 0.0007646643207408488
in O 0 0.0011881237151101232
leucocytes O 0 0.055576078593730927
) O 0 0.00167749950196594
, O 0 0.0017530933255329728
clinical O 0 0.1856347620487213
severity O 1 0.8452189564704895
and O 0 0.003443941241130233
age O 0 0.01655670814216137
of O 0 0.2565665543079376
onset O 1 0.9999967813491821
. O 0 0.03139621019363403

The O 0 0.023882916197180748
trinucleotide O 1 0.9970533847808838
repeat O 0 0.12915606796741486
instability O 0 0.1212785616517067
mechanisms O 0 0.008058530278503895
involved O 0 0.005045425612479448
in O 0 0.006023467052727938
DM B-Disease 1 0.9999996423721313
and O 0 0.0028928827960044146
other O 0 0.002309727016836405
human O 1 0.7458178997039795
genetic B-Disease 1 0.9998793601989746
diseases I-Disease 1 0.9999996423721313
are O 0 0.0050317575223743916
unknown O 0 0.015485631301999092
. O 0 0.011653070338070393

We O 0 0.01105538196861744
studied O 0 0.012674457393586636
somatic O 0 0.019688094034790993
instability O 0 0.015534922480583191
by O 0 0.0032168342731893063
measuring O 0 0.010104356333613396
the O 0 0.005721537861973047
CTG O 1 0.9952249526977539
repeat O 0 0.007165328599512577
length O 0 0.0024222531355917454
at O 0 0.0013645859435200691
several O 0 0.0008016870124265552
ages O 0 0.0014641463058069348
in O 0 0.0009728464647196233
various O 0 0.0012959704035893083
tissues O 0 0.0037236150819808245
of O 0 0.0026184991002082825
transgenic O 0 0.19614624977111816
mice O 0 0.0039011570625007153
carrying O 0 0.002574039390310645
a O 0 0.0025314530357718468
( O 0 0.00409436272457242
CTG O 1 0.9612676501274109
) O 0 0.002668227767571807
55expansion O 0 0.008918562904000282
surrounded O 0 0.004047570284456015
by O 0 0.0014848834834992886
45 O 0 0.0027523597236722708
kb O 0 0.007760147098451853
of O 0 0.00216122530400753
the O 0 0.0037296696100383997
human O 0 0.23096799850463867
DM B-Disease 1 0.9999994039535522
region O 0 0.00435130950063467
, O 0 0.0018175945151597261
using O 0 0.0021517733111977577
small O 0 0.0033226266968995333
- O 0 0.012406473979353905
pool O 0 0.0265185683965683
PCR O 0 0.03503526747226715
. O 0 0.013930429704487324

These O 0 0.007799694314599037
mice O 0 0.011588722467422485
have O 0 0.002145242877304554
been O 0 0.0017145662568509579
shown O 0 0.0018646091921254992
to O 0 0.0012021820293739438
reproduce O 0 0.0022385420743376017
the O 0 0.0019694152288138866
intergenerational O 0 0.08175402879714966
and O 0 0.0020359137561172247
somatic O 0 0.010467623360455036
instability O 0 0.006705467123538256
of O 0 0.002247309312224388
the O 0 0.0036630856338888407
55 O 0 0.008678209967911243
CTG O 1 0.9972746968269348
repeat O 0 0.005983712617307901
suggesting O 0 0.002904593711718917
that O 0 0.0011126460740342736
surrounding O 0 0.001959758810698986
sequences O 0 0.0018209595000371337
and O 0 0.0013370884116739035
the O 0 0.0020697391591966152
chromatin O 0 0.004752420354634523
environment O 0 0.0028774256352335215
are O 0 0.0011285911314189434
involved O 0 0.0031807036139070988
in O 0 0.004452377092093229
instability O 1 0.8036202788352966
mechanisms O 0 0.07028854638338089
. O 0 0.014478247612714767

As O 0 0.005769292823970318
observed O 0 0.003932303749024868
in O 0 0.0016494814772158861
some O 0 0.0010284832678735256
of O 0 0.0016362533206120133
the O 0 0.0035305339843034744
tissues O 1 0.9493464231491089
of O 1 0.9989354014396667
DM B-Disease 1 1.0
patients O 1 0.9999665021896362
, O 0 0.0020494326017796993
there O 0 0.001193222007714212
is O 0 0.0010115813929587603
a O 0 0.0013170745223760605
tendency O 0 0.00249958666972816
for O 0 0.001263837912119925
repeat O 0 0.00483541376888752
length O 0 0.00249088485725224
and O 0 0.0015508050564676523
somatic O 0 0.0087242741137743
mosaicism O 0 0.08597008138895035
to O 0 0.0013126813573762774
increase O 0 0.0015061701415106654
with O 0 0.0011190961813554168
the O 0 0.002033734694123268
age O 0 0.003654979169368744
of O 0 0.004611594136804342
the O 0 0.04945525527000427
mouse O 0 0.03590609133243561
. O 0 0.012309693731367588

Furthermore O 0 0.014949234202504158
, O 0 0.0045344955287873745
we O 0 0.0024635836016386747
observed O 0 0.002337464364245534
no O 0 0.0017366838874295354
correlation O 0 0.002377548022195697
between O 0 0.001317946589551866
the O 0 0.002219374757260084
somatic O 0 0.0187542624771595
mutation O 0 0.0068348478525877
rate O 0 0.005591935012489557
and O 0 0.004726921673864126
tissue O 1 0.9392662048339844
proliferation O 0 0.41311249136924744
capacity O 0 0.01940304785966873
. O 0 0.012275101616978645

The O 0 0.017743004485964775
somatic O 0 0.1635497361421585
mutation O 0 0.009292722679674625
rates O 0 0.0041106692515313625
in O 0 0.0017235217383131385
different O 0 0.0013405755162239075
tissues O 0 0.004036400001496077
were O 0 0.0014307000674307346
also O 0 0.0012662308290600777
not O 0 0.0008017248474061489
correlated O 0 0.001889011706225574
to O 0 0.0008167403866536915
the O 0 0.0014729585964232683
relative O 0 0.004034511744976044
inter O 0 0.3795420229434967
- O 0 0.4100252091884613
tissue O 0 0.02608824521303177
difference O 0 0.0024630913976579905
in O 0 0.0013448161771520972
transcriptional O 0 0.003875819966197014
levels O 0 0.0017882362008094788
of O 0 0.0011115025263279676
the O 0 0.001212672214023769
three O 0 0.001191235613077879
genes O 0 0.0024737557396292686
( O 0 0.0025563461240381002
DMAHP O 0 0.4674067199230194
, O 0 0.0022291215136647224
DMPK O 0 0.20276035368442535
and O 0 0.001920855836942792
59 O 0 0.004427686799317598
) O 0 0.001860025804489851
surrounding O 0 0.003007591003552079
the O 0 0.0036166298668831587
repeat O 0 0.02186325006186962
. O 0 0.0050964029505848885
. O 0 0.009326017461717129

A O 0 0.021853752434253693
novel O 0 0.02243805304169655
missense O 0 0.051274772733449936
mutation O 0 0.011285534128546715
in O 0 0.0037472983822226524
patients O 0 0.3447614908218384
from O 0 0.003090774407610297
a O 0 0.007052537053823471
retinoblastoma B-Disease 1 0.9994722008705139
pedigree O 0 0.3768153786659241
showing O 0 0.006572880782186985
only O 0 0.002817785134539008
mild O 0 0.3956408202648163
expression O 0 0.0049116890877485275
of O 0 0.008222624659538269
the O 1 0.9303062558174133
tumor B-Disease 1 0.9999982118606567
phenotype O 1 0.9155694246292114
. O 0 0.013741410337388515

We O 0 0.006116769276559353
have O 0 0.0028041412588208914
used O 0 0.003081776900216937
single O 0 0.004219593480229378
strand O 0 0.006505677942186594
conformation O 0 0.006020830478519201
polymorphism O 0 0.004634035751223564
analysis O 0 0.0020824444945901632
to O 0 0.0011425464181229472
study O 0 0.0018038825364783406
the O 0 0.0018749741138890386
27 O 0 0.0030694487504661083
exons O 0 0.004428283777087927
of O 0 0.002447158796712756
the O 0 0.005296636372804642
RB1 O 1 0.998292863368988
gene O 0 0.002581051317974925
in O 0 0.001144137466326356
individuals O 0 0.000910468865185976
from O 0 0.001132554025389254
a O 0 0.002103901468217373
family O 0 0.004720157012343407
showing O 0 0.01230521872639656
mild O 1 0.8958621025085449
expression O 0 0.005142903421074152
of O 0 0.007991025224328041
the O 0 0.4075809717178345
retinoblastoma B-Disease 1 0.9999477863311768
phenotype O 1 0.6353734135627747
. O 0 0.016246091574430466

In O 0 0.00781345646828413
this O 0 0.003611084073781967
family O 0 0.006040613166987896
affected O 0 0.005039235111325979
individuals O 0 0.0025119842030107975
developed O 0 0.3048870265483856
unilateral B-Disease 1 0.9929344654083252
tumors I-Disease 1 0.9999991655349731
and O 0 0.0038367346860468388
, O 0 0.0019575757905840874
as O 0 0.0011745928786695004
a O 0 0.00140048423781991
result O 0 0.001530613866634667
of O 0 0.0018090395024046302
linkage O 0 0.00734329130500555
analysis O 0 0.002180864568799734
, O 0 0.002442889381200075
unaffected O 0 0.012657088227570057
mutation O 0 0.004251640290021896
carriers O 0 0.003055350622162223
were O 0 0.0016713355435058475
also O 0 0.0018875864334404469
identified O 0 0.003016751492395997
within O 0 0.002884361892938614
the O 0 0.007055662106722593
pedigree O 0 0.11057206988334656
. O 0 0.014198090881109238

A O 0 0.01415762398391962
single O 0 0.008466316387057304
band O 0 0.007340223528444767
shift O 0 0.005355461500585079
using O 0 0.003405388444662094
SSCP O 0 0.3878384828567505
was O 0 0.005516583565622568
identified O 0 0.003316615941002965
in O 0 0.002180239884182811
exon O 0 0.010453005321323872
21 O 0 0.0029603480361402035
which O 0 0.0013890272239223123
resulted O 0 0.0028976870235055685
in O 0 0.0016433954006060958
a O 0 0.0029876299668103456
missense O 0 0.008455068804323673
mutation O 0 0.0044578141532838345
converting O 0 0.005188607610762119
a O 0 0.005215047392994165
cys O 1 0.9988448619842529
- O 1 0.764237105846405
- O 0 0.10956573486328125
> O 0 0.011476383544504642
arg O 0 0.013405109755694866
at O 0 0.003167529357597232
nucleotide O 0 0.0037067632656544447
position O 0 0.002836340805515647
28 O 0 0.0029739041347056627
in O 0 0.0024683657102286816
the O 0 0.005962131079286337
exon O 0 0.04178681969642639
. O 0 0.013290380127727985

The O 0 0.020940672606229782
mutation O 0 0.02226918376982212
destroyed O 0 0.02099018543958664
an O 0 0.009187910705804825
NdeI O 1 0.9409809708595276
restriction O 0 0.023162364959716797
enzyme O 0 0.018429143354296684
site O 0 0.01508319191634655
. O 0 0.015534434467554092

Analysis O 0 0.007450534030795097
of O 0 0.004096782300621271
all O 0 0.0023491783067584038
family O 0 0.003524139989167452
members O 0 0.0016291893552988768
demonstrated O 0 0.0027833236381411552
that O 0 0.0011777853360399604
the O 0 0.0020940096583217382
missense O 0 0.011676082387566566
mutation O 0 0.005316018592566252
co O 0 0.06077371910214424
- O 0 0.05907023698091507
segregated O 0 0.034214381128549576
with O 0 0.002413603011518717
patients O 1 0.996841311454773
with O 0 0.13580204546451569
tumors B-Disease 1 0.9999997615814209
or O 0 0.008335801772773266
who O 0 0.007927179336547852
, O 0 0.0014178891433402896
as O 0 0.0009783878922462463
a O 0 0.0011211043456569314
result O 0 0.001171077718026936
of O 0 0.0015528809744864702
linkage O 0 0.005784980952739716
analysis O 0 0.0015926007181406021
had O 0 0.0016503100050613284
been O 0 0.0015095133567228913
predicted O 0 0.0027526188641786575
to O 0 0.0015049435896798968
carry O 0 0.0031222293619066477
the O 0 0.005387308541685343
predisposing O 0 0.29698747396469116
mutation O 0 0.0213974267244339
. O 0 0.012053290382027626

These O 0 0.00464047584682703
observations O 0 0.004699248820543289
point O 0 0.003864343510940671
to O 0 0.001348255667835474
another O 0 0.0019644799176603556
region O 0 0.002304316032677889
of O 0 0.0024758419021964073
the O 0 0.022048400714993477
RB1 O 1 0.9999234676361084
gene O 0 0.0028244091663509607
where O 0 0.0013840054161846638
mutations O 0 0.001724477857351303
only O 0 0.000763733172789216
modify O 0 0.001967382151633501
the O 0 0.0012791043845936656
function O 0 0.0014757700264453888
of O 0 0.0014824534300714731
the O 0 0.0021507274359464645
gene O 0 0.00194993382319808
and O 0 0.0010367399081587791
raise O 0 0.001763489912264049
important O 0 0.0012114091077819467
questions O 0 0.0014317590976133943
for O 0 0.0012772863265126944
genetic O 0 0.0028962823562324047
counseling O 0 0.005731917917728424
in O 0 0.0011634289985522628
families O 0 0.0014438725775107741
with O 0 0.0012429215712472796
these O 0 0.0014301218325272202
distinctive O 0 0.016056472435593605
phenotypes O 0 0.14200124144554138
. O 0 0.005797307938337326
. O 0 0.009445234201848507

Maternal B-Disease 1 0.9905520677566528
disomy I-Disease 1 0.9970797896385193
and O 1 0.8409222364425659
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9931222796440125
with O 0 0.035970792174339294
gamete O 1 0.9986831545829773
complementation O 1 0.9983987212181091
in O 0 0.002866035560145974
a O 0 0.0031557700131088495
case O 0 0.0035595649387687445
of O 0 0.004125533625483513
familial O 1 0.9989776611328125
translocation O 0 0.2084016650915146
( O 0 0.0031074436847120523
3 O 0 0.0023216158151626587
; O 0 0.0012185112573206425
15 O 0 0.0019821387249976397
) O 0 0.0016480968333780766
( O 0 0.0025441113393753767
p25 O 0 0.013575092889368534
; O 0 0.002787454519420862
q11 O 0 0.012902969494462013
. O 0 0.0033847882878035307
2 O 0 0.006377379409968853
) O 0 0.005907041486352682
. O 0 0.00877393875271082

Maternal B-Disease 1 0.9996203184127808
uniparental I-Disease 1 0.9999922513961792
disomy I-Disease 1 0.999925971031189
( I-Disease 1 0.8043414950370789
UPD I-Disease 1 0.9999850988388062
) I-Disease 0 0.004137697629630566
for I-Disease 0 0.0023074622731655836
chromosome I-Disease 0 0.004073146265000105
15 I-Disease 0 0.0017201785231009126
is O 0 0.001077495515346527
responsible O 0 0.0013775763800367713
for O 0 0.0008205871563404799
an O 0 0.0010339750442653894
estimated O 0 0.0016479211626574397
30 O 0 0.001385688316076994
% O 0 0.0011663162149488926
of O 0 0.0013105451362207532
cases O 0 0.002967637497931719
of O 1 0.9512175917625427
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999934434890747
PWS B-Disease 1 1.0
) O 0 0.03368367999792099
. O 0 0.013408376835286617

We O 0 0.007049725856631994
report O 0 0.004702787380665541
on O 0 0.002390136243775487
an O 0 0.0018026531906798482
unusual O 0 0.002512526698410511
case O 0 0.002913599368184805
of O 0 0.0034360471181571484
maternal B-Disease 1 0.9991914629936218
disomy I-Disease 1 0.9983723759651184
15 I-Disease 0 0.003658709581941366
in O 0 0.0033761358354240656
PWS B-Disease 1 0.9999974966049194
that O 0 0.0011961122509092093
is O 0 0.000980818527750671
most O 0 0.0007133855833671987
consistent O 0 0.0014479276724159718
with O 0 0.0008654241682961583
adjacent O 0 0.002715867478400469
- O 0 0.005170491524040699
1 O 0 0.0020651037339121103
segregation O 0 0.004987184423953295
of O 0 0.001521359197795391
a O 0 0.0032817379105836153
paternal O 1 0.906477689743042
t O 0 0.033777691423892975
( O 0 0.0018211457645520568
3 O 0 0.001708593568764627
; O 0 0.0009976670844480395
15 O 0 0.0013879600446671247
) O 0 0.0014158503618091345
( O 0 0.0020236261188983917
p25 O 0 0.010203061625361443
; O 0 0.0018967079231515527
q11 O 0 0.007033454719930887
. O 0 0.0013995729386806488
2 O 0 0.0021624041255563498
) O 0 0.0013985363766551018
with O 0 0.001300303265452385
simultaneous O 0 0.004213474690914154
maternal O 1 0.970920205116272
meiotic O 1 0.9997352957725525
nondisjunction O 1 0.9801164865493774
for O 0 0.0061198570765554905
chromosome O 0 0.013180268928408623
15 O 0 0.009555011987686157
. O 0 0.01059943251311779

The O 0 0.013493393547832966
patient O 1 0.9551945924758911
( O 0 0.010959690436720848
J O 1 0.8313449621200562
. O 0 0.0023176742251962423
B O 0 0.005507617723196745
. O 0 0.0009497815044596791
) O 0 0.0008454133057966828
, O 0 0.0007491115247830749
a O 0 0.0011525978334248066
17 O 0 0.002007559174671769
- O 0 0.0029649173375219107
year O 0 0.0018278890056535602
- O 0 0.004477472044527531
old O 0 0.006424421910196543
white O 0 0.0052331117913126945
male O 0 0.003995537292212248
with O 0 0.0026396047323942184
PWS B-Disease 1 1.0
, O 0 0.0038062892854213715
was O 0 0.005019185598939657
found O 0 0.0011998803820461035
to O 0 0.0006382663268595934
have O 0 0.0006245521362870932
47 O 0 0.001699340296909213
chromosomes O 0 0.0013839403400197625
with O 0 0.000718971889000386
a O 0 0.0020963794086128473
supernumerary O 1 0.8256381750106812
, O 0 0.002915407298132777
paternal O 0 0.1476212739944458
der O 1 0.8802540302276611
( O 0 0.002481393748894334
15 O 0 0.0018341062823310494
) O 0 0.0011219666339457035
consisting O 0 0.001545818173326552
of O 0 0.0014512091875076294
the O 0 0.002019877079874277
short O 0 0.0034623208921402693
arm O 0 0.03995528817176819
and O 0 0.0013690777122974396
the O 0 0.0030620743054896593
proximal O 1 0.9967977404594421
long O 0 0.010461930185556412
arm O 0 0.07160638272762299
of O 0 0.0030609522946178913
chromosome O 0 0.008408094756305218
15 O 0 0.0024873472284525633
, O 0 0.0027551238890737295
and O 0 0.003804602427408099
distal O 1 0.9975346326828003
chromosome O 1 0.6787040829658508
arm O 1 0.9575890302658081
3p O 1 0.9456400275230408
. O 0 0.016964947804808617

The O 0 0.015761474147439003
t O 0 0.024741172790527344
( O 0 0.005911959335207939
3 O 0 0.0038439640775322914
; O 0 0.0020117920357733965
15 O 0 0.002155377995222807
) O 0 0.0016698064282536507
was O 0 0.0023624482564628124
present O 0 0.0015066440682858229
in O 0 0.0011161759030073881
the O 0 0.0015268318820744753
balanced O 0 0.0022391811944544315
state O 0 0.0013784937327727675
in O 0 0.0013211047044023871
the O 0 0.0037958440370857716
patients O 1 0.9869194626808167
father O 1 0.6844828724861145
and O 0 0.0051683783531188965
a O 0 0.017591973766684532
sister O 1 0.7214838862419128
. O 0 0.012866556644439697

Fluorescent O 0 0.03775440528988838
in O 0 0.009509106166660786
situ O 0 0.03894689679145813
hybridization O 0 0.008620074018836021
analysis O 0 0.003416100051254034
demonstrated O 0 0.004730977118015289
that O 0 0.0021403897553682327
the O 0 0.004178118892014027
PWS B-Disease 1 0.9999912977218628
critical O 0 0.00880846194922924
region O 0 0.004200383089482784
resided O 0 0.007945079356431961
on O 0 0.0019704755395650864
the O 0 0.0025025273207575083
derivative O 0 0.005963391624391079
chromosome O 0 0.0031933707650750875
3 O 0 0.0014426556881517172
and O 0 0.000699165218975395
that O 0 0.0006562321214005351
there O 0 0.0010050298878923059
was O 0 0.002149031264707446
no O 0 0.0015172665007412434
deletion O 0 0.003490286646410823
of O 0 0.002394078066572547
the O 0 0.10018890351057053
PWS B-Disease 1 0.9999996423721313
region O 0 0.004446023143827915
on O 0 0.0018282736418768764
the O 0 0.0022615562193095684
normal O 0 0.0030358373187482357
pair O 0 0.003098871558904648
of O 0 0.003478954778984189
15s O 0 0.44330471754074097
present O 0 0.005859883036464453
in O 0 0.007198802195489407
J O 1 0.9711349010467529
. O 0 0.012884575873613358

B O 0 0.49672314524650574
. O 0 0.04491085931658745

Methylation O 0 0.01758396625518799
analysis O 0 0.007234462536871433
at O 0 0.007165175396949053
exon O 0 0.014605014584958553
alpha O 0 0.00686393678188324
of O 0 0.0025982377119362354
the O 0 0.0028526794631034136
small O 0 0.003472971962764859
nuclear O 0 0.006798677612096071
ribonucleoprotein O 1 0.8414745926856995
- O 0 0.008928650058805943
associated O 0 0.0037308749742805958
polypeptide O 0 0.014979090541601181
N O 0 0.010562293231487274
( O 0 0.005271643400192261
SNRPN O 0 0.3565084934234619
) O 0 0.002715443493798375
gene O 0 0.002580469474196434
showed O 0 0.0023276007268577814
a O 0 0.0017520537367090583
pattern O 0 0.0029400798957794905
characteristic O 0 0.0027284251991659403
of O 0 0.0018669685814529657
only O 0 0.0016057302709668875
the O 0 0.003289217595010996
maternal O 1 0.9104754328727722
chromosome O 0 0.006663900334388018
15 O 0 0.0033408007584512234
in O 0 0.004236800596117973
J O 1 0.914745032787323
. O 0 0.010613513179123402

B O 1 0.5152946710586548
. O 0 0.04999658092856407

Maternal B-Disease 1 0.9990754127502441
disomy I-Disease 1 0.9901965856552124
was O 0 0.09026967734098434
confirmed O 0 0.00791223905980587
by O 0 0.003652026643976569
polymerase O 0 0.010542253963649273
chain O 0 0.006446648854762316
reaction O 0 0.0030031059868633747
analysis O 0 0.00223292363807559
of O 0 0.0025953599251806736
microsatellite O 0 0.013128582388162613
repeats O 0 0.006141979712992907
at O 0 0.0033579629380255938
the O 0 0.0038117878139019012
gamma O 0 0.01814372092485428
- O 0 0.027546782046556473
aminobutyric O 1 0.5239079594612122
acid O 0 0.016450876370072365
receptor O 0 0.01156514510512352
beta3 O 0 0.028740128502249718
subunit O 0 0.014990423806011677
( O 0 0.010755892843008041
GABRB3 O 1 0.6081820130348206
) O 0 0.011132879182696342
locus O 0 0.03849855065345764
. O 0 0.01936318539083004

A O 0 0.021986128762364388
niece O 1 0.9959933757781982
( O 0 0.013012532144784927
B O 0 0.13297595083713531
. O 0 0.0021864043083041906
B O 0 0.005394257139414549
. O 0 0.0009049627115018666
) O 0 0.0009116408182308078
with O 0 0.0006743193953298032
45 O 0 0.00138667447026819
chromosomes O 0 0.0015572061529383063
and O 0 0.0007553602918051183
the O 0 0.0012867114273831248
derivative O 0 0.002851206576451659
3 O 0 0.0014113561483100057
but O 0 0.0007918460760265589
without O 0 0.0009349883766844869
the O 0 0.0017459298251196742
der O 1 0.7916858196258545
( O 0 0.002372397342696786
15 O 0 0.0020079833921045065
) O 0 0.0015748117584735155
demonstrated O 0 0.0027181447949260473
a O 0 0.002287308219820261
phenotype O 0 0.0041875336319208145
consistent O 0 0.0022301238495856524
with O 0 0.0010344081092625856
that O 0 0.0010029551340267062
reported O 0 0.0024483660236001015
for O 0 0.002030406380072236
haploinsufficiency O 0 0.1064758449792862
of O 0 0.0075329365208745
distal O 1 0.9889739751815796
3 O 0 0.015594439581036568
p O 0 0.027906889095902443
. O 0 0.012808257713913918

Uniparental B-Disease 1 0.9999775886535645
disomy I-Disease 1 0.996414303779602
associated O 0 0.009459628723561764
with O 0 0.004345586523413658
unbalanced O 1 0.8880690336227417
segregation O 1 0.9326306581497192
of O 0 0.06725768744945526
non O 1 0.9896100759506226
- O 1 0.9971480965614319
Robertsonian O 1 0.9991744160652161
translocations O 0 0.240840882062912
has O 0 0.0018688765121623874
been O 0 0.0015431082574650645
reported O 0 0.0021164186764508486
previously O 0 0.0016799136064946651
but O 0 0.000751140178181231
has O 0 0.0009797230595722795
not O 0 0.0005920710973441601
, O 0 0.0008188242791220546
to O 0 0.0006638251361437142
our O 0 0.0009301006211899221
knowledge O 0 0.0014381591463461518
, O 0 0.0010541259543970227
been O 0 0.0010820346651598811
observed O 0 0.0014417615020647645
in O 0 0.0011897932272404432
a O 0 0.0028581346850842237
case O 0 0.0065079801715910435
of O 0 0.1313050389289856
PWS B-Disease 1 0.9999995231628418
. O 0 0.024750981479883194

Furthermore O 0 0.01822800189256668
, O 0 0.0050830114632844925
our O 0 0.0034913450945168734
findings O 0 0.003257631091400981
are O 0 0.0011933083878830075
best O 0 0.0023788795806467533
interpreted O 0 0.0032709622755646706
as O 0 0.002274267841130495
true O 0 0.0065297153778374195
gamete O 0 0.16424092650413513
complementation O 1 0.9799119830131531
resulting O 0 0.01602032221853733
in O 0 0.017253365367650986
maternal B-Disease 1 0.9999830722808838
UPD I-Disease 1 0.9999990463256836
15 I-Disease 0 0.0933942049741745
and O 0 0.03374011814594269
PWS B-Disease 1 0.9999899864196777

Schwartz B-Disease 1 0.991445779800415
- I-Disease 1 0.9962848424911499
Jampel I-Disease 1 0.999920129776001
syndrome I-Disease 1 0.9999996423721313
type I-Disease 1 0.784843921661377
2 I-Disease 0 0.009097769856452942
and O 0 0.005044614430516958
Stuve B-Disease 1 0.9999345541000366
- I-Disease 1 0.9999500513076782
Wiedemann I-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999998807907104
: O 0 0.003750402247533202
a O 0 0.0026898763608187437
case O 0 0.0034994769375771284
for O 0 0.0024248138070106506
" O 0 0.007325354497879744
lumping O 0 0.036574479192495346
" O 0 0.011874133720993996
. O 0 0.010965263471007347

Recent O 0 0.010236019268631935
studies O 0 0.005845641251653433
demonstrated O 0 0.005247302819043398
the O 0 0.002389002125710249
existence O 0 0.00344947911798954
of O 0 0.002744255820289254
a O 0 0.004164511803537607
genetically O 0 0.0034718713723123074
distinct O 0 0.002047434216365218
, O 0 0.0016527277184650302
usually O 0 0.0015046325279399753
lethal O 0 0.0025284579023718834
form O 0 0.0013345640618354082
of O 0 0.001751870266161859
the O 0 0.006444590166211128
Schwartz B-Disease 1 0.9993451237678528
- I-Disease 1 0.9998016953468323
Jampel I-Disease 1 0.9999978542327881
syndrome I-Disease 1 1.0
( O 1 0.9768282175064087
SJS B-Disease 1 0.9999943971633911
) O 0 0.003270865883678198
of O 0 0.0064904955215752125
myotonia B-Disease 1 0.9999996423721313
and O 1 0.9192681908607483
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 0.9999998807907104
, O 0 0.010527804493904114
which O 0 0.0024635775480419397
we O 0 0.002831681165844202
called O 0 0.02206943929195404
SJS B-Disease 1 0.9999721050262451
type I-Disease 0 0.02482948638498783
2 I-Disease 0 0.011422811076045036
. O 0 0.010483430698513985

This O 0 0.01382029801607132
disorder O 1 0.9999063014984131
is O 0 0.0058460962027311325
reminiscent O 0 0.2201649695634842
of O 0 0.019360054284334183
another O 0 0.10715603828430176
rare O 0 0.3700278401374817
condition O 1 0.8706895709037781
, O 0 0.002184075303375721
the O 0 0.012024978175759315
Stuve B-Disease 1 0.9999840259552002
- I-Disease 1 0.9999430179595947
Wiedemann I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 1 0.867863655090332
SWS B-Disease 1 0.9999479055404663
) O 0 0.001969100208953023
, O 0 0.0012078540166839957
which O 0 0.0009705112315714359
comprises O 0 0.0026426855474710464
campomelia B-Disease 0 0.012790277600288391
at O 0 0.002977839671075344
birth O 0 0.12600335478782654
with O 0 0.025370461866259575
skeletal B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
, O 1 0.9668189883232117
contractures B-Disease 1 0.999998927116394
, O 0 0.00873972661793232
and O 0 0.004314647056162357
early B-Disease 0 0.009013662114739418
death I-Disease 0 0.19976063072681427
. O 0 0.013660426251590252

To O 0 0.005184427369385958
test O 0 0.00411717826500535
for O 0 0.002163869794458151
possible O 0 0.0028851027600467205
nosologic O 0 0.0385715626180172
identity O 0 0.003130088560283184
between O 0 0.0020503904670476913
these O 0 0.0018596648005768657
disorders O 1 0.9999896287918091
, O 0 0.0029421800281852484
we O 0 0.0013512996956706047
reviewed O 0 0.0018979549640789628
the O 0 0.0011842901585623622
literature O 0 0.0018707365961745381
and O 0 0.0010575087508186698
obtained O 0 0.0015965757193043828
a O 0 0.0016544280806556344
follow O 0 0.0014709701063111424
- O 0 0.002050490817055106
up O 0 0.0010612133191898465
of O 0 0.000899151258636266
the O 0 0.0009817506652325392
only O 0 0.0006621052161790431
two O 0 0.0008216825663112104
surviving O 0 0.04044497758150101
patients O 0 0.037509653717279434
, O 0 0.0010938310297206044
one O 0 0.001049216603860259
with O 0 0.0018243601080030203
SJS B-Disease 1 0.9999321699142456
type I-Disease 0 0.0038630571216344833
2 I-Disease 0 0.0016213174676522613
at O 0 0.0011664045741781592
age O 0 0.001134791993536055
10 O 0 0.0007638976676389575
years O 0 0.000776591885369271
and O 0 0.0006788884638808668
another O 0 0.0013372106477618217
with O 0 0.0014600959839299321
SWS B-Disease 1 0.983590304851532
at O 0 0.00375526025891304
age O 0 0.005266644526273012
7 O 0 0.006044573616236448
years O 0 0.006484391633421183
. O 0 0.009537044912576675

Patients O 1 0.6449602246284485
reported O 0 0.008914635516703129
as O 0 0.004565038718283176
having O 0 0.00876060500741005
either O 0 0.017017759382724762
neonatal O 1 1.0
SJS B-Disease 1 0.9999998807907104
or O 0 0.012632065452635288
SWS B-Disease 1 0.99662846326828
presented O 0 0.0035174500662833452
a O 0 0.0020017866045236588
combination O 0 0.002658660989254713
of O 0 0.0017951105255633593
a O 0 0.005776561796665192
severe O 1 0.9999972581863403
, O 1 0.9448355436325073
prenatal O 1 0.9999998807907104
- O 1 0.9999996423721313
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9996843338012695
with O 1 0.9878028035163879
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999998807907104
contractures I-Disease 1 1.0
, O 1 0.9999841451644897
respiratory O 1 1.0
and O 1 0.9942865967750549
feeding O 1 0.9994298815727234
difficulties O 1 0.9997988343238831
, O 0 0.02637968771159649
tendency O 1 0.500100314617157
to O 0 0.002069242065772414
hyperthermia B-Disease 1 0.9999414682388306
, O 0 0.0015236425679177046
and O 0 0.001069487421773374
frequent O 0 0.0025134484749287367
death O 0 0.02131887525320053
in O 0 0.001659457222558558
infancy O 0 0.42659991979599
) O 0 0.0011845710687339306
with O 0 0.0008990431670099497
a O 0 0.0023600107524544
distinct O 0 0.00589285884052515
campomelic B-Disease 1 0.9999234676361084
- I-Disease 1 0.9998743534088135
metaphyseal I-Disease 1 0.9999850988388062
skeletal I-Disease 1 0.9999988079071045
dysplasia I-Disease 1 0.9999992847442627
. O 0 0.035169027745723724

The O 0 0.010576304979622364
similarity O 0 0.008655213750898838
of O 0 0.004255274310708046
the O 0 0.00510699488222599
clinical O 1 0.9834970235824585
and O 0 0.006023975554853678
radiographic O 1 0.9998652935028076
findings O 0 0.023736929520964622
is O 0 0.0018005917081609368
so O 0 0.0009794370271265507
extensive O 0 0.0021646074019372463
that O 0 0.0012551059480756521
these O 0 0.0015524064656347036
disorders O 1 0.9999743700027466
appear O 0 0.002608727663755417
to O 0 0.0014353578444570303
be O 0 0.0013896293239668012
a O 0 0.0032892017625272274
single O 0 0.005250297486782074
entity O 0 0.01187942735850811
. O 0 0.010695068165659904

The O 0 0.00836455449461937
follow O 0 0.00631035678088665
- O 0 0.005789205431938171
up O 0 0.002038407837972045
observation O 0 0.0035351605620235205
of O 0 0.0013309732312336564
an O 0 0.0013131703017279506
identical O 0 0.0014950094046071172
and O 0 0.0009133509011007845
unique O 0 0.001708476454950869
pattern O 0 0.00447792699560523
of O 0 0.3623310625553131
progressive O 1 0.9999998807907104
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9999997615814209
in O 0 0.0032506941352039576
the O 0 0.005055813118815422
two O 0 0.0014791691210120916
patients O 1 0.9556412100791931
( O 0 0.0018751883180812001
one O 0 0.0010568831348791718
with O 0 0.001690964912995696
SJS B-Disease 1 0.999923586845398
type I-Disease 0 0.004083508159965277
2 I-Disease 0 0.0018425742164254189
, O 0 0.0009975215652957559
one O 0 0.0008920158143155277
with O 0 0.0014017459470778704
SWS B-Disease 1 0.9955945611000061
) O 0 0.0020822552032768726
surviving O 0 0.003911377862095833
beyond O 0 0.0026885182596743107
infancy O 0 0.009036295115947723
adds O 0 0.00278482330031693
to O 0 0.001106643001548946
the O 0 0.0015333433402702212
evidence O 0 0.002041333355009556
in O 0 0.0018965138588100672
favor O 0 0.0035696998238563538
of O 0 0.004648271948099136
identity O 0 0.014703585766255856
. O 0 0.014475656673312187

The O 0 0.013488425873219967
hypothesis O 0 0.015500365756452084
that O 0 0.005679306108504534
SWS B-Disease 1 0.9978227615356445
and O 0 0.009156656451523304
SJS B-Disease 1 0.9999814033508301
type I-Disease 0 0.007764230947941542
2 I-Disease 0 0.002716630697250366
are O 0 0.0009911597007885575
the O 0 0.0017565179150551558
same O 0 0.002806125907227397
disorder O 1 0.9999487400054932
should O 0 0.0018408981850370765
be O 0 0.0012846847530454397
testable O 0 0.004551509395241737
by O 0 0.0017418523784726858
molecular O 0 0.004167233593761921
methods O 0 0.00538727268576622
. O 0 0.005183519795536995
. O 0 0.009402023628354073

A O 0 0.015349376946687698
mouse O 0 0.01209915429353714
model O 0 0.007267206907272339
of O 0 0.02198721468448639
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999747276306152
defects O 1 0.9999998807907104
in O 1 0.9903777837753296
hemostasis O 1 0.9999998807907104
and O 1 0.9879712462425232
thrombosis B-Disease 1 0.9999997615814209
. O 0 0.17605453729629517

von B-Disease 1 0.9990424513816833
Willebrand I-Disease 1 0.9999949932098389
factor I-Disease 1 0.9631112813949585
( I-Disease 1 0.8899625539779663
vWf I-Disease 1 0.9999539852142334
) I-Disease 1 0.9857997894287109
deficiency I-Disease 1 1.0
causes O 1 0.9999997615814209
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9995181560516357
humans O 1 0.9278039932250977
. O 0 0.014741899445652962

We O 0 0.0073453569784760475
generated O 0 0.006597136612981558
a O 0 0.004562227055430412
mouse O 0 0.0063180397264659405
model O 0 0.003731968579813838
for O 0 0.0019890100229531527
this O 0 0.0027075097896158695
disease O 1 0.9944789409637451
by O 0 0.0029145025182515383
using O 0 0.0048742773942649364
gene O 0 0.008864497765898705
targeting O 0 0.012888755649328232
. O 0 0.01102507021278143

vWf B-Disease 1 0.9982175230979919
- I-Disease 1 0.9921244978904724
deficient I-Disease 1 0.997714638710022
mice O 0 0.014413196593523026
appeared O 0 0.006771120708435774
normal O 0 0.003638348774984479
at O 0 0.0029537277296185493
birth O 0 0.00482636783272028
; O 0 0.0014863342512398958
they O 0 0.0010399180464446545
were O 0 0.001854518661275506
viable O 0 0.0063250367529690266
and O 0 0.004847088363021612
fertile O 0 0.1218060702085495
. O 0 0.01364342961460352

Neither O 0 0.03957495838403702
vWf O 0 0.371836394071579
nor O 0 0.023782750591635704
vWf O 1 0.7090559005737305
propolypeptide O 1 0.9445009827613831
( O 0 0.02854875475168228
von B-Disease 1 0.9997333884239197
Willebrand I-Disease 1 0.9999997615814209
antigen O 1 0.9998917579650879
II O 1 0.9999535083770752
) O 0 0.002787152072414756
were O 0 0.001967940479516983
detectable O 0 0.006864424329251051
in O 0 0.001866995356976986
plasma O 0 0.009573712944984436
, O 0 0.0036527488846331835
platelets O 1 0.7682999968528748
, O 0 0.0031311248894780874
or O 0 0.0035946317948400974
endothelial O 0 0.34075918793678284
cells O 0 0.003986467607319355
of O 0 0.0037977914325892925
the O 0 0.008706378750503063
homozygous O 0 0.09821216762065887
mutant O 0 0.4037988483905792
mice O 0 0.028044577687978745
. O 0 0.012951225973665714

The O 0 0.01696288026869297
mutant O 1 0.5975984334945679
mice O 0 0.3678019940853119
exhibited O 1 0.850843071937561
defects O 1 0.9999399185180664
in O 0 0.01917583867907524
hemostasis O 1 0.9999901056289673
with O 0 0.003547227941453457
a O 0 0.024049555882811546
highly O 1 0.9782620668411255
prolonged O 1 0.9999997615814209
bleeding O 1 1.0
time O 0 0.006815286353230476
and O 0 0.002955410396680236
spontaneous O 0 0.47140681743621826
bleeding O 1 0.9999232292175293
events O 0 0.0022225533612072468
in O 0 0.001421179622411728
approximately O 0 0.0021168969105929136
10 O 0 0.002452877350151539
% O 0 0.003197137266397476
of O 0 0.006088127847760916
neonates O 1 0.8299036622047424
. O 0 0.013138014823198318

As O 0 0.006092962808907032
in O 0 0.003905127989128232
the O 0 0.006400256883352995
human O 1 0.785011887550354
disease O 1 0.9999985694885254
, O 0 0.0038311020471155643
the O 0 0.011882936581969261
factor O 0 0.07785826176404953
VIII O 1 0.9789215922355652
level O 0 0.0020279798191040754
in O 0 0.0010490078711882234
these O 0 0.000846576876938343
mice O 0 0.0033968884963542223
was O 0 0.002612271113321185
reduced O 0 0.0019272903446108103
strongly O 0 0.0013946924591436982
as O 0 0.0010148256551474333
a O 0 0.001260371063835919
result O 0 0.0012194296577945352
of O 0 0.0016154919285327196
the O 0 0.0029060840606689453
lack O 0 0.016887016594409943
of O 0 0.019445965066552162
protection O 1 0.9362491369247437
provided O 0 0.00987168774008751
by O 0 0.007997022941708565
vWf O 1 0.902877926826477
. O 0 0.01184884924441576

Defective O 1 0.9999536275863647
thrombosis B-Disease 1 0.9999974966049194
in O 0 0.35401496291160583
mutant O 1 0.9997584223747253
mice O 1 0.8805017471313477
was O 0 0.013674973510205746
also O 0 0.00177821796387434
evident O 0 0.0027048462070524693
in O 0 0.0011458040680736303
an O 0 0.0014516415540128946
in O 0 0.0018111641984432936
vivo O 0 0.045314330607652664
model O 0 0.005938203074038029
of O 0 0.11116837710142136
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999958276748657
. O 0 0.04969353973865509

In O 0 0.005465229507535696
this O 0 0.0028428486548364162
model O 0 0.004093732684850693
, O 0 0.0025060665793716908
the O 0 0.0038920817896723747
exteriorized O 1 0.9695127010345459
mesentery O 1 0.9969184398651123
was O 0 0.3304084539413452
superfused O 1 0.9913955330848694
with O 0 0.01020482461899519
ferric O 1 0.999997615814209
chloride O 1 0.9932084679603577
and O 0 0.0027699496131390333
the O 0 0.004128999076783657
accumulation O 1 0.8763388991355896
of O 0 0.13147801160812378
fluorescently O 1 0.9999735355377197
labeled O 1 0.9923457503318787
platelets O 1 0.9698489904403687
was O 0 0.010428992100059986
observed O 0 0.0055824765004217625
by O 0 0.0050194445066154
intravital O 0 0.4433753192424774
microscopy O 0 0.028480540961027145
. O 0 0.014391982927918434

We O 0 0.0061523509211838245
conclude O 0 0.0072547923773527145
that O 0 0.002376832067966461
these O 0 0.0017063445411622524
mice O 0 0.004436935763806105
very O 0 0.002207354875281453
closely O 0 0.0037584099918603897
mimic O 0 0.14831271767616272
severe O 1 0.9999806880950928
human O 1 0.9999245405197144
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.7553504109382629
will O 0 0.002022587228566408
be O 0 0.0009361882694065571
very O 0 0.0008887994918040931
useful O 0 0.0009819116676226258
for O 0 0.0007192412158474326
investigating O 0 0.0018851192435249686
the O 0 0.0013125212863087654
role O 0 0.001895314664579928
of O 0 0.0020716115832328796
vWf O 0 0.3329371511936188
in O 0 0.0014401881489902735
normal O 0 0.0032674791291356087
physiology O 1 0.7964107990264893
and O 0 0.002568140160292387
in O 0 0.04451017081737518
disease O 1 0.9999990463256836
models O 0 0.03473025932908058
. O 0 0.005552975460886955
. O 0 0.009336565621197224

Oral O 1 0.8985275030136108
contraceptives O 1 0.9762425422668457
and O 0 0.006447589490562677
the O 0 0.010523667559027672
risk O 1 0.9801710844039917
of O 1 0.9997158646583557
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9991040825843811

Hereditary B-Disease 1 0.9999990463256836
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999953508377075
Study O 1 0.9809165596961975
Group O 0 0.4463845491409302
. O 0 0.01937701739370823

BACKGROUND O 0 0.021602189168334007
Women O 0 0.0077589345164597034
with O 0 0.002676712814718485
mutations O 0 0.003084048628807068
in O 0 0.001540383673273027
either O 0 0.0018492249073460698
the O 0 0.003017009701579809
BRCA1 O 1 0.831759512424469
or O 0 0.002106207190081477
the O 0 0.0034687069710344076
BRCA2 O 1 0.7293717265129089
gene O 0 0.002262713387608528
have O 0 0.001032172585837543
a O 0 0.002054113894701004
high O 0 0.005503453779965639
lifetime O 0 0.2965507507324219
risk O 1 0.9337093234062195
of O 1 0.9997885823249817
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9759816527366638

Oral O 1 0.9859768152236938
contraceptives O 1 0.9997524619102478
protect O 1 0.9848200082778931
against O 1 0.9997654557228088
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.8460256457328796
general O 1 0.9928902387619019
, O 0 0.004430638626217842
but O 0 0.0010249613551422954
it O 0 0.000677787174936384
is O 0 0.0007890667184256017
not O 0 0.0006594075239263475
known O 0 0.0010308768833056092
whether O 0 0.0008814268512651324
they O 0 0.0007177123334258795
also O 0 0.0012542145559564233
protect O 0 0.0022989287972450256
against O 0 0.0031488665845245123
hereditary B-Disease 1 0.9997488856315613
forms I-Disease 1 0.9882662892341614
of I-Disease 1 0.9999988079071045
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.993200957775116

METHODS O 0 0.014348341152071953
We O 0 0.0048263766802847385
enrolled O 0 0.010226444341242313
207 O 0 0.01462255883961916
women O 0 0.005753164645284414
with O 0 0.05655219405889511
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8868098855018616
161 O 1 0.7806922793388367
of O 0 0.004567544441670179
their O 0 0.0015630279667675495
sisters O 0 0.010805346071720123
as O 0 0.0011263787746429443
controls O 0 0.0015532062388956547
in O 0 0.0010470290435478091
a O 0 0.0021198573522269726
case O 0 0.005549585446715355
- O 0 0.027914507314562798
control O 0 0.005366899073123932
study O 0 0.007153147831559181
. O 0 0.008514893241226673

All O 0 0.00664086127653718
the O 0 0.0070821363478899
patients O 0 0.03776519000530243
carried O 0 0.005092103965580463
a O 0 0.0035990739706903696
pathogenic O 0 0.016795692965388298
mutation O 0 0.003253140952438116
in O 0 0.0015830773627385497
either O 0 0.002147221937775612
BRCA1 O 0 0.4422726631164551
( O 0 0.0024895628448575735
179 O 0 0.004515996668487787
women O 0 0.002299576299265027
) O 0 0.001859160140156746
or O 0 0.0022559792269021273
BRCA2 O 0 0.22737444937229156
( O 0 0.00418906519189477
28 O 0 0.005553603172302246
women O 0 0.007094043307006359
) O 0 0.006633497774600983
. O 0 0.009209074079990387

The O 0 0.009153135120868683
control O 0 0.007735727820545435
women O 0 0.00534816924482584
were O 0 0.0027555248234421015
enrolled O 0 0.007010865490883589
regardless O 0 0.00281053245998919
of O 0 0.002043284010142088
whether O 0 0.0019512176513671875
or O 0 0.0013382603647187352
not O 0 0.0010371697135269642
they O 0 0.0013317468110471964
had O 0 0.003350952174514532
either O 0 0.0046504950150847435
mutation O 0 0.013017996214330196
. O 0 0.010053099133074284

Lifetime O 0 0.03192512318491936
histories O 0 0.01984954997897148
of O 0 0.037572842091321945
oral O 1 0.9999707937240601
- O 1 0.999756395816803
contraceptive O 1 0.9987536668777466
use O 0 0.0020859839860349894
were O 0 0.0015930358786135912
obtained O 0 0.001901045092381537
by O 0 0.001074358937330544
interview O 0 0.00197307369671762
or O 0 0.0008620851440355182
by O 0 0.0007012238493189216
written O 0 0.0011732203420251608
questionnaire O 0 0.0026876069605350494
and O 0 0.0009978541638702154
were O 0 0.0011426759883761406
compared O 0 0.0017399556236341596
between O 0 0.0015266940463334322
patients O 0 0.1110558956861496
and O 0 0.001520107383839786
control O 0 0.005253326613456011
women O 0 0.0031996427569538355
, O 0 0.0016186259454116225
after O 0 0.002134144539013505
adjustment O 0 0.0074821352027356625
for O 0 0.0012979801977053285
year O 0 0.002090433845296502
of O 0 0.0034743142314255238
birth O 0 0.1979844719171524
and O 0 0.0063836644403636456
parity O 0 0.49421975016593933
. O 0 0.012458045035600662

RESULTS O 0 0.010622099041938782
The O 0 0.005274529103189707
adjusted O 0 0.009518060833215714
odds O 0 0.011969092302024364
ratio O 0 0.02651233784854412
for O 0 0.16661851108074188
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
associated O 0 0.01007396262139082
with O 0 0.0015093983383849263
any O 0 0.0011610863730311394
past O 0 0.001583057688549161
use O 0 0.0013384100748226047
of O 0 0.003030363703146577
oral O 1 0.9720361828804016
contraceptives O 1 0.9993093013763428
was O 0 0.33718451857566833
0 O 0 0.013986872509121895
. O 0 0.010198839008808136

5 O 0 0.014283397234976292
( O 0 0.00727116409689188
95 O 0 0.006948745343834162
percent O 0 0.0038481876254081726
confidence O 0 0.004569415934383869
interval O 0 0.003830608678981662
, O 0 0.0017626708140596747
0 O 0 0.0019923392683267593
. O 0 0.000987405190244317
3 O 0 0.0016188679728657007
to O 0 0.0011868298752233386
0 O 0 0.0030063446611166
. O 0 0.001799000077880919
8 O 0 0.005465379916131496
) O 0 0.005651273764669895
. O 0 0.008583114482462406

The O 0 0.023864205926656723
risk O 1 0.5578606128692627
decreased O 0 0.027008330449461937
with O 0 0.00228880369104445
increasing O 0 0.0037703500129282475
duration O 0 0.004538422916084528
of O 0 0.0020050788298249245
use O 0 0.0018279587384313345
( O 0 0.0018687840783968568
P O 0 0.00455889105796814
for O 0 0.00117983459495008
trend O 0 0.0030870961491018534
, O 0 0.0019233748316764832
< O 0 0.005452560726553202
0 O 0 0.0026587483007460833
. O 0 0.0013191959587857127
001 O 0 0.008343824185431004
) O 0 0.0012802552664652467
; O 0 0.000796522363089025
use O 0 0.0007352728862315416
for O 0 0.0006884892354719341
six O 0 0.0010100010549649596
or O 0 0.0007951921434141695
more O 0 0.0006361033301800489
years O 0 0.001174282981082797
was O 0 0.0018170805415138602
associated O 0 0.001156048383563757
with O 0 0.0008757835021242499
a O 0 0.0018129564123228192
60 O 0 0.0025021096225827932
percent O 0 0.0029813728760927916
reduction O 0 0.006054671481251717
in O 0 0.0038905327674001455
risk O 0 0.015800733119249344
. O 0 0.010429725050926208

Oral O 1 0.9704657793045044
- O 1 0.8578753471374512
contraceptive O 1 0.991510808467865
use O 0 0.005168005358427763
protected O 1 0.7924673557281494
against O 1 0.9972436428070068
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
both O 0 0.002121019409969449
for O 0 0.001793961739167571
carriers O 0 0.0032995734363794327
of O 0 0.0020063442643731833
the O 0 0.006947547663003206
BRCA1 O 1 0.995420515537262
mutation O 0 0.004560843575745821
( O 0 0.002043686341494322
odds O 0 0.004159917589277029
ratio O 0 0.0027544794138520956
, O 0 0.0014002255629748106
0 O 0 0.001964050345122814
. O 0 0.000864309084136039
5 O 0 0.0014740003971382976
; O 0 0.0011841151863336563
95 O 0 0.0024539371952414513
percent O 0 0.0019856183789670467
confidence O 0 0.0028880455065518618
interval O 0 0.002560658613219857
, O 0 0.0011988087790086865
0 O 0 0.0016032553976401687
. O 0 0.0007209527539089322
3 O 0 0.0011726461816579103
to O 0 0.0007282890728674829
0 O 0 0.001500236103311181
. O 0 0.0008514876826666296
9 O 0 0.0014281918993219733
) O 0 0.0009162272326648235
and O 0 0.0006189755513332784
for O 0 0.000692674657329917
carriers O 0 0.0015920123551040888
of O 0 0.001272187102586031
the O 0 0.0035401193890720606
BRCA2 O 1 0.9901337027549744
mutation O 0 0.004201595671474934
( O 0 0.0019223481649532914
odds O 0 0.0037495079450309277
ratio O 0 0.002591795055195689
, O 0 0.0010424157371744514
0 O 0 0.0015888927737250924
. O 0 0.0007416249136440456
4 O 0 0.001506056054495275
; O 0 0.0009577031596563756
95 O 0 0.001908574835397303
percent O 0 0.001539256307296455
confidence O 0 0.0026762213092297316
interval O 0 0.0027243357617408037
, O 0 0.0012093979166820645
0 O 0 0.001745595713146031
. O 0 0.0008008864242583513
2 O 0 0.0011996643152087927
to O 0 0.0008170798537321389
1 O 0 0.0019478423055261374
. O 0 0.0018411523196846247
1 O 0 0.004369653295725584
) O 0 0.005598609801381826
. O 0 0.009632482193410397

CONCLUSIONS O 0 0.030383264645934105
Oral O 1 0.9806860685348511
- O 1 0.9404507279396057
contraceptive O 1 0.9877661466598511
use O 0 0.003181916195899248
may O 0 0.0030888665933161974
reduce O 0 0.003958036657422781
the O 0 0.003019405994564295
risk O 0 0.2292470932006836
of O 1 0.9912030696868896
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.1956510692834854
women O 0 0.23093146085739136
with O 0 0.003293844871222973
pathogenic O 1 0.5998868346214294
mutations O 0 0.0038230668287724257
in O 0 0.0027018815744668245
the O 0 0.008866543881595135
BRCA1 O 1 0.9993069171905518
or O 0 0.015022662468254566
BRCA2 O 1 0.9923471212387085
gene O 0 0.04226529598236084

A O 0 0.018067196011543274
Japanese O 0 0.028597233816981316
family O 0 0.008782491087913513
with O 0 0.005873879883438349
adrenoleukodystrophy B-Disease 1 0.9999927282333374
with O 0 0.0031772658694535494
a O 0 0.005023112986236811
codon O 0 0.009897634387016296
291 O 0 0.008589422330260277
deletion O 0 0.005972002167254686
: O 0 0.001728797797113657
a O 0 0.0023249159567058086
clinical O 0 0.03633008524775505
, O 0 0.002560909604653716
biochemical O 0 0.010897715575993061
, O 0 0.003324013203382492
pathological O 1 0.9123269319534302
, O 0 0.00427989661693573
and O 0 0.004098954144865274
genetic O 0 0.011548020876944065
report O 0 0.01297304779291153
. O 0 0.012727711349725723

We O 0 0.007244338747113943
report O 0 0.0051168156787753105
a O 0 0.003963759168982506
Japanese O 0 0.00851464830338955
family O 0 0.0063457186333835125
with O 0 0.008417807519435883
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9990430474281311
ALD B-Disease 1 0.9999998807907104
) O 0 0.002527093281969428
with O 0 0.0011206058552488685
a O 0 0.0014968884643167257
three O 0 0.0011206325143575668
base O 0 0.0021824827417731285
pair O 0 0.0026425349060446024
deletion O 0 0.0062019010074436665
( O 0 0.00285413209348917
delGAG O 0 0.012265791185200214
291 O 0 0.007207774557173252
) O 0 0.0021800033282488585
in O 0 0.0027372753247618675
the O 0 0.010136404074728489
ALD B-Disease 1 0.9999991655349731
gene O 0 0.02574707381427288
. O 0 0.012704919092357159

A O 0 0.013124190270900726
variety O 0 0.007106276229023933
of O 0 0.005972364451736212
phenotypes O 0 0.015848856419324875
were O 0 0.0035844689700752497
observed O 0 0.004218118730932474
within O 0 0.0026454883627593517
this O 0 0.0034543867222964764
family O 0 0.009571379981935024
. O 0 0.011487120762467384

While O 0 0.007389627397060394
the O 0 0.006303244270384312
proband O 1 0.827408492565155
( O 0 0.006007156800478697
patient O 0 0.4788733720779419
1 O 0 0.004127394873648882
) O 0 0.0016222507692873478
was O 0 0.0020615493413060904
classified O 0 0.0023393386509269476
as O 0 0.0012140237959101796
having O 0 0.0016923219664022326
a O 0 0.0015508816577494144
rare O 0 0.003069346770644188
intermediate O 0 0.007962755858898163
type O 0 0.0033655327279120684
of O 0 0.0026134441141039133
adult O 0 0.053776826709508896
cerebral O 1 0.9994877576828003
and O 0 0.0077279107645154
cerebello O 1 0.999987006187439
- O 1 0.9994968175888062
brain O 1 0.9934949278831482
stem O 0 0.006030168384313583
forms O 0 0.0018888103077188134
, O 0 0.0016143473330885172
his O 0 0.00306963874027133
younger O 0 0.0078089553862810135
brother O 0 0.04575234651565552
( O 0 0.002871790435165167
patient O 0 0.04435078799724579
2 O 0 0.0020922657568007708
) O 0 0.0011320317862555385
and O 0 0.0011255715508013964
nephew O 0 0.13557083904743195
( O 0 0.002858835970982909
patient O 0 0.028048068284988403
3 O 0 0.00211177091114223
) O 0 0.0016098531195893884
had O 0 0.002631165785714984
a O 0 0.006802407093346119
childhood O 1 0.9999899864196777
ALD B-Disease 1 1.0
type O 1 0.9998375177383423
. O 0 0.02009620890021324

Another O 0 0.018217824399471283
nephew O 1 0.9312751293182373
( O 0 0.01068615261465311
patient O 1 0.5331912040710449
4 O 0 0.004494410008192062
) O 0 0.0018034513341262937
of O 0 0.0018391937483102083
patient O 1 0.5089319944381714
1 O 0 0.0038006429094821215
was O 0 0.0037099733017385006
classified O 0 0.0033821400720626116
as O 0 0.0018065269105136395
having O 0 0.002868115436285734
an O 0 0.004024990368634462
adolescent O 1 0.9969762563705444
form O 0 0.015150592662394047
. O 0 0.01447080634534359

The O 0 0.012968230061233044
tau O 0 0.025317611172795296
level O 0 0.006201659329235554
in O 0 0.0030839634127914906
the O 0 0.004769845865666866
cerebrospinal O 1 0.9999539852142334
fluid O 1 0.9993268251419067
( O 0 0.2676633596420288
CSF O 1 0.9986370205879211
) O 0 0.001955218380317092
in O 0 0.0014456481439992785
patient O 0 0.1984785944223404
1 O 0 0.002238356741145253
was O 0 0.0021012460347265005
as O 0 0.0009982878109440207
high O 0 0.001581590506248176
as O 0 0.0008394070900976658
that O 0 0.0006404747255146503
of O 0 0.0015891068615019321
patients O 1 0.9828456044197083
with O 1 0.9163370132446289
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9839667677879333
AD B-Disease 1 0.949635922908783
) O 0 0.006767731159925461
. O 0 0.008365306071937084

His O 0 0.025345655158162117
brain O 0 0.29303696751594543
magnetic O 0 0.010657920502126217
resonance O 0 0.008666319772601128
image O 0 0.013005577959120274
( O 0 0.006504562217742205
MRI O 1 0.7543315887451172
) O 0 0.0029483356047421694
showed O 0 0.004229217302054167
abnormalities B-Disease 0 0.07188517600297928
in I-Disease 0 0.001588461804203689
the I-Disease 0 0.0040759555995464325
bilateral I-Disease 1 0.9482658505439758
cerebellar I-Disease 1 0.9999992847442627
hemispheres I-Disease 1 0.9936193823814392
and O 1 0.6466081738471985
brain O 1 0.9999796152114868
stem O 1 0.6296696066856384
, O 0 0.0015701896045356989
but O 0 0.0008402233943343163
not O 0 0.0006864039460197091
in O 0 0.0010053857695311308
the O 0 0.003069609170779586
cerebral O 1 0.9997847676277161
white O 0 0.07036658376455307
matter O 0 0.001954625593498349
, O 0 0.0012276775669306517
where O 0 0.0011634979164227843
marked O 0 0.002613418037071824
reductions O 0 0.002661632839590311
of O 0 0.0019747777841985226
the O 0 0.12782031297683716
cerebral O 1 0.999998927116394
blood O 1 0.9992511868476868
flow O 0 0.01582617312669754
and O 0 0.0027749754954129457
oxygen O 0 0.023099683225154877
metabolism O 0 0.00475519523024559
were O 0 0.0016727851470932364
clearly O 0 0.0027868556790053844
demonstrated O 0 0.0030536665581166744
by O 0 0.0017188999336212873
positron O 0 0.009095216169953346
emission O 0 0.00574657553806901
tomography O 0 0.009275512769818306
( O 0 0.005600473377853632
PET O 0 0.032220833003520966
) O 0 0.0072506447322666645
. O 0 0.011042585596442223

In O 0 0.010297316126525402
patients O 0 0.1336497664451599
2 O 0 0.005390610080212355
and O 0 0.0020247858483344316
3 O 0 0.0027944643516093493
, O 0 0.0017384644597768784
the O 0 0.002313376637175679
autopsy O 0 0.009294292889535427
findings O 0 0.00444042170420289
showed O 0 0.00747846020385623
massive O 0 0.49757811427116394
demyelination B-Disease 1 0.9999901056289673
of I-Disease 0 0.2483140528202057
the I-Disease 1 0.947902500629425
cerebral I-Disease 1 0.9999974966049194
white I-Disease 0 0.271576851606369
matter I-Disease 0 0.0021586583461612463
with O 0 0.0013429257087409496
sparing O 0 0.005163935478776693
of O 0 0.002637372352182865
the O 0 0.16780449450016022
U O 1 0.9999936819076538
- O 1 0.9900526404380798
fibers O 0 0.4552079737186432
, O 0 0.001613754197023809
compatible O 0 0.0020523855928331614
with O 0 0.0011830723378807306
the O 0 0.0021649778354912996
findings O 0 0.004674950148910284
of O 0 0.01785408891737461
childhood O 1 0.9999908208847046
ALD B-Disease 1 1.0
. O 0 0.06265310943126678

Oleic O 1 0.8915331959724426
and O 0 0.011226137168705463
erucic O 1 0.968539297580719
acids O 0 0.01093168556690216
( O 0 0.006530099082738161
Lorenzos O 0 0.12205138802528381
Oil O 0 0.004675076808780432
) O 0 0.0019323526648804545
were O 0 0.0015927228378131986
administered O 0 0.003225613385438919
to O 0 0.0015049593057483435
patients O 0 0.026624329388141632
1 O 0 0.002460018964484334
and O 0 0.0012487194035202265
4 O 0 0.002417386509478092
, O 0 0.0015740043018013239
but O 0 0.0013252748176455498
sufficient O 0 0.0036418731324374676
effectiveness O 0 0.006508347112685442
was O 0 0.0044573089107871056
not O 0 0.002757040085271001
obtained O 0 0.0074774837121367455
. O 0 0.009944124147295952

The O 0 0.00794645119458437
findings O 0 0.005949427839368582
in O 0 0.0025347131304442883
this O 0 0.001600967487320304
family O 0 0.0029816224705427885
suggest O 0 0.0028202033136039972
that O 0 0.0015088394284248352
delGAG291 O 0 0.015971176326274872
is O 0 0.001495510688982904
part O 0 0.001694345148280263
of O 0 0.001963232411071658
the O 0 0.0031406572088599205
cause O 0 0.10008671879768372
of O 0 0.061212070286273956
Japanese O 1 0.9995181560516357
ALD B-Disease 1 0.9999997615814209
with O 0 0.006672498304396868
phenotypic O 0 0.03795568645000458
variations O 0 0.015790831297636032
. O 0 0.014636981301009655

Moreover O 0 0.015362348407506943
, O 0 0.004057805519551039
although O 0 0.002554961945861578
the O 0 0.0018598082242533565
scale O 0 0.002741115400567651
of O 0 0.001664010458625853
the O 0 0.0017802681541070342
study O 0 0.0017827436095103621
is O 0 0.0012443620944395661
limited O 0 0.0010981304803863168
, O 0 0.0007963288808241487
there O 0 0.0006744770798832178
is O 0 0.000688864616677165
a O 0 0.0009441066649742424
possibility O 0 0.0017141330754384398
that O 0 0.0009474461548961699
PET O 0 0.005328713450580835
can O 0 0.0011185398325324059
detect O 0 0.0025711983907967806
an O 0 0.002162984572350979
insidious B-Disease 1 0.9983695149421692
lesion I-Disease 1 0.9997857213020325
which O 0 0.0016453044954687357
is O 0 0.002031243173405528
undetectable O 0 0.031110208481550217
by O 0 0.001696422346867621
computed O 0 0.0053696646355092525
tomogram O 0 0.16668112576007843
( O 0 0.004516824148595333
CT O 1 0.8432605266571045
) O 0 0.002095616888254881
or O 0 0.0014161416329443455
MRI O 0 0.006361909676343203
analysis O 0 0.001448876690119505
, O 0 0.0009563941857777536
and O 0 0.0006802926072850823
that O 0 0.000755680666770786
the O 0 0.0011522796703502536
higher O 0 0.001466341782361269
level O 0 0.001639577909372747
of O 0 0.0017462539253756404
tau O 0 0.07438979297876358
reflects O 0 0.003426085226237774
the O 0 0.0020380381029099226
process O 0 0.002456648973748088
of O 0 0.006007996853441
neuronal B-Disease 1 0.9792060852050781
degeneration I-Disease 1 0.9999991655349731
in O 1 0.9188002943992615
ALD B-Disease 1 0.9999998807907104
. O 0 0.06797563284635544

Lorenzos O 1 0.5475184321403503
Oil O 0 0.013390127569437027
should O 0 0.004358152858912945
be O 0 0.0020021782256662846
given O 0 0.002281604567542672
in O 0 0.0017907882574945688
the O 0 0.002817329717800021
early O 0 0.004065300803631544
stage O 0 0.01062639057636261
. O 0 0.006195649039000273
. O 0 0.011748070828616619

Nonsense O 0 0.050797536969184875
mutation O 0 0.012665647082030773
in O 0 0.004475954454392195
exon O 0 0.015355496667325497
4 O 0 0.004321141168475151
of O 0 0.002823814284056425
human O 0 0.0052351029589772224
complement O 0 0.11822578310966492
C9 O 1 0.9997150301933289
gene O 0 0.004320038016885519
is O 0 0.0018257267074659467
the O 0 0.002172488020732999
major O 0 0.004662397783249617
cause O 0 0.048141948878765106
of O 0 0.0878470167517662
Japanese O 1 0.9999268054962158
complement B-Disease 1 0.999916672706604
C9 I-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999997615814209
. O 0 0.031124787405133247

Deficiency B-Disease 1 0.9999679327011108
of I-Disease 0 0.016342245042324066
the I-Disease 0 0.023989824578166008
ninth I-Disease 1 0.9943775534629822
component I-Disease 0 0.024135077372193336
of I-Disease 0 0.004647308960556984
human I-Disease 0 0.01877029426395893
complement I-Disease 0 0.15896153450012207
( O 0 0.015162937343120575
C9 O 1 0.9985343217849731
) O 0 0.0017581909196451306
is O 0 0.001111809047870338
the O 0 0.0014911466278135777
most O 0 0.0013370385859161615
common O 0 0.016302097588777542
complement B-Disease 1 0.9991723299026489
deficiency I-Disease 1 1.0
in O 0 0.10292455554008484
Japan O 1 0.9346670508384705
but O 0 0.0013204908464103937
is O 0 0.0014810340944677591
rare O 0 0.0021952842362225056
in O 0 0.001423459267243743
other O 0 0.0015227245166897774
countries O 0 0.002867346629500389
. O 0 0.007132100872695446

We O 0 0.006999290082603693
studied O 0 0.005496213678270578
the O 0 0.0029166925232857466
molecular O 0 0.004016087856143713
basis O 0 0.003449449548497796
of O 0 0.009564139880239964
C9 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999991655349731
in O 0 0.0033568653743714094
four O 0 0.003932972438633442
Japanese O 1 0.998863935470581
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999325275421143
deficient I-Disease 1 0.9999816417694092
patients O 1 0.9899401068687439
who O 0 0.06022974103689194
had O 1 0.755369246006012
suffered O 1 0.9999996423721313
from O 1 0.9997497200965881
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.8435163497924805

Direct O 0 0.013608617708086967
sequencing O 0 0.014634779654443264
of O 0 0.007995657622814178
amplified O 0 0.030754832550883293
C9 O 1 0.9904869198799133
cDNA O 0 0.014300110749900341
and O 0 0.003471517004072666
DNA O 0 0.004835742060095072
revealed O 0 0.004371485207229853
a O 0 0.003251874353736639
nonsense O 0 0.011016475968062878
substitution O 0 0.0081900330260396
( O 0 0.005667889025062323
CGA O 0 0.25819534063339233
- O 0 0.06447985768318176
- O 0 0.03917676955461502
> O 0 0.018608134239912033
TGA O 0 0.4583251178264618
) O 0 0.0026335243601351976
at O 0 0.002566550625488162
codon O 0 0.004822892602533102
95 O 0 0.0032950083259493113
in O 0 0.0018819163087755442
exon O 0 0.007493191864341497
4 O 0 0.0023383186198771
in O 0 0.0015357468510046601
the O 0 0.0027290116995573044
four O 0 0.005660798866301775
C9 B-Disease 1 0.9999834299087524
- I-Disease 1 0.9960760474205017
deficient I-Disease 1 0.9947420358657837
individuals O 0 0.00858268141746521
. O 0 0.011951938271522522

An O 0 0.013718041591346264
allele O 0 0.020076029002666473
- O 0 0.012523815035820007
specific O 0 0.004746641032397747
polymerase O 0 0.013023780658841133
chain O 0 0.009633215144276619
reaction O 0 0.005406776908785105
system O 0 0.0035473594907671213
designed O 0 0.0030548744834959507
to O 0 0.0014975386438891292
detect O 0 0.0024614541325718164
exclusively O 0 0.0015502956230193377
only O 0 0.0007435369770973921
one O 0 0.0007075095199979842
of O 0 0.0009390701889060438
the O 0 0.0014918914530426264
normal O 0 0.002135514048859477
and O 0 0.0014907511649653316
mutant O 0 0.004820455331355333
alleles O 0 0.002615085570141673
indicated O 0 0.0016306954203173518
that O 0 0.0006833714433014393
all O 0 0.0005965482559986413
the O 0 0.0009645080426707864
four O 0 0.0013612378388643265
patients O 0 0.005981934256851673
were O 0 0.0014719321625307202
homozygous O 0 0.0025495586451143026
for O 0 0.0010769396321848035
the O 0 0.0017528361640870571
mutation O 0 0.0028868550434708595
in O 0 0.0015834339428693056
exon O 0 0.007753592450171709
4 O 0 0.0022615403868258
and O 0 0.0011032915208488703
that O 0 0.0009843717562034726
the O 0 0.001652287319302559
parents O 0 0.002461961004883051
of O 0 0.0033939338754862547
patient O 1 0.8108010292053223
2 O 0 0.006514985579997301
were O 0 0.005330222658813
heterozygous O 0 0.015697607770562172
. O 0 0.011192159727215767

The O 0 0.009844393469393253
common O 0 0.007417113054543734
mutation O 0 0.006438370794057846
at O 0 0.003820928279310465
codon O 0 0.007432747632265091
95 O 0 0.00407793466001749
in O 0 0.0022808099165558815
exon O 0 0.009067586623132229
4 O 0 0.0029834744054824114
might O 0 0.0015271789161488414
be O 0 0.0011167327174916863
responsible O 0 0.0021535104606300592
for O 0 0.00215395400300622
most O 0 0.0042378343641757965
Japanese O 1 0.9998273849487305
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.014242985285818577
. O 0 0.012844772078096867

BRCA1 O 0 0.058300189673900604
required O 0 0.008512655273079872
for O 0 0.006494524423032999
transcription O 0 0.049169499427080154
- O 0 0.45958036184310913
coupled O 0 0.21071651577949524
repair O 1 0.9920268654823303
of O 0 0.1234704926609993
oxidative O 1 0.9995388984680176
DNA O 0 0.2953346073627472
damage O 1 0.7870416045188904
. O 0 0.018975263461470604

The O 0 0.431755930185318
breast B-Disease 1 0.9999994039535522
and I-Disease 1 0.9996988773345947
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999996423721313
gene O 1 0.9909964799880981
BRCA1 O 1 0.9990849494934082
encodes O 0 0.015303939580917358
a O 0 0.009273369796574116
zinc O 1 0.99835205078125
finger O 0 0.054414451122283936
protein O 0 0.006170141045004129
of O 0 0.004827805794775486
unknown O 0 0.010308811441063881
function O 0 0.01257080677896738
. O 0 0.01331389881670475

Association O 0 0.01535782590508461
of O 0 0.006476979702711105
the O 0 0.009478390216827393
BRCA1 O 1 0.9661396741867065
protein O 0 0.0034067558590322733
with O 0 0.0015103704063221812
the O 0 0.0028786230832338333
DNA O 0 0.008327835239470005
repair O 1 0.9652594923973083
protein O 0 0.005004763137549162
Rad51 O 0 0.11239450424909592
and O 0 0.001424070680513978
changes O 0 0.0014022651594132185
in O 0 0.001197055447846651
the O 0 0.001593637396581471
phosphorylation O 0 0.002627437934279442
and O 0 0.0013833149569109082
cellular O 0 0.0025016621220856905
localization O 0 0.0032000169157981873
of O 0 0.001506588188931346
the O 0 0.0019077719189226627
protein O 0 0.002253976184874773
after O 0 0.002132012974470854
exposure O 0 0.0040407865308225155
to O 0 0.0013460046611726284
DNA O 0 0.0037223289255052805
- O 0 0.004872020334005356
damaging O 0 0.004323624540120363
agents O 0 0.0016979293432086706
are O 0 0.00078963692067191
consistent O 0 0.0016500515630468726
with O 0 0.0009033973328769207
a O 0 0.0019550053402781487
role O 0 0.0031807036139070988
for O 0 0.002685865620151162
BRCA1 O 1 0.8740529417991638
in O 0 0.004620629362761974
DNA O 0 0.01833200454711914
repair O 1 0.9463474154472351
. O 0 0.013606082648038864

Here O 0 0.008495848625898361
, O 0 0.0033675709273666143
it O 0 0.0016630823956802487
is O 0 0.001685066265054047
shown O 0 0.0017694075359031558
that O 0 0.0014876873465254903
mouse O 0 0.008574249222874641
embryonic O 0 0.08175788819789886
stem O 0 0.45989248156547546
cells O 0 0.07114740461111069
deficient B-Disease 1 0.9718586802482605
in I-Disease 0 0.0036157576832920313
BRCA1 I-Disease 1 0.9069746732711792
are O 0 0.001656941371038556
defective O 0 0.13069270551204681
in O 0 0.0014230918604880571
the O 0 0.0014674152480438352
ability O 0 0.0014147182228043675
to O 0 0.0008456166833639145
carry O 0 0.0013163710245862603
out O 0 0.0014625241747125983
transcription O 0 0.005031098611652851
- O 0 0.009715626016259193
coupled O 0 0.011052791029214859
repair O 1 0.6637843251228333
of O 0 0.01115269772708416
oxidative O 1 0.9984563589096069
DNA O 0 0.04573821276426315
damage O 0 0.09610776603221893
, O 0 0.0016314953099936247
and O 0 0.001288817496970296
are O 0 0.0013048546388745308
hypersensitive O 0 0.0838259682059288
to O 0 0.003139112377539277
ionizing O 1 0.7908165454864502
radiation O 0 0.35813477635383606
and O 0 0.004526906181126833
hydrogen O 0 0.015773896127939224
peroxide O 0 0.05974305793642998
. O 0 0.01589834690093994

These O 0 0.006208287551999092
results O 0 0.005637908820062876
suggest O 0 0.0051624970510602
that O 0 0.0031067535746842623
BRCA1 O 1 0.522041380405426
participates O 0 0.004842559341341257
, O 0 0.0017571978969499469
directly O 0 0.0016554458998143673
or O 0 0.0013351476518437266
indirectly O 0 0.00252830283716321
, O 0 0.0014258293667808175
in O 0 0.0019498640904203057
transcription O 0 0.01807665452361107
- O 0 0.04476635530591011
coupled O 0 0.01681441068649292
repair O 1 0.6607354283332825
of O 0 0.01427034568041563
oxidative O 1 0.9991992115974426
DNA O 0 0.24838486313819885
damage O 1 0.7317533493041992
. O 0 0.006644209381192923
. O 0 0.010472001507878304

Truncation O 0 0.11953452974557877
mutations O 0 0.012149997055530548
in O 0 0.005305270664393902
the O 0 0.005862242076545954
transactivation O 1 0.6374509930610657
region O 0 0.007409337908029556
of O 0 0.02496948093175888
PAX6 O 1 0.9999905824661255
result O 0 0.009307132102549076
in O 0 0.005036736838519573
dominant O 0 0.45980650186538696
- O 1 0.5063859224319458
negative O 0 0.014852398075163364
mutants O 0 0.030496710911393166
. O 0 0.013171774335205555

PAX6 O 1 0.9960619807243347
is O 0 0.008061617612838745
a O 0 0.0061518000438809395
transcription O 0 0.008167890831828117
factor O 0 0.003534270217642188
with O 0 0.0012032497907057405
two O 0 0.0011220199521631002
DNA O 0 0.0031398285645991564
- O 0 0.003824552521109581
binding O 0 0.001931884791702032
domains O 0 0.00328115769661963
( O 0 0.0027556875720620155
paired O 0 0.004916282836347818
box O 0 0.006139148026704788
and O 0 0.0028069934342056513
homeobox O 1 0.8512094616889954
) O 0 0.0020508919842541218
and O 0 0.0014970538904890418
a O 0 0.0034616789780557156
proline O 0 0.20832964777946472
- O 0 0.01688789576292038
serine O 0 0.01678243838250637
- O 0 0.01173542719334364
threonine O 0 0.01683652773499489
( O 0 0.008332640863955021
PST O 1 0.8757900595664978
) O 0 0.007278285920619965
- O 0 0.015132575295865536
rich O 0 0.014070172794163227
transactivation O 0 0.05969737097620964
domain O 0 0.02076791785657406
. O 0 0.016285818070173264

PAX6 O 1 0.9997766613960266
regulates O 1 0.6336619853973389
eye O 1 0.6423757076263428
development O 0 0.0063403453677892685
in O 0 0.003010921413078904
animals O 0 0.0031201434321701527
ranging O 0 0.004260364454239607
from O 0 0.0033570060040801764
jellyfish O 0 0.008388334885239601
to O 0 0.0029701737221330404
Drosophila O 0 0.012895186431705952
to O 0 0.005525149870663881
humans O 0 0.011087344028055668
. O 0 0.013626192696392536

Heterozygous O 0 0.025651300325989723
mutations O 0 0.009253479540348053
in O 0 0.0035429256968200207
the O 0 0.004486740566790104
human O 0 0.03189587593078613
PAX6 O 1 0.9999819993972778
gene O 0 0.00405812868848443
result O 0 0.001737114624120295
in O 0 0.0012025015894323587
various O 0 0.001327555626630783
phenotypes O 0 0.005378475412726402
, O 0 0.0019526276737451553
including O 0 0.002627461915835738
aniridia B-Disease 1 0.9999386072158813
, O 0 0.024245522916316986
Peters B-Disease 1 0.9998730421066284
anomaly I-Disease 1 0.9997196793556213
, O 0 0.05152886360883713
autosomal B-Disease 1 0.9998008608818054
dominant I-Disease 1 0.9988790154457092
keratitis I-Disease 1 0.9999995231628418
, O 1 0.6444010138511658
and O 1 0.8564343452453613
familial B-Disease 1 0.9999998807907104
foveal I-Disease 1 0.9999997615814209
dysplasia I-Disease 1 0.9999998807907104
. O 0 0.4527798891067505

It O 0 0.006580682005733252
is O 0 0.00471236789599061
believed O 0 0.004947389476001263
that O 0 0.002441994845867157
the O 0 0.0036495395470410585
mutated O 0 0.008317352272570133
allele O 0 0.006394540425390005
of O 0 0.0037219736259430647
PAX6 O 1 0.9979588985443115
produces O 0 0.004402095451951027
an O 0 0.002942532766610384
inactive O 0 0.014701803214848042
protein O 0 0.0030065402388572693
and O 0 0.0022845000494271517
aniridia B-Disease 1 0.9992468357086182
is O 0 0.004265665542334318
caused O 0 0.10443957895040512
due O 0 0.007165451068431139
to O 0 0.003730913856998086
genetic O 0 0.03245292976498604
haploinsufficiency O 1 0.9092638492584229
. O 0 0.011483689770102501

However O 0 0.008032667450606823
, O 0 0.0036080866120755672
several O 0 0.0024431205820292234
truncation O 0 0.4941142499446869
mutations O 0 0.0047617037780582905
have O 0 0.0010761372977867723
been O 0 0.0010891974670812488
found O 0 0.0009971709223464131
to O 0 0.0007592928013764322
occur O 0 0.0007912373403087258
in O 0 0.0008868119330145419
the O 0 0.0018424559384584427
C O 0 0.10310160368680954
- O 0 0.0072154998779296875
terminal O 0 0.006927620619535446
half O 0 0.0015116630820557475
of O 0 0.002478906884789467
PAX6 O 1 0.9999041557312012
in O 0 0.002452538814395666
patients O 1 0.5822615623474121
with O 0 0.0022440312895923853
Aniridia B-Disease 1 0.9999303817749023
resulting O 0 0.007558721583336592
in O 0 0.002248993143439293
mutant O 0 0.006802977528423071
proteins O 0 0.0016306883189827204
that O 0 0.0009353742352686822
retain O 0 0.002292006043717265
the O 0 0.0016721944557502866
DNA O 0 0.003301647026091814
- O 0 0.003360323142260313
binding O 0 0.0015010535717010498
domains O 0 0.0021497735287994146
but O 0 0.0009894787799566984
have O 0 0.0009198091574944556
lost O 0 0.002589008305221796
most O 0 0.0012428256450220942
of O 0 0.003102465532720089
the O 0 0.010418878868222237
transactivation O 1 0.9939038157463074
domain O 0 0.020106565207242966
. O 0 0.014149346388876438

It O 0 0.007347780279815197
is O 0 0.0034654615446925163
not O 0 0.0016235944349318743
clear O 0 0.0022105900570750237
whether O 0 0.0016641531838104129
such O 0 0.0014300993643701077
mutants O 0 0.007480733562260866
really O 0 0.002984952414408326
behave O 0 0.0024497152771800756
as O 0 0.001611307612620294
loss O 0 0.004603650886565447
- O 0 0.004936024080961943
of O 0 0.0033314116299152374
- O 0 0.09273945540189743
function O 0 0.0033179540187120438
mutants O 0 0.0070426794700324535
as O 0 0.002568963449448347
predicted O 0 0.006882219575345516
by O 0 0.004852800630033016
haploinsufficiency O 0 0.4067159593105316
. O 0 0.012515521608293056

Contrary O 0 0.012765562161803246
to O 0 0.0031674616038799286
this O 0 0.0021719608921557665
theory O 0 0.003335581161081791
, O 0 0.0018900152062997222
our O 0 0.0015994802815839648
data O 0 0.0013348197098821402
showed O 0 0.0017981498967856169
that O 0 0.0007816688739694655
these O 0 0.0007549810106866062
mutants O 0 0.003255898365750909
are O 0 0.0009360776166431606
dominant O 0 0.003612978383898735
- O 0 0.005254784598946571
negative O 0 0.0029717443976551294
in O 0 0.0020278312731534243
transient O 0 0.37350142002105713
transfection O 1 0.6907500624656677
assays O 0 0.0038539974484592676
when O 0 0.00153949367813766
they O 0 0.0009353540954180062
are O 0 0.0010878251632675529
coexpressed O 0 0.008949975483119488
with O 0 0.0026057742070406675
wild O 0 0.0120480852201581
- O 1 0.5761024355888367
type O 1 0.7136064171791077
PAX6 O 1 0.9997302889823914
. O 0 0.01938798278570175

We O 0 0.006733724847435951
found O 0 0.004088889341801405
that O 0 0.002160573611035943
the O 0 0.0030042086727917194
dominant O 0 0.01059502363204956
- O 0 0.11944015324115753
negative O 0 0.0037581583019346
effects O 0 0.0043839518912136555
result O 0 0.0023489738814532757
from O 0 0.001922569703310728
the O 0 0.0030256782192736864
enhanced O 0 0.006030980963259935
DNA O 0 0.00340886483900249
binding O 0 0.0024103205651044846
ability O 0 0.002619930310174823
of O 0 0.0029747607186436653
these O 0 0.004357263445854187
mutants O 0 0.02601052261888981
. O 0 0.011450814083218575

Kinetic O 0 0.01866583339869976
studies O 0 0.006443411577492952
of O 0 0.004046116955578327
binding O 0 0.0036980933509767056
and O 0 0.0027589707169681787
dissociation O 0 0.014548520557582378
revealed O 0 0.004028940107673407
that O 0 0.0011929805623367429
various O 0 0.0015608236426487565
truncation O 0 0.009421548806130886
mutants O 0 0.0050569744780659676
have O 0 0.0011693519772961736
3 O 0 0.0023389270063489676
- O 0 0.0038127400912344456
5 O 0 0.0025962400250136852
- O 0 0.004465201403945684
fold O 0 0.0036905240267515182
higher O 0 0.002252824604511261
affinity O 0 0.0019546172115951777
to O 0 0.0010460579069331288
various O 0 0.0010437871096655726
DNA O 0 0.002311914460733533
- O 0 0.002462955191731453
binding O 0 0.0011111816857010126
sites O 0 0.0010413319105282426
when O 0 0.0010007480159401894
compared O 0 0.001375465071760118
with O 0 0.000987534993328154
the O 0 0.002827106975018978
wild O 0 0.019965214654803276
- O 1 0.897834300994873
type O 1 0.8652083873748779
PAX6 O 1 0.9997056126594543
. O 0 0.016276437789201736

These O 0 0.0064344522543251514
results O 0 0.0043629189021885395
provide O 0 0.0030131854582577944
a O 0 0.0024745126720517874
new O 0 0.002348858630284667
insight O 0 0.0034949390683323145
into O 0 0.0014896796783432364
the O 0 0.0020933940540999174
role O 0 0.0034420157317072153
of O 0 0.00492976326495409
mutant O 1 0.8680461645126343
PAX6 O 1 0.9996364116668701
in O 0 0.006663699168711901
causing O 1 0.6297873258590698
aniridia B-Disease 1 0.9994636178016663
. O 0 0.011002819985151291
. O 0 0.015165814198553562

Reversal O 1 0.62650066614151
of O 1 0.9328202605247498
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9993603825569153
excellent O 1 0.9992399215698242
neuropsychologic O 1 0.9984261989593506
outcome O 0 0.0032603461295366287
in O 0 0.0016721561551094055
very B-Disease 0 0.002297120401635766
- I-Disease 0 0.008530317805707455
long I-Disease 0 0.006283289287239313
- I-Disease 0 0.06444669514894485
chain I-Disease 0 0.16437821090221405
acyl I-Disease 1 0.9743729829788208
- I-Disease 1 0.8551364541053772
coenzyme I-Disease 1 0.9603533744812012
A I-Disease 1 0.9878465533256531
dehydrogenase I-Disease 1 0.9999520778656006
deficiency I-Disease 1 0.9999980926513672
. O 0 0.03145555034279823

Very B-Disease 0 0.013316422700881958
- I-Disease 0 0.021253323182463646
long I-Disease 0 0.010327537544071674
- I-Disease 0 0.016176585108041763
chain I-Disease 0 0.020297817885875702
acyl I-Disease 0 0.4289376735687256
- I-Disease 0 0.022357571870088577
coenzyme I-Disease 0 0.04905937612056732
A I-Disease 0 0.022084662690758705
dehydrogenase I-Disease 1 0.9970019459724426
( I-Disease 0 0.24526502192020416
VLCAD I-Disease 1 0.9999957084655762
) I-Disease 1 0.7047475576400757
deficiency I-Disease 1 0.9999996423721313
is O 0 0.01355485338717699
a O 1 0.6103529334068298
disorder O 1 0.9999998807907104
of O 1 0.9999037981033325
fatty O 1 0.9999994039535522
acid O 1 0.9998695850372314
beta O 0 0.48071354627609253
oxidation O 0 0.008817695081233978
that O 0 0.001535695744678378
reportedly O 0 0.004581064451485872
has O 0 0.0021131678950041533
high O 0 0.0036358607467263937
rates O 0 0.004012133460491896
of O 0 0.006162425968796015
morbidity O 1 0.999777615070343
and O 0 0.011348176747560501
mortality O 1 0.99143385887146
. O 0 0.014220855198800564

We O 0 0.006439746357500553
describe O 0 0.005234353709965944
the O 0 0.0023317511659115553
outcome O 0 0.002408422529697418
of O 0 0.0016882987692952156
a O 0 0.0020559928379952908
5 O 0 0.0024246028624475002
- O 0 0.003831789828836918
year O 0 0.0020269230008125305
- O 0 0.007427448406815529
old O 0 0.045747559517621994
girl O 1 0.6973440051078796
with O 0 0.032592494040727615
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.26719924807548523
was O 0 0.08294941484928131
first O 0 0.0015134736895561218
seen O 0 0.001165341236628592
at O 0 0.0010781802702695131
5 O 0 0.0008590634097345173
months O 0 0.0008547091274522245
of O 0 0.001075012143701315
age O 0 0.007571362890303135
with O 0 0.05202127620577812
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.999998927116394
encephalopathy B-Disease 1 1.0
, O 1 0.9923040270805359
and O 1 0.8103589415550232
hypotonia B-Disease 1 0.9999363422393799
. O 0 0.020807724446058273

Biochemical O 0 0.03920205682516098
studies O 0 0.022582359611988068
indicated O 1 0.9973114728927612
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9997797608375549
by O 0 0.009094610810279846
a O 0 0.13326287269592285
stable O 1 0.9919866323471069
yet O 0 0.008709391579031944
inactive O 0 0.36352285742759705
enzyme O 0 0.01446871180087328
. O 0 0.010684913024306297

Molecular O 0 0.015092859044671059
genetic O 0 0.007557237986475229
analysis O 0 0.0037976293824613094
of O 0 0.004118715412914753
her O 0 0.0637301504611969
VLCAD O 1 0.9997897744178772
gene O 0 0.006228480953723192
revealed O 0 0.005603406112641096
a O 0 0.004028224851936102
T1372C O 0 0.21869106590747833
( O 0 0.005771497264504433
F458L O 0 0.021095983684062958
) O 0 0.003677781904116273
missense O 0 0.01030916627496481
mutation O 0 0.0048660640604794025
and O 0 0.0028523807413876057
a O 0 0.007027935702353716
1668 O 1 0.998030960559845
ACAG O 1 0.9992938041687012
1669 O 1 0.9920624494552612
splice O 0 0.056528571993112564
site O 0 0.018437402322888374
mutation O 0 0.024574104696512222
. O 0 0.01528867706656456

After O 0 0.011347245424985886
initial O 0 0.014540093950927258
treatment O 1 0.9778663516044617
with O 0 0.010937579907476902
intravenous O 1 0.9999994039535522
glucose O 1 0.9989786148071289
and O 0 0.011038544587790966
carnitine O 1 0.9999116659164429
, O 0 0.003139328444376588
the O 0 0.0039041575510054827
patient O 0 0.45507141947746277
has O 0 0.001918979687616229
thrived O 0 0.004600025713443756
on O 0 0.001699440530501306
a O 0 0.002362918108701706
low O 0 0.00605196924880147
- O 0 0.025998910889029503
fat O 0 0.008766005747020245
diet O 0 0.005951130762696266
supplemented O 0 0.0042751245200634
with O 0 0.0018272974994033575
medium O 0 0.005844987463206053
- O 0 0.00817946158349514
chain O 0 0.009902318008244038
triglyceride O 0 0.2089647352695465
oil O 0 0.0064156739972531796
and O 0 0.004497423302382231
carnitine O 1 0.9942063093185425
and O 0 0.005486908834427595
avoidance O 1 0.9652562737464905
of O 0 0.20957918465137482
fasting O 1 0.9512475728988647
. O 0 0.017703663557767868

Her O 1 0.9737716913223267
ventricular O 1 0.9999932050704956
hypertrophy O 1 0.999983549118042
resolved O 0 0.16653135418891907
significantly O 0 0.00516580929979682
over O 0 0.0026915529742836952
1 O 0 0.003079849760979414
year O 0 0.0018298772629350424
, O 0 0.001570028136484325
and O 0 0.001853258814662695
cognitively O 1 0.6109504699707031
, O 0 0.00205792672932148
she O 0 0.0023465880658477545
is O 0 0.0013053618604317307
in O 0 0.0011209618533030152
the O 0 0.0021697275806218386
superior O 0 0.005443764850497246
range O 0 0.002978525124490261
for O 0 0.0031176083721220493
age O 0 0.010785970836877823
. O 0 0.009902970865368843

Clinical O 0 0.19207538664340973
recognition O 0 0.05119343101978302
of O 1 0.9994875192642212
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.8591395020484924
important O 0 0.0038782048504799604
because O 0 0.0015254673780873418
it O 0 0.0008658390725031495
is O 0 0.000839376705698669
one O 0 0.0007985016563907266
of O 0 0.0010090122232213616
the O 0 0.0014124116860330105
few O 0 0.001402424299158156
directly O 0 0.0033350170124322176
treatable O 1 0.9999923706054688
causes O 1 0.994161069393158
of O 1 0.9975758194923401
cardiomyopathy B-Disease 1 1.0
in O 1 0.9994633793830872
children O 1 0.998842716217041
. O 0 0.008576853200793266
. O 0 0.010736661031842232

Cloning O 0 0.016252221539616585
of O 0 0.005072243977338076
a O 0 0.004395853728055954
novel O 0 0.005977966357022524
member O 0 0.0029279787559062243
of O 0 0.0025600281078368425
the O 0 0.006726652849465609
low O 1 0.64710533618927
- O 1 0.8799079656600952
density O 0 0.060852110385894775
lipoprotein O 1 0.9965682029724121
receptor O 0 0.019573161378502846
family O 0 0.014472064562141895
. O 0 0.016048185527324677

A O 0 0.01722683571279049
gene O 0 0.008588757365942001
encoding O 0 0.0057467385195195675
a O 0 0.004030517302453518
novel O 0 0.009323122911155224
transmembrane O 0 0.020926324650645256
protein O 0 0.004164606798440218
was O 0 0.0028255991637706757
identified O 0 0.0020613649394363165
by O 0 0.0010796892456710339
DNA O 0 0.0018231518333777785
sequence O 0 0.0013686749152839184
analysis O 0 0.0011725142830982804
within O 0 0.0012831451604142785
the O 0 0.0029269640799611807
insulin B-Disease 1 0.9983758926391602
- I-Disease 1 0.9914992451667786
dependent I-Disease 1 0.9716485142707825
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9575203657150269
IDDM B-Disease 1 0.999942421913147
) O 0 0.0071828849613666534
locus O 0 0.02926248125731945
IDDM4 O 1 0.7372584939002991
on O 0 0.00863687414675951
chromosome O 0 0.02312292717397213
11q13 O 0 0.05620461702346802
. O 0 0.018390702083706856

Based O 0 0.007927951402962208
on O 0 0.00464574946090579
its O 0 0.0032408887054771185
chromosomal O 0 0.010380013845860958
position O 0 0.0036694430746138096
, O 0 0.002079985337331891
this O 0 0.0014706621877849102
gene O 0 0.002041855128481984
is O 0 0.001234753173775971
a O 0 0.0016860016621649265
candidate O 0 0.0030178187880665064
for O 0 0.0023841678630560637
conferring O 0 0.41049113869667053
susceptibility O 1 0.9975546002388
to O 0 0.012987783178687096
diabetes B-Disease 1 0.9999983310699463
. O 0 0.021138986572623253

The O 0 0.01277266163378954
gene O 0 0.008927494287490845
, O 0 0.004438195843249559
termed O 0 0.020034633576869965
low O 0 0.02184322290122509
- O 0 0.06260233372449875
density O 0 0.012134154327213764
lipoprotein O 1 0.9029916524887085
receptor O 0 0.005839980207383633
related O 0 0.0028636709321290255
protein O 0 0.0031945486553013325
5 O 0 0.0031583707313984632
( O 0 0.0033281014766544104
LRP5 O 0 0.1347530484199524
) O 0 0.0018530241213738918
, O 0 0.0015361419646069407
encodes O 0 0.002833461621776223
a O 0 0.0018657696200534701
protein O 0 0.0020467443391680717
of O 0 0.001969362376257777
1615 O 0 0.0137734804302454
amino O 0 0.0032060209196060896
acids O 0 0.0019886656664311886
that O 0 0.0009736893698573112
contains O 0 0.0016855834983289242
conserved O 0 0.002433458110317588
modules O 0 0.002700363053008914
which O 0 0.0009835088858380914
are O 0 0.0007135494379326701
characteristic O 0 0.001911916653625667
of O 0 0.0014816842740401626
the O 0 0.0030540351290255785
low O 0 0.04472183808684349
- O 0 0.23513801395893097
density O 0 0.05336910858750343
lipoprotein O 1 0.9997013211250305
( O 0 0.10165632516145706
LDL O 1 0.999873161315918
) O 0 0.007288242690265179
receptor O 0 0.011967173777520657
family O 0 0.01249505952000618
. O 0 0.01177820935845375

These O 0 0.0065149120055139065
modules O 0 0.009987764991819859
include O 0 0.004725620616227388
a O 0 0.005559407640248537
putative O 0 0.061950258910655975
signal O 0 0.006515578366816044
peptide O 0 0.005689622834324837
for O 0 0.0017816467443481088
protein O 0 0.0023974445648491383
export O 0 0.0024489229544997215
, O 0 0.001756544690579176
four O 0 0.002474393928423524
epidermal O 1 0.7423575520515442
growth O 0 0.006161159370094538
factor O 0 0.008759843185544014
( O 0 0.0050097922794520855
EGF O 1 0.8512408137321472
) O 0 0.0024429287295788527
repeats O 0 0.003661744063720107
with O 0 0.001202792627736926
associated O 0 0.0019485709490254521
spacer O 0 0.0092349573969841
domains O 0 0.0032940078526735306
, O 0 0.0018328462028875947
three O 0 0.0024754852056503296
LDL O 1 0.9999723434448242
- O 0 0.13867218792438507
receptor O 0 0.006102968007326126
( O 0 0.00313224527053535
LDLR O 0 0.44189518690109253
) O 0 0.0021018320694565773
repeats O 0 0.003303282428532839
, O 0 0.0014190010260790586
a O 0 0.00224502244964242
single O 0 0.002981754019856453
transmembrane O 0 0.0092270253226161
spanning O 0 0.005177059676498175
domain O 0 0.004277909640222788
, O 0 0.00248047336935997
and O 0 0.002891950309276581
a O 0 0.0066778226755559444
cytoplasmic O 0 0.016543282195925713
domain O 0 0.014890623278915882
. O 0 0.012337587773799896

The O 0 0.011435678228735924
encoded O 0 0.007793019060045481
protein O 0 0.004723648075014353
has O 0 0.002143475692719221
a O 0 0.0020371065475046635
unique O 0 0.002387995133176446
organization O 0 0.0029777633026242256
of O 0 0.004876784980297089
EGF O 1 0.9999620914459229
and O 0 0.004940039943903685
LDLR O 1 0.9991939663887024
repeats O 0 0.009295902214944363
; O 0 0.001965927891433239
therefore O 0 0.0023456416092813015
, O 0 0.0022921457421034575
LRP5 O 0 0.2283635288476944
likely O 0 0.0023199112620204687
represents O 0 0.002857215702533722
a O 0 0.001974770100787282
new O 0 0.0017447187565267086
category O 0 0.0034407791681587696
of O 0 0.0029600525740534067
the O 0 0.008117717690765858
LDLR O 1 0.9995954632759094
family O 0 0.03298585116863251
. O 0 0.011757802218198776

Both O 0 0.007401318289339542
human O 0 0.006919155362993479
and O 0 0.004656966309994459
mouse O 0 0.16896742582321167
LRP5 O 1 0.9995695948600769
cDNAs O 1 0.7873421907424927
have O 0 0.00173084472771734
been O 0 0.0019076174357905984
isolated O 0 0.0028891717083752155
and O 0 0.001451023854315281
the O 0 0.00193987344391644
encoded O 0 0.0023790898267179728
mature O 0 0.002240265952423215
proteins O 0 0.0011295160511508584
are O 0 0.0007139263325370848
95 O 0 0.001957283355295658
% O 0 0.0013744222233071923
identical O 0 0.001940396148711443
, O 0 0.0016054193256422877
indicating O 0 0.0026710652746260166
a O 0 0.001957041211426258
high O 0 0.0033944146707654
degree O 0 0.003696289611980319
of O 0 0.0034646710846573114
evolutionary O 0 0.008786539547145367
conservation O 0 0.00963643193244934
. O 0 0.005025211255997419
. O 0 0.010870027355849743

The O 0 0.017375484108924866
APC B-Disease 1 0.8917555212974548
variants O 0 0.011594278737902641
I1307K O 0 0.039467405527830124
and O 0 0.003048649290576577
E1317Q O 0 0.015249952673912048
are O 0 0.001679909648373723
associated O 0 0.004792166408151388
with O 1 0.9213129878044128
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.3068232834339142
but O 0 0.0017412140732631087
not O 0 0.0011177826672792435
always O 0 0.0016534074675291777
with O 0 0.0012057992862537503
a O 0 0.0029563363641500473
family O 0 0.005971271079033613
history O 0 0.009799785912036896
. O 0 0.010443735867738724

Classical O 0 0.394607275724411
familial B-Disease 1 0.9999984502792358
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999908208847046
FAP B-Disease 1 0.9999998807907104
) O 0 0.007516142912209034
is O 0 0.003079584799706936
a O 0 0.0038958843797445297
high O 0 0.14638632535934448
- O 1 0.9883368611335754
penetrance O 1 0.9998675584793091
autosomal B-Disease 1 0.9999792575836182
dominant I-Disease 1 0.999885082244873
disease I-Disease 1 0.9999998807907104
that O 0 0.004746902734041214
predisposes O 1 0.8633769154548645
to O 0 0.0015356126241385937
hundreds O 0 0.0020466293208301067
or O 0 0.0015700040385127068
thousands O 0 0.0036628542002290487
of O 1 0.992235004901886
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999897480010986
carcinoma I-Disease 1 1.0
and O 0 0.12540914118289948
that O 0 0.0016632202314212918
results O 0 0.001994837075471878
from O 0 0.001768989721313119
truncating O 0 0.29985931515693665
mutations O 0 0.0037870798259973526
in O 0 0.002707424806430936
the O 0 0.007422345224767923
APC B-Disease 1 0.9900166392326355
gene O 0 0.01670180633664131
. O 0 0.014059700071811676

A O 0 0.021832028403878212
variant O 0 0.1522073745727539
of O 0 0.13551487028598785
FAP B-Disease 1 0.9999996423721313
is O 1 0.961416482925415
attenuated B-Disease 1 0.9999817609786987
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999991655349731
, O 0 0.00558446766808629
which O 0 0.0022192164324223995
results O 0 0.0025800990406423807
from O 0 0.002875720150768757
germ O 1 0.9997202754020691
- O 0 0.11048781871795654
line O 0 0.0034357046242803335
mutations O 0 0.002000401960685849
in O 0 0.001073004212230444
the O 0 0.0016542800003662705
5 O 0 0.0017314546275883913
and O 0 0.0011890277964994311
3 O 0 0.0019090144196525216
regions O 0 0.001508852350525558
of O 0 0.0028609654400497675
the O 0 0.010261398740112782
APC B-Disease 1 0.9987504482269287
gene O 0 0.01513013057410717
. O 0 0.012458777986466885

Attenuated B-Disease 1 0.9999796152114868
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999825954437256
have O 0 0.005342586897313595
" O 0 0.013703531585633755
multiple O 0 0.0926520973443985
" O 1 0.9985002279281616
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.07264737039804459
typically O 0 0.002189767314121127
fewer O 0 0.0016323134768754244
than O 0 0.0009356130613014102
100 O 0 0.001672205631621182
) O 0 0.0011150760110467672
without O 0 0.0011028768494725227
the O 0 0.002514160005375743
florid O 1 0.5973829627037048
phenotype O 0 0.014155353419482708
of O 0 0.007772405631840229
classical O 0 0.21291162073612213
FAP B-Disease 1 0.9999828338623047
. O 0 0.023127399384975433

Another O 0 0.008627807721495628
group O 0 0.004867918789386749
of O 0 0.005630856845527887
patients O 1 0.9935437440872192
with O 0 0.004047416150569916
multiple O 1 0.6010153293609619
adenomas B-Disease 1 0.9999936819076538
has O 0 0.0045931353233754635
no O 0 0.0020615276880562305
mutations O 0 0.0020922827534377575
in O 0 0.0014178337296471
the O 0 0.0037714249920099974
APC B-Disease 1 0.9991375207901001
gene O 0 0.0025458969175815582
, O 0 0.0011504506692290306
and O 0 0.0009895089315250516
their O 0 0.001104801776818931
phenotype O 0 0.003944741562008858
probably O 0 0.001863735495135188
results O 0 0.0012679060455411673
from O 0 0.0010466669918969274
variation O 0 0.002120987279340625
at O 0 0.001972191035747528
a O 0 0.0025091448333114386
locus O 0 0.00759105896577239
, O 0 0.0019594214390963316
or O 0 0.001977629028260708
loci O 0 0.005348100792616606
, O 0 0.0018923860043287277
elsewhere O 0 0.002588086063042283
in O 0 0.002430616645142436
the O 0 0.005655841436237097
genome O 0 0.015661200508475304
. O 0 0.010850801132619381

Recently O 0 0.015936201438307762
, O 0 0.004458426497876644
however O 0 0.0031872051768004894
, O 0 0.0022284213919192553
a O 0 0.0030689004343003035
missense O 0 0.010548891499638557
variant O 0 0.009564321488142014
of O 0 0.006606116890907288
APC B-Disease 1 0.9999418258666992
( O 0 0.011840403079986572
I1307K O 0 0.410861611366272
) O 0 0.0022319932468235493
was O 0 0.0026999483816325665
described O 0 0.00204673083499074
that O 0 0.0010522818192839622
confers O 0 0.004446458537131548
an O 0 0.0012938539730384946
increased O 0 0.003295564092695713
risk O 0 0.4864138066768646
of O 1 0.9967047572135925
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.33410051465034485
including O 0 0.01153560634702444
multiple O 1 0.8252211213111877
adenomas B-Disease 1 0.9999967813491821
, O 0 0.006456361617892981
in O 0 0.009012354537844658
Ashkenazim O 1 0.9559792280197144
. O 0 0.014969609677791595

We O 0 0.006411626003682613
have O 0 0.002447467530146241
studied O 0 0.003354530781507492
a O 0 0.0018865499878302217
set O 0 0.0017102560959756374
of O 0 0.0022438715677708387
164 O 1 0.5386388897895813
patients O 1 0.8341082334518433
with O 0 0.0030790825840085745
multiple O 1 0.9802151918411255
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9992150068283081
/ I-Disease 1 0.9999977350234985
or I-Disease 1 0.8530302047729492
carcinoma I-Disease 1 1.0
and O 0 0.004814710933715105
analyzed O 0 0.00946643203496933
codons O 0 0.014707261696457863
1263 O 0 0.37802672386169434
- O 0 0.014162861742079258
1377 O 0 0.30981189012527466
( O 0 0.00534795643761754
exon O 0 0.014559587463736534
15G O 0 0.015887578949332237
) O 0 0.00227029575034976
of O 0 0.002303551184013486
the O 0 0.004374525509774685
APC B-Disease 1 0.9712445139884949
gene O 0 0.004996994975954294
for O 0 0.0038206921890378
germ O 1 0.9998001456260681
- O 0 0.47215867042541504
line O 0 0.013900138437747955
variants O 0 0.016538091003894806
. O 0 0.015012949705123901

Three O 0 0.009939162991940975
patients O 0 0.029454804956912994
with O 0 0.0033022526185959578
the O 0 0.005554108880460262
I1307K O 1 0.7910041809082031
allele O 0 0.007556304335594177
were O 0 0.0023148739710450172
detected O 0 0.004516884218901396
, O 0 0.0021818482782691717
each O 0 0.002505631186068058
of O 0 0.005592597182840109
Ashkenazi O 1 0.5139493346214294
descent O 0 0.04094608128070831
. O 0 0.017559239640831947

Four O 0 0.010538598522543907
patients O 0 0.09781739860773087
had O 0 0.005274219438433647
a O 0 0.009678485803306103
germ O 1 0.9999589920043945
- O 1 0.7023799419403076
line O 0 0.008235888555645943
E1317Q O 0 0.07414199411869049
missense O 0 0.015735402703285217
variant O 0 0.009091435931622982
of O 0 0.004952610936015844
APC O 1 0.9938364624977112
that O 0 0.0016749461647123098
was O 0 0.002496808534488082
not O 0 0.0008694270509295166
present O 0 0.0010533027816563845
in O 0 0.0009655681205913424
controls O 0 0.001642896211706102
; O 0 0.0008128389599733055
one O 0 0.0006507309153676033
of O 0 0.0009457496926188469
these O 0 0.0005704717477783561
individuals O 0 0.0006858314736746252
had O 0 0.0012461623409762979
an O 0 0.0010972353629767895
unusually O 0 0.003124239621683955
large O 0 0.0015938462456688285
number O 0 0.001648914534598589
of O 0 0.003709497395902872
metaplastic B-Disease 1 0.9927378296852112
polyps I-Disease 1 0.9494600892066956
of I-Disease 0 0.009425260126590729
the I-Disease 0 0.03795061632990837
colorectum I-Disease 1 0.9968926310539246
. O 0 0.017199842259287834

There O 0 0.009201054461300373
is O 0 0.004836212377995253
increasing O 0 0.0037096699234098196
evidence O 0 0.002574700629338622
that O 0 0.0013393752742558718
there O 0 0.0016759192803874612
exist O 0 0.0023331348784267902
germ O 1 0.9823680520057678
- O 0 0.007387793622910976
line O 0 0.0034660149831324816
variants O 0 0.0025182384997606277
of O 0 0.0021609251853078604
the O 0 0.0055703818798065186
APC B-Disease 1 0.9946807026863098
gene O 0 0.003319305833429098
that O 0 0.001420440967194736
predispose O 0 0.004168448969721794
to O 0 0.001071819569915533
the O 0 0.001690300996415317
development O 0 0.0027194302529096603
of O 0 0.0062741306610405445
multiple O 1 0.9993500113487244
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999963045120239
carcinoma I-Disease 1 1.0
, O 1 0.7144363522529602
but O 0 0.0020533117931336164
without O 0 0.0015874148812144995
the O 0 0.0026222877204418182
florid O 1 0.9877339601516724
phenotype O 0 0.007398537360131741
of O 0 0.0027386138681322336
classical O 0 0.13840660452842712
FAP B-Disease 1 0.9999933242797852
, O 0 0.002129011321812868
and O 0 0.0011389093706384301
possibly O 0 0.0016805623890832067
with O 0 0.0012335301144048572
importance O 0 0.05097876489162445
for O 1 0.9054775834083557
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9982011318206787
in O 0 0.0032810987904667854
the O 0 0.005423585418611765
general O 0 0.04551779851317406
population O 0 0.00410208897665143
. O 0 0.004038096871227026
. O 0 0.007892551831901073

Genomic O 0 0.023884592577815056
structure O 0 0.01021209079772234
of O 0 0.0061131492257118225
the O 0 0.4925490915775299
human O 1 0.9999896287918091
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.499197781085968
gene O 0 0.017572948709130287
. O 0 0.011841509491205215

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999992847442627
CLD B-Disease 1 1.0
) O 0 0.20743054151535034
is O 0 0.004175886046141386
caused O 0 0.018807880580425262
by O 0 0.0014136017998680472
mutations O 0 0.0019837976433336735
in O 0 0.0012477164855226874
a O 0 0.0022780350409448147
gene O 0 0.0025198273360729218
which O 0 0.0016737235710024834
encodes O 0 0.008442549034953117
an O 0 0.00943798292428255
intestinal O 1 0.9999998807907104
anion O 1 0.9999516010284424
transporter O 1 0.9945487380027771
. O 0 0.02079250104725361

We O 0 0.007618524134159088
report O 0 0.0047358362935483456
here O 0 0.0032651580404490232
the O 0 0.0023834151215851307
complete O 0 0.003166773822158575
genomic O 0 0.004919400438666344
organization O 0 0.002661569509655237
of O 0 0.002126072533428669
the O 0 0.0036042158026248217
human O 0 0.02148347906768322
CLD B-Disease 1 0.9999703168869019
gene O 0 0.004098669160157442
which O 0 0.0016578796785324812
spans O 0 0.005365688353776932
approximately O 0 0.003480958752334118
39kb O 0 0.04945831745862961
, O 0 0.003096203785389662
and O 0 0.002869877964258194
comprises O 0 0.008753940463066101
21 O 0 0.01212953682988882
exons O 0 0.026332726702094078
. O 0 0.01415304560214281

All O 0 0.016108941286802292
exon O 0 0.23573502898216248
/ O 0 0.044017285108566284
intron O 0 0.03415152058005333
boundaries O 0 0.005851796828210354
conform O 0 0.007011828478425741
to O 0 0.0035916632041335106
the O 0 0.0081874905154109
GT O 1 0.9989822506904602
/ O 1 0.9970766305923462
AG O 1 0.9981691837310791
rule O 0 0.017304571345448494
. O 0 0.01347676757723093

An O 0 0.007393083535134792
analysis O 0 0.005175954196602106
of O 0 0.00483187660574913
the O 0 0.0065192715264856815
putative O 0 0.30760443210601807
promoter O 0 0.2490205615758896
region O 0 0.004411262925714254
sequence O 0 0.0035136195365339518
shows O 0 0.0029163931030780077
a O 0 0.003907266538590193
putative O 0 0.41157087683677673
TATA O 1 0.9991829991340637
box O 0 0.01654607430100441
and O 0 0.0038105007261037827
predicts O 0 0.011931143701076508
multiple O 0 0.005819490645080805
transcription O 0 0.010105634108185768
factor O 0 0.0070595452561974525
binding O 0 0.00473059993237257
sites O 0 0.0065909456461668015
. O 0 0.010547332465648651

The O 0 0.01109959464520216
genomic O 0 0.015241963788866997
structure O 0 0.0075238291174173355
was O 0 0.0054373666644096375
determined O 0 0.0032565766014158726
using O 0 0.0015381235862150788
DNA O 0 0.0016847460065037012
from O 0 0.0008646168280392885
several O 0 0.0007981088128872216
sources O 0 0.0010704939486458898
including O 0 0.0011268052039667964
multiple O 0 0.002062919083982706
large O 0 0.003045405726879835
- O 0 0.17716990411281586
insert O 0 0.3227904736995697
libaries O 0 0.06200290471315384
and O 0 0.001974561484530568
genomic O 0 0.0054784175008535385
DNA O 0 0.003863150719553232
from O 0 0.0034498523455113173
Finnish O 1 0.986943244934082
CLD B-Disease 1 0.9999942779541016
patients O 1 0.9890479445457458
and O 0 0.006966186687350273
controls O 0 0.01808887906372547
. O 0 0.01395669486373663

Exon O 1 0.6500685214996338
- O 0 0.01792357861995697
specific O 0 0.005253884941339493
primers O 0 0.012899911031126976
developed O 0 0.004122296813875437
in O 0 0.0016125976108014584
this O 0 0.0010836062720045447
study O 0 0.001640703878365457
will O 0 0.0012511539971455932
facilitate O 0 0.0028399983420968056
mutation O 0 0.0029550804756581783
screening O 0 0.002845842856913805
studies O 0 0.0023436842020601034
of O 0 0.0030799536034464836
patients O 1 0.8390742540359497
with O 0 0.004329298157244921
the O 1 0.8816021680831909
disease O 1 0.9999995231628418
. O 0 0.02483232691884041

Genomic O 0 0.03349968418478966
sequencing O 0 0.016984114423394203
of O 0 0.007690943777561188
a O 0 0.013841070234775543
BAC O 1 0.9999210834503174
clone O 1 0.992856502532959
H O 1 0.9975318908691406
_ O 0 0.0040531400591135025
RG364P16 O 0 0.015757713466882706
revealed O 0 0.004404880106449127
the O 0 0.002136537106707692
presence O 0 0.0019693973008543253
of O 0 0.0018950575031340122
another O 0 0.002446480095386505
, O 0 0.0017760787159204483
highly O 0 0.002851559082046151
homologous O 0 0.003706104587763548
gene O 0 0.001986953429877758
3 O 0 0.0014929133467376232
of O 0 0.0016329848440364003
the O 0 0.004761473275721073
CLD B-Disease 1 0.9999878406524658
gene O 0 0.0033233752474188805
, O 0 0.0012857364490628242
with O 0 0.0008396150660701096
a O 0 0.0015370154287666082
similar O 0 0.0015727017307654023
genomic O 0 0.0038581278640776873
structure O 0 0.002611973090097308
, O 0 0.001408400945365429
recently O 0 0.0024066129699349403
identified O 0 0.0018577342852950096
as O 0 0.0016522587975487113
the O 0 0.015130642801523209
Pendred B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
gene O 1 0.9649285078048706
( O 1 0.7491135001182556
PDS B-Disease 1 0.9999769926071167
) O 0 0.006348323076963425
. O 0 0.005998709239065647
. O 0 0.010083790868520737

The O 0 0.019715026021003723
APCI1307K O 1 0.999665379524231
allele O 0 0.16441217064857483
and O 0 0.01560556422919035
cancer B-Disease 1 0.9999909400939941
risk O 0 0.34811896085739136
in O 0 0.002415248891338706
a O 0 0.003262779675424099
community O 0 0.002861019456759095
- O 0 0.004883987363427877
based O 0 0.0020395333413034678
study O 0 0.003091021440923214
of O 0 0.0052748448215425014
Ashkenazi O 1 0.6031227111816406
Jews O 0 0.017910532653331757
. O 0 0.015844864770770073

Mutations O 0 0.01996142603456974
in O 0 0.008158069103956223
APC O 1 0.9378074407577515
are O 0 0.0030058000702410936
classically O 0 0.17465978860855103
associated O 0 0.005562726873904467
with O 0 0.013284572400152683
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999978542327881
FAP B-Disease 1 1.0
) O 0 0.006444931961596012
, O 0 0.0022267107851803303
a O 0 0.003513075178489089
highly O 0 0.375339150428772
penetrant O 1 0.9999982118606567
autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 0.9999958276748657
disorder I-Disease 1 1.0
characterized O 1 0.9999988079071045
by O 1 0.9937230944633484
multiple O 1 0.9999986886978149
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.8596025705337524
, O 0 0.026351692155003548
without O 0 0.00270769651979208
surgical O 1 0.9998688697814941
intervention O 0 0.04462366923689842
, O 0 0.001440440653823316
the O 0 0.0018370855832472444
development O 0 0.006891464814543724
of O 1 0.9899622201919556
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999275207519531
CRC B-Disease 1 0.999997615814209
) O 0 0.013832313939929008
. O 0 0.012515043839812279

APC B-Disease 1 0.9653604626655579
is O 0 0.011905050836503506
a O 0 0.3257383704185486
tumour O 1 1.0
- O 1 0.9999469518661499
suppressor O 1 0.9987892508506775
gene O 0 0.00537286140024662
, O 0 0.002773038577288389
and O 0 0.00301187951117754
somatic O 0 0.16021019220352173
loss O 1 0.5220128297805786
occurs O 0 0.009455787017941475
in O 0 0.013743172399699688
tumours B-Disease 1 0.9999971389770508
. O 0 0.018614107742905617

The O 0 0.021907582879066467
germline O 1 0.9882370829582214
T O 1 0.9849705696105957
- O 0 0.012427453882992268
to O 0 0.0027765838894993067
- O 0 0.006770196370780468
A O 0 0.00469379173591733
transversion O 0 0.02166777104139328
responsible O 0 0.0030157219152897596
for O 0 0.0017376785399392247
the O 0 0.0037936230655759573
APC O 1 0.9704318642616272
I1307K O 0 0.06011563539505005
allele O 0 0.004574268124997616
converts O 0 0.003005180275067687
the O 0 0.0017405262915417552
wild O 0 0.0032850089482963085
- O 0 0.0036651778500527143
type O 0 0.0025860597379505634
sequence O 0 0.001640568021684885
to O 0 0.0010992127936333418
a O 0 0.002796088345348835
homopolymer O 1 0.9930013418197632
tract O 1 0.9999682903289795
( O 0 0.3672923147678375
A8 O 1 0.9998956918716431
) O 0 0.0025211649481207132
that O 0 0.001403201138600707
is O 0 0.0022766427136957645
genetically O 0 0.005177221726626158
unstable O 1 0.6940467953681946
and O 0 0.004865787457674742
prone O 1 0.9764264822006226
to O 0 0.006634949240833521
somatic O 0 0.35559016466140747
mutation O 0 0.019981132820248604
. O 0 0.012177224270999432

The O 0 0.01825796067714691
I1307K O 1 0.5466976165771484
allele O 0 0.01740221679210663
was O 0 0.009725857526063919
found O 0 0.004973852075636387
in O 0 0.005844421684741974
6 O 0 0.015979938209056854
. O 0 0.013242914341390133

1 O 0 0.012882919050753117
% O 0 0.006239789072424173
of O 0 0.0054044900462031364
unselected O 1 0.9040448069572449
Ashkenazi O 0 0.38485202193260193
Jews O 0 0.0057847448624670506
and O 0 0.002273049671202898
higher O 0 0.0030629769898951054
proportions O 0 0.006753243040293455
of O 0 0.0031593076419085264
Ashkenazim O 1 0.5471289157867432
with O 0 0.0019930957350879908
family O 0 0.003954888321459293
or O 0 0.0016859316965565085
personal O 0 0.0037327432073652744
histories O 0 0.029759474098682404
of O 0 0.3039003014564514
CRC B-Disease 1 0.9999967813491821
( O 0 0.029411843046545982
ref O 0 0.13536116480827332
. O 0 0.002806662581861019
2 O 0 0.005545186810195446
) O 0 0.005417100619524717
. O 0 0.008708737790584564

To O 0 0.0072852689772844315
evaluate O 0 0.007980570197105408
the O 0 0.0036271477583795786
role O 0 0.004327666014432907
of O 0 0.00420839199796319
I1307K O 1 0.980131208896637
in O 0 0.00798444077372551
cancer B-Disease 1 0.999846339225769
, O 0 0.0023178691044449806
we O 0 0.0018817164236679673
genotyped O 0 0.010919283144176006
5 O 0 0.003316842718049884
, O 0 0.003335819113999605
081 O 0 0.31327879428863525
Ashkenazi O 0 0.019116206094622612
volunteers O 0 0.0065186042338609695
in O 0 0.002957540098577738
a O 0 0.004449799191206694
community O 0 0.006550786085426807
survey O 0 0.013686195015907288
. O 0 0.012092533521354198

Risk O 0 0.023376360535621643
of O 0 0.028070207685232162
developing O 1 0.9998102784156799
colorectal B-Disease 1 1.0
, I-Disease 1 0.9992150068283081
breast I-Disease 1 0.9999997615814209
and I-Disease 0 0.03151771426200867
other I-Disease 0 0.002466366859152913
cancers I-Disease 1 0.9973452687263489
were O 0 0.0017570749623700976
compared O 0 0.0025262210983783007
between O 0 0.002045782282948494
genotyped O 1 0.7532190680503845
I1307K O 0 0.4202844798564911
carriers O 0 0.004257711116224527
and O 0 0.0019290081690996885
non O 0 0.006107268389314413
- O 0 0.034164924174547195
carriers O 0 0.003039360512048006
and O 0 0.00125706207472831
their O 0 0.001302837859839201
first O 0 0.00320851500146091
- O 0 0.010424367152154446
degree O 0 0.009078682400286198
relatives O 0 0.013767197728157043
. O 0 0.010119248181581497

Sperm O 0 0.023054461926221848
DNA O 0 0.009415079839527607
analysis O 0 0.004973346833139658
in O 0 0.004170587286353111
a O 0 0.010570801794528961
Friedreich B-Disease 1 0.999997615814209
ataxia I-Disease 1 0.9999997615814209
premutation O 1 0.9999916553497314
carrier O 1 0.9934245347976685
suggests O 0 0.009393624030053616
both O 0 0.003216273384168744
meiotic O 1 0.9969297051429749
and O 0 0.00429428368806839
mitotic O 1 0.7552271485328674
expansion O 0 0.007319718133658171
in O 0 0.0038940091617405415
the O 0 0.00935149285942316
FRDA B-Disease 1 0.9987679123878479
gene O 0 0.018457874655723572
. O 0 0.011687390506267548

Friedreich B-Disease 1 0.9999914169311523
ataxia I-Disease 1 0.9999964237213135
is O 0 0.06235603988170624
usually O 0 0.006467802450060844
caused O 0 0.020205175504088402
by O 0 0.0020031265448778868
an O 0 0.002399689983576536
expansion O 0 0.00405470747500658
of O 0 0.0032823211513459682
a O 0 0.00601850776001811
GAA O 0 0.16215454041957855
trinucleotide O 1 0.8241403102874756
repeat O 0 0.008332239463925362
in O 0 0.0033657182939350605
intron O 0 0.07963313907384872
1 O 0 0.004798515234142542
of O 0 0.004592697601765394
the O 0 0.010247667320072651
FRDA B-Disease 1 0.998360812664032
gene O 0 0.01854255422949791
. O 0 0.011996517889201641

Occasionally O 0 0.01145260687917471
, O 0 0.0043272715993225574
a O 0 0.004010133445262909
fully O 0 0.004406030289828777
expanded O 0 0.004027517046779394
allele O 0 0.0038529434241354465
has O 0 0.0015472304075956345
been O 0 0.0012447733897715807
found O 0 0.0012369172181934118
to O 0 0.0009914444526657462
arise O 0 0.0019539236091077328
from O 0 0.0013114067260175943
a O 0 0.002066367771476507
premutation O 0 0.011063800193369389
of O 0 0.0028050746768712997
100 O 0 0.0036326765548437834
or O 0 0.003314513713121414
less O 0 0.004552831407636404
triplet O 0 0.07375067472457886
repeats O 0 0.02366875857114792
. O 0 0.011560197919607162

We O 0 0.0075987353920936584
have O 0 0.0037236574571579695
examined O 0 0.007399573922157288
the O 0 0.00421494385227561
sperm O 0 0.006149397697299719
DNA O 0 0.004383491817861795
of O 0 0.00396745977923274
a O 0 0.009646289050579071
premutation O 1 0.9778117537498474
carrier O 0 0.14362968504428864
. O 0 0.0165926031768322

This O 0 0.010104632936418056
mans O 0 0.02891983650624752
leucocyte O 0 0.06840886175632477
DNA O 0 0.007033461704850197
showed O 0 0.005004321690648794
one O 0 0.0022801526356488466
normal O 0 0.003307722043246031
allele O 0 0.0033604614436626434
and O 0 0.0013949981657788157
one O 0 0.0018238427583128214
allele O 0 0.003774371463805437
of O 0 0.002593538723886013
approximately O 0 0.005211063660681248
100 O 0 0.008055069483816624
repeats O 0 0.018684852868318558
. O 0 0.011864184401929379

His O 0 0.014385303482413292
sperm O 0 0.01020821649581194
showed O 0 0.00613308185711503
an O 0 0.00287549733184278
expanded O 0 0.004157588351517916
allele O 0 0.004322581924498081
in O 0 0.0018167294329032302
a O 0 0.0021375948563218117
tight O 0 0.0034487645607441664
range O 0 0.0021936020348221064
centering O 0 0.004345520865172148
on O 0 0.0020453569013625383
a O 0 0.002100166631862521
size O 0 0.002530735684558749
of O 0 0.0026784646324813366
approximately O 0 0.006771819666028023
320 O 0 0.01970956102013588
trinucleotide O 1 0.9161363244056702
repeats O 0 0.0296220313757658
. O 0 0.01629764586687088

His O 0 0.024666626006364822
affected O 0 0.05443529784679413
son O 1 0.8804978728294373
has O 0 0.005088710691779852
repeat O 0 0.008900281973183155
sizes O 0 0.00468726921826601
of O 0 0.005255111027508974
1040 O 1 0.8831521272659302
and O 0 0.006664895452558994
540 O 0 0.03733156993985176
. O 0 0.011688976548612118

These O 0 0.005757166538387537
data O 0 0.004379799123853445
suggest O 0 0.003456789068877697
that O 0 0.0017040782840922475
expansion O 0 0.0026727200020104647
occurs O 0 0.0014600069262087345
in O 0 0.0010482101934030652
two O 0 0.0009042438468895853
stages O 0 0.0024464454036206007
, O 0 0.0012674422468990088
the O 0 0.0013146419078111649
first O 0 0.0017919784877449274
during O 0 0.002591065363958478
meiosis O 0 0.006981376092880964
followed O 0 0.0021577554289251566
by O 0 0.0014938339591026306
a O 0 0.0031576650217175484
second O 0 0.007349235471338034
mitotic O 1 0.6117754578590393
expansion O 0 0.01928277686238289
. O 0 0.012134176678955555

We O 0 0.006442423444241285
also O 0 0.003486504079774022
show O 0 0.002677501877769828
that O 0 0.0011167556513100863
in O 0 0.0010668376926332712
all O 0 0.0009956577559933066
informative O 0 0.004096421878784895
carrier O 0 0.013138620182871819
father O 0 0.0053537762723863125
to O 0 0.0018519994337111712
affected O 0 0.004028331954032183
child O 0 0.021403789520263672
transmissions O 0 0.003469254123046994
, O 0 0.0012912243837490678
with O 0 0.0009066408965736628
the O 0 0.0012174136936664581
notable O 0 0.0019529883284121752
exception O 0 0.002504796953871846
of O 0 0.002220391295850277
the O 0 0.005726954434067011
premutation O 1 0.9957175850868225
carrier O 0 0.02898871898651123
, O 0 0.0020292734261602163
the O 0 0.0025090347044169903
expansion O 0 0.005847614724189043
size O 0 0.005574268754571676
decreases O 0 0.009900915436446667
. O 0 0.00495550874620676
. O 0 0.009969756007194519

The O 0 0.016571076586842537
R496H O 0 0.19825391471385956
mutation O 0 0.011391703970730305
of O 0 0.006153875961899757
arylsulfatase O 1 0.9880516529083252
A O 0 0.030001115053892136
does O 0 0.00491529842838645
not O 0 0.004904397763311863
cause O 1 0.6747363805770874
metachromatic B-Disease 1 0.9999616146087646
leukodystrophy I-Disease 1 0.9999936819076538
. O 0 0.02868254855275154

Deficiency B-Disease 1 0.9999868869781494
of I-Disease 0 0.09590473771095276
arylsulfatase I-Disease 1 0.9998672008514404
A I-Disease 1 0.9854869842529297
( O 1 0.8775166273117065
ARSA O 1 0.9999734163284302
) O 0 0.0063627297058701515
enzyme O 0 0.009411557577550411
activity O 0 0.00801609456539154
causes O 1 0.6744894981384277
metachromatic B-Disease 1 0.9999862909317017
leukodystrophy I-Disease 1 0.9999998807907104
( O 1 0.994097113609314
MLD B-Disease 1 0.9999988079071045
) O 0 0.018175434321165085
. O 0 0.014666968025267124

A O 0 0.013095979578793049
number O 0 0.005469196941703558
of O 0 0.008169598877429962
ARSA O 1 0.9998670816421509
gene O 0 0.008518106304109097
mutations O 0 0.005422168876975775
responsible O 0 0.005251661874353886
for O 0 0.005336746573448181
MLD B-Disease 1 0.9999951124191284
have O 0 0.003811309579759836
been O 0 0.005815320182591677
identified O 0 0.011556318961083889
. O 0 0.01137281209230423

Recently O 0 0.015574666671454906
, O 0 0.005577328149229288
the O 0 0.005337339360266924
R496H O 0 0.09601408988237381
mutation O 0 0.007141301408410072
of O 0 0.004898167680948973
ARSA O 1 0.9999228715896606
was O 0 0.006747079081833363
proposed O 0 0.0024032187648117542
to O 0 0.0012197038158774376
be O 0 0.0010696030221879482
a O 0 0.001863279496319592
cause O 0 0.004667401313781738
of O 0 0.007444700226187706
MLD B-Disease 1 0.9999997615814209
( O 0 0.02000713162124157
Draghia O 1 0.9407222270965576
et O 0 0.04670310392975807
al O 0 0.0077065275982022285
. O 0 0.0023874931503087282
, O 0 0.00326197175309062
1997 O 0 0.008419392630457878
) O 0 0.0074362559244036674
. O 0 0.012725146487355232

We O 0 0.006967023480683565
have O 0 0.003434601239860058
investigated O 0 0.00801504123955965
the O 0 0.004560817498713732
R496H O 1 0.5907082557678223
mutation O 0 0.005765704903751612
and O 0 0.0017674150876700878
found O 0 0.0017817263724282384
this O 0 0.0013335096882656217
mutation O 0 0.0024128213990479708
at O 0 0.0019144171383231878
a O 0 0.0016551403095945716
relatively O 0 0.001872344291768968
high O 0 0.0019156256457790732
frequency O 0 0.00130831531714648
in O 0 0.0007439368055202067
an O 0 0.0008980158600024879
African O 0 0.0017400856595486403
American O 0 0.0015270878793671727
population O 0 0.0014142938889563084
( O 0 0.0019858365412801504
f O 0 0.003433018457144499
= O 0 0.0036046220920979977
0 O 0 0.00232897000387311
. O 0 0.001167351147159934
09 O 0 0.007078274618834257
, O 0 0.002774740569293499
n O 0 0.0066670011729002
= O 0 0.006696592550724745
61 O 0 0.0067235492169857025
subjects O 0 0.008555632084608078
) O 0 0.008324386551976204
. O 0 0.010861139744520187

The O 0 0.02819281816482544
ARSA O 1 0.9998846054077148
enzyme O 0 0.013728303834795952
activity O 0 0.003662601811811328
in O 0 0.001777782803401351
subjects O 0 0.002674409653991461
with O 0 0.0012847228208556771
and O 0 0.0011861873790621758
without O 0 0.001258445787243545
the O 0 0.002628189278766513
R496H O 1 0.7591376304626465
mutation O 0 0.0045349691063165665
was O 0 0.0027825678698718548
determined O 0 0.0020334203727543354
and O 0 0.0011852483730763197
found O 0 0.0017447320278733969
to O 0 0.0018642987124621868
be O 0 0.0023299437016248703
normal O 0 0.00736115500330925
. O 0 0.008327064104378223

It O 0 0.006127605680376291
is O 0 0.004528507124632597
therefore O 0 0.0037733244244009256
concluded O 0 0.004198077600449324
that O 0 0.0014615014661103487
the O 0 0.0027044215239584446
R496H O 0 0.1258201003074646
mutation O 0 0.004915168043226004
of O 0 0.004689401015639305
ARSA O 1 0.9999641180038452
does O 0 0.0016720049316063523
not O 0 0.0009747252333909273
negatively O 0 0.0017505984287708998
influence O 0 0.001366678043268621
the O 0 0.001504000392742455
activity O 0 0.0021425720769912004
of O 0 0.0037957103922963142
ARSA O 1 0.9999641180038452
and O 0 0.002793744206428528
is O 0 0.0026791603304445744
not O 0 0.0020396835170686245
a O 0 0.005397108383476734
cause O 0 0.09944001585245132
of O 0 0.43123963475227356
MLD B-Disease 1 0.9999986886978149

Down O 0 0.022015651687979698
- O 0 0.014810677617788315
regulation O 0 0.007465679664164782
of O 0 0.006460551172494888
transmembrane O 1 0.9067861437797546
carbonic O 1 0.9978787899017334
anhydrases O 1 0.9989039897918701
in O 0 0.45526283979415894
renal B-Disease 1 1.0
cell I-Disease 1 0.9999946355819702
carcinoma I-Disease 1 1.0
cell O 1 0.822913646697998
lines O 0 0.004796735011041164
by O 0 0.0021929237991571426
wild O 0 0.007310068234801292
- O 0 0.11065006256103516
type O 0 0.1466842144727707
von B-Disease 1 0.9971761703491211
Hippel I-Disease 1 0.999951958656311
- I-Disease 1 0.9952785968780518
Lindau I-Disease 1 0.9997461438179016
transgenes O 1 0.9164600372314453
. O 0 0.024141669273376465

To O 0 0.00867196824401617
discover O 0 0.01131158322095871
genes O 0 0.0047662281431257725
involved O 0 0.0034305588342249393
in O 0 0.0030618717428296804
von B-Disease 1 0.9656934142112732
Hippel I-Disease 1 0.9999853372573853
- I-Disease 1 0.9994053840637207
Lindau I-Disease 1 0.9999905824661255
( O 0 0.12587681412696838
VHL B-Disease 1 0.999885082244873
) O 0 0.0048021371476352215
- O 0 0.011177140288054943
mediated O 0 0.010348652489483356
carcinogenesis O 1 0.9902888536453247
, O 0 0.003067984478548169
we O 0 0.002950930269435048
used O 0 0.00933484174311161
renal B-Disease 1 1.0
cell I-Disease 1 0.9999810457229614
carcinoma I-Disease 1 1.0
cell O 1 0.9770382642745972
lines O 0 0.012564226984977722
stably O 0 0.22571736574172974
transfected O 0 0.038227278739213943
with O 0 0.003436050610616803
wild O 0 0.012417467311024666
- O 1 0.7973464131355286
type O 1 0.8939260244369507
VHL O 1 0.9999840259552002
- O 1 0.89815753698349
expressing O 0 0.17075428366661072
transgenes O 1 0.8989223837852478
. O 0 0.019877512007951736

Large O 0 0.017588118091225624
- O 0 0.018990781158208847
scale O 0 0.010724128223955631
RNA O 0 0.009532123804092407
differential O 0 0.006803203374147415
display O 0 0.004422661382704973
technology O 0 0.002926802495494485
applied O 0 0.0023509422317147255
to O 0 0.0012222380610182881
these O 0 0.0010144970146939158
cell O 0 0.0023781100753694773
lines O 0 0.002158520743250847
identified O 0 0.0019315950339660048
several O 0 0.0016238604439422488
differentially O 0 0.007410537917166948
expressed O 0 0.002873732941225171
genes O 0 0.0019637555815279484
, O 0 0.0013521828223019838
including O 0 0.0017442520475015044
an O 0 0.0035460179205983877
alpha O 0 0.08696997910737991
carbonic O 1 0.9751378893852234
anhydrase O 1 0.9937270879745483
gene O 0 0.010439755395054817
, O 0 0.0071973642334342
termed O 0 0.07420296221971512
CA12 O 1 0.9967402815818787
. O 0 0.018946120515465736

The O 0 0.011467012576758862
deduced O 0 0.01512961182743311
protein O 0 0.005014337133616209
sequence O 0 0.004074566066265106
was O 0 0.0036382575053721666
classified O 0 0.003658114932477474
as O 0 0.001623684074729681
a O 0 0.0018633725121617317
one O 0 0.0019430185202509165
- O 0 0.007002975791692734
pass O 0 0.0040319147519767284
transmembrane O 0 0.049583762884140015
CA O 0 0.006649507209658623
possessing O 0 0.0043189493007957935
an O 0 0.0024759373627603054
apparently O 0 0.005691409111022949
intact O 0 0.006975963711738586
catalytic O 0 0.005899569019675255
domain O 0 0.004303683061152697
in O 0 0.002553305821493268
the O 0 0.00555585790425539
extracellular O 0 0.12057854980230331
CA O 0 0.1950332522392273
module O 0 0.10123629122972488
. O 0 0.018691634759306908

Reintroduced O 0 0.04313826933503151
wild O 0 0.026310214772820473
- O 1 0.5717930793762207
type O 1 0.8385213017463684
VHL B-Disease 1 0.999744713306427
strongly O 0 0.007616970222443342
inhibited O 0 0.009220444597303867
the O 0 0.003712085308507085
overexpression O 0 0.008935404010117054
of O 0 0.003302072174847126
the O 0 0.004807163029909134
CA12 O 1 0.9952576756477356
gene O 0 0.003401338355615735
in O 0 0.0020508754532784224
the O 0 0.006723843049257994
parental O 1 0.9994173049926758
renal B-Disease 1 1.0
cell I-Disease 1 0.9999991655349731
carcinoma I-Disease 1 1.0
cell O 1 0.9996379613876343
lines O 0 0.23646090924739838
. O 0 0.01596876233816147

Similar O 0 0.008777721785008907
results O 0 0.005137198138982058
were O 0 0.002881886437535286
obtained O 0 0.004047204740345478
with O 0 0.003461450571194291
CA9 O 1 0.9994495511054993
, O 0 0.003543399041518569
encoding O 0 0.005153409671038389
another O 0 0.004565265960991383
transmembrane O 0 0.028820812702178955
CA O 0 0.008874588645994663
with O 0 0.003007998690009117
an O 0 0.004360843449831009
intact O 0 0.016133099794387817
catalytic O 0 0.018754655495285988
domain O 0 0.01731870323419571
. O 0 0.01578902080655098

Although O 0 0.008794175460934639
both O 0 0.003980887122452259
domains O 0 0.0056432513520121574
of O 0 0.004542224574834108
the O 0 0.03494736924767494
VHL B-Disease 1 0.9999724626541138
protein O 0 0.004373366478830576
contribute O 0 0.0028106020763516426
to O 0 0.0015534887788817286
regulation O 0 0.0028822743333876133
of O 0 0.0026106415316462517
CA12 O 1 0.9045042991638184
expression O 0 0.0043779406696558
, O 0 0.0021987997461110353
the O 0 0.0028637114446610212
elongin O 0 0.03936446085572243
binding O 0 0.0036151474341750145
domain O 0 0.004365247208625078
alone O 0 0.004059906117618084
could O 0 0.0032415848691016436
effectively O 0 0.008165276609361172
regulate O 0 0.01613892801105976
CA9 O 1 0.9918747544288635
expression O 0 0.021398814395070076
. O 0 0.016231819987297058

We O 0 0.01248557772487402
mapped O 0 0.023963237181305885
CA12 O 1 0.9220314621925354
and O 0 0.008858769200742245
CA9 O 1 0.9982971549034119
loci O 0 0.020543383434414864
to O 0 0.00521071907132864
chromosome O 0 0.013621321879327297
bands O 0 0.01059633307158947
15q22 O 0 0.07029056549072266
and O 0 0.011171413585543633
17q21 O 0 0.28707337379455566
. O 0 0.019825611263513565

2 O 0 0.01360615249723196
respectively O 0 0.008286898955702782
, O 0 0.003574448637664318
regions O 0 0.0038948964793235064
prone O 0 0.061239100992679596
to O 0 0.002397193806245923
amplification O 0 0.006770215462893248
in O 0 0.0022087679244577885
some O 0 0.0028490747790783644
human O 0 0.013343756087124348
cancers B-Disease 1 0.9996479749679565
. O 0 0.01570882648229599

Additional O 0 0.011224756017327309
experiments O 0 0.007775288075208664
are O 0 0.0023684122134000063
needed O 0 0.003643638454377651
to O 0 0.001495544915087521
define O 0 0.002756698988378048
the O 0 0.0020487343426793814
role O 0 0.003252486465498805
of O 0 0.005904166027903557
CA O 1 0.9881992340087891
IX O 1 0.999972939491272
and O 0 0.005270302761346102
CA O 1 0.6772156357765198
XII O 1 0.999336302280426
enzymes O 0 0.0025304516311734915
in O 0 0.0014544628793373704
the O 0 0.0015597882447764277
regulation O 0 0.0026658636052161455
of O 0 0.0025558697525411844
pH O 0 0.019660232588648796
in O 0 0.001756137702614069
the O 0 0.002919078804552555
extracellular O 0 0.007699530106037855
microenvironment O 0 0.01781606674194336
and O 0 0.0017194588435813785
its O 0 0.0017720271134749055
potential O 0 0.0034543867222964764
impact O 0 0.006480860058218241
on O 0 0.016775529831647873
cancer B-Disease 1 0.9999964237213135
cell O 1 0.8423689007759094
growth O 0 0.05834759771823883
. O 0 0.01240068394690752

A O 0 0.015670353546738625
gene O 0 0.008598764427006245
encoding O 0 0.006886140909045935
a O 0 0.004430099856108427
transmembrane O 0 0.011873618699610233
protein O 0 0.004160238429903984
is O 0 0.0027245404198765755
mutated O 0 0.006698473356664181
in O 0 0.002952386625111103
patients O 1 0.998630702495575
with O 1 0.9912266135215759
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999997615814209
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999997615814209
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.894706130027771
. O 0 0.016976021230220795

Wolfram B-Disease 1 0.9999988079071045
syndrome I-Disease 1 1.0
( O 1 0.9980946183204651
WFS B-Disease 1 0.999997615814209
; O 0 0.021144870668649673
OMIM O 1 0.9999470710754395
222300 O 1 0.9774477481842041
) O 0 0.003562657628208399
is O 0 0.0024821371771395206
an O 0 0.005280376877635717
autosomal B-Disease 1 0.9999966621398926
recessive I-Disease 1 0.9999998807907104
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.642968475818634
by O 0 0.014718832448124886
young O 1 0.9571831822395325
- O 1 0.99896240234375
onset O 1 0.9999991655349731
non O 1 0.9993405938148499
- O 1 0.9999861717224121
immune O 1 0.9999983310699463
insulin B-Disease 1 0.9999973773956299
- I-Disease 1 0.9999780654907227
dependent I-Disease 1 0.9997031092643738
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9997108578681946
progressive O 1 0.9999998807907104
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999997615814209
. O 1 0.5218634605407715

Linkage O 0 0.029910825192928314
to O 0 0.006010257638990879
markers O 0 0.011565614491701126
on O 0 0.005811735522001982
chromosome O 0 0.014817253686487675
4p O 1 0.8155191540718079
was O 0 0.006846931762993336
confirmed O 0 0.00442700507119298
in O 0 0.0026702869217842817
five O 0 0.004205369856208563
families O 0 0.007575556635856628
. O 0 0.010815723799169064

On O 0 0.006974147632718086
the O 0 0.003884183242917061
basis O 0 0.0035671107470989227
of O 0 0.00465541472658515
meiotic O 1 0.9999388456344604
recombinants O 1 0.9999351501464844
and O 1 0.8673720955848694
disease O 1 1.0
- O 1 0.992379903793335
associated O 0 0.00957801379263401
haplotypes O 0 0.03141263499855995
, O 0 0.0019035672303289175
the O 0 0.003535469528287649
WFS B-Disease 1 0.9998880624771118
gene O 0 0.004157111980021
was O 0 0.0036769660655409098
localized O 0 0.004304870031774044
to O 0 0.002021098742261529
a O 0 0.005794038064777851
BAC O 1 0.9999282360076904
/ O 1 0.9702690839767456
P1 O 1 0.5122512578964233
contig O 0 0.013500949367880821
of O 0 0.0032977231312543154
less O 0 0.0035052683670073748
than O 0 0.003414159407839179
250 O 0 0.011290638707578182
kb O 0 0.04613678529858589
. O 0 0.01562580093741417

Mutations O 0 0.013676026836037636
in O 0 0.004641711711883545
a O 0 0.005279415287077427
novel O 0 0.012483278289437294
gene O 0 0.007053434383124113
( O 0 0.005399706773459911
WFS1 O 0 0.40838390588760376
) O 0 0.003169457195326686
encoding O 0 0.0035045321565121412
a O 0 0.003286967286840081
putative O 0 0.010730290785431862
transmembrane O 0 0.011810427531599998
protein O 0 0.0026229247450828552
were O 0 0.0013119069626554847
found O 0 0.001396206091158092
in O 0 0.0012237932533025742
all O 0 0.0010506520047783852
affected O 0 0.00170731614343822
individuals O 0 0.0008780737989582121
in O 0 0.001156215788796544
six O 0 0.0026740245521068573
WFS B-Disease 1 0.9998677968978882
families O 0 0.002329058712348342
, O 0 0.001370523008517921
and O 0 0.0010367261711508036
these O 0 0.0008643816690891981
mutations O 0 0.0018394249491393566
were O 0 0.0013148548314347863
associated O 0 0.002245105803012848
with O 0 0.0031094944570213556
the O 1 0.9576518535614014
disease O 1 0.9999998807907104
phenotype O 1 0.9980308413505554
. O 0 0.01428032387048006

WFS1 O 1 0.9252685904502869
appears O 0 0.008998014032840729
to O 0 0.0028598227072507143
function O 0 0.002722113858908415
in O 0 0.0017483280971646309
survival O 0 0.008668221533298492
of O 0 0.004569133743643761
islet O 1 0.9994657635688782
beta O 1 0.9957929849624634
- O 1 0.9690295457839966
cells O 0 0.0077646272256970406
and O 0 0.0035023847594857216
neurons O 0 0.009299740195274353
. O 0 0.005639894399791956
. O 0 0.009943922981619835

Stable O 0 0.023379812017083168
interaction O 0 0.005879496224224567
between O 0 0.00287060160189867
the O 0 0.0031549360137432814
products O 0 0.0032822436187416315
of O 0 0.00471060536801815
the O 0 0.44428813457489014
BRCA1 O 1 0.9999817609786987
and O 0 0.22957384586334229
BRCA2 O 1 0.9999899864196777
tumor B-Disease 1 0.9999829530715942
suppressor O 1 0.704757809638977
genes O 0 0.0050623174756765366
in O 0 0.004267494194209576
mitotic O 1 0.5892736315727234
and O 0 0.010228355415165424
meiotic O 1 0.9998819828033447
cells O 0 0.04325969144701958
. O 0 0.014240922406315804

BRCA1 O 1 0.9767642617225647
and O 0 0.007570316549390554
BRCA2 O 1 0.6709109544754028
account O 0 0.0028650681488215923
for O 0 0.0016818972071632743
most O 0 0.001322296797297895
cases O 0 0.0017357092583552003
of O 0 0.0028311454225331545
familial O 1 0.9995643496513367
, O 0 0.008192870765924454
early O 0 0.47463905811309814
onset O 1 0.9999998807907104
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9934142827987671
/ I-Disease 1 0.9999992847442627
or I-Disease 1 0.999194324016571
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.12811608612537384
encode O 0 0.004922931082546711
products O 0 0.0029914788901805878
that O 0 0.0016442443011328578
each O 0 0.0016165422275662422
interact O 0 0.004068309441208839
with O 0 0.004836478736251593
hRAD51 O 0 0.2738739550113678
. O 0 0.014107940718531609

Results O 0 0.010250043123960495
presented O 0 0.00869996938854456
here O 0 0.004540948197245598
show O 0 0.004108385648578405
that O 0 0.0027997565921396017
BRCA1 O 1 0.7195948362350464
and O 0 0.0027733026072382927
BRCA2 O 1 0.8797425031661987
coexist O 0 0.003846758510917425
in O 0 0.0017410152358934283
a O 0 0.002569301053881645
biochemical O 0 0.005721826106309891
complex O 0 0.004017808474600315
and O 0 0.002160698641091585
colocalize O 0 0.0817473828792572
in O 0 0.002417192328721285
subnuclear O 1 0.6071380376815796
foci O 0 0.1067294180393219
in O 0 0.0026020945515483618
somatic O 0 0.08259864896535873
cells O 0 0.0022458878811448812
and O 0 0.0010741215664893389
on O 0 0.001575555419549346
the O 0 0.0024913728702813387
axial O 0 0.006707162596285343
elements O 0 0.003321638097986579
of O 0 0.004222940653562546
developing O 0 0.07153357565402985
synaptonemal O 1 0.9925702214241028
complexes O 0 0.1383509337902069
. O 0 0.016003010794520378

Like O 0 0.024910977110266685
BRCA1 O 1 0.8931542038917542
and O 0 0.010825308971107006
RAD51 O 1 0.9996904134750366
, O 0 0.010389883071184158
BRCA2 O 1 0.9825075268745422
relocates O 0 0.08044476807117462
to O 0 0.005937420763075352
PCNA O 1 0.9757132530212402
+ O 0 0.00831560604274273
replication O 0 0.005516468547284603
sites O 0 0.0021146689541637897
following O 0 0.0023286682553589344
exposure O 0 0.006113789509981871
of O 0 0.005409939214587212
S O 1 0.9987925291061401
phase O 1 0.5470042824745178
cells O 0 0.005914743524044752
to O 0 0.004381134174764156
hydroxyurea O 1 0.8579279184341431
or O 0 0.011796572245657444
UV O 1 0.9944325089454651
irradiation O 0 0.09845257550477982
. O 0 0.01789093390107155

Thus O 0 0.01497049629688263
, O 0 0.009336107410490513
BRCA1 O 1 0.9608347415924072
and O 0 0.004494688007980585
BRCA2 O 1 0.8680524230003357
participate O 0 0.0022654500789940357
, O 0 0.0014129845658317208
together O 0 0.0011537623358890414
, O 0 0.0010721638100221753
in O 0 0.0011509641772136092
a O 0 0.002373797120526433
pathway O 0 0.006225538440048695
( O 0 0.002823042217642069
s O 0 0.005402481183409691
) O 0 0.0012043500319123268
associated O 0 0.0011028868611901999
with O 0 0.0007943053497001529
the O 0 0.0013465924421325326
activation O 0 0.002218794310465455
of O 0 0.0017356978496536613
double O 0 0.012155651114881039
- O 0 0.11282312870025635
strand O 0 0.0072712367400527
break O 0 0.005459838546812534
repair O 1 0.9147051572799683
and O 0 0.004682512953877449
/ O 1 0.7145993709564209
or O 0 0.004619787912815809
homologous O 0 0.019881920889019966
recombination O 0 0.020886652171611786
. O 0 0.012709442526102066

Dysfunction O 1 0.9997982382774353
of O 0 0.050614021718502045
this O 0 0.009699329733848572
pathway O 0 0.24810929596424103
may O 0 0.0024494589306414127
be O 0 0.0010061690118163824
a O 0 0.0014733114512637258
general O 0 0.002191255334764719
phenomenon O 0 0.0022452971898019314
in O 0 0.0009022046579048038
the O 0 0.0010111939627677202
majority O 0 0.0008920428226701915
of O 0 0.0011264720233157277
cases O 0 0.001890713581815362
of O 0 0.4256037771701813
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999529123306274
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9998965263366699
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.13935969769954681
. O 0 0.013614154420793056

A O 0 0.023376066237688065
novel O 0 0.028613384813070297
Arg362Ser O 0 0.24407123029232025
mutation O 0 0.008718469180166721
in O 0 0.0034179873764514923
the O 0 0.005103269591927528
sterol O 0 0.051921021193265915
27 O 0 0.009185496717691422
- O 0 0.014921767637133598
hydroxylase O 0 0.023250898346304893
gene O 0 0.005556089337915182
( O 0 0.004203978460282087
CYP27 O 0 0.19926416873931885
) O 0 0.001915516215376556
: O 0 0.0014333348954096437
its O 0 0.001252148300409317
effects O 0 0.002672960050404072
on O 0 0.002199791604653001
pre O 0 0.018995387479662895
- O 0 0.013403104618191719
mRNA O 0 0.00809506606310606
splicing O 0 0.00877718348056078
and O 0 0.004180877935141325
enzyme O 0 0.01102692261338234
activity O 0 0.010247304104268551
. O 0 0.013375458307564259

A O 0 0.013500753790140152
novel O 0 0.015325662679970264
C O 0 0.00964993517845869
to O 0 0.002066670684143901
A O 0 0.0032465311232954264
mutation O 0 0.00267358822748065
in O 0 0.0011777085019275546
the O 0 0.0024192272685468197
sterol O 0 0.030445411801338196
27 O 0 0.005456181708723307
- O 0 0.010526388883590698
hydroxylase O 0 0.020689593628048897
gene O 0 0.004054411314427853
( O 0 0.003099462715908885
CYP27 O 0 0.32962822914123535
) O 0 0.002007725415751338
was O 0 0.0020523525308817625
identified O 0 0.002210893202573061
by O 0 0.0014788396656513214
sequencing O 0 0.004543263930827379
amplified O 0 0.0068168737925589085
CYP27 O 1 0.506658673286438
gene O 0 0.002603498287498951
products O 0 0.0018885009922087193
from O 0 0.0014571206411346793
a O 0 0.0031781785655766726
patient O 0 0.3850281238555908
with O 0 0.005190503317862749
cerebrotendinous B-Disease 1 0.9999773502349854
xanthomatosis I-Disease 1 0.9999834299087524
( O 0 0.3732767403125763
CTX B-Disease 1 0.9999834299087524
) O 0 0.012424551881849766
. O 0 0.012169580906629562

The O 0 0.016141993924975395
mutation O 0 0.015840692445635796
changed O 0 0.007960150018334389
the O 0 0.006105879321694374
adrenodoxin O 0 0.45814040303230286
cofactor O 0 0.03605205565690994
binding O 0 0.005260458216071129
residue O 0 0.011435549706220627
362Arg O 0 0.013881403021514416
to O 0 0.0032847512047737837
362Ser O 0 0.07153334468603134
( O 0 0.007560607511550188
CGT O 1 0.9931633472442627
362Arg O 0 0.40183448791503906
to O 0 0.00490698404610157
AGT O 1 0.9999957084655762
362Ser O 1 0.9194653630256653
) O 0 0.0026630826760083437
, O 0 0.0015093637630343437
and O 0 0.0012444189051166177
was O 0 0.003956312779337168
responsible O 0 0.004401539918035269
for O 0 0.00365894241258502
deficiency O 1 0.999997615814209
in O 0 0.002655551303178072
the O 0 0.005612335167825222
sterol O 1 0.955896258354187
27 O 0 0.008973352611064911
- O 0 0.030385611578822136
hydroxylase O 0 0.010491089895367622
activity O 0 0.002274339087307453
, O 0 0.001338744885288179
as O 0 0.0015059498837217689
confirmed O 0 0.0018685278482735157
by O 0 0.0009882813319563866
expression O 0 0.002068587113171816
of O 0 0.0026653818786144257
mutant O 0 0.00969135481864214
cDNA O 0 0.009748387150466442
into O 0 0.004998094867914915
COS O 1 0.9986225366592407
- O 0 0.08339345455169678
1 O 0 0.012907885015010834
cells O 0 0.01243116520345211
. O 0 0.010797281749546528

Quantitative O 0 0.01531250774860382
analysis O 0 0.00576162850484252
showed O 0 0.005393561441451311
that O 0 0.00185516313649714
the O 0 0.002393634058535099
expression O 0 0.0030149449594318867
of O 0 0.0034010037779808044
CYP27 O 1 0.9948856234550476
gene O 0 0.004006809089332819
mRNA O 0 0.003555628238245845
in O 0 0.001898328773677349
the O 0 0.003262355225160718
patient O 0 0.017186323180794716
represented O 0 0.008181950077414513
52 O 0 0.014067554846405983
. O 0 0.011070333421230316

5 O 0 0.01289154589176178
% O 0 0.006169205531477928
of O 0 0.0038832554128021
the O 0 0.007267426699399948
normal O 0 0.01186281442642212
level O 0 0.013205524533987045
. O 0 0.011569180525839329

As O 0 0.009869817644357681
the O 0 0.006409354507923126
mutation O 0 0.006988579872995615
occurred O 0 0.004355261567980051
at O 0 0.002922258572652936
the O 0 0.003293500514701009
penultimate O 0 0.030567551031708717
nucleotide O 0 0.004434088710695505
of O 0 0.0026748294476419687
exon O 0 0.010252732783555984
6 O 0 0.003687656717374921
( O 0 0.002564447233453393
- O 0 0.0031760577112436295
2 O 0 0.0022794094402343035
position O 0 0.0020247127395123243
of O 0 0.002410834189504385
exon O 0 0.011260487139225006
6 O 0 0.005469295661896467
- O 0 0.0074349394999444485
intron O 0 0.11432276666164398
6 O 0 0.0044914474710822105
splice O 0 0.0063832588493824005
site O 0 0.002499405760318041
) O 0 0.0013446278171613812
of O 0 0.00139376160223037
the O 0 0.002028333954513073
gene O 0 0.002243822207674384
, O 0 0.0014395597390830517
we O 0 0.0014825536636635661
hypothesized O 0 0.003600770141929388
that O 0 0.001199862570501864
the O 0 0.001894467743113637
mutation O 0 0.004340378567576408
may O 0 0.0024310399312525988
partially O 0 0.004746659193187952
affect O 0 0.002184045035392046
the O 0 0.002015609759837389
normal O 0 0.003447158494964242
splicing O 0 0.0042453729547560215
efficiency O 0 0.004057181067764759
in O 0 0.0020276198629289865
exon O 0 0.009996917098760605
6 O 0 0.0034453473053872585
and O 0 0.0018932977691292763
cause O 0 0.0042809173464775085
alternative O 0 0.0030130078084766865
splicing O 0 0.003828175365924835
elsewhere O 0 0.001973118633031845
, O 0 0.0013955507893115282
which O 0 0.0011982722207903862
resulted O 0 0.0028198922518640757
in O 0 0.002183258533477783
decreased O 0 0.02672305330634117
transcript O 0 0.006917333696037531
in O 0 0.0032242550514638424
the O 0 0.0071776257827878
patient O 1 0.9632710218429565
. O 0 0.012641329318284988

Transfection O 0 0.17511673271656036
of O 0 0.010144813917577267
constructed O 0 0.21919994056224823
minigenes O 1 0.8832197785377502
, O 0 0.002696582581847906
with O 0 0.0014794813469052315
or O 0 0.0012553606647998095
without O 0 0.0011717678280547261
the O 0 0.0015171610284596682
mutation O 0 0.0023788611870259047
, O 0 0.001492515904828906
into O 0 0.002451202366501093
COS O 1 0.999871015548706
- O 0 0.009020015597343445
1 O 0 0.0027334587648510933
cells O 0 0.0015803786227479577
confirmed O 0 0.0013607051223516464
that O 0 0.0007588345324620605
the O 0 0.0014771058922633529
mutant O 0 0.006747398059815168
minigene O 0 0.20338229835033417
was O 0 0.0034470963291823864
responsible O 0 0.002111164154484868
for O 0 0.0010323377791792154
a O 0 0.0019851764664053917
mRNA O 0 0.003156419610604644
species O 0 0.0010999238584190607
alternatively O 0 0.0030088683124631643
spliced O 0 0.0035932029131799936
at O 0 0.0020566601306200027
an O 0 0.0020646790508180857
activated O 0 0.00771444384008646
cryptic O 0 0.006649554241448641
5 O 0 0.0031771045178174973
splice O 0 0.0075056166388094425
site O 0 0.0037996068131178617
88 O 0 0.005808509886264801
bp O 0 0.006165213417261839
upstream O 0 0.0036388190928846598
from O 0 0.0016334062675014138
the O 0 0.002363582607358694
3 O 0 0.003456679405644536
end O 0 0.004022617824375629
of O 0 0.005564621649682522
exon O 0 0.047546543180942535
6 O 0 0.015836484730243683
. O 0 0.012531701475381851

Our O 0 0.008459806442260742
data O 0 0.00411205505952239
suggest O 0 0.0035201702266931534
that O 0 0.0014270003885030746
the O 0 0.0020734278950840235
C O 0 0.0042757755145430565
to O 0 0.0012191595742478967
A O 0 0.0026184627786278725
mutation O 0 0.002771650906652212
at O 0 0.0019898337777704
the O 0 0.002127921674400568
penultimate O 0 0.015022026374936104
nucleotide O 0 0.0032451024744659662
of O 0 0.002085116459056735
exon O 0 0.006598195992410183
6 O 0 0.002341251587495208
of O 0 0.001535812858492136
the O 0 0.00243417383171618
CYP27 O 1 0.9941551089286804
gene O 0 0.0020009875297546387
not O 0 0.0008343990193679929
only O 0 0.0011785485548898578
causes O 0 0.010720031335949898
the O 0 0.026474300771951675
deficiency B-Disease 1 0.9999990463256836
in I-Disease 0 0.0030631404370069504
the I-Disease 0 0.00567967165261507
sterol I-Disease 1 0.9395626783370972
27 I-Disease 0 0.009498857893049717
- I-Disease 0 0.025755519047379494
hydroxylase I-Disease 0 0.012518119066953659
activity I-Disease 0 0.00209347577765584
, O 0 0.0012122559128329158
but O 0 0.0009430197533220053
also O 0 0.001486060325987637
partially O 0 0.0041030398570001125
leads O 0 0.0028289789333939552
to O 0 0.0015743350377306342
alternative O 0 0.0036252953577786684
pre O 0 0.008841226808726788
- O 0 0.007835577242076397
mRNA O 0 0.006357166450470686
splicing O 0 0.006729628425091505
of O 0 0.003441263223066926
the O 0 0.005566510371863842
gene O 0 0.013453204184770584
. O 0 0.011393053457140923

To O 0 0.007290071342140436
our O 0 0.0054328530095517635
knowledge O 0 0.004219368565827608
, O 0 0.0023549371398985386
this O 0 0.0012879334390163422
is O 0 0.0014025476993992925
the O 0 0.0015809686155989766
first O 0 0.0015363480197265744
report O 0 0.0017182162264361978
regarding O 0 0.0018911075312644243
effects O 0 0.0029723122715950012
on O 0 0.001916590379551053
pre O 0 0.007768295239657164
- O 0 0.004885862581431866
mRNA O 0 0.003165394999086857
splicing O 0 0.002265757415443659
of O 0 0.0011381865479052067
a O 0 0.0015454200329259038
mutation O 0 0.0020202326122671366
at O 0 0.001777233905158937
the O 0 0.002200237475335598
- O 0 0.0035743771586567163
2 O 0 0.002274860627949238
position O 0 0.001828478998504579
of O 0 0.0018348712474107742
a O 0 0.003324319841340184
5 O 0 0.005461385007947683
splice O 0 0.01658838614821434
site O 0 0.012537302449345589
. O 0 0.012318595312535763

ATM O 0 0.07218005508184433
germline O 0 0.06472543627023697
mutations O 0 0.009220149368047714
in O 0 0.004943088162690401
classical O 0 0.34920841455459595
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999985694885254
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.9996864795684814
in O 0 0.00403164466843009
the O 0 0.006072270218282938
Dutch O 0 0.0617503859102726
population O 0 0.00793401524424553
. O 0 0.010561036877334118

Germline O 0 0.4601256549358368
mutations O 0 0.012173369526863098
in O 0 0.004024212714284658
the O 0 0.004113428294658661
ATM O 0 0.01159162912517786
gene O 0 0.0024016336537897587
are O 0 0.00092480139574036
responsible O 0 0.0021591205149888992
for O 0 0.0020488612353801727
the O 0 0.3185417950153351
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9998418092727661
A B-Disease 1 0.9999899864196777
- I-Disease 1 0.9999895095825195
T I-Disease 1 0.9999583959579468
) O 0 0.0084144975990057
. O 0 0.01071101427078247

In O 0 0.00626641558483243
our O 0 0.004103661514818668
study O 0 0.003231834853067994
, O 0 0.0017241134773939848
we O 0 0.0012206394458189607
have O 0 0.0008405621047131717
determined O 0 0.0017844762187451124
the O 0 0.0016114097088575363
ATM O 0 0.005090420600026846
mutation O 0 0.002340938663110137
spectrum O 0 0.001577395829372108
in O 0 0.0008991538197733462
19 O 0 0.0017672206740826368
classical O 0 0.003306508529931307
A B-Disease 1 0.9883236885070801
- I-Disease 1 0.9999873638153076
T I-Disease 1 0.9999970197677612
patients O 1 0.690559983253479
, O 0 0.0010707755573093891
including O 0 0.0007788804941810668
some O 0 0.0008423412800766528
immigrant O 0 0.002914067357778549
populations O 0 0.0015655540628358722
, O 0 0.0010886624222621322
as O 0 0.0009773465571925044
well O 0 0.0008394183241762221
as O 0 0.001202864688821137
12 O 0 0.0018158704042434692
of O 0 0.0018874101806432009
Dutch O 0 0.006767028942704201
ethnic O 0 0.005609866231679916
origin O 0 0.007670199498534203
. O 0 0.01076310034841299

Both O 0 0.009513413533568382
the O 0 0.007548523601144552
protein O 0 0.0075571732595562935
truncation O 0 0.014599191024899483
test O 0 0.0053711747750639915
( O 0 0.004338003229349852
PTT O 0 0.01183998677879572
) O 0 0.0020228857174515724
and O 0 0.0012968829832971096
the O 0 0.002384399063885212
restriction O 0 0.004937369376420975
endonuclease O 0 0.019547034054994583
fingerprinting O 0 0.010295159183442593
( O 0 0.00443110940977931
REF O 0 0.028877750039100647
) O 0 0.001552306697703898
method O 0 0.0014716973528265953
were O 0 0.0011130309430882335
used O 0 0.0011499199317768216
and O 0 0.0009583104983903468
compared O 0 0.0013090930879116058
for O 0 0.0008688867092132568
their O 0 0.0010266202734783292
detection O 0 0.002827015472576022
efficiency O 0 0.0028846680652350187
, O 0 0.0012904794421046972
identifying O 0 0.002474689157679677
76 O 0 0.003499403828755021
% O 0 0.0013044170336797833
and O 0 0.000934639188926667
60 O 0 0.0018293512985110283
% O 0 0.0015623226063326001
of O 0 0.0017290051328018308
the O 0 0.003271755063906312
mutations O 0 0.005902803502976894
, O 0 0.004293631296604872
respectively O 0 0.01182007510215044
. O 0 0.010304238647222519

Most O 0 0.012301996350288391
patients O 0 0.10894517600536346
were O 0 0.0037318409886211157
found O 0 0.0034617038909345865
to O 0 0.0029970675241202116
be O 0 0.004340337123721838
compound O 0 0.025678865611553192
heterozygote O 0 0.4511300027370453
. O 0 0.01402329932898283

Seventeen O 0 0.024511992931365967
mutations O 0 0.009074916131794453
were O 0 0.0032513225451111794
distinct O 0 0.0029469062574207783
, O 0 0.0018084213370457292
of O 0 0.0019975232426077127
which O 0 0.0013528023846447468
10 O 0 0.0020936510991305113
were O 0 0.001791209215298295
not O 0 0.001999689033254981
reported O 0 0.006120765116065741
previously O 0 0.009988689795136452
. O 0 0.013151783496141434

Mutations O 0 0.014112716540694237
are O 0 0.00331299239769578
small O 0 0.004427858628332615
deletions O 0 0.01032850332558155
or O 0 0.003838121658191085
point O 0 0.0075137559324502945
mutations O 0 0.008313757367432117
frequently O 0 0.008006928488612175
affecting O 0 0.013673029839992523
splice O 0 0.03324372321367264
sites O 0 0.014209935441613197
. O 0 0.015257645398378372

Moreover O 0 0.02801375277340412
, O 0 0.010019117034971714
a O 0 0.012432236224412918
16 O 0 0.018824592232704163
. O 0 0.017600389197468758

7 O 0 0.027998344972729683
- O 0 0.021138103678822517
kb O 0 0.027407173067331314
genomic O 0 0.011412370949983597
deletion O 0 0.006861102767288685
of O 0 0.002778166439384222
the O 0 0.0022929476108402014
3 O 0 0.0025542578659951687
end O 0 0.001850993256084621
of O 0 0.0016553711611777544
the O 0 0.002414185320958495
gene O 0 0.0020196675322949886
, O 0 0.0009845298482105136
most O 0 0.0007002911297604442
likely O 0 0.0010049217380583286
a O 0 0.0011022971011698246
result O 0 0.0011755273444578052
of O 0 0.0012870975770056248
recombination O 0 0.002486059907823801
between O 0 0.0010085077956318855
two O 0 0.0010861947666853666
LINE O 0 0.004021490458399057
elements O 0 0.002719910116866231
, O 0 0.0031929458491504192
was O 0 0.008554807864129543
identified O 0 0.01092554721981287
. O 0 0.011539136059582233

The O 0 0.009285884909331799
most O 0 0.0036807989235967398
frequently O 0 0.0035969370510429144
found O 0 0.0030245091766119003
mutation O 0 0.003739530686289072
, O 0 0.0014514686772599816
identified O 0 0.0014516194351017475
in O 0 0.0008232577820308506
three O 0 0.0009250357979908586
unrelated O 0 0.0033537368290126324
Turkish O 0 0.006801343522965908
A B-Disease 1 0.998012900352478
- I-Disease 1 0.9997759461402893
T I-Disease 1 0.9991893172264099
individuals O 0 0.0010088892886415124
, O 0 0.0011758796172216535
was O 0 0.002250709803774953
previously O 0 0.001738979248329997
described O 0 0.0016328642377629876
to O 0 0.0008333120495080948
be O 0 0.0007342799799516797
a O 0 0.0016907387180253863
Turkish O 0 0.005757731851190329
A B-Disease 1 0.9560606479644775
- I-Disease 1 0.9992030262947083
T I-Disease 1 0.9999054670333862
founder O 1 0.8796870708465576
mutation O 0 0.023800194263458252
. O 0 0.01413094811141491

The O 0 0.00829241331666708
presence O 0 0.0051513249054551125
of O 0 0.0033501493744552135
a O 0 0.005957046989351511
founder O 1 0.9942721128463745
mutation O 0 0.024780409410595894
among O 0 0.0017041811952367425
relatively O 0 0.0014679142041131854
small O 0 0.001035645604133606
ethnic O 0 0.0014338986948132515
population O 0 0.0011488392483443022
groups O 0 0.0007839574827812612
in O 0 0.0010101828956976533
Western O 0 0.0016785539919510484
Europe O 0 0.0018718374194577336
could O 0 0.001137223094701767
indicate O 0 0.001980107743293047
a O 0 0.0017866180278360844
high O 0 0.0039058492984622717
carrier O 0 0.006298556923866272
frequency O 0 0.0024250801652669907
in O 0 0.002062807325273752
such O 0 0.0025550092104822397
communities O 0 0.006687393877655268
. O 0 0.010910212993621826

In O 0 0.009176284074783325
patients O 0 0.046060651540756226
of O 0 0.004433522932231426
Dutch O 0 0.07220663130283356
ethnic O 0 0.0041985162533819675
origin O 0 0.0028624169062823057
, O 0 0.002074691466987133
however O 0 0.0015267301350831985
, O 0 0.0016210597241297364
no O 0 0.0020071924664080143
significant O 0 0.002757103182375431
founder O 0 0.41678526997566223
effect O 0 0.004273196216672659
could O 0 0.0022602539975196123
be O 0 0.0030320524238049984
identified O 0 0.008237072266638279
. O 0 0.009513081051409245

The O 0 0.009751765988767147
observed O 0 0.00808661337941885
genetic O 0 0.006041451822966337
heterogeneity O 0 0.008064203895628452
including O 0 0.0021775858476758003
the O 0 0.002792232669889927
relative O 0 0.0039529395289719105
high O 0 0.004248632118105888
percentage O 0 0.0036172710824757814
of O 0 0.003097008913755417
splice O 1 0.5569766163825989
- O 0 0.014278315007686615
site O 0 0.004463241435587406
mutations O 0 0.0034306489396840334
had O 0 0.002307870425283909
no O 0 0.0025363063905388117
reflection O 0 0.006560052279382944
on O 0 0.004850991070270538
the O 0 0.01026063784956932
phenotype O 0 0.04101886600255966
. O 0 0.013430958613753319

All O 0 0.009523438289761543
patients O 0 0.16124634444713593
manifested O 0 0.3162382245063782
classical O 0 0.030810290947556496
A B-Disease 1 0.9998458623886108
- I-Disease 1 0.9999910593032837
T I-Disease 1 0.9999547004699707
and O 0 0.003290640190243721
increased O 0 0.0059168655425310135
cellular O 0 0.010305717587471008
radioresistant O 0 0.4925914704799652
DNA O 0 0.011573171243071556
synthesis O 0 0.016699159517884254
. O 0 0.011546846479177475

Determination O 0 0.016544600948691368
of O 0 0.00546356150880456
the O 0 0.004177387338131666
genomic O 0 0.0070981355383992195
structure O 0 0.003932214342057705
of O 0 0.0028242950793355703
the O 0 0.007538770325481892
COL4A4 O 1 0.9986650943756104
gene O 0 0.0030604880303144455
and O 0 0.0015039178542792797
of O 0 0.003150275442749262
novel O 1 0.918133556842804
mutations O 1 0.9551423192024231
causing O 1 0.9998718500137329
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.998960018157959

Autosomal B-Disease 1 0.9999967813491821
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.989697277545929
a O 1 0.9936362504959106
progressive O 1 0.9999990463256836
hematuric B-Disease 1 0.9999996423721313
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9998865127563477
by O 1 0.7002713680267334
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999984502792358
membrane I-Disease 1 0.9984757304191589
abnormalities I-Disease 1 0.9971129894256592
and O 0 0.0017296143341809511
associated O 0 0.0020752009004354477
with O 0 0.0011235954007133842
mutations O 0 0.0017224301118403673
in O 0 0.0009418156696483493
either O 0 0.0012327971635386348
the O 0 0.00196079071611166
COL4A3 O 1 0.9865381717681885
or O 0 0.0017577407415956259
the O 0 0.0028149676509201527
COL4A4 O 1 0.9916085600852966
gene O 0 0.001965013099834323
, O 0 0.0010047360556200147
which O 0 0.0008137766853906214
encode O 0 0.0019513737643137574
the O 0 0.001908354926854372
alpha3 O 0 0.020750664174556732
and O 0 0.0032318714074790478
alpha4 O 1 0.9995885491371155
type O 1 0.9998455047607422
IV O 1 0.9999998807907104
collagen O 1 0.9999970197677612
chains O 0 0.23244795203208923
, O 0 0.007988576777279377
respectively O 0 0.016101568937301636
. O 0 0.012943041510879993

To O 0 0.00722001725807786
date O 0 0.006803973112255335
, O 0 0.0033750084694474936
mutation O 0 0.004539935849606991
screening O 0 0.0033183563500642776
in O 0 0.0014849853469058871
the O 0 0.0016174566699191928
two O 0 0.0010941248619928956
genes O 0 0.001590432832017541
has O 0 0.0013373849214985967
been O 0 0.0015343187842518091
hampered O 0 0.025390537455677986
by O 0 0.0013900620397180319
the O 0 0.002340512117370963
lack O 0 0.005223243962973356
of O 0 0.004903730005025864
genomic O 0 0.02647673711180687
structure O 0 0.009088476188480854
information O 0 0.00672195153310895
. O 0 0.011624044738709927

We O 0 0.007234756834805012
report O 0 0.004990121815353632
here O 0 0.0030872547067701817
the O 0 0.0023803734220564365
complete O 0 0.003016452072188258
characterization O 0 0.005369447637349367
of O 0 0.0022744862362742424
the O 0 0.002614016178995371
48 O 0 0.0035094330087304115
exons O 0 0.004210434854030609
of O 0 0.0019070111447945237
the O 0 0.0032563507556915283
COL4A4 O 1 0.9714909791946411
gene O 0 0.0029736622236669064
, O 0 0.0014915455831214786
a O 0 0.0017786521930247545
comprehensive O 0 0.0036355964839458466
gene O 0 0.002128257881850004
screen O 0 0.0020263735204935074
, O 0 0.0010930373100563884
and O 0 0.0010046048555523157
the O 0 0.0013253025244921446
subsequent O 0 0.0021752475295215845
detection O 0 0.002830141456797719
of O 0 0.001684405142441392
10 O 0 0.001867811195552349
novel O 0 0.0032958807423710823
mutations O 0 0.002141387900337577
in O 0 0.0015451963990926743
eight O 0 0.005102966912090778
patients O 1 0.999980092048645
diagnosed O 1 1.0
with O 1 0.9972387552261353
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9988372921943665

Furthermore O 0 0.01723724976181984
, O 0 0.004088906571269035
we O 0 0.002785570453852415
identified O 0 0.0031552405562251806
a O 0 0.002937427954748273
glycine O 0 0.008064966648817062
to O 0 0.002222216222435236
alanine O 0 0.00857299380004406
substitution O 0 0.0046273935586214066
in O 0 0.0023452001623809338
the O 0 0.00389499100856483
collagenous O 1 0.9766806960105896
domain O 0 0.003573697991669178
that O 0 0.0012484827311709523
is O 0 0.0014346621464937925
apparently O 0 0.0025461679324507713
silent O 0 0.003942488227039576
in O 0 0.0016694837249815464
the O 0 0.0024190591648221016
heterozygous O 0 0.004796612076461315
carriers O 0 0.003531441790983081
, O 0 0.002395864576101303
in O 0 0.003080441150814295
11 O 0 0.008748430758714676
. O 0 0.00934252142906189

5 O 0 0.008327134884893894
% O 0 0.003932565450668335
of O 0 0.0020079929381608963
all O 0 0.0014512146590277553
control O 0 0.002250660676509142
individuals O 0 0.0010294017847627401
, O 0 0.000983576406724751
and O 0 0.0008759546326473355
in O 0 0.0011375757167115808
one O 0 0.0011634501861408353
control O 0 0.0019862328190356493
individual O 0 0.0015036271652206779
homozygous O 0 0.0037090599071234465
for O 0 0.0019795142579823732
this O 0 0.0032146580051630735
glycine O 0 0.02166864089667797
substitution O 0 0.016478179022669792
. O 0 0.012863433919847012

There O 0 0.007133613806217909
has O 0 0.003875589929521084
been O 0 0.002138886833563447
no O 0 0.0018208591500297189
previous O 0 0.00186634692363441
finding O 0 0.0020537397358566523
of O 0 0.0021350819151848555
a O 0 0.003988910466432571
glycine O 0 0.18742455542087555
substitution O 0 0.004093647468835115
that O 0 0.0011073031928390265
is O 0 0.0010635077487677336
not O 0 0.0007633831119164824
associated O 0 0.0012308164732530713
with O 0 0.0010568841826170683
any O 0 0.0017861452652141452
obvious O 0 0.00759371742606163
phenotype O 0 0.0103241465985775
in O 0 0.0037446964997798204
homozygous O 0 0.012833001092076302
individuals O 0 0.005894213914871216
. O 0 0.0109719168394804

Founder O 1 0.9217087626457214
BRCA1 O 1 0.9713547825813293
and O 0 0.008484167978167534
BRCA2 O 1 0.8997635245323181
mutations O 0 0.004862975794821978
in O 0 0.002569276373833418
French O 1 0.5990007519721985
Canadian O 1 0.9996974468231201
breast B-Disease 1 1.0
and I-Disease 1 0.9999725818634033
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9864708781242371
. O 0 0.021243780851364136

We O 0 0.005928173661231995
have O 0 0.0023950838949531317
identified O 0 0.0024072998203337193
four O 0 0.0013518016785383224
mutations O 0 0.0014550082851201296
in O 0 0.0007615707581862807
each O 0 0.0007149057346396148
of O 0 0.001639454741962254
the O 1 0.8344637751579285
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9999387264251709
susceptibility O 1 0.9991664886474609
genes O 0 0.003302141325548291
, O 0 0.0024000483099371195
BRCA1 O 0 0.20969736576080322
and O 0 0.0020292955450713634
BRCA2 O 0 0.009917804040014744
, O 0 0.0015832417411729693
in O 0 0.0016057563479989767
French O 0 0.007760786917060614
Canadian O 1 0.9226107001304626
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
and O 1 0.9999682903289795
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.7669094800949097
from O 0 0.015040481463074684
Quebec O 1 0.8831064701080322
. O 0 0.015760326758027077

To O 0 0.007457724306732416
identify O 0 0.008381403982639313
founder O 0 0.16823753714561462
effects O 0 0.012096510268747807
, O 0 0.0025812648236751556
we O 0 0.0017686260398477316
examined O 0 0.0032024544198065996
independently O 0 0.0024872547946870327
ascertained O 0 0.006708306726068258
French O 0 0.006120491772890091
Canadian O 0 0.0858188048005104
cancer B-Disease 1 0.9988802075386047
families O 0 0.0021519800648093224
for O 0 0.0016574141336604953
the O 0 0.0019171925960108638
distribution O 0 0.002144648926332593
of O 0 0.0023427880369126797
these O 0 0.0021971850655972958
eight O 0 0.005486729554831982
mutations O 0 0.010440344922244549
. O 0 0.009873542003333569

Mutations O 0 0.012675847858190536
were O 0 0.00391795951873064
found O 0 0.0032358048483729362
in O 0 0.003131367266178131
41 O 0 0.007067035883665085
of O 0 0.00605627940967679
97 O 0 0.03564637526869774
families O 0 0.011210363358259201
. O 0 0.01376213040202856

Six O 0 0.006763168144971132
of O 0 0.003976273350417614
eight O 0 0.003464269684627652
mutations O 0 0.0033565338235348463
were O 0 0.0015578276943415403
observed O 0 0.002409059554338455
at O 0 0.0029043438844382763
least O 0 0.0031063479837030172
twice O 0 0.00729010533541441
. O 0 0.008633332327008247

The O 0 0.023523807525634766
BRCA1 O 1 0.9962520003318787
C4446T O 1 0.9384825825691223
mutation O 0 0.020493490621447563
was O 0 0.006983181461691856
the O 0 0.00277905841358006
most O 0 0.0018039148999378085
common O 0 0.0031626340933144093
mutation O 0 0.003965199459344149
found O 0 0.002082433784380555
, O 0 0.001958224456757307
followed O 0 0.0029594835359603167
by O 0 0.00276185036636889
the O 0 0.009487774223089218
BRCA2 O 1 0.9992812275886536
8765delAG O 1 0.9853559136390686
mutation O 0 0.023297229781746864
. O 0 0.013572193682193756

Together O 0 0.007799030747264624
, O 0 0.004193989094346762
these O 0 0.0017984247533604503
mutations O 0 0.0025890935212373734
were O 0 0.0012551371473819017
found O 0 0.0013053871225565672
in O 0 0.00120269984472543
28 O 0 0.0019845557399094105
of O 0 0.0016590234590694308
41 O 0 0.0033392994664609432
families O 0 0.0017549049807712436
identified O 0 0.002025203313678503
to O 0 0.0013558831997215748
have O 0 0.0018161062616854906
a O 0 0.004778387490659952
mutation O 0 0.012478407472372055
. O 0 0.008566909469664097

The O 0 0.011553939431905746
odds O 0 0.012927832081913948
of O 0 0.004103160463273525
detection O 0 0.005883700679987669
of O 0 0.0024394034408032894
any O 0 0.0013269811170175672
of O 0 0.0016552078304812312
the O 0 0.002554625039920211
four O 0 0.0030512535013258457
BRCA1 O 1 0.9768451452255249
mutations O 0 0.0053656622767448425
was O 0 0.006940728053450584
18 O 0 0.008182141929864883
. O 0 0.00909312441945076

7x O 1 0.761541485786438
greater O 0 0.008281947113573551
if O 0 0.002801073482260108
one O 0 0.0016329730860888958
or O 0 0.0013021494960412383
more O 0 0.0009561353945173323
cases O 0 0.0027832372579723597
of O 1 0.9976168870925903
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.05872463434934616
also O 0 0.0030247217509895563
present O 0 0.002407077932730317
in O 0 0.0020966720767319202
the O 0 0.005579994060099125
family O 0 0.020749066025018692
. O 0 0.010540776886045933

The O 0 0.012074500322341919
odds O 0 0.013103388249874115
of O 0 0.00424091424793005
detection O 0 0.006839205976575613
of O 0 0.0030586090870201588
any O 0 0.0015464636962860823
of O 0 0.0019138596253469586
the O 0 0.0032932059839367867
four O 0 0.003971067722886801
BRCA2 O 1 0.9653186202049255
mutations O 0 0.007175413891673088
was O 0 0.009376521222293377
5 O 0 0.009827995672821999
. O 0 0.010167338885366917

3x O 1 0.5235724449157715
greater O 0 0.0073753418400883675
if O 0 0.0018272523302584887
there O 0 0.0010947422124445438
were O 0 0.0009378184331580997
at O 0 0.001080935588106513
least O 0 0.0008619733853265643
five O 0 0.0009158903849311173
cases O 0 0.002007202012464404
of O 1 0.8287249803543091
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.08586077392101288
the O 0 0.31339123845100403
family O 0 0.20167459547519684
. O 0 0.01071859523653984

Interestingly O 0 0.022398408502340317
, O 0 0.004238170571625233
the O 0 0.003343901364132762
presence O 0 0.0036900995764881372
of O 0 0.004605334252119064
a O 1 0.9771023392677307
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
case O 0 0.44577327370643616
< O 0 0.048511404544115067
36 O 0 0.0025240015238523483
years O 0 0.0014261859469115734
of O 0 0.0013175129424780607
age O 0 0.00305347191169858
was O 0 0.0038424853701144457
strongly O 0 0.0019055269658565521
predictive O 0 0.0024906406179070473
of O 0 0.0011688899248838425
the O 0 0.0012993047712370753
presence O 0 0.0014075145591050386
of O 0 0.0011523908469825983
any O 0 0.0011975567322224379
of O 0 0.0018327936995774508
the O 0 0.003237998578697443
eight O 0 0.005208723247051239
mutations O 0 0.009105007164180279
screened O 0 0.015318822115659714
. O 0 0.009829920716583729

Carriers O 0 0.01647510565817356
of O 0 0.005604017060250044
the O 0 0.004765993915498257
same O 0 0.003047881182283163
mutation O 0 0.004168021026998758
, O 0 0.0014810056891292334
from O 0 0.00098618573974818
different O 0 0.0006804151344113052
families O 0 0.0012296282220631838
, O 0 0.0013029990950599313
shared O 0 0.001953838160261512
similar O 0 0.0018206628737971187
haplotypes O 0 0.0057701244950294495
, O 0 0.0017080113757401705
indicating O 0 0.002640362596139312
that O 0 0.0009938465664163232
the O 0 0.0018617123132571578
mutant O 0 0.008419985882937908
alleles O 0 0.002520757494494319
were O 0 0.0009941316675394773
likely O 0 0.0010276864049956203
to O 0 0.0006521346513181925
be O 0 0.0005995747051201761
identical O 0 0.0010877209715545177
by O 0 0.0007290543289855123
descent O 0 0.002383747138082981
for O 0 0.001333411200903356
a O 0 0.0023267304059118032
mutation O 0 0.002879278501495719
in O 0 0.0016576492926105857
the O 0 0.0040076239965856075
founder O 1 0.5578760504722595
population O 0 0.007159866392612457
. O 0 0.009141163900494576

The O 0 0.010706407018005848
identification O 0 0.008052834309637547
of O 0 0.006692920345813036
common O 0 0.3310784101486206
BRCA1 O 1 0.9999250173568726
and O 0 0.033250387758016586
BRCA2 O 1 0.9996732473373413
mutations O 0 0.004870966076850891
will O 0 0.0017182683805003762
facilitate O 0 0.002820640569552779
carrier O 0 0.004703612998127937
detection O 0 0.0032855034805834293
in O 0 0.0018338618101552129
French O 0 0.00877708476036787
Canadian O 1 0.9703373312950134
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999315738677979
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9508584141731262
. O 0 0.018521765246987343

Are O 0 0.011228793300688267
Dp71 O 0 0.4636704921722412
and O 0 0.01172951702028513
Dp140 O 1 0.9992057681083679
brain O 1 0.994884192943573
dystrophin O 1 0.9654442667961121
isoforms O 0 0.008843199349939823
related O 0 0.005641178227961063
to O 0 0.004377055447548628
cognitive B-Disease 1 0.9985257983207703
impairment I-Disease 1 0.999998927116394
in O 1 0.9998821020126343
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9995527863502502

Molecular O 0 0.015441855415701866
study O 0 0.00659254752099514
and O 0 0.0030360391829162836
neuropsychological O 0 0.010231977328658104
analysis O 0 0.0026158627588301897
were O 0 0.0015187712851911783
performed O 0 0.002234573010355234
concurrently O 0 0.0031852759420871735
on O 0 0.0017887332942336798
49 O 0 0.005739316809922457
patients O 1 0.8435482978820801
with O 0 0.3982977867126465
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999986886978149
DMD B-Disease 1 1.0
) O 0 0.002883015898987651
in O 0 0.0011044597486034036
order O 0 0.0013798868749290705
to O 0 0.000840178516227752
find O 0 0.0012309672310948372
a O 0 0.0013137232745066285
molecular O 0 0.0021839963737875223
explanation O 0 0.002107809530571103
for O 0 0.0012799882097169757
the O 0 0.002865035319700837
cognitive B-Disease 1 0.7019537687301636
impairment I-Disease 1 0.9976656436920166
observed O 0 0.005414254497736692
in O 0 0.004939100705087185
most O 0 0.014103617519140244
DMD B-Disease 1 0.9999996423721313
patients O 1 0.9996857643127441
. O 0 0.01741684228181839

Complete O 0 0.013331657275557518
analysis O 0 0.005736661609262228
of O 0 0.0044358656741678715
the O 0 0.0060198428109288216
dystrophin O 1 0.9827123880386353
gene O 0 0.004949904512614012
was O 0 0.003375489031895995
performed O 0 0.0022195568308234215
to O 0 0.001091108424589038
define O 0 0.0020190023351460695
the O 0 0.0017439596122130752
localization O 0 0.004799321293830872
of O 0 0.0023519950918853283
deletions O 0 0.0078013623133301735
and O 0 0.002162247896194458
duplications O 0 0.011512799188494682
in O 0 0.002316622529178858
relation O 0 0.0042279488407075405
to O 0 0.0024556147400289774
the O 0 0.004851594101637602
different O 0 0.006959328427910805
DMD B-Disease 1 0.9999592304229736
promoters O 0 0.2629982531070709
. O 0 0.018158040940761566

Qualitative O 0 0.01695835590362549
analysis O 0 0.0058820052072405815
of O 0 0.003969005309045315
the O 0 0.005101076327264309
Dp71 O 1 0.7263308167457581
transcript O 0 0.007332067005336285
and O 0 0.0017074188217520714
testing O 0 0.002370934933423996
for O 0 0.0010542500531300902
the O 0 0.0013698432594537735
specific O 0 0.001275386312045157
first O 0 0.0020384492818266153
exon O 0 0.007509954739362001
of O 0 0.0025711762718856335
Dp140 O 0 0.02079867757856846
were O 0 0.0025827360805124044
also O 0 0.00291701452806592
carried O 0 0.005868731532245874
out O 0 0.006827892269939184
. O 0 0.011050357483327389

Neuropsychological O 0 0.05725782737135887
analysis O 0 0.010312596336007118
assessed O 0 0.012338193133473396
verbal O 0 0.010814433917403221
and O 0 0.004907640628516674
visuospatial O 1 0.9450575709342957
intelligence O 0 0.007710890378803015
, O 0 0.003681148635223508
verbal O 0 0.0135726910084486
memory O 0 0.39607134461402893
, O 0 0.003783188760280609
and O 0 0.0038598929531872272
reading O 0 0.016647186130285263
skills O 0 0.034377217292785645
. O 0 0.013147619552910328

Comparison O 0 0.015308935195207596
of O 0 0.006539599504321814
molecular O 0 0.007121408823877573
and O 0 0.0038803014904260635
psychometric O 0 0.025954727083444595
findings O 0 0.005208510439842939
demonstrated O 0 0.005407463759183884
that O 0 0.0017557113897055387
deletions O 0 0.004971898160874844
and O 0 0.0018391397316008806
duplications O 0 0.007879025302827358
that O 0 0.001348532852716744
were O 0 0.0015495457919314504
localized O 0 0.004413135349750519
in O 0 0.0015469600912183523
the O 0 0.0026611466892063618
distal O 1 0.6287121772766113
part O 0 0.0026782688219100237
of O 0 0.0027310368604958057
the O 0 0.008472992107272148
gene O 0 0.002958057215437293
seemed O 0 0.0021258166525512934
to O 0 0.0010492136934772134
be O 0 0.0011180468136444688
preferentially O 0 0.004030023235827684
associated O 0 0.0032610855996608734
with O 0 0.005088303238153458
cognitive B-Disease 1 0.9955716133117676
impairment I-Disease 1 0.9999847412109375
. O 0 0.03167752921581268

Two O 0 0.009097988717257977
altered O 0 0.014139000326395035
Dp71 O 0 0.026077501475811005
transcripts O 0 0.008705951273441315
and O 0 0.0027667286340147257
two O 0 0.002364885061979294
deleted O 0 0.006306698080152273
Dp140 O 0 0.009231332689523697
DNA O 0 0.0028261742554605007
sequences O 0 0.001537633826956153
were O 0 0.0010246719466522336
found O 0 0.0011782959336414933
in O 0 0.0013121580705046654
four O 0 0.0026596642564982176
patients O 1 0.9986496567726135
with O 1 0.8952524065971375
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9957557916641235

These O 0 0.006340459454804659
findings O 0 0.006689662113785744
suggest O 0 0.004306763410568237
that O 0 0.0014882951509207487
some O 0 0.0012457292759791017
sequences O 0 0.001869566971436143
located O 0 0.0021180131006985903
in O 0 0.0014160244027152658
the O 0 0.00221784645691514
distal O 0 0.215101420879364
part O 0 0.002613359596580267
of O 0 0.002200690098106861
the O 0 0.010667507536709309
gene O 0 0.002207762561738491
and O 0 0.0008511985652148724
, O 0 0.000984081532806158
in O 0 0.0008927698945626616
particular O 0 0.0013546331319957972
, O 0 0.0013628137530758977
some O 0 0.001506078988313675
DMD B-Disease 1 0.9996278285980225
isoforms O 0 0.0029513509944081306
expressed O 0 0.002050915267318487
in O 0 0.0013954658061265945
the O 0 0.003904398763552308
brain O 1 0.8937833309173584
may O 0 0.0014104980509728193
be O 0 0.000815081293694675
related O 0 0.0011741493362933397
to O 0 0.0011217402061447501
the O 0 0.003779061371460557
cognitive B-Disease 1 0.999294638633728
impairment I-Disease 1 0.9999957084655762
associated O 1 0.8234643340110779
with O 1 0.696389377117157
DMD B-Disease 1 0.9999998807907104
. O 0 0.010076007805764675
. O 0 0.011492828838527203

I1307K O 1 0.7566924095153809
APC O 1 0.8581292629241943
and O 0 0.006065217778086662
hMLH1 O 0 0.2246721237897873
mutations O 0 0.00455161789432168
in O 0 0.001967251067981124
a O 0 0.002797325374558568
non O 0 0.004562658257782459
- O 0 0.005720952060073614
Jewish O 0 0.003843717509880662
family O 0 0.003701093839481473
with O 0 0.0038457904011011124
hereditary B-Disease 1 0.9999966621398926
non I-Disease 1 0.9999974966049194
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9935696125030518

We O 0 0.006911145523190498
describe O 0 0.006617840379476547
a O 0 0.004129794891923666
French O 0 0.009507485665380955
Canadian O 0 0.11233492940664291
hereditary B-Disease 1 0.9999940395355225
non I-Disease 1 0.9999949932098389
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999994039535522
HNPCC B-Disease 1 1.0
) O 0 0.10952774435281754
kindred O 1 0.8340171575546265
which O 0 0.0022244988940656185
carries O 0 0.003945661708712578
a O 0 0.00432246271520853
novel O 0 0.020123625174164772
truncating O 1 0.8350409269332886
mutation O 0 0.014579125680029392
in O 0 0.008763875812292099
hMLH1 O 1 0.7164720296859741
. O 0 0.017118124291300774

Interestingly O 0 0.026878634467720985
, O 0 0.007216351106762886
the O 0 0.00789840891957283
I1307K O 1 0.8978342413902283
APC O 1 0.9476932287216187
polymorphism O 0 0.008792626671493053
, O 0 0.0022782613523304462
associated O 0 0.0015641021309420466
with O 0 0.0009531548712402582
an O 0 0.001374677987769246
increased O 0 0.004628940485417843
risk O 1 0.9366627335548401
of O 1 0.9998713731765747
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.6828734874725342
is O 0 0.003654609201475978
also O 0 0.0018294906476512551
present O 0 0.0017168499762192369
in O 0 0.0019508200930431485
this O 0 0.0030506860930472612
family O 0 0.00868657324463129
. O 0 0.009582343511283398

The O 0 0.01598999835550785
I1307K O 0 0.37240833044052124
polymorphism O 0 0.013234480284154415
has O 0 0.0031350520439445972
previously O 0 0.002823716029524803
only O 0 0.0013730196515098214
been O 0 0.001256708987057209
identified O 0 0.0016156311612576246
in O 0 0.0011119218543171883
individuals O 0 0.0010988089488819242
of O 0 0.0027046515606343746
self O 1 0.917129635810852
- O 1 0.9610052108764648
reported O 0 0.013352911919355392
Ashkenazi O 0 0.06816685944795609
Jewish O 0 0.010755600407719612
origins O 0 0.02194046415388584
. O 0 0.014317582361400127

In O 0 0.005408971570432186
addition O 0 0.0036294402088969946
, O 0 0.002088999841362238
in O 0 0.0013916741590946913
this O 0 0.0012649723794311285
family O 0 0.00207965774461627
, O 0 0.001271177432499826
there O 0 0.0011087158927693963
appears O 0 0.0016389614902436733
to O 0 0.000743417942430824
be O 0 0.0006428773049265146
no O 0 0.0009702565730549395
relationship O 0 0.0014511012705042958
between O 0 0.0011877927463501692
the O 0 0.0024142952170222998
I1307K O 0 0.32947593927383423
polymorphism O 0 0.003813776420429349
and O 0 0.0010051092831417918
the O 0 0.0014697605511173606
presence O 0 0.0023827936965972185
or O 0 0.0020867525599896908
absence O 0 0.021827509626746178
of O 1 0.7749035954475403
cancer B-Disease 1 0.9999996423721313
. O 0 0.010608161799609661
. O 0 0.011414899490773678

Identification O 0 0.01202727947384119
of O 0 0.005550358910113573
a O 0 0.005432208068668842
novel O 0 0.011896319687366486
mutation O 0 0.005337708629667759
of O 0 0.0038171366322785616
the O 0 0.007575821131467819
CPO O 1 0.9667609333992004
gene O 0 0.003670872887596488
in O 0 0.002362786792218685
a O 0 0.004656650125980377
Japanese O 1 0.7411929368972778
hereditary B-Disease 1 0.9999653100967407
coproporphyria I-Disease 1 0.9997492432594299
family O 0 0.3222244083881378
. O 0 0.017170334234833717

Hereditary B-Disease 1 0.9995666146278381
coproporphyria I-Disease 1 0.9996949434280396
( O 1 0.7020707726478577
HCP B-Disease 1 0.9999386072158813
) O 0 0.004276396706700325
is O 0 0.0025415197014808655
an O 0 0.0044588493183255196
autosomal B-Disease 1 0.9999662637710571
dominant I-Disease 1 0.999953031539917
disease I-Disease 1 1.0
characterized O 1 0.9999773502349854
by O 1 0.6184608340263367
a O 1 0.9997013211250305
deficiency B-Disease 1 1.0
of I-Disease 1 0.9989284873008728
coproporphyrinogen I-Disease 1 0.9999996423721313
oxidase I-Disease 1 0.999955415725708
( O 0 0.10581786185503006
CPO O 1 0.9460275769233704
) O 0 0.0027264030650258064
caused O 0 0.00356331467628479
by O 0 0.0015876677352935076
a O 0 0.003135594306513667
mutation O 0 0.004657647106796503
in O 0 0.0029769367538392544
the O 0 0.008802426047623158
CPO O 1 0.9839658737182617
gene O 0 0.016395555809140205
. O 0 0.012597065418958664

Only O 0 0.0062178089283406734
11 O 0 0.0053061614744365215
mutations O 0 0.003755874466150999
of O 0 0.0023064196575433016
the O 0 0.002878865459933877
gene O 0 0.0028207828290760517
have O 0 0.0013379454612731934
been O 0 0.0025892581325024366
reported O 0 0.005735467653721571
in O 0 0.008156719617545605
HCP B-Disease 1 0.9999626874923706
patients O 1 0.9718592762947083
. O 0 0.017029985785484314

We O 0 0.006465232465416193
report O 0 0.005200003273785114
another O 0 0.004406481981277466
mutation O 0 0.0051900180988013744
in O 0 0.0025482047349214554
a O 0 0.005612500011920929
Japanese O 0 0.15539482235908508
family O 0 0.018392246216535568
. O 0 0.013444810174405575

Polymerase O 0 0.05385195091366768
chain O 0 0.032850757241249084
reaction O 0 0.01794331520795822
- O 0 0.021326586604118347
single O 0 0.006638690363615751
strand O 0 0.009935873560607433
conformational O 0 0.007131674792617559
polymorphism O 0 0.0054085408337414265
and O 0 0.0016156666679307818
direct O 0 0.001859086100012064
sequence O 0 0.002108120359480381
analyses O 0 0.003028701525181532
demonstrated O 0 0.0035550654865801334
a O 0 0.0030476623214781284
C O 0 0.006066448055207729
to O 0 0.0021021030843257904
T O 0 0.007516803685575724
substitution O 0 0.0035709552466869354
in O 0 0.0018275914480909705
exon O 0 0.007057981565594673
1 O 0 0.0024186542723327875
of O 0 0.0015883995220065117
the O 0 0.002823492046445608
CPO O 0 0.12377242743968964
gene O 0 0.0027929709758609533
at O 0 0.002137836767360568
nucleotide O 0 0.0031231811735779047
position O 0 0.002474790206179023
85 O 0 0.003104445058852434
, O 0 0.001725909998640418
which O 0 0.0013929323758929968
lies O 0 0.0029129632748663425
in O 0 0.002034803619608283
the O 0 0.003241144586354494
putative O 0 0.024077091366052628
presequence O 0 0.10991235077381134
for O 0 0.002752372995018959
targeting O 0 0.005375960376113653
to O 0 0.00432517658919096
mitochondria O 0 0.016327833756804466
. O 0 0.010841977782547474

This O 0 0.007786884903907776
mutation O 0 0.008216840215027332
changes O 0 0.0032570594921708107
the O 0 0.00297976890578866
codon O 0 0.006557796616107225
for O 0 0.0019638780504465103
glutamine O 0 0.0051590572111308575
to O 0 0.001529816770926118
a O 0 0.003061364172026515
termination O 0 0.008903772570192814
codon O 0 0.006818349938839674
at O 0 0.0036127176135778427
amino O 0 0.0053676702082157135
acid O 0 0.007868824526667595
position O 0 0.006984729319810867
29 O 0 0.013673410750925541
. O 0 0.011446458287537098

MaeI O 0 0.0897153839468956
restriction O 0 0.01527089811861515
analysis O 0 0.004908767994493246
showed O 0 0.004832101054489613
two O 0 0.0016407797811552882
other O 0 0.0014533457579091191
carriers O 0 0.004045715089887381
in O 0 0.0026188690681010485
the O 0 0.0065544056706130505
family O 0 0.02161775343120098
. O 0 0.01119611319154501

The O 0 0.025092918425798416
C O 1 0.9972357153892517
- O 1 0.9946962594985962
T O 1 0.9893133044242859
mutation O 0 0.0063465666025877
is O 0 0.0024025251623243093
located O 0 0.002536442596465349
within O 0 0.0014642718015238643
a O 0 0.0017847651615738869
recently O 0 0.0028718740213662386
proposed O 0 0.0027432157658040524
putative O 0 0.005229102447628975
alternative O 0 0.0024081601295620203
translation O 0 0.003001405159011483
initiation O 0 0.005932193715125322
codon O 0 0.00777328759431839
( O 0 0.004573477897793055
TIC O 1 0.9585433602333069
- O 0 0.005192522890865803
1 O 0 0.0029046335257589817
) O 0 0.001353124505840242
, O 0 0.001147683011367917
supporting O 0 0.0022462806664407253
that O 0 0.001671884092502296
TIC O 1 0.9984850287437439
- O 0 0.005414511077105999
1 O 0 0.0024800284299999475
is O 0 0.0013732329243794084
the O 0 0.0016475124284625053
real O 0 0.003889448707923293
TIC O 1 0.8757116198539734
rather O 0 0.002586069516837597
than O 0 0.002649919828400016
TIC O 1 0.9967435598373413
- O 0 0.013668966479599476
2 O 0 0.006931045558303595
. O 0 0.005436448380351067
. O 0 0.010420580394566059

Human B-Disease 0 0.026348499581217766
complement I-Disease 0 0.2937144637107849
factor I-Disease 1 0.9945173859596252
H I-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999998807907104
associated O 1 0.998706579208374
with O 1 0.9998672008514404
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999786615371704

This O 0 0.006014515180140734
study O 0 0.004698383156210184
reports O 0 0.0027780423406511545
on O 0 0.00180293049197644
six O 0 0.0018385793082416058
cases O 0 0.0028091310523450375
of O 0 0.3220231831073761
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 0.0037126531824469566
the I-Disease 0 0.0029645985923707485
human I-Disease 0 0.00289849191904068
complement I-Disease 0 0.0038349947426468134
regulatory I-Disease 0 0.004167197737842798
protein I-Disease 0 0.0032098942901939154
Factor I-Disease 0 0.005944880191236734
H I-Disease 1 0.9204753041267395
( O 0 0.004651523660868406
FH O 1 0.9540048837661743
) O 0 0.0014217996504157782
in O 0 0.0009286351851187646
the O 0 0.0013358897995203733
context O 0 0.0024210575502365828
of O 0 0.004648687783628702
an O 1 0.9942400455474854
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9998924732208252

Five O 0 0.006362879648804665
of O 0 0.003824069397523999
the O 0 0.003134348662570119
cases O 0 0.002322743646800518
were O 0 0.0015183680225163698
observed O 0 0.0018997063161805272
in O 0 0.001619447604753077
children O 0 0.0035966429859399796
presenting O 0 0.12989093363285065
with O 1 0.9525291323661804
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9932725429534912
. O 0 0.02159607969224453

Two O 0 0.004528834484517574
of O 0 0.00449851481243968
the O 0 0.005445841234177351
children O 0 0.015177755616605282
exhibited O 1 0.6998813152313232
a O 1 0.793092668056488
homozygous O 1 0.9999223947525024
deficiency O 1 1.0
characterized O 1 0.9760323762893677
by O 0 0.0022439374588429928
the O 0 0.0029746561776846647
absence O 0 0.004741260781884193
of O 0 0.002152776811271906
the O 0 0.002272462472319603
150 O 0 0.003353580366820097
- O 0 0.017749445512890816
kD O 0 0.11534999310970306
form O 0 0.001834488706663251
of O 0 0.002454326953738928
Factor O 0 0.014225948601961136
H O 1 0.6725481152534485
and O 0 0.0013223295100033283
the O 0 0.0015434890519827604
presence O 0 0.0017805446404963732
, O 0 0.0012388232862576842
upon O 0 0.0018991873366758227
immunoblotting O 0 0.006096931640058756
, O 0 0.0014012708561494946
of O 0 0.001616217428818345
the O 0 0.002280134940519929
42 O 0 0.005954700522124767
- O 0 0.0287565179169178
kD O 1 0.8159497380256653
Factor O 0 0.0066472869366407394
H O 0 0.17893405258655548
- O 0 0.003655995475128293
like O 0 0.0017001960659399629
protein O 0 0.002204765798524022
1 O 0 0.002914508106186986
( O 0 0.0033824520651251078
FHL O 1 0.5942345857620239
- O 0 0.004977227654308081
1 O 0 0.0026067011058330536
) O 0 0.001406109775416553
and O 0 0.0011841231025755405
other O 0 0.0017304675420746207
FH O 1 0.9992062449455261
- O 0 0.008239203132689
related O 0 0.004115255083888769
protein O 0 0.0054767238907516
( O 0 0.006249024532735348
FHR O 1 0.8377923369407654
) O 0 0.006465581711381674
bands O 0 0.012349599041044712
. O 0 0.010813489556312561

Southern O 0 0.024993065744638443
blot O 0 0.04351823404431343
and O 0 0.004985492676496506
PCR O 0 0.009204111061990261
analysis O 0 0.002992411609739065
of O 0 0.0019291643984615803
DNA O 0 0.0026289692614227533
of O 0 0.001985243521630764
one O 0 0.002289328956976533
patient O 1 0.970600962638855
with O 0 0.0036261966452002525
homozygous O 1 0.9782639145851135
deficiency O 1 0.999998927116394
ruled O 0 0.010409051552414894
out O 0 0.0014983946457505226
the O 0 0.001345012686215341
presence O 0 0.0013764885952696204
of O 0 0.0010951284784823656
a O 0 0.001659000525251031
large O 0 0.0015572000993415713
deletion O 0 0.003772174008190632
of O 0 0.0021412449423223734
the O 0 0.017678596079349518
FH O 1 0.9999892711639404
gene O 0 0.0029542387928813696
as O 0 0.001721756299957633
the O 0 0.0027964874170720577
underlying O 1 0.7767404317855835
defect O 1 0.9997182488441467
for O 0 0.07151064276695251
the O 1 0.996748685836792
deficiency O 1 1.0
. O 0 0.088044673204422

The O 0 0.006946482229977846
other O 0 0.0023714560084044933
four O 0 0.002292780904099345
children O 0 0.0031823457684367895
presented O 0 0.005561788100749254
with O 0 0.007884061895310879
heterozygous O 1 0.9869118928909302
deficiency O 1 0.9999997615814209
and O 0 0.004262122791260481
exhibited O 1 0.6300362944602966
a O 0 0.005277381744235754
normal O 0 0.005540826357901096
immunoblotting O 0 0.138518288731575
pattern O 0 0.003952274564653635
of O 0 0.002515566535294056
proteins O 0 0.0025591806042939425
of O 0 0.0036369385197758675
the O 0 0.05812869593501091
FH O 1 0.9999865293502808
family O 0 0.020846771076321602
. O 0 0.01381403487175703

Factor B-Disease 1 0.9985149502754211
H I-Disease 1 0.9999986886978149
deficiency I-Disease 1 0.9999995231628418
is O 0 0.008308663964271545
the O 0 0.01388414017856121
only O 0 0.020899247378110886
complement B-Disease 1 0.9999175071716309
deficiency I-Disease 1 1.0
associated O 1 0.8906995058059692
with O 1 0.7674643993377686
HUS B-Disease 1 1.0
. O 0 0.09311363846063614

These O 0 0.005890498869121075
observations O 0 0.007935869507491589
suggest O 0 0.0054858108051121235
a O 0 0.003784878645092249
role O 0 0.0047327084466814995
for O 0 0.003992331214249134
FH O 1 0.9999510049819946
and O 0 0.006208834238350391
/ O 1 0.8647742867469788
or O 0 0.00499954167753458
FH O 1 0.9986639022827148
receptors O 0 0.004408526699990034
in O 0 0.002027905313298106
the O 0 0.004729013424366713
pathogenesis O 1 0.9999854564666748
of O 1 0.9980043768882751
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.5310881733894348
. O 0 0.02084670402109623

Further O 0 0.008237379603087902
evidence O 0 0.005224808119237423
for O 0 0.003031356493011117
a O 0 0.003612230531871319
major O 0 0.005858485586941242
ancient O 0 0.18555359542369843
mutation O 1 0.9984318614006042
underlying O 1 0.9999971389770508
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.8837906718254089
linkage O 1 0.9969857335090637
disequilibrium O 1 0.9974608421325684
studies O 0 0.004175003618001938
in O 0 0.002869579242542386
the O 0 0.005865504965186119
Japanese O 0 0.2833764851093292
population O 0 0.008729434572160244
. O 0 0.012312325648963451

The O 1 0.8937565088272095
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9999583959579468
DM B-Disease 1 1.0
) O 0 0.00842136051505804
mutation O 0 0.00491134449839592
is O 0 0.002017517574131489
an O 0 0.0023733365815132856
unstable O 1 0.9400545954704285
( O 0 0.008335549384355545
CTG O 1 0.9894357919692993
) O 0 0.0026628493797034025
n O 0 0.004143936559557915
repeat O 0 0.0034046226646751165
, O 0 0.0013867650413885713
present O 0 0.00133301701862365
at O 0 0.0014790791319683194
a O 0 0.0012876163236796856
copy O 0 0.001858598436228931
number O 0 0.0009095515124499798
of O 0 0.0011462070979177952
5 O 0 0.0020407389383763075
- O 0 0.0026245347689837217
37 O 0 0.0023137256503105164
repeats O 0 0.0029658502899110317
on O 0 0.0012370115146040916
normal O 0 0.00231138220988214
chromosomes O 0 0.0021194820292294025
but O 0 0.001154707744717598
amplified O 0 0.0031481091864407063
to O 0 0.0016010022955015302
50 O 0 0.0029564066790044308
- O 0 0.005836105439811945
3000 O 0 0.010478267446160316
copies O 0 0.006664645858108997
on O 0 0.00914339255541563
DM B-Disease 1 0.9999122619628906
chromosomes O 0 0.023472821339964867
. O 0 0.014512716792523861

Previous O 0 0.012119530700147152
findings O 0 0.007829409092664719
in O 0 0.0041228290647268295
Caucasian O 0 0.02195531316101551
populations O 0 0.004431887995451689
of O 0 0.0047338902950286865
a O 1 0.6865861415863037
DM B-Disease 1 1.0
founder O 1 0.9992799162864685
chromosome O 0 0.013001494109630585
raise O 0 0.0029046472627669573
a O 0 0.0019886104855686426
question O 0 0.0020836032927036285
about O 0 0.001269328175112605
the O 0 0.0014363478403538465
molecular O 0 0.0020920478273183107
events O 0 0.0013984775869175792
involved O 0 0.0015968568623065948
in O 0 0.0017203879542648792
the O 0 0.004238726571202278
expansion O 0 0.02065052092075348
mutation O 0 0.01936008222401142
. O 0 0.010105395689606667

To O 0 0.006919043604284525
investigate O 0 0.008207934908568859
whether O 0 0.004139791242778301
a O 0 0.003880312666296959
founder O 0 0.1296856850385666
chromosome O 0 0.006078045815229416
for O 0 0.002652198076248169
the O 0 0.10086964815855026
DM B-Disease 1 1.0
mutation O 0 0.005863787606358528
exists O 0 0.0017415687907487154
in O 0 0.001007981481961906
the O 0 0.0015926770865917206
Japanese O 0 0.00519687170162797
population O 0 0.0012283840915188193
, O 0 0.0011287255911156535
we O 0 0.0012078522704541683
genotyped O 0 0.005511374678462744
families O 0 0.0016459892503917217
using O 0 0.0019128797575831413
polymorphic O 0 0.005757019389420748
markers O 0 0.004706681240350008
near O 0 0.0036316204350441694
the O 0 0.0031023104675114155
( O 0 0.0054753622971475124
CTG O 1 0.9837596416473389
) O 0 0.00310310535132885
n O 0 0.005903810728341341
repeat O 0 0.006511098239570856
region O 0 0.004326240625232458
and O 0 0.004225701093673706
constructed O 0 0.028523584827780724
haplotypes O 0 0.05547649785876274
. O 0 0.014222792349755764

Six O 0 0.007188585586845875
different O 0 0.003150149481371045
haplotypes O 0 0.010046400129795074
were O 0 0.0029708484653383493
found O 0 0.004245607182383537
and O 0 0.0071300785057246685
DM B-Disease 1 0.9999988079071045
alleles O 0 0.012667674571275711
were O 0 0.003921985160559416
always O 0 0.00744436914101243
haplotype O 0 0.021318776533007622
A O 0 0.013423139229416847
. O 0 0.013666165061295033

To O 0 0.004903208930045366
find O 0 0.003640517359599471
an O 0 0.00190415617544204
origin O 0 0.0016841798787936568
of O 0 0.0019827838987112045
the O 0 0.004077523946762085
( O 0 0.00986021850258112
CTG O 1 0.9982722997665405
) O 0 0.0023270384408533573
n O 0 0.003673007944598794
repeat O 0 0.0044102743268013
mutation O 0 0.0018687555566430092
and O 0 0.0009172029094770551
to O 0 0.0009620356140658259
investigate O 0 0.0024760982487350702
the O 0 0.0017280144384130836
mechanism O 0 0.0023359092883765697
of O 0 0.001539125689305365
the O 0 0.0020391216967254877
expansion O 0 0.0034270198084414005
mutation O 0 0.002345295622944832
in O 0 0.0010403422638773918
the O 0 0.0014040458481758833
Japanese O 0 0.0038787536323070526
population O 0 0.001141593442298472
we O 0 0.0007716413238085806
have O 0 0.0006886694463901222
studied O 0 0.0018911600345745683
90 O 0 0.002735726535320282
Japanese O 0 0.015208747237920761
DM B-Disease 1 0.9999607801437378
families O 0 0.0025545924436300993
comprising O 0 0.0034613667521625757
190 O 0 0.0057141538709402084
affected O 0 0.004016018472611904
and O 0 0.0026416853070259094
130 O 0 0.007724429480731487
unaffected O 0 0.014715797267854214
members O 0 0.006308299954980612
. O 0 0.01183395180851221

The O 0 0.011016765609383583
results O 0 0.006637961603701115
suggest O 0 0.004492099862545729
that O 0 0.0019515113672241569
a O 0 0.0024966264609247446
few O 0 0.001969167497009039
common O 0 0.00263298861682415
ancestral O 0 0.00729634752497077
mutations O 0 0.0031143645755946636
in O 0 0.0017564712325111032
both O 0 0.0018349268939346075
Caucasian O 1 0.9922053217887878
and O 0 0.002596871228888631
Japanese O 0 0.35303443670272827
populations O 0 0.0018537245923653245
have O 0 0.0009469100623391569
originated O 0 0.0021130081731826067
by O 0 0.001150233205407858
expansion O 0 0.002411655383184552
of O 0 0.0018221073551103473
an O 0 0.002359896432608366
ancestral O 0 0.009115617722272873
n O 0 0.0057154432870447636
= O 0 0.004594517406076193
5 O 0 0.0019143660319969058
repeat O 0 0.0034295874647796154
to O 0 0.0015487433411180973
n O 0 0.005720710847526789
= O 0 0.006384078413248062
19 O 0 0.004978139419108629
- O 0 0.0073213051073253155
37 O 0 0.008784701116383076
copies O 0 0.01043608970940113
. O 0 0.012629562988877296

These O 0 0.005621614865958691
data O 0 0.004909932613372803
support O 0 0.004275530111044645
multistep O 0 0.013117270544171333
models O 0 0.004649157170206308
of O 0 0.005015426315367222
triplet O 1 0.9954231381416321
repeat O 0 0.26106590032577515
expansion O 0 0.00447350786998868
that O 0 0.0010321076260879636
have O 0 0.0007846244261600077
been O 0 0.0010475877206772566
proposed O 0 0.0018169907853007317
for O 0 0.0019193898187950253
both O 0 0.004485751502215862
DM B-Disease 1 0.9999998807907104
and O 0 0.08227892220020294
Friedreichs B-Disease 1 0.9999547004699707
ataxia I-Disease 1 0.9999905824661255
. O 0 0.01094895601272583
. O 0 0.016936978325247765

The O 0 0.009220950305461884
molecular O 0 0.008502221666276455
basis O 0 0.0061913467943668365
of O 1 0.840489387512207
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.008870952762663364
the O 0 0.008640198037028313
western O 0 0.008120209909975529
Cape O 0 0.4419412910938263
, O 0 0.0052566141821444035
South O 0 0.00881415419280529
Africa O 0 0.014263283461332321
. O 0 0.01316041313111782

Deficiency B-Disease 1 0.999976396560669
of I-Disease 0 0.012948757968842983
the I-Disease 0 0.014882057905197144
sixth I-Disease 1 0.9027472138404846
component I-Disease 0 0.02522112801671028
of I-Disease 0 0.004516926594078541
human I-Disease 0 0.03859374672174454
complement I-Disease 0 0.47218549251556396
( O 0 0.15836842358112335
C6 O 1 0.9999464750289917
) O 0 0.0015070817898958921
has O 0 0.0010487169492989779
been O 0 0.001052157487720251
reported O 0 0.0014420924708247185
in O 0 0.0008336122264154255
a O 0 0.0010974721517413855
number O 0 0.0009195085731334984
of O 0 0.0010832101106643677
families O 0 0.0013251561904326081
from O 0 0.0011249551316723228
the O 0 0.001788969966582954
western O 0 0.0031570452265441418
Cape O 0 0.012341980822384357
, O 0 0.0047183288261294365
South O 0 0.008325044065713882
Africa O 0 0.01212348137050867
. O 0 0.01141146756708622

Meningococcal B-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999998807907104
is O 0 0.3427813947200775
endemic O 1 0.9897928237915039
in O 0 0.0029259012080729008
the O 0 0.004588019568473101
Cape O 0 0.13492625951766968
and O 0 0.001169470138847828
almost O 0 0.0012349813478067517
all O 0 0.000741001742426306
pedigrees O 0 0.003575423499569297
of O 0 0.0026997646782547235
total O 1 0.9796900749206543
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9037452936172485
C6Q0 O 1 0.999841570854187
) O 0 0.001574801979586482
have O 0 0.0007452788995578885
been O 0 0.0013267347821965814
ascertained O 0 0.005403139162808657
because O 0 0.003186326939612627
of O 0 0.4073302745819092
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.5847578644752502

We O 0 0.0077452100813388824
have O 0 0.0028366688638925552
sequenced O 0 0.00607494218274951
the O 0 0.0028207718860358
expressed O 0 0.003390036290511489
exons O 0 0.0049257464706897736
of O 0 0.0024820829275995493
the O 0 0.030307192355394363
C6 O 1 0.9999884366989136
gene O 0 0.0025732729118317366
from O 0 0.0010928502306342125
selected O 0 0.0015028143534436822
cases O 0 0.001300280331633985
and O 0 0.0008337297476828098
have O 0 0.0005552346119657159
found O 0 0.0009387526079080999
three O 0 0.0008492828928865492
molecular O 0 0.003674097126349807
defects O 1 0.9703974723815918
leading O 0 0.010360277257859707
to O 0 0.0022213461343199015
total O 1 0.5511928796768188
deficiency O 1 1.0
879delG O 1 0.9997881054878235
, O 0 0.0017916527576744556
which O 0 0.0009124863427132368
is O 0 0.001009250758215785
the O 0 0.0013811785029247403
common O 0 0.0030428229365497828
defect O 1 0.9298150539398193
in O 0 0.001491038710810244
the O 0 0.0023708424996584654
Cape O 0 0.02390771359205246
and O 0 0.0018338364316150546
hitherto O 0 0.009505149908363819
unreported O 0 0.005786396097391844
, O 0 0.0021708556450903416
and O 0 0.0020871686283499002
1195delC O 1 0.6984807848930359
and O 0 0.0025374586693942547
1936delG O 1 0.6339253187179565
, O 0 0.001512863440439105
which O 0 0.0009485878399573267
have O 0 0.0007273097289726138
been O 0 0.0011568013578653336
previously O 0 0.002315401565283537
reported O 0 0.0031617681961506605
in O 0 0.003090796759352088
African O 0 0.009501846507191658
- O 0 0.02451126091182232
Americans O 0 0.011492754332721233
. O 0 0.01146432664245367

We O 0 0.006553241517394781
also O 0 0.003102573100477457
show O 0 0.0028455075807869434
that O 0 0.0013417418813332915
the O 0 0.0026725430507212877
879delG O 1 0.6927520036697388
and O 0 0.0037358691915869713
1195delC O 1 0.9945012331008911
defects O 1 0.9845496416091919
are O 0 0.0013079141499474645
associated O 0 0.0028191227465867996
with O 0 0.003333017462864518
characteristic O 1 0.9997736811637878
C6 O 1 1.0
/ O 1 0.9999693632125854
C7 O 1 0.999969482421875
region O 0 0.008236534893512726
DNA O 0 0.007409975863993168
marker O 0 0.02469780296087265
haplotypes O 0 0.008775818161666393
, O 0 0.0019664117135107517
although O 0 0.0019221880938857794
small O 0 0.0021909603383392096
variations O 0 0.004422803875058889
were O 0 0.004441718105226755
observed O 0 0.00914656464010477
. O 0 0.011311786249279976

The O 0 0.01798158697783947
1936delG O 1 0.9975263476371765
defect O 1 0.9959031939506531
was O 0 0.013590770773589611
observed O 0 0.0029945720452815294
only O 0 0.0011765498202294111
once O 0 0.0017576896352693439
in O 0 0.0012027501361444592
the O 0 0.0018969271332025528
Cape O 0 0.02569211646914482
, O 0 0.0016145332483574748
but O 0 0.0011166257318109274
its O 0 0.0015605505323037505
associated O 0 0.003399756271392107
haplotype O 0 0.008436382748186588
could O 0 0.0030367460567504168
be O 0 0.0040002684108912945
deduced O 0 0.019716456532478333
. O 0 0.01122758723795414

The O 0 0.008474033325910568
data O 0 0.004810022655874491
from O 0 0.003292439505457878
the O 0 0.003294464899227023
haplotypes O 0 0.0069925058633089066
indicate O 0 0.002595482161268592
that O 0 0.0008343282388523221
these O 0 0.000654611096251756
three O 0 0.0011220596497878432
molecular O 0 0.003740962827578187
defects O 1 0.690409243106842
account O 0 0.0017371780704706907
for O 0 0.0013210002798587084
the O 0 0.0026672801468521357
defects O 1 0.9375881552696228
in O 0 0.0013586882269009948
all O 0 0.0009676818153820932
the O 0 0.001803422113880515
38 O 0 0.003806193359196186
unrelated O 0 0.00607670983299613
C6Q0 O 1 0.5141342878341675
individuals O 0 0.0014151250943541527
we O 0 0.0009919947478920221
have O 0 0.000892836251296103
studied O 0 0.0025013680569827557
from O 0 0.0021988856606185436
the O 0 0.004704903811216354
Cape O 0 0.19746235013008118
. O 0 0.011239483021199703

We O 0 0.007101711817085743
have O 0 0.002918245969340205
also O 0 0.002903793938457966
observed O 0 0.003338188398629427
the O 0 0.003300293115898967
879delG O 0 0.08963716775178909
defect O 0 0.12089186161756516
in O 0 0.001870765001513064
two O 0 0.002120355376973748
Dutch O 1 0.9441896677017212
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9993489384651184
deficient I-Disease 1 0.9999085664749146
kindreds O 0 0.057681433856487274
, O 0 0.002085303422063589
but O 0 0.001416979474015534
the O 0 0.002534962957724929
879delG O 1 0.9032838344573975
defect O 1 0.8446119427680969
in O 0 0.0018935742555186152
the O 0 0.0029284812044352293
Cape O 0 0.3473164439201355
probably O 0 0.00241733156144619
did O 0 0.001169658498838544
not O 0 0.0007353720138780773
come O 0 0.0010382609907537699
from O 0 0.0013328969944268465
The O 0 0.0028412514366209507
Netherlands O 0 0.007561687845736742
. O 0 0.004430234897881746
. O 0 0.008753374218940735

Complement B-Disease 1 0.9990000128746033
C7 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
: O 0 0.008541867136955261
seven O 0 0.004937238059937954
further O 0 0.004348620772361755
molecular O 0 0.02942785434424877
defects O 1 0.9988881945610046
and O 0 0.003838910022750497
their O 0 0.0033748906571418047
associated O 0 0.01177404634654522
marker O 1 0.8470766544342041
haplotypes O 0 0.06291163712739944
. O 0 0.014358015730977058

Seven O 0 0.012094401754438877
further O 0 0.006824296899139881
molecular O 0 0.009443552233278751
bases O 0 0.00982056837528944
of O 1 0.8774503469467163
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.010994676500558853
described O 0 0.4800257682800293
. O 0 0.01809944398701191

All O 0 0.005256591830402613
these O 0 0.0030066119506955147
new O 0 0.004173241555690765
molecular O 0 0.006820627488195896
defects O 1 0.7644603252410889
involve O 0 0.004389011766761541
single O 0 0.004818554501980543
- O 0 0.014366776682436466
nucleotide O 0 0.0030849603936076164
events O 0 0.0016081425128504634
, O 0 0.0014805467799305916
deletions O 0 0.003431520890444517
and O 0 0.0014677868457511067
substitutions O 0 0.0031507895328104496
, O 0 0.00146420206874609
some O 0 0.0011461402755230665
of O 0 0.0020163150038570166
which O 0 0.0019615646451711655
alter O 0 0.005316949915140867
splice O 0 0.007338813040405512
sites O 0 0.0027462923899292946
, O 0 0.00245708622969687
and O 0 0.0032024576794356108
others O 0 0.006645177956670523
codons O 0 0.024174753576517105
. O 0 0.014227259904146194

They O 0 0.004975027404725552
are O 0 0.0023785759694874287
distributed O 0 0.0034655770286917686
along O 0 0.0032253097742795944
the O 0 0.00529056740924716
C7 O 1 0.9999674558639526
gene O 0 0.003814471885561943
, O 0 0.0016134376637637615
but O 0 0.0012967544607818127
predominantly O 0 0.0021160778123885393
towards O 0 0.0029046558775007725
the O 0 0.003457526909187436
3 O 0 0.006648467853665352
end O 0 0.008931840769946575
. O 0 0.0098534245043993

All O 0 0.005912682972848415
were O 0 0.003876224858686328
found O 0 0.004548643250018358
in O 0 0.003919404000043869
compound O 0 0.01898903027176857
heterozygous O 0 0.01659277267754078
individuals O 0 0.008513339795172215
. O 0 0.012693021446466446

The O 0 0.1282653659582138
C6 O 1 0.9999936819076538
/ O 1 0.999672532081604
C7 O 1 0.999936580657959
marker O 1 0.5387281775474548
haplotypes O 0 0.021236231550574303
associated O 0 0.004345546010881662
with O 0 0.0030242300126701593
most O 0 0.006177695468068123
C7 B-Disease 1 0.9999988079071045
defects I-Disease 1 0.9999713897705078
are O 0 0.0036172315012663603
tabulated O 0 0.022275932133197784
. O 0 0.006539618596434593
. O 0 0.010500267148017883

A O 0 0.019173912703990936
genome O 0 0.015700392425060272
- O 0 0.008423743769526482
wide O 0 0.004147319123148918
search O 0 0.004112645052373409
for O 0 0.0030124105978757143
chromosomal O 0 0.054231032729148865
loci O 0 0.014822100289165974
linked O 0 0.01136220246553421
to O 0 0.0032464107498526573
mental O 1 0.999995231628418
health O 1 0.9998977184295654
wellness O 1 0.9998213648796082
in O 0 0.002681143581867218
relatives O 0 0.0041784802451729774
at O 0 0.0025316504761576653
high O 0 0.010562143288552761
risk O 1 0.5000296831130981
for O 1 0.5960645079612732
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.757623016834259
the O 1 0.7455029487609863
Old O 1 0.9977715611457825
Order O 0 0.018682250753045082
Amish O 0 0.09697503596544266
. O 0 0.014409851282835007

Bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
( O 1 0.9999794960021973
BPAD B-Disease 1 1.0
; O 1 0.998193085193634
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 1 0.5517152547836304
is O 0 0.0028258543461561203
characterized O 0 0.022349465638399124
by O 0 0.0014015365159139037
episodes O 0 0.004360069055110216
of O 0 0.21825121343135834
mania B-Disease 1 0.9999998807907104
and O 1 0.7988985180854797
/ O 1 0.9995995163917542
or O 0 0.00748446537181735
hypomania B-Disease 1 0.9998787641525269
interspersed O 0 0.012069199234247208
with O 0 0.0030110173393040895
periods O 0 0.012552697211503983
of O 0 0.31994563341140747
depression B-Disease 1 0.9999995231628418
. O 0 0.19328632950782776

Compelling O 0 0.0222624484449625
evidence O 0 0.010515477508306503
supports O 0 0.008482656441628933
a O 0 0.005498061887919903
significant O 0 0.00457283528521657
genetic O 0 0.006052892655134201
component O 0 0.007013382855802774
in O 0 0.0033414470963180065
the O 0 0.006177952978760004
susceptibility O 1 0.5418703556060791
to O 0 0.006552052218466997
develop O 0 0.02517380751669407
BPAD B-Disease 1 0.9994576573371887
. O 0 0.020546507090330124

To O 0 0.006176928523927927
date O 0 0.005017492454499006
, O 0 0.00253664655610919
however O 0 0.0020071847829967737
, O 0 0.0017192534869536757
linkage O 0 0.00412066001445055
studies O 0 0.001813731505535543
have O 0 0.0008222261094488204
attempted O 0 0.0021335850469768047
only O 0 0.0009562310297042131
to O 0 0.0011708901729434729
identify O 0 0.0025364402681589127
chromosomal O 0 0.010831784456968307
loci O 0 0.006103984080255032
that O 0 0.0016371882520616055
cause O 0 0.014332824386656284
or O 0 0.001791982795111835
increase O 0 0.0023149587213993073
the O 0 0.0036177539732307196
risk O 0 0.03795916587114334
of O 0 0.019471945241093636
developing O 1 0.980164110660553
BPAD B-Disease 1 0.9999896287918091
. O 0 0.01737828552722931

To O 0 0.005663242191076279
determine O 0 0.004571663215756416
whether O 0 0.002388222375884652
there O 0 0.0016556697664782405
could O 0 0.0015218077460303903
be O 0 0.0015216614119708538
protective O 0 0.06306470185518265
alleles O 0 0.0033455672673881054
that O 0 0.001105159637518227
prevent O 0 0.0025284423027187586
or O 0 0.0014733283314853907
reduce O 0 0.0030458318069577217
the O 0 0.002050762064754963
risk O 0 0.009747236035764217
of O 0 0.003389164572581649
developing O 1 0.7860431671142578
BPAD B-Disease 1 0.9999779462814331
, O 0 0.001226054155267775
similar O 0 0.0008515968220308423
to O 0 0.0006831676000729203
what O 0 0.00069067208096385
is O 0 0.0006996211595833302
observed O 0 0.0009643830126151443
in O 0 0.0007889787084423006
other O 0 0.0010820090537890792
genetic B-Disease 1 0.9107385873794556
disorders I-Disease 1 0.9999995231628418
, O 0 0.016166314482688904
we O 0 0.0021279824431985617
used O 0 0.003771590068936348
mental O 1 0.9999938011169434
health O 1 0.9997543692588806
wellness O 1 0.9999791383743286
( O 0 0.005166858434677124
absence O 0 0.005841563455760479
of O 0 0.016985660418868065
any O 0 0.22959044575691223
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.012626727111637592
as O 0 0.0016695376252755523
the O 0 0.0021662372164428234
phenotype O 0 0.003944423049688339
in O 0 0.0011408552527427673
our O 0 0.001821588957682252
genome O 0 0.004230550955981016
- O 0 0.004657510202378035
wide O 0 0.0027904859744012356
linkage O 0 0.005644450429826975
scan O 0 0.0038621744606643915
of O 0 0.0018919628346338868
several O 0 0.0015375899383798242
large O 0 0.003209335496649146
multigeneration O 0 0.2518194615840912
Old O 0 0.011860896833240986
Order O 0 0.004438906442373991
Amish O 0 0.01103335153311491
pedigrees O 0 0.009992511011660099
exhibiting O 0 0.007982607930898666
an O 0 0.003401561640202999
extremely O 0 0.011498512700200081
high O 0 0.07033532857894897
incidence O 1 0.9997005462646484
of O 1 0.806282639503479
BPAD B-Disease 1 0.9999984502792358
. O 0 0.023515384644269943

We O 0 0.00596995884552598
have O 0 0.002387719228863716
found O 0 0.0028961997013539076
strong O 0 0.002779127098619938
evidence O 0 0.0019108306150883436
for O 0 0.0014708254020661116
a O 0 0.0025310858618468046
locus O 0 0.007667390629649162
on O 0 0.0030264679808169603
chromosome O 0 0.006371975876390934
4p O 0 0.027686832472682
at O 0 0.004180957097560167
D4S2949 O 0 0.01612367108464241
( O 0 0.004028546158224344
maximum O 0 0.0061418660916388035
GENEHUNTER O 1 0.7551002502441406
- O 0 0.00804217904806137
PLUS O 0 0.00803493894636631
nonparametric O 0 0.013018326833844185
linkage O 0 0.006857269909232855
score O 0 0.0033034002408385277
= O 0 0.00456638028845191
4 O 0 0.0023339143954217434
. O 0 0.0015257378108799458
05 O 0 0.008727590553462505
, O 0 0.0025448508094996214
P O 0 0.008044058457016945
= O 0 0.0038200351409614086
5 O 0 0.0015984275378286839
. O 0 0.0008464923012070358
22 O 0 0.0016522336518391967
x O 0 0.002291708718985319
10 O 0 0.0015382979763671756
( O 0 0.0020245653577148914
- O 0 0.00288764457218349
4 O 0 0.0023259760346263647
) O 0 0.0014152707299217582
; O 0 0.0015790052711963654
SIBPAL O 0 0.014374477788805962
Pempirical O 0 0.010196216404438019
value O 0 0.0027848156169056892
< O 0 0.006585758179426193
3 O 0 0.0025653347838670015
x O 0 0.0029681690502911806
10 O 0 0.0018037552945315838
( O 0 0.002117142314091325
- O 0 0.0032109441235661507
5 O 0 0.0019137210911139846
) O 0 0.0013140980154275894
) O 0 0.0011609813664108515
and O 0 0.001016580150462687
suggestive O 0 0.0036284849047660828
evidence O 0 0.0015090836677700281
for O 0 0.0010884497314691544
a O 0 0.002161961980164051
locus O 0 0.006568386219441891
on O 0 0.002675274619832635
chromosome O 0 0.00663354154676199
4q O 0 0.04779199883341789
at O 0 0.004111332818865776
D4S397 O 0 0.01722506619989872
( O 0 0.0038303034380078316
maximum O 0 0.005367442034184933
GENEHUNTER O 1 0.6469200253486633
- O 0 0.007830766960978508
PLUS O 0 0.0075214398093521595
nonparametric O 0 0.01311843004077673
linkage O 0 0.006972720846533775
score O 0 0.0035592790227383375
= O 0 0.004299049265682697
3 O 0 0.0019136426271870732
. O 0 0.0010658157989382744
29 O 0 0.002252063946798444
, O 0 0.001573568326421082
P O 0 0.006648701149970293
= O 0 0.003690683748573065
2 O 0 0.0018276420887559652
. O 0 0.0009450255311094224
57 O 0 0.0027137035503983498
x O 0 0.002673461101949215
10 O 0 0.0016039792681112885
( O 0 0.001789685571566224
- O 0 0.002669738372787833
3 O 0 0.0018351725302636623
) O 0 0.001556466449983418
; O 0 0.0015383507125079632
SIBPAL O 0 0.01100444421172142
Pempirical O 0 0.00930870696902275
value O 0 0.002697509713470936
< O 0 0.005305567756295204
1 O 0 0.002269883407279849
x O 0 0.002335590310394764
10 O 0 0.0013767015188932419
( O 0 0.001661775168031454
- O 0 0.002366941189393401
3 O 0 0.0017146015306934714
) O 0 0.0011114203371107578
) O 0 0.0008998779812827706
that O 0 0.0007666082237847149
are O 0 0.0009269847651012242
linked O 0 0.0048516541719436646
to O 0 0.004153301939368248
mental O 1 0.9999969005584717
health O 1 0.9999818801879883
wellness O 1 0.9999899864196777
. O 0 0.045442041009664536

These O 0 0.006347541697323322
findings O 0 0.005823569372296333
are O 0 0.002080488484352827
consistent O 0 0.0033157963771373034
with O 0 0.0014245040947571397
the O 0 0.00227508251555264
hypothesis O 0 0.003962797112762928
that O 0 0.001133453450165689
certain O 0 0.0014839478535577655
alleles O 0 0.0027661325875669718
could O 0 0.0012087604263797402
prevent O 0 0.002232285914942622
or O 0 0.0014111087657511234
modify O 0 0.0026916395872831345
the O 0 0.00219474034383893
clinical O 0 0.36780455708503723
manifestations O 1 0.8871119022369385
of O 0 0.35480639338493347
BPAD B-Disease 1 0.9999990463256836
and O 0 0.0049255904741585255
perhaps O 0 0.004793972708284855
other O 0 0.002994048409163952
related O 1 0.9155345559120178
affective B-Disease 1 0.9999997615814209
disorders I-Disease 1 1.0
. O 1 0.8617074489593506

Segregation O 1 0.9982225298881531
distortion O 1 0.9993189573287964
in O 1 0.9632819294929504
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
. O 1 0.9111039638519287

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.999941349029541
DM B-Disease 1 1.0
) O 0 0.00640324829146266
is O 0 0.00282290019094944
an O 0 0.004250241909176111
autosomal B-Disease 1 0.9999402761459351
dominant I-Disease 1 0.9998742341995239
disease I-Disease 1 0.9999998807907104
which O 0 0.0022367320489138365
, O 0 0.0016164083499461412
in O 0 0.0013450499391183257
the O 0 0.0020818382035940886
typical O 0 0.009312422946095467
pedigree O 0 0.01609937846660614
, O 0 0.0014227551873773336
shows O 0 0.0017517420928925276
a O 0 0.002096431329846382
three O 0 0.0026474480982869864
generation O 0 0.014092773199081421
anticipation O 0 0.029699476435780525
cascade O 0 0.38748785853385925
. O 0 0.01268055196851492

This O 0 0.0059258705005049706
results O 0 0.006366782356053591
in O 0 0.009596288204193115
infertility B-Disease 1 0.9999994039535522
and O 1 0.9999587535858154
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999938011169434
CDM B-Disease 1 0.9999980926513672
) O 0 0.003236923133954406
with O 0 0.0016084496164694428
the O 0 0.0023809759877622128
disappearance O 0 0.023788176476955414
of O 0 0.31235471367836
DM B-Disease 1 0.9999998807907104
in O 0 0.0065317596308887005
that O 0 0.005638527683913708
pedigree O 0 0.03830030933022499
. O 0 0.013405871577560902

The O 0 0.007877488620579243
concept O 0 0.006838794331997633
of O 0 0.006065372843295336
segregation O 1 0.9990960359573364
distortion O 1 0.9881972670555115
, O 0 0.0025243593845516443
where O 0 0.0018068708013743162
there O 0 0.0014660324668511748
is O 0 0.0018406520830467343
preferential O 0 0.004675851669162512
transmission O 0 0.0029707245994359255
of O 0 0.0016254353104159236
the O 0 0.0015590769471600652
larger O 0 0.0019164006225764751
allele O 0 0.0028915295843034983
at O 0 0.0024346006102859974
the O 0 0.005485106259584427
DM B-Disease 1 0.9999994039535522
locus O 0 0.03488558903336525
, O 0 0.0017956686206161976
has O 0 0.0013626114232465625
been O 0 0.0013317536795511842
put O 0 0.0014150968054309487
forward O 0 0.0013289573835209012
to O 0 0.0008371290750801563
explain O 0 0.002222532406449318
partially O 0 0.0031960129272192717
the O 0 0.0019116272451356053
maintenance O 0 0.2829049527645111
of O 0 0.13675156235694885
DM B-Disease 1 0.9999996423721313
in O 0 0.003879719413816929
the O 0 0.00586911803111434
population O 0 0.008349972777068615
. O 0 0.011733094230294228

In O 0 0.007605735678225756
a O 0 0.005645280238240957
survey O 0 0.006145342253148556
of O 0 0.007585478480905294
DM B-Disease 1 0.9999985694885254
in O 0 0.00300355302169919
Northern O 0 0.0032942614052444696
Ireland O 0 0.0036163378972560167
, O 0 0.003346777521073818
59 O 0 0.008081612177193165
pedigrees O 0 0.014736075885593891
were O 0 0.006754566915333271
ascertained O 0 0.031341854482889175
. O 0 0.01538896281272173

Sibships O 0 0.06035879626870155
where O 0 0.005521634593605995
the O 0 0.003287248546257615
status O 0 0.003033560700714588
of O 0 0.0016856807051226497
all O 0 0.0009180959896184504
the O 0 0.0013100173091515899
members O 0 0.000985267455689609
had O 0 0.0014824928948655725
been O 0 0.0009906862396746874
identified O 0 0.001356092980131507
were O 0 0.0008527494501322508
examined O 0 0.0017879868391901255
to O 0 0.0006686761626042426
determine O 0 0.0010712407529354095
the O 0 0.0011773410951718688
transmission O 0 0.002381735248491168
of O 0 0.002015448408201337
the O 0 0.22145795822143555
DM B-Disease 1 0.9999998807907104
expansion O 0 0.005617138464003801
from O 0 0.0019513124134391546
affected O 0 0.0026486872229725122
parents O 0 0.002296768594533205
to O 0 0.0017617378616705537
their O 0 0.0023906889837235212
offspring O 0 0.011422887444496155
. O 0 0.008425023406744003

Where O 0 0.01177128404378891
the O 0 0.009099300019443035
transmitting O 0 0.3708193600177765
parent O 0 0.04274822026491165
was O 0 0.0868634432554245
male O 0 0.011328884400427341
, O 0 0.006537846755236387
58 O 0 0.019850756973028183
. O 0 0.013217099010944366

3 O 0 0.010307706892490387
% O 0 0.004508947487920523
of O 0 0.002464529126882553
the O 0 0.0032454016618430614
offspring O 0 0.00797690823674202
were O 0 0.0018167071975767612
affected O 0 0.0026036310009658337
, O 0 0.0013534388272091746
and O 0 0.0008826790144667029
in O 0 0.0010809231316670775
the O 0 0.0015168150421231985
case O 0 0.0019469237886369228
of O 0 0.0020125943701714277
a O 0 0.004144287668168545
female O 0 0.026771709322929382
transmitting O 0 0.1117568388581276
parent O 0 0.009029251523315907
, O 0 0.004693449009209871
68 O 0 0.01620439998805523
. O 0 0.010284077376127243

7 O 0 0.025616781786084175
% O 0 0.013975159265100956
were O 0 0.009906604886054993
affected O 0 0.020990459248423576
. O 0 0.01994631439447403

Studies O 0 0.011598324403166771
on O 0 0.007960617542266846
meiotic O 1 0.9359408020973206
drive O 0 0.01161667238920927
in O 0 0.0076980507001280785
DM B-Disease 1 0.9999994039535522
have O 0 0.0020288764499127865
shown O 0 0.002957508899271488
increased O 0 0.002706990810111165
transmission O 0 0.0030558868311345577
of O 0 0.0017075649229809642
the O 0 0.002073919400572777
larger O 0 0.0022461581975221634
allele O 0 0.0032816880848258734
at O 0 0.0025672856718301773
the O 0 0.00404516002163291
DM B-Disease 1 0.9999873638153076
locus O 0 0.014018579386174679
in O 0 0.004120859783142805
non O 0 0.3796134293079376
- O 1 0.9989898800849915
DM O 1 0.9999991655349731
heterozygotes O 1 0.9234182238578796
for O 0 0.011095513589680195
CTGn O 1 0.9497672915458679
. O 0 0.018727555871009827

This O 0 0.00556449219584465
study O 0 0.005460561253130436
provides O 0 0.003675902495160699
further O 0 0.002345398301258683
evidence O 0 0.0025576958432793617
that O 0 0.0020583164878189564
the O 0 0.00826326571404934
DM B-Disease 1 0.9999997615814209
expansion O 0 0.015831224620342255
tends O 0 0.006680720951408148
to O 0 0.003058934584259987
be O 0 0.004012929741293192
transmitted O 0 0.012967370450496674
preferentially O 0 0.020731711760163307
. O 0 0.01245114766061306

Diagnosis O 1 0.999742329120636
of O 1 0.9851980805397034
hemochromatosis B-Disease 1 0.9999998807907104
. O 1 0.7631276249885559

If O 0 0.022638892754912376
untreated O 1 0.9999926090240479
, O 1 0.8995075821876526
hemochromatosis B-Disease 1 1.0
can O 0 0.2225407361984253
cause O 1 0.9999575614929199
serious O 1 0.9999991655349731
illness O 1 1.0
and O 1 0.7682679891586304
early B-Disease 0 0.3300253748893738
death I-Disease 1 0.956604540348053
, O 0 0.0016044025542214513
but O 0 0.0010806836653500795
the O 0 0.0039039854891598225
disease O 1 0.9999892711639404
is O 0 0.002971228677779436
still O 0 0.003943492192775011
substantially O 0 0.009660933166742325
under O 0 0.04551707208156586
- O 1 0.9994762539863586
diagnosed O 1 0.999997615814209
. O 0 0.018885083496570587

The O 0 0.012129861861467361
cornerstone O 0 0.281222403049469
of O 0 0.007075613830238581
screening O 0 0.028326960280537605
and O 0 0.0031888296362012625
case O 0 0.004422812722623348
detection O 0 0.005569864064455032
is O 0 0.001811961061321199
the O 0 0.002197584602981806
measurement O 0 0.005724554881453514
of O 0 0.006201369222253561
serum O 1 0.9989292025566101
transferrin O 1 0.7375276684761047
saturation O 0 0.013136425986886024
and O 0 0.00323788751848042
the O 0 0.006769026163965464
serum O 1 0.9933068156242371
ferritin O 1 0.955122172832489
level O 0 0.012709620408713818
. O 0 0.010730342008173466

Once O 0 0.01497578527778387
the O 0 0.009916539303958416
diagnosis O 1 0.9989457726478577
is O 0 0.004989872686564922
suspected O 0 0.02512679062783718
, O 0 0.002766461344435811
physicians O 0 0.018882395699620247
must O 0 0.0027757356874644756
use O 0 0.0033700461499392986
serum O 1 0.9939887523651123
ferritin O 1 0.9716672897338867
levels O 0 0.006792559754103422
and O 0 0.0044924733228981495
hepatic O 1 0.9999445676803589
iron O 1 0.9998176693916321
stores O 0 0.01237161923199892
on O 0 0.013787453062832355
liver O 1 0.9999762773513794
biopsy O 1 0.9947580695152283
specimens O 0 0.005403602961450815
to O 0 0.0016515227034687996
assess O 0 0.004790328908711672
patients O 0 0.004422930534929037
for O 0 0.001623253570869565
the O 0 0.0025508711114525795
presence O 0 0.00523648364469409
of O 0 0.04432229697704315
iron B-Disease 1 0.9999921321868896
overload I-Disease 1 0.9999719858169556
. O 0 0.019798267632722855

Liver O 1 0.9999983310699463
biopsy O 1 0.9998769760131836
is O 0 0.006372151430696249
also O 0 0.0024116074200719595
used O 0 0.00162981147877872
to O 0 0.0010697741527110338
establish O 0 0.001723740017041564
the O 0 0.0013869083486497402
presence O 0 0.0017459947848692536
or O 0 0.0012694001197814941
absence O 0 0.005145001690834761
of O 0 0.37956947088241577
cirrhosis B-Disease 1 1.0
, O 0 0.1343023180961609
which O 0 0.002199593000113964
can O 0 0.002220399212092161
affect O 0 0.00632348982617259
prognosis O 1 0.9999135732650757
and O 0 0.006255038548260927
management O 0 0.42989280819892883
. O 0 0.013001030310988426

A O 0 0.016108345240354538
DNA O 0 0.01068934891372919
- O 0 0.00641951709985733
based O 0 0.0024136018473654985
test O 0 0.002163585741072893
for O 0 0.001521631726063788
the O 0 0.0036224424839019775
HFE O 1 0.9996570348739624
gene O 0 0.0028925007209181786
is O 0 0.0012988309608772397
commercially O 0 0.00174326344858855
available O 0 0.0008321520290337503
, O 0 0.0007871564594097435
but O 0 0.000619599421042949
its O 0 0.0006935852579772472
place O 0 0.0012039996217936277
in O 0 0.0011736360611394048
the O 0 0.003330901963636279
diagnosis O 1 0.9999082088470459
of O 1 0.9727076292037964
hemochromatosis B-Disease 1 1.0
is O 0 0.23187008500099182
still O 0 0.006940826307982206
being O 0 0.007059004157781601
evaluated O 0 0.0181161779910326
. O 0 0.010361768305301666

Currently O 0 0.01053968258202076
, O 0 0.0040613566525280476
the O 0 0.0027874624356627464
most O 0 0.0014851848827674985
useful O 0 0.0018204706721007824
role O 0 0.001704725669696927
for O 0 0.0008882194524630904
this O 0 0.0006996841984800994
test O 0 0.001079547218978405
is O 0 0.000803676899522543
in O 0 0.0006928198854438961
the O 0 0.001221219077706337
detection O 0 0.004369684495031834
of O 0 0.0037831130903214216
hemochromatosis B-Disease 1 0.9999996423721313
in O 0 0.001575071131810546
the O 0 0.0014366445830091834
family O 0 0.0014919611858204007
members O 0 0.0008677072473801672
of O 0 0.00203762692399323
patients O 1 0.9256638884544373
with O 0 0.0011747641256079078
a O 0 0.0029477498028427362
proven O 0 0.02019447833299637
case O 0 0.003340216586366296
of O 0 0.005722146015614271
the O 1 0.7446451783180237
disease O 1 0.9999990463256836
. O 0 0.01701897382736206

It O 0 0.0064352331683039665
is O 0 0.004127981141209602
crucial O 0 0.006670842412859201
to O 0 0.005994678940623999
diagnose O 1 0.9999983310699463
hemochromatosis B-Disease 1 1.0
before O 1 0.9994865655899048
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999959468841553
because O 1 0.8958978652954102
phlebotomy O 1 0.9999994039535522
therapy O 1 0.9999743700027466
can O 0 0.007913563400506973
avert O 1 0.9999804496765137
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9448124170303345
can O 0 0.002020915038883686
even O 0 0.0013551764423027635
lead O 0 0.0016847627703100443
to O 0 0.0012942372122779489
normal O 0 0.00333679118193686
life O 0 0.0055160135962069035
expectancy O 1 0.6063615083694458
. O 0 0.005558355711400509
. O 0 0.009443610906600952

Prevalence O 0 0.15607944130897522
of O 0 0.010355961509048939
the O 0 0.01706482283771038
I1307K O 1 0.9991649389266968
APC B-Disease 1 0.9990366697311401
gene O 0 0.005273606162518263
variant O 0 0.0045150271616876125
in O 0 0.0014326389646157622
Israeli O 0 0.0021894939709454775
Jews O 0 0.002119071315973997
of O 0 0.0014979849802330136
differing O 0 0.0018173608696088195
ethnic O 0 0.0020645740441977978
origin O 0 0.002696749521419406
and O 0 0.003866489976644516
risk O 1 0.9925099611282349
for O 1 0.9963164329528809
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8276444673538208

BACKGROUND O 0 0.036372385919094086
& O 0 0.0266246497631073
AIMS O 0 0.01482374221086502
Israeli O 0 0.0062907543033361435
Jews O 0 0.004036321304738522
of O 0 0.0026573478244245052
European O 0 0.003582376753911376
birth O 0 0.4928644299507141
, O 0 0.0025872138794511557
i O 0 0.0027188214007765055
. O 0 0.0009715265478007495
e O 0 0.0017857798375189304
. O 0 0.0007565665291622281
, O 0 0.0010269812773913145
Ashkenazim O 0 0.0046386392787098885
, O 0 0.0013013576390221715
have O 0 0.0009642847580835223
the O 0 0.003611320862546563
highest O 1 0.9999758005142212
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999991655349731
of O 1 0.6514835357666016
any O 0 0.0048571182414889336
Israeli O 0 0.007038765586912632
ethnic O 0 0.006644038483500481
group O 0 0.007120062597095966
. O 0 0.009258516132831573

The O 0 0.020207040011882782
I1307K O 1 0.986189067363739
APC B-Disease 1 0.9981772899627686
gene O 0 0.01045631431043148
variant O 0 0.01936746947467327
was O 0 0.006168672814965248
found O 0 0.003625920508056879
in O 0 0.004977813456207514
6 O 0 0.012721091508865356
. O 0 0.011642427183687687

1 O 0 0.011313466355204582
% O 0 0.004130283370614052
of O 0 0.0027120134327560663
American O 0 0.0026911008171737194
Jews O 0 0.0027732790913432837
, O 0 0.001559457159601152
28 O 0 0.002183054806664586
% O 0 0.0014313936699181795
of O 0 0.0018135571153834462
their O 0 0.004333040211349726
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9998873472213745
, O 0 0.15811805427074432
but O 0 0.0015599990729242563
not O 0 0.0011299611069262028
in O 0 0.0018710659351199865
non O 0 0.00785073172301054
- O 0 0.047971099615097046
Jews O 0 0.012593104504048824
. O 0 0.011075105518102646

We O 0 0.0076506840996444225
assessed O 0 0.010317805223166943
the O 0 0.005397097673267126
I1307K O 1 0.7685813903808594
prevalence O 1 0.5094432830810547
in O 0 0.0025187393184751272
Israeli O 0 0.003011177759617567
Jews O 0 0.0027834794018417597
of O 0 0.001870715175755322
differing O 0 0.00206813239492476
ethnic O 0 0.0023136530071496964
origin O 0 0.002808451419696212
and O 0 0.003909036051481962
risk O 1 0.9646587371826172
for O 1 0.9858124256134033
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9268861413002014

METHODS O 0 0.015277288854122162
DNA O 0 0.00834276620298624
samples O 0 0.003894922323524952
from O 0 0.001986123388633132
500 O 0 0.003513372503221035
unrelated O 0 0.003211368340998888
Jews O 0 0.002257806481793523
of O 0 0.001707807183265686
European O 0 0.0019920137710869312
or O 0 0.002029948402196169
non O 0 0.0036285780370235443
- O 0 0.003191659227013588
European O 0 0.0014090012991800904
origin O 0 0.0010595920030027628
, O 0 0.0008090432966127992
with O 0 0.0006039355066604912
or O 0 0.0008603155147284269
without O 0 0.0007051017601042986
a O 0 0.0012759780511260033
personal O 0 0.0034062054473906755
and O 0 0.002139350865036249
/ O 0 0.36981433629989624
or O 0 0.001177106867544353
family O 0 0.0016996662598103285
history O 0 0.0020892422180622816
of O 0 0.003977448213845491
neoplasia B-Disease 1 0.9999648332595825
, O 0 0.001532037160359323
were O 0 0.001189753646031022
examined O 0 0.002146400511264801
for O 0 0.0012103692861273885
the O 0 0.0018896518740803003
I1307K O 0 0.06525599211454391
variant O 0 0.004331245087087154
by O 0 0.0014375526225194335
the O 0 0.0024707457050681114
allele O 0 0.005457651801407337
- O 0 0.004746150225400925
specific O 0 0.0030932161025702953
oligonucleotide O 0 0.01864505559206009
( O 0 0.007558238226920366
ASO O 1 0.9931465983390808
) O 0 0.006021680310368538
method O 0 0.01081188302487135
. O 0 0.012049548327922821

RESULTS O 0 0.007797179277986288
In O 0 0.0024817290250211954
persons O 0 0.002793177030980587
at O 0 0.002705139108002186
average O 0 0.004650070797652006
risk O 0 0.3972242474555969
for O 1 0.5429543852806091
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.7324544191360474
I1307K O 1 0.9973978996276855
was O 0 0.06300007551908493
found O 0 0.0033575627021491528
in O 0 0.0037088152021169662
5 O 0 0.008993737399578094
. O 0 0.009352854453027248

0 O 0 0.015386277809739113
% O 0 0.005760492291301489
of O 0 0.004010050091892481
120 O 0 0.005911878775805235
European O 0 0.004473019391298294
and O 0 0.004543039947748184
1 O 0 0.011991136707365513
. O 0 0.012462833896279335

6 O 0 0.012630525045096874
% O 0 0.004604883957654238
of O 0 0.003432274330407381
188 O 0 0.008737297728657722
non O 0 0.005023552570492029
- O 0 0.004755409900099039
European O 0 0.002606750698760152
Jews O 0 0.004694438073784113
( O 0 0.004783698357641697
P O 0 0.012424779124557972
= O 0 0.007190308067947626
0 O 0 0.004818582907319069
. O 0 0.0033621788024902344
08 O 0 0.0170326828956604
) O 0 0.007855837233364582
. O 0 0.009636162780225277

It O 0 0.009816044941544533
occurred O 0 0.013805228285491467
in O 0 0.008517397567629814
15 O 0 0.015101778320968151
. O 0 0.016463633626699448

4 O 0 0.01129736378788948
% O 0 0.004221761599183083
of O 0 0.0031638999935239553
52 O 0 0.005754418671131134
Ashkenazi O 0 0.010240526869893074
Israelis O 0 0.003652015933766961
with O 0 0.002330547897145152
familial O 1 0.9999829530715942
cancer B-Disease 1 0.9999991655349731
( O 0 0.14433002471923828
P O 1 0.6802960634231567
= O 0 0.0055624316446483135
0 O 0 0.002552266465499997
. O 0 0.0013875099830329418
02 O 0 0.011273563839495182
) O 0 0.001379080698825419
and O 0 0.0008990509086288512
was O 0 0.0017863151151686907
not O 0 0.0008825848926790059
detected O 0 0.0021706344559788704
in O 0 0.0011050490429624915
51 O 0 0.003049466758966446
non O 0 0.0025238909292966127
- O 0 0.0034158858470618725
European O 0 0.0018814890645444393
Jews O 0 0.003916041925549507
at O 0 0.0072030979208648205
increased O 0 0.19046899676322937
cancer B-Disease 1 0.9999730587005615
risk O 1 0.9044927954673767
. O 0 0.014951719902455807

Colorectal B-Disease 1 0.9999986886978149
neoplasia I-Disease 1 0.9999889135360718
occurred O 0 0.1799919307231903
personally O 0 0.08427075296640396
or O 0 0.002505167620256543
in O 0 0.0014458114746958017
the O 0 0.001344813616015017
families O 0 0.0010009085526689887
of O 0 0.0010858842870220542
13 O 0 0.0015751400496810675
of O 0 0.0016488784458488226
20 O 0 0.0026507009752094746
Ashkenazi O 0 0.06590765714645386
I1307K O 0 0.0497598759829998
carriers O 0 0.0030198192689567804
, O 0 0.001287425053305924
8 O 0 0.0017876100027933717
of O 0 0.0012365815928205848
whom O 0 0.0023147265892475843
also O 0 0.0015691649168729782
had O 0 0.0016727453330531716
a O 0 0.0019235536456108093
personal O 0 0.004160265903919935
or O 0 0.0020381389185786247
family O 0 0.00399806909263134
history O 0 0.006762210745364428
of O 0 0.04134272783994675
noncolonic O 1 0.9999222755432129
neoplasia B-Disease 1 0.9999371767044067
. O 0 0.025220243260264397

CONCLUSIONS O 0 0.021554790437221527
The O 0 0.013474790379405022
I1307K O 1 0.871640682220459
APC O 1 0.981082558631897
variant O 0 0.016547804698348045
may O 0 0.003113824175670743
represent O 0 0.0025257477536797523
a O 0 0.0036733290180563927
susceptibility O 1 0.7895121574401855
gene O 0 0.004994539078325033
for O 0 0.0035356224980205297
colorectal B-Disease 1 0.9999990463256836
, I-Disease 0 0.003318517468869686
or I-Disease 0 0.0017815668834373355
other I-Disease 0 0.0012747086584568024
, I-Disease 0 0.0028056963346898556
cancers I-Disease 1 0.9543404579162598
in O 0 0.002366109285503626
Ashkenazi O 1 0.6858339309692383
Jews O 0 0.003731413511559367
, O 0 0.0016947854310274124
and O 0 0.0015410087071359158
partially O 0 0.005145319737493992
explains O 0 0.004330220632255077
the O 0 0.0025988901033997536
higher O 0 0.0062894136644899845
incidence O 1 0.9995197057723999
of O 1 0.9998099207878113
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.42784583568573
European O 0 0.0163036547601223
Israelis O 0 0.014683392830193043
. O 0 0.011995352804660797

Systematic O 0 0.024743186309933662
analysis O 0 0.01007760502398014
of O 0 0.011152408085763454
coproporphyrinogen O 1 0.9992715716362
oxidase O 1 0.9948679208755493
gene O 0 0.024780891835689545
defects O 1 0.9972307085990906
in O 0 0.008080564439296722
hereditary B-Disease 1 0.999991774559021
coproporphyria I-Disease 1 0.9999805688858032
and O 0 0.03705132007598877
mutation O 0 0.20204715430736542
update O 0 0.023739224299788475
. O 0 0.012664979323744774

Hereditary B-Disease 1 0.9997944235801697
coproporphyria I-Disease 1 0.9997163414955139
( O 1 0.7621231079101562
HC B-Disease 1 0.9999985694885254
) O 0 0.012740904465317726
is O 0 0.006044453475624323
an O 0 0.18330202996730804
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9994149208068848
autosomal O 1 0.9999996423721313
dominant O 1 0.9999796152114868
inheritance O 1 0.9999643564224243
caused O 1 0.9998559951782227
by O 0 0.17384615540504456
deficient B-Disease 1 0.9997598528862
activity I-Disease 0 0.003636580891907215
of I-Disease 0 0.010338499210774899
coproporphyrinogen I-Disease 1 0.9999512434005737
III I-Disease 1 0.999985933303833
oxidase I-Disease 1 0.9802572131156921
( O 0 0.012320981360971928
CPO O 0 0.46046650409698486
) O 0 0.010082602500915527
. O 0 0.01085291150957346

Clinical O 0 0.496758371591568
manifestations O 1 0.8525813221931458
of O 0 0.35038089752197266
the O 1 0.9995051622390747
disease O 1 1.0
are O 0 0.0024239292833954096
characterized O 1 0.9800965189933777
by O 0 0.06118673086166382
acute O 1 1.0
attacks O 1 0.9917301535606384
of O 1 0.9999808073043823
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9913649559020996
precipitated O 1 0.9999985694885254
by O 0 0.08004312962293625
drugs O 1 0.9806315898895264
, O 0 0.00660795159637928
fasting O 0 0.18088412284851074
, O 0 0.004741300828754902
cyclical O 1 0.9838877320289612
hormonal O 1 0.9879547357559204
changes O 0 0.005409416276961565
, O 0 0.008717332035303116
or O 0 0.29844459891319275
infectious B-Disease 1 0.9999997615814209
diseases I-Disease 1 0.9999998807907104
. O 0 0.26464030146598816

Skin O 1 0.9999982118606567
photosensitivity O 1 0.9999938011169434
may O 0 0.05089305341243744
also O 0 0.006155777256935835
be O 0 0.004353789146989584
present O 0 0.009410837665200233
. O 0 0.011494520120322704

The O 0 0.009589921683073044
seven O 0 0.006742025725543499
exons O 0 0.011942223645746708
, O 0 0.003480019746348262
the O 0 0.0051819439977407455
exon O 1 0.7610019445419312
/ O 0 0.10384445637464523
intron O 0 0.0241633839905262
boundaries O 0 0.0023063404951244593
and O 0 0.0015704033430665731
part O 0 0.002311415271833539
of O 0 0.0023006859701126814
3 O 0 0.003429665695875883
noncoding O 0 0.007094694301486015
sequence O 0 0.002061637584120035
of O 0 0.0017871061572805047
the O 0 0.002893637865781784
CPO O 0 0.2804376780986786
gene O 0 0.002447222825139761
were O 0 0.0013077185722067952
systematically O 0 0.002933369716629386
analyzed O 0 0.002222944749519229
by O 0 0.001192159834317863
an O 0 0.0019702569115906954
exon O 0 0.011557691730558872
- O 0 0.004522704053670168
by O 0 0.0023184085730463266
- O 0 0.009176388382911682
exon O 0 0.02039334364235401
denaturing O 0 0.1061517521739006
gradient O 0 0.02504473738372326
gel O 1 0.6076067686080933
electrophoresis O 0 0.3261573016643524
( O 0 0.007086245343089104
DGGE O 1 0.832903265953064
) O 0 0.0026649893261492252
strategy O 0 0.002968132495880127
followed O 0 0.0019106469117105007
by O 0 0.0011498903622850776
direct O 0 0.0016949308337643743
sequencing O 0 0.002542683854699135
in O 0 0.0013696580426767468
seven O 0 0.0022497184108942747
unrelated O 0 0.0062092081643640995
heterozygous O 0 0.011539435014128685
HC B-Disease 1 0.9999945163726807
patients O 1 0.9617639183998108
from O 0 0.003747748676687479
France O 0 0.07002396136522293
, O 0 0.003729793708771467
Holland O 0 0.0848495289683342
, O 0 0.002862657653167844
and O 0 0.0032961938995867968
Czech O 0 0.01811937615275383
Republic O 0 0.02136017382144928
. O 0 0.01152848545461893

Seven O 0 0.014805237762629986
novel O 0 0.016727371141314507
mutations O 0 0.007078981958329678
and O 0 0.0029186152387410402
two O 0 0.0023282498586922884
new O 0 0.00449949037283659
polymorphisms O 0 0.012964569963514805
were O 0 0.005664443131536245
detected O 0 0.019886977970600128
. O 0 0.013337402604520321

Among O 0 0.00718535715714097
these O 0 0.0031303460709750652
mutations O 0 0.003660437650978565
two O 0 0.00137832120526582
are O 0 0.0014063321286812425
missense O 0 0.008473393507301807
( O 0 0.003546019783243537
G197W O 0 0.027397489175200462
, O 0 0.0022915974259376526
W427R O 0 0.011206232011318207
) O 0 0.0012790417531505227
, O 0 0.0009676383924670517
two O 0 0.0006319920066744089
are O 0 0.0008514317451044917
nonsense O 0 0.00652891444042325
( O 0 0.0030631485860794783
Q306X O 0 0.034941066056489944
, O 0 0.002359905280172825
Q385X O 0 0.020012618973851204
) O 0 0.0014707715017721057
, O 0 0.001013956032693386
two O 0 0.0006861900328658521
are O 0 0.0005823144456371665
small O 0 0.0012629884295165539
deletions O 0 0.004747834987938404
( O 0 0.002974180970340967
662de14bp O 0 0.01629532501101494
; O 0 0.0026350817643105984
1168del3bp O 0 0.012473917566239834
removing O 0 0.004713910631835461
a O 0 0.002615806646645069
glycine O 0 0.005603823345154524
at O 0 0.0019416339928284287
position O 0 0.002333421492949128
390 O 0 0.0057795667089521885
) O 0 0.0012204586528241634
, O 0 0.0009655057219788432
and O 0 0.0008279600297100842
one O 0 0.0009632867295295
is O 0 0.0010824162745848298
a O 0 0.0016337219858542085
splicing O 0 0.0036694060545414686
mutation O 0 0.003504648571833968
( O 0 0.0034660939127206802
IVS1 O 1 0.6352994441986084
- O 0 0.013245400041341782
15c O 0 0.23954111337661743
- O 0 0.12717854976654053
- O 0 0.038388170301914215
> O 0 0.012521137483417988
g O 0 0.005577761214226484
) O 0 0.0018860038835555315
which O 0 0.0012371729826554656
creates O 0 0.0032218960113823414
a O 0 0.002871315460652113
new O 0 0.004617665894329548
acceptor O 0 0.022039838135242462
splice O 0 0.0264065470546484
site O 0 0.01343970000743866
. O 0 0.012904949486255646

The O 0 0.01262154895812273
pathological O 0 0.03076115809381008
significance O 0 0.007368307560682297
of O 0 0.003744098823517561
the O 0 0.004795469809323549
point O 0 0.005872149020433426
mutations O 0 0.005635908804833889
G197W O 0 0.07664734870195389
, O 0 0.0024916904512792826
W427R O 0 0.012695711106061935
, O 0 0.0014962279237806797
and O 0 0.001032483414746821
the O 0 0.0015491768717765808
in O 0 0.0020531495101749897
- O 0 0.030209332704544067
frame O 0 0.011723234318196774
deletion O 0 0.009235852397978306
390delGly O 0 0.010009845718741417
were O 0 0.0015745718264952302
assessed O 0 0.0025519486516714096
by O 0 0.0009530040551908314
their O 0 0.0009897768031805754
respective O 0 0.0018877929542213678
expression O 0 0.0019213504856452346
in O 0 0.0012859983835369349
a O 0 0.0020273844711482525
prokaryotic O 0 0.005215764977037907
system O 0 0.0027063835877925158
using O 0 0.0022161726374179125
site O 0 0.005596226546913385
- O 0 0.012274685315787792
directed O 0 0.01342680212110281
mutagenesis O 0 0.03439348563551903
. O 0 0.01564052142202854

These O 0 0.008352917619049549
mutations O 0 0.009092875756323338
resulted O 0 0.006291117984801531
in O 0 0.0028156531043350697
the O 0 0.004337284713983536
absence O 0 0.03461586683988571
or O 0 0.002598666353151202
a O 0 0.0037015436682850122
dramatic O 0 0.012232479639351368
decrease O 0 0.011914016678929329
of O 0 0.011265001259744167
CPO O 1 0.9893162250518799
activity O 0 0.014753366820514202
. O 0 0.010956837795674801

The O 0 0.009348791092634201
two O 0 0.004584242589771748
polymorphisms O 0 0.00959759671241045
were O 0 0.003005960024893284
localized O 0 0.007355568464845419
in O 0 0.0022041562478989363
noncoding O 0 0.010172830894589424
part O 0 0.002357575809583068
of O 0 0.0019693400245159864
the O 0 0.0026448445860296488
gene O 0 0.002540668472647667
1 O 0 0.002025600289925933
) O 0 0.001324290526099503
a O 0 0.0022219063248485327
C O 0 0.010405515320599079
/ O 0 0.01140566449612379
G O 0 0.0076127066276967525
polymorphism O 0 0.004188627004623413
in O 0 0.0019464707002043724
the O 0 0.003073653904721141
promotor O 0 0.25484561920166016
region O 0 0.0043579209595918655
, O 0 0.0029597876127809286
142 O 0 0.007578535471111536
bp O 0 0.006253971252590418
upstream O 0 0.003863187273964286
from O 0 0.0015186960808932781
the O 0 0.0019635360222309828
transcriptional O 0 0.004933781456202269
initiation O 0 0.0042698499746620655
site O 0 0.0035328599624335766
( O 0 0.003927685786038637
- O 0 0.007811534218490124
142C O 0 0.16883517801761627
/ O 0 0.19213593006134033
G O 0 0.00913027860224247
) O 0 0.0013267226750031114
, O 0 0.0010078055784106255
and O 0 0.001062503783032298
2 O 0 0.0019722231663763523
) O 0 0.00120514293666929
a O 0 0.0018856306560337543
6 O 0 0.0031438712030649185
bp O 0 0.004787943325936794
deletion O 0 0.004671032074838877
polymorphism O 0 0.0036060574930161238
in O 0 0.001477875281125307
the O 0 0.0020033936016261578
3 O 0 0.0032711459789425135
noncoding O 0 0.0076172794215381145
part O 0 0.0026869794819504023
of O 0 0.002922997809946537
the O 0 0.0049131158739328384
CPO O 1 0.7377458214759827
gene O 0 0.005200047977268696
, O 0 0.003581190714612603
574 O 0 0.016728954389691353
bp O 0 0.008824145421385765
downstream O 0 0.004102712497115135
of O 0 0.002043295418843627
the O 0 0.0021704279351979494
last O 0 0.0024969344958662987
base O 0 0.0027189957909286022
of O 0 0.0019714501686394215
the O 0 0.003125059651210904
normal O 0 0.005755753256380558
termination O 0 0.01572701707482338
codon O 0 0.015417443588376045
( O 0 0.008851001039147377
+ O 0 0.01771966740489006
574 O 0 0.03941575437784195
delATTCTT O 0 0.05362293869256973
) O 0 0.012797614559531212
. O 0 0.016396954655647278

Five O 0 0.015521503984928131
intragenic O 1 0.8875724673271179
dimorphisms O 0 0.4445783495903015
are O 0 0.0026328107342123985
now O 0 0.0029861077200621367
well O 0 0.001990455901250243
characterized O 0 0.006869133096188307
and O 0 0.0017631088849157095
the O 0 0.002690736437216401
high O 0 0.005294742528349161
degree O 0 0.004515379201620817
of O 0 0.004487042315304279
allelic O 1 0.9112135171890259
heterogeneity O 1 0.5052468776702881
in O 0 0.005008406471461058
HC B-Disease 1 0.999998927116394
is O 0 0.0029731914401054382
demonstrated O 0 0.0029158524703234434
with O 0 0.0009200804634019732
seven O 0 0.0012603073846548796
new O 0 0.000909952912479639
different O 0 0.000591110554523766
mutations O 0 0.0012066757772117853
making O 0 0.0008425507694482803
a O 0 0.0010968116112053394
total O 0 0.0012568621896207333
of O 0 0.0022456953302025795
nineteen O 1 0.7558832764625549
CPO O 1 0.9994778037071228
gene B-Disease 0 0.009914947673678398
defects I-Disease 1 0.9562510251998901
reported O 0 0.00450058002024889
so O 0 0.002518831519410014
far O 0 0.0034574493765830994
. O 0 0.004697076510637999
. O 0 0.009474003687500954

Coincidence O 0 0.017127495259046555
of O 0 0.0060391612350940704
two O 0 0.003726343624293804
novel O 0 0.015372853726148605
arylsulfatase O 0 0.382525771856308
A O 0 0.007887564599514008
alleles O 0 0.007006524596363306
and O 0 0.0027458169497549534
mutation O 0 0.008765687234699726
459 O 1 0.8623273372650146
+ O 0 0.029761964455246925
1G O 1 0.549578070640564
> O 0 0.00677149835973978
A O 0 0.0029832187574356794
within O 0 0.0019630156457424164
a O 0 0.002494723768904805
family O 0 0.004287059884518385
with O 0 0.003862475510686636
metachromatic B-Disease 1 0.9999679327011108
leukodystrophy I-Disease 1 0.9999887943267822
: O 0 0.004917029291391373
molecular O 0 0.005442546680569649
basis O 0 0.004239808768033981
of O 0 0.006046688184142113
phenotypic O 0 0.026947027072310448
heterogeneity O 0 0.07316996157169342
. O 0 0.01892690174281597

In O 0 0.006577683612704277
a O 0 0.005721603520214558
family O 0 0.004182120785117149
with O 0 0.001739452825859189
three O 0 0.002029198920354247
siblings O 0 0.005115301348268986
, O 0 0.001544182887300849
one O 0 0.001405842020176351
developed O 0 0.002430468564853072
classical O 0 0.005285202991217375
late O 0 0.062088266015052795
infantile O 1 0.9999991655349731
metachromatic B-Disease 1 0.9999980926513672
leukodystrophy I-Disease 1 0.9999998807907104
( O 1 0.9825382232666016
MLD B-Disease 1 0.9999994039535522
) O 0 0.0032421457581222057
, O 0 0.001780637656338513
fatal O 0 0.06358145922422409
at O 0 0.0023067796137183905
age O 0 0.002707769861444831
5 O 0 0.0017034253105521202
years O 0 0.0011695035500451922
, O 0 0.001349999220110476
with O 0 0.0019494392909109592
deficient O 1 0.9956027269363403
arylsulfatase O 1 0.8754560947418213
A O 0 0.02387901209294796
( O 0 0.006981456186622381
ARSA O 1 0.9970595240592957
) O 0 0.0023977388627827168
activity O 0 0.001979472814127803
and O 0 0.0019000408938154578
increased O 0 0.0050699179992079735
galactosylsulfatide O 1 0.9803689122200012
( O 0 0.053968895226716995
GS O 1 0.9999828338623047
) O 0 0.011871369555592537
excretion O 0 0.04095984250307083
. O 0 0.015073910355567932

The O 0 0.006601700559258461
two O 0 0.0024261786602437496
other O 0 0.0018824690487235785
siblings O 0 0.004816635046154261
, O 0 0.0021683862432837486
apparently O 0 0.0031690476462244987
healthy O 0 0.003204427659511566
at O 0 0.001953516388311982
12 O 0 0.0019688087049871683
( O 0 0.0019306549802422523
1 O 0 0.0021769467275589705
/ O 0 0.0036912059877067804
2 O 0 0.0013639836106449366
) O 0 0.0008570741629227996
and O 0 0.0006354967481456697
15 O 0 0.0009785868460312486
years O 0 0.0008622388122603297
, O 0 0.00086727284360677
respectively O 0 0.0013663136633113027
, O 0 0.0007562988321296871
and O 0 0.0007546472479589283
their O 0 0.0007666367455385625
father O 0 0.015869442373514175
, O 0 0.001922707655467093
apparently O 0 0.004211380612105131
healthy O 0 0.0033617569133639336
as O 0 0.0010535004548728466
well O 0 0.001101055066101253
, O 0 0.0017707236111164093
presented O 0 0.006592459045350552
ARSA O 1 0.9997360110282898
and O 0 0.0034200081136077642
GS O 1 0.9902542233467102
values O 0 0.0024651179555803537
within O 0 0.0015201877104118466
the O 0 0.00226929085329175
range O 0 0.004049535375088453
of O 0 0.013115121982991695
MLD B-Disease 1 0.9999997615814209
patients O 1 0.9986144304275513
. O 0 0.0196098480373621

Mutation O 0 0.023967823013663292
screening O 0 0.011043532751500607
and O 0 0.0033081069122999907
sequence O 0 0.0032690756488591433
analysis O 0 0.002679066266864538
disclosed O 0 0.004894278012216091
the O 0 0.002227118704468012
involvement O 0 0.0032067103311419487
of O 0 0.0020840305369347334
three O 0 0.0016926892567425966
different O 0 0.0020587483886629343
ARSA O 1 0.9982140064239502
mutations O 0 0.0032656032126396894
being O 0 0.0019356459379196167
the O 0 0.0018129150848835707
molecular O 0 0.0035365179646760225
basis O 0 0.0030423265416175127
of O 0 0.005303798709064722
intrafamilial O 1 0.806956946849823
phenotypic O 0 0.05814296379685402
heterogeneity O 0 0.20687337219715118
. O 0 0.020327091217041016

The O 0 0.014141155406832695
late O 0 0.20094992220401764
infantile O 1 0.9999995231628418
patient O 1 0.9999967813491821
inherited O 1 0.9999961853027344
from O 0 0.022946219891309738
his O 1 0.6381146311759949
mother O 1 0.8660373091697693
the O 0 0.0039156475104391575
frequent O 0 0.0062757316045463085
0 O 0 0.004623414017260075
- O 0 0.004883856978267431
type O 0 0.005062444601207972
mutation O 0 0.005786566063761711
459 O 0 0.07236751914024353
+ O 0 0.011474383063614368
1G O 0 0.2665821611881256
> O 0 0.005159872584044933
A O 0 0.0023303795605897903
, O 0 0.0011289884569123387
and O 0 0.0009119861642830074
from O 0 0.0011315137380734086
his O 0 0.0024181504268199205
father O 0 0.027548670768737793
a O 0 0.0032420933712273836
novel O 0 0.011872655712068081
, O 0 0.002583949826657772
single O 0 0.0042869457975029945
basepair O 0 0.09352197498083115
microdeletion O 0 0.0153374457731843
of O 0 0.0034013791009783745
guanine O 0 0.007888609543442726
at O 0 0.0032443192321807146
nucleotide O 0 0.004423799458891153
7 O 0 0.0032239488791674376
in O 0 0.0024893663357943296
exon O 0 0.01310522761195898
1 O 0 0.006387425120919943
( O 0 0.0075869569554924965
7delG O 0 0.03917858004570007
) O 0 0.009623167105019093
. O 0 0.01004821714013815

The O 0 0.011582803912460804
two O 0 0.005516141653060913
clinically O 1 0.9129074811935425
unaffected O 0 0.09087952971458435
siblings O 0 0.010021965019404888
carried O 0 0.0047783320769667625
the O 0 0.005340007599443197
maternal O 1 0.9901096820831299
mutation O 0 0.18570123612880707
459 O 1 0.9956113696098328
+ O 0 0.3065670430660248
1G O 1 0.9366731643676758
> O 0 0.007410368882119656
A O 0 0.002507126424461603
and O 0 0.001182691426947713
, O 0 0.0011171619407832623
on O 0 0.0012332750484347343
their O 0 0.0012051280355080962
paternal O 0 0.020488210022449493
allele O 0 0.003791797673329711
, O 0 0.001649533398449421
a O 0 0.002141997218132019
novel O 0 0.005258938763290644
cytosine O 0 0.006619348656386137
to O 0 0.0018887779442593455
thymidine O 0 0.008701713755726814
transition O 0 0.004665532149374485
at O 0 0.0032583277206867933
nucleotide O 0 0.006165423896163702
2435 O 0 0.021686341613531113
in O 0 0.002348956884816289
exon O 0 0.008668783120810986
8 O 0 0.0025909878313541412
, O 0 0.0013020785991102457
resulting O 0 0.0018833042122423649
in O 0 0.0014727700036019087
substitution O 0 0.003840204793959856
of O 0 0.003071760991588235
alanine O 0 0.10211189836263657
464 O 0 0.347594290971756
by O 0 0.00405168766155839
valine O 1 0.875531017780304
( O 0 0.012015317566692829
A464V O 0 0.22725747525691986
) O 0 0.010905573144555092
. O 0 0.012901312671601772

The O 0 0.016621384769678116
fathers O 0 0.023740699514746666
genotype O 0 0.02358681708574295
thus O 0 0.009767886251211166
was O 0 0.09157000482082367
7delG O 1 0.998930037021637
/ O 1 0.9896284341812134
A464V O 1 0.6359113454818726
. O 0 0.024219758808612823

Mutation O 0 0.027188001200556755
A464V O 0 0.04078260064125061
was O 0 0.006968713365495205
not O 0 0.0015126748476177454
found O 0 0.0016391956014558673
in O 0 0.0018087193602696061
18 O 0 0.004586420953273773
unrelated O 1 0.8081638216972351
MLD B-Disease 1 0.9999998807907104
patients O 1 0.9905925393104553
and O 0 0.004622665699571371
50 O 0 0.00769065273925662
controls O 0 0.013117664493620396
. O 0 0.010902764275670052

A464V O 0 0.0855303630232811
, O 0 0.007910209707915783
although O 0 0.005254448391497135
clearly O 0 0.0067716073244810104
modifying O 0 0.03191034123301506
ARSA O 1 0.9998981952667236
and O 0 0.00789269432425499
GS O 1 0.9999896287918091
levels O 0 0.007549280766397715
, O 0 0.0023492027539759874
apparently O 0 0.0035055920016020536
bears O 0 0.0036100135184824467
little O 0 0.0029422950465232134
significance O 0 0.0033687842078506947
for O 0 0.0022526157554239035
clinical O 1 0.7654093503952026
manifestation O 1 0.9993988275527954
of O 1 0.8982700705528259
MLD B-Disease 1 1.0
, O 0 0.01604197546839714
mimicking O 0 0.47689926624298096
the O 0 0.008768558502197266
frequent O 0 0.12056345492601395
ARSA O 1 0.9999467134475708
pseudodeficiency O 1 0.9927922487258911
allele O 0 0.038787756115198135
. O 0 0.019625239074230194

Our O 0 0.013069504871964455
results O 0 0.005964284762740135
demonstrate O 0 0.005627213977277279
that O 0 0.0018138885498046875
in O 0 0.001750221592374146
certain O 0 0.002374323084950447
genetic O 0 0.006177121307700872
conditions O 0 0.4576636254787445
MLD B-Disease 1 0.9999997615814209
- O 1 0.964509904384613
like O 0 0.008920645341277122
ARSA O 1 0.999946117401123
and O 0 0.0049860794097185135
GS O 1 0.999876856803894
values O 0 0.0024031272623687983
need O 0 0.001333366148173809
not O 0 0.0006515177665278316
be O 0 0.0008077580132521689
paralleled O 0 0.0036016912199556828
by O 0 0.0018082252936437726
clinical O 1 0.9998143315315247
disease O 1 0.9999988079071045
, O 0 0.00267236540094018
a O 0 0.0027039970736950636
finding O 0 0.004006342962384224
with O 0 0.0023063758853822947
serious O 1 0.9902348518371582
diagnostic O 1 0.9993661046028137
and O 0 0.03990381211042404
prognostic O 1 0.99943608045578
implications O 0 0.18932607769966125
. O 0 0.016664335504174232

Moreover O 0 0.023715727031230927
, O 0 0.009804695844650269
further O 0 0.009623571299016476
ARSA O 1 0.9927502870559692
alleles O 0 0.011897368356585503
functionally O 0 0.0102927777916193
similar O 0 0.002830900251865387
to O 0 0.002089340705424547
A464V O 0 0.012310401536524296
might O 0 0.002087285974994302
exist O 0 0.0014268332161009312
which O 0 0.0009412505896762013
, O 0 0.0010807686485350132
together O 0 0.001158177386969328
with O 0 0.0012196851894259453
0 O 0 0.0031461974140256643
- O 0 0.004530463367700577
type O 0 0.004135306924581528
mutations O 0 0.0024653442669659853
, O 0 0.0013198269298300147
may O 0 0.0022186676505953074
cause O 0 0.17095685005187988
pathological O 1 0.999962568283081
ARSA O 1 0.9999997615814209
and O 1 0.5198394060134888
GS O 1 0.9999996423721313
levels O 0 0.0047005778178572655
, O 0 0.0014221366727724671
but O 0 0.001008831663057208
not O 0 0.0010463319486007094
clinical O 0 0.01984994299709797
outbreak O 1 0.9831878542900085
of O 0 0.18351824581623077
the O 1 0.9970647692680359
disease O 1 0.9999998807907104
. O 0 0.008218410424888134
. O 0 0.010014638304710388

Human O 1 0.9930444359779358
MLH1 O 1 0.9999994039535522
deficiency O 1 1.0
predisposes O 1 0.9999790191650391
to O 0 0.15995097160339355
hematological B-Disease 1 0.9999995231628418
malignancy I-Disease 1 1.0
and O 1 0.9983640313148499
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9995686411857605
1 I-Disease 0 0.08884315192699432
. O 0 0.015425334684550762

Heterozygous O 0 0.05889400467276573
germ O 1 0.999496579170227
- O 0 0.2018853724002838
line O 0 0.008536230772733688
mutations O 0 0.004338594153523445
in O 0 0.0022181544918566942
the O 0 0.0036978228017687798
DNA O 0 0.009248480200767517
mismatch O 1 0.9763208031654358
repair O 1 0.8966776132583618
genes O 0 0.004693591967225075
lead O 0 0.00614130450412631
to O 0 0.006501542869955301
hereditary B-Disease 1 0.9999979734420776
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9629704356193542

The O 1 0.7838928699493408
disease O 1 0.9999982118606567
susceptibility O 1 0.9858734607696533
of O 0 0.024916529655456543
individuals O 0 0.0035695848055183887
who O 0 0.00832115113735199
constitutionally O 0 0.06237196922302246
lack O 0 0.016313862055540085
both O 0 0.002206220990046859
wild O 0 0.028608499094843864
- O 1 0.6051861643791199
type O 0 0.06365352123975754
alleles O 0 0.00956668984144926
is O 0 0.004883996676653624
unknown O 0 0.01132241915911436
. O 0 0.011913012713193893

We O 0 0.006341862957924604
have O 0 0.002199708018451929
identified O 0 0.0027607737574726343
three O 0 0.001659297733567655
offspring O 0 0.0031436863355338573
in O 0 0.0016488471301272511
a O 0 0.017562702298164368
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999512434005737
who O 1 0.9956151247024536
developed O 1 0.9995564818382263
hematological B-Disease 1 0.9999997615814209
malignancy I-Disease 1 0.9999995231628418
at O 0 0.012783488258719444
a O 0 0.0024411026388406754
very O 0 0.0013692406937479973
early O 0 0.0016659761313349009
age O 0 0.0020208123605698347
, O 0 0.000920101476367563
and O 0 0.0007058265036903322
at O 0 0.001043182099238038
least O 0 0.0006834828527644277
two O 0 0.0004772850079461932
of O 0 0.00089928915258497
them O 0 0.0009306174470111728
displayed O 0 0.00370366545394063
signs O 0 0.005457273684442043
of O 0 0.008779332041740417
neurofibromatosis B-Disease 1 0.9999991655349731
type I-Disease 1 0.9482221007347107
1 I-Disease 0 0.017556490376591682
( O 0 0.010614961385726929
NF1 B-Disease 1 0.9640280604362488
) O 0 0.008458591066300869
. O 0 0.011893080547451973

DNA O 0 0.01478570606559515
sequence O 0 0.006455352995544672
analysis O 0 0.003989355638623238
and O 0 0.0028490410186350346
allele O 0 0.006594461388885975
- O 0 0.004153767600655556
specific O 0 0.0018277446506544948
amplification O 0 0.003537731245160103
in O 0 0.00135002750903368
two O 0 0.0012216100003570318
siblings O 0 0.004600610584020615
revealed O 0 0.0043474710546433926
a O 0 0.004364700522273779
homozygous O 0 0.012309229001402855
MLH1 O 1 0.9909282326698303
mutation O 0 0.009383486583828926
( O 0 0.006649529095739126
C676T O 0 0.47821348905563354
- O 0 0.4944164454936981
- O 1 0.5209254026412964
> O 0 0.0681484043598175
Arg226Stop O 0 0.436434805393219
) O 0 0.011711902916431427
. O 0 0.01227525807917118

Thus O 0 0.011384859681129456
, O 0 0.005586936138570309
a O 0 0.007427786011248827
homozygous O 0 0.03280317410826683
germ O 1 0.999686598777771
- O 1 0.6418241262435913
line O 0 0.036126475781202316
MLH1 O 1 0.9999021291732788
mutation O 0 0.029266543686389923
and O 0 0.00689085153862834
consequent O 1 0.9999899864196777
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.05898001790046692
in O 0 0.004044872242957354
a O 0 0.04116350784897804
mutator O 1 0.9999880790710449
phenotype O 1 0.6732760071754456
characterized O 0 0.342851847410202
by O 0 0.0047414181753993034
leukemia B-Disease 1 0.9999998807907104
and O 1 0.5776091814041138
/ O 1 0.9999836683273315
or O 1 0.660262942314148
lymphoma B-Disease 1 1.0
associated O 1 0.8636065125465393
with O 1 0.8065155148506165
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.999711811542511
1 I-Disease 0 0.04172031581401825
. O 0 0.005648755468428135
. O 0 0.008597357198596

Missense O 0 0.04749181121587753
mutations O 0 0.010461491532623768
in O 0 0.0033611375838518143
the O 0 0.003102363320067525
most O 0 0.0018605622462928295
ancient O 0 0.0038139503449201584
residues O 0 0.004871560260653496
of O 0 0.003484328044578433
the O 0 0.030379891395568848
PAX6 O 1 0.9999651908874512
paired O 0 0.01180945336818695
domain O 0 0.005357684567570686
underlie O 0 0.008874878287315369
a O 0 0.004022846929728985
spectrum O 0 0.008334288373589516
of O 0 0.2867511808872223
human O 1 0.9999747276306152
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9751485586166382

Mutations O 0 0.013288915157318115
of O 0 0.0069152116775512695
the O 0 0.007115665357559919
human O 0 0.03619423136115074
PAX6 O 1 0.9999905824661255
gene O 0 0.1340000182390213
underlie O 1 0.9996998310089111
aniridia B-Disease 1 0.9999991655349731
( O 1 0.9936543703079224
congenital B-Disease 1 1.0
absence I-Disease 1 0.9906298518180847
of I-Disease 1 0.929829478263855
the I-Disease 1 0.9973742961883545
iris I-Disease 1 0.9999638795852661
) O 0 0.002754275221377611
, O 0 0.0016579284565523267
a O 0 0.002588780364021659
rare O 0 0.014591982588171959
dominant O 0 0.3949350118637085
malformation B-Disease 1 0.9999850988388062
of I-Disease 1 0.8883976936340332
the I-Disease 1 0.9959790706634521
eye I-Disease 1 0.999955415725708
. O 0 0.01794368587434292

The O 0 0.012758334167301655
spectrum O 0 0.015155055560171604
of O 0 0.010475065559148788
PAX6 O 1 0.9997851252555847
mutations O 0 0.018295735120773315
in O 0 0.006566899362951517
aniridia B-Disease 1 0.9999915361404419
patients O 1 0.9926209449768066
is O 0 0.0035827732644975185
highly O 0 0.004359804093837738
biased O 0 0.004084330517798662
, O 0 0.0016112660523504019
with O 0 0.001347398036159575
92 O 0 0.004516776651144028
% O 0 0.001389535260386765
of O 0 0.0011606693733483553
all O 0 0.0010552936000749469
reported O 0 0.002679948229342699
mutations O 0 0.0021832960192114115
leading O 0 0.0022964607924222946
to O 0 0.001352379797026515
premature O 0 0.005397839937359095
truncation O 0 0.006229351740330458
of O 0 0.0018094787374138832
the O 0 0.0025043922942131758
protein O 0 0.0030845440924167633
( O 0 0.0019534213934093714
nonsense O 0 0.005060557276010513
, O 0 0.001769129536114633
splicing O 0 0.003666418371722102
, O 0 0.0018443431472405791
insertions O 0 0.00507496390491724
and O 0 0.0017234537517651916
deletions O 0 0.004656265489757061
) O 0 0.001473663724027574
and O 0 0.0009699043584987521
just O 0 0.0016182669205591083
2 O 0 0.0021138146985322237
% O 0 0.0012742012040689588
leading O 0 0.0014379216590896249
to O 0 0.00097618717700243
substitution O 0 0.002048329683020711
of O 0 0.00125727872364223
one O 0 0.001265924540348351
amino O 0 0.002294892445206642
acid O 0 0.0031173385214060545
by O 0 0.0017378457123413682
another O 0 0.004594814032316208
( O 0 0.007399888709187508
missense O 0 0.02185741998255253
) O 0 0.007957777939736843
. O 0 0.011721367947757244

The O 0 0.01094839721918106
extraordinary O 0 0.013069245964288712
conservation O 0 0.0076631405390799046
of O 0 0.0045920806005597115
the O 0 0.006038262974470854
PAX6 O 1 0.9987008571624756
protein O 0 0.004168737679719925
at O 0 0.0023644878529012203
the O 0 0.0021859360858798027
amino O 0 0.0033854718785732985
acid O 0 0.004548900760710239
level O 0 0.0026014449540525675
amongst O 0 0.004176970571279526
vertebrates O 0 0.0069855498149991035
predicts O 0 0.007783334236592054
that O 0 0.002382230246439576
pathological O 1 0.5404273271560669
missense O 0 0.07901119440793991
mutations O 0 0.0037410156801342964
should O 0 0.0012325504794716835
in O 0 0.0010725264437496662
fact O 0 0.0017114757793024182
be O 0 0.000947567168623209
common O 0 0.0012785145081579685
even O 0 0.0010486020473763347
though O 0 0.0009477892890572548
they O 0 0.000672383583150804
are O 0 0.0007454867591150105
hardly O 0 0.0026372168213129044
ever O 0 0.002837333595380187
seen O 0 0.0034046003129333258
in O 0 0.004645421169698238
aniridia B-Disease 1 0.9999728202819824
patients O 1 0.9932519793510437
. O 0 0.015058406628668308

This O 0 0.007509940769523382
indicates O 0 0.0076004755683243275
that O 0 0.0018582722404971719
there O 0 0.0018953046528622508
is O 0 0.0020680122543126345
a O 0 0.0030547031201422215
heavy O 0 0.21271665394306183
ascertainment O 1 0.9989595413208008
bias O 0 0.0075486875139176846
in O 0 0.0017418672796338797
the O 0 0.001887379796244204
selection O 0 0.0029911145102232695
of O 0 0.0032175162341445684
patients O 1 0.5659908652305603
for O 0 0.0031720628030598164
PAX6 O 1 0.9998078942298889
mutation O 0 0.0035424798261374235
analysis O 0 0.0014786425745114684
and O 0 0.0011066293809562922
that O 0 0.000982190016657114
the O 0 0.0022662102710455656
missing O 0 0.008820992894470692
PAX6 O 1 0.9994800686836243
missense O 0 0.0806843489408493
mutations O 0 0.006286243442445993
frequently O 0 0.0038983391132205725
may O 0 0.004112086724489927
underlie O 0 0.048618268221616745
phenotypes O 0 0.01507509034126997
distinct O 0 0.005622496362775564
from O 0 0.007216189987957478
textbook O 1 0.9988366961479187
aniridia B-Disease 1 0.999923586845398
. O 0 0.027178648859262466

Here O 0 0.008958451449871063
we O 0 0.004009390249848366
present O 0 0.0033189114183187485
four O 0 0.0031714974902570248
novel O 0 0.01588401570916176
PAX6 O 1 0.9994837045669556
missense O 0 0.02602260559797287
mutations O 0 0.0041611590422689915
, O 0 0.001439767307601869
two O 0 0.0010065967217087746
in O 0 0.0016394132981076837
association O 0 0.0047518229112029076
with O 0 0.0030875131487846375
atypical O 1 0.9997456669807434
phenotypes O 1 0.8462588787078857
ectopia B-Disease 1 0.9981246590614319
pupillae I-Disease 1 0.995227575302124
( O 0 0.006558092776685953
displaced B-Disease 0 0.014540900476276875
pupils I-Disease 0 0.018094545230269432
) O 0 0.0032306581269949675
and O 0 0.004922926425933838
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999958276748657
( O 0 0.2628762423992157
searching B-Disease 0 0.02149166911840439
gaze I-Disease 0 0.29606109857559204
) O 0 0.00136231177020818
, O 0 0.0007471092976629734
and O 0 0.0005922132986597717
two O 0 0.0006444252794608474
in O 0 0.0010413159616291523
association O 0 0.0031283977441489697
with O 0 0.0017655340489000082
more O 0 0.002781308488920331
recognizable O 1 0.8215376138687134
aniridia B-Disease 1 0.9998917579650879
phenotypes O 1 0.7007375955581665
. O 0 0.014135146513581276

Strikingly O 0 0.022127380594611168
, O 0 0.004863813519477844
all O 0 0.0022112885490059853
four O 0 0.002202657051384449
mutations O 0 0.0023558202665299177
are O 0 0.0010033088037744164
located O 0 0.0021391422487795353
within O 0 0.001583349658176303
the O 0 0.003415335901081562
PAX6 O 1 0.9998433589935303
paired O 0 0.006520858500152826
domain O 0 0.0024279034696519375
and O 0 0.0012305984273552895
affect O 0 0.0018448005430400372
amino O 0 0.0017407815903425217
acids O 0 0.0014397900085896254
which O 0 0.0007544387481175363
are O 0 0.0006322616245597601
highly O 0 0.0018422743305563927
conserved O 0 0.002264550421386957
in O 0 0.0012637333711609244
all O 0 0.001408569049090147
known O 0 0.003985287621617317
paired O 0 0.010247411206364632
domain O 0 0.00869673676788807
proteins O 0 0.010425528511404991
. O 0 0.010506510734558105

Our O 0 0.009520083665847778
results O 0 0.004948758520185947
support O 0 0.003428851254284382
the O 0 0.0024954797700047493
hypothesis O 0 0.0037862523458898067
that O 0 0.0011716382578015327
the O 0 0.001563535537570715
under O 0 0.002599528059363365
- O 0 0.0033592015970498323
representation O 0 0.0020926790311932564
of O 0 0.002307543298229575
missense O 0 0.058659907430410385
mutations O 0 0.004170538857579231
is O 0 0.0024151154793798923
caused O 0 0.03627007454633713
by O 0 0.0027392881456762552
ascertainment O 1 0.9999722242355347
bias O 0 0.1315149962902069
and O 0 0.001779258600436151
suggest O 0 0.002221982227638364
that O 0 0.001036333036608994
a O 0 0.0018532515969127417
substantial O 0 0.0037513412535190582
burden O 0 0.23849307000637054
of O 0 0.20104223489761353
PAX6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999402761459351
related I-Disease 1 0.9636282920837402
disease I-Disease 1 0.9999986886978149
remains O 0 0.1477007120847702
to O 0 0.002007243921980262
be O 0 0.0020141408313065767
uncovered O 0 0.0118916230276227
. O 0 0.005006435327231884
. O 0 0.008839125744998455

The O 0 0.012546190991997719
chromosomal O 0 0.016685182228684425
order O 0 0.0048922584392130375
of O 0 0.004255146253854036
genes O 0 0.004373615141957998
controlling O 0 0.007562138605862856
the O 0 0.004515666048973799
major O 0 0.26197829842567444
histocompatibility O 1 0.9999974966049194
complex O 0 0.3694918751716614
, O 0 0.010955030098557472
properdin O 1 0.9989374279975891
factor O 0 0.34397193789482117
B O 1 0.6713380813598633
, O 0 0.0025746708270162344
and O 0 0.003033028682693839
deficiency B-Disease 1 0.999967098236084
of I-Disease 0 0.006161515600979328
the I-Disease 0 0.027303367853164673
second I-Disease 0 0.053167786449193954
component I-Disease 0 0.0495767742395401
of I-Disease 0 0.008057565428316593
complement I-Disease 0 0.021457713097333908
. O 0 0.011363294906914234

The O 0 0.008058004081249237
relationship O 0 0.00603393092751503
of O 0 0.004084143787622452
the O 0 0.0054820505902171135
genes O 0 0.003987873904407024
coding O 0 0.0067803687416017056
for O 0 0.002506904536858201
HLA O 1 0.9383883476257324
to O 0 0.001342903939075768
those O 0 0.0012364225694909692
coding O 0 0.0034301872365176678
for O 0 0.0019063042709603906
properdin O 0 0.18063268065452576
Factor O 0 0.009237222373485565
B O 0 0.04125631973147392
allotypes O 0 0.08453565835952759
and O 0 0.001991831697523594
for O 0 0.0025629543233662844
deficiency B-Disease 1 0.9999775886535645
of I-Disease 0 0.004020809195935726
the I-Disease 0 0.008506556041538715
second I-Disease 0 0.010706407018005848
component I-Disease 0 0.005275670439004898
of I-Disease 0 0.0025068398099392653
complement I-Disease 0 0.007085638120770454
( O 0 0.0037600230425596237
C2 O 1 0.9773370623588562
) O 0 0.0013122675009071827
was O 0 0.0016260574338957667
studied O 0 0.0014844199176877737
in O 0 0.001068929792381823
families O 0 0.0015882960287854075
of O 0 0.010952156968414783
patients O 1 0.9999738931655884
with O 1 0.9821471571922302
connective O 1 1.0
tissue O 1 0.9999998807907104
disorders O 1 1.0
. O 1 0.8059473037719727

Patients O 0 0.15592454373836517
were O 0 0.0046919253654778
selected O 0 0.0039164102636277676
because O 0 0.002075974829494953
they O 0 0.0013384362682700157
were O 0 0.00205201655626297
heterozygous O 0 0.005955330096185207
or O 0 0.003847219282761216
homozygous O 0 0.018656380474567413
for O 0 0.0403902530670166
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.4693601429462433

12 O 0 0.009394414722919464
families O 0 0.004701399244368076
with O 0 0.0025312951765954494
15 O 0 0.004510894883424044
matings O 0 0.013763275928795338
informative O 0 0.013340407982468605
for O 0 0.05031966790556908
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.023357132449746132
found O 0 0.014363482594490051
. O 0 0.01443510688841343

Of O 0 0.011763115413486958
57 O 0 0.013136548921465874
informative O 0 0.009889011271297932
meioses O 0 0.01688597910106182
, O 0 0.002206922508776188
two O 0 0.001165251829661429
crossovers O 0 0.0028930590488016605
were O 0 0.001626430545002222
noted O 0 0.0025430405512452126
between O 0 0.002208015648648143
the O 0 0.22389286756515503
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.008588074706494808
and O 0 0.0028733680956065655
the O 0 0.05726585537195206
HLA O 1 0.9999994039535522
- O 1 0.9730731844902039
B O 0 0.33612266182899475
gene O 0 0.003065287135541439
, O 0 0.0016172336181625724
with O 0 0.0014563859440386295
a O 0 0.0034629167057573795
recombinant O 0 0.01173840370029211
fraction O 0 0.007463666144758463
of O 0 0.00624993909150362
0 O 0 0.015036795288324356
. O 0 0.012385966256260872

035 O 1 0.9823915362358093
. O 0 0.06629689037799835

A O 0 0.016945088282227516
lod O 0 0.031604036688804626
score O 0 0.00427443441003561
of O 0 0.0025406843051314354
13 O 0 0.0032799383625388145
was O 0 0.002637778641656041
calculated O 0 0.002842159476131201
for O 0 0.002087365137413144
linkage O 0 0.011773469857871532
between O 0 0.010146393440663815
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9983441829681396
HLA O 1 1.0
- O 1 0.998426079750061
B O 0 0.10781403630971909
at O 0 0.0018654480809345841
a O 0 0.0017178242560476065
maximum O 0 0.002316342433914542
likelihood O 0 0.0024021754506975412
value O 0 0.001562926801852882
of O 0 0.0018641363130882382
the O 0 0.0028562273364514112
recombinant O 0 0.010442780330777168
fraction O 0 0.005615242291241884
of O 0 0.004443136975169182
0 O 0 0.0114326486364007
. O 0 0.009957846254110336

04 O 1 0.8266948461532593
. O 0 0.05893122777342796

18 O 0 0.010877366177737713
families O 0 0.005506818648427725
with O 0 0.003113788552582264
21 O 0 0.004202060401439667
informative O 0 0.005230178590863943
matings O 0 0.006762797012925148
for O 0 0.0017748379614204168
both O 0 0.0023525580763816833
properdin O 0 0.054117511957883835
Factor O 0 0.010794654488563538
B O 0 0.028231509029865265
allotype O 0 0.23447129130363464
and O 0 0.007737100590020418
HLA O 1 0.9999798536300659
- O 1 0.7625207304954529
B O 0 0.03633575886487961
were O 0 0.004474714398384094
found O 0 0.009277124889194965
. O 0 0.011253024451434612

Of O 0 0.012856022454798222
72 O 0 0.01629747822880745
informative O 0 0.012846997007727623
meioses O 0 0.01923929713666439
, O 0 0.0028125056996941566
three O 0 0.002218283247202635
recombinants O 0 0.0524655357003212
were O 0 0.0020430507138371468
found O 0 0.00218388088978827
, O 0 0.0018853130750358105
giving O 0 0.002833577571436763
a O 0 0.0033355369232594967
recombinant O 0 0.010549926199018955
fraction O 0 0.006643302273005247
of O 0 0.005491815507411957
0 O 0 0.013999822549521923
. O 0 0.010984807275235653

042 O 1 0.7145510911941528
. O 0 0.06296008825302124

A O 0 0.016395725309848785
lod O 0 0.028582671657204628
score O 0 0.004871054086834192
of O 0 0.002989522647112608
16 O 0 0.0042706262320280075
between O 0 0.004520590417087078
HLA O 1 0.9999958276748657
- O 1 0.7017257809638977
B O 0 0.07989095151424408
and O 0 0.002271138597279787
Factor O 0 0.005636475048959255
B O 0 0.010612827725708485
allotypes O 0 0.010300301015377045
was O 0 0.003084722673520446
calculated O 0 0.002656301250681281
at O 0 0.0018972755642607808
a O 0 0.0023549050092697144
maximum O 0 0.0030749370343983173
likelihood O 0 0.003195809666067362
value O 0 0.00190652662422508
of O 0 0.0020847893320024014
the O 0 0.0041784802451729774
recombinant O 0 0.013456433080136776
fraction O 0 0.00767903495579958
of O 0 0.006872992031276226
0 O 0 0.013484860770404339
. O 0 0.011631320230662823

04 O 1 0.6049869060516357
. O 0 0.06161702796816826

A O 0 0.01542824599891901
crossover O 0 0.012449413537979126
was O 0 0.007331341039389372
shown O 0 0.003171795979142189
to O 0 0.0012407302856445312
have O 0 0.0009002858423627913
occurred O 0 0.001729199313558638
between O 0 0.0011634478578343987
genes O 0 0.0012639022897928953
for O 0 0.001231551170349121
Factor O 0 0.00415763957425952
B O 0 0.012993005104362965
and O 0 0.003193112788721919
HLA O 1 0.999948263168335
- O 0 0.1719740331172943
D O 0 0.0416833832859993
, O 0 0.0015099970623850822
in O 0 0.001467054826207459
which O 0 0.0027380199171602726
HLA O 1 0.9998908042907715
- O 1 0.5258557796478271
D O 1 0.8570407629013062
segregared O 0 0.25696951150894165
with O 0 0.006310333032160997
HLA O 1 0.999992847442627
- O 0 0.18949994444847107
A O 0 0.011097564361989498
and O 0 0.00725883524864912
B O 0 0.10977532714605331
. O 0 0.012164863757789135

These O 0 0.004513411782681942
studies O 0 0.0039059827104210854
suggest O 0 0.0026497431099414825
that O 0 0.0011995958629995584
the O 0 0.0015498888678848743
genes O 0 0.0014868744183331728
for O 0 0.001376657048240304
Factor O 0 0.013680892065167427
B O 1 0.9712590575218201
and O 0 0.39716947078704834
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.001396732754074037
located O 0 0.002624458633363247
outside O 0 0.0016673249192535877
those O 0 0.0010326727060601115
for O 0 0.0019442361081019044
HLA O 1 0.9992185831069946
, O 0 0.0015355832874774933
that O 0 0.0008893178310245275
the O 0 0.001097600325010717
order O 0 0.001206108252517879
of O 0 0.002053892007097602
genese O 1 0.9344841241836548
is O 0 0.005387809127569199
HLA O 1 0.9998546838760376
- O 0 0.005868319422006607
A O 0 0.0028358125127851963
, O 0 0.001846656552515924
- O 0 0.005098579917103052
B O 0 0.0053061917424201965
, O 0 0.0019364660838618875
- O 0 0.005308457650244236
D O 0 0.012762382626533508
, O 0 0.0019441822078078985
Factor O 0 0.00487242266535759
B O 0 0.14422708749771118
allotype O 1 0.9806952476501465
, O 0 0.3916429579257965
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.002596246311441064
that O 0 0.00132175802718848
the O 0 0.001866973121650517
genes O 0 0.002587816445156932
coding O 0 0.0077725304290652275
for O 0 0.010663643479347229
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.022316159680485725
Factor O 0 0.13947266340255737
B O 0 0.028293853625655174
allotypes O 0 0.006512384861707687
are O 0 0.0008833853644318879
approximately O 0 0.001775486278347671
3 O 0 0.0025794634129852057
- O 0 0.003747663227841258
- O 0 0.0032317794393748045
5 O 0 0.002109105698764324
centimorgans O 0 0.0052603487856686115
from O 0 0.0015821860870346427
the O 0 0.003338997717946768
HLA O 1 0.9999816417694092
- O 0 0.02170908823609352
A O 0 0.004596276208758354
and O 0 0.004001727793365717
HLA O 1 0.9999961853027344
- O 1 0.8465249538421631
B O 0 0.2459394931793213
loci O 0 0.005133669823408127
, O 0 0.0013759506400674582
and O 0 0.000946011976338923
that O 0 0.0008124258019961417
the O 0 0.0015530968084931374
apparent O 0 0.00488132331520319
lack O 0 0.00386009830981493
of O 0 0.003345286240801215
recombinants O 1 0.7259875535964966
between O 0 0.002139489632099867
the O 0 0.0029725199565291405
Factor O 0 0.03294213116168976
B O 1 0.509147584438324
gene O 0 0.0057635135017335415
and O 0 0.022114505991339684
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.00895010307431221
suggests O 0 0.002961682388558984
that O 0 0.0009950706735253334
these O 0 0.0006982689374126494
two O 0 0.00077863410115242
genes O 0 0.0015116740250959992
lie O 0 0.002544986316934228
in O 0 0.0013876388547942042
close O 0 0.002341694664210081
proximity O 0 0.003146834671497345
to O 0 0.0019759698770940304
one O 0 0.0031070581171661615
another O 0 0.007374016102403402
. O 0 0.009668727405369282

Distribution O 0 0.010362420231103897
of O 0 0.008255255408585072
emerin O 1 0.9816898107528687
and O 0 0.005242349114269018
lamins O 1 0.9894357919692993
in O 0 0.003125833347439766
the O 0 0.019902661442756653
heart O 1 0.9997712969779968
and O 0 0.003586670383810997
implications O 0 0.037461332976818085
for O 0 0.009645461104810238
Emery B-Disease 1 0.9999189376831055
- I-Disease 1 0.9999597072601318
Dreifuss I-Disease 1 0.9999996423721313
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.5167698860168457

Emerin O 0 0.40211451053619385
is O 0 0.006246424745768309
a O 0 0.005085529759526253
nuclear O 0 0.005643264856189489
membrane O 0 0.005612589884549379
protein O 0 0.002573334379121661
which O 0 0.0014069657772779465
is O 0 0.0016445026267319918
missing O 0 0.0033548336941748857
or O 0 0.002351612551137805
defective O 0 0.4616906940937042
in O 0 0.0060079568065702915
Emery B-Disease 1 0.9992196559906006
- I-Disease 1 0.9998881816864014
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9998719692230225
EDMD B-Disease 1 0.999998927116394
) O 0 0.021583812311291695
. O 0 0.01399961020797491

It O 0 0.004746686201542616
is O 0 0.0028591700829565525
one O 0 0.0015466050244867802
member O 0 0.0019126629922538996
of O 0 0.0014905019197613
a O 0 0.002198341768234968
family O 0 0.00401665223762393
of O 0 0.1767038255929947
lamina O 1 0.999998927116394
- O 1 0.9351477026939392
associated O 0 0.00272213201969862
proteins O 0 0.0018220917554572225
which O 0 0.001172178192064166
includes O 0 0.0026346640661358833
LAP1 O 1 0.6314842104911804
, O 0 0.00444794911891222
LAP2 O 0 0.39876312017440796
and O 0 0.005303990561515093
lamin O 1 0.9389437437057495
B O 1 0.5792538523674011
receptor O 0 0.021518142893910408
( O 0 0.01394020114094019
LBR O 1 0.9958457350730896
) O 0 0.013391324318945408
. O 0 0.013343208469450474

A O 0 0.014530962333083153
panel O 0 0.01121786143630743
of O 0 0.0062957704067230225
16 O 0 0.009419322945177555
monoclonal O 0 0.21106992661952972
antibodies O 0 0.1540689468383789
( O 0 0.007194183301180601
mAbs O 0 0.09758120030164719
) O 0 0.002497796667739749
has O 0 0.0016832140972837806
been O 0 0.0016121016815304756
mapped O 0 0.0027117105200886726
to O 0 0.0009472150704823434
six O 0 0.0009251887095160782
specific O 0 0.0008576656691730022
sites O 0 0.001144253183156252
throughout O 0 0.0014082499546930194
the O 0 0.0019082605140283704
emerin O 0 0.019001835957169533
molecule O 0 0.00380808487534523
using O 0 0.00271446886472404
phage O 0 0.2244349718093872
- O 0 0.007176049519330263
displayed O 0 0.00572054460644722
peptide O 0 0.004946173634380102
libraries O 0 0.002272631973028183
and O 0 0.001046566292643547
has O 0 0.0012114194687455893
been O 0 0.0012352324556559324
used O 0 0.0012474569957703352
to O 0 0.0013525395188480616
localize O 0 0.009721517562866211
emerin O 0 0.0559016577899456
in O 0 0.0024823048152029514
human O 0 0.004908120725303888
and O 0 0.006853237748146057
rabbit O 1 0.9983519315719604
heart O 1 0.9991094470024109
. O 0 0.018971526995301247

Several O 0 0.011958190239965916
mAbs O 0 0.04983850568532944
against O 0 0.006450143177062273
different O 0 0.003617691807448864
emerin O 0 0.36479058861732483
epitopes O 0 0.01567866839468479
did O 0 0.002797474153339863
not O 0 0.0016692597419023514
recognize O 0 0.0030566221103072166
intercalated O 0 0.10056432336568832
discs O 0 0.0056318482384085655
in O 0 0.0020050881430506706
the O 0 0.005344892852008343
heart O 1 0.9979674220085144
, O 0 0.002061325591057539
though O 0 0.0013748167548328638
they O 0 0.0008397487108595669
recognized O 0 0.0025095960590988398
cardiomyocyte O 0 0.25319769978523254
nuclei O 0 0.0033663485664874315
strongly O 0 0.0017594493692740798
, O 0 0.0009125419892370701
both O 0 0.0008002746035344899
at O 0 0.001687732059508562
the O 0 0.002210554201155901
rim O 0 0.010800960473716259
and O 0 0.0016647697193548083
in O 0 0.002662952058017254
intranuclear O 1 0.9591484665870667
spots O 0 0.008558148518204689
or O 0 0.004343746695667505
channels O 0 0.00755951227620244
. O 0 0.008554095402359962

A O 0 0.06561850011348724
polyclonal O 1 0.9937499165534973
rabbit O 1 0.9741031527519226
antiserum O 1 0.75834059715271
against O 0 0.0103445528075099
emerin O 0 0.27686119079589844
did O 0 0.0043368893675506115
recognize O 0 0.0036864725407212973
both O 0 0.002016454003751278
nuclear O 0 0.0037164962850511074
membrane O 0 0.0047018094919621944
and O 0 0.002180610317736864
intercalated O 1 0.867713212966919
discs O 0 0.006409387569874525
but O 0 0.0013625762658193707
, O 0 0.0013348248321563005
after O 0 0.002033223630860448
affinity O 0 0.0029885931871831417
purification O 0 0.013967907056212425
against O 0 0.002281658584252
a O 0 0.002817831002175808
pure O 0 0.04547787830233574
- O 0 0.07434432953596115
emerin O 0 0.1061779335141182
band O 0 0.0032433634623885155
on O 0 0.00145274109672755
a O 0 0.0019782090093940496
western O 0 0.002838869346305728
blot O 0 0.10818669945001602
, O 0 0.002381241414695978
it O 0 0.0017012115567922592
stained O 0 0.13788515329360962
only O 0 0.0021854371298104525
the O 0 0.00443957420065999
nuclear O 0 0.011384564451873302
membrane O 0 0.01677933894097805
. O 0 0.012548536993563175

These O 0 0.005597245879471302
results O 0 0.004474340472370386
would O 0 0.0017666117055341601
not O 0 0.0011600218713283539
be O 0 0.0009905672632157803
expected O 0 0.0013099785428494215
if O 0 0.0011464537819847465
immunostaining O 0 0.007815948687493801
at O 0 0.0027027090545743704
intercalated O 1 0.6417992115020752
discs O 0 0.004494947846978903
were O 0 0.0014250962994992733
due O 0 0.001398897380568087
to O 0 0.0008358791819773614
a O 0 0.0011804417008534074
product O 0 0.0013199558015912771
of O 0 0.0013915130402892828
the O 0 0.003132204059511423
emerin O 1 0.9960097074508667
gene O 0 0.0020321153569966555
and O 0 0.0008500864496454597
, O 0 0.0009229079587385058
therefore O 0 0.0011340132914483547
, O 0 0.0009570207912474871
cast O 0 0.0011769515695050359
some O 0 0.0006954265991225839
doubt O 0 0.0015472467057406902
upon O 0 0.0012406115420162678
the O 0 0.0014637029962614179
hypothesis O 0 0.008193321526050568
that O 0 0.002973563503473997
cardiac B-Disease 1 0.9999992847442627
defects I-Disease 1 0.9999926090240479
in O 0 0.2300097942352295
EDMD B-Disease 1 0.9999984502792358
are O 0 0.0019246432930231094
caused O 0 0.01174058299511671
by O 0 0.0019580733496695757
absence O 0 0.007592115551233292
of O 0 0.031671952456235886
emerin O 1 0.9996919631958008
from O 0 0.00891043245792389
intercalated O 1 0.997408926486969
discs O 0 0.42677658796310425
. O 0 0.01373949646949768

Although O 0 0.013582922518253326
emerin O 0 0.4490095376968384
was O 0 0.009521747939288616
abundant O 0 0.0055139497853815556
in O 0 0.0023659844882786274
the O 0 0.002947581699118018
membranes O 0 0.005727855954319239
of O 0 0.004120887257158756
cardiomyocyte O 1 0.995161235332489
nuclei O 0 0.006054964382201433
, O 0 0.0015838169492781162
it O 0 0.001137966988608241
was O 0 0.002316327067092061
absent O 0 0.0027681433130055666
from O 0 0.001114920829422772
many O 0 0.001227687462233007
non O 0 0.00938017014414072
- O 1 0.9278480410575867
myocyte O 1 0.9998766183853149
cells O 0 0.00492568826302886
in O 0 0.002984702819958329
the O 0 0.008027816191315651
heart O 1 0.9828478097915649
. O 0 0.016827140003442764

This O 0 0.006443454883992672
distribution O 0 0.00536910118535161
of O 0 0.005803857464343309
emerin O 1 0.9831096529960632
was O 0 0.007734136655926704
similar O 0 0.0018045090837404132
to O 0 0.0011392170563340187
that O 0 0.0010229219915345311
of O 0 0.0025443811900913715
lamin O 1 0.9762769341468811
A O 0 0.004236810840666294
, O 0 0.0017297378508374095
a O 0 0.002034085104241967
candidate O 0 0.0026610225904732943
gene O 0 0.0018577644368633628
for O 0 0.001215194002725184
an O 0 0.002347409725189209
autosomal O 0 0.1613256335258484
form O 0 0.006785714067518711
of O 1 0.7539901733398438
EDMD B-Disease 1 0.9999992847442627
. O 0 0.03503970056772232

In O 0 0.010418022982776165
contrast O 0 0.011087678372859955
, O 0 0.009616765193641186
lamin O 1 0.9997521042823792
B1 O 1 0.9999737739562988
was O 0 0.020148538053035736
absent O 0 0.0075927539728581905
from O 0 0.0028156021144241095
cardiomyocyte O 1 0.6665809750556946
nuclei O 0 0.005594034679234028
, O 0 0.002484220778569579
showing O 0 0.005975915119051933
that O 0 0.0035930494777858257
lamin O 1 0.9999008178710938
B1 O 1 0.9999638795852661
is O 0 0.0022205535788089037
not O 0 0.0010410681134089828
essential O 0 0.0022387655917555094
for O 0 0.0015545793576166034
localization O 0 0.005444886162877083
of O 0 0.003135677892714739
emerin O 0 0.147014781832695
to O 0 0.0028708470053970814
the O 0 0.005689736921340227
nuclear O 0 0.023145705461502075
lamina O 1 0.9946954846382141
. O 0 0.014848248101770878

Lamin O 1 0.9997406601905823
B1 O 1 0.9998589754104614
is O 0 0.006105421576648951
also O 0 0.0036180291790515184
almost O 0 0.0032897675409913063
completely O 0 0.00829448364675045
absent O 0 0.09737507998943329
from O 0 0.01644783653318882
skeletal O 1 0.9999974966049194
muscle O 1 0.9999535083770752
nuclei O 1 0.5989435315132141
. O 0 0.02211744524538517

In O 0 0.014456450939178467
EDMD B-Disease 1 0.9823128581047058
, O 0 0.004760415758937597
the O 0 0.0037124522496014833
additional O 0 0.0033623005729168653
absence O 0 0.006631034892052412
of O 0 0.015957774594426155
lamin O 1 0.9999960660934448
B1 O 1 0.9999988079071045
from O 0 0.014841091819107533
heart O 1 0.9999438524246216
and O 0 0.2259688675403595
skeletal O 1 0.999998927116394
muscle O 1 0.9999285936355591
nuclei O 0 0.10940881073474884
which O 0 0.0019980340730398893
already O 0 0.0037174078170210123
lack O 0 0.02341838739812374
emerin O 1 0.972252368927002
may O 0 0.0016403524205088615
offer O 0 0.0010203788988292217
an O 0 0.0008249917300418019
alternative O 0 0.0013213229831308126
explanation O 0 0.0018806214211508632
of O 0 0.0015355597715824842
why O 0 0.002145692240446806
these O 0 0.0011022021062672138
tissues O 0 0.004415599629282951
are O 0 0.0013041537022218108
particularly O 0 0.0036685140803456306
affected O 0 0.007011224050074816
. O 0 0.00485481321811676
. O 0 0.009630068205296993

Genetic O 0 0.016451669856905937
mapping O 0 0.011633667163550854
of O 0 0.006252987310290337
the O 0 0.010777579620480537
copper B-Disease 1 0.9995301961898804
toxicosis I-Disease 1 0.9999722242355347
locus O 0 0.26103684306144714
in O 0 0.005864771082997322
Bedlington O 1 0.9905567169189453
terriers O 0 0.024382583796977997
to O 0 0.0025352751836180687
dog O 0 0.010382413864135742
chromosome O 0 0.0034833052195608616
10 O 0 0.001363652409054339
, O 0 0.0011629242217168212
in O 0 0.001100921886973083
a O 0 0.001889716717414558
region O 0 0.0031310338526964188
syntenic O 0 0.055565714836120605
to O 0 0.0020626795012503862
human O 0 0.004509630147367716
chromosome O 0 0.009697617962956429
region O 0 0.009403914213180542
2p13 O 1 0.9057157635688782
- O 0 0.4761587977409363
p16 O 0 0.13648191094398499
. O 0 0.015770167112350464

Abnormal O 1 0.9999874830245972
hepatic B-Disease 1 0.9999997615814209
copper I-Disease 1 0.9999924898147583
accumulation I-Disease 1 0.9998987913131714
is O 0 0.006478311959654093
recognized O 0 0.006351283751428127
as O 0 0.004377774428576231
an O 1 0.5575087070465088
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9974365830421448
man O 1 0.9999014139175415
, O 0 0.06274227797985077
mouse O 0 0.09103593975305557
, O 0 0.004606129601597786
rat O 0 0.49614638090133667
and O 0 0.0064300308004021645
dog O 0 0.06709323078393936
. O 0 0.01432918943464756

The O 0 0.012896448373794556
major O 0 0.029791127890348434
cause O 1 0.9446028470993042
of O 1 0.9969634413719177
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999996423721313
accumulation I-Disease 1 0.999964714050293
in O 0 0.032282669097185135
man O 0 0.18987426161766052
is O 0 0.00244532385841012
a O 0 0.003832967719063163
dysfunctional O 1 0.9278173446655273
ATP7B O 1 0.9982681274414062
gene O 0 0.005531965754926205
, O 0 0.004297102335840464
causing O 1 0.977046549320221
Wilson B-Disease 1 0.999984860420227
disease I-Disease 1 1.0
( O 1 0.996531069278717
WD B-Disease 1 0.9999819993972778
) O 0 0.01261854823678732
. O 0 0.013653995469212532

Mutations O 0 0.013151510618627071
in O 0 0.0049765948206186295
the O 0 0.007210084702819586
ATP7B O 1 0.9982206225395203
genes O 0 0.0035376118030399084
have O 0 0.0014288702514022589
also O 0 0.0016178818186745048
been O 0 0.0019099158234894276
demonstrated O 0 0.004447167739272118
in O 0 0.0028343484736979008
mouse O 0 0.012300769798457623
and O 0 0.006671686191111803
rat O 1 0.9503589868545532
. O 0 0.01363407727330923

The O 0 0.017719004303216934
ATP7B O 1 0.9991519451141357
gene O 0 0.006655743345618248
has O 0 0.002518607536330819
been O 0 0.0017437138594686985
excluded O 0 0.0027299646753817797
in O 0 0.0013898356119170785
the O 0 0.0018868893384933472
much O 0 0.002184551442041993
rarer O 0 0.26828110218048096
human O 0 0.08251908421516418
copper B-Disease 1 0.9999908208847046
overload I-Disease 1 0.9999994039535522
disease O 1 1.0
non B-Disease 1 0.9961714148521423
- I-Disease 1 0.9972443580627441
Indian I-Disease 1 0.7538495659828186
childhood I-Disease 1 0.9999974966049194
cirrhosis I-Disease 1 1.0
, O 0 0.11883042007684708
indicating O 1 0.7086520195007324
genetic O 0 0.06708115339279175
heterogeneity O 0 0.29755401611328125
. O 0 0.016343478113412857

By O 0 0.007702586241066456
investigating O 0 0.010793482884764671
the O 0 0.00819299928843975
common O 0 0.1455143690109253
autosomal O 1 0.9999487400054932
recessive O 1 0.9999935626983643
copper B-Disease 1 0.9999995231628418
toxicosis I-Disease 1 1.0
( O 1 0.9957886338233948
CT B-Disease 1 0.9999217987060547
) O 0 0.0036231616977602243
in O 0 0.0027540435548871756
Bedlington O 1 0.9969743490219116
terriers O 0 0.1190909817814827
, O 0 0.0018027767073363066
we O 0 0.0010552454041317105
have O 0 0.0006849988712929189
identified O 0 0.0012399370316416025
a O 0 0.0011339097982272506
new O 0 0.0013405386125668883
locus O 0 0.006527404300868511
involved O 0 0.0034421300515532494
in O 0 0.07221335172653198
progressive O 1 0.9999998807907104
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.996698796749115

We O 0 0.009431593120098114
examined O 0 0.011203775182366371
whether O 0 0.0048473733477294445
the O 0 0.007129518780857325
WD B-Disease 1 0.9996298551559448
gene O 0 0.006268271245062351
ATP7B O 1 0.8597031235694885
was O 0 0.00631098123267293
also O 0 0.0026144550647586584
causative O 0 0.058547262102365494
for O 0 0.0020051931496709585
CT B-Disease 0 0.3007497787475586
by O 0 0.0013671141350641847
investigating O 0 0.0030239711049944162
the O 0 0.0031954420264810324
chromosomal O 0 0.3050134479999542
co O 0 0.22988834977149963
- O 0 0.00968750286847353
localization O 0 0.007829923182725906
of O 0 0.003406369127333164
ATP7B O 1 0.9902439713478088
and O 0 0.002584178699180484
C04107 O 0 0.013010579161345959
, O 0 0.0022711753845214844
using O 0 0.0023363525979220867
fluorescence O 0 0.006017880514264107
in O 0 0.002958444179967046
situ O 0 0.02600172348320484
hybridization O 0 0.009897895157337189
( O 0 0.006113986950367689
FISH O 0 0.010621167719364166
) O 0 0.0071919080801308155
. O 0 0.010708174668252468

C04107 O 0 0.058551203459501266
is O 0 0.008030882105231285
an O 0 0.005296344868838787
anonymous O 0 0.010628464631736279
microsatellite O 0 0.07183993607759476
marker O 0 0.018912550061941147
closely O 0 0.007730866316705942
linked O 0 0.013205492869019508
to O 0 0.00952808279544115
CT B-Disease 1 0.9874495267868042
. O 0 0.01944241300225258

However O 0 0.013749120756983757
, O 0 0.011022034101188183
BAC O 1 0.9973428845405579
clones O 0 0.03247088938951492
containing O 0 0.010698894970119
ATP7B O 1 0.8145487904548645
and O 0 0.004435217473655939
C04107 O 0 0.016897255554795265
mapped O 0 0.0063204290345311165
to O 0 0.0020497855730354786
the O 0 0.0031239043455570936
canine O 1 0.9411701560020447
chromosome O 0 0.006021914537996054
regions O 0 0.002789753722026944
CFA22q11 O 1 0.5565068125724792
and O 0 0.0028620741795748472
CFA10q26 O 0 0.4138334393501282
, O 0 0.00197353377006948
respectively O 0 0.002891433658078313
, O 0 0.0019453649874776602
demonstrating O 0 0.00593219930306077
that O 0 0.002936689415946603
WD B-Disease 1 0.9913201928138733
cannot O 0 0.003047351259738207
be O 0 0.001967262476682663
homologous O 0 0.008467625826597214
to O 0 0.005701899528503418
CT B-Disease 1 0.7933254837989807
. O 0 0.012837277725338936

The O 0 0.015961121767759323
copper O 1 0.9613968729972839
transport O 0 0.18427827954292297
genes O 0 0.010235849767923355
CTR1 O 1 0.989909291267395
and O 0 0.003885747864842415
CTR2 O 1 0.9518938064575195
were O 0 0.00245653185993433
also O 0 0.0018317471258342266
excluded O 0 0.003058547852560878
as O 0 0.0016202835831791162
candidate O 0 0.003010473446920514
genes O 0 0.001959982793778181
for O 0 0.0019303939770907164
CT B-Disease 0 0.4364093244075775
since O 0 0.0015439416747540236
they O 0 0.0010113385505974293
both O 0 0.0014277234440669417
mapped O 0 0.005088131409138441
to O 0 0.003250329289585352
canine O 1 0.5109825730323792
chromosome O 0 0.0179061871021986
region O 0 0.014533831737935543
CFA11q22 O 1 0.6702134013175964
. O 0 0.01651196926832199

2 O 0 0.031335242092609406
- O 0 0.04090564697980881
22 O 0 0.025531167164444923
. O 0 0.02051985263824463

5 O 0 0.06176316738128662
. O 0 0.04551152139902115

A O 0 0.012832590378820896
transcribed O 0 0.010377975180745125
sequence O 0 0.004271844867616892
identified O 0 0.0027969847433269024
from O 0 0.001765739289112389
the O 0 0.0029289857484400272
C04107 O 1 0.8220190405845642
- O 0 0.09776634722948074
containing O 0 0.009472111240029335
BAC O 1 0.9946359992027283
was O 0 0.003958493005484343
found O 0 0.0015900611178949475
to O 0 0.0010234271176159382
be O 0 0.0009921115124598145
homologous O 0 0.0024981913156807423
to O 0 0.0010378946317359805
a O 0 0.0018387703457847238
gene O 0 0.001979408785700798
expressed O 0 0.002134468173608184
from O 0 0.0018529817461967468
human O 0 0.003598187817260623
chromosome O 0 0.011033647693693638
2p13 O 1 0.8020499348640442
- O 0 0.23259824514389038
p16 O 0 0.02805292420089245
, O 0 0.002670035697519779
a O 0 0.0030443493742495775
region O 0 0.004014665260910988
devoid O 0 0.008272375911474228
of O 0 0.003839531447738409
any O 0 0.003693317761644721
positional O 0 0.020137101411819458
candidate O 0 0.013251970522105694
genes O 0 0.011327316053211689
. O 0 0.012526669539511204

Molecular O 0 0.014386431314051151
analysis O 0 0.00704091927036643
of O 0 0.005654855165630579
the O 0 0.0062858350574970245
APC B-Disease 1 0.5290019512176514
gene O 0 0.003988991491496563
in O 0 0.002126747742295265
205 O 0 0.006568068638443947
families O 0 0.002212375635281205
: O 0 0.0023560691624879837
extended O 0 0.005198989994823933
genotype O 0 0.011456666514277458
- O 0 0.007326512597501278
phenotype O 0 0.006862318143248558
correlations O 0 0.005495603196322918
in O 0 0.003057624911889434
FAP B-Disease 1 0.9996411800384521
and O 0 0.0018636820605024695
evidence O 0 0.0018153587589040399
for O 0 0.00115983618889004
the O 0 0.0020114330109208822
role O 0 0.002936996752396226
of O 0 0.003908126149326563
APC B-Disease 1 0.993370532989502
amino O 0 0.005168226547539234
acid O 0 0.007708307821303606
changes O 0 0.004191751126199961
in O 0 0.3847489058971405
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999991655349731
. O 1 0.6225457191467285

BACKGROUND O 0 0.0384230874478817
/ O 0 0.03468141332268715
AIMS O 0 0.014169874601066113
The O 0 0.004433588590472937
development O 0 0.02818811684846878
of O 1 0.9994075298309326
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.28521406650543213
a O 0 0.007841826416552067
variable O 0 0.003289078129455447
range O 0 0.0021532541140913963
of O 0 0.002960790880024433
extracolonic O 1 0.9206656217575073
manifestations O 1 0.6938096284866333
in O 0 0.027200201526284218
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999948740005493
FAP B-Disease 1 1.0
) O 0 0.005788168869912624
is O 0 0.0018665778916329145
the O 0 0.0015593740390613675
result O 0 0.0014864382101222873
of O 0 0.0018097785068675876
the O 0 0.0037044426426291466
dominant O 0 0.028216978535056114
inheritance O 1 0.5452930927276611
of O 1 0.9849932193756104
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999376535415649
APC B-Disease 1 0.999995231628418
) O 0 0.014817748218774796
gene O 0 0.015195811167359352
mutations O 0 0.015157383866608143
. O 0 0.011660861782729626

In O 0 0.006459556054323912
this O 0 0.002710774540901184
study O 0 0.002847589086741209
, O 0 0.0020800409838557243
direct O 0 0.0021179576870054007
mutation O 0 0.002478883368894458
analysis O 0 0.0014548244653269649
of O 0 0.0017451004823669791
the O 0 0.004405708517879248
APC B-Disease 1 0.9972633123397827
gene O 0 0.00296986592002213
was O 0 0.0026573501527309418
performed O 0 0.0021844191942363977
to O 0 0.0011831152951344848
determine O 0 0.002607187023386359
genotype O 0 0.007073165848851204
- O 0 0.004808942787349224
phenotype O 0 0.004544100724160671
correlations O 0 0.003697977401316166
for O 0 0.0016418915474787354
nine O 0 0.0030500059947371483
extracolonic O 1 0.6612927317619324
manifestations O 0 0.025662453845143318
and O 0 0.001531759975478053
to O 0 0.0013679697876796126
investigate O 0 0.003142744768410921
the O 0 0.002527151256799698
incidence O 1 0.9834944605827332
of O 0 0.04488367959856987
APC B-Disease 1 0.9999394416809082
mutations O 0 0.005970705300569534
in O 0 0.003951692953705788
non O 1 0.9829936027526855
- O 1 0.9999954700469971
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.4638505280017853

METHODS O 0 0.018702508881688118
The O 0 0.010145245119929314
APC B-Disease 1 0.6782658696174622
gene O 0 0.006469478830695152
was O 0 0.004782311152666807
analysed O 0 0.005965754855424166
in O 0 0.002329894108697772
190 O 0 0.006764654535800219
unrelated O 0 0.00782816018909216
FAP B-Disease 1 0.9896458983421326
and O 0 0.003164596389979124
15 O 0 0.006536139640957117
non O 1 0.7968512773513794
- O 1 0.9999871253967285
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999740123748779
using O 0 0.018345538526773453
denaturing O 1 0.999639630317688
gradient O 1 0.9230251908302307
gel O 1 0.8801202178001404
electrophoresis O 0 0.01370589155703783
, O 0 0.0026996389497071505
the O 0 0.003253028029575944
protein O 0 0.00388519954867661
truncation O 0 0.00871309731155634
test O 0 0.0029839009512215853
, O 0 0.002212953520938754
and O 0 0.002283330773934722
direct O 0 0.005703534930944443
sequencing O 0 0.015136342495679855
. O 0 0.011951854452490807

RESULTS O 0 0.016498534008860588
Chain O 0 0.0162857323884964
terminating O 0 0.014238432981073856
signals O 0 0.0042853704653680325
were O 0 0.0014463553670793772
only O 0 0.0011140396818518639
identified O 0 0.0019559217616915703
in O 0 0.0013862453633919358
patients O 0 0.005195020232349634
belonging O 0 0.00238858163356781
to O 0 0.0014303834177553654
the O 0 0.003290604567155242
FAP B-Disease 1 0.9999037981033325
group O 0 0.004027933813631535
( O 0 0.005550479982048273
105 O 0 0.014721100218594074
patients O 0 0.28473129868507385
) O 0 0.007011065259575844
. O 0 0.009335560724139214

Amino O 0 0.0152682950720191
acid O 0 0.01097803469747305
changes O 0 0.0028437369037419558
were O 0 0.002180461771786213
identified O 0 0.0023381183855235577
in O 0 0.0013025073567405343
four O 0 0.0017203408060595393
patients O 0 0.0069488706067204475
, O 0 0.0012107850052416325
three O 0 0.0008741110796108842
of O 0 0.0013048022519797087
whom O 0 0.002339419210329652
belonged O 0 0.0031674057245254517
to O 0 0.0011324594961479306
the O 0 0.002095423173159361
non O 0 0.012467247433960438
- O 1 0.763556957244873
FAP O 1 0.9999786615371704
group O 0 0.013532083481550217
of O 1 0.9991742968559265
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999994039535522
. O 0 0.3996894657611847

Genotype O 1 0.5511369705200195
- O 0 0.11033134162425995
phenotype O 0 0.01933557540178299
correlations O 0 0.008837041445076466
identified O 0 0.004501101095229387
significant O 0 0.002395825693383813
differences O 0 0.0021962341852486134
in O 0 0.0013445772929117084
the O 0 0.001700075576081872
nature O 0 0.0023143093567341566
of O 0 0.0023962019477039576
certain O 0 0.0033530930522829294
extracolonic O 1 0.997860848903656
manifestations O 1 0.9930434226989746
in O 0 0.15190547704696655
FAP B-Disease 1 0.9999997615814209
patients O 1 0.9810898900032043
belonging O 0 0.006217254791408777
to O 0 0.002230564132332802
three O 0 0.0031654254999011755
mutation O 0 0.012898658402264118
subgroups O 0 0.024501634761691093
. O 0 0.014042115770280361

CONCLUSIONS O 0 0.02374529466032982
Extended O 0 0.02076435461640358
genotype O 0 0.17781980335712433
- O 0 0.04497823491692543
phenotype O 0 0.010273076593875885
correlations O 0 0.005368933547288179
made O 0 0.001913218293339014
in O 0 0.0012785997241735458
this O 0 0.0011131124338135123
study O 0 0.0016731563955545425
may O 0 0.0014349695993587375
have O 0 0.0008456007344648242
the O 0 0.0013462052447721362
potential O 0 0.0015835659578442574
to O 0 0.0008722117054276168
determine O 0 0.0011029468150809407
the O 0 0.0010963226668536663
most O 0 0.00098020292352885
appropriate O 0 0.0017696485156193376
surveillance O 0 0.0033947452902793884
and O 0 0.002290857257321477
prophylactic O 1 0.9982913136482239
treatment O 1 0.9994122982025146
regimens O 1 0.998866081237793
for O 0 0.0023455724585801363
those O 0 0.0016472968272864819
patients O 0 0.3282136023044586
with O 0 0.0018116108840331435
mutations O 0 0.004119619261473417
associated O 0 0.003026556922122836
with O 0 0.0028135625179857016
life O 0 0.33329862356185913
threatening O 1 0.9398472905158997
conditions O 1 0.6839113235473633
. O 0 0.015357378870248795

This O 0 0.005799696780741215
study O 0 0.0045804474502801895
also O 0 0.0027957377023994923
provided O 0 0.0023891860619187355
evidence O 0 0.0016788911307230592
for O 0 0.0011371993459761143
the O 0 0.001993435202166438
pathological O 0 0.4410531520843506
nature O 0 0.00313550210557878
of O 0 0.0027362366672605276
amino O 0 0.0037520613986998796
acid O 0 0.004529233556240797
changes O 0 0.001531065790913999
in O 0 0.0018487954512238503
APC O 0 0.14264996349811554
associated O 0 0.0016686684684827924
with O 0 0.001212182454764843
both O 0 0.0020596273243427277
FAP B-Disease 1 0.9999898672103882
and O 0 0.02059773914515972
non O 1 0.999747097492218
- O 1 0.9999995231628418
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999998927116394
. O 0 0.08025124669075012
. O 0 0.014608625322580338

Inherited B-Disease 1 0.9999994039535522
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999107122421265
cancer B-Disease 1 1.0
risk O 1 0.9986134767532349
of O 1 0.945061206817627
the O 1 0.9990793466567993
APC O 1 0.9999945163726807
I1307K O 1 0.9983611702919006
polymorphism O 0 0.0415927954018116
. O 0 0.015983110293745995

Germ O 1 0.9989582300186157
- O 0 0.15718421339988708
line O 0 0.009394041262567043
and O 0 0.004502526018768549
somatic O 0 0.022540340200066566
truncating O 0 0.13105101883411407
mutations O 0 0.004681204911321402
of O 0 0.0029755104333162308
the O 0 0.007404303643852472
APC B-Disease 1 0.9977627992630005
gene O 0 0.002358220750465989
are O 0 0.0009013552335090935
thought O 0 0.0020040322560817003
to O 0 0.0018912290688604116
initiate O 0 0.30114492774009705
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999992847442627
formation O 1 0.9985130429267883
in O 1 0.9888513684272766
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999964237213135
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9361726641654968
respectively O 0 0.32117369771003723
. O 0 0.0158124677836895

Recently O 0 0.015104757621884346
, O 0 0.004997983109205961
an O 0 0.005615759175270796
isoleucine O 1 0.9989895224571228
- O 1 0.9110766649246216
- O 0 0.16171571612358093
> O 0 0.013046016916632652
lysine O 0 0.009775379672646523
polymorphism O 0 0.006314507685601711
at O 0 0.0033842402044683695
codon O 0 0.00836784578859806
1307 O 0 0.017015445977449417
( O 0 0.0037266977597028017
I1307K O 0 0.008786053396761417
) O 0 0.0019670415204018354
of O 0 0.002025019843131304
the O 0 0.0038477196358144283
APC B-Disease 1 0.9896727800369263
gene O 0 0.0025127921253442764
has O 0 0.0013098014751449227
been O 0 0.0012280530063435435
identified O 0 0.0015059987781569362
in O 0 0.001181956147775054
6 O 0 0.0021943110041320324
% O 0 0.001617545960471034
- O 0 0.002785289427265525
7 O 0 0.0021309349685907364
% O 0 0.0014710347168147564
of O 0 0.0016091923462226987
the O 0 0.0036065098829567432
Ashkenazi O 0 0.4204631447792053
Jewish O 0 0.008676338940858841
population O 0 0.007094439584761858
. O 0 0.011253672651946545

To O 0 0.007716408930718899
assess O 0 0.009763145819306374
the O 0 0.004211293067783117
risk O 0 0.00426053861156106
of O 0 0.002929534064605832
this O 0 0.002733170287683606
common O 0 0.0062046959064900875
APC B-Disease 1 0.9980959296226501
allelic O 1 0.8930619955062866
variant O 1 0.8329715132713318
in O 0 0.02059403620660305
colorectal O 1 1.0
carcinogenesis O 1 0.9999983310699463
, O 0 0.004357743542641401
we O 0 0.0017223252216354012
have O 0 0.0010249882470816374
analyzed O 0 0.0023544374853372574
a O 0 0.0018546944484114647
large O 0 0.0024707617703825235
cohort O 0 0.010610680095851421
of O 0 0.00421276455745101
unselected O 1 0.8436474204063416
Ashkenazi O 0 0.020422201603651047
Jewish O 0 0.004686181433498859
subjects O 0 0.005736531689763069
with O 0 0.004868790041655302
adenomatous B-Disease 1 0.9999995231628418
polyps I-Disease 1 0.99998939037323
and O 0 0.03345371410250664
. O 0 0.07363206893205643
or O 1 0.9824832677841187
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.08131272345781326
for O 0 0.005960085429251194
the O 0 0.08103778213262558
APC O 1 0.999483585357666
I1307K O 1 0.9396641254425049
polymorphism O 0 0.02877352200448513
. O 0 0.014393797144293785

The O 0 0.02195850759744644
APC O 1 0.9794570803642273
I1307K O 0 0.34341034293174744
allele O 0 0.009997700341045856
was O 0 0.004133834969252348
identified O 0 0.0027689251583069563
in O 0 0.0012768551241606474
48 O 0 0.0020712704863399267
( O 0 0.0014622630551457405
10 O 0 0.001039945869706571
. O 0 0.0009205438545905054
1 O 0 0.0018180911429226398
% O 0 0.0017357944743707776
) O 0 0.0020135792437940836
of O 0 0.004061167594045401
476 O 1 0.8952304124832153
patients O 1 0.8997750282287598
. O 0 0.01380093116313219

Compared O 0 0.009432127699255943
with O 0 0.0029585890006273985
the O 0 0.0021663298830389977
frequency O 0 0.00167359272018075
in O 0 0.0008547209436073899
two O 0 0.0006462014280259609
separate O 0 0.0009617781033739448
population O 0 0.0009383233264088631
control O 0 0.0012966482900083065
groups O 0 0.0007355833658948541
, O 0 0.0013315258547663689
the O 0 0.0030651006381958723
APC O 1 0.9963305592536926
I1307K O 1 0.8232345581054688
allele O 0 0.005305915139615536
is O 0 0.001516583957709372
associated O 0 0.001584224752150476
with O 0 0.001091687474399805
an O 0 0.0015721627278253436
estimated O 0 0.002752965781837702
relative O 0 0.004223180934786797
risk O 0 0.005671502556651831
of O 0 0.005078526213765144
1 O 0 0.011990607716143131
. O 0 0.010104851797223091

5 O 0 0.03337584435939789
- O 0 0.041565101593732834
1 O 0 0.025630325078964233
. O 0 0.021196244284510612

7 O 0 0.020731816068291664
for O 0 0.012270993553102016
colorectal B-Disease 1 0.9999991655349731
neoplasia I-Disease 1 0.9999809265136719
( O 0 0.014916435815393925
both O 0 0.005074973683804274
P O 1 0.5093464255332947
= O 0 0.013774296268820763
. O 0 0.004540272057056427
01 O 0 0.20186591148376465
) O 0 0.009782765991985798
. O 0 0.012883155606687069

Furthermore O 0 0.01596677117049694
, O 0 0.005141571629792452
compared O 0 0.005175087600946426
with O 0 0.003343348391354084
noncarriers O 1 0.9007235765457153
, O 0 0.00654235715046525
APC O 1 0.9968252182006836
I1307K O 1 0.6497142314910889
carriers O 0 0.004918467253446579
had O 0 0.002618896309286356
increased O 0 0.0025058542378246784
numbers O 0 0.0021382682025432587
of O 0 0.003231120528653264
adenomas B-Disease 1 0.9998447895050049
and O 0 0.04936554655432701
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999903440475464
per O 0 0.009850066155195236
patient O 1 0.9962342381477356
( O 0 0.0062098875641822815
P O 0 0.23168154060840607
= O 0 0.004538978915661573
. O 0 0.0015198101755231619
03 O 0 0.010169009678065777
) O 0 0.0013669669860973954
, O 0 0.0009913614485412836
as O 0 0.0009600587654858828
well O 0 0.0010377942817285657
as O 0 0.0012686150148510933
a O 0 0.0024043379817157984
younger O 0 0.00533398799598217
age O 0 0.006340507883578539
at O 0 0.011147786863148212
diagnosis O 1 0.999313473701477
. O 0 0.0130607383325696

We O 0 0.008179905824363232
conclude O 0 0.009103364311158657
that O 0 0.0034102564677596092
the O 0 0.005349268205463886
APC O 1 0.9852983951568604
I1307K O 1 0.7255015969276428
variant O 0 0.04503834992647171
leads O 0 0.00579300569370389
to O 0 0.002731551183387637
increased O 0 0.03187761455774307
adenoma B-Disease 1 0.9999994039535522
formation O 0 0.17649434506893158
and O 0 0.0019239353714510798
directly O 0 0.0020603882148861885
contributes O 0 0.0034507133532315493
to O 0 0.001348996884189546
3 O 0 0.002045318018645048
% O 0 0.0016406320501118898
- O 0 0.002399799646809697
4 O 0 0.001962002133950591
% O 0 0.0013266934547573328
of O 0 0.0014930915785953403
all O 0 0.0027388921007514
Ashkenazi O 1 0.946948230266571
Jewish O 1 0.9919090867042542
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.5800766348838806

The O 0 0.010707072913646698
estimated O 0 0.00738945510238409
relative O 0 0.007946936413645744
risk O 0 0.008584349416196346
for O 0 0.0023284023627638817
carriers O 0 0.005379434209316969
may O 0 0.002246984513476491
justify O 0 0.003788209520280361
specific O 0 0.001712050405330956
clinical O 0 0.006619996856898069
screening O 0 0.0028642085380852222
for O 0 0.0012210021959617734
the O 0 0.0017018950311467052
360 O 0 0.0033724172972142696
, O 0 0.0014538053655996919
000 O 0 0.0028549209237098694
Americans O 0 0.0015743992989882827
expected O 0 0.00120177969802171
to O 0 0.0011004824191331863
harbor O 0 0.004046839661896229
this O 0 0.0011888387380167842
allele O 0 0.0026754525024443865
, O 0 0.0011642792960628867
and O 0 0.001152336597442627
genetic O 0 0.0017724093049764633
testing O 0 0.0014884979464113712
in O 0 0.0007987272110767663
the O 0 0.0009895127732306719
setting O 0 0.0015790723264217377
of O 0 0.0018924754112958908
long O 0 0.015537053346633911
- O 0 0.05972679704427719
term O 0 0.0036224492359906435
- O 0 0.0031361577566713095
outcome O 0 0.001895288354717195
studies O 0 0.0015099325682967901
may O 0 0.0015039235586300492
impact O 0 0.0028358770068734884
significantly O 0 0.00402853824198246
on O 0 0.036472074687480927
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.999998927116394
in O 0 0.07399904727935791
this O 0 0.005157885141670704
population O 0 0.00626261904835701
. O 0 0.009997686371207237

Localization O 0 0.028338590636849403
of O 0 0.008813808672130108
human O 0 0.013261226937174797
BRCA1 O 1 0.8128730058670044
and O 0 0.0022230716422200203
its O 0 0.001784858526661992
loss O 0 0.005633884109556675
in O 0 0.001843946403823793
high O 0 0.020483488216996193
- O 0 0.08093159645795822
grade O 0 0.39438027143478394
, O 0 0.0035881376825273037
non B-Disease 0 0.38227227330207825
- I-Disease 1 0.999329686164856
inherited I-Disease 1 0.9999983310699463
breast I-Disease 1 1.0
carcinomas I-Disease 1 0.9999997615814209
. O 0 0.19790717959403992

Although O 0 0.006824310403317213
the O 0 0.004309982992708683
link O 0 0.004844733979552984
between O 0 0.0027464490849524736
the O 0 0.053360067307949066
BRCA1 O 1 0.9999979734420776
tumour B-Disease 1 1.0
- O 1 0.9977388381958008
suppressor O 1 0.9709389805793762
gene O 0 0.004253319930285215
and O 0 0.0026053341571241617
hereditary B-Disease 1 0.9999947547912598
breast I-Disease 1 1.0
and I-Disease 1 0.9999948740005493
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9096125364303589
established O 0 0.045351333916187286
, O 0 0.0014952265191823244
the O 0 0.0016180219827219844
role O 0 0.0021411688067018986
, O 0 0.0008492464548908174
if O 0 0.0005505864392034709
any O 0 0.00048558798152953386
, O 0 0.0007390032988041639
of O 0 0.0013422338524833322
BRCA1 O 1 0.6092529892921448
in O 0 0.002424761652946472
non B-Disease 1 0.9327883720397949
- I-Disease 1 0.9999042749404907
familial I-Disease 1 0.9999991655349731
cancers I-Disease 1 0.9999979734420776
is O 0 0.08907977491617203
unclear O 0 0.014671923592686653
. O 0 0.010025574825704098

BRCA1 O 1 0.9899673461914062
mutations O 0 0.009891374036669731
are O 0 0.002073299838230014
rare O 0 0.004524531774222851
in O 0 0.0031082178466022015
sporadic B-Disease 1 0.9281776547431946
cancers I-Disease 1 0.9999305009841919
, O 0 0.0029263377655297518
but O 0 0.0016454487340524793
loss O 0 0.04276691749691963
of O 0 0.019679080694913864
BRCA1 O 1 0.9992049336433411
resulting O 0 0.005555046256631613
from O 0 0.0018006139434874058
reduced O 0 0.0036433753557503223
expression O 0 0.0026713870465755463
or O 0 0.0017658945871517062
incorrect O 0 0.004282934125512838
subcellular O 0 0.008455803617835045
localization O 0 0.005528593435883522
is O 0 0.0018206390086561441
postulated O 0 0.003417868632823229
to O 0 0.0009437230182811618
be O 0 0.0008659916347824037
important O 0 0.0011240869062021375
in O 0 0.0013896464370191097
non B-Disease 0 0.0654204860329628
- I-Disease 1 0.9998201727867126
familial I-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
and I-Disease 1 0.9999901056289673
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9682536721229553

Epigenetic O 0 0.11550944298505783
loss O 0 0.39055660367012024
, O 0 0.005422947462648153
however O 0 0.003465814283117652
, O 0 0.002523509319871664
has O 0 0.0017793227452784777
not O 0 0.0010807294165715575
received O 0 0.0024960257578641176
general O 0 0.0035991522017866373
acceptance O 0 0.004509959369897842
due O 0 0.002541164169088006
to O 0 0.001537739997729659
controversy O 0 0.0032926020212471485
regarding O 0 0.002814454957842827
the O 0 0.0025564946699887514
subcellular O 0 0.009727547876536846
localization O 0 0.0076936595141887665
of O 0 0.0031374043319374323
BRCA1 O 1 0.7025930285453796
proteins O 0 0.0018030890496447682
, O 0 0.0012976673897355795
reports O 0 0.0016201107064262033
of O 0 0.001277749426662922
which O 0 0.0009562693885527551
have O 0 0.0006920184823684394
ranged O 0 0.002234393497928977
from O 0 0.0011451424797996879
exclusively O 0 0.0016369427321478724
nuclear O 0 0.0017837630584836006
, O 0 0.0011100342962890863
to O 0 0.00104242074303329
conditionally O 0 0.003835803596302867
nuclear O 0 0.001813246519304812
, O 0 0.0012210384011268616
to O 0 0.0014632500242441893
the O 0 0.005052458494901657
ER O 1 0.9999842643737793
/ O 1 0.8984012603759766
golgi O 1 0.5767466425895691
, O 0 0.003050158265978098
to O 0 0.002707087667658925
cytoplasmic O 0 0.009420382790267467
invaginations O 0 0.01742449961602688
into O 0 0.00480243843048811
the O 0 0.0079022366553545
nucleus O 0 0.023347115144133568
. O 0 0.0131322480738163

In O 0 0.005669125821441412
an O 0 0.003047969890758395
attempt O 0 0.004262974020093679
to O 0 0.0019387344364076853
resolve O 0 0.003966186195611954
this O 0 0.0013325015315786004
issue O 0 0.0016117063350975513
, O 0 0.0012745484709739685
we O 0 0.001078357920050621
have O 0 0.0011235885322093964
comprehensively O 0 0.007372986990958452
characterized O 0 0.007549987640231848
19 O 0 0.009840243496000767
anti O 1 0.9831395745277405
- O 1 0.9990668892860413
BRCA1 O 1 0.9996591806411743
antibodies O 0 0.0971040427684784
. O 0 0.01348897721618414

These O 0 0.007620604243129492
reagents O 0 0.016964899376034737
detect O 0 0.00894185807555914
a O 0 0.005453853402286768
220 O 0 0.013207175768911839
- O 0 0.06187748163938522
kD O 1 0.8083478808403015
protein O 0 0.00419441144913435
localized O 0 0.004296588245779276
in O 0 0.0015239814529195428
discrete O 0 0.0037257031071931124
nuclear O 0 0.003071331651881337
foci O 0 0.006582864094525576
in O 0 0.0016070663696154952
all O 0 0.001877065165899694
epithelial O 1 0.9922648668289185
cell O 0 0.009043739177286625
lines O 0 0.0026987663004547358
, O 0 0.0015699084615334868
including O 0 0.001376684638671577
those O 0 0.0017610688228160143
derived O 0 0.005529199261218309
from O 0 0.008201236836612225
breast B-Disease 1 0.9999884366989136
malignancies I-Disease 1 0.9998668432235718
. O 0 0.021403227001428604

Immunohistochemical O 1 0.9544237852096558
staining O 0 0.451762318611145
of O 0 0.017005503177642822
human O 1 0.5090886354446411
breast O 1 0.9999862909317017
specimens O 0 0.05724214389920235
also O 0 0.00480023305863142
revealed O 0 0.03195108845829964
BRCA1 O 1 0.7193940281867981
nuclear O 0 0.005078436806797981
foci O 0 0.02654119022190571
in O 0 0.004464071709662676
benign O 1 0.9999805688858032
breast O 1 0.9999994039535522
, O 1 0.8902713060379028
invasive B-Disease 1 0.9999982118606567
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
and O 1 0.9336163401603699
low B-Disease 1 0.9998431205749512
- I-Disease 1 0.9999833106994629
grade I-Disease 1 0.999992847442627
ductal I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 0.9999997615814209
. O 0 0.06428460031747818

Conversely O 0 0.03455263003706932
, O 0 0.00942967738956213
BRCA1 O 1 0.5218147039413452
expression O 0 0.006909410934895277
was O 0 0.010363244451582432
reduced O 0 0.004627134185284376
or O 0 0.0020960215479135513
undetectable O 0 0.05508176237344742
in O 0 0.0014439524384215474
the O 0 0.0013050321722403169
majority O 0 0.001386276911944151
of O 0 0.0018325650598853827
high O 0 0.4483147859573364
- O 1 0.9753130674362183
grade O 1 0.9970340728759766
, O 0 0.017206987366080284
ductal B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 0.9999978542327881
, O 0 0.002757192123681307
suggesting O 0 0.0028743601869791746
that O 0 0.0011001889361068606
absence O 0 0.004451252520084381
of O 0 0.01797151006758213
BRCA1 O 1 0.9998100399971008
may O 0 0.001951860380358994
contribute O 0 0.0017207418568432331
to O 0 0.0009034863323904574
the O 0 0.0016328215133398771
pathogenesis O 0 0.39708924293518066
of O 0 0.0018692894373089075
a O 0 0.0019433737033978105
significant O 0 0.0021502443123608828
percentage O 0 0.00296666007488966
of O 0 0.0034958673641085625
sporadic B-Disease 1 0.9986070990562439
breast I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999973773956299
. O 0 0.01016964204609394
. O 0 0.01215238869190216

